data_5o2m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5o2m _Structure_validation_residue.Date_analyzed 2017-09-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 112.392 0.515 . . . . 50.0 112.392 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.5 t30 55.0 39.61 31.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.09 0.774 . . . . 50.0 113.09 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 m -113.75 155.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.282 -2.488 . . . . 50.0 104.282 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.51 172.02 8.13 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 107.007 -1.479 . . . . 50.0 107.007 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.73 144.87 29.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.317 -0.401 . . . . 25.0 110.811 173.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -95.36 135.76 36.58 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.0 -0.741 . . . . 50.0 109.0 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 130.36 39.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.548 0.69 . . . . 25.0 109.367 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.53 -28.08 15.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.78 -0.645 . . . . 50.0 109.466 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -129.77 160.52 33.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.365 -1.346 . . . . 50.0 107.365 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.0 p-10 -101.76 159.88 14.95 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.581 0.752 . . . . 50.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.83 -177.99 5.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.013 0.435 . . . . 50.0 110.583 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.89 147.81 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.696 -3.816 . . . . 25.0 100.696 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.97 139.61 38.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -99.55 -13.3 19.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.245 0.545 . . . . 50.0 110.295 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -128.8 151.11 76.71 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.518 . . . . 50.0 109.865 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.01 -15.14 36.03 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 117.046 -1.502 . . . . 25.0 113.687 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.63 -7.72 59.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.701 0.763 . . . . 50.0 110.294 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -106.62 143.86 34.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.372 -1.344 . . . . 50.0 107.372 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 134.88 34.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.425 0.631 . . . . 50.0 111.89 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.0 p -93.09 122.6 35.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.906 -1.516 . . . . 50.0 106.906 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -141.21 164.76 29.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.379 -1.341 . . . . 25.0 107.379 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -132.3 154.51 49.63 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.842 -0.799 . . . . 50.0 108.842 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.501 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 64.0 pttt -56.37 137.32 52.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.375 0.607 . . . . 50.0 109.685 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.42 45.98 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.551 -0.749 . . . . 25.0 112.869 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -77.89 160.63 28.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.221 0.51 . . . . 50.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -130.44 132.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.032 -0.729 . . . . 50.0 109.032 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.6 ptp -131.59 151.12 51.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.454 . . . . 50.0 110.634 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -85.02 130.47 34.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.872 -0.418 . . . . 25.0 109.872 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.6 t -90.23 124.38 42.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.577 -1.268 . . . . 50.0 107.577 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.54 -43.15 8.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 50.0 110.862 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -156.42 171.79 19.64 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.364 -1.347 . . . . 50.0 107.364 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -127.38 154.73 44.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.754 -0.461 . . . . 50.0 109.754 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 58.81 39.01 24.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 50.0 108.9 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -65.54 -20.47 66.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.982 -1.917 . . . . 25.0 114.96 -168.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -114.76 13.05 17.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.661 -0.649 . . . . 50.0 110.265 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 -3.59 81.73 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.582 -1.007 . . . . 25.0 110.582 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.42 118.61 30.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.052 -0.721 . . . . 50.0 109.052 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -60.34 130.33 46.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.584 -0.735 . . . . 50.0 109.269 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.75 -1.71 83.81 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 114.982 0.753 . . . . 25.0 114.982 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -101.05 121.66 42.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.677 1.239 . . . . 50.0 108.762 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -111.07 146.49 36.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 50.0 109.493 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.8 tp -85.13 111.84 20.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.034 -2.21 . . . . 50.0 105.034 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.31 164.9 12.69 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.79 -0.819 . . . . 25.0 108.79 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -127.65 130.55 49.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.163 -0.68 . . . . 50.0 109.163 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -159.29 142.79 14.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.875 -0.787 . . . . 50.0 108.875 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 53.61 38.94 29.41 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.097 1.147 . . . . 25.0 114.097 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 2.93 89.56 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 115.289 0.876 . . . . 25.0 115.289 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -125.9 165.46 18.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.835 -0.802 . . . . 50.0 108.835 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -127.2 148.2 50.2 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 104.113 -2.551 . . . . 50.0 104.113 167.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.58 172.57 45.04 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 110.043 -1.223 . . . . 50.0 110.043 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 pt -75.27 141.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 50.0 110.308 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.0 t -140.67 133.9 14.79 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 108.877 -0.786 . . . . 25.0 108.877 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 112.97 3.45 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 117.339 -1.307 . . . . 50.0 111.751 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.75 -19.11 69.05 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.997 -0.547 . . . . 50.0 112.949 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.18 -5.86 7.91 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.351 0.5 . . . . 50.0 112.351 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -116.64 11.27 14.63 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.914 -0.491 . . . . 50.0 110.642 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.3 mt -122.33 155.2 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.035 0.445 . . . . 50.0 111.332 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -121.55 118.06 28.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.253 -0.647 . . . . 50.0 109.253 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.677 0.275 . . . . 50.0 110.537 179.554 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 115.058 1.503 . . . . 50.0 115.058 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 t30 50.15 42.44 25.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.197 0.814 . . . . 50.0 113.197 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.74 157.74 32.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 N-CA-C 105.887 -1.894 . . . . 50.0 105.887 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 161.66 36.48 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.325 0.583 . . . . 50.0 110.941 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.34 163.27 33.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.196 -0.911 . . . . 25.0 110.869 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -111.27 133.35 53.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.997 -1.112 . . . . 50.0 107.997 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.67 133.54 43.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.313 0.578 . . . . 25.0 109.585 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.46 -25.81 17.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.669 -0.696 . . . . 50.0 109.814 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -129.9 160.66 32.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.281 -1.007 . . . . 50.0 108.281 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.49 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.6 p-10 -98.15 158.54 15.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.325 -0.62 . . . . 50.0 109.325 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -156.42 135.84 12.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.909 -0.587 . . . . 50.0 112.168 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.32 127.03 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 127.14 30.41 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.143 -0.317 . . . . 25.0 110.143 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -100.08 -8.59 23.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.961 0.886 . . . . 50.0 108.615 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.1 m -128.4 152.33 78.01 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.783 -1.099 . . . . 50.0 108.655 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.24 -25.62 21.87 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 117.043 -1.504 . . . . 25.0 114.374 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -83.98 -9.92 58.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.195 0.521 . . . . 50.0 110.77 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -87.11 148.5 25.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.497 -0.557 . . . . 50.0 109.497 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.64 134.73 38.2 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.072 -0.392 . . . . 50.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 m -85.04 124.9 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.814 -1.55 . . . . 50.0 106.814 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -145.57 167.93 21.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.341 -0.985 . . . . 25.0 108.341 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -128.99 154.45 46.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 121.972 -0.455 . . . . 50.0 111.509 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.49 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.8 pttp -57.75 131.27 49.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.767 -0.827 . . . . 50.0 108.767 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.89 46.42 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-O 119.351 -0.694 . . . . 25.0 113.973 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -73.19 161.72 30.23 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.345 0.573 . . . . 50.0 111.035 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -121.84 130.15 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.22 -0.659 . . . . 50.0 109.22 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.39 147.81 47.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.551 . . . . 50.0 111.439 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -82.59 132.79 35.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.0 t -94.12 121.37 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.111 -1.811 . . . . 50.0 106.111 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.45 -46.73 9.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.654 -0.703 . . . . 50.0 110.191 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -154.7 163.05 40.82 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.554 -0.906 . . . . 50.0 108.554 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.6 154.09 37.22 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.989 0.516 . . . . 50.0 110.024 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.4 t0 54.66 45.85 25.94 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 123.454 1.597 . . . . 50.0 108.719 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.55 -6.34 35.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.776 -1.556 . . . . 25.0 114.347 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -136.57 6.15 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.294 1.22 . . . . 50.0 114.294 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.14 22.82 64.72 Favored Glycine 0 CA--C 1.517 0.209 0 N-CA-C 108.578 -1.809 . . . . 25.0 108.578 -174.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt -122.72 110.01 14.95 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 104.619 -2.363 . . . . 50.0 104.619 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -65.1 144.15 57.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.954 0.883 . . . . 50.0 109.053 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.34 -16.49 43.9 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-O 118.456 -1.191 . . . . 25.0 114.033 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -88.65 132.28 34.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.596 1.698 . . . . 50.0 109.998 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -120.19 144.22 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.675 -0.861 . . . . 50.0 108.675 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.63 118.6 25.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.933 -1.877 . . . . 50.0 105.933 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.1 m -120.46 164.43 16.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.292 -0.262 . . . . 25.0 110.292 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.6 t -125.62 130.48 51.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.364 -0.606 . . . . 50.0 109.364 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.7 tp -161.61 146.63 13.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.493 -0.928 . . . . 50.0 108.493 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 58.18 32.73 22.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.281 0.845 . . . . 25.0 113.281 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 6.56 88.79 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.877 -0.677 . . . . 25.0 114.735 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -133.31 162.9 30.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 117.839 0.82 . . . . 50.0 109.863 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -105.36 158.28 16.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 104.265 -2.494 . . . . 50.0 104.265 172.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.01 161.1 29.47 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.852 -0.689 . . . . 50.0 111.557 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -78.58 141.82 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.865 -0.791 . . . . 50.0 108.865 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.9 t -140.1 133.89 15.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.38 117.04 4.89 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 114.93 -2.913 . . . . 50.0 110.758 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -19.52 70.0 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 116.068 -0.514 . . . . 50.0 113.607 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -72.8 -3.23 24.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.264 -0.55 . . . . 50.0 111.767 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -108.71 8.95 27.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.09 -0.708 . . . . 50.0 109.09 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.18 155.3 34.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.073 -0.714 . . . . 50.0 109.073 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -126.12 120.75 30.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.801 -0.814 . . . . 50.0 108.801 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 mm . . . . . 0 C--O 1.242 0.663 0 N-CA-C 108.298 -1.001 . . . . 50.0 108.298 179.009 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 114.24 1.2 . . . . 50.0 114.24 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t30 53.84 31.86 13.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.456 0.91 . . . . 50.0 113.456 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -119.53 156.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 105.867 -1.901 . . . . 50.0 105.867 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.29 158.82 43.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.816 -0.438 . . . . 50.0 109.816 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.21 151.18 44.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 25.0 110.983 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -97.24 134.29 40.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.771 -0.825 . . . . 50.0 108.771 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.82 130.52 40.09 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.717 -0.475 . . . . 25.0 109.717 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.2 mt -92.07 -28.1 17.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 50.0 109.593 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -129.28 162.21 28.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.334 -1.358 . . . . 50.0 107.334 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.3 p-10 -98.72 163.01 12.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.791 0.329 . . . . 50.0 110.699 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -150.42 153.39 35.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 50.0 110.784 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.09 118.12 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.614 -2.365 . . . . 25.0 104.614 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.57 30.41 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.217 0.323 . . . . 25.0 110.511 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.7 -22.05 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 50.0 110.559 174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.9 m -97.79 151.02 37.37 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.243 -0.28 . . . . 50.0 110.243 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.82 -17.99 25.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 117.697 -1.069 . . . . 25.0 113.297 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -85.53 -7.58 58.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.09 -0.505 . . . . 50.0 110.436 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -103.39 146.47 28.45 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.64 0.776 . . . . 50.0 110.007 -176.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -100.26 135.65 41.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.608 0.595 . . . . 50.0 112.608 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -84.95 139.85 31.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.387 -2.079 . . . . 50.0 105.387 168.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -159.11 163.7 35.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.593 -2.003 . . . . 25.0 105.593 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -129.77 154.81 46.85 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 120.222 -0.591 . . . . 50.0 111.855 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.0 pttp -55.73 130.34 42.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.413 -0.812 . . . . 50.0 109.621 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.52 22.74 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.397 -0.819 . . . . 25.0 113.082 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -73.37 162.15 29.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 122.731 0.413 . . . . 50.0 111.745 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -121.47 130.97 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.545 0.738 . . . . 50.0 109.34 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -135.44 145.79 47.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.787 0.327 . . . . 50.0 110.344 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -84.77 131.26 34.57 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.124 -1.065 . . . . 25.0 108.124 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -90.05 124.68 42.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.331 -1.359 . . . . 50.0 107.331 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.6 mt -91.75 -49.18 6.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 50.0 110.156 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -153.58 171.92 18.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.529 -1.285 . . . . 50.0 107.529 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -126.88 157.18 40.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 110.203 -0.295 . . . . 50.0 110.203 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 60.17 32.58 20.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 123.129 1.442 . . . . 50.0 109.467 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.57 -20.52 62.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.356 -1.747 . . . . 25.0 114.544 -170.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -100.99 3.09 41.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.367 0.603 . . . . 50.0 109.713 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.66 79.76 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 109.489 -1.444 . . . . 25.0 109.489 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.33 124.35 39.32 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.33 -1.359 . . . . 50.0 107.33 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.02 133.86 55.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.24 -0.652 . . . . 50.0 109.24 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 1.03 88.94 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 115.352 0.901 . . . . 25.0 115.352 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -99.04 124.13 43.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.173 1.486 . . . . 50.0 108.635 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -113.89 143.84 44.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.03 -0.419 . . . . 50.0 110.329 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.6 tp -82.87 118.07 23.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.417 -2.068 . . . . 50.0 105.417 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.63 163.84 16.76 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.255 -0.646 . . . . 25.0 109.255 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -122.91 137.81 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.118 0.485 . . . . 50.0 110.765 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 tp -159.46 143.4 14.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.94 -1.504 . . . . 50.0 106.94 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 58.99 22.25 10.21 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.606 0.965 . . . . 25.0 113.606 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.8 89.44 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.996 -0.621 . . . . 25.0 112.509 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -112.09 167.28 10.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.168 -1.79 . . . . 50.0 106.168 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.58 150.88 50.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.858 -1.534 . . . . 50.0 106.858 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.65 167.06 39.87 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 109.525 -1.43 . . . . 50.0 109.525 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.87 144.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.811 0.815 . . . . 50.0 111.131 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 64.4 t -140.2 134.18 15.44 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.66 117.99 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 114.621 -3.12 . . . . 50.0 110.696 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.0 -21.61 69.83 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 116.143 -0.48 . . . . 50.0 113.491 -174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -67.67 -14.5 63.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.533 -0.392 . . . . 50.0 111.696 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -94.63 6.72 48.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.037 -0.414 . . . . 50.0 111.123 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.82 154.33 34.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 50.0 111.751 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -123.97 117.72 25.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 50.0 108.969 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 50.0 111.177 -177.461 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 109.361 -0.607 . . . . 50.0 109.361 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 t30 51.36 40.25 26.06 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.484 1.291 . . . . 50.0 114.484 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.34 166.16 11.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 N-CA-C 105.03 -2.211 . . . . 50.0 105.03 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.62 157.52 43.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.536 0.684 . . . . 50.0 111.495 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.58 152.3 43.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.008 -0.996 . . . . 25.0 110.46 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.45 137.43 35.54 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.73 -0.841 . . . . 50.0 108.73 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 131.99 42.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.1 mt -86.59 -25.8 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 50.0 109.632 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.48 161.21 35.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 50.0 109.081 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.567 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.6 p-10 -99.91 155.79 17.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.429 -0.952 . . . . 50.0 108.429 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.13 172.96 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.674 0.749 . . . . 50.0 112.729 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.71 135.93 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 1 N-CA-C 100.141 -4.022 . . . . 25.0 100.141 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.38 47.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.396 -0.965 . . . . 25.0 108.396 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.63 -25.07 8.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.585 0.553 . . . . 50.0 112.055 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -93.88 148.36 35.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.339 -0.225 . . . . 50.0 110.876 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.3 -15.7 38.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 116.762 -1.692 . . . . 25.0 112.614 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -83.73 -15.56 48.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.862 0.363 . . . . 50.0 110.103 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -95.34 135.06 37.42 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.946 0.498 . . . . 50.0 111.532 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 136.53 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.508 -0.477 . . . . 50.0 110.954 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -91.23 118.47 30.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.62 -1.252 . . . . 50.0 107.62 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -136.13 166.33 23.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.316 0.579 . . . . 25.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -125.2 152.27 44.74 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.771 -0.455 . . . . 50.0 109.771 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.9 pttt -56.61 132.62 52.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.746 . . . . 50.0 108.987 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -13.04 66.98 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 119.247 -0.751 . . . . 25.0 114.265 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -76.28 158.04 31.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 117.936 0.868 . . . . 50.0 110.126 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mm -116.66 125.1 73.46 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 123.061 0.544 . . . . 50.0 109.868 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -131.42 147.25 52.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 50.0 111.376 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -89.0 127.12 35.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.084 -0.71 . . . . 25.0 109.084 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.3 t -86.73 123.13 39.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.335 -1.357 . . . . 50.0 107.335 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.77 -40.9 8.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 50.0 110.81 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.83 158.59 44.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.33 -0.618 . . . . 50.0 109.33 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -129.6 148.61 51.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.733 -0.84 . . . . 50.0 108.733 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.3 t0 55.38 43.6 28.59 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.361 1.553 . . . . 50.0 107.1 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -70.63 -6.34 36.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.568 -1.651 . . . . 25.0 114.352 -170.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.08 6.76 3.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.718 0.636 . . . . 50.0 112.718 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.86 9.65 85.13 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 109.496 -1.441 . . . . 25.0 109.496 -174.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -109.43 110.04 21.06 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 105.509 -2.034 . . . . 50.0 105.509 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.36 145.86 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.083 0.944 . . . . 50.0 108.701 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.4 48.12 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-O 118.624 -1.098 . . . . 25.0 113.749 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -93.5 129.7 39.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 119.367 1.583 . . . . 50.0 110.007 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -119.07 143.72 46.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.767 -0.827 . . . . 50.0 108.767 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.33 116.4 22.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 105.614 -1.995 . . . . 50.0 105.614 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -118.18 164.24 15.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.9 p -129.72 132.98 46.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.98 -0.748 . . . . 50.0 108.98 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.1 tp -159.31 141.56 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 50.0 109.252 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 57.35 31.18 19.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.282 1.216 . . . . 25.0 114.282 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.26 85.98 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 115.239 0.856 . . . . 25.0 115.239 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -135.01 162.81 31.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.726 -0.842 . . . . 50.0 108.726 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -117.75 160.23 21.69 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.25 167.55 39.64 Favored Glycine 0 C--O 1.238 0.374 0 N-CA-C 110.316 -1.114 . . . . 50.0 110.316 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -78.25 142.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.371 0.605 . . . . 50.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -141.68 134.63 14.16 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.994 -1.113 . . . . 25.0 107.994 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.58 119.72 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 114.672 -3.086 . . . . 50.0 111.182 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.68 -18.4 65.98 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.088 -0.506 . . . . 50.0 114.155 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.1 -29.98 70.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.424 -0.457 . . . . 50.0 110.282 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.53 10.28 26.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.377 -0.374 . . . . 50.0 111.983 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.8 mt -117.68 152.59 34.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.326 0.584 . . . . 50.0 111.078 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -124.72 117.99 25.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.121 -0.696 . . . . 50.0 109.121 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.4 mm . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 109.453 -0.573 . . . . 50.0 109.453 -179.824 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 110.927 -0.027 . . . . 50.0 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.1 t30 46.9 46.05 15.43 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.071 1.137 . . . . 50.0 114.071 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -125.29 149.04 29.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.549 -1.649 . . . . 50.0 106.549 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 155.33 30.75 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.248 0.547 . . . . 50.0 110.511 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 154.73 49.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.04 -0.982 . . . . 25.0 108.703 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -105.67 135.45 47.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.631 -1.248 . . . . 50.0 107.631 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.03 131.39 42.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.191 0.52 . . . . 25.0 109.74 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.68 -26.9 18.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.573 0.702 . . . . 50.0 109.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -130.58 158.72 39.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.508 -1.293 . . . . 50.0 107.508 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.6 p-10 -97.42 160.05 14.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.242 -0.651 . . . . 50.0 109.242 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.38 171.88 13.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 50.0 110.563 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.2 124.59 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 101.029 -3.693 . . . . 25.0 101.029 172.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.51 140.17 29.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -119.12 -29.37 5.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.658 0.599 . . . . 50.0 111.553 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -89.21 148.98 42.03 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.764 -0.828 . . . . 50.0 108.764 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.77 -18.22 32.41 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 116.746 -1.703 . . . . 25.0 112.797 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.84 -13.8 59.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 50.0 110.744 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -96.08 142.51 28.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.199 0.523 . . . . 50.0 110.94 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.47 137.7 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.867 -0.333 . . . . 50.0 110.605 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -93.23 124.5 37.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.268 -1.382 . . . . 50.0 107.268 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.88 168.25 24.3 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.361 -1.348 . . . . 25.0 107.361 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -133.02 159.32 40.38 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.964 -0.46 . . . . 50.0 110.229 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.484 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 27.0 pttt -56.57 136.35 54.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.584 0.707 . . . . 50.0 110.078 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.63 -24.04 31.28 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.08 -0.964 . . . . 25.0 113.303 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.61 159.39 34.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 117.141 0.47 . . . . 50.0 110.219 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.9 127.95 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.193 0.597 . . . . 50.0 110.101 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.63 148.52 50.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.366 0.603 . . . . 50.0 110.094 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -87.45 126.83 35.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.52 127.18 41.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 106.632 -1.618 . . . . 50.0 106.632 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -108.42 -33.36 7.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.82 -0.627 . . . . 50.0 112.52 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -151.68 163.76 38.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.383 -1.34 . . . . 50.0 107.383 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -126.08 152.29 46.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.582 0.628 . . . . 50.0 110.823 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 55.25 38.77 30.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.745 1.259 . . . . 50.0 109.382 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.54 -12.68 61.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 -165.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -116.07 6.67 14.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.287 0.565 . . . . 50.0 109.617 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.12 -5.93 69.57 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.731 -0.948 . . . . 25.0 110.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.09 124.84 30.2 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.539 -1.652 . . . . 50.0 106.539 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.47 132.25 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.635 0.731 . . . . 50.0 110.964 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.36 -0.12 85.37 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 115.38 0.912 . . . . 25.0 115.38 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -95.39 108.59 20.8 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.767 1.784 . . . . 50.0 110.21 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -97.8 144.28 27.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.158 -0.473 . . . . 50.0 110.977 -172.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.8 111.76 19.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.582 -2.007 . . . . 50.0 105.582 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.1 m -114.85 163.33 15.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.479 -0.934 . . . . 25.0 108.479 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -125.1 132.22 53.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.457 -0.572 . . . . 50.0 109.457 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.99 140.17 13.0 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.226 -1.027 . . . . 50.0 108.226 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 57.74 27.6 14.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.823 0.82 . . . . 25.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.94 -0.63 86.72 Favored Glycine 0 N--CA 1.458 0.152 0 N-CA-C 114.445 0.538 . . . . 25.0 114.445 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -107.08 153.98 21.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -116.22 140.02 49.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 103.507 -2.775 . . . . 50.0 103.507 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.43 168.07 40.7 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.959 -0.639 . . . . 50.0 112.126 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -76.48 141.22 16.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.771 0.796 . . . . 50.0 110.005 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.21 132.99 13.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.2 114.47 3.78 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 116.564 -1.824 . . . . 50.0 111.548 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.4 -22.35 65.46 Favored Glycine 0 C--O 1.219 -0.838 0 N-CA-C 114.667 0.627 . . . . 50.0 114.667 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.67 -23.42 67.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.739 0.78 . . . . 50.0 111.21 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.92 6.41 46.33 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 121.513 -0.742 . . . . 50.0 111.377 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -118.47 152.72 35.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.2 0.524 . . . . 50.0 111.183 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -123.28 117.46 25.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.738 -0.467 . . . . 50.0 109.738 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.2 mm . . . . . 0 C--O 1.238 0.451 0 N-CA-C 108.838 -0.801 . . . . 50.0 108.838 -179.781 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 110.102 -0.333 . . . . 50.0 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.1 t30 50.86 46.12 26.54 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.069 0.856 . . . . 50.0 113.089 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.8 m -111.46 169.99 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 103.717 -2.697 . . . . 50.0 103.717 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.97 159.81 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.181 0.901 . . . . 50.0 111.178 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.03 40.27 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.063 -0.971 . . . . 25.0 111.404 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -97.39 131.62 43.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.306 -1.368 . . . . 50.0 107.306 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.16 138.62 43.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.649 0.738 . . . . 25.0 109.544 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -96.38 -21.4 17.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 50.0 110.41 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -128.33 160.17 33.02 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.435 -1.32 . . . . 50.0 107.435 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.7 p-10 -100.5 153.03 19.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.945 -0.761 . . . . 50.0 108.945 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -156.37 151.6 26.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.568 -0.742 . . . . 50.0 110.937 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -116.13 150.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.62 110.51 16.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -93.89 -8.84 39.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.52 -1.289 . . . . 50.0 107.52 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 t -134.8 149.02 69.52 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.734 -1.58 . . . . 50.0 106.734 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.76 -18.9 41.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 116.687 -1.742 . . . . 25.0 113.666 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.57 -15.7 58.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.194 0.521 . . . . 50.0 110.817 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -92.39 143.21 26.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.041 0.536 . . . . 50.0 110.703 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.08 133.83 35.85 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.706 -0.798 . . . . 50.0 111.098 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.2 p -82.29 137.59 34.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 50.0 106.974 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -156.49 165.77 35.36 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -124.78 155.13 39.86 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.574 -0.703 . . . . 50.0 110.932 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.3 pttp -59.1 128.05 35.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.21 -1.033 . . . . 50.0 108.21 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.91 -12.19 68.8 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.703 -0.68 . . . . 25.0 113.903 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -79.37 158.02 27.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.039 -0.726 . . . . 50.0 109.039 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -120.66 127.63 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.957 -0.386 . . . . 50.0 109.957 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.69 152.27 51.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 50.0 111.873 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 m -86.84 133.86 33.6 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.5 t -98.72 121.42 49.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.737 -1.579 . . . . 50.0 106.737 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -93.64 -42.31 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.682 -0.69 . . . . 50.0 110.988 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.11 164.61 30.71 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.962 -1.125 . . . . 50.0 107.962 -173.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -132.01 150.04 52.26 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.466 -1.679 . . . . 50.0 106.466 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 58.28 39.91 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.81 1.319 . . . . 50.0 108.675 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -70.46 -14.22 62.45 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.808 -1.542 . . . . 25.0 114.35 -169.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -116.39 11.13 14.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.996 -0.547 . . . . 50.0 109.704 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.43 -6.8 63.11 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.806 -0.918 . . . . 25.0 110.806 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -86.0 118.13 25.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.429 -0.952 . . . . 50.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.5 128.78 38.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.793 -0.818 . . . . 50.0 108.793 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.12 78.55 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 115.779 1.071 . . . . 25.0 115.779 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -104.13 112.83 26.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.541 1.671 . . . . 50.0 110.046 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -107.82 142.73 37.42 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.228 -0.295 . . . . 50.0 111.643 -170.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.95 116.09 22.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.43 -1.322 . . . . 50.0 107.43 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.5 m -117.97 169.53 9.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.727 -0.215 . . . . 25.0 110.443 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -133.11 129.1 37.5 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.66 -0.496 . . . . 50.0 109.66 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.2 tp -161.04 155.47 23.22 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.747 -1.575 . . . . 50.0 106.747 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.4 t60 60.03 23.55 12.72 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.801 0.667 . . . . 25.0 112.801 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.08 11.56 85.25 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 25.0 114.051 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -142.28 162.84 34.44 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.0 -0.37 . . . . 50.0 110.0 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -110.72 155.85 21.89 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.224 -1.028 . . . . 50.0 108.224 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.45 165.97 37.15 Favored Glycine 0 C--O 1.24 0.523 0 N-CA-C 110.179 -1.168 . . . . 50.0 110.179 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -79.25 147.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 50.0 109.851 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.5 t -142.46 131.81 12.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 25.0 107.289 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 121.84 8.69 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 114.882 -2.945 . . . . 50.0 111.326 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -22.8 61.74 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 115.954 -0.566 . . . . 50.0 113.686 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -65.67 -13.01 58.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.091 -0.652 . . . . 50.0 112.418 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -103.18 7.98 38.57 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 50.0 110.747 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -118.64 152.82 35.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.612 0.72 . . . . 50.0 111.044 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -126.87 117.72 23.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.646 -1.242 . . . . 50.0 107.646 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 108.705 -0.85 . . . . 50.0 108.705 -179.872 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 109.369 -0.604 . . . . 50.0 109.369 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 t30 46.91 46.91 15.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.988 1.107 . . . . 50.0 113.988 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.93 125.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.671 -1.233 . . . . 50.0 107.671 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -82.01 154.4 25.7 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.81 0.814 . . . . 75.0 108.975 -175.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.62 161.63 35.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.498 -1.228 . . . . 25.0 108.231 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -113.11 133.87 54.81 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.112 -1.07 . . . . 50.0 108.112 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.76 123.44 24.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.433 0.635 . . . . 25.0 109.797 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -82.46 -29.96 30.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.783 -0.644 . . . . 50.0 109.989 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -132.4 164.06 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 50.0 107.38 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.583 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.3 p-10 -99.22 166.62 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.487 -0.19 . . . . 50.0 110.487 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -148.15 160.53 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 50.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.54 118.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 102.855 -3.017 . . . . 25.0 102.855 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 144.27 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.9 -0.407 . . . . 25.0 109.9 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -33.89 3.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 50.0 110.002 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 t -81.03 146.75 59.69 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.969 -1.122 . . . . 50.0 107.969 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.88 -13.76 29.32 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 117.493 -1.205 . . . . 25.0 114.058 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -86.79 -15.65 38.65 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.875 0.845 . . . . 50.0 109.762 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -85.24 137.31 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 50.0 111.253 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.56 134.69 34.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.33 0.586 . . . . 50.0 111.105 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -84.29 114.05 21.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.894 -1.15 . . . . 50.0 107.894 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -140.14 161.06 38.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -131.08 164.11 26.16 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.936 0.398 . . . . 50.0 111.887 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.583 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 49.5 pttt -60.23 137.68 58.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.179 0.514 . . . . 50.0 110.712 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.96 -23.82 31.36 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.236 -0.893 . . . . 25.0 112.679 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -70.47 157.67 37.43 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 122.572 0.349 . . . . 50.0 111.407 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.13 127.47 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.308 0.643 . . . . 50.0 110.017 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.46 146.91 46.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.308 -0.256 . . . . 50.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 37.4 m -90.1 122.94 33.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 25.0 110.081 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -82.95 121.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 107.297 -1.371 . . . . 50.0 107.297 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -90.16 -45.91 8.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.751 -0.659 . . . . 50.0 110.067 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -153.5 171.89 18.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 50.0 109.388 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -130.19 155.53 46.1 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.884 -1.895 . . . . 50.0 105.884 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.3 t0 60.57 41.12 15.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 123.19 1.471 . . . . 50.0 108.905 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -70.72 -18.53 62.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.806 -1.543 . . . . 25.0 114.181 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -120.27 8.88 10.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.182 0.438 . . . . 50.0 112.182 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.79 7.88 85.2 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 109.642 -1.383 . . . . 25.0 109.642 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.9 mt -113.54 110.03 19.6 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.066 -1.457 . . . . 50.0 107.066 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -66.77 147.83 52.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.264 -1.384 . . . . 50.0 107.264 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.6 -22.27 40.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.457 -0.792 . . . . 25.0 112.466 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -93.18 132.01 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.208 1.004 . . . . 50.0 108.95 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -119.4 139.7 51.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.596 -0.89 . . . . 50.0 108.596 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.08 121.86 28.0 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.257 -1.757 . . . . 50.0 106.257 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.8 m -123.04 156.31 35.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.944 -0.391 . . . . 25.0 109.944 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.0 p -117.18 131.15 56.93 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.708 -1.219 . . . . 50.0 107.708 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.83 131.78 13.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.419 -0.81 . . . . 50.0 108.856 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 52.91 37.41 24.27 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.659 0.985 . . . . 25.0 113.659 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.36 3.45 85.94 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.096 -0.573 . . . . 25.0 114.476 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -118.08 167.2 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.495 -1.668 . . . . 50.0 106.495 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -134.03 157.37 46.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.024 -1.473 . . . . 50.0 107.024 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.1 171.49 43.95 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 109.315 -1.514 . . . . 50.0 109.315 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.85 144.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.703 0.763 . . . . 50.0 110.507 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.0 t -138.62 134.82 17.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 119.48 6.34 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 115.1 -2.8 . . . . 50.0 110.812 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.31 62.48 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 115.009 0.764 . . . . 50.0 115.009 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.99 -28.58 67.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 50.0 111.281 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -89.39 8.98 27.96 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.718 0.636 . . . . 50.0 112.718 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.23 151.51 39.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.249 0.547 . . . . 50.0 112.394 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -122.93 117.67 26.08 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.75 -0.833 . . . . 50.0 108.75 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 C--N 1.324 -0.512 0 N-CA-C 108.015 -1.106 . . . . 50.0 108.015 175.852 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--O 1.226 -0.178 0 N-CA-C 109.852 -0.425 . . . . 50.0 109.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.0 t30 51.23 38.85 22.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.283 -0.871 . . . . 50.0 112.485 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.19 170.5 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 104.327 -2.472 . . . . 50.0 104.327 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.85 153.46 51.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 118.879 0.763 . . . . 50.0 110.54 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.67 149.47 50.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.998 -1.001 . . . . 25.0 110.93 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -95.34 131.39 41.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.529 -1.285 . . . . 50.0 107.529 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.41 136.63 42.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.43 -20.59 18.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.441 -0.799 . . . . 50.0 109.64 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -134.03 159.66 40.1 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.636 -0.876 . . . . 50.0 108.636 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.6 p-10 -100.36 156.66 17.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.013 0.525 . . . . 50.0 109.663 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -155.34 161.13 41.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.738 -0.665 . . . . 50.0 110.577 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 p -122.72 147.76 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.97 114.91 22.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.778 -0.823 . . . . 25.0 108.778 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -93.2 -8.49 42.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.231 -1.025 . . . . 50.0 108.231 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -129.85 148.14 68.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.939 -1.134 . . . . 50.0 107.939 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.53 -12.45 31.46 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 117.211 -1.393 . . . . 25.0 113.248 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -85.89 -14.19 45.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.932 0.872 . . . . 50.0 110.013 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -94.41 147.84 22.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 50.0 109.931 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.08 137.79 34.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.149 0.5 . . . . 50.0 111.233 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -87.37 116.7 25.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.691 -1.226 . . . . 50.0 107.691 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -135.07 162.56 32.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 80.0 mtm-85 -131.38 154.01 49.07 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.958 -0.463 . . . . 50.0 111.009 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.463 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.1 pttp -58.89 131.89 52.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 50.0 109.938 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.92 -19.52 53.57 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.426 -0.806 . . . . 25.0 113.374 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -75.35 159.11 31.81 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.275 0.537 . . . . 50.0 110.312 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.5 mm -119.38 127.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.123 -0.695 . . . . 50.0 109.123 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptp -133.83 149.35 51.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.0 0.429 . . . . 50.0 111.767 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.7 m -79.9 136.31 36.63 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.301 -1.0 . . . . 25.0 108.301 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -104.38 120.8 55.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.477 -1.675 . . . . 50.0 106.477 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.79 -45.64 10.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 50.0 111.322 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.27 171.84 18.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.459 -1.312 . . . . 50.0 107.459 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.66 154.75 44.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 110.302 -0.259 . . . . 50.0 110.302 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 57.57 35.53 25.85 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 125.032 1.458 . . . . 50.0 109.472 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -70.48 -20.48 62.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.676 -1.602 . . . . 25.0 113.513 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -99.4 0.98 43.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.376 0.608 . . . . 50.0 110.193 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 -6.02 67.48 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 109.787 -1.325 . . . . 25.0 109.787 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.7 mt -88.25 126.81 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.827 -1.546 . . . . 50.0 106.827 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -61.02 131.15 49.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.375 0.607 . . . . 50.0 109.899 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.69 0.66 90.24 Favored Glycine 0 C--O 1.219 -0.788 0 CA-C-O 118.428 -1.207 . . . . 25.0 116.055 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -97.43 110.76 23.25 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.125 1.962 . . . . 50.0 110.93 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.78 144.85 30.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 50.0 111.058 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.95 118.0 23.17 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.014 -1.476 . . . . 50.0 107.014 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.3 m -119.86 167.76 11.79 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.479 -0.563 . . . . 25.0 109.479 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -134.0 130.86 38.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.851 0.358 . . . . 50.0 110.238 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 tp -160.75 152.34 19.5 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 106.976 -1.49 . . . . 50.0 106.976 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.2 m80 58.69 24.16 11.86 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.76 82.4 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.665 -0.779 . . . . 25.0 112.295 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -125.13 167.13 15.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.629 -1.619 . . . . 50.0 106.629 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.78 150.55 50.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 105.123 -2.176 . . . . 50.0 105.123 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.1 171.08 43.93 Favored Glycine 0 C--O 1.241 0.532 0 N-CA-C 110.682 -0.967 . . . . 50.0 110.682 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -78.41 143.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 50.0 111.157 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.0 t -141.44 134.23 14.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.81 118.69 5.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 114.987 -2.875 . . . . 50.0 111.472 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.55 -21.24 66.68 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 114.772 0.669 . . . . 50.0 114.772 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -64.42 -21.81 66.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.571 . . . . 50.0 110.83 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -91.91 9.86 31.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.992 -0.443 . . . . 50.0 111.152 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.1 mt -125.36 155.04 40.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.78 0.432 . . . . 50.0 110.404 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -129.19 117.68 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.632 -0.507 . . . . 50.0 109.632 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 mm . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 109.247 -0.649 . . . . 50.0 109.247 -178.387 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.8 mt . . . . . 0 C--O 1.217 -0.647 0 N-CA-C 115.14 1.534 . . . . 50.0 115.14 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.9 t30 49.52 41.99 22.06 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.316 1.228 . . . . 50.0 114.316 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.82 166.38 5.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 105.186 -2.153 . . . . 50.0 105.186 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 155.98 45.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.147 0.499 . . . . 50.0 110.108 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.45 144.69 33.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.75 -0.659 . . . . 25.0 112.107 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -90.84 135.45 33.72 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.767 -0.827 . . . . 50.0 108.767 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.56 121.27 22.16 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.89 0.744 . . . . 25.0 109.118 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.98 -26.43 27.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.147 -0.479 . . . . 50.0 110.324 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.29 163.87 26.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.244 -1.391 . . . . 50.0 107.244 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.21 157.66 15.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.975 -0.75 . . . . 50.0 108.975 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -147.17 131.14 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.936 0.495 . . . . 50.0 110.492 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -100.87 121.97 52.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 101.616 -3.475 . . . . 25.0 101.616 168.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 143.09 48.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.977 -0.749 . . . . 25.0 108.977 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -110.92 -26.29 9.38 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 123.479 0.487 . . . . 50.0 110.058 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.6 t -97.02 146.26 31.0 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 108.366 -0.976 . . . . 50.0 108.366 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.55 -14.95 27.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 116.763 -1.691 . . . . 25.0 113.153 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.47 -15.54 57.6 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 122.969 0.508 . . . . 50.0 110.58 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -93.73 143.46 26.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.318 0.647 . . . . 50.0 111.864 -171.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.15 133.13 35.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 50.0 110.729 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 84.0 6.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.849 0.833 . . . . 50.0 108.947 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.405 ' CE1' HG11 ' A' ' 57' ' ' VAL . 36.3 p90 -93.88 162.99 13.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.636 -0.875 . . . . 25.0 108.636 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -126.26 155.96 41.07 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.252 0.549 . . . . 50.0 110.795 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -57.95 132.85 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 50.0 109.922 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.05 -21.44 46.01 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-O 119.014 -0.881 . . . . 25.0 114.245 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -74.93 160.59 30.42 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.194 -0.669 . . . . 50.0 109.194 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.61 133.51 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.284 -1.006 . . . . 50.0 108.284 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.67 148.68 52.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 50.0 110.889 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -81.0 127.26 32.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -91.15 122.17 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.888 -1.523 . . . . 50.0 106.888 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 mt -96.93 -41.09 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.123 -0.944 . . . . 50.0 111.884 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.46 157.69 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.321 -0.992 . . . . 50.0 108.321 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -134.29 147.26 50.59 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.013 -1.477 . . . . 50.0 107.013 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 t0 59.29 38.93 23.03 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 123.98 1.848 . . . . 50.0 107.335 -170.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -69.32 -11.8 61.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.322 -1.763 . . . . 25.0 114.626 -169.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -129.77 15.11 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.131 0.491 . . . . 50.0 110.806 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.83 22.26 77.23 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 109.514 -1.434 . . . . 25.0 109.514 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.93 114.06 21.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.788 -1.93 . . . . 50.0 105.788 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -59.52 141.16 55.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.882 0.849 . . . . 50.0 109.456 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.8 38.96 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-O 118.92 -0.933 . . . . 25.0 115.1 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.2 130.78 40.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.474 1.637 . . . . 50.0 110.422 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -119.92 149.39 42.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.593 -0.521 . . . . 50.0 109.593 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.1 tp -89.8 120.46 31.07 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 106.436 -1.69 . . . . 50.0 106.436 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -122.23 155.64 35.45 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 121.026 -0.269 . . . . 25.0 110.568 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 p -111.69 125.81 54.36 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.362 -0.607 . . . . 50.0 109.362 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -152.93 143.62 22.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.834 -1.172 . . . . 50.0 107.834 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.87 26.1 12.86 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.582 0.706 . . . . 25.0 112.73 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.21 9.17 87.18 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.491 -0.861 . . . . 25.0 114.474 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -128.24 163.25 25.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.693 -0.484 . . . . 50.0 109.693 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.05 149.54 38.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.088 -1.079 . . . . 50.0 108.088 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 171.21 42.86 Favored Glycine 0 C--O 1.241 0.561 0 N-CA-C 108.887 -1.685 . . . . 50.0 108.887 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -86.81 146.4 6.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.67 0.748 . . . . 50.0 110.226 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.405 HG11 ' CE1' ' A' ' 26' ' ' PHE . 54.7 t -139.42 133.67 16.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.412 -0.813 . . . . 25.0 109.067 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.99 115.49 4.01 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 115.278 -2.682 . . . . 50.0 110.536 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.6 -17.56 66.96 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 115.051 0.78 . . . . 50.0 115.051 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.16 -17.92 64.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.258 1.029 . . . . 50.0 111.436 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -90.78 5.61 47.61 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.81 -0.556 . . . . 50.0 110.658 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.29 151.58 37.41 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.541 0.525 . . . . 50.0 111.328 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -122.1 117.46 26.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.419 -0.956 . . . . 50.0 108.419 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 107.86 -1.163 . . . . 50.0 107.86 177.294 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.215 -0.724 0 N-CA-C 109.052 -0.721 . . . . 50.0 109.052 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 51.08 45.45 27.79 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.491 1.116 . . . . 50.0 112.906 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.72 163.48 6.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 105.478 -2.045 . . . . 50.0 105.478 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.13 148.57 52.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.235 1.017 . . . . 50.0 111.13 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.64 157.72 44.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.269 -1.332 . . . . 25.0 108.981 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -111.16 134.26 52.89 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.713 -0.847 . . . . 50.0 108.713 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.91 130.44 42.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.44 -26.8 19.66 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.857 -0.794 . . . . 50.0 108.857 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.05 158.33 35.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.545 -1.28 . . . . 50.0 107.545 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.4 p-10 -90.58 160.52 15.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.733 -1.581 . . . . 50.0 106.733 174.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -143.8 168.01 20.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 50.0 110.069 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.56 120.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 101.929 -3.359 . . . . 25.0 101.929 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 122.27 23.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.188 -1.042 . . . . 25.0 108.188 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -104.32 -21.14 13.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.888 -0.596 . . . . 50.0 111.325 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.3 m -102.26 150.35 37.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.443 -0.947 . . . . 50.0 108.443 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.83 -21.1 33.61 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 116.204 -2.064 . . . . 25.0 113.369 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.57 -8.02 58.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.177 -0.465 . . . . 50.0 111.477 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -90.05 140.93 29.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.672 0.273 . . . . 50.0 110.601 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mt -85.02 137.88 32.79 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.826 -0.546 . . . . 50.0 110.843 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -91.67 118.46 30.66 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.916 -1.142 . . . . 50.0 107.916 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.67 170.9 14.84 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.079 -0.712 . . . . 25.0 109.079 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.5 158.13 40.78 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 109.175 -0.676 . . . . 50.0 109.175 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.8 pttp -59.27 129.81 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.064 -0.717 . . . . 50.0 109.064 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -20.8 42.9 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.507 -0.77 . . . . 25.0 113.293 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.0 149.42 50.27 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 117.599 0.7 . . . . 50.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -114.13 127.68 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.457 -0.942 . . . . 50.0 108.457 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.8 ptp -137.81 147.7 44.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.824 0.345 . . . . 50.0 110.368 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 m -84.38 130.82 34.75 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 107.912 -1.144 . . . . 25.0 107.912 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.22 125.92 47.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 N-CA-C 107.39 -1.337 . . . . 50.0 107.39 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.77 -39.04 7.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.595 -0.729 . . . . 50.0 112.253 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -146.0 161.61 39.7 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.071 -0.715 . . . . 50.0 109.071 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -125.78 150.42 47.78 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 109.139 -0.689 . . . . 50.0 109.139 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 54.2 37.19 26.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.496 1.617 . . . . 50.0 108.889 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -69.55 -12.67 61.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 112.842 -1.981 . . . . 25.0 114.188 -169.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 7.91 17.21 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.219 -0.659 . . . . 50.0 109.219 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.42 -17.42 13.97 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.882 -0.887 . . . . 25.0 110.882 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.98 127.13 31.59 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.343 -1.355 . . . . 50.0 107.343 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.8 135.11 57.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.733 0.778 . . . . 50.0 110.459 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 -0.07 89.02 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-O 119.181 -0.788 . . . . 25.0 114.805 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -97.95 104.76 16.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.221 1.51 . . . . 50.0 110.534 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -94.82 147.59 23.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 50.0 111.371 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -85.99 117.27 24.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.948 -1.871 . . . . 50.0 105.948 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.7 m -115.89 162.14 17.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -122.64 124.94 44.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.519 -0.919 . . . . 50.0 108.519 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 tp -155.65 139.81 16.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.989 -0.745 . . . . 50.0 108.989 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 54.48 38.16 29.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.943 0.877 . . . . 25.0 113.049 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.07 0.7 77.39 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 115.129 0.812 . . . . 25.0 115.129 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -119.25 154.41 33.49 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.135 -0.691 . . . . 50.0 109.135 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -110.35 148.12 32.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 104.441 -2.429 . . . . 50.0 104.441 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.72 168.82 41.64 Favored Glycine 0 C--O 1.243 0.706 0 N-CA-C 111.39 -0.684 . . . . 50.0 111.39 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -78.26 142.91 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.877 0.846 . . . . 50.0 109.964 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.17 134.57 14.61 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.39 114.69 4.01 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 114.659 -3.094 . . . . 50.0 112.319 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 -23.07 63.49 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 114.263 0.465 . . . . 50.0 114.263 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.0 -25.46 67.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.267 -0.549 . . . . 50.0 111.206 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -92.19 8.34 38.5 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 112.266 0.469 . . . . 50.0 112.266 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -116.71 149.99 38.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 50.0 112.326 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.47 118.77 28.18 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.408 -0.59 . . . . 50.0 109.408 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.1 mm . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 108.634 -0.876 . . . . 50.0 108.634 177.672 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--O 1.224 -0.247 0 CA-C-O 120.627 0.251 . . . . 50.0 111.44 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.7 t30 49.33 46.93 22.85 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.153 1.168 . . . . 50.0 114.153 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.6 m -109.81 169.98 3.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 104.581 -2.377 . . . . 50.0 104.581 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.97 158.76 43.62 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.382 -0.599 . . . . 50.0 109.382 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 149.64 34.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.746 -0.661 . . . . 25.0 112.091 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.18 134.38 37.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.964 -0.562 . . . . 50.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.78 132.0 42.14 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.209 0.528 . . . . 25.0 109.676 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 mt -96.9 -23.95 16.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.636 -0.711 . . . . 50.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.06 161.45 26.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.274 -1.38 . . . . 50.0 107.274 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.56 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.4 p-10 -102.16 162.37 12.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 50.0 109.269 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -151.96 159.11 43.86 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.507 0.504 . . . . 50.0 111.163 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.62 133.2 68.83 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 110.6 7.03 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -78.46 -35.4 46.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.012 -1.449 . . . . 50.0 107.708 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -119.36 154.55 54.08 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 50.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.5 -15.94 34.37 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.661 -1.093 . . . . 25.0 113.697 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.79 -10.2 58.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 50.0 110.698 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -94.29 144.16 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.039 -0.726 . . . . 50.0 109.039 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.46 135.24 33.57 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.774 -0.77 . . . . 50.0 110.21 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -85.27 125.08 32.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.842 -1.91 . . . . 50.0 105.842 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -148.81 163.72 36.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.028 -1.471 . . . . 25.0 107.028 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -129.52 159.03 37.59 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.224 0.535 . . . . 50.0 110.803 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.56 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.9 pttp -59.2 132.5 54.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.816 -1.179 . . . . 50.0 107.816 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.99 -23.34 32.52 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.783 -0.644 . . . . 25.0 113.06 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.35 163.28 26.58 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.073 0.437 . . . . 50.0 110.207 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.01 132.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.642 -0.873 . . . . 50.0 108.642 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -133.4 153.5 51.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 50.0 110.585 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -88.18 131.02 34.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.289 -0.634 . . . . 25.0 109.289 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.3 t -96.06 124.18 48.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.08 -1.081 . . . . 50.0 108.08 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.09 -42.2 8.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.771 -0.649 . . . . 50.0 112.096 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.38 159.75 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 50.0 109.009 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -129.91 151.28 50.65 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 107.894 -1.15 . . . . 50.0 107.894 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t0 58.83 39.6 23.83 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.144 1.45 . . . . 50.0 107.973 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -71.29 -13.8 62.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.854 -1.521 . . . . 25.0 112.859 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -119.46 4.88 11.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.961 0.726 . . . . 50.0 112.961 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.37 20.34 69.58 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 110.086 -1.206 . . . . 25.0 110.086 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.57 113.76 15.23 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.337 -1.727 . . . . 50.0 106.337 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -64.84 141.78 58.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.483 -1.302 . . . . 50.0 107.483 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.57 -15.43 63.33 Favored Glycine 0 C--O 1.209 -1.406 0 CA-C-O 118.441 -1.199 . . . . 25.0 113.377 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -98.57 125.23 43.74 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.658 1.729 . . . . 50.0 109.798 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -119.61 146.96 45.06 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.941 -0.392 . . . . 50.0 109.941 -172.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.1 tp -85.43 116.2 23.6 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.624 -1.251 . . . . 50.0 107.624 176.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -115.31 167.19 11.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.641 0.258 . . . . 25.0 110.652 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 m -131.62 132.94 44.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.448 -0.575 . . . . 50.0 109.448 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 tp -160.24 146.29 15.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.446 -0.946 . . . . 50.0 108.446 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 58.5 24.4 11.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.004 1.113 . . . . 25.0 114.004 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.44 4.66 87.68 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.909 -0.662 . . . . 25.0 113.228 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -122.83 163.89 19.42 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 122.947 0.499 . . . . 50.0 109.669 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -118.1 154.55 31.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.942 -1.873 . . . . 50.0 105.942 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.6 162.66 31.33 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 111.779 -0.528 . . . . 50.0 111.779 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.4 pt -78.12 145.64 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.557 . . . . 50.0 110.682 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -144.84 133.69 11.07 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 108.492 -0.929 . . . . 25.0 108.492 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.6 121.21 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 115.534 -2.511 . . . . 50.0 112.02 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.62 -22.36 65.91 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-N 115.342 -0.845 . . . . 50.0 114.188 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -70.47 -2.4 13.82 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.089 -0.654 . . . . 50.0 111.675 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.0 11.23 17.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.917 -0.401 . . . . 50.0 109.917 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.95 152.63 38.29 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.367 0.417 . . . . 50.0 111.078 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -117.88 117.81 30.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.08 -1.081 . . . . 50.0 108.08 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 N--CA 1.471 0.581 0 O-C-N 123.821 0.7 . . . . 50.0 109.254 177.088 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 120.544 0.211 . . . . 50.0 111.564 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 51.44 43.78 29.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.4 1.259 . . . . 50.0 114.4 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.63 164.34 13.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 103.025 -2.954 . . . . 50.0 103.025 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.61 160.85 37.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.714 0.688 . . . . 50.0 110.386 -174.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.45 163.24 33.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.448 -0.796 . . . . 25.0 110.887 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.58 134.4 52.43 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.042 -1.466 . . . . 50.0 107.042 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.87 136.11 43.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.721 0.772 . . . . 25.0 109.231 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.82 -24.62 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.489 -0.778 . . . . 50.0 109.63 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -128.98 162.75 26.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.818 -1.178 . . . . 50.0 107.818 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.17 156.69 17.06 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.857 -1.164 . . . . 50.0 107.857 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -156.49 135.77 12.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.357 0.503 . . . . 50.0 112.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -100.64 146.92 8.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.98 -1.859 . . . . 25.0 105.98 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.93 133.54 37.26 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.255 -0.276 . . . . 25.0 110.255 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.55 -7.17 23.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.666 0.745 . . . . 50.0 109.117 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.7 t -129.46 148.65 70.18 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.631 -0.713 . . . . 50.0 109.347 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.32 -16.84 35.3 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.716 -1.722 . . . . 25.0 113.3 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -82.17 -15.56 52.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.471 0.653 . . . . 50.0 110.674 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -92.5 140.85 29.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.628 -0.879 . . . . 50.0 108.628 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 132.56 36.04 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.123 -0.631 . . . . 50.0 110.044 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p -84.53 133.08 34.47 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.394 -2.076 . . . . 50.0 105.394 171.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -150.64 166.12 31.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.933 -0.766 . . . . 25.0 108.933 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -127.04 152.99 46.53 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.872 -0.518 . . . . 50.0 110.696 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -59.49 138.37 57.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.279 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.5 -16.02 57.27 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.503 -0.771 . . . . 25.0 114.035 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -76.89 159.76 29.76 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 117.387 0.593 . . . . 50.0 109.93 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.51 130.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.983 0.513 . . . . 50.0 109.638 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.12 147.07 45.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.972 0.415 . . . . 50.0 110.728 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -85.66 130.74 34.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.6 t -88.83 116.41 30.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.809 -1.923 . . . . 50.0 105.809 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.24 -37.76 13.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.309 -0.859 . . . . 50.0 111.147 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -147.43 156.18 42.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.597 -1.26 . . . . 50.0 107.597 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -124.51 147.43 48.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.621 -0.511 . . . . 50.0 109.621 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 57.25 38.21 28.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.745 1.736 . . . . 50.0 107.618 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.5 t -70.56 -11.4 60.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 112.283 -2.235 . . . . 25.0 115.699 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.06 10.07 13.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.145 0.497 . . . . 50.0 110.028 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.62 66.79 Favored Glycine 0 C--O 1.225 -0.425 0 N-CA-C 109.688 -1.365 . . . . 25.0 109.688 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.69 116.74 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.643 -1.614 . . . . 50.0 106.643 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.42 133.82 55.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.795 -0.639 . . . . 50.0 109.457 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.29 -0.43 85.58 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.506 0.962 . . . . 25.0 115.506 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -102.92 116.57 32.8 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.127 1.464 . . . . 50.0 110.538 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -108.59 145.0 35.54 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.208 -0.308 . . . . 50.0 111.09 -174.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.52 120.98 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.473 -1.677 . . . . 50.0 106.473 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.2 m -119.86 165.22 14.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.697 -0.483 . . . . 25.0 109.697 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 p -122.95 131.66 53.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.059 0.457 . . . . 50.0 110.027 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 tp -160.27 148.61 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.664 -1.235 . . . . 50.0 107.664 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 59.64 23.25 12.01 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.272 0.841 . . . . 25.0 113.272 176.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.07 81.08 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.842 -0.694 . . . . 25.0 112.686 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -130.76 164.21 25.6 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.48 -0.933 . . . . 50.0 108.48 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -117.77 152.91 34.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.941 -1.874 . . . . 50.0 105.941 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.04 163.98 36.44 Favored Glycine 0 C--O 1.239 0.462 0 N-CA-C 110.387 -1.085 . . . . 50.0 110.387 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.8 pt -79.43 145.19 9.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.611 . . . . 50.0 110.062 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.4 t -140.74 133.7 14.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 107.64 -1.244 . . . . 25.0 107.64 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.41 121.57 8.11 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 114.667 -3.089 . . . . 50.0 111.212 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.16 -25.67 62.59 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 116.015 -0.539 . . . . 50.0 114.263 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -65.48 -18.52 65.38 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.23 -0.57 . . . . 50.0 112.374 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.84 8.0 41.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.888 -0.507 . . . . 50.0 111.232 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.0 mt -122.41 156.79 33.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.903 0.383 . . . . 50.0 110.786 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -131.62 120.07 22.32 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.512 -0.551 . . . . 50.0 109.512 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.1 mm . . . . . 0 N--CA 1.469 0.519 0 O-C-N 123.67 0.606 . . . . 50.0 110.358 -179.071 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.892 1.441 . . . . 50.0 114.892 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.4 43.26 26.88 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.042 1.497 . . . . 50.0 115.042 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.2 163.63 8.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 104.297 -2.483 . . . . 50.0 104.297 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.17 154.06 47.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 118.891 0.769 . . . . 50.0 110.63 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.91 143.79 34.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.657 -0.701 . . . . 25.0 111.36 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -95.19 132.42 40.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.083 -0.71 . . . . 50.0 109.083 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 134.88 41.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.392 0.615 . . . . 25.0 109.417 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.27 -25.1 17.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.578 -0.737 . . . . 50.0 109.488 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -131.22 157.65 42.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.512 -1.292 . . . . 50.0 107.512 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.556 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -95.35 161.65 14.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.667 -0.494 . . . . 50.0 109.667 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -152.92 149.84 28.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.444 -0.576 . . . . 50.0 109.444 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -124.1 128.74 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 103.773 -2.677 . . . . 25.0 103.773 173.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.91 136.09 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.913 -0.585 . . . . 25.0 109.923 -176.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -102.94 -12.9 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.332 -0.988 . . . . 50.0 108.332 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.35 155.66 53.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 50.0 110.312 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.23 -19.31 20.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 117.71 -1.06 . . . . 25.0 114.418 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -86.37 -15.03 41.71 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.985 0.898 . . . . 50.0 109.591 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -89.89 145.6 25.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.418 -0.81 . . . . 50.0 108.897 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.44 135.79 40.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.795 0.665 . . . . 50.0 112.795 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.31 138.67 32.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.068 -1.827 . . . . 50.0 106.068 170.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -157.4 164.01 37.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -124.15 153.06 42.07 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.618 -0.676 . . . . 50.0 112.197 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 46.2 pttt -58.3 132.43 53.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.543 -1.28 . . . . 50.0 107.543 175.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.21 -14.52 65.15 Favored Glycine 0 C--O 1.226 -0.348 0 CA-C-O 118.79 -1.005 . . . . 25.0 114.089 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.53 163.02 20.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.686 0.743 . . . . 50.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.49 132.11 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.026 -0.731 . . . . 50.0 109.026 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -129.13 151.37 49.88 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 116.055 -0.521 . . . . 50.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.1 m -85.42 129.08 34.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.259 -1.015 . . . . 25.0 108.259 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 83.7 t -91.87 119.62 39.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.684 -1.598 . . . . 50.0 106.684 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -97.87 -40.45 8.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.303 -0.862 . . . . 50.0 111.129 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -148.03 164.68 33.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.888 -1.523 . . . . 50.0 106.888 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -130.56 152.88 49.46 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.507 -1.294 . . . . 50.0 107.507 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 56.57 37.17 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.884 1.365 . . . . 50.0 108.166 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -69.34 -17.39 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 113.631 -1.622 . . . . 25.0 112.857 -169.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.17 6.48 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.721 -0.672 . . . . 50.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 -8.22 67.42 Favored Glycine 0 C--O 1.228 -0.257 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt -83.63 117.27 23.07 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.713 . . . . 50.0 109.076 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -60.39 128.27 35.88 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 50.0 109.412 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.22 -1.3 82.41 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 115.461 0.944 . . . . 25.0 115.461 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -100.63 122.59 43.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.926 1.363 . . . . 50.0 109.247 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -112.49 145.42 40.26 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.993 -0.442 . . . . 50.0 111.162 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.9 tp -83.57 115.07 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.545 -1.65 . . . . 50.0 106.545 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.6 m -122.45 164.84 17.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.536 0.208 . . . . 25.0 110.857 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.5 p -123.18 131.36 53.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.224 -0.658 . . . . 50.0 109.224 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -157.93 139.71 13.93 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.357 -0.979 . . . . 50.0 108.357 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 57.45 32.98 22.64 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.732 0.777 . . . . 25.0 112.632 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.08 4.47 63.18 Favored Glycine 0 CA--C 1.522 0.491 0 O-C-N 121.567 -0.708 . . . . 25.0 113.427 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.73 164.1 13.77 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.014 -1.476 . . . . 50.0 107.014 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -132.19 146.0 51.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 104.22 -2.511 . . . . 50.0 104.22 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.62 177.87 48.55 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 111.11 -0.796 . . . . 50.0 111.11 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.34 143.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.387 0.613 . . . . 50.0 110.299 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.7 t -139.33 134.18 16.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.75 118.54 5.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 115.015 -2.857 . . . . 50.0 110.749 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -23.92 70.78 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.706 -0.679 . . . . 50.0 113.988 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.59 -16.47 64.19 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.289 -0.536 . . . . 50.0 111.62 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -90.06 1.14 56.68 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.93 -0.481 . . . . 50.0 110.918 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.58 150.64 36.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.306 0.574 . . . . 50.0 111.343 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -121.96 113.86 20.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.331 -0.988 . . . . 50.0 108.331 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.754 0.311 . . . . 50.0 110.848 -177.138 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 114.699 1.37 . . . . 50.0 114.699 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.06 30.24 19.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.816 1.413 . . . . 50.0 114.816 173.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -115.94 164.01 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.175 -1.787 . . . . 50.0 106.175 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.95 164.11 23.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.207 -0.664 . . . . 50.0 109.207 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.28 145.21 30.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 25.0 110.857 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -95.05 134.49 37.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.31 136.55 40.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.274 0.559 . . . . 25.0 109.616 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.26 -26.22 17.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 50.0 110.071 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -130.24 162.78 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.41 -1.33 . . . . 50.0 107.41 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.511 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.9 p-10 -101.71 157.07 17.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.888 -0.412 . . . . 50.0 109.888 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -157.87 122.78 4.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.575 -0.739 . . . . 50.0 110.099 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 138.93 19.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.13 148.97 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -111.22 -20.41 12.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.639 -0.504 . . . . 50.0 109.639 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -105.09 152.46 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.49 -0.323 . . . . 50.0 110.265 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.6 -20.91 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 117.1 -1.466 . . . . 25.0 114.013 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.35 -4.79 59.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.536 0.684 . . . . 50.0 110.599 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -99.26 141.73 31.66 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.18 -1.044 . . . . 50.0 108.18 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.97 134.14 35.06 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.674 -0.641 . . . . 50.0 111.724 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.8 m -84.16 119.44 25.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.526 -1.657 . . . . 50.0 106.526 170.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -136.16 161.62 35.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.55 -0.537 . . . . 25.0 109.55 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -123.43 153.74 40.02 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.062 0.458 . . . . 50.0 110.079 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.511 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 14.0 ptmt -59.6 133.74 56.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.208 -1.034 . . . . 50.0 108.208 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 -10.81 72.17 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-O 119.102 -0.832 . . . . 25.0 114.302 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.65 158.29 25.68 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.916 0.858 . . . . 50.0 109.207 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.86 129.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.453 -0.573 . . . . 50.0 109.453 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -130.76 153.23 49.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 50.0 109.899 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 m -87.53 132.32 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.68 -1.229 . . . . 25.0 107.68 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.12 125.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.864 -1.532 . . . . 50.0 106.864 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -92.95 -47.78 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.04 -0.527 . . . . 50.0 111.183 -175.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.74 171.92 18.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.538 -1.282 . . . . 50.0 107.538 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -121.9 155.0 36.38 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.234 -0.654 . . . . 50.0 109.234 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 57.51 38.6 28.1 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.64 1.213 . . . . 50.0 109.924 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -69.88 -18.59 63.42 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.067 -1.424 . . . . 25.0 114.374 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -110.97 9.73 22.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.265 -0.643 . . . . 50.0 109.265 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.58 1.84 89.26 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.445 -1.062 . . . . 25.0 110.445 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.38 122.36 35.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.144 -1.058 . . . . 50.0 108.144 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -61.45 129.36 40.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.419 0.628 . . . . 50.0 109.98 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 0.45 87.96 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -101.58 108.43 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 118.827 1.313 . . . . 50.0 110.227 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.718 -0.475 . . . . 50.0 109.718 -173.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -82.41 120.1 25.02 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.671 -1.974 . . . . 50.0 105.671 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.71 160.68 24.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 25.0 109.236 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -121.47 132.53 54.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.435 0.636 . . . . 50.0 109.746 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.22 141.38 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.157 -0.928 . . . . 50.0 108.617 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 58.79 26.75 15.12 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.677 0.992 . . . . 25.0 113.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.74 6.06 89.61 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 121.097 -0.573 . . . . 25.0 113.293 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -122.11 167.33 13.28 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.05 -1.463 . . . . 50.0 107.05 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -135.41 154.32 51.5 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.777 -1.564 . . . . 50.0 106.777 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.7 171.33 44.27 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.856 -0.898 . . . . 50.0 110.856 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.5 143.3 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.506 0.67 . . . . 50.0 110.587 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.4 t -141.9 132.42 12.86 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.255 -1.017 . . . . 25.0 108.255 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.77 119.52 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 115.178 -2.748 . . . . 50.0 111.582 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.45 -21.77 62.77 Favored Glycine 0 C--O 1.221 -0.678 0 CA-C-N 115.888 -0.597 . . . . 50.0 114.473 -175.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -61.25 -28.12 68.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.267 -0.549 . . . . 50.0 111.37 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -89.15 6.28 40.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.869 0.322 . . . . 50.0 111.869 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.73 143.97 44.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.6 . . . . 50.0 111.913 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -117.75 117.69 30.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.807 -1.183 . . . . 50.0 107.807 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm . . . . . 0 C--O 1.24 0.563 0 CA-C-O 121.202 0.525 . . . . 50.0 110.157 -177.517 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.826 -0.435 . . . . 50.0 109.826 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 t30 56.17 36.83 28.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.464 -0.789 . . . . 50.0 112.284 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.16 129.75 55.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 106.728 -1.582 . . . . 50.0 106.728 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.47 153.85 19.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.738 0.78 . . . . 50.0 110.101 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.23 152.13 42.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.826 -1.079 . . . . 25.0 109.948 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -103.49 135.09 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.558 -0.904 . . . . 50.0 108.558 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 135.54 43.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.361 0.601 . . . . 25.0 110.169 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.44 -27.19 17.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.5 -0.773 . . . . 50.0 110.68 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.51 158.26 33.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.35 -1.722 . . . . 50.0 106.35 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 12.0 p-10 -97.95 146.16 25.76 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.296 -1.372 . . . . 50.0 107.296 174.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -144.6 129.99 18.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.776 -0.647 . . . . 50.0 110.741 -174.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -103.91 121.3 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.403 -1.703 . . . . 25.0 106.403 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.66 35.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.911 -0.586 . . . . 25.0 110.108 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -99.55 -17.26 17.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.158 0.504 . . . . 50.0 109.941 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 143.32 40.61 Favored Pre-proline 0 CA--C 1.513 -0.455 0 N-CA-C 107.722 -1.214 . . . . 50.0 107.722 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 -15.61 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 116.937 -1.576 . . . . 25.0 114.023 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -94.48 -9.0 36.83 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.315 0.579 . . . . 50.0 110.964 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.62 140.82 30.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.776 -0.824 . . . . 50.0 108.776 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.38 132.3 34.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.432 0.634 . . . . 50.0 111.169 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -86.93 136.32 32.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.14 -1.8 . . . . 50.0 106.14 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -156.55 166.78 32.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.978 0.418 . . . . 25.0 110.441 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -121.44 154.88 35.97 Favored 'General case' 0 C--O 1.213 -0.868 0 O-C-N 121.909 -0.495 . . . . 50.0 110.683 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.468 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.3 pttt -60.56 131.79 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.946 -1.131 . . . . 50.0 107.946 174.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.91 -20.57 49.81 Favored Glycine 0 C--O 1.224 -0.515 0 CA-C-N 115.903 -0.589 . . . . 25.0 113.026 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -71.49 154.19 41.67 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.326 0.563 . . . . 50.0 110.117 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -117.47 126.96 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.109 -0.7 . . . . 50.0 109.109 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.7 ptp -134.89 157.73 46.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.937 -0.764 . . . . 50.0 108.937 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.6 m -107.03 126.75 52.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.233 -0.284 . . . . 25.0 110.233 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -79.95 123.55 36.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.434 -1.321 . . . . 50.0 107.434 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.92 -46.62 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.92 -0.771 . . . . 50.0 108.92 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.26 169.25 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.165 -1.42 . . . . 50.0 107.165 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -124.16 157.14 35.39 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 110.259 -0.274 . . . . 50.0 110.259 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 56.53 41.42 28.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.74 1.275 . . . . 50.0 108.681 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.47 -16.26 62.9 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.704 1.372 . . . . 25.0 114.704 -167.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -111.94 9.0 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.509 -0.552 . . . . 50.0 109.509 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.11 -9.78 59.83 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 110.864 -0.894 . . . . 25.0 110.864 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.92 124.53 28.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.932 -1.136 . . . . 50.0 107.932 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -61.08 131.32 50.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.449 0.642 . . . . 50.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.45 89.58 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 118.566 -1.13 . . . . 25.0 115.482 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -99.02 105.44 17.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.755 1.777 . . . . 50.0 109.817 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -102.34 143.37 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.038 -0.528 . . . . 50.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.0 tp -83.66 112.78 20.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.673 -1.603 . . . . 50.0 106.673 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 67.3 m -112.08 163.14 14.63 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.555 -0.906 . . . . 25.0 108.555 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.2 p -123.74 130.7 53.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 50.0 109.048 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 tp -162.26 146.56 12.21 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.572 -0.899 . . . . 50.0 108.572 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 57.43 30.74 19.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.785 1.032 . . . . 25.0 113.785 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.56 11.44 82.81 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 120.702 -0.761 . . . . 25.0 113.161 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -124.55 165.51 17.71 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.44 -1.318 . . . . 50.0 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.36 152.61 47.97 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 103.448 -2.797 . . . . 50.0 103.448 167.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.59 167.09 38.82 Favored Glycine 0 C--O 1.24 0.508 0 N-CA-C 110.262 -1.135 . . . . 50.0 110.262 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.9 pt -75.48 143.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.548 0.69 . . . . 50.0 110.509 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -141.62 132.27 13.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.959 -1.126 . . . . 25.0 107.959 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.07 120.29 6.73 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 115.185 -2.743 . . . . 50.0 111.737 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.38 -25.8 60.97 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-N 115.742 -0.663 . . . . 50.0 114.397 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -63.42 -22.94 67.18 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.191 0.52 . . . . 50.0 111.646 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -91.56 5.5 49.33 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.757 -0.59 . . . . 50.0 111.667 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.5 mt -115.4 156.28 25.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 50.0 111.458 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -122.8 117.7 26.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.114 . . . . 50.0 107.991 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 107.891 -1.151 . . . . 50.0 107.891 178.93 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 113.949 1.092 . . . . 50.0 113.949 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.88 38.51 29.47 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.89 0.853 . . . . 50.0 111.967 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.0 t -107.52 149.09 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 104.527 -2.398 . . . . 50.0 104.527 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.69 153.28 50.93 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.251 -1.018 . . . . 50.0 108.251 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.57 149.68 36.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.912 -0.585 . . . . 25.0 111.2 -172.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -96.3 136.44 36.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.596 -0.52 . . . . 50.0 109.596 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.81 134.18 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.203 0.525 . . . . 25.0 109.717 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.86 -32.73 15.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.351 0.596 . . . . 50.0 109.768 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.86 164.7 17.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.068 -1.456 . . . . 50.0 107.068 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.498 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.7 p-10 -98.9 163.06 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.676 -0.861 . . . . 50.0 108.676 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -151.62 144.66 24.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.181 -0.463 . . . . 50.0 111.626 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.14 125.33 73.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.214 -2.884 . . . . 25.0 103.214 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.03 146.22 41.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 25.0 110.147 -175.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -31.29 7.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.465 -0.568 . . . . 50.0 109.465 173.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -94.93 150.34 37.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.261 -0.644 . . . . 50.0 109.261 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.58 -16.96 26.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.734 -1.044 . . . . 25.0 113.303 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.94 -9.5 58.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 50.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.18 144.53 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.17 0.588 . . . . 50.0 110.236 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mt -94.9 134.55 37.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.56 0.695 . . . . 50.0 112.645 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.3 m -88.3 140.71 29.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.289 -1.374 . . . . 50.0 107.289 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -160.19 167.17 28.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -118.56 156.51 29.02 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.635 -0.665 . . . . 50.0 110.911 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 11.0 ptmm? -59.58 129.68 43.13 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.494 -0.928 . . . . 50.0 108.494 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.05 67.83 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 115.836 -0.62 . . . . 25.0 113.937 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.36 161.24 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.892 -0.781 . . . . 50.0 108.892 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.07 134.05 65.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.353 -0.98 . . . . 50.0 108.353 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -135.48 152.82 51.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.669 -0.696 . . . . 50.0 110.614 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.7 m -89.04 131.9 35.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 25.0 108.031 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.59 120.6 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.748 -1.575 . . . . 50.0 106.748 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.4 mt -92.37 -42.35 9.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 50.0 110.065 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.98 166.23 29.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.984 -0.747 . . . . 50.0 108.984 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -133.38 152.76 51.95 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 117.936 0.334 . . . . 50.0 110.236 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 57.32 36.36 27.15 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.95 1.357 . . . . 50.0 107.766 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.48 -7.1 40.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.17 -1.832 . . . . 25.0 115.644 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -126.87 12.36 7.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.82 -5.78 68.84 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.712 -0.955 . . . . 25.0 110.712 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.99 120.98 25.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.329 -0.989 . . . . 50.0 108.329 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -61.88 127.43 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.706 -0.679 . . . . 50.0 109.939 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.58 1.5 90.1 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.754 1.062 . . . . 25.0 115.754 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -98.68 119.09 36.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.301 1.551 . . . . 50.0 109.898 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -110.0 143.8 39.47 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.185 -0.322 . . . . 50.0 111.304 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.7 tp -81.57 111.59 18.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.614 -1.995 . . . . 50.0 105.614 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.2 m -115.34 164.15 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.834 -0.802 . . . . 25.0 108.834 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -139.26 130.7 27.03 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.758 0.313 . . . . 50.0 111.738 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.21 152.16 25.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 50.0 109.644 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.4 t60 53.07 36.45 22.25 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.83 7.24 74.86 Favored Glycine 0 C--O 1.226 -0.394 0 N-CA-C 114.874 0.71 . . . . 25.0 114.874 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -120.82 156.57 31.64 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.096 -1.446 . . . . 50.0 107.096 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -134.34 145.74 49.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.765 -1.939 . . . . 50.0 105.765 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.61 44.2 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.743 -0.943 . . . . 50.0 110.743 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 pt -76.29 143.89 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.614 0.721 . . . . 50.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.8 t -141.91 133.34 13.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.35 119.15 6.13 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 114.974 -2.884 . . . . 50.0 110.984 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.09 -18.02 66.41 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.703 -0.681 . . . . 50.0 113.781 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.07 -28.65 69.76 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.513 -0.404 . . . . 50.0 110.883 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -87.7 7.17 31.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.074 0.398 . . . . 50.0 112.074 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -118.92 147.91 43.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.111 0.481 . . . . 50.0 111.091 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -116.21 117.59 30.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.582 -0.895 . . . . 50.0 108.582 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm . . . . . 0 C--O 1.242 0.686 0 C-N-CA 123.417 0.687 . . . . 50.0 110.103 178.308 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 mt . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 113.109 0.781 . . . . 50.0 113.109 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 54.69 24.53 5.62 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.361 1.245 . . . . 50.0 114.361 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.63 174.28 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 106.911 -1.514 . . . . 50.0 106.911 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.22 152.38 49.81 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.765 -0.584 . . . . 50.0 110.55 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.59 146.67 42.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 25.0 111.628 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -95.17 134.57 37.76 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.167 -1.049 . . . . 50.0 108.167 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.35 135.03 39.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.529 0.681 . . . . 25.0 110.676 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.0 mt -94.92 -23.05 17.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.12 -0.945 . . . . 50.0 109.531 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -127.61 159.04 35.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.098 -1.075 . . . . 50.0 108.098 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.499 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -99.39 145.35 27.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.531 -0.544 . . . . 50.0 109.531 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.58 109.89 3.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 50.0 110.299 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.52 138.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 105.335 -2.098 . . . . 25.0 105.335 175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.86 122.38 24.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -101.27 -17.66 16.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.969 -0.752 . . . . 50.0 108.969 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -109.63 151.59 42.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.99 -0.744 . . . . 50.0 108.99 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.48 -20.91 20.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.015 -1.523 . . . . 25.0 114.467 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -84.91 -9.54 58.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.693 0.759 . . . . 50.0 110.601 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -88.51 140.81 29.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.36 -0.836 . . . . 50.0 110.35 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.39 134.45 34.33 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.497 -0.557 . . . . 50.0 109.497 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -95.18 131.51 41.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.44 -0.578 . . . . 50.0 109.44 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -157.14 168.03 28.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.869 0.366 . . . . 25.0 110.03 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -127.14 158.37 37.22 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.807 -0.558 . . . . 50.0 110.33 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.499 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 13.7 pttt -60.86 133.67 56.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.418 -1.327 . . . . 50.0 107.418 174.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.28 55.24 Favored Glycine 0 C--O 1.223 -0.541 0 CA-C-O 119.357 -0.69 . . . . 25.0 113.358 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -81.57 163.02 22.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.218 0.509 . . . . 50.0 109.668 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.8 132.01 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.459 -0.571 . . . . 50.0 109.459 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.86 156.35 41.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 50.0 110.064 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -84.27 133.56 34.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.91 121.81 49.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 50.0 106.462 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.71 -49.62 5.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.237 -0.892 . . . . 50.0 111.695 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.19 162.98 34.19 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.622 0.576 . . . . 50.0 109.564 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -132.17 151.58 51.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.518 -0.919 . . . . 50.0 108.518 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t0 56.84 40.29 29.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.325 1.536 . . . . 50.0 107.663 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 t -70.58 -6.12 34.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.784 -1.553 . . . . 25.0 114.202 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -136.16 10.93 3.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.969 0.729 . . . . 50.0 112.969 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.79 20.31 73.93 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 109.201 -1.56 . . . . 25.0 109.201 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.5 mt -122.32 109.92 15.03 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 105.557 -2.016 . . . . 50.0 105.557 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -68.65 149.07 49.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.645 -1.242 . . . . 50.0 107.645 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.18 -14.21 58.0 Favored Glycine 0 C--O 1.222 -0.611 0 CA-C-O 119.068 -0.851 . . . . 25.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -97.94 134.22 41.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.678 1.239 . . . . 50.0 109.782 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -121.13 147.58 45.37 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.034 -0.728 . . . . 50.0 109.034 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 tp -85.89 115.48 23.54 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 105.907 -1.886 . . . . 50.0 105.907 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.3 m -118.08 160.63 21.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.391 -0.226 . . . . 25.0 110.391 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -131.18 132.2 44.56 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.137 0.494 . . . . 50.0 111.699 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tt -150.49 141.17 22.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.058 -0.974 . . . . 50.0 108.682 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 56.86 33.37 23.02 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.159 0.8 . . . . 25.0 113.159 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.1 10.75 81.49 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.731 -0.747 . . . . 25.0 113.686 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -118.45 162.76 17.8 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 105.564 -2.013 . . . . 50.0 105.564 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.37 149.48 41.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.466 -1.309 . . . . 50.0 107.466 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.64 -179.14 43.23 Favored Glycine 0 C--O 1.239 0.435 0 N-CA-C 110.97 -0.852 . . . . 50.0 110.97 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.14 146.14 7.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.345 0.593 . . . . 50.0 112.244 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -142.72 134.66 13.2 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.397 -0.819 . . . . 25.0 108.813 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.36 115.89 4.38 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 114.64 -3.107 . . . . 50.0 110.178 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.59 -17.01 66.29 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.277 0.471 . . . . 50.0 114.277 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -70.24 -4.13 20.34 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.415 -0.462 . . . . 50.0 111.661 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -104.69 10.28 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.226 -0.296 . . . . 50.0 110.629 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.4 153.27 40.62 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.88 0.326 . . . . 50.0 111.88 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.24 117.68 24.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.532 -0.914 . . . . 50.0 108.532 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.4 mm . . . . . 0 N--CA 1.476 0.825 0 C-N-CA 122.778 0.431 . . . . 50.0 111.359 -177.208 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 114.849 1.425 . . . . 50.0 114.849 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t30 50.75 45.24 27.39 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.76 1.393 . . . . 50.0 114.76 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.65 147.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.169 -1.789 . . . . 50.0 106.169 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.66 162.84 13.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.566 0.698 . . . . 75.0 110.136 -174.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.47 138.7 29.44 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.394 -0.821 . . . . 25.0 109.92 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -95.28 134.99 37.44 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.648 -0.871 . . . . 50.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.25 134.59 42.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.247 0.546 . . . . 25.0 110.548 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.06 -30.56 15.96 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.646 . . . . 50.0 109.352 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -126.44 163.66 22.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.219 -1.4 . . . . 50.0 107.219 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.8 p-10 -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.665 -0.865 . . . . 50.0 108.665 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -151.46 129.87 12.11 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.697 0.629 . . . . 50.0 112.697 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -98.62 128.15 50.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.174 -2.899 . . . . 25.0 103.174 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.59 117.49 9.6 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.819 -0.808 . . . . 25.0 108.819 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -95.1 -13.34 25.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.536 0.684 . . . . 50.0 109.286 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 m -120.41 150.7 52.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 50.0 108.507 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.81 -20.43 26.14 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 117.636 -1.109 . . . . 25.0 114.487 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -82.13 -15.45 53.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.763 0.792 . . . . 50.0 109.801 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -84.05 147.18 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.48 -0.782 . . . . 50.0 110.517 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.92 132.52 43.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.95 0.405 . . . . 50.0 109.941 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -89.34 143.21 27.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.991 -1.115 . . . . 50.0 107.991 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -160.93 170.17 21.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.151 -1.796 . . . . 25.0 106.151 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtm-85 -124.26 159.29 30.55 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.928 -0.483 . . . . 50.0 111.087 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 10.6 ptmm? -59.09 133.44 56.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.042 -0.725 . . . . 50.0 109.042 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.1 -11.39 72.07 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.57 -0.741 . . . . 25.0 113.635 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -80.93 161.31 24.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.454 -0.943 . . . . 50.0 108.454 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.37 134.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.965 -0.754 . . . . 50.0 108.965 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.0 ptp -130.61 158.71 39.27 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.617 -0.883 . . . . 50.0 108.617 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 m -97.86 125.43 42.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.241 -0.652 . . . . 25.0 109.241 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.5 t -82.62 127.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.478 -1.305 . . . . 50.0 107.478 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -102.34 -41.09 6.46 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 50.0 110.454 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -146.67 164.58 32.23 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.772 -1.196 . . . . 50.0 107.772 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -132.69 152.39 51.72 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.505 -1.294 . . . . 50.0 107.505 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 31.04 20.81 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 123.052 1.406 . . . . 50.0 108.42 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.1 t -70.5 -20.43 62.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 113.311 -1.768 . . . . 25.0 114.701 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -102.85 3.82 37.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.29 0.567 . . . . 50.0 109.873 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.51 85.81 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 109.052 -1.619 . . . . 25.0 109.052 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.0 mt -111.26 122.8 48.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.394 -1.706 . . . . 50.0 106.394 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.7 132.69 54.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.695 0.759 . . . . 50.0 110.08 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -1.11 89.22 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-O 118.767 -1.018 . . . . 25.0 115.506 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.359 1.58 . . . . 50.0 108.712 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -110.23 142.5 41.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.202 -0.311 . . . . 50.0 110.921 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.73 114.83 20.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.336 -2.098 . . . . 50.0 105.336 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -117.89 162.96 17.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -129.68 138.63 51.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.96 0.41 . . . . 50.0 110.265 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.66 140.19 15.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.586 -1.264 . . . . 50.0 107.586 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 55.65 29.27 13.34 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.422 1.267 . . . . 25.0 114.422 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.92 1.87 90.64 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.952 -0.642 . . . . 25.0 114.351 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -114.06 162.8 16.01 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 106.883 -1.525 . . . . 50.0 106.883 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -131.83 138.51 48.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.901 -1.518 . . . . 50.0 106.901 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.53 164.46 28.07 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.378 -1.089 . . . . 50.0 110.378 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.6 pt -81.63 145.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.094 -1.076 . . . . 50.0 108.094 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.8 t -141.62 135.29 14.62 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.13 113.32 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 115.765 -2.357 . . . . 50.0 111.641 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.1 -20.0 59.89 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 114.545 0.578 . . . . 50.0 114.545 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.22 -30.11 68.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.932 0.396 . . . . 50.0 111.373 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -89.53 8.82 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.213 0.449 . . . . 50.0 112.213 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.69 153.67 36.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.149 0.499 . . . . 50.0 112.298 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -125.09 117.58 24.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.198 -0.667 . . . . 50.0 109.198 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 123.179 0.592 . . . . 50.0 110.535 179.86 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 114.677 1.362 . . . . 50.0 114.677 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.9 t30 53.87 41.65 31.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.771 1.026 . . . . 50.0 113.771 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -120.12 151.98 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 105.901 -1.888 . . . . 50.0 105.901 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.73 151.97 37.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.128 0.489 . . . . 50.0 111.614 -174.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.63 148.62 51.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.54 -0.755 . . . . 25.0 112.465 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.31 132.61 40.13 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 114.988 -1.005 . . . . 50.0 108.295 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.97 125.4 28.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.2 mt -91.64 -26.99 18.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 50.0 110.752 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -127.96 163.03 25.38 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.411 -1.329 . . . . 50.0 107.411 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.62 165.63 12.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.273 -0.639 . . . . 50.0 109.273 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -148.61 156.55 42.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.608 -0.516 . . . . 50.0 109.608 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.36 105.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.41 30.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.167 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -104.91 -12.31 16.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 50.0 111.753 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -122.39 149.83 55.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.984 -0.553 . . . . 50.0 110.511 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.89 -16.07 40.89 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 117.393 -1.271 . . . . 25.0 114.583 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -76.86 -19.64 57.24 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.77 0.795 . . . . 50.0 109.945 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -94.18 137.89 32.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.805 0.812 . . . . 50.0 110.49 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.62 131.48 35.21 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.83 -0.748 . . . . 50.0 111.276 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.7 t -78.72 109.98 13.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.781 -1.192 . . . . 50.0 107.781 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.16 162.46 35.43 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.461 -0.94 . . . . 25.0 108.461 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.47 167.49 20.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.879 . . . . 50.0 108.625 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -61.92 140.66 58.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.522 -0.547 . . . . 50.0 109.522 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.51 -15.0 62.43 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-O 118.792 -1.004 . . . . 25.0 113.272 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -73.07 155.74 39.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.505 1.152 . . . . 50.0 110.697 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.9 mm -122.38 126.14 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.371 -1.344 . . . . 50.0 107.371 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.4 ptp -135.97 154.92 50.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.18 0.192 . . . . 50.0 111.31 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 m -92.96 129.8 38.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.625 -0.879 . . . . 25.0 108.625 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.95 125.74 40.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.502 -1.295 . . . . 50.0 107.502 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.3 mt -94.74 -48.11 6.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.046 -0.524 . . . . 50.0 110.442 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.2 167.12 22.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.237 0.96 . . . . 50.0 109.11 -174.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -129.92 155.46 46.02 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 57.5 36.02 26.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 123.55 1.643 . . . . 50.0 107.914 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -70.17 -12.5 61.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.835 -1.529 . . . . 25.0 114.089 -171.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.474 ' C ' ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -110.46 4.79 20.83 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.42 0.628 . . . . 50.0 109.337 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 -20.29 11.17 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 109.431 -1.468 . . . . 25.0 109.431 -173.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 40' ' ' GLN . 91.7 mt -81.02 123.77 28.62 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.751 -1.574 . . . . 50.0 106.751 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.7 135.46 57.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.511 -0.922 . . . . 50.0 108.511 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.75 -3.65 83.24 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 115.878 1.111 . . . . 25.0 115.878 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -96.35 121.56 38.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.635 1.218 . . . . 50.0 108.078 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -111.87 143.99 41.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.728 -0.389 . . . . 50.0 110.55 -172.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -85.37 120.77 27.2 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.818 -2.29 . . . . 50.0 104.818 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.4 m -121.68 161.78 21.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.59 -0.522 . . . . 25.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -123.44 129.87 51.88 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.525 -0.917 . . . . 50.0 108.525 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.88 142.22 14.82 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.918 -1.142 . . . . 50.0 107.918 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 58.57 29.95 19.15 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.355 0.662 . . . . 25.0 112.662 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.0 7.77 88.25 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.766 -0.731 . . . . 25.0 114.706 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.9 164.9 25.88 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.669 -1.234 . . . . 50.0 107.669 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -124.43 153.7 41.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.51 -1.293 . . . . 50.0 107.51 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 169.4 42.4 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 110.441 -1.064 . . . . 50.0 110.441 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 pt -78.22 147.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 117.742 0.771 . . . . 50.0 111.995 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.92 135.42 13.49 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.749 -1.204 . . . . 25.0 107.749 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.15 116.57 4.56 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 115.844 -2.304 . . . . 50.0 111.489 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.88 -25.49 69.27 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 115.935 1.134 . . . . 50.0 115.935 -172.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -69.07 -12.4 61.65 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.874 -0.78 . . . . 50.0 112.043 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.58 5.77 50.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.356 -0.84 . . . . 50.0 110.252 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -116.94 154.8 30.22 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 122.61 0.364 . . . . 50.0 111.462 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -126.86 114.5 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.165 -1.05 . . . . 50.0 108.165 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.3 mm . . . . . 0 C--N 1.321 -0.649 0 N-CA-C 108.145 -1.058 . . . . 50.0 108.145 178.896 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.47 0.176 . . . . 50.0 111.182 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 57.48 22.38 7.97 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.547 0.943 . . . . 50.0 113.547 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -89.7 132.94 33.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 N-CA-C 107.737 -1.209 . . . . 50.0 107.737 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.27 160.51 14.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.334 0.588 . . . . 75.0 109.747 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.09 150.75 34.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.616 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.79 133.5 39.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 50.0 109.649 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.95 134.13 38.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.391 0.615 . . . . 25.0 109.854 175.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.24 -21.55 19.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.524 -0.762 . . . . 50.0 110.152 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.88 159.88 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 50.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 17.3 p-10 -101.98 147.57 26.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.983 -0.747 . . . . 50.0 108.983 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -153.07 156.95 39.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.7 -0.682 . . . . 50.0 110.875 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -124.96 131.48 72.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 104.472 -2.418 . . . . 25.0 104.472 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 121.65 14.31 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.13 0.269 . . . . 25.0 110.406 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -94.6 -14.62 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.358 -0.978 . . . . 50.0 108.358 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.7 155.44 59.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.471 -0.786 . . . . 50.0 109.774 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.16 -19.86 25.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 117.31 -1.327 . . . . 25.0 113.753 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -15.57 49.1 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.618 0.723 . . . . 50.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.29 153.17 21.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 50.0 111.232 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.6 136.61 41.15 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.039 -0.413 . . . . 50.0 111.841 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.1 m -85.19 109.81 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.046 -1.094 . . . . 50.0 108.046 171.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -126.55 162.05 26.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.649 -0.871 . . . . 25.0 108.649 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 43.5 mtm105 -127.39 155.23 43.96 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.918 -0.488 . . . . 50.0 111.102 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.8 pttt -59.99 128.9 39.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.43 -0.952 . . . . 50.0 108.43 175.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.19 65.83 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.627 -0.715 . . . . 25.0 114.353 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.75 156.76 30.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.881 0.841 . . . . 50.0 109.872 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.16 130.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.676 -0.861 . . . . 50.0 108.676 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -135.28 160.6 37.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.584 -0.524 . . . . 50.0 109.584 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.4 m -101.85 127.15 48.79 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 25.0 109.824 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.93 125.53 40.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.886 -1.153 . . . . 50.0 107.886 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.7 mt -95.5 -41.57 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.607 -0.724 . . . . 50.0 110.237 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -148.23 164.17 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.324 -0.621 . . . . 50.0 109.324 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -135.11 151.88 51.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.494 -1.669 . . . . 50.0 106.494 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 59.39 34.45 22.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.175 1.464 . . . . 50.0 107.913 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -70.55 -16.54 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.829 -1.532 . . . . 25.0 112.613 -172.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -113.35 7.98 17.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 50.0 112.05 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.84 19.81 78.54 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 109.418 -1.473 . . . . 25.0 109.418 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.7 mt -130.05 114.86 16.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 106.97 -1.493 . . . . 50.0 106.97 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -65.7 149.93 49.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.68 -1.6 . . . . 50.0 106.68 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.86 -12.55 69.17 Favored Glycine 0 C--O 1.215 -1.07 0 CA-C-O 118.573 -1.126 . . . . 25.0 112.224 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -106.28 128.28 53.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.179 1.489 . . . . 50.0 110.337 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.16 142.34 50.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.77 -0.456 . . . . 50.0 109.77 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.2 tp -83.87 119.03 24.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.02 -1.474 . . . . 50.0 107.02 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.0 m -123.42 164.79 18.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.349 0.119 . . . . 25.0 111.209 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.7 p -121.94 124.13 43.34 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.032 0.444 . . . . 50.0 110.256 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 tp -162.17 164.64 27.75 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 106.076 -1.824 . . . . 50.0 106.076 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.19 17.63 7.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.789 1.403 . . . . 25.0 114.789 169.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.33 13.57 80.32 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.934 -0.65 . . . . 25.0 113.261 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.9 167.61 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.559 -0.534 . . . . 50.0 109.559 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -105.98 154.81 20.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 103.6 -2.741 . . . . 50.0 103.6 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.78 163.77 34.27 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 110.121 -1.192 . . . . 50.0 110.121 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 pt -79.61 141.93 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.877 0.846 . . . . 50.0 109.983 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.6 132.99 17.74 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.362 -1.347 . . . . 25.0 107.362 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.07 121.74 8.36 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 114.218 -3.388 . . . . 50.0 111.258 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.17 -19.07 69.86 Favored Glycine 0 C--O 1.22 -0.763 0 CA-C-N 115.801 -0.636 . . . . 50.0 112.121 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -69.73 -5.59 26.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.109 0.481 . . . . 50.0 111.378 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -114.4 11.43 17.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.748 -0.464 . . . . 50.0 109.748 175.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.0 mt -120.57 150.09 41.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.275 0.56 . . . . 50.0 110.779 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -120.45 119.75 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.349 -0.982 . . . . 50.0 108.349 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.882 -0.599 . . . . 50.0 109.772 179.138 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 114.191 1.182 . . . . 50.0 114.191 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.7 t30 47.09 46.56 16.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.124 1.527 . . . . 50.0 115.124 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.7 m -111.25 169.5 4.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 104.483 -2.414 . . . . 50.0 104.483 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.41 164.38 29.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.527 -0.545 . . . . 50.0 109.527 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.42 28.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.496 -0.774 . . . . 25.0 109.75 -175.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.35 136.34 53.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.681 -1.229 . . . . 50.0 107.681 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 135.38 45.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.48 0.657 . . . . 25.0 109.727 177.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.01 -30.16 16.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.182 -0.917 . . . . 50.0 109.356 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.83 158.49 39.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.821 -1.177 . . . . 50.0 107.821 -177.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.1 p-10 -87.91 152.98 21.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.432 . . . . 50.0 110.08 177.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.76 87.25 1.41 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.711 -0.848 . . . . 50.0 108.711 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.16 121.55 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.59 51.64 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.379 0.424 . . . . 25.0 111.418 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.05 -18.18 12.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.361 -0.836 . . . . 50.0 110.184 175.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -104.93 150.79 39.1 Favored Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 109.613 -0.514 . . . . 50.0 109.613 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.62 -21.6 19.05 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 117.585 -1.144 . . . . 25.0 114.42 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.62 -14.95 56.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 50.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -89.15 140.61 29.29 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.91 . . . . 50.0 111.134 -176.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.87 124.74 34.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.674 -0.641 . . . . 50.0 111.147 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -80.45 121.22 25.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.544 -0.539 . . . . 50.0 109.544 174.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -143.26 168.56 19.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.306 -0.998 . . . . 25.0 108.306 178.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -129.28 164.82 22.69 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.973 -0.455 . . . . 50.0 111.23 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 34.9 pttt -62.03 134.27 56.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 50.0 109.729 -177.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.47 -13.38 67.45 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 115.524 -0.762 . . . . 25.0 113.407 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -75.87 157.64 33.05 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 117.419 0.609 . . . . 50.0 110.988 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.88 126.37 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.292 0.637 . . . . 50.0 111.042 -175.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -129.49 147.78 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.41 0.624 . . . . 50.0 111.43 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -87.97 130.25 35.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.24 124.13 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.773 -1.195 . . . . 50.0 107.773 177.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -99.59 -41.32 7.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.3 -0.864 . . . . 50.0 111.791 -174.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.06 160.41 42.43 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.88 -0.785 . . . . 50.0 108.88 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -128.36 154.58 45.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.899 -1.149 . . . . 50.0 107.899 176.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t0 55.67 40.57 30.92 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.547 1.642 . . . . 50.0 108.309 -175.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -70.86 -8.0 49.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.646 -1.616 . . . . 25.0 114.193 -171.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -135.86 12.49 3.39 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.811 0.671 . . . . 50.0 112.811 -175.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 15.96 74.41 Favored Glycine 0 N--CA 1.459 0.224 0 N-CA-C 110.692 -0.963 . . . . 25.0 110.692 -176.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.3 mt -122.52 110.68 15.88 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.479 -1.674 . . . . 50.0 106.479 176.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.9 144.07 57.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.559 -1.275 . . . . 50.0 107.559 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 -17.2 57.04 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 115.217 -0.902 . . . . 25.0 113.107 -177.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -94.33 128.2 40.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.96 1.38 . . . . 50.0 108.61 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -119.72 146.3 45.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.644 -0.502 . . . . 50.0 109.644 -174.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.2 tp -86.22 112.64 21.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.654 -1.61 . . . . 50.0 106.654 174.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -112.04 168.32 9.69 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.923 -0.399 . . . . 25.0 109.923 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -128.71 131.71 47.95 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.064 -1.088 . . . . 50.0 108.064 174.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -158.61 140.12 13.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.173 -0.677 . . . . 50.0 109.173 -176.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 56.43 33.2 22.05 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.547 0.689 . . . . 25.0 112.356 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.2 3.34 90.68 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 115.758 1.063 . . . . 25.0 115.758 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -127.85 161.48 28.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 118.503 1.152 . . . . 50.0 109.035 177.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -113.15 151.74 30.51 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 105.903 -1.888 . . . . 50.0 105.903 176.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.73 38.19 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.437 -1.065 . . . . 50.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -78.62 144.79 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.51 0.671 . . . . 50.0 109.217 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.55 134.12 15.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.314 -0.857 . . . . 25.0 109.106 -176.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.95 114.65 3.96 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 116.05 -2.167 . . . . 50.0 110.855 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.57 -18.28 63.4 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-N 116.066 -0.515 . . . . 50.0 113.07 -176.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.47 -31.13 67.52 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.53 0.332 . . . . 50.0 111.414 174.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -88.58 6.9 35.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.112 0.412 . . . . 50.0 112.112 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.9 mt -119.4 151.33 38.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.851 0.358 . . . . 50.0 111.818 -176.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -124.43 123.31 39.89 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.956 -0.757 . . . . 50.0 108.956 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.471 0.593 0 C-N-CA 123.284 0.633 . . . . 50.0 110.388 -177.84 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 120.257 0.075 . . . . 50.0 111.144 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.6 t30 48.55 47.35 20.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.352 1.241 . . . . 50.0 114.352 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 165.8 12.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 N-CA-C 105.334 -2.098 . . . . 50.0 105.334 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.23 159.64 39.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.524 -0.917 . . . . 50.0 108.524 -178.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.35 164.65 29.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.562 -0.744 . . . . 25.0 110.388 -172.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -114.81 135.15 54.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.75 -1.204 . . . . 50.0 107.75 175.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.99 124.49 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 25.0 110.7 178.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.42 -29.42 41.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.041 -0.527 . . . . 50.0 109.972 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -126.73 162.7 25.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.76 -0.83 . . . . 50.0 108.76 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 p-10 -98.29 160.38 14.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.613 -0.884 . . . . 50.0 108.613 175.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -144.14 175.0 10.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.462 0.648 . . . . 50.0 112.265 177.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.8 t -126.96 137.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 100.215 -3.994 . . . . 25.0 100.215 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.8 16.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.173 -1.047 . . . . 25.0 108.173 -178.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.64 -11.45 53.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.22 1.01 . . . . 50.0 109.354 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -138.33 152.52 71.57 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.02 -0.991 . . . . 50.0 109.088 -176.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.98 -15.78 29.25 Favored 'Trans proline' 0 C--N 1.35 0.608 0 N-CA-C 114.016 0.737 . . . . 25.0 114.016 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -84.35 -20.01 32.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.835 0.826 . . . . 50.0 109.621 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.56 135.73 35.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.662 -0.699 . . . . 50.0 110.199 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.95 138.46 36.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.108 -0.701 . . . . 50.0 109.108 177.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 p -90.03 131.74 35.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.194 -1.409 . . . . 50.0 107.194 172.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.39 169.02 22.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.716 -1.216 . . . . 25.0 107.716 -177.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -128.24 158.78 37.2 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 109.25 -0.648 . . . . 50.0 109.25 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.4 pttt -56.29 128.62 36.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.127 -1.064 . . . . 50.0 108.127 173.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.78 -20.84 42.5 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.944 -0.571 . . . . 25.0 113.868 -176.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -66.89 151.02 48.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.403 0.601 . . . . 50.0 109.989 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -115.42 128.38 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.541 -0.911 . . . . 50.0 108.541 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.5 148.61 50.58 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.455 0.645 . . . . 50.0 111.168 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 m -89.86 126.43 35.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.141 -1.429 . . . . 25.0 107.141 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.2 t -91.57 114.05 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.279 -1.748 . . . . 50.0 106.279 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.2 mt -88.77 -43.21 11.42 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.187 -0.915 . . . . 50.0 110.206 -176.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -145.72 161.19 40.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.499 -0.926 . . . . 50.0 108.499 -173.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -126.8 150.32 49.21 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.823 -1.547 . . . . 50.0 106.823 177.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 58.92 34.02 23.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.995 1.379 . . . . 50.0 108.267 177.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -69.61 -20.53 63.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.693 -1.594 . . . . 25.0 113.673 -169.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -102.46 6.22 39.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.701 -0.681 . . . . 50.0 110.144 -177.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 12.36 84.64 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 109.658 -1.377 . . . . 25.0 109.658 -173.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -113.36 121.02 43.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.783 -0.821 . . . . 50.0 108.783 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.4 128.51 37.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.54 0.686 . . . . 50.0 110.311 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.98 -0.92 84.63 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 115.766 1.066 . . . . 25.0 115.766 175.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -100.79 123.86 45.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.049 1.424 . . . . 50.0 109.237 177.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -113.3 143.02 45.14 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.251 -0.28 . . . . 50.0 111.133 -171.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.6 tp -81.99 112.98 19.57 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.661 -1.607 . . . . 50.0 106.661 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.3 m -114.11 159.05 20.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.901 0.382 . . . . 25.0 110.43 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -135.59 127.0 28.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.698 -0.683 . . . . 50.0 109.76 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.98 141.82 29.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.545 0.528 . . . . 50.0 110.889 176.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 48.08 38.57 9.87 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 178.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.61 89.82 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 115.019 0.768 . . . . 25.0 115.019 176.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -122.96 145.27 48.63 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.103 -0.703 . . . . 50.0 109.103 178.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -118.04 150.35 39.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.696 -0.853 . . . . 50.0 108.696 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.5 169.22 42.17 Favored Glycine 0 C--O 1.243 0.704 0 N-CA-C 109.789 -1.324 . . . . 50.0 109.789 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -82.27 146.89 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.504 0.652 . . . . 50.0 109.706 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.3 t -140.83 135.02 15.19 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 -177.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.06 119.76 6.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 115.323 -2.652 . . . . 50.0 110.776 174.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.63 -22.6 68.13 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 114.31 0.484 . . . . 50.0 114.31 -173.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.91 -26.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 122.524 -0.398 . . . . 50.0 111.932 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -85.71 6.62 26.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.84 0.681 . . . . 50.0 112.84 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -118.98 146.69 44.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.47 0.544 . . . . 50.0 112.47 -175.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -118.2 121.77 41.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 170.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm . . . . . 0 C--O 1.24 0.56 0 O-C-N 123.982 0.801 . . . . 50.0 109.009 -179.805 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 115.35 1.611 . . . . 50.0 115.35 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.1 t30 51.77 41.69 29.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.402 1.63 . . . . 50.0 115.402 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 m -114.84 163.07 12.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.008 -1.849 . . . . 50.0 106.008 175.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 155.8 49.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.618 0.723 . . . . 50.0 111.839 -176.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.49 152.97 47.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.916 -1.038 . . . . 25.0 110.71 -173.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.41 139.23 37.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.708 -0.849 . . . . 50.0 108.708 174.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.98 130.34 41.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.419 -0.586 . . . . 25.0 109.419 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.31 -34.39 15.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.858 -0.793 . . . . 50.0 108.858 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -123.95 168.51 12.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.962 -1.125 . . . . 50.0 107.962 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.0 p-10 -103.77 158.77 16.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.054 0.454 . . . . 50.0 110.387 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -153.06 133.52 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 50.0 110.53 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.94 125.77 57.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 102.901 -2.999 . . . . 25.0 102.901 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.12 129.33 38.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -100.47 -9.69 21.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.688 1.232 . . . . 50.0 109.054 177.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 m -127.71 152.66 77.27 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.402 -1.272 . . . . 50.0 108.948 -177.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.46 -25.62 17.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 114.718 1.007 . . . . 25.0 114.718 -176.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.71 -19.44 60.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.51 0.672 . . . . 50.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -90.02 143.59 26.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.28 -0.873 . . . . 50.0 109.972 -175.06 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.37 137.11 33.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.222 -0.591 . . . . 50.0 111.428 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.0 m -85.6 128.02 34.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 106.32 -1.733 . . . . 50.0 106.32 171.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -149.43 156.69 42.42 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.67 152.78 41.66 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 119.962 -0.695 . . . . 50.0 110.009 179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.4 pttp -55.57 126.33 24.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.158 -178.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.39 -22.67 28.44 Favored Glycine 0 C--O 1.221 -0.662 0 CA-C-N 115.379 -0.828 . . . . 25.0 112.902 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -70.74 157.95 37.15 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.565 0.683 . . . . 50.0 112.044 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -118.03 126.61 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.334 0.653 . . . . 50.0 109.979 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.9 ptp -132.45 151.36 51.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.924 0.392 . . . . 50.0 111.131 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.2 m -92.79 128.11 38.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 25.0 107.808 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.17 124.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.524 -1.288 . . . . 50.0 107.524 178.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 mt -102.83 -33.14 9.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.665 0.617 . . . . 50.0 112.665 -176.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.84 162.01 41.13 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 124.247 0.967 . . . . 50.0 108.603 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -133.86 144.46 48.94 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 108.392 -0.966 . . . . 50.0 108.392 178.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.51 32.98 20.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.511 1.624 . . . . 50.0 107.521 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.41 -14.34 62.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.892 -1.958 . . . . 25.0 115.221 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -110.84 6.15 21.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.057 -0.72 . . . . 50.0 109.057 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.2 -6.88 73.99 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.578 -1.409 . . . . 25.0 109.578 -174.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.72 115.38 27.82 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.768 -0.827 . . . . 50.0 108.768 179.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -61.75 132.65 53.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.397 -0.964 . . . . 50.0 108.397 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.59 -0.49 67.92 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-O 118.908 -0.94 . . . . 25.0 114.497 176.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -106.11 124.23 49.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.663 1.231 . . . . 50.0 109.574 177.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -111.31 145.42 38.85 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 121.968 -0.457 . . . . 50.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.4 tp -85.02 114.56 22.27 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 105.547 -2.02 . . . . 50.0 105.547 175.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.1 m -119.92 157.05 29.59 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.842 -0.429 . . . . 25.0 109.842 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 p -123.74 130.58 52.86 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.954 -1.128 . . . . 50.0 107.954 177.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -151.79 137.72 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.787 -1.097 . . . . 50.0 108.618 -174.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.7 t60 55.48 33.99 22.13 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.819 1.044 . . . . 25.0 113.819 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.05 7.03 89.02 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.816 0.686 . . . . 25.0 114.816 177.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -128.42 163.82 24.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.735 -1.209 . . . . 50.0 107.735 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -124.98 157.99 34.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 50.0 108.062 173.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.26 172.61 45.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.463 -1.455 . . . . 50.0 109.463 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.2 pt -84.22 143.05 12.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-O 121.785 0.802 . . . . 50.0 109.653 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.83 134.05 16.88 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.676 -1.231 . . . . 25.0 107.676 -178.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.3 119.57 6.6 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 114.61 -3.126 . . . . 50.0 110.95 175.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -26.68 72.04 Favored Glycine 0 C--O 1.223 -0.576 0 CA-C-N 115.867 -0.606 . . . . 50.0 114.375 -173.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.33 -9.97 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.956 -0.732 . . . . 50.0 111.325 178.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -93.12 4.59 53.74 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.699 -0.626 . . . . 50.0 109.633 174.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.42 165.24 14.13 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.83 0.452 . . . . 50.0 111.032 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -137.31 118.18 14.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.929 -0.578 . . . . 50.0 109.991 173.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 107.639 -1.245 . . . . 50.0 107.639 178.752 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--O 1.224 -0.253 0 CA-C-O 120.227 0.061 . . . . 50.0 110.925 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 55.26 30.03 13.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.792 0.837 . . . . 50.0 110.518 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.96 162.74 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 104.06 -2.57 . . . . 50.0 104.06 -179.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.15 160.94 38.61 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.383 -0.969 . . . . 50.0 108.383 -177.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.71 159.32 44.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.668 -0.696 . . . . 25.0 110.77 -174.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.88 135.59 48.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.722 -1.214 . . . . 50.0 107.722 174.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.24 135.84 46.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.371 0.605 . . . . 25.0 109.794 178.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.31 -25.79 16.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.469 -0.787 . . . . 50.0 110.041 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -124.01 158.51 31.94 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.632 -1.247 . . . . 50.0 107.632 -178.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 13.4 p-10 -101.52 159.12 15.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.335 -0.617 . . . . 50.0 109.335 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -150.78 158.34 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.355 0.409 . . . . 50.0 111.068 -173.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.71 125.38 65.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 103.076 -2.935 . . . . 25.0 103.076 173.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.81 121.73 17.84 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.74 -0.384 . . . . 25.0 110.029 -176.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -101.65 -15.1 17.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.383 0.611 . . . . 50.0 109.385 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 t -111.62 147.55 37.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 50.0 109.352 175.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.39 -15.4 34.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 117.775 -1.016 . . . . 25.0 113.491 175.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.47 -15.49 56.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.756 0.789 . . . . 50.0 110.19 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -92.62 143.29 26.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.178 -0.919 . . . . 50.0 112.803 -172.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.62 137.57 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.861 -0.524 . . . . 50.0 110.493 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 117.41 23.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.617 -1.253 . . . . 50.0 107.617 172.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 164.66 32.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 36.9 ptt-85 -137.01 164.03 29.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.68 -0.408 . . . . 50.0 111.985 177.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -60.01 136.81 58.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.193 0.52 . . . . 50.0 110.358 179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.36 -19.43 54.28 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.186 -0.915 . . . . 25.0 113.317 -178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -77.54 156.78 30.72 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 117.168 0.484 . . . . 50.0 110.412 -178.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.1 mm -115.18 130.5 69.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 123.332 0.653 . . . . 50.0 109.282 -174.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.9 ptp -138.94 151.83 47.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.949 0.404 . . . . 50.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 m -87.23 146.05 26.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.923 -1.51 . . . . 25.0 106.923 177.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.86 121.03 63.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 106.844 -1.539 . . . . 50.0 106.844 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.08 -49.44 8.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.596 . . . . 50.0 110.303 -177.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.55 170.84 19.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.208 -1.034 . . . . 50.0 108.208 -177.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -134.72 153.69 51.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.731 -0.176 . . . . 50.0 111.163 -175.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 60.46 38.75 19.01 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.298 1.523 . . . . 50.0 107.8 -177.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.45 -18.83 63.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.237 -1.802 . . . . 25.0 114.785 -167.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -111.4 6.38 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.497 0.665 . . . . 50.0 109.597 -177.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.53 -4.39 81.98 Favored Glycine 0 CA--C 1.518 0.241 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -174.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.4 127.02 35.49 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.274 -1.38 . . . . 50.0 107.274 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.53 132.41 52.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.297 0.57 . . . . 50.0 110.167 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.2 1.59 90.4 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 115.519 0.968 . . . . 25.0 115.519 174.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -100.94 115.41 30.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.143 1.472 . . . . 50.0 110.075 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -108.21 146.84 32.21 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.258 -0.276 . . . . 50.0 110.335 -172.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.1 tp -86.26 110.97 20.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.749 -1.575 . . . . 50.0 106.749 176.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -113.69 161.02 18.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.865 -0.42 . . . . 25.0 109.865 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.33 131.46 53.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.38 -0.6 . . . . 50.0 109.38 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.16 140.62 14.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 50.0 108.881 -177.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 56.96 35.06 25.88 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.074 1.138 . . . . 25.0 114.074 175.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.35 85.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.905 -0.664 . . . . 25.0 114.05 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.87 167.61 14.99 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.913 -1.143 . . . . 50.0 107.913 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -136.46 150.24 48.62 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.243 -1.762 . . . . 50.0 106.243 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.69 174.58 45.73 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 109.636 -1.386 . . . . 50.0 109.636 -176.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 pt -77.84 144.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.328 0.585 . . . . 50.0 110.437 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.0 t -144.26 136.19 13.04 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.34 112.05 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 116.009 -2.194 . . . . 50.0 111.662 174.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -24.86 73.29 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 115.902 -0.59 . . . . 50.0 113.941 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -70.44 -0.56 8.56 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 50.0 111.559 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -114.28 13.77 17.93 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.752 -0.462 . . . . 50.0 109.752 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.3 mt -118.75 155.19 31.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 50.0 109.928 178.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.81 117.76 27.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.179 -0.304 . . . . 50.0 110.179 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm . . . . . 0 C--O 1.24 0.558 0 O-C-N 123.773 0.671 . . . . 50.0 110.31 -179.285 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 114.69 1.367 . . . . 50.0 114.69 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t30 54.82 24.49 5.76 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.982 1.475 . . . . 50.0 114.982 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.81 174.16 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 N-CA-C 104.69 -2.337 . . . . 50.0 104.69 174.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.72 162.26 33.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.563 0.619 . . . . 50.0 109.961 -177.193 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.6 144.18 30.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.94 -0.573 . . . . 25.0 111.656 -177.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.24 135.09 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 50.0 109.837 176.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.04 131.05 40.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 25.0 110.062 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.41 -30.63 17.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 50.0 110.784 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -130.57 162.53 29.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.22 -1.771 . . . . 50.0 106.22 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.519 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.4 p-10 -96.83 160.37 14.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.977 0.353 . . . . 50.0 110.39 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -150.02 144.4 25.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.399 0.518 . . . . 50.0 112.399 -177.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 126.79 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.748 -2.315 . . . . 25.0 104.748 174.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.63 128.57 33.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 -178.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -97.2 -24.1 15.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.416 -0.957 . . . . 50.0 108.416 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -104.31 147.16 33.91 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.174 -0.676 . . . . 50.0 109.174 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.1 -14.81 35.47 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.118 -1.455 . . . . 25.0 113.932 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -81.89 -19.81 40.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.898 0.856 . . . . 50.0 110.289 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.07 144.6 25.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.496 -0.774 . . . . 50.0 109.526 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.69 132.92 44.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.189 0.519 . . . . 50.0 110.648 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t -88.86 145.16 25.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.949 -1.13 . . . . 50.0 107.949 175.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.36 165.58 32.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 -178.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -120.71 154.06 36.1 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 121.836 -0.54 . . . . 50.0 109.774 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.519 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 22.4 pttp -58.5 134.02 56.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.386 -0.968 . . . . 50.0 108.386 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.17 -14.01 65.93 Favored Glycine 0 C--O 1.221 -0.699 0 CA-C-O 119.209 -0.773 . . . . 25.0 112.996 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.21 159.8 28.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.02 0.91 . . . . 50.0 109.398 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.78 131.47 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.744 -0.465 . . . . 50.0 109.744 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.6 ptp -130.89 155.26 47.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.185 0.594 . . . . 50.0 110.051 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.3 m -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.825 -1.176 . . . . 25.0 107.825 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.7 125.63 54.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.757 -1.201 . . . . 50.0 107.757 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.0 mt -102.34 -36.59 8.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.554 -0.748 . . . . 50.0 111.876 -174.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.82 161.28 42.56 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.434 -1.321 . . . . 50.0 107.434 -178.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -129.41 150.25 50.85 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.553 -1.277 . . . . 50.0 107.553 177.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 59.09 35.64 23.9 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.287 1.617 . . . . 50.0 106.961 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.53 -10.48 59.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 112.546 -2.116 . . . . 25.0 115.923 -163.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -126.48 13.96 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.448 0.642 . . . . 50.0 109.611 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.58 -5.38 78.33 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 109.802 -1.319 . . . . 25.0 109.802 -175.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.18 115.59 26.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.041 -1.096 . . . . 50.0 108.041 178.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.33 130.83 48.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.793 0.806 . . . . 50.0 109.806 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 2.22 85.81 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-O 118.62 -1.1 . . . . 25.0 115.316 176.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -102.67 128.3 49.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.224 1.512 . . . . 50.0 108.442 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -117.1 144.43 44.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 50.0 109.647 -174.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.7 tp -84.34 117.38 23.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 106.061 -1.829 . . . . 50.0 106.061 175.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.92 158.08 27.44 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.34 129.93 52.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.248 -0.649 . . . . 50.0 109.248 177.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.08 137.76 19.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.509 -0.768 . . . . 50.0 109.173 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 54.99 30.94 15.06 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 176.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.33 13.02 82.45 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.138 -0.554 . . . . 25.0 113.991 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.37 165.3 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.243 -1.762 . . . . 50.0 106.243 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -137.23 140.61 41.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 118.471 0.578 . . . . 50.0 109.721 175.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.46 164.48 29.4 Favored Glycine 0 C--O 1.238 0.374 0 O-C-N 124.039 0.837 . . . . 50.0 111.574 -176.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.21 143.81 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.947 -1.131 . . . . 50.0 107.947 174.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.5 t -140.26 135.63 16.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 -175.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.58 116.99 4.8 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 115.21 -2.727 . . . . 50.0 110.385 174.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.05 -16.85 71.18 Favored Glycine 0 CA--C 1.508 -0.397 0 CA-C-N 116.163 -0.471 . . . . 50.0 112.948 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.49 -4.29 18.19 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.61 -0.347 . . . . 50.0 111.008 175.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -109.89 10.67 24.39 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.414 -0.179 . . . . 50.0 111.049 175.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.82 157.04 33.31 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.623 0.601 . . . . 50.0 112.623 -176.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -127.18 117.55 22.58 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.661 -0.866 . . . . 50.0 108.661 174.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.6 mm . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.614 0.245 . . . . 50.0 110.382 -177.963 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.98 1.104 . . . . 50.0 113.98 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 56.12 34.28 23.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.927 0.891 . . . . 50.0 112.67 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.87 135.49 39.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 104.153 -2.536 . . . . 50.0 104.153 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.75 161.47 29.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.991 0.814 . . . . 50.0 109.75 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.62 153.86 33.11 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.486 0.66 . . . . 25.0 112.768 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -91.64 134.58 34.57 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.167 -0.924 . . . . 50.0 109.962 176.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.97 127.56 32.98 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 108.33 -0.989 . . . . 25.0 108.33 173.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -87.03 -27.73 23.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.93 0.871 . . . . 50.0 109.602 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -124.97 160.0 29.94 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.926 -1.034 . . . . 50.0 108.972 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -98.76 158.22 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.586 -1.635 . . . . 50.0 106.586 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -142.91 159.84 41.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 112.703 0.631 . . . . 50.0 112.703 -174.132 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.63 119.77 55.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 102.535 -3.135 . . . . 25.0 102.535 172.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.07 113.25 13.39 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.354 -0.539 . . . . 25.0 109.593 -177.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -82.48 -15.52 52.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.937 0.875 . . . . 50.0 109.221 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.3 m -122.21 156.28 60.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.746 -0.661 . . . . 50.0 109.323 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.39 -14.13 22.77 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 117.548 -1.168 . . . . 25.0 112.739 175.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -84.85 -16.57 40.85 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.804 1.288 . . . . 50.0 110.962 178.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -91.59 140.93 29.25 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.32 134.32 34.11 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.675 0.75 . . . . 50.0 112.573 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -86.91 106.05 17.5 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.313 -0.858 . . . . 50.0 109.101 177.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -128.79 165.12 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.565 -0.709 . . . . 25.0 112.595 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 mtt85 -122.69 156.7 33.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.507 -0.183 . . . . 50.0 110.507 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -62.18 134.38 56.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 178.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.38 -11.54 68.73 Favored Glycine 0 C--O 1.214 -1.148 0 CA-C-N 115.484 -0.78 . . . . 25.0 112.559 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.16 159.82 32.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.342 1.071 . . . . 50.0 109.361 177.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.55 124.17 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.017 -0.734 . . . . 50.0 109.017 -176.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.6 ptp -131.86 152.35 51.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.26 0.837 . . . . 50.0 113.26 -176.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 m -92.83 131.24 38.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.22 -0.445 . . . . 25.0 110.223 -177.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.84 126.78 43.57 Favored 'Isoleucine or valine' 0 C--O 1.257 1.5 0 N-CA-C 108.104 -1.073 . . . . 50.0 108.104 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.8 mt -102.98 -38.75 7.21 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 114.735 -1.12 . . . . 50.0 111.889 -177.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -143.39 160.99 39.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.827 -1.078 . . . . 50.0 108.215 -176.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 -131.77 145.3 51.52 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.059 -1.83 . . . . 50.0 106.059 174.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 63.59 37.68 10.12 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 123.858 1.79 . . . . 50.0 108.305 -176.081 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -69.39 -19.63 63.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.03 -1.895 . . . . 25.0 116.054 -172.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -119.55 10.51 11.81 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.013 0.911 . . . . 50.0 108.82 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.23 79.64 Favored Glycine 0 CA--C 1.511 -0.16 0 CA-C-N 115.397 -0.819 . . . . 25.0 111.242 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.89 139.1 31.07 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 106.675 -1.602 . . . . 50.0 106.675 176.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.58 150.31 48.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.175 0.988 . . . . 50.0 110.404 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.4 -3.69 38.94 Favored Glycine 0 C--O 1.207 -1.572 0 O-C-N 120.873 -1.142 . . . . 25.0 115.329 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -99.73 131.04 45.97 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 118.967 1.384 . . . . 50.0 110.298 -179.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -125.82 142.34 51.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.97 -0.292 . . . . 50.0 111.389 -172.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp -82.77 120.73 26.0 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 106.618 -1.623 . . . . 50.0 106.618 176.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.46 164.13 15.72 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.386 0.275 . . . . 25.0 110.393 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 89.8 p -120.32 127.05 51.99 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.353 -0.61 . . . . 50.0 109.353 175.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 tp -153.1 146.24 24.68 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.391 -1.337 . . . . 50.0 107.391 -179.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.7 t60 60.92 10.86 2.97 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.406 1.261 . . . . 25.0 114.406 178.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 10.21 62.1 Favored Glycine 0 C--O 1.22 -0.761 0 C-N-CA 120.429 -0.891 . . . . 25.0 112.17 -179.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -124.39 165.76 17.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.677 -1.601 . . . . 50.0 106.677 178.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -118.82 156.88 28.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.026 -2.213 . . . . 50.0 105.026 172.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.72 162.87 31.55 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.879 -0.676 . . . . 50.0 111.865 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -77.02 141.97 14.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 122.313 1.054 . . . . 50.0 108.806 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.23 136.85 17.26 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.434 -1.257 . . . . 25.0 110.228 178.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.37 115.63 4.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 117.564 -1.157 . . . . 50.0 111.338 178.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.85 -25.46 70.63 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 115.996 -0.547 . . . . 50.0 113.576 -174.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -64.77 -22.85 67.07 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.899 0.849 . . . . 50.0 111.551 178.04 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -91.59 10.42 28.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.413 -0.358 . . . . 50.0 111.463 -178.073 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.9 144.87 45.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.528 0.68 . . . . 50.0 111.987 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -112.64 113.28 25.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 121.96 -0.463 . . . . 50.0 110.649 178.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mm . . . . . 0 C--O 1.214 -0.785 0 C-N-CA 123.063 0.545 . . . . 50.0 109.812 -174.645 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.347 0.117 . . . . 50.0 110.959 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 49.95 39.19 18.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.581 0.956 . . . . 50.0 113.581 176.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.55 141.56 32.18 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 107.335 -1.357 . . . . 50.0 107.335 -178.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.88 154.48 18.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.749 0.785 . . . . 50.0 111.879 -174.009 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.16 46.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.829 -1.078 . . . . 25.0 109.866 -179.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -97.02 134.62 40.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.024 -1.102 . . . . 50.0 108.024 175.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.85 136.79 45.4 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.638 0.732 . . . . 25.0 110.088 176.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.7 mt -94.61 -34.32 12.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 50.0 109.169 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -125.4 164.85 19.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.405 -1.702 . . . . 50.0 106.405 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.17 165.39 13.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.851 -0.796 . . . . 50.0 108.851 174.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.09 110.53 3.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.6 . . . . 50.0 109.787 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.57 131.87 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 174.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.92 15.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.478 -1.305 . . . . 25.0 107.478 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -96.84 -6.75 35.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.323 1.058 . . . . 50.0 108.296 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -132.31 149.58 73.56 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.194 -1.41 . . . . 50.0 107.194 178.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.38 -24.51 19.34 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 116.038 -2.175 . . . . 25.0 115.068 -174.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.62 -15.62 58.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.752 0.787 . . . . 50.0 110.617 -179.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -81.02 141.36 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.361 -1.348 . . . . 50.0 107.361 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.08 130.2 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.726 -0.609 . . . . 50.0 110.124 178.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.38 116.34 21.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.87 -1.159 . . . . 50.0 107.87 174.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -141.34 165.88 26.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.484 -0.562 . . . . 25.0 109.484 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.69 155.21 46.26 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.938 0.399 . . . . 50.0 111.921 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.5 129.84 37.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.981 -0.554 . . . . 50.0 110.594 176.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -21.74 44.32 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.435 -179.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -72.16 160.99 31.52 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 117.34 0.57 . . . . 50.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.7 mm -119.65 128.67 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.888 -0.782 . . . . 50.0 108.888 -176.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -135.87 148.45 48.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.068 0.461 . . . . 50.0 110.237 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -87.07 128.77 35.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.463 -0.94 . . . . 25.0 108.463 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.3 t -89.01 124.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.755 -1.572 . . . . 50.0 106.755 175.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.12 -45.29 7.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.624 -0.716 . . . . 50.0 110.247 -179.223 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.27 164.63 34.29 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.488 -0.56 . . . . 50.0 109.488 -175.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -129.88 152.66 49.12 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.402 -0.592 . . . . 50.0 109.402 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t0 56.53 39.43 29.91 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 123.608 1.67 . . . . 50.0 107.414 -175.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -70.48 -12.93 61.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.401 -1.727 . . . . 25.0 114.179 -169.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.05 9.85 5.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 50.0 111.472 -176.796 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.39 14.49 78.46 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 108.951 -1.66 . . . . 25.0 108.951 -174.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.92 111.25 23.82 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.172 -1.418 . . . . 50.0 107.172 177.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -63.78 141.75 58.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.814 -0.81 . . . . 50.0 108.814 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.04 -14.75 31.0 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-O 119.273 -0.737 . . . . 25.0 114.846 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -94.01 136.44 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.794 1.297 . . . . 50.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -121.83 146.14 47.37 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.232 -0.655 . . . . 50.0 109.232 -175.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -84.91 116.05 23.12 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.486 -1.672 . . . . 50.0 106.486 175.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.1 m -117.41 164.73 14.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.581 -0.526 . . . . 25.0 109.581 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -125.59 127.66 46.7 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.938 -0.764 . . . . 50.0 108.938 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.7 tp -161.11 152.36 18.87 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.01 -1.478 . . . . 50.0 107.01 -177.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.1 t60 58.95 28.23 17.33 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.64 0.733 . . . . 25.0 112.109 177.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.74 2.12 85.1 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 115.023 0.769 . . . . 25.0 115.023 178.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -133.86 164.21 27.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 117.866 0.833 . . . . 50.0 110.656 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -101.71 158.93 15.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.618 -1.623 . . . . 50.0 106.618 176.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 162.66 33.11 Favored Glycine 0 C--O 1.24 0.496 0 N-CA-C 109.872 -1.291 . . . . 50.0 109.872 178.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -81.88 145.7 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.514 0.673 . . . . 50.0 109.643 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.31 134.83 16.76 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 25.0 108.809 -176.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.22 109.19 2.15 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.079 -1.481 . . . . 50.0 110.696 172.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.15 61.84 Favored Glycine 0 C--O 1.22 -0.723 0 N-CA-C 115.394 0.918 . . . . 50.0 115.394 -172.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -16.99 64.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.874 -0.78 . . . . 50.0 111.464 177.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.53 3.83 51.2 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.908 -0.495 . . . . 50.0 111.002 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -118.51 157.59 26.99 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.613 0.365 . . . . 50.0 110.321 -178.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -127.49 117.82 22.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.381 -0.97 . . . . 50.0 108.381 171.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.0 mm . . . . . 0 C--N 1.32 -0.683 0 N-CA-C 108.234 -1.024 . . . . 50.0 108.234 177.926 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.549 0.214 . . . . 50.0 111.141 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 55.31 26.7 8.92 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.904 0.882 . . . . 50.0 113.214 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.73 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 N-CA-C 105.798 -1.927 . . . . 50.0 105.798 177.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.24 159.63 37.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.898 -0.779 . . . . 50.0 108.898 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.279 -0.419 . . . . 25.0 109.973 -178.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -95.42 133.86 38.91 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.108 -0.701 . . . . 50.0 109.108 178.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 132.18 42.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.199 0.523 . . . . 25.0 110.686 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.8 -32.8 15.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.78 -0.822 . . . . 50.0 108.78 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.65 162.18 18.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.073 -0.967 . . . . 50.0 108.825 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.34 148.99 22.19 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.339 -2.097 . . . . 50.0 105.339 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -148.28 130.51 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 50.0 111.672 -172.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.46 132.26 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 102.833 -3.025 . . . . 25.0 102.833 172.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.13 126.33 28.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.96 -0.755 . . . . 25.0 108.96 -178.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.33 -7.07 32.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.435 -0.95 . . . . 50.0 108.435 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.9 155.68 80.19 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.316 -0.856 . . . . 50.0 109.171 178.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.38 -24.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 116.994 -1.537 . . . . 25.0 113.591 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.76 -15.55 51.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.222 -0.444 . . . . 50.0 110.143 -178.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.74 147.06 29.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.602 0.715 . . . . 50.0 110.894 -178.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.89 134.24 36.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.102 -0.499 . . . . 50.0 110.224 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -84.62 142.84 29.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.758 -1.571 . . . . 50.0 106.758 172.027 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -158.24 166.35 32.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -126.14 155.5 41.59 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.942 -0.474 . . . . 50.0 110.653 -178.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.04 135.3 56.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.119 -0.697 . . . . 50.0 109.119 -179.027 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.68 -9.97 76.09 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.153 -0.804 . . . . 25.0 114.711 -178.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -81.42 162.98 23.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.966 0.883 . . . . 50.0 108.71 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.54 131.48 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.659 -0.867 . . . . 50.0 108.659 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.6 ptp -129.48 152.21 49.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.916 -0.584 . . . . 50.0 110.002 -178.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 m -82.31 131.64 35.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.217 -1.031 . . . . 25.0 108.217 178.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.4 t -100.03 121.07 50.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.658 -1.608 . . . . 50.0 106.658 176.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.5 mt -91.28 -52.36 4.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.724 -0.671 . . . . 50.0 110.689 -176.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -146.43 170.55 16.61 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.757 -0.831 . . . . 50.0 108.757 -177.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -128.27 157.04 42.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.154 -1.795 . . . . 50.0 106.154 -179.218 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.6 t0 62.17 35.56 15.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 123.397 1.57 . . . . 50.0 108.759 177.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -70.98 -12.59 61.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.476 -1.693 . . . . 25.0 112.349 -176.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -118.9 5.81 11.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.347 0.499 . . . . 50.0 112.347 -175.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.52 11.14 82.4 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.555 -1.418 . . . . 25.0 109.555 -174.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.65 114.91 16.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.301 -1.741 . . . . 50.0 106.301 176.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.95 156.88 31.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.82 -1.548 . . . . 50.0 106.82 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.56 -15.4 62.07 Favored Glycine 0 C--O 1.218 -0.848 0 N-CA-C 108.186 -1.966 . . . . 25.0 108.186 -173.054 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.91 126.41 52.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.196 -1.409 . . . . 50.0 107.196 173.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -119.79 143.07 48.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.266 -1.013 . . . . 50.0 108.266 -177.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.8 tp -82.97 107.86 15.87 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.377 -1.712 . . . . 50.0 106.377 177.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.7 m -108.65 163.81 12.92 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.371 -0.604 . . . . 25.0 109.371 179.383 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.5 t -130.1 129.67 43.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.313 -0.625 . . . . 50.0 109.313 175.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 tp -161.39 155.05 21.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.509 -1.663 . . . . 50.0 106.509 -175.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 58.8 23.83 11.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.438 0.903 . . . . 25.0 113.438 174.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.76 4.21 88.99 Favored Glycine 0 C--O 1.202 -1.904 0 N-CA-C 115.602 1.001 . . . . 25.0 115.602 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -129.36 166.16 20.07 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.372 1.069 . . . . 50.0 108.136 -178.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -118.44 158.2 25.76 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.986 -1.857 . . . . 50.0 105.986 169.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.67 167.37 39.95 Favored Glycine 0 CA--C 1.507 -0.435 0 N-CA-C 110.747 -0.941 . . . . 50.0 110.747 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 pt -75.86 145.56 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.291 -1.374 . . . . 50.0 107.291 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.26 133.6 15.09 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 -179.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.12 108.4 1.95 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 116.374 -1.951 . . . . 50.0 110.246 172.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.18 -18.62 58.15 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-N 115.565 -0.743 . . . . 50.0 114.112 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -65.19 -18.48 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.59 -0.359 . . . . 50.0 111.062 176.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -90.47 4.51 50.85 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.969 -0.457 . . . . 50.0 111.736 176.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.9 mt -122.85 157.23 32.94 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.628 0.603 . . . . 50.0 112.628 -173.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -125.08 117.78 24.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.88 -0.785 . . . . 50.0 108.88 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 116.105 -0.498 . . . . 50.0 112.171 -174.75 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 115.186 1.55 . . . . 50.0 115.186 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 t30 49.91 42.35 24.14 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.05 0.759 . . . . 50.0 113.05 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.1 p -116.4 161.95 14.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 103.685 -2.709 . . . . 50.0 103.685 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.52 156.93 45.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.179 0.899 . . . . 50.0 109.714 -177.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.85 151.78 43.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.654 -0.703 . . . . 25.0 110.4 -174.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -97.63 133.33 42.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.334 -1.358 . . . . 50.0 107.334 174.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.74 137.06 43.75 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.417 0.627 . . . . 25.0 109.378 176.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.29 -26.66 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.458 -0.792 . . . . 50.0 109.541 178.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -127.26 159.47 34.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.12 -1.067 . . . . 50.0 108.12 -178.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -100.06 163.5 12.4 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.29 0.636 . . . . 50.0 109.481 178.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.21 160.29 43.92 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.311 -0.996 . . . . 50.0 108.311 -178.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.15 133.42 68.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 102.391 -3.188 . . . . 25.0 102.391 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.94 143.47 27.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.96 -0.385 . . . . 25.0 109.96 -175.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -122.34 -23.97 5.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.553 0.533 . . . . 50.0 110.662 173.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.3 m -85.46 147.22 46.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 176.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -71.63 -20.36 26.85 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.968 -1.555 . . . . 25.0 113.718 -178.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -86.15 -4.5 59.18 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.763 0.425 . . . . 50.0 111.099 179.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.91 143.08 28.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.927 0.491 . . . . 50.0 111.128 -175.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mt -96.49 133.5 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.82 -0.55 . . . . 50.0 111.611 177.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.2 t -88.75 85.06 6.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.868 -1.16 . . . . 50.0 107.868 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -96.46 160.33 14.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.347 -0.612 . . . . 25.0 109.347 -179.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -129.56 152.87 48.61 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 122.202 -0.311 . . . . 50.0 110.742 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -60.11 136.25 57.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 50.0 109.813 178.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.35 -27.54 13.33 Favored Glycine 0 C--N 1.321 -0.286 0 CA-C-N 115.418 -0.81 . . . . 25.0 113.053 -178.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -73.57 162.53 29.13 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.075 0.437 . . . . 50.0 111.048 -178.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.67 129.54 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 122.91 0.484 . . . . 50.0 110.227 -174.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -132.24 146.22 51.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.088 0.471 . . . . 50.0 110.937 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.0 m -85.19 132.0 34.35 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.77 126.79 51.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.393 -1.336 . . . . 50.0 107.393 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -101.83 -50.7 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 50.0 111.1 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -136.3 170.45 16.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.34 0.656 . . . . 50.0 110.097 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -133.25 155.49 49.27 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.447 -1.686 . . . . 50.0 106.447 174.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.6 t0 56.89 41.95 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.133 1.444 . . . . 50.0 109.213 -177.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 t -76.29 4.58 8.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.235 -1.348 . . . . 25.0 113.507 -174.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -139.49 -0.68 1.75 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.956 0.724 . . . . 50.0 112.956 -177.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.32 -2.61 87.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 108.383 -1.887 . . . . 25.0 108.383 -170.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.7 mt -96.02 110.09 22.38 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.734 -1.951 . . . . 50.0 105.734 174.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.89 150.11 47.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.672 -1.233 . . . . 50.0 107.672 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.97 -16.12 44.29 Favored Glycine 0 C--O 1.222 -0.63 0 CA-C-O 119.089 -0.839 . . . . 25.0 113.337 -178.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -93.37 133.84 36.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.831 1.316 . . . . 50.0 108.877 177.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -118.94 146.28 45.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.195 -0.669 . . . . 50.0 109.195 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -84.07 113.97 21.41 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 106.052 -1.833 . . . . 50.0 106.052 176.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.5 m -116.9 166.22 12.42 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.977 -0.379 . . . . 25.0 109.977 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -129.28 132.22 47.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.795 -0.446 . . . . 50.0 109.795 175.127 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -150.95 137.57 18.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.414 -0.958 . . . . 50.0 108.414 -176.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 54.53 32.69 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.776 1.028 . . . . 25.0 113.776 177.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -0.54 89.24 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 114.825 0.69 . . . . 25.0 114.825 177.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -111.81 162.76 14.93 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.906 -1.146 . . . . 50.0 107.906 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -117.25 155.5 29.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.298 -2.482 . . . . 50.0 104.298 170.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.77 164.98 34.31 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.4 -0.68 . . . . 50.0 111.4 179.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -80.41 142.63 13.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.615 0.721 . . . . 50.0 110.239 -177.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.7 t -140.43 133.08 14.63 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.235 -1.024 . . . . 25.0 108.235 -177.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 115.046 -2.836 . . . . 50.0 110.449 174.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.72 -20.49 68.29 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 115.033 0.773 . . . . 50.0 115.033 -173.109 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.03 -8.44 49.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.369 0.584 . . . . 50.0 111.705 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -98.46 6.45 47.2 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.091 -0.381 . . . . 50.0 110.609 175.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.94 143.95 45.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.939 0.4 . . . . 50.0 111.487 -176.071 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -111.16 117.64 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.709 -1.589 . . . . 50.0 106.709 173.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.242 0.71 0 CA-C-N 116.19 -0.459 . . . . 50.0 111.039 -177.882 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 119.841 -0.123 . . . . 50.0 110.958 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.0 t30 55.53 42.2 29.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.215 0.531 . . . . 50.0 111.934 178.018 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.92 172.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.998 -1.853 . . . . 50.0 105.998 176.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 162.53 34.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.423 0.63 . . . . 50.0 110.956 -177.304 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.69 150.09 36.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.016 -0.993 . . . . 25.0 110.42 -178.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -99.53 136.67 39.12 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.595 -0.891 . . . . 50.0 108.595 176.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.33 46.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.982 0.42 . . . . 25.0 109.995 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.98 -24.98 14.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.721 -0.672 . . . . 50.0 110.372 178.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -123.69 158.27 31.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.795 -1.928 . . . . 50.0 105.795 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.4 p-10 -103.02 144.33 31.42 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.089 -0.708 . . . . 50.0 109.089 175.399 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -148.9 122.29 9.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.375 -0.375 . . . . 50.0 110.421 -175.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.91 130.5 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 175.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.91 8.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.945 0.402 . . . . 25.0 111.477 -175.564 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -89.39 -11.54 42.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.435 0.636 . . . . 50.0 109.807 176.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 m -122.86 146.31 47.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.196 -1.409 . . . . 50.0 107.196 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -23.11 27.83 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 117.388 -1.275 . . . . 25.0 114.873 -174.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -77.66 -20.52 53.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.15 0.5 . . . . 50.0 110.567 -178.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.42 152.35 25.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.211 -1.033 . . . . 50.0 108.211 178.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 139.76 32.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.929 0.395 . . . . 50.0 111.093 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -84.66 126.56 33.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.956 -1.498 . . . . 50.0 106.956 172.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.18 163.98 37.6 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -129.78 154.23 47.43 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.762 -0.586 . . . . 50.0 109.943 176.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.517 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 53.3 pttt -56.97 135.12 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.379 0.609 . . . . 50.0 110.198 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.02 -25.66 27.43 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.127 -0.942 . . . . 25.0 112.669 -175.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -72.65 155.89 39.54 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.117 0.458 . . . . 50.0 110.33 -179.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.4 mm -117.06 129.02 74.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.375 0.67 . . . . 50.0 109.67 -175.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -130.89 149.61 52.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.579 0.705 . . . . 50.0 110.525 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.3 m -84.88 128.28 34.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.541 -0.911 . . . . 25.0 108.541 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.64 123.47 46.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.066 -1.457 . . . . 50.0 107.066 177.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.39 -42.94 9.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.6 -0.727 . . . . 50.0 111.787 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -156.31 171.31 20.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.123 -1.066 . . . . 50.0 108.123 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -134.21 157.13 47.05 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 107.287 -1.375 . . . . 50.0 107.287 -178.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t0 60.11 38.47 20.39 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 123.341 1.543 . . . . 50.0 107.691 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -70.51 -12.27 61.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.578 -1.646 . . . . 25.0 114.055 -171.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.16 13.88 6.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.836 0.31 . . . . 50.0 111.836 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.99 18.89 79.23 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.365 -1.094 . . . . 25.0 110.365 -176.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.44 114.84 22.93 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.883 -1.525 . . . . 50.0 106.883 178.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -62.18 144.32 55.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.124 0.964 . . . . 50.0 109.453 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 -16.16 40.89 Favored Glycine 0 C--O 1.217 -0.926 0 CA-C-O 118.876 -0.958 . . . . 25.0 114.112 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -89.58 131.12 35.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.325 1.563 . . . . 50.0 109.94 178.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -120.53 146.19 46.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.976 -0.749 . . . . 50.0 108.976 -175.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.1 tp -86.43 115.35 23.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.457 -1.683 . . . . 50.0 106.457 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -112.75 158.47 20.05 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 -178.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -124.99 126.24 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.756 -0.831 . . . . 50.0 108.756 178.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -159.23 148.42 18.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.316 -1.364 . . . . 50.0 107.316 -174.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 58.24 25.84 13.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.734 0.778 . . . . 25.0 112.494 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.68 88.98 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 114.834 0.693 . . . . 25.0 114.834 176.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -136.16 162.73 32.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 117.773 0.786 . . . . 50.0 110.636 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -96.08 160.61 14.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.242 -1.021 . . . . 50.0 108.242 175.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.75 161.97 34.91 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.917 -1.673 . . . . 50.0 108.917 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 pt -81.77 143.86 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.904 -0.776 . . . . 50.0 108.904 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.13 133.95 13.38 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.46 114.39 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 116.524 -1.85 . . . . 50.0 111.033 175.088 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.02 -21.79 66.12 Favored Glycine 0 C--O 1.223 -0.584 0 N-CA-C 116.165 1.226 . . . . 50.0 116.165 -173.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -67.54 -16.88 64.43 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.879 . . . . 50.0 110.542 177.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -93.1 9.33 36.33 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.451 -0.156 . . . . 50.0 110.83 177.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -121.34 154.69 36.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.168 0.509 . . . . 50.0 110.852 -178.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -119.07 116.28 26.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.086 -1.079 . . . . 50.0 108.086 175.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 106.988 -1.486 . . . . 50.0 106.988 175.972 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 114.604 1.335 . . . . 50.0 114.604 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.3 t30 49.91 42.32 24.08 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.574 2.064 . . . . 50.0 116.574 175.466 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -118.05 164.68 14.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 N-CA-C 105.227 -2.138 . . . . 50.0 105.227 170.357 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.57 157.86 42.51 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.681 0.753 . . . . 50.0 109.611 -173.767 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.37 162.59 32.61 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.423 -0.808 . . . . 25.0 110.119 -172.727 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.2 134.99 47.38 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.515 -1.291 . . . . 50.0 107.515 178.095 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 120.04 19.77 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.856 -1.164 . . . . 25.0 107.856 173.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.56 -16.86 31.49 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.946 -0.39 . . . . 50.0 109.946 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -138.75 169.25 18.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.156 -1.424 . . . . 50.0 107.156 -176.7 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -104.01 164.97 11.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.824 0.449 . . . . 50.0 111.958 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -156.31 156.73 34.5 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.435 0.694 . . . . 50.0 111.38 175.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -125.55 129.55 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.919 -2.623 . . . . 25.0 103.919 171.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.27 130.6 41.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.739 0.644 . . . . 25.0 112.739 -177.365 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -100.57 -41.53 6.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.59 -1.633 . . . . 50.0 106.59 175.685 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -85.33 147.97 48.6 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.178 -1.045 . . . . 50.0 108.178 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.51 -15.2 27.74 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 119.123 0.722 . . . . 25.0 113.346 175.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 -18.64 49.73 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 121.404 0.621 . . . . 50.0 110.504 177.938 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -87.5 154.08 20.92 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.643 1.211 . . . . 50.0 110.28 -173.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.81 136.92 42.58 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 120.691 -1.256 . . . . 50.0 110.551 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.28 125.13 31.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.119 -2.549 . . . . 50.0 104.119 169.176 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -137.72 159.33 42.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 177.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -124.49 152.12 43.77 Favored 'General case' 0 CA--C 1.491 -1.314 0 O-C-N 121.701 -0.624 . . . . 50.0 112.345 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -57.02 123.08 13.93 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.187 -0.915 . . . . 50.0 111.558 178.146 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -12.76 49.99 Favored Glycine 0 C--O 1.236 0.227 0 CA-C-O 118.944 -0.92 . . . . 25.0 113.859 179.908 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.65 160.13 25.13 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.253 0.62 . . . . 50.0 111.946 -176.382 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.14 136.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.385 0.674 . . . . 50.0 109.311 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -144.86 151.6 38.99 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.518 -0.739 . . . . 50.0 111.078 179.374 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -82.57 132.25 35.2 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.566 -0.288 . . . . 25.0 110.833 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.3 t -88.81 122.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.331 -0.989 . . . . 50.0 108.331 174.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.6 mt -92.67 -51.28 5.18 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.184 0.516 . . . . 50.0 110.402 -176.648 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -137.15 163.82 29.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.868 -1.901 . . . . 50.0 105.868 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -131.35 148.45 52.67 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 109.015 -0.735 . . . . 50.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.85 38.94 30.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.205 1.566 . . . . 50.0 108.133 -177.749 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -67.76 -13.45 62.13 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.012 -1.904 . . . . 25.0 115.359 -175.157 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.78 0.01 20.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.95 -0.389 . . . . 50.0 109.95 -179.248 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.77 77.72 Favored Glycine 0 CA--C 1.511 -0.196 0 N-CA-C 109.263 -1.535 . . . . 25.0 109.263 -174.524 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.39 116.72 29.07 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 106.53 -1.656 . . . . 50.0 106.53 177.045 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.67 138.77 58.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.22 -1.4 . . . . 50.0 107.22 178.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 0.74 72.36 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.43 -1.206 . . . . 25.0 113.54 178.616 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -109.59 115.92 30.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.733 1.766 . . . . 50.0 111.21 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -109.5 144.65 37.48 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.348 -0.845 . . . . 50.0 112.093 -173.535 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.5 tp -82.56 122.27 27.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.649 -1.982 . . . . 50.0 105.649 175.563 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.2 m -120.07 161.49 20.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 177.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.3 t -125.88 133.78 51.81 Favored 'General case' 0 C--O 1.256 1.425 0 C-N-CA 123.476 0.711 . . . . 50.0 109.729 177.258 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -160.88 138.52 9.36 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.888 -1.051 . . . . 50.0 108.884 -177.004 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 t60 58.24 34.9 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.525 0.679 . . . . 25.0 112.675 176.939 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.55 2.34 63.61 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 121.245 -0.502 . . . . 25.0 113.85 177.442 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -115.06 160.29 19.81 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.237 -2.135 . . . . 50.0 105.237 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -137.35 143.41 42.0 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 103.007 -2.96 . . . . 50.0 103.007 175.457 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 174.67 43.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.831 -1.308 . . . . 50.0 109.831 -174.501 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -83.12 140.44 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.675 0.75 . . . . 50.0 112.066 -172.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.4 131.3 15.07 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.044 -1.435 . . . . 25.0 108.843 -176.731 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.13 119.14 6.16 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 114.813 -2.992 . . . . 50.0 112.873 175.316 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.42 -16.84 69.89 Favored Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 119.466 -0.63 . . . . 50.0 114.175 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.82 -15.35 63.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 120.553 -0.459 . . . . 50.0 110.374 174.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -101.42 8.79 42.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.942 0.349 . . . . 50.0 111.942 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 mt -117.66 149.23 41.07 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.284 1.04 . . . . 50.0 111.818 -173.055 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -120.32 120.66 36.66 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.583 -1.266 . . . . 50.0 107.583 174.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 C--O 1.247 0.972 0 O-C-N 123.656 0.598 . . . . 50.0 109.848 -179.952 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 114.932 1.456 . . . . 50.0 114.932 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 t30 51.66 40.38 27.22 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.103 1.149 . . . . 50.0 114.103 -178.476 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.72 172.54 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 105.563 -2.014 . . . . 50.0 105.563 177.08 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.7 156.69 48.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.705 0.684 . . . . 50.0 110.162 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.29 158.6 43.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.21 -0.904 . . . . 25.0 111.059 -173.633 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.8 134.65 48.57 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.367 -0.975 . . . . 50.0 108.367 175.231 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.77 130.29 39.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.742 -0.466 . . . . 25.0 109.742 178.026 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.35 -26.29 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.946 -0.57 . . . . 50.0 109.571 179.306 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -126.28 162.55 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.658 -1.238 . . . . 50.0 107.658 -179.399 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.533 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 25.3 p-10 -103.89 151.21 23.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.864 -0.421 . . . . 50.0 109.864 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -144.58 126.88 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.155 -0.475 . . . . 50.0 110.885 -176.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.7 t -92.04 126.99 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 102.983 -2.969 . . . . 25.0 102.983 174.277 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.46 114.85 5.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 -179.084 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -99.05 -10.97 21.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.724 0.773 . . . . 50.0 108.981 179.18 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 t -116.03 146.72 37.7 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 106.873 -1.528 . . . . 50.0 106.873 172.708 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.68 -18.71 32.47 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 115.819 -2.321 . . . . 25.0 113.618 177.328 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -79.96 -15.71 56.7 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.039 0.923 . . . . 50.0 110.348 179.304 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -86.38 142.68 28.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.653 -0.703 . . . . 50.0 110.19 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 134.25 34.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.741 -0.466 . . . . 50.0 109.741 178.25 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.39 118.67 25.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.101 -1.074 . . . . 50.0 108.101 175.343 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.91 164.57 30.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -178.481 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -131.58 157.1 44.52 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 121.254 0.55 . . . . 50.0 112.056 179.58 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.533 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.0 pttt -56.69 131.67 49.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.468 -0.787 . . . . 50.0 108.987 179.191 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.07 -25.7 25.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.692 -0.686 . . . . 25.0 113.321 -176.651 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.17 161.85 30.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.216 0.508 . . . . 50.0 111.826 -176.456 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.12 131.17 73.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.241 -1.022 . . . . 50.0 108.241 -177.427 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -139.81 154.02 47.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.058 -0.349 . . . . 50.0 110.058 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -87.79 131.02 34.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.583 -1.265 . . . . 25.0 107.583 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.9 t -95.48 116.27 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.327 -2.101 . . . . 50.0 105.327 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.45 -45.66 10.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.4 -0.818 . . . . 50.0 109.636 -176.475 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -146.09 169.47 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.96 -0.756 . . . . 50.0 108.96 -177.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -129.58 156.03 44.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.846 -0.798 . . . . 50.0 108.846 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.16 33.9 23.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.147 1.451 . . . . 50.0 109.286 174.629 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.8 t -70.53 -19.01 62.94 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.594 1.701 . . . . 25.0 115.594 -168.005 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -101.26 2.59 40.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.135 0.493 . . . . 50.0 110.362 -175.61 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.34 -2.36 87.25 Favored Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.003 -1.639 . . . . 25.0 109.003 -172.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -100.83 119.37 38.56 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.435 -1.691 . . . . 50.0 106.435 176.78 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -60.17 136.12 57.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.507 0.67 . . . . 50.0 109.218 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.3 -2.35 86.57 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 115.693 1.037 . . . . 25.0 115.693 177.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -99.94 116.91 33.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.312 1.556 . . . . 50.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -107.05 148.13 29.12 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.094 -0.379 . . . . 50.0 110.806 -171.644 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.0 tp -87.93 113.45 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.765 -1.569 . . . . 50.0 106.765 176.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.14 160.28 21.28 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.2 -0.2 . . . . 25.0 110.749 179.707 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -119.9 128.93 54.08 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.263 0.554 . . . . 50.0 109.594 175.344 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 tp -162.29 152.83 17.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.114 -1.81 . . . . 50.0 106.114 -177.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 58.57 27.75 16.12 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.459 0.647 . . . . 25.0 112.737 177.009 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.5 16.66 77.54 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.803 -0.713 . . . . 25.0 114.11 178.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.52 21.99 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.836 -0.802 . . . . 50.0 108.836 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -109.3 156.92 19.39 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.141 -2.17 . . . . 50.0 105.141 173.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.5 37.47 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 108.87 -1.692 . . . . 50.0 108.87 177.53 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.3 pt -78.83 145.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.504 0.669 . . . . 50.0 109.255 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.2 t -140.39 134.2 15.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 -178.491 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 106.49 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 117.261 -1.36 . . . . 50.0 110.559 174.258 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.21 69.83 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 116.176 1.23 . . . . 50.0 116.176 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -69.92 -8.44 48.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.534 0.667 . . . . 50.0 111.373 178.364 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -93.68 6.28 48.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.03 -0.419 . . . . 50.0 110.451 175.492 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.3 mt -119.15 155.2 32.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.633 -0.506 . . . . 50.0 109.633 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -122.34 121.57 37.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.128 -0.323 . . . . 50.0 110.128 171.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.6 mm . . . . . 0 C--O 1.245 0.855 0 C-N-CA 123.278 0.631 . . . . 50.0 109.884 177.924 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 113.045 0.757 . . . . 50.0 113.045 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.57 48.47 16.93 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.777 1.028 . . . . 50.0 113.777 -179.123 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 m -112.79 172.7 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 103.469 -2.789 . . . . 50.0 103.469 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 155.42 50.23 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.61 0.719 . . . . 50.0 110.944 -177.822 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.71 153.08 44.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.781 -1.1 . . . . 25.0 110.901 -175.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -95.52 133.59 39.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.961 -0.755 . . . . 50.0 108.961 176.828 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.59 123.99 24.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.047 -0.723 . . . . 25.0 109.047 171.37 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.89 -25.98 21.84 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 108.946 -0.761 . . . . 50.0 108.946 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.27 166.51 20.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.277 -1.379 . . . . 50.0 107.277 -178.478 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.95 159.18 15.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.581 0.229 . . . . 50.0 110.71 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -151.49 143.61 23.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.989 -0.551 . . . . 50.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -117.41 126.17 74.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 102.591 -3.114 . . . . 25.0 102.591 174.219 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 127.92 34.07 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.812 0.339 . . . . 25.0 111.2 -174.352 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -97.84 -6.14 33.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.066 0.936 . . . . 50.0 109.193 179.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -141.55 153.15 65.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.773 . . . . 50.0 108.949 -177.082 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.13 -22.83 46.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 116.99 -1.54 . . . . 25.0 112.869 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -73.76 -19.75 60.69 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.482 0.489 . . . . 50.0 110.512 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -95.3 153.08 17.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.963 0.411 . . . . 50.0 111.939 -172.297 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.52 138.33 36.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.699 1.0 . . . . 50.0 113.699 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -87.02 136.87 32.77 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.838 -1.542 . . . . 50.0 106.838 172.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -160.81 162.35 32.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -129.19 158.34 39.29 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.387 -0.821 . . . . 50.0 111.319 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -53.77 131.97 40.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.18 -0.918 . . . . 50.0 109.951 178.725 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.01 -23.18 36.83 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.618 -0.719 . . . . 25.0 113.166 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.68 157.19 38.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.115 0.957 . . . . 50.0 110.791 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -120.79 131.02 73.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.376 -0.972 . . . . 50.0 108.376 -176.039 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -131.47 152.21 50.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.065 0.46 . . . . 50.0 111.332 178.186 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 m -84.76 132.02 34.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 25.0 107.972 177.293 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.9 t -96.03 123.05 48.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 106.282 -1.747 . . . . 50.0 106.282 176.093 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -93.42 -39.79 10.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.561 -0.745 . . . . 50.0 110.823 -174.2 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -159.81 171.92 18.6 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.608 -0.886 . . . . 50.0 108.608 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -120.92 160.98 22.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.97 -1.122 . . . . 50.0 107.97 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.3 42.73 22.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.34 1.067 . . . . 50.0 110.837 179.204 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -68.72 -22.02 64.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.491 -176.767 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.445 ' C ' ' H ' ' A' ' 42' ' ' LEU . 2.3 tp60 -97.83 1.02 47.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 50.0 110.133 179.603 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 -20.13 8.13 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.159 -1.176 . . . . 25.0 110.159 -172.542 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.445 ' H ' ' C ' ' A' ' 40' ' ' GLN . 95.8 mt -78.19 133.49 37.76 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.993 -1.854 . . . . 50.0 105.993 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.72 153.9 42.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.727 0.775 . . . . 50.0 110.702 -177.075 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.5 -19.65 4.7 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 115.557 0.983 . . . . 25.0 115.557 177.095 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -84.33 107.12 16.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.715 1.258 . . . . 50.0 111.291 -179.404 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -96.81 147.31 24.07 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.061 -0.348 . . . . 50.0 110.061 -176.007 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.1 tp -85.72 117.3 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.765 -1.939 . . . . 50.0 105.765 172.916 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 63.9 m -120.28 163.24 18.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.387 -0.597 . . . . 25.0 109.387 179.294 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -124.51 125.82 44.84 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.037 0.535 . . . . 50.0 111.774 -179.658 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.69 153.09 18.61 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 106.946 -1.501 . . . . 50.0 106.946 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 59.06 36.3 24.21 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.825 0.821 . . . . 25.0 110.912 178.575 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 14.32 59.3 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 115.518 0.967 . . . . 25.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -142.36 163.86 31.71 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 118.002 0.901 . . . . 50.0 109.195 177.591 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.85 154.73 26.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.807 -1.183 . . . . 50.0 107.807 173.987 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.13 169.56 41.51 Favored Glycine 0 C--O 1.248 0.971 0 N-CA-C 108.416 -1.873 . . . . 50.0 108.416 -177.684 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.03 143.08 13.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 117.217 0.508 . . . . 50.0 110.441 -177.764 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -140.07 131.53 14.4 Favored Pre-proline 0 C--O 1.242 0.681 0 C-N-CA 123.765 0.826 . . . . 25.0 108.833 178.583 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.09 119.4 6.33 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 115.29 -2.673 . . . . 50.0 111.156 177.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.55 -25.74 61.28 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 114.893 0.717 . . . . 50.0 114.893 -175.77 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.5 -21.3 66.25 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.865 0.364 . . . . 50.0 111.747 178.395 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.35 3.57 53.33 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.66 -0.65 . . . . 50.0 112.257 178.157 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.51 154.98 30.53 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.99 0.424 . . . . 50.0 112.031 -177.31 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -123.17 117.95 26.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.533 -0.303 . . . . 50.0 110.366 171.442 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 C--N 1.321 -0.634 0 O-C-N 123.88 0.738 . . . . 50.0 109.697 179.468 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 112.983 0.734 . . . . 50.0 112.983 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.4 m120 45.59 48.32 11.22 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.227 1.011 . . . . 50.0 113.471 178.014 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.96 151.92 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 106.605 -1.628 . . . . 50.0 106.605 179.449 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 162.43 13.41 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.137 0.494 . . . . 75.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.06 154.05 42.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.285 -0.87 . . . . 25.0 111.373 172.085 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -107.66 133.72 51.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.167 0.987 . . . . 50.0 109.628 -179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 134.95 45.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 124.525 1.141 . . . . 25.0 111.359 175.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.51 -34.06 12.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.832 0.825 . . . . 50.0 109.918 177.323 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.86 165.24 14.86 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 106.642 -1.614 . . . . 50.0 106.642 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.8 p-10 -103.48 155.85 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.992 0.36 . . . . 50.0 111.93 177.588 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.56 98.48 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.705 0.802 . . . . 50.0 108.953 -177.867 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -78.52 140.06 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 172.42 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.43 140.9 54.14 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 123.488 0.715 . . . . 25.0 112.395 -173.062 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.428 ' HG3' ' HG ' ' A' ' 20' ' ' SER . 18.7 pt-20 -110.74 -9.72 14.49 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 114.333 -1.303 . . . . 50.0 110.864 174.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.428 ' HG ' ' HG3' ' A' ' 19' ' ' GLU . 56.2 m -131.44 158.64 74.73 Favored Pre-proline 0 N--CA 1.475 0.81 0 O-C-N 121.248 -0.907 . . . . 50.0 110.707 -178.532 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -71.14 -21.98 26.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 116.69 -1.74 . . . . 25.0 113.995 -179.699 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -16.14 59.49 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 124.297 0.998 . . . . 50.0 109.491 -179.732 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -98.0 150.64 21.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 122.121 0.962 . . . . 50.0 110.28 -168.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.04 133.86 42.7 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.595 -0.691 . . . . 50.0 112.039 178.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.66 104.18 15.82 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.363 -0.606 . . . . 50.0 109.363 179.217 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -134.46 162.57 31.86 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.888 -0.782 . . . . 25.0 108.888 -178.709 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -126.84 162.47 25.82 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.946 -0.761 . . . . 50.0 108.946 -179.169 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 19.8 ptpt -56.01 139.86 45.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.682 -1.229 . . . . 50.0 107.682 178.233 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.11 -14.2 59.62 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 115.611 1.005 . . . . 25.0 115.611 177.943 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.69 163.85 27.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.268 -1.012 . . . . 50.0 108.268 176.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.17 131.12 73.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 N-CA-C 108.266 -1.013 . . . . 50.0 108.266 -178.705 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.7 ptp -130.85 155.49 46.63 Favored 'General case' 0 C--O 1.251 1.158 0 O-C-N 121.627 -0.671 . . . . 50.0 111.604 176.268 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -90.65 135.92 33.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.761 -1.94 . . . . 25.0 105.761 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -96.68 126.69 49.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.148 -1.427 . . . . 50.0 107.148 176.743 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 mt -97.7 -42.85 7.43 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.298 -0.865 . . . . 50.0 110.961 -176.569 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -143.21 161.63 37.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.313 -1.366 . . . . 50.0 107.313 -178.555 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -128.16 144.38 51.11 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.843 -0.799 . . . . 50.0 108.843 173.241 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 59.03 43.15 18.04 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.427 -1.323 . . . . 50.0 107.427 -177.739 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -68.99 -15.11 63.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.722 1.749 . . . . 25.0 115.722 -172.335 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.79 16.63 13.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 122.409 1.1 . . . . 50.0 109.157 178.252 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.98 -21.91 7.4 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.31 -0.859 . . . . 25.0 112.052 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.96 119.15 12.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.905 -0.569 . . . . 50.0 109.819 176.361 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -56.34 132.64 51.51 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.711 0.767 . . . . 50.0 110.132 178.826 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.02 89.66 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.722 -1.043 . . . . 25.0 115.239 175.659 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -96.35 102.19 13.94 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.718 1.759 . . . . 50.0 110.804 179.155 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -91.71 140.35 29.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.549 -0.75 . . . . 50.0 111.917 -172.848 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.21 115.52 21.98 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.405 -1.702 . . . . 50.0 106.405 174.213 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.4 m -112.0 166.87 10.84 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 25.0 110.39 -179.702 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -135.5 125.82 26.51 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.767 -0.457 . . . . 50.0 109.767 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tt -152.34 138.86 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.123 -0.944 . . . . 50.0 108.839 -174.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 53.82 38.51 28.76 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 113.557 0.947 . . . . 25.0 113.557 176.527 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.66 -0.51 85.74 Favored Glycine 0 C--O 1.217 -0.965 0 CA-C-O 118.467 -1.185 . . . . 25.0 115.765 175.773 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -126.07 164.53 20.68 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 118.849 1.324 . . . . 50.0 108.193 178.417 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -113.29 164.15 13.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.101 -1.444 . . . . 50.0 107.101 176.574 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.07 162.55 31.55 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.765 -0.934 . . . . 50.0 110.765 174.581 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 pt -79.38 142.32 14.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.78 -0.822 . . . . 50.0 108.78 175.698 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.6 t -139.64 133.65 15.79 Favored Pre-proline 0 C--N 1.311 -1.078 0 C-N-CA 123.407 0.683 . . . . 25.0 109.525 -175.363 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.2 114.79 3.17 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 116.471 -1.886 . . . . 50.0 112.161 175.937 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.66 -16.58 72.14 Favored Glycine 0 C--O 1.21 -1.352 0 C-N-CA 119.567 -1.301 . . . . 50.0 115.133 -173.552 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.8 -16.01 62.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.518 1.159 . . . . 50.0 111.722 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -94.65 8.48 42.24 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.594 -0.73 . . . . 50.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.08 157.06 29.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.118 0.961 . . . . 50.0 109.92 -177.047 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.05 122.31 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.346 -0.843 . . . . 50.0 108.758 174.382 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.7 mm . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 107.699 -1.223 . . . . 50.0 107.699 -179.839 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 C--O 1.204 -1.311 0 N-CA-C 113.71 1.004 . . . . 50.0 113.71 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.0 t30 53.12 42.33 32.18 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 113.521 0.934 . . . . 50.0 113.521 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -112.44 147.17 16.37 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.718 0 N-CA-C 105.188 -2.153 . . . . 50.0 105.188 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.65 155.38 46.68 Favored 'General case' 0 C--O 1.267 2.024 0 CA-C-N 119.611 1.096 . . . . 50.0 112.521 177.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.5 161.72 36.8 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.897 -1.047 . . . . 25.0 111.021 -170.166 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -110.68 132.27 54.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.378 0.671 . . . . 50.0 110.574 177.261 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.66 127.52 33.32 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.544 0.688 . . . . 25.0 110.247 178.126 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.0 mt -93.44 -23.91 18.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.114 -1.069 . . . . 50.0 108.114 -179.255 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -126.4 165.36 19.19 Favored 'General case' 0 C--O 1.202 -1.432 0 N-CA-C 109.866 -0.42 . . . . 50.0 109.866 178.162 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -100.77 160.85 14.02 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.725 0.81 . . . . 50.0 109.742 178.274 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -148.2 135.79 20.7 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 113.158 0.799 . . . . 50.0 113.158 -177.731 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -94.89 119.81 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 168.159 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.68 116.93 12.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 -177.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.11 -21.28 29.35 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.714 1.245 . . . . 50.0 111.798 -178.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -133.44 154.13 80.75 Favored Pre-proline 0 C--O 1.215 -0.751 0 CA-C-N 115.477 -0.783 . . . . 50.0 109.948 -170.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.48 -21.54 60.13 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 116.22 1.585 . . . . 25.0 116.22 -178.981 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.24 -19.89 45.8 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.058 0.932 . . . . 50.0 110.273 176.425 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -81.87 140.33 34.18 Favored 'General case' 0 C--O 1.195 -1.771 0 O-C-N 121.022 -1.049 . . . . 50.0 112.246 -176.344 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.02 135.99 33.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 123.566 1.65 . . . . 50.0 110.627 177.725 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.28 110.17 18.88 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.801 -1.545 . . . . 50.0 108.192 176.212 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -135.87 166.39 23.41 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.405 0.621 . . . . 25.0 112.424 -176.282 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -128.4 152.79 47.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.594 -1.262 . . . . 50.0 107.594 -179.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -62.27 139.64 58.5 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.828 -1.175 . . . . 50.0 107.828 175.413 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -22.51 40.58 Favored Glycine 0 C--O 1.264 2.02 0 CA-C-O 117.843 -1.531 . . . . 25.0 110.284 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.19 166.17 23.06 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 119.468 1.634 . . . . 50.0 109.977 -176.616 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -121.71 132.24 71.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 114.781 -1.099 . . . . 50.0 110.253 -174.519 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.6 ptp -139.96 155.53 47.09 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 124.028 0.83 . . . . 50.0 112.071 -178.602 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -93.41 138.68 31.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 -179.406 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -103.02 119.22 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 106.787 -1.56 . . . . 50.0 106.787 177.744 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.9 mt -93.87 -41.04 9.84 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.341 -1.3 . . . . 50.0 111.555 -174.166 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -149.27 159.19 44.48 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 104.978 -2.23 . . . . 50.0 104.978 -177.479 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -130.73 149.11 52.53 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 101.496 -3.52 . . . . 50.0 101.496 178.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 t0 62.86 34.55 14.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.997 0.919 . . . . 50.0 108.583 -177.464 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -66.24 -20.63 66.17 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.363 1.616 . . . . 25.0 115.363 -177.387 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -5.97 21.76 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.239 -0.891 . . . . 50.0 112.292 -177.391 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.9 -6.47 83.44 Favored Glycine 0 N--CA 1.464 0.52 0 CA-C-O 122.597 1.11 . . . . 25.0 111.48 -170.388 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.1 mt -94.14 118.69 31.91 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 106.912 -1.514 . . . . 50.0 106.912 177.584 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -56.83 126.68 28.04 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 106.997 -1.483 . . . . 50.0 106.997 171.831 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.0 64.37 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-O 116.634 -2.203 . . . . 25.0 115.302 178.25 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -104.52 125.81 51.03 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 120.772 2.286 . . . . 50.0 110.025 171.235 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -116.61 148.68 40.72 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.438 -1.319 . . . . 50.0 107.438 -176.054 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.3 tp -92.33 113.35 25.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.847 -1.538 . . . . 50.0 106.847 178.276 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.2 m -121.94 157.1 31.98 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.47 0.652 . . . . 25.0 110.121 -177.539 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -118.64 133.43 55.86 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.063 0.945 . . . . 50.0 110.097 173.279 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.2 138.93 19.75 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 124.625 1.203 . . . . 50.0 109.45 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t60 57.86 29.35 17.4 Favored 'General case' 0 C--O 1.183 -2.428 0 O-C-N 124.218 0.949 . . . . 25.0 110.727 173.287 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.76 -2.24 74.76 Favored Glycine 0 N--CA 1.473 1.159 0 C-N-CA 118.922 -1.609 . . . . 25.0 113.443 -179.31 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -107.12 167.4 9.93 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.081 -1.822 . . . . 50.0 106.081 -179.919 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -141.34 144.5 34.59 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 103.493 -2.78 . . . . 50.0 103.493 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -177.85 47.53 Favored Glycine 0 CA--C 1.545 1.96 0 O-C-N 125.394 1.684 . . . . 50.0 110.208 179.291 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.06 143.08 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.29 0.545 . . . . 50.0 111.042 -174.331 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.3 t -139.08 136.21 18.03 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 -172.16 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.66 112.42 3.05 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 CA-C-O 122.819 1.091 . . . . 50.0 111.828 172.594 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -26.26 63.42 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-N 115.407 -0.815 . . . . 50.0 115.038 -179.313 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -68.89 -15.3 63.46 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.678 0.739 . . . . 50.0 109.913 179.622 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -92.18 3.46 55.29 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 120.655 -0.418 . . . . 50.0 110.896 175.505 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -117.33 157.13 26.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.002 0.521 . . . . 50.0 111.127 -177.188 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -124.02 129.08 50.31 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.082 -1.451 . . . . 50.0 107.082 172.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.1 mm . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 104.484 -2.413 . . . . 50.0 104.484 -179.762 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 114.275 1.213 . . . . 50.0 114.275 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.4 t30 45.81 47.36 12.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.32 0.648 . . . . 50.0 112.258 -178.073 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.97 165.35 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 105.751 -1.944 . . . . 50.0 105.751 165.673 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.32 156.2 45.24 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 115.507 -0.769 . . . . 50.0 109.518 -177.139 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.55 162.47 35.0 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 123.896 0.878 . . . . 25.0 110.894 -175.211 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -101.45 133.57 45.89 Favored 'General case' 0 C--O 1.206 -1.23 0 O-C-N 124.185 0.928 . . . . 50.0 108.631 172.246 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 130.5 39.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 105.616 -1.994 . . . . 25.0 105.616 174.731 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.32 -16.54 22.32 Favored 'General case' 0 C--O 1.264 1.82 0 O-C-N 121.439 -0.788 . . . . 50.0 110.44 -178.72 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -135.85 164.78 27.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.383 -1.339 . . . . 50.0 107.383 -178.847 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -100.5 161.01 13.88 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 109.036 -0.727 . . . . 50.0 109.036 -175.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -147.97 136.24 21.38 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 123.863 1.792 . . . . 50.0 111.922 178.731 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.85 122.38 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.8 -1.187 . . . . 25.0 108.719 169.72 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.27 115.41 22.45 Favored 'General case' 0 CA--C 1.565 1.558 0 O-C-N 124.041 0.838 . . . . 25.0 109.386 -177.657 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.54 -20.63 14.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.272 -0.876 . . . . 50.0 111.309 177.049 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -96.22 151.45 38.18 Favored Pre-proline 0 C--O 1.207 -1.14 0 CA-C-N 115.36 -0.836 . . . . 50.0 110.165 177.291 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.95 -19.66 13.74 Favored 'Trans proline' 0 C--O 1.205 -1.129 0 C-N-CA 117.184 -1.41 . . . . 25.0 113.241 -179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -86.08 -20.57 28.55 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.122 1.439 . . . . 50.0 109.838 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -77.5 143.95 38.08 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.947 1.092 . . . . 50.0 113.947 178.151 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.86 137.51 32.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.94 1.352 . . . . 50.0 112.522 176.231 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 p -82.06 125.09 30.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.486 -1.233 . . . . 50.0 109.653 171.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -150.96 172.75 15.2 Favored 'General case' 0 C--O 1.191 -2.002 0 CA-C-O 121.588 0.709 . . . . 25.0 112.449 175.676 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -134.19 163.72 28.97 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.716 -1.587 . . . . 50.0 106.716 -178.436 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -63.98 141.0 58.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.292 -1.373 . . . . 50.0 107.292 174.836 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.59 -15.36 51.79 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 117.302 1.681 . . . . 25.0 117.302 -177.01 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.5 156.81 34.78 Favored 'General case' 0 C--O 1.263 1.765 0 C-N-CA 120.522 -0.471 . . . . 50.0 110.652 173.648 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.96 130.02 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 107.553 -1.277 . . . . 50.0 107.553 -176.547 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.9 150.65 48.36 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 121.026 -1.046 . . . . 50.0 110.853 179.85 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 m -81.62 138.87 35.29 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.046 -0.979 . . . . 25.0 109.585 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.93 122.3 59.36 Favored 'Isoleucine or valine' 0 C--O 1.254 1.314 0 N-CA-C 105.759 -1.941 . . . . 50.0 105.759 178.274 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.52 -36.91 12.19 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 124.329 1.018 . . . . 50.0 113.14 -177.709 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -155.79 149.08 24.68 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.757 -0.831 . . . . 50.0 108.757 -174.515 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.13 147.87 36.47 Favored 'General case' 0 C--O 1.197 -1.669 0 CA-C-O 117.086 -1.435 . . . . 50.0 107.677 -178.645 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 55.81 44.08 26.63 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 125.252 1.595 . . . . 50.0 109.104 179.104 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -72.38 -12.92 61.33 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 116.269 1.952 . . . . 25.0 116.269 -173.7 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -115.39 3.12 14.09 Favored 'General case' 0 C--O 1.256 1.439 0 CA-C-O 121.748 0.785 . . . . 50.0 109.693 -174.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.41 -15.77 59.25 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.05 -1.432 . . . . 25.0 109.925 -178.401 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.34 127.07 32.87 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.462 1.331 . . . . 50.0 111.111 176.336 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.06 129.05 38.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.849 1.309 . . . . 50.0 109.776 -177.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.63 10.16 73.7 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 174.882 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -107.77 103.3 12.54 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 123.778 1.751 . . . . 50.0 113.019 171.346 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -97.86 152.98 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.729 -1.232 . . . . 50.0 110.744 -174.527 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.54 119.93 29.46 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.541 1.15 . . . . 50.0 108.004 174.144 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -122.09 162.58 20.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.347 -0.983 . . . . 25.0 108.347 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.1 t -127.04 133.74 50.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.637 -1.245 . . . . 50.0 107.637 174.591 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 tp -154.89 136.69 14.46 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.752 1.283 . . . . 50.0 110.287 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 59.39 31.76 21.32 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-N 114.428 -1.26 . . . . 25.0 109.771 179.249 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.67 4.69 85.44 Favored Glycine 0 CA--C 1.545 1.937 0 C-N-CA 119.816 -1.183 . . . . 25.0 113.568 -179.775 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.7 mtp85 -117.66 140.11 50.1 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.746 1.773 . . . . 50.0 107.673 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -103.51 151.93 22.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.716 -1.587 . . . . 50.0 106.716 176.118 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.15 172.29 45.21 Favored Glycine 0 C--O 1.263 1.921 0 C-N-CA 118.714 -1.708 . . . . 50.0 113.9 175.051 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -79.83 142.74 13.54 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 117.448 0.624 . . . . 50.0 109.922 -177.888 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.09 132.05 14.58 Favored Pre-proline 0 C--O 1.263 1.764 0 O-C-N 122.014 -0.429 . . . . 25.0 110.588 -174.27 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 125.89 11.69 Favored 'Trans proline' 0 C--O 1.208 -0.985 1 C-N-CA 111.387 -5.275 . . . . 50.0 111.464 178.791 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.06 -21.53 67.69 Favored Glycine 0 C--N 1.306 -1.09 0 CA-C-N 114.75 -1.114 . . . . 50.0 113.756 -171.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.98 -3.65 33.57 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 120.199 -1.765 . . . . 50.0 108.031 178.123 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -109.38 12.21 24.76 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.673 0.749 . . . . 50.0 110.222 176.473 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.8 mt -120.02 154.28 34.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 122.344 1.069 . . . . 50.0 111.508 177.218 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -126.89 113.85 17.09 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.412 -0.813 . . . . 50.0 109.488 171.219 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.3 mm . . . . . 0 N--CA 1.516 2.836 0 O-C-N 124.787 1.305 . . . . 50.0 108.965 175.592 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--O 1.216 -0.674 0 CA-C-O 121.184 0.516 . . . . 50.0 111.379 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.87 37.64 17.79 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.356 -1.293 . . . . 50.0 113.662 174.598 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 p -109.34 160.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 103.49 -2.782 . . . . 50.0 103.49 175.299 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 159.03 28.67 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 107.064 -1.458 . . . . 75.0 107.064 -177.869 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.88 155.71 49.9 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 124.194 0.934 . . . . 25.0 109.597 -176.299 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -98.65 137.03 37.87 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 122.789 0.435 . . . . 50.0 110.86 169.207 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.9 130.6 36.8 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.209 0.448 . . . . 25.0 112.209 172.695 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.69 -22.1 17.77 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.091 -1.078 . . . . 50.0 108.091 -177.017 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -130.99 162.79 28.99 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 125.168 1.542 . . . . 50.0 111.869 178.42 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.53 161.83 13.55 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.781 -0.574 . . . . 50.0 109.782 -179.141 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -151.52 153.85 35.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.871 0.468 . . . . 50.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.1 t -116.87 123.55 71.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.551 -1.648 . . . . 25.0 106.551 167.302 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.35 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.128 -0.983 . . . . 25.0 113.227 -178.376 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -81.9 -15.4 54.06 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.983 -1.008 . . . . 50.0 110.72 176.387 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -134.25 151.67 76.81 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 108.685 -0.857 . . . . 50.0 108.685 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.62 -11.38 26.12 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 117.722 -1.052 . . . . 25.0 112.115 -178.332 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.91 -12.33 55.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.06 0.944 . . . . 50.0 110.531 175.287 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.6 149.49 22.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.233 -0.44 . . . . 50.0 111.554 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.28 139.93 31.7 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 114.189 1.181 . . . . 50.0 114.189 177.071 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 m -85.1 80.44 9.25 Favored 'General case' 0 C--O 1.271 2.206 0 N-CA-C 109.062 -0.718 . . . . 50.0 109.062 169.381 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -86.7 157.75 19.58 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.578 -1.638 . . . . 25.0 106.578 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.66 146.51 50.53 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 107.063 -1.458 . . . . 50.0 107.063 -174.776 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.54 138.07 57.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.133 -0.627 . . . . 50.0 111.246 177.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.44 -16.74 47.68 Favored Glycine 0 C--O 1.255 1.437 0 CA-C-O 117.319 -1.823 . . . . 25.0 112.351 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.75 163.68 26.58 Favored 'General case' 0 C--O 1.269 2.086 0 CA-C-N 119.06 1.43 . . . . 50.0 110.642 179.884 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.5 mm -122.41 128.01 75.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.005 -1.109 . . . . 50.0 108.005 -176.057 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.73 148.12 52.55 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.654 0.74 . . . . 50.0 112.329 177.257 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -81.27 131.24 35.28 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.265 -0.88 . . . . 25.0 110.976 175.545 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.25 128.59 45.44 Favored 'Isoleucine or valine' 0 C--O 1.273 2.29 0 N-CA-C 106.771 -1.566 . . . . 50.0 106.771 179.585 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.73 -38.52 7.04 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 113.442 0.904 . . . . 50.0 113.442 -173.856 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -151.12 147.79 27.49 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.359 -0.837 . . . . 50.0 109.613 -177.131 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -113.66 156.08 24.36 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.859 -1.163 . . . . 50.0 107.859 175.377 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t0 58.34 39.83 25.03 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.187 1.47 . . . . 50.0 109.163 -177.53 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -70.04 -20.11 63.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 121.185 -0.947 . . . . 25.0 113.554 -168.3 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 42' ' ' LEU . 1.4 tp60 -115.73 6.9 14.53 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-N 118.294 0.497 . . . . 50.0 111.851 -174.193 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.98 -18.21 32.6 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.757 -1.337 . . . . 25.0 109.757 -172.922 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 40' ' ' GLN . 90.6 mt -83.97 117.77 23.59 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.535 -2.024 . . . . 50.0 105.535 178.072 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.94 144.12 56.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.999 -1.111 . . . . 50.0 107.999 -175.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.58 81.58 Favored Glycine 0 N--CA 1.437 -1.266 0 O-C-N 121.062 -1.023 . . . . 25.0 114.971 179.798 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -97.39 116.42 29.57 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 118.328 1.064 . . . . 50.0 109.794 177.085 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -108.36 148.53 29.96 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.843 1.783 . . . . 50.0 108.914 -174.753 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -87.78 117.93 26.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.316 -1.311 . . . . 50.0 109.155 172.499 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -121.06 162.84 19.29 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.527 0.566 . . . . 25.0 112.527 -179.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.4 t -121.78 131.24 53.96 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.522 -0.751 . . . . 50.0 110.179 175.519 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 tp -161.49 142.88 11.39 Favored 'General case' 0 C--O 1.181 -2.541 0 CA-C-O 118.121 -0.942 . . . . 50.0 110.487 -175.887 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t60 54.18 29.76 11.06 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.917 1.081 . . . . 25.0 113.917 178.743 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.38 7.04 87.08 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 115.65 1.02 . . . . 25.0 115.65 175.571 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -123.94 164.89 18.39 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 107.458 -1.312 . . . . 50.0 107.458 175.214 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -124.97 150.75 46.33 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 105.264 -2.124 . . . . 50.0 105.264 166.548 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.0 175.0 47.51 Favored Glycine 0 C--O 1.283 3.157 0 N-CA-C 108.522 -1.831 . . . . 50.0 108.522 -178.54 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.2 pt -78.9 140.11 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 124.832 2.253 . . . . 50.0 112.066 -179.378 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -137.32 133.45 18.26 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-N 113.34 -1.755 . . . . 25.0 107.258 -178.722 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.58 118.9 5.95 Favored 'Trans proline' 0 CA--C 1.56 1.816 0 C-N-CA 114.217 -3.389 . . . . 50.0 113.068 172.631 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.65 -21.9 65.49 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 115.023 0.769 . . . . 50.0 115.023 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -56.57 -32.59 65.34 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.234 0.54 . . . . 50.0 111.417 173.179 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -92.06 5.14 51.35 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 113.838 1.051 . . . . 50.0 113.838 179.498 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.9 mt -110.0 155.98 21.09 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.454 1.121 . . . . 50.0 113.288 177.42 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -125.82 115.28 19.75 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.626 -0.879 . . . . 50.0 108.626 174.164 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm . . . . . 0 C--O 1.256 1.447 0 CA-C-N 116.165 -0.47 . . . . 50.0 111.406 176.605 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.4 mt . . . . . 0 C--O 1.249 1.063 0 N-CA-C 109.27 -0.641 . . . . 50.0 109.27 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 59.01 36.86 24.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 125.041 1.463 . . . . 50.0 111.041 177.624 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t -104.87 146.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 106.065 -1.828 . . . . 50.0 106.065 177.252 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 153.4 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 119.304 0.957 . . . . 50.0 111.395 -179.299 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.3 162.34 33.81 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 116.115 -0.493 . . . . 25.0 109.929 -172.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -110.65 140.8 44.66 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.797 -2.297 . . . . 50.0 104.797 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.87 124.98 28.77 Favored 'General case' 0 C--O 1.2 -1.509 0 O-C-N 125.275 1.609 . . . . 25.0 111.09 176.836 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -92.94 -18.83 22.27 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.665 -0.698 . . . . 50.0 110.241 -176.542 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -134.79 163.73 29.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.147 -1.798 . . . . 50.0 106.147 178.883 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -93.47 168.69 10.88 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 119.625 -0.83 . . . . 50.0 110.078 177.809 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -150.29 144.69 25.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.527 0.936 . . . . 50.0 113.527 -179.865 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -116.38 103.78 15.65 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.004 0 N-CA-C 104.082 -2.562 . . . . 25.0 104.082 176.034 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.91 127.38 32.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.076 -1.42 . . . . 25.0 111.268 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.48 -19.96 15.31 Favored 'General case' 0 C--O 1.262 1.759 0 CA-C-O 121.104 0.478 . . . . 50.0 109.715 -176.877 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -107.95 153.49 41.64 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 121.838 -0.539 . . . . 50.0 110.922 -176.467 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.06 -14.66 23.51 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 N-CA-C 113.92 0.7 . . . . 25.0 113.92 178.262 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -85.88 -10.64 54.96 Favored 'General case' 0 C--O 1.209 -1.036 0 O-C-N 124.895 1.372 . . . . 50.0 109.569 176.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.41 144.1 30.63 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.987 0.899 . . . . 50.0 111.137 -174.2 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -92.12 130.61 37.8 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 120.197 -1.564 . . . . 50.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 t -78.18 132.29 37.55 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.584 -0.895 . . . . 50.0 108.584 167.726 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -157.83 166.79 31.78 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.436 -1.69 . . . . 25.0 106.436 176.343 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -133.65 163.99 28.2 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.602 1.191 . . . . 50.0 109.212 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -60.28 132.72 54.79 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 114.683 -1.144 . . . . 50.0 109.952 -176.622 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.46 -5.86 84.23 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 118.286 -1.285 . . . . 25.0 115.863 -171.383 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.56 155.42 28.18 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.003 1.901 . . . . 50.0 110.501 175.436 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.05 122.54 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 123.536 0.523 . . . . 50.0 109.899 -176.491 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.2 ptp -130.69 156.5 44.82 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.983 -0.747 . . . . 50.0 108.983 -175.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -93.99 125.82 38.84 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.264 0.626 . . . . 25.0 111.716 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.67 121.21 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.362 -1.347 . . . . 50.0 107.362 177.532 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.3 -40.33 11.55 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.768 -0.651 . . . . 50.0 110.51 178.82 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.42 168.14 27.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.606 0.763 . . . . 50.0 110.051 178.867 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -122.2 155.13 36.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.923 -1.51 . . . . 50.0 106.923 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 56.13 38.36 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.506 1.753 . . . . 50.0 111.454 177.5 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -66.36 -15.67 63.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.693 2.108 . . . . 25.0 116.693 -167.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -116.63 13.11 15.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 108.321 -0.992 . . . . 50.0 108.321 -178.999 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.22 78.08 Favored Glycine 0 C--O 1.203 -1.785 0 CA-C-O 122.706 1.17 . . . . 25.0 111.025 -177.016 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.28 116.51 21.83 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.762 -1.199 . . . . 50.0 107.762 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -65.2 115.34 5.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.306 -0.861 . . . . 50.0 108.758 176.218 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.23 0.97 47.76 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 117.554 -1.692 . . . . 25.0 115.287 178.322 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -109.45 117.95 35.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 120.452 2.126 . . . . 50.0 110.586 175.594 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -105.82 154.51 20.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.387 -1.279 . . . . 50.0 108.178 -170.8 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.5 tp -93.99 119.54 33.01 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 106.636 -1.616 . . . . 50.0 106.636 177.032 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.4 m -118.01 163.25 16.87 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 119.554 -0.859 . . . . 25.0 110.392 178.398 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.5 t -118.85 129.04 55.0 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 124.076 0.86 . . . . 50.0 112.166 173.673 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 tp -157.55 142.22 16.54 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-N 114.056 -1.429 . . . . 50.0 109.033 -176.225 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.4 t60 56.71 27.31 12.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.176 0.436 . . . . 25.0 112.176 -178.37 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.71 -3.41 74.84 Favored Glycine 0 C--O 1.246 0.856 0 CA-C-O 116.54 -2.255 . . . . 25.0 115.018 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -113.48 160.35 18.56 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.5 1.15 . . . . 50.0 108.267 -178.128 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -109.82 149.25 30.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.322 -2.103 . . . . 50.0 105.322 175.922 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.22 163.33 36.78 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.883 -1.287 . . . . 50.0 109.883 177.471 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 pt -82.64 141.54 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.419 1.104 . . . . 50.0 108.812 -179.174 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.75 137.69 20.36 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.189 -2.152 . . . . 25.0 105.189 -175.334 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -72.69 122.49 8.26 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 113.723 -3.718 . . . . 50.0 115.384 175.391 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.61 -19.95 78.19 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.509 -1.223 . . . . 50.0 113.918 -177.419 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -70.45 -8.95 54.95 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 118.716 -1.194 . . . . 50.0 112.215 172.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -108.93 4.37 23.3 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.589 0.709 . . . . 50.0 109.857 -179.601 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.3 mt -111.85 146.35 37.85 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-O 123.069 1.414 . . . . 50.0 112.186 179.919 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -114.65 116.92 29.49 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.525 -1.216 . . . . 50.0 111.089 170.649 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mm . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 107.327 -1.36 . . . . 50.0 107.327 178.727 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 CA--C 1.497 -1.074 0 N-CA-C 114.639 1.348 . . . . 50.0 114.639 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.4 t30 44.36 46.42 7.75 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.566 1.321 . . . . 50.0 114.566 -179.143 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.86 157.11 35.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 N-CA-C 103.596 -2.742 . . . . 50.0 103.596 -177.06 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.11 163.36 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.446 -0.946 . . . . 50.0 108.446 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.16 156.36 43.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 25.0 110.938 -177.533 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.14 137.36 37.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.217 -1.031 . . . . 50.0 108.217 174.629 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.82 135.04 43.44 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 172.63 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -94.24 -33.18 13.36 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 125.122 1.514 . . . . 50.0 112.103 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -121.57 162.2 21.02 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.553 -1.647 . . . . 50.0 106.553 -177.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.04 149.25 23.67 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 121.896 -0.502 . . . . 50.0 110.806 177.423 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -145.42 122.47 11.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.144 0.974 . . . . 50.0 111.942 -172.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -84.21 132.1 32.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 105.76 -1.941 . . . . 25.0 105.76 171.983 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.18 122.1 26.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.216 -0.994 . . . . 25.0 108.674 178.629 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.44 -12.15 18.79 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.504 0.722 . . . . 50.0 110.101 -178.858 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 m -127.78 152.68 77.43 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 107.391 -1.337 . . . . 50.0 107.391 -176.13 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.01 -15.19 23.5 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 114.866 -2.956 . . . . 25.0 112.672 -179.662 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.48 -15.06 57.66 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.578 -1.267 . . . . 50.0 107.578 -179.476 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -89.88 144.47 25.91 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.29 -0.868 . . . . 50.0 112.65 -173.387 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 128.81 37.94 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.836 -0.745 . . . . 50.0 110.607 177.52 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -73.31 131.21 41.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.834 -2.284 . . . . 50.0 104.834 171.995 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.75 167.46 30.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.089 0.471 . . . . 25.0 110.048 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -133.37 159.88 39.0 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.222 -0.659 . . . . 50.0 109.222 -178.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -63.0 139.62 58.79 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 107.593 -1.262 . . . . 50.0 107.593 -179.877 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -12.3 68.53 Favored Glycine 0 CA--C 1.498 -0.974 0 CA-C-N 115.209 -0.905 . . . . 25.0 112.626 179.007 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -84.75 157.54 21.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.158 -0.682 . . . . 50.0 109.158 -179.489 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 mp -128.28 131.24 69.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-O 122.03 0.919 . . . . 50.0 109.383 -176.419 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.13 144.37 50.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.661 -0.699 . . . . 50.0 111.287 -177.126 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 m -75.14 134.11 41.34 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.13 -1.063 . . . . 25.0 108.13 175.728 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.48 124.82 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.024 -1.102 . . . . 50.0 108.024 174.301 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.0 mt -96.54 -47.25 6.02 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 123.9 0.75 . . . . 50.0 112.13 -174.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.69 168.37 23.04 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.75 -1.944 . . . . 50.0 105.75 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -120.55 160.29 23.5 Favored 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 108.92 -0.771 . . . . 50.0 108.92 -179.261 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 51.32 42.51 29.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 123.496 1.617 . . . . 50.0 111.038 179.925 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -67.4 -21.87 65.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 115.305 1.594 . . . . 25.0 115.305 -168.18 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -109.08 8.14 25.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.398 -0.521 . . . . 50.0 111.019 178.732 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.17 -1.8 86.57 Favored Glycine 0 C--O 1.215 -1.04 0 CA-C-O 122.901 1.278 . . . . 25.0 110.257 -175.797 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.92 122.13 37.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.697 -1.594 . . . . 50.0 106.697 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.34 132.36 49.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.174 -1.417 . . . . 50.0 107.174 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.75 -12.85 61.08 Favored Glycine 0 CA--C 1.485 -1.797 0 O-C-N 121.722 -0.611 . . . . 25.0 114.348 174.29 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.451 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 92.8 m95 -97.43 110.26 22.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.16 -0.612 . . . . 50.0 111.7 177.769 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -101.81 145.39 29.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.732 -0.84 . . . . 50.0 108.732 -174.709 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.09 121.8 28.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.363 -1.347 . . . . 50.0 107.363 173.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.3 m -123.94 164.65 18.88 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.4 -0.963 . . . . 25.0 108.4 178.541 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -124.27 128.06 48.59 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.003 -1.061 . . . . 50.0 109.23 -178.227 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -158.23 151.45 23.01 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 125.202 1.564 . . . . 50.0 110.548 -176.908 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 55.24 31.84 17.37 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.761 0.791 . . . . 25.0 110.545 -179.586 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.22 21.95 66.69 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 117.906 1.922 . . . . 25.0 117.906 -176.101 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -143.7 165.66 27.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.199 -1.778 . . . . 50.0 106.199 -177.912 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -117.72 161.03 20.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.7 -1.593 . . . . 50.0 106.7 -176.648 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.73 166.35 36.58 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.736 -0.745 . . . . 50.0 112.763 176.57 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 pt -73.71 144.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 122.788 1.28 . . . . 50.0 109.675 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.8 t -142.84 134.32 12.91 Favored Pre-proline 0 C--O 1.217 -0.643 0 O-C-N 120.408 -1.433 . . . . 25.0 107.695 179.489 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HD3' ' CZ3' ' A' ' 45' ' ' TRP . 79.1 Cg_endo -73.58 116.98 4.87 Favored 'Trans proline' 0 C--O 1.255 1.344 0 C-N-CA 115.87 -2.286 . . . . 50.0 113.038 176.86 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.05 -23.25 59.21 Favored Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 120.666 -0.778 . . . . 50.0 114.711 -175.241 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.91 -4.9 14.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 120.606 -1.526 . . . . 50.0 112.527 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -114.94 11.97 16.69 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 122.842 0.457 . . . . 50.0 110.403 178.522 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.4 mt -118.33 153.86 33.29 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.33 -0.85 . . . . 50.0 111.181 -179.293 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -121.1 127.17 51.37 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.502 -0.555 . . . . 50.0 109.502 169.815 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.6 mm . . . . . 0 C--O 1.24 0.576 0 CA-C-O 121.792 0.806 . . . . 50.0 110.686 179.058 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 121.869 0.842 . . . . 50.0 109.405 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.3 m120 53.54 32.78 14.88 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-O 122.685 1.231 . . . . 50.0 111.366 -178.239 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.45 147.1 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 101.686 -3.45 . . . . 50.0 101.686 179.168 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.49 163.53 28.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.235 -0.654 . . . . 50.0 109.235 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.14 153.63 38.01 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 122.025 -0.422 . . . . 25.0 109.962 -175.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -101.41 137.28 39.96 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.088 -1.449 . . . . 50.0 107.088 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.63 128.72 33.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 112.917 0.71 . . . . 25.0 112.917 179.157 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.4 mt -89.2 -18.2 27.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.918 0.887 . . . . 50.0 111.218 179.765 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.9 169.49 17.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.271 -1.381 . . . . 50.0 107.271 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.89 154.4 25.25 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.675 0.79 . . . . 50.0 111.523 179.089 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.5 162.56 40.68 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-O 122.118 0.961 . . . . 50.0 110.996 -174.018 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.42 129.21 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.081 -2.933 . . . . 25.0 103.081 173.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.43 126.54 30.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.286 -0.635 . . . . 25.0 109.286 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.47 -14.27 33.12 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.998 0.904 . . . . 50.0 111.178 176.385 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -131.03 155.25 81.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.079 -1.082 . . . . 50.0 108.079 -175.983 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.26 -10.23 20.72 Favored 'Trans proline' 0 C--O 1.205 -1.132 0 CA-C-N 119.967 1.024 . . . . 25.0 113.343 176.013 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -85.29 -4.6 59.21 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.503 -1.295 . . . . 50.0 107.503 178.661 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -118.24 149.37 41.23 Favored 'General case' 0 C--O 1.252 1.217 0 N-CA-C 105.464 -2.05 . . . . 50.0 105.464 -170.654 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -102.97 133.8 47.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.468 1.128 . . . . 50.0 113.579 -178.435 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.8 82.72 8.0 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 121.015 -1.053 . . . . 50.0 113.154 170.341 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -97.21 154.67 17.24 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.882 -1.508 . . . . 25.0 112.698 176.856 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -125.84 152.95 44.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.16 -1.793 . . . . 50.0 106.16 -178.376 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -59.19 135.0 57.5 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 120.303 -0.559 . . . . 50.0 111.455 -179.117 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.07 -14.84 62.42 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 115.43 -0.804 . . . . 25.0 114.231 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -73.39 158.86 34.22 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 121.735 -0.862 . . . . 50.0 112.563 173.359 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -117.46 133.61 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 O-C-N 124.363 1.039 . . . . 50.0 110.295 -178.912 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 ptp -140.84 147.98 39.83 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.36 1.076 . . . . 50.0 111.578 177.636 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 m -86.34 130.57 34.47 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.007 -1.451 . . . . 25.0 111.181 -177.764 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t -90.77 126.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.25 -1.759 . . . . 50.0 106.25 -179.736 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.8 mt -101.06 -35.99 9.15 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 124.255 0.972 . . . . 50.0 112.412 -178.644 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -147.53 145.48 29.11 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.836 -1.172 . . . . 50.0 107.836 177.688 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -112.48 151.01 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 104.003 -2.591 . . . . 50.0 104.003 173.843 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 59.61 42.16 17.67 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.952 0.882 . . . . 50.0 110.66 -175.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.71 -18.44 62.81 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 116.866 2.173 . . . . 25.0 116.866 -169.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.76 5.06 13.06 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.169 0.985 . . . . 50.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.69 -17.41 25.84 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.184 -0.916 . . . . 25.0 112.349 -168.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.4 126.61 28.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.632 -0.507 . . . . 50.0 109.632 172.254 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.0 124.04 19.72 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 122.666 1.222 . . . . 50.0 112.821 -179.852 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.59 79.0 Favored Glycine 0 CA--C 1.503 -0.716 0 N-CA-C 118.094 1.998 . . . . 25.0 118.094 176.903 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -104.82 119.14 38.29 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.912 1.356 . . . . 50.0 108.694 178.552 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -106.12 142.64 35.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.872 -0.604 . . . . 50.0 111.588 -169.404 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -82.31 120.67 25.69 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.431 -0.581 . . . . 50.0 109.431 171.226 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 m -126.17 160.72 29.45 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 112.837 0.68 . . . . 25.0 112.837 -179.217 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.0 t -120.2 135.35 55.01 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 123.731 0.644 . . . . 50.0 110.758 174.906 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 tp -150.58 137.04 18.79 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.927 -1.508 . . . . 50.0 106.927 178.073 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.5 m170 57.44 30.88 19.35 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.361 0.875 . . . . 25.0 113.361 179.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.84 9.43 79.33 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 117.22 1.648 . . . . 25.0 117.22 -175.461 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -110.03 158.99 17.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.81 -1.181 . . . . 50.0 107.81 177.53 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -123.73 142.76 50.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.632 -1.293 . . . . 50.0 108.059 171.887 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.94 161.36 35.05 Favored Glycine 0 CA--C 1.491 -1.43 0 O-C-N 124.294 0.996 . . . . 50.0 111.117 177.6 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.9 pt -77.53 149.74 5.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.539 1.161 . . . . 50.0 108.727 -176.08 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.2 t -145.66 134.91 11.3 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 -176.933 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.21 119.47 6.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 117.188 -1.408 . . . . 50.0 113.114 179.33 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -24.1 63.34 Favored Glycine 0 C--O 1.198 -2.127 0 N-CA-C 117.249 1.66 . . . . 50.0 117.249 -177.463 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.06 -16.33 62.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 118.088 0.944 . . . . 50.0 109.623 178.553 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -94.42 9.53 37.98 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.15 0.976 . . . . 50.0 111.341 178.255 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.6 mt -124.86 147.63 48.68 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.603 -0.686 . . . . 50.0 111.006 -176.918 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -116.34 125.21 51.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.748 -1.114 . . . . 50.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 118.452 0.569 . . . . 50.0 110.973 177.375 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.637 0 N-CA-C 116.807 1.483 . . . . 25.0 116.807 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 p -85.74 165.11 17.18 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.985 -1.303 . . . . 25.0 111.811 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 tpt 49.76 49.15 20.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.667 1.729 . . . . 25.0 115.667 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -91.95 144.77 25.13 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.05 -0.523 . . . . 25.0 110.812 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -87.36 165.76 15.36 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.598 -0.519 . . . . 50.0 109.598 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.95 -41.59 99.56 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.392 0.515 . . . . 50.0 112.392 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.5 t30 55.0 39.61 31.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.09 0.774 . . . . 50.0 113.09 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 m -113.75 155.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.282 -2.488 . . . . 50.0 104.282 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.51 172.02 8.13 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 107.007 -1.479 . . . . 50.0 107.007 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.73 144.87 29.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.317 -0.401 . . . . 25.0 110.811 173.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -95.36 135.76 36.58 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.0 -0.741 . . . . 50.0 109.0 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 130.36 39.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.548 0.69 . . . . 25.0 109.367 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.53 -28.08 15.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.78 -0.645 . . . . 50.0 109.466 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -129.77 160.52 33.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.365 -1.346 . . . . 50.0 107.365 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.0 p-10 -101.76 159.88 14.95 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.581 0.752 . . . . 50.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.83 -177.99 5.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.013 0.435 . . . . 50.0 110.583 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.89 147.81 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.696 -3.816 . . . . 25.0 100.696 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.97 139.61 38.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -99.55 -13.3 19.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.245 0.545 . . . . 50.0 110.295 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -128.8 151.11 76.71 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.518 . . . . 50.0 109.865 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.01 -15.14 36.03 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 117.046 -1.502 . . . . 25.0 113.687 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.63 -7.72 59.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.701 0.763 . . . . 50.0 110.294 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -106.62 143.86 34.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.372 -1.344 . . . . 50.0 107.372 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 134.88 34.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.425 0.631 . . . . 50.0 111.89 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.0 p -93.09 122.6 35.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.906 -1.516 . . . . 50.0 106.906 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -141.21 164.76 29.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.379 -1.341 . . . . 25.0 107.379 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -132.3 154.51 49.63 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.842 -0.799 . . . . 50.0 108.842 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.501 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 64.0 pttt -56.37 137.32 52.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.375 0.607 . . . . 50.0 109.685 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.42 45.98 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.551 -0.749 . . . . 25.0 112.869 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -77.89 160.63 28.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.221 0.51 . . . . 50.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -130.44 132.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.032 -0.729 . . . . 50.0 109.032 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.6 ptp -131.59 151.12 51.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.454 . . . . 50.0 110.634 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -85.02 130.47 34.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.872 -0.418 . . . . 25.0 109.872 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.6 t -90.23 124.38 42.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.577 -1.268 . . . . 50.0 107.577 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.54 -43.15 8.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 50.0 110.862 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -156.42 171.79 19.64 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.364 -1.347 . . . . 50.0 107.364 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -127.38 154.73 44.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.754 -0.461 . . . . 50.0 109.754 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 58.81 39.01 24.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 50.0 108.9 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -65.54 -20.47 66.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.982 -1.917 . . . . 25.0 114.96 -168.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -114.76 13.05 17.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.661 -0.649 . . . . 50.0 110.265 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 -3.59 81.73 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.582 -1.007 . . . . 25.0 110.582 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.42 118.61 30.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.052 -0.721 . . . . 50.0 109.052 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -60.34 130.33 46.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.584 -0.735 . . . . 50.0 109.269 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.75 -1.71 83.81 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 114.982 0.753 . . . . 25.0 114.982 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -101.05 121.66 42.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.677 1.239 . . . . 50.0 108.762 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -111.07 146.49 36.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 50.0 109.493 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.8 tp -85.13 111.84 20.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.034 -2.21 . . . . 50.0 105.034 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.31 164.9 12.69 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.79 -0.819 . . . . 25.0 108.79 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -127.65 130.55 49.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.163 -0.68 . . . . 50.0 109.163 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -159.29 142.79 14.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.875 -0.787 . . . . 50.0 108.875 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 53.61 38.94 29.41 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.097 1.147 . . . . 25.0 114.097 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 2.93 89.56 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 115.289 0.876 . . . . 25.0 115.289 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -125.9 165.46 18.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.835 -0.802 . . . . 50.0 108.835 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -127.2 148.2 50.2 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 104.113 -2.551 . . . . 50.0 104.113 167.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.58 172.57 45.04 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 110.043 -1.223 . . . . 50.0 110.043 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 pt -75.27 141.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 50.0 110.308 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.0 t -140.67 133.9 14.79 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 108.877 -0.786 . . . . 25.0 108.877 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 112.97 3.45 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 117.339 -1.307 . . . . 50.0 111.751 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.75 -19.11 69.05 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.997 -0.547 . . . . 50.0 112.949 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.18 -5.86 7.91 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.351 0.5 . . . . 50.0 112.351 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -116.64 11.27 14.63 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.914 -0.491 . . . . 50.0 110.642 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.3 mt -122.33 155.2 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.035 0.445 . . . . 50.0 111.332 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -121.55 118.06 28.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.253 -0.647 . . . . 50.0 109.253 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mm -60.27 132.24 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 120.677 0.275 . . . . 50.0 110.537 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.8 mt -137.24 133.1 34.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.983 -1.118 . . . . 50.0 107.983 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.2 t -86.84 89.43 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.615 -1.254 . . . . 25.0 107.615 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.16 -19.66 56.83 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.514 -0.851 . . . . 25.0 113.661 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.84 135.23 45.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.979 0.419 . . . . 25.0 110.085 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -110.15 -45.74 3.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.187 -1.412 . . . . 25.0 107.187 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -71.19 143.77 50.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.267 -1.383 . . . . 25.0 107.267 172.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -171.16 171.47 5.72 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.984 -1.487 . . . . 25.0 106.984 -172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -60.28 142.42 90.16 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.117 -0.697 . . . . 25.0 109.117 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -70.8 -24.28 25.09 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 117.239 -1.374 . . . . 25.0 113.046 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.08 -154.18 0.36 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.662 0.785 . . . . 25.0 110.061 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.86 -14.74 62.58 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-O 120.076 -0.291 . . . . 25.0 112.951 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -72.98 90.72 1.5 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.234 -0.654 . . . . 25.0 109.234 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -161.12 165.39 29.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.262 -1.014 . . . . 25.0 108.262 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 pt -72.84 162.88 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.481 0.658 . . . . 50.0 110.046 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.5 m -66.27 148.6 12.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.52 -0.548 . . . . 25.0 109.52 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.49 150.76 33.97 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.897 -1.149 . . . . 25.0 107.897 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 C--O 1.21 -0.982 0 CA-C-O 123.734 1.73 . . . . 25.0 112.873 179.384 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.799 0 CA-C-O 124.007 1.893 . . . . 25.0 114.045 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -74.48 161.46 29.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.229 -1.485 . . . . 25.0 111.256 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.3 mtm 54.77 54.98 8.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.535 0.734 . . . . 25.0 112.545 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -97.72 165.86 11.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.308 -0.627 . . . . 25.0 109.308 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -139.73 133.15 30.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.287 -1.746 . . . . 50.0 106.287 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.7 mt -95.81 -16.31 21.96 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 115.058 1.503 . . . . 50.0 115.058 -172.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 t30 50.15 42.44 25.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.197 0.814 . . . . 50.0 113.197 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.74 157.74 32.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 N-CA-C 105.887 -1.894 . . . . 50.0 105.887 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 161.66 36.48 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.325 0.583 . . . . 50.0 110.941 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.34 163.27 33.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.196 -0.911 . . . . 25.0 110.869 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -111.27 133.35 53.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.997 -1.112 . . . . 50.0 107.997 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.67 133.54 43.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.313 0.578 . . . . 25.0 109.585 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.46 -25.81 17.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.669 -0.696 . . . . 50.0 109.814 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -129.9 160.66 32.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.281 -1.007 . . . . 50.0 108.281 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.49 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.6 p-10 -98.15 158.54 15.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.325 -0.62 . . . . 50.0 109.325 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -156.42 135.84 12.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.909 -0.587 . . . . 50.0 112.168 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.32 127.03 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 127.14 30.41 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.143 -0.317 . . . . 25.0 110.143 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -100.08 -8.59 23.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.961 0.886 . . . . 50.0 108.615 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.1 m -128.4 152.33 78.01 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.783 -1.099 . . . . 50.0 108.655 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.24 -25.62 21.87 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 117.043 -1.504 . . . . 25.0 114.374 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -83.98 -9.92 58.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.195 0.521 . . . . 50.0 110.77 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -87.11 148.5 25.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.497 -0.557 . . . . 50.0 109.497 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.64 134.73 38.2 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.072 -0.392 . . . . 50.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 m -85.04 124.9 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.814 -1.55 . . . . 50.0 106.814 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -145.57 167.93 21.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.341 -0.985 . . . . 25.0 108.341 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -128.99 154.45 46.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 121.972 -0.455 . . . . 50.0 111.509 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.49 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.8 pttp -57.75 131.27 49.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.767 -0.827 . . . . 50.0 108.767 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.89 46.42 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-O 119.351 -0.694 . . . . 25.0 113.973 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -73.19 161.72 30.23 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.345 0.573 . . . . 50.0 111.035 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -121.84 130.15 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.22 -0.659 . . . . 50.0 109.22 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.39 147.81 47.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.551 . . . . 50.0 111.439 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -82.59 132.79 35.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.0 t -94.12 121.37 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.111 -1.811 . . . . 50.0 106.111 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.45 -46.73 9.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.654 -0.703 . . . . 50.0 110.191 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -154.7 163.05 40.82 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.554 -0.906 . . . . 50.0 108.554 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.6 154.09 37.22 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.989 0.516 . . . . 50.0 110.024 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.4 t0 54.66 45.85 25.94 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 123.454 1.597 . . . . 50.0 108.719 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.55 -6.34 35.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.776 -1.556 . . . . 25.0 114.347 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -136.57 6.15 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.294 1.22 . . . . 50.0 114.294 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.14 22.82 64.72 Favored Glycine 0 CA--C 1.517 0.209 0 N-CA-C 108.578 -1.809 . . . . 25.0 108.578 -174.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt -122.72 110.01 14.95 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 104.619 -2.363 . . . . 50.0 104.619 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -65.1 144.15 57.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.954 0.883 . . . . 50.0 109.053 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.34 -16.49 43.9 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-O 118.456 -1.191 . . . . 25.0 114.033 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -88.65 132.28 34.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.596 1.698 . . . . 50.0 109.998 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -120.19 144.22 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.675 -0.861 . . . . 50.0 108.675 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.63 118.6 25.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.933 -1.877 . . . . 50.0 105.933 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.1 m -120.46 164.43 16.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.292 -0.262 . . . . 25.0 110.292 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.6 t -125.62 130.48 51.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.364 -0.606 . . . . 50.0 109.364 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.7 tp -161.61 146.63 13.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.493 -0.928 . . . . 50.0 108.493 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 58.18 32.73 22.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.281 0.845 . . . . 25.0 113.281 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 6.56 88.79 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.877 -0.677 . . . . 25.0 114.735 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -133.31 162.9 30.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 117.839 0.82 . . . . 50.0 109.863 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -105.36 158.28 16.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 104.265 -2.494 . . . . 50.0 104.265 172.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.01 161.1 29.47 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.852 -0.689 . . . . 50.0 111.557 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -78.58 141.82 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.865 -0.791 . . . . 50.0 108.865 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.9 t -140.1 133.89 15.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.38 117.04 4.89 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 114.93 -2.913 . . . . 50.0 110.758 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -19.52 70.0 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 116.068 -0.514 . . . . 50.0 113.607 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -72.8 -3.23 24.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.264 -0.55 . . . . 50.0 111.767 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -108.71 8.95 27.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.09 -0.708 . . . . 50.0 109.09 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.18 155.3 34.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.073 -0.714 . . . . 50.0 109.073 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -126.12 120.75 30.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.801 -0.814 . . . . 50.0 108.801 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 mm -58.58 129.26 20.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.298 -1.001 . . . . 50.0 108.298 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.7 tp -154.18 105.85 2.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.577 -0.738 . . . . 50.0 109.178 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.9 t -110.36 112.05 38.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.157 -1.423 . . . . 25.0 107.157 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.83 4.46 2.7 Favored Glycine 0 C--O 1.227 -0.316 0 CA-C-N 116.158 -0.474 . . . . 25.0 112.444 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 27.6 ttt -104.13 148.18 26.57 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.856 -2.275 . . . . 25.0 104.856 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -59.43 125.74 24.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.549 0.214 . . . . 25.0 110.625 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -69.72 127.99 34.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.397 -1.334 . . . . 25.0 107.397 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.51 143.06 30.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -66.41 146.9 99.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.291 -1.374 . . . . 25.0 107.291 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.73 159.63 52.73 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 117.838 -0.975 . . . . 25.0 112.13 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.38 -21.79 58.02 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.108 0.48 . . . . 25.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.73 178.81 23.24 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 106.165 -2.774 . . . . 25.0 106.165 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.16 -53.3 3.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.853 0.826 . . . . 25.0 110.744 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 58.3 -169.67 0.12 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.163 0.985 . . . . 25.0 112.153 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.7 pt -134.74 157.94 41.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.906 -1.516 . . . . 50.0 106.906 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -109.23 -13.12 10.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.056 0.455 . . . . 25.0 111.134 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.7 p -145.53 145.06 30.89 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.315 -2.106 . . . . 25.0 105.315 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 C--O 1.208 -1.13 0 CA-C-O 124.929 2.3 . . . . 25.0 112.345 178.611 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 122.785 1.214 . . . . 25.0 115.269 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -151.46 153.71 35.16 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.726 -1.213 . . . . 25.0 107.726 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.14 164.28 37.63 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.17 47.54 2.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.353 1.073 . . . . 25.0 109.153 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -144.55 133.12 22.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.441 -1.254 . . . . 50.0 107.653 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.4 mt -110.85 -11.03 14.4 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.24 1.2 . . . . 50.0 114.24 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t30 53.84 31.86 13.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.456 0.91 . . . . 50.0 113.456 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -119.53 156.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 105.867 -1.901 . . . . 50.0 105.867 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.29 158.82 43.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.816 -0.438 . . . . 50.0 109.816 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.21 151.18 44.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 25.0 110.983 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -97.24 134.29 40.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.771 -0.825 . . . . 50.0 108.771 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.82 130.52 40.09 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.717 -0.475 . . . . 25.0 109.717 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.2 mt -92.07 -28.1 17.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 50.0 109.593 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -129.28 162.21 28.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.334 -1.358 . . . . 50.0 107.334 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.3 p-10 -98.72 163.01 12.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.791 0.329 . . . . 50.0 110.699 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -150.42 153.39 35.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 50.0 110.784 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.09 118.12 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.614 -2.365 . . . . 25.0 104.614 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.57 30.41 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.217 0.323 . . . . 25.0 110.511 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.7 -22.05 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 50.0 110.559 174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.9 m -97.79 151.02 37.37 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.243 -0.28 . . . . 50.0 110.243 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.82 -17.99 25.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 117.697 -1.069 . . . . 25.0 113.297 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -85.53 -7.58 58.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.09 -0.505 . . . . 50.0 110.436 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -103.39 146.47 28.45 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.64 0.776 . . . . 50.0 110.007 -176.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -100.26 135.65 41.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.608 0.595 . . . . 50.0 112.608 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -84.95 139.85 31.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.387 -2.079 . . . . 50.0 105.387 168.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -159.11 163.7 35.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.593 -2.003 . . . . 25.0 105.593 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -129.77 154.81 46.85 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 120.222 -0.591 . . . . 50.0 111.855 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.0 pttp -55.73 130.34 42.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.413 -0.812 . . . . 50.0 109.621 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.52 22.74 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.397 -0.819 . . . . 25.0 113.082 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -73.37 162.15 29.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 122.731 0.413 . . . . 50.0 111.745 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -121.47 130.97 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.545 0.738 . . . . 50.0 109.34 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -135.44 145.79 47.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.787 0.327 . . . . 50.0 110.344 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -84.77 131.26 34.57 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.124 -1.065 . . . . 25.0 108.124 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -90.05 124.68 42.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.331 -1.359 . . . . 50.0 107.331 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.6 mt -91.75 -49.18 6.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 50.0 110.156 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -153.58 171.92 18.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.529 -1.285 . . . . 50.0 107.529 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -126.88 157.18 40.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 110.203 -0.295 . . . . 50.0 110.203 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 60.17 32.58 20.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 123.129 1.442 . . . . 50.0 109.467 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.57 -20.52 62.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.356 -1.747 . . . . 25.0 114.544 -170.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -100.99 3.09 41.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.367 0.603 . . . . 50.0 109.713 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.66 79.76 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 109.489 -1.444 . . . . 25.0 109.489 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.33 124.35 39.32 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.33 -1.359 . . . . 50.0 107.33 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.02 133.86 55.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.24 -0.652 . . . . 50.0 109.24 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 1.03 88.94 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 115.352 0.901 . . . . 25.0 115.352 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -99.04 124.13 43.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.173 1.486 . . . . 50.0 108.635 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -113.89 143.84 44.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.03 -0.419 . . . . 50.0 110.329 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.6 tp -82.87 118.07 23.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.417 -2.068 . . . . 50.0 105.417 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.63 163.84 16.76 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.255 -0.646 . . . . 25.0 109.255 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -122.91 137.81 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.118 0.485 . . . . 50.0 110.765 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 tp -159.46 143.4 14.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.94 -1.504 . . . . 50.0 106.94 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 58.99 22.25 10.21 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.606 0.965 . . . . 25.0 113.606 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.8 89.44 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.996 -0.621 . . . . 25.0 112.509 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -112.09 167.28 10.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.168 -1.79 . . . . 50.0 106.168 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.58 150.88 50.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.858 -1.534 . . . . 50.0 106.858 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.65 167.06 39.87 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 109.525 -1.43 . . . . 50.0 109.525 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.87 144.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.811 0.815 . . . . 50.0 111.131 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 64.4 t -140.2 134.18 15.44 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.66 117.99 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 114.621 -3.12 . . . . 50.0 110.696 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.0 -21.61 69.83 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 116.143 -0.48 . . . . 50.0 113.491 -174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -67.67 -14.5 63.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.533 -0.392 . . . . 50.0 111.696 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -94.63 6.72 48.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.037 -0.414 . . . . 50.0 111.123 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.82 154.33 34.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 50.0 111.751 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -123.97 117.72 25.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 50.0 108.969 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.6 mt -66.78 136.51 26.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 50.0 111.177 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.42 144.14 26.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.459 -2.793 . . . . 50.0 103.459 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.6 t -46.39 109.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 114.073 1.138 . . . . 25.0 114.073 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.39 39.03 0.04 OUTLIER Glycine 0 C--O 1.225 -0.46 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.7 ttm -68.03 113.19 5.5 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.118 -0.637 . . . . 25.0 111.323 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 53.77 46.73 25.23 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.176 0.922 . . . . 25.0 112.013 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -61.65 138.17 58.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.971 -0.559 . . . . 25.0 109.823 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -146.09 153.11 40.33 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.265 -0.643 . . . . 25.0 109.265 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -71.91 147.35 91.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 105.502 -2.036 . . . . 25.0 105.502 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.01 -3.22 13.52 Favored 'Trans proline' 0 C--N 1.346 0.408 0 N-CA-C 114.492 0.92 . . . . 25.0 114.492 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.32 168.82 22.97 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.725 -1.583 . . . . 25.0 106.725 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.93 -179.93 27.09 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 108.572 -1.811 . . . . 25.0 108.572 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.01 161.02 28.67 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.786 -0.45 . . . . 25.0 109.786 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -83.93 138.47 33.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.777 0.322 . . . . 25.0 110.143 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.4 tt -84.46 143.57 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.137 -1.431 . . . . 50.0 107.137 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.09 -4.52 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.42 0.629 . . . . 25.0 111.564 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.9 m -63.49 -44.19 95.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.403 0.621 . . . . 25.0 112.242 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 C--O 1.211 -0.933 0 CA-C-O 125.458 2.551 . . . . 25.0 112.105 -174.858 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.671 0 CA-C-O 122.867 1.259 . . . . 25.0 114.319 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -140.92 132.02 26.32 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.4 -1.647 . . . . 25.0 109.979 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.8 mtm 51.07 37.23 17.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.071 0.548 . . . . 25.0 112.041 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 65.78 3.58 2.57 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.432 1.641 . . . . 25.0 115.432 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -93.69 159.66 15.11 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.206 -0.665 . . . . 50.0 109.206 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.54 -46.71 88.09 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.361 -0.607 . . . . 50.0 109.361 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 t30 51.36 40.25 26.06 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.484 1.291 . . . . 50.0 114.484 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.34 166.16 11.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 N-CA-C 105.03 -2.211 . . . . 50.0 105.03 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.62 157.52 43.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.536 0.684 . . . . 50.0 111.495 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.58 152.3 43.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.008 -0.996 . . . . 25.0 110.46 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.45 137.43 35.54 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.73 -0.841 . . . . 50.0 108.73 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 131.99 42.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.1 mt -86.59 -25.8 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 50.0 109.632 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.48 161.21 35.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 50.0 109.081 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.567 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.6 p-10 -99.91 155.79 17.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.429 -0.952 . . . . 50.0 108.429 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.13 172.96 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.674 0.749 . . . . 50.0 112.729 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.71 135.93 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 1 N-CA-C 100.141 -4.022 . . . . 25.0 100.141 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.38 47.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.396 -0.965 . . . . 25.0 108.396 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.63 -25.07 8.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.585 0.553 . . . . 50.0 112.055 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -93.88 148.36 35.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.339 -0.225 . . . . 50.0 110.876 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.3 -15.7 38.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 116.762 -1.692 . . . . 25.0 112.614 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -83.73 -15.56 48.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.862 0.363 . . . . 50.0 110.103 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -95.34 135.06 37.42 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.946 0.498 . . . . 50.0 111.532 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 136.53 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.508 -0.477 . . . . 50.0 110.954 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -91.23 118.47 30.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.62 -1.252 . . . . 50.0 107.62 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -136.13 166.33 23.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.316 0.579 . . . . 25.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -125.2 152.27 44.74 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.771 -0.455 . . . . 50.0 109.771 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.9 pttt -56.61 132.62 52.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.746 . . . . 50.0 108.987 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -13.04 66.98 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 119.247 -0.751 . . . . 25.0 114.265 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -76.28 158.04 31.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 117.936 0.868 . . . . 50.0 110.126 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mm -116.66 125.1 73.46 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 123.061 0.544 . . . . 50.0 109.868 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -131.42 147.25 52.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 50.0 111.376 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -89.0 127.12 35.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.084 -0.71 . . . . 25.0 109.084 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.3 t -86.73 123.13 39.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.335 -1.357 . . . . 50.0 107.335 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.77 -40.9 8.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 50.0 110.81 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.83 158.59 44.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.33 -0.618 . . . . 50.0 109.33 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -129.6 148.61 51.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.733 -0.84 . . . . 50.0 108.733 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.3 t0 55.38 43.6 28.59 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.361 1.553 . . . . 50.0 107.1 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -70.63 -6.34 36.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.568 -1.651 . . . . 25.0 114.352 -170.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.08 6.76 3.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.718 0.636 . . . . 50.0 112.718 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.86 9.65 85.13 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 109.496 -1.441 . . . . 25.0 109.496 -174.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -109.43 110.04 21.06 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 105.509 -2.034 . . . . 50.0 105.509 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.36 145.86 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.083 0.944 . . . . 50.0 108.701 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.4 48.12 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-O 118.624 -1.098 . . . . 25.0 113.749 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -93.5 129.7 39.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 119.367 1.583 . . . . 50.0 110.007 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -119.07 143.72 46.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.767 -0.827 . . . . 50.0 108.767 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.33 116.4 22.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 105.614 -1.995 . . . . 50.0 105.614 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -118.18 164.24 15.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.9 p -129.72 132.98 46.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.98 -0.748 . . . . 50.0 108.98 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.1 tp -159.31 141.56 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 50.0 109.252 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 57.35 31.18 19.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.282 1.216 . . . . 25.0 114.282 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.26 85.98 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 115.239 0.856 . . . . 25.0 115.239 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -135.01 162.81 31.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.726 -0.842 . . . . 50.0 108.726 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -117.75 160.23 21.69 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.25 167.55 39.64 Favored Glycine 0 C--O 1.238 0.374 0 N-CA-C 110.316 -1.114 . . . . 50.0 110.316 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -78.25 142.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.371 0.605 . . . . 50.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -141.68 134.63 14.16 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.994 -1.113 . . . . 25.0 107.994 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.58 119.72 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 114.672 -3.086 . . . . 50.0 111.182 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.68 -18.4 65.98 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.088 -0.506 . . . . 50.0 114.155 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.1 -29.98 70.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.424 -0.457 . . . . 50.0 110.282 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.53 10.28 26.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.377 -0.374 . . . . 50.0 111.983 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.8 mt -117.68 152.59 34.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.326 0.584 . . . . 50.0 111.078 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -124.72 117.99 25.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.121 -0.696 . . . . 50.0 109.121 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.4 mm -57.62 137.81 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.453 -0.573 . . . . 50.0 109.453 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.62 173.41 8.53 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.238 -0.653 . . . . 50.0 109.238 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t 60.25 79.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-O 122.258 1.028 . . . . 25.0 112.297 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.23 47.21 0.92 Allowed Glycine 0 C--O 1.223 -0.532 0 CA-C-N 115.217 -0.901 . . . . 25.0 112.164 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.5 tpt -114.71 123.33 49.0 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.573 -0.529 . . . . 25.0 109.573 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -80.29 -45.44 17.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.46 0.648 . . . . 25.0 110.294 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -73.93 138.66 44.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.629 -0.714 . . . . 25.0 110.181 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -154.26 161.95 41.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.251 -0.648 . . . . 25.0 109.251 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -93.31 151.63 40.48 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.627 -1.249 . . . . 25.0 107.627 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.86 163.46 38.33 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 117.489 -1.207 . . . . 25.0 111.538 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.28 163.43 35.52 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.191 -1.411 . . . . 25.0 107.191 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.76 86.95 0.54 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 109.391 -1.484 . . . . 25.0 109.391 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -118.43 146.5 44.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 -175.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -135.55 143.52 45.75 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.2 pt -88.59 161.62 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.434 0.159 . . . . 50.0 110.892 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 t 38.5 75.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.736 1.384 . . . . 25.0 114.736 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -129.73 133.98 47.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.668 -1.605 . . . . 25.0 106.668 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 124.522 2.106 . . . . 25.0 111.513 -174.552 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.857 0 CA-C-O 124.02 1.9 . . . . 25.0 115.382 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 p -82.66 149.76 27.18 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.461 -1.023 . . . . 25.0 108.945 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 ttm -81.64 -73.31 0.39 Allowed 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 120.771 -0.372 . . . . 25.0 110.372 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -157.54 152.43 25.54 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.282 -1.377 . . . . 25.0 107.282 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.12 175.8 11.4 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 103.392 -2.818 . . . . 50.0 103.392 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.39 -45.92 72.99 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.926 0.784 . . . . 50.0 110.927 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.1 t30 46.9 46.05 15.43 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.071 1.137 . . . . 50.0 114.071 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -125.29 149.04 29.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.549 -1.649 . . . . 50.0 106.549 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 155.33 30.75 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.248 0.547 . . . . 50.0 110.511 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 154.73 49.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.04 -0.982 . . . . 25.0 108.703 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -105.67 135.45 47.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.631 -1.248 . . . . 50.0 107.631 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.03 131.39 42.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.191 0.52 . . . . 25.0 109.74 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.68 -26.9 18.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.573 0.702 . . . . 50.0 109.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -130.58 158.72 39.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.508 -1.293 . . . . 50.0 107.508 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.6 p-10 -97.42 160.05 14.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.242 -0.651 . . . . 50.0 109.242 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.38 171.88 13.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 50.0 110.563 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.2 124.59 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 101.029 -3.693 . . . . 25.0 101.029 172.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.51 140.17 29.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -119.12 -29.37 5.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.658 0.599 . . . . 50.0 111.553 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -89.21 148.98 42.03 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.764 -0.828 . . . . 50.0 108.764 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.77 -18.22 32.41 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 116.746 -1.703 . . . . 25.0 112.797 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.84 -13.8 59.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 50.0 110.744 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -96.08 142.51 28.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.199 0.523 . . . . 50.0 110.94 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.47 137.7 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.867 -0.333 . . . . 50.0 110.605 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -93.23 124.5 37.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.268 -1.382 . . . . 50.0 107.268 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.88 168.25 24.3 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.361 -1.348 . . . . 25.0 107.361 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -133.02 159.32 40.38 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.964 -0.46 . . . . 50.0 110.229 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.484 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 27.0 pttt -56.57 136.35 54.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.584 0.707 . . . . 50.0 110.078 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.63 -24.04 31.28 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.08 -0.964 . . . . 25.0 113.303 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.61 159.39 34.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 117.141 0.47 . . . . 50.0 110.219 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.9 127.95 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.193 0.597 . . . . 50.0 110.101 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.63 148.52 50.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.366 0.603 . . . . 50.0 110.094 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -87.45 126.83 35.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.52 127.18 41.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 106.632 -1.618 . . . . 50.0 106.632 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -108.42 -33.36 7.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.82 -0.627 . . . . 50.0 112.52 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -151.68 163.76 38.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.383 -1.34 . . . . 50.0 107.383 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -126.08 152.29 46.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.582 0.628 . . . . 50.0 110.823 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 55.25 38.77 30.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.745 1.259 . . . . 50.0 109.382 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.54 -12.68 61.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 -165.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -116.07 6.67 14.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.287 0.565 . . . . 50.0 109.617 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.12 -5.93 69.57 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.731 -0.948 . . . . 25.0 110.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.09 124.84 30.2 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.539 -1.652 . . . . 50.0 106.539 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.47 132.25 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.635 0.731 . . . . 50.0 110.964 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.36 -0.12 85.37 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 115.38 0.912 . . . . 25.0 115.38 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -95.39 108.59 20.8 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.767 1.784 . . . . 50.0 110.21 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -97.8 144.28 27.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.158 -0.473 . . . . 50.0 110.977 -172.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.8 111.76 19.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.582 -2.007 . . . . 50.0 105.582 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.1 m -114.85 163.33 15.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.479 -0.934 . . . . 25.0 108.479 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -125.1 132.22 53.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.457 -0.572 . . . . 50.0 109.457 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.99 140.17 13.0 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.226 -1.027 . . . . 50.0 108.226 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 57.74 27.6 14.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.823 0.82 . . . . 25.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.94 -0.63 86.72 Favored Glycine 0 N--CA 1.458 0.152 0 N-CA-C 114.445 0.538 . . . . 25.0 114.445 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -107.08 153.98 21.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -116.22 140.02 49.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 103.507 -2.775 . . . . 50.0 103.507 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.43 168.07 40.7 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.959 -0.639 . . . . 50.0 112.126 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -76.48 141.22 16.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.771 0.796 . . . . 50.0 110.005 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.21 132.99 13.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.2 114.47 3.78 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 116.564 -1.824 . . . . 50.0 111.548 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.4 -22.35 65.46 Favored Glycine 0 C--O 1.219 -0.838 0 N-CA-C 114.667 0.627 . . . . 50.0 114.667 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.67 -23.42 67.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.739 0.78 . . . . 50.0 111.21 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.92 6.41 46.33 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 121.513 -0.742 . . . . 50.0 111.377 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -118.47 152.72 35.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.2 0.524 . . . . 50.0 111.183 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -123.28 117.46 25.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.738 -0.467 . . . . 50.0 109.738 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.12 135.63 27.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.838 -0.801 . . . . 50.0 108.838 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.98 109.11 10.53 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 106.835 -1.543 . . . . 50.0 106.835 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 t 59.22 72.13 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -149.76 116.55 0.79 Allowed Glycine 0 N--CA 1.459 0.174 0 N-CA-C 110.961 -0.855 . . . . 25.0 110.961 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.3 ttm -169.59 173.49 6.36 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.01 116.49 0.05 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.565 1.691 . . . . 25.0 115.565 173.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.91 -36.59 3.25 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 114.636 1.347 . . . . 25.0 114.636 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 89.7 mttt 46.55 66.63 0.93 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.546 0.943 . . . . 25.0 113.546 -174.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -59.27 155.48 35.33 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.123 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.56 172.23 16.59 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 N-CA-C 113.293 0.459 . . . . 25.0 113.293 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.13 170.89 18.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.546 -1.649 . . . . 25.0 106.546 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.1 118.79 0.92 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 110.127 -1.189 . . . . 25.0 110.127 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.69 -15.71 41.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.032 0.444 . . . . 25.0 111.869 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -115.72 112.09 21.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.114 0.783 . . . . 25.0 113.114 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.4 pt -131.81 155.22 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 104.636 -2.357 . . . . 50.0 104.636 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m -141.39 156.9 21.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.717 -1.216 . . . . 25.0 107.717 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.1 p -135.12 -69.6 0.5 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.409 0.623 . . . . 25.0 110.14 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 C--O 1.204 -1.3 0 CA-C-O 124.162 1.934 . . . . 25.0 112.244 -173.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 CA-C-O 124.96 2.422 . . . . 25.0 113.659 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -83.93 95.22 8.44 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 113.159 -1.521 . . . . 25.0 111.544 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.6 ttt -126.36 137.78 53.49 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -164.04 116.16 1.37 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.487 0.315 . . . . 25.0 111.224 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -147.23 165.92 28.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.136 -2.172 . . . . 50.0 105.136 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.14 -42.98 83.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.419 0.554 . . . . 50.0 110.102 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.1 t30 50.86 46.12 26.54 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.069 0.856 . . . . 50.0 113.089 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.8 m -111.46 169.99 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 103.717 -2.697 . . . . 50.0 103.717 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.97 159.81 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.181 0.901 . . . . 50.0 111.178 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.03 40.27 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.063 -0.971 . . . . 25.0 111.404 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -97.39 131.62 43.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.306 -1.368 . . . . 50.0 107.306 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.16 138.62 43.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.649 0.738 . . . . 25.0 109.544 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -96.38 -21.4 17.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 50.0 110.41 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -128.33 160.17 33.02 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.435 -1.32 . . . . 50.0 107.435 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.7 p-10 -100.5 153.03 19.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.945 -0.761 . . . . 50.0 108.945 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -156.37 151.6 26.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.568 -0.742 . . . . 50.0 110.937 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -116.13 150.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.62 110.51 16.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -93.89 -8.84 39.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.52 -1.289 . . . . 50.0 107.52 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 t -134.8 149.02 69.52 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.734 -1.58 . . . . 50.0 106.734 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.76 -18.9 41.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 116.687 -1.742 . . . . 25.0 113.666 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.57 -15.7 58.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.194 0.521 . . . . 50.0 110.817 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -92.39 143.21 26.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.041 0.536 . . . . 50.0 110.703 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.08 133.83 35.85 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.706 -0.798 . . . . 50.0 111.098 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.2 p -82.29 137.59 34.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 50.0 106.974 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -156.49 165.77 35.36 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -124.78 155.13 39.86 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.574 -0.703 . . . . 50.0 110.932 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.3 pttp -59.1 128.05 35.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.21 -1.033 . . . . 50.0 108.21 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.91 -12.19 68.8 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.703 -0.68 . . . . 25.0 113.903 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -79.37 158.02 27.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.039 -0.726 . . . . 50.0 109.039 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -120.66 127.63 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.957 -0.386 . . . . 50.0 109.957 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.69 152.27 51.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 50.0 111.873 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 m -86.84 133.86 33.6 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.5 t -98.72 121.42 49.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.737 -1.579 . . . . 50.0 106.737 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -93.64 -42.31 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.682 -0.69 . . . . 50.0 110.988 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.11 164.61 30.71 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.962 -1.125 . . . . 50.0 107.962 -173.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -132.01 150.04 52.26 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.466 -1.679 . . . . 50.0 106.466 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 58.28 39.91 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.81 1.319 . . . . 50.0 108.675 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -70.46 -14.22 62.45 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.808 -1.542 . . . . 25.0 114.35 -169.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -116.39 11.13 14.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.996 -0.547 . . . . 50.0 109.704 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.43 -6.8 63.11 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.806 -0.918 . . . . 25.0 110.806 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -86.0 118.13 25.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.429 -0.952 . . . . 50.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.5 128.78 38.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.793 -0.818 . . . . 50.0 108.793 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.12 78.55 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 115.779 1.071 . . . . 25.0 115.779 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -104.13 112.83 26.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.541 1.671 . . . . 50.0 110.046 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -107.82 142.73 37.42 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.228 -0.295 . . . . 50.0 111.643 -170.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.95 116.09 22.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.43 -1.322 . . . . 50.0 107.43 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.5 m -117.97 169.53 9.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.727 -0.215 . . . . 25.0 110.443 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -133.11 129.1 37.5 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.66 -0.496 . . . . 50.0 109.66 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.2 tp -161.04 155.47 23.22 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.747 -1.575 . . . . 50.0 106.747 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.4 t60 60.03 23.55 12.72 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.801 0.667 . . . . 25.0 112.801 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.08 11.56 85.25 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 25.0 114.051 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -142.28 162.84 34.44 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.0 -0.37 . . . . 50.0 110.0 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -110.72 155.85 21.89 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.224 -1.028 . . . . 50.0 108.224 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.45 165.97 37.15 Favored Glycine 0 C--O 1.24 0.523 0 N-CA-C 110.179 -1.168 . . . . 50.0 110.179 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -79.25 147.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 50.0 109.851 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.5 t -142.46 131.81 12.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 25.0 107.289 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 121.84 8.69 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 114.882 -2.945 . . . . 50.0 111.326 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -22.8 61.74 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 115.954 -0.566 . . . . 50.0 113.686 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -65.67 -13.01 58.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.091 -0.652 . . . . 50.0 112.418 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -103.18 7.98 38.57 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 50.0 110.747 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -118.64 152.82 35.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.612 0.72 . . . . 50.0 111.044 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -126.87 117.72 23.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.646 -1.242 . . . . 50.0 107.646 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.1 mm -57.8 135.41 21.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.705 -0.85 . . . . 50.0 108.705 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mt -106.1 -176.24 3.02 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.316 -0.624 . . . . 50.0 109.316 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t 73.6 92.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.434 1.494 . . . . 25.0 111.622 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.9 -38.73 0.97 Allowed Glycine 0 C--O 1.226 -0.403 0 CA-C-N 114.993 -1.003 . . . . 25.0 114.419 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 20.8 mmt -139.27 114.92 9.96 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 52.72 45.25 29.06 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.645 -0.707 . . . . 25.0 112.34 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.49 -40.73 87.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.804 1.409 . . . . 25.0 114.804 -171.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -156.2 166.11 34.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.096 0.474 . . . . 25.0 110.896 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.09 158.17 32.29 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.441 -2.059 . . . . 25.0 105.441 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.75 149.88 67.53 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 116.396 -1.936 . . . . 25.0 112.74 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.1 165.63 29.32 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.839 -2.652 . . . . 25.0 103.839 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.97 155.62 35.16 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.001 -2.039 . . . . 25.0 108.001 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -89.24 141.57 28.41 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.69 131.94 35.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.953 -0.567 . . . . 25.0 112.404 -173.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.95 131.68 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 105.554 -2.017 . . . . 50.0 105.554 174.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.7 m -105.95 146.67 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.243 -1.392 . . . . 25.0 107.243 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.9 m -154.0 95.88 1.9 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.707 0.765 . . . . 25.0 109.137 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.213 -0.851 0 CA-C-O 124.037 1.875 . . . . 25.0 112.62 -178.405 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.041 0 CA-C-O 124.51 2.172 . . . . 25.0 113.733 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -148.71 126.02 11.53 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 113.384 -1.408 . . . . 25.0 108.269 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.5 mmm -76.4 118.35 19.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.82 -0.437 . . . . 25.0 109.82 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -157.77 162.65 38.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.168 -0.308 . . . . 25.0 110.168 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -146.81 168.13 22.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 103.666 -2.716 . . . . 50.0 103.666 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.61 -42.65 74.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.754 0.706 . . . . 50.0 109.369 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 t30 46.91 46.91 15.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.988 1.107 . . . . 50.0 113.988 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.93 125.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.671 -1.233 . . . . 50.0 107.671 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -82.01 154.4 25.7 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.81 0.814 . . . . 75.0 108.975 -175.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.62 161.63 35.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.498 -1.228 . . . . 25.0 108.231 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -113.11 133.87 54.81 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.112 -1.07 . . . . 50.0 108.112 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.76 123.44 24.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.433 0.635 . . . . 25.0 109.797 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -82.46 -29.96 30.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.783 -0.644 . . . . 50.0 109.989 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -132.4 164.06 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 50.0 107.38 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.583 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.3 p-10 -99.22 166.62 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.487 -0.19 . . . . 50.0 110.487 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -148.15 160.53 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 50.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.54 118.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 102.855 -3.017 . . . . 25.0 102.855 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 144.27 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.9 -0.407 . . . . 25.0 109.9 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -33.89 3.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 50.0 110.002 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 t -81.03 146.75 59.69 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.969 -1.122 . . . . 50.0 107.969 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.88 -13.76 29.32 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 117.493 -1.205 . . . . 25.0 114.058 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -86.79 -15.65 38.65 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.875 0.845 . . . . 50.0 109.762 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -85.24 137.31 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 50.0 111.253 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.56 134.69 34.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.33 0.586 . . . . 50.0 111.105 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -84.29 114.05 21.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.894 -1.15 . . . . 50.0 107.894 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -140.14 161.06 38.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -131.08 164.11 26.16 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.936 0.398 . . . . 50.0 111.887 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.583 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 49.5 pttt -60.23 137.68 58.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.179 0.514 . . . . 50.0 110.712 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.96 -23.82 31.36 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.236 -0.893 . . . . 25.0 112.679 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -70.47 157.67 37.43 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 122.572 0.349 . . . . 50.0 111.407 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.13 127.47 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.308 0.643 . . . . 50.0 110.017 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.46 146.91 46.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.308 -0.256 . . . . 50.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 37.4 m -90.1 122.94 33.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 25.0 110.081 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -82.95 121.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 107.297 -1.371 . . . . 50.0 107.297 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -90.16 -45.91 8.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.751 -0.659 . . . . 50.0 110.067 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -153.5 171.89 18.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 50.0 109.388 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -130.19 155.53 46.1 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.884 -1.895 . . . . 50.0 105.884 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.3 t0 60.57 41.12 15.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 123.19 1.471 . . . . 50.0 108.905 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -70.72 -18.53 62.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.806 -1.543 . . . . 25.0 114.181 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -120.27 8.88 10.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.182 0.438 . . . . 50.0 112.182 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.79 7.88 85.2 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 109.642 -1.383 . . . . 25.0 109.642 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.9 mt -113.54 110.03 19.6 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.066 -1.457 . . . . 50.0 107.066 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -66.77 147.83 52.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.264 -1.384 . . . . 50.0 107.264 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.6 -22.27 40.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.457 -0.792 . . . . 25.0 112.466 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -93.18 132.01 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.208 1.004 . . . . 50.0 108.95 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -119.4 139.7 51.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.596 -0.89 . . . . 50.0 108.596 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.08 121.86 28.0 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.257 -1.757 . . . . 50.0 106.257 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.8 m -123.04 156.31 35.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.944 -0.391 . . . . 25.0 109.944 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.0 p -117.18 131.15 56.93 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.708 -1.219 . . . . 50.0 107.708 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.83 131.78 13.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.419 -0.81 . . . . 50.0 108.856 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 52.91 37.41 24.27 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.659 0.985 . . . . 25.0 113.659 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.36 3.45 85.94 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.096 -0.573 . . . . 25.0 114.476 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -118.08 167.2 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.495 -1.668 . . . . 50.0 106.495 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -134.03 157.37 46.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.024 -1.473 . . . . 50.0 107.024 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.1 171.49 43.95 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 109.315 -1.514 . . . . 50.0 109.315 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.85 144.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.703 0.763 . . . . 50.0 110.507 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.0 t -138.62 134.82 17.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 119.48 6.34 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 115.1 -2.8 . . . . 50.0 110.812 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.31 62.48 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 115.009 0.764 . . . . 50.0 115.009 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.99 -28.58 67.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 50.0 111.281 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -89.39 8.98 27.96 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.718 0.636 . . . . 50.0 112.718 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.23 151.51 39.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.249 0.547 . . . . 50.0 112.394 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -122.93 117.67 26.08 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.75 -0.833 . . . . 50.0 108.75 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.0 mm -63.19 134.13 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.015 -1.106 . . . . 50.0 108.015 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.84 116.8 24.31 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.549 -0.908 . . . . 50.0 108.549 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.4 t -95.77 128.45 46.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.157 -1.053 . . . . 25.0 108.157 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.64 42.0 0.33 Allowed Glycine 0 C--O 1.225 -0.428 0 C-N-CA 121.433 -0.413 . . . . 25.0 112.288 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -133.8 165.65 24.49 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.94 -0.763 . . . . 25.0 108.94 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -65.63 148.93 50.94 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.153 0.283 . . . . 25.0 110.943 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.01 148.47 50.07 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.636 0.731 . . . . 25.0 110.704 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -72.17 161.72 30.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.257 -0.883 . . . . 25.0 112.71 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.52 168.9 15.69 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.904 -1.517 . . . . 25.0 106.904 172.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.52 171.02 13.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 115.91 -2.26 . . . . 25.0 110.043 170.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.37 136.33 43.31 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 106.87 -1.53 . . . . 25.0 106.87 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.87 164.32 38.2 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 108.767 -1.733 . . . . 25.0 108.767 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -154.74 -48.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.922 0.342 . . . . 25.0 111.922 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -133.18 163.87 28.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.786 0.326 . . . . 25.0 110.481 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.9 tt -82.91 155.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.018 -0.734 . . . . 50.0 109.018 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.64 133.77 65.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.374 -1.343 . . . . 25.0 107.374 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.2 m 56.67 66.07 1.27 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.307 1.051 . . . . 25.0 113.629 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 124.718 2.199 . . . . 25.0 111.141 173.844 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 CA-C-O 123.364 1.535 . . . . 25.0 115.644 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -77.09 18.75 0.35 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 114.874 1.435 . . . . 25.0 114.874 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.8 ttt -124.58 131.2 53.49 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.311 -0.626 . . . . 25.0 109.311 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt 54.88 59.36 4.11 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 123.818 0.699 . . . . 25.0 112.618 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -65.33 159.44 23.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.494 -0.928 . . . . 50.0 108.494 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.3 mt -63.72 -42.04 97.98 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.852 -0.425 . . . . 50.0 109.852 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.0 t30 51.23 38.85 22.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.283 -0.871 . . . . 50.0 112.485 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.19 170.5 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 104.327 -2.472 . . . . 50.0 104.327 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.85 153.46 51.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 118.879 0.763 . . . . 50.0 110.54 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.67 149.47 50.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.998 -1.001 . . . . 25.0 110.93 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -95.34 131.39 41.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.529 -1.285 . . . . 50.0 107.529 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.41 136.63 42.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.43 -20.59 18.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.441 -0.799 . . . . 50.0 109.64 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -134.03 159.66 40.1 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.636 -0.876 . . . . 50.0 108.636 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.6 p-10 -100.36 156.66 17.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.013 0.525 . . . . 50.0 109.663 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -155.34 161.13 41.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.738 -0.665 . . . . 50.0 110.577 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 p -122.72 147.76 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.97 114.91 22.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.778 -0.823 . . . . 25.0 108.778 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -93.2 -8.49 42.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.231 -1.025 . . . . 50.0 108.231 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -129.85 148.14 68.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.939 -1.134 . . . . 50.0 107.939 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.53 -12.45 31.46 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 117.211 -1.393 . . . . 25.0 113.248 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -85.89 -14.19 45.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.932 0.872 . . . . 50.0 110.013 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -94.41 147.84 22.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 50.0 109.931 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.08 137.79 34.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.149 0.5 . . . . 50.0 111.233 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -87.37 116.7 25.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.691 -1.226 . . . . 50.0 107.691 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -135.07 162.56 32.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 80.0 mtm-85 -131.38 154.01 49.07 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.958 -0.463 . . . . 50.0 111.009 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.463 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.1 pttp -58.89 131.89 52.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 50.0 109.938 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.92 -19.52 53.57 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.426 -0.806 . . . . 25.0 113.374 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -75.35 159.11 31.81 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.275 0.537 . . . . 50.0 110.312 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.5 mm -119.38 127.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.123 -0.695 . . . . 50.0 109.123 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptp -133.83 149.35 51.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.0 0.429 . . . . 50.0 111.767 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.7 m -79.9 136.31 36.63 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.301 -1.0 . . . . 25.0 108.301 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -104.38 120.8 55.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.477 -1.675 . . . . 50.0 106.477 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.79 -45.64 10.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 50.0 111.322 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.27 171.84 18.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.459 -1.312 . . . . 50.0 107.459 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.66 154.75 44.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 110.302 -0.259 . . . . 50.0 110.302 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 57.57 35.53 25.85 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 125.032 1.458 . . . . 50.0 109.472 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -70.48 -20.48 62.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.676 -1.602 . . . . 25.0 113.513 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -99.4 0.98 43.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.376 0.608 . . . . 50.0 110.193 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 -6.02 67.48 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 109.787 -1.325 . . . . 25.0 109.787 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.7 mt -88.25 126.81 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.827 -1.546 . . . . 50.0 106.827 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -61.02 131.15 49.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.375 0.607 . . . . 50.0 109.899 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.69 0.66 90.24 Favored Glycine 0 C--O 1.219 -0.788 0 CA-C-O 118.428 -1.207 . . . . 25.0 116.055 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -97.43 110.76 23.25 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.125 1.962 . . . . 50.0 110.93 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.78 144.85 30.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 50.0 111.058 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.95 118.0 23.17 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.014 -1.476 . . . . 50.0 107.014 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.3 m -119.86 167.76 11.79 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.479 -0.563 . . . . 25.0 109.479 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -134.0 130.86 38.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.851 0.358 . . . . 50.0 110.238 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 tp -160.75 152.34 19.5 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 106.976 -1.49 . . . . 50.0 106.976 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.2 m80 58.69 24.16 11.86 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.76 82.4 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.665 -0.779 . . . . 25.0 112.295 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -125.13 167.13 15.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.629 -1.619 . . . . 50.0 106.629 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.78 150.55 50.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 105.123 -2.176 . . . . 50.0 105.123 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.1 171.08 43.93 Favored Glycine 0 C--O 1.241 0.532 0 N-CA-C 110.682 -0.967 . . . . 50.0 110.682 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -78.41 143.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 50.0 111.157 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.0 t -141.44 134.23 14.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.81 118.69 5.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 114.987 -2.875 . . . . 50.0 111.472 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.55 -21.24 66.68 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 114.772 0.669 . . . . 50.0 114.772 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -64.42 -21.81 66.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.571 . . . . 50.0 110.83 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -91.91 9.86 31.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.992 -0.443 . . . . 50.0 111.152 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.1 mt -125.36 155.04 40.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.78 0.432 . . . . 50.0 110.404 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -129.19 117.68 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.632 -0.507 . . . . 50.0 109.632 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 mm -67.88 133.72 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.247 -0.649 . . . . 50.0 109.247 -178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.88 121.59 22.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.847 -1.168 . . . . 50.0 107.847 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.0 t 50.48 45.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 115.093 -0.958 . . . . 25.0 111.862 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.81 7.67 8.94 Favored Glycine 0 C--O 1.225 -0.446 0 N-CA-C 116.815 1.486 . . . . 25.0 116.815 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 54.6 ttp -148.62 101.95 3.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.781 0.791 . . . . 25.0 109.33 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -157.36 111.41 2.63 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 112.154 0.427 . . . . 25.0 112.154 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -76.65 152.27 35.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.71 0.29 . . . . 25.0 111.675 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -142.33 -37.94 0.38 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.643 1.349 . . . . 25.0 114.643 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.66 151.95 57.92 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 122.122 -0.361 . . . . 25.0 110.134 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.14 170.54 19.91 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 117.939 -0.907 . . . . 25.0 110.51 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.28 147.83 51.64 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.758 -0.83 . . . . 25.0 108.758 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.96 -179.93 45.85 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 108.8 -1.72 . . . . 25.0 108.8 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.83 164.08 26.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.73 125.05 49.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.42 -0.956 . . . . 25.0 108.42 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.1 pt -79.43 161.87 4.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.794 -0.639 . . . . 50.0 111.849 -175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.32 19.02 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.28 -0.873 . . . . 25.0 109.39 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.9 p -117.61 124.29 48.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 25.0 110.697 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 C--O 1.215 -0.733 0 CA-C-O 124.245 1.974 . . . . 25.0 111.249 178.045 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.101 0 N-CA-C 115.817 1.087 . . . . 25.0 115.817 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m 60.87 2.01 0.5 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.672 1.989 . . . . 25.0 116.049 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.3 ttt -146.62 124.13 11.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -111.74 -31.7 6.88 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.114 0.483 . . . . 25.0 110.095 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -147.81 173.23 13.01 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 102.403 -3.184 . . . . 50.0 102.403 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.8 mt -58.43 -47.56 83.55 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 115.14 1.534 . . . . 50.0 115.14 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.9 t30 49.52 41.99 22.06 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.316 1.228 . . . . 50.0 114.316 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.82 166.38 5.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 105.186 -2.153 . . . . 50.0 105.186 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 155.98 45.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.147 0.499 . . . . 50.0 110.108 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.45 144.69 33.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.75 -0.659 . . . . 25.0 112.107 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -90.84 135.45 33.72 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.767 -0.827 . . . . 50.0 108.767 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.56 121.27 22.16 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.89 0.744 . . . . 25.0 109.118 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.98 -26.43 27.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.147 -0.479 . . . . 50.0 110.324 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.29 163.87 26.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.244 -1.391 . . . . 50.0 107.244 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.21 157.66 15.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.975 -0.75 . . . . 50.0 108.975 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -147.17 131.14 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.936 0.495 . . . . 50.0 110.492 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -100.87 121.97 52.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 101.616 -3.475 . . . . 25.0 101.616 168.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 143.09 48.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.977 -0.749 . . . . 25.0 108.977 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -110.92 -26.29 9.38 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 123.479 0.487 . . . . 50.0 110.058 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.6 t -97.02 146.26 31.0 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 108.366 -0.976 . . . . 50.0 108.366 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.55 -14.95 27.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 116.763 -1.691 . . . . 25.0 113.153 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.47 -15.54 57.6 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 122.969 0.508 . . . . 50.0 110.58 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -93.73 143.46 26.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.318 0.647 . . . . 50.0 111.864 -171.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.15 133.13 35.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 50.0 110.729 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 84.0 6.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.849 0.833 . . . . 50.0 108.947 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.405 ' CE1' HG11 ' A' ' 57' ' ' VAL . 36.3 p90 -93.88 162.99 13.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.636 -0.875 . . . . 25.0 108.636 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -126.26 155.96 41.07 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.252 0.549 . . . . 50.0 110.795 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -57.95 132.85 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 50.0 109.922 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.05 -21.44 46.01 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-O 119.014 -0.881 . . . . 25.0 114.245 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -74.93 160.59 30.42 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.194 -0.669 . . . . 50.0 109.194 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.61 133.51 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.284 -1.006 . . . . 50.0 108.284 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.67 148.68 52.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 50.0 110.889 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -81.0 127.26 32.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -91.15 122.17 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.888 -1.523 . . . . 50.0 106.888 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 mt -96.93 -41.09 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.123 -0.944 . . . . 50.0 111.884 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.46 157.69 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.321 -0.992 . . . . 50.0 108.321 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -134.29 147.26 50.59 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.013 -1.477 . . . . 50.0 107.013 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 t0 59.29 38.93 23.03 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 123.98 1.848 . . . . 50.0 107.335 -170.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -69.32 -11.8 61.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.322 -1.763 . . . . 25.0 114.626 -169.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -129.77 15.11 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.131 0.491 . . . . 50.0 110.806 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.83 22.26 77.23 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 109.514 -1.434 . . . . 25.0 109.514 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.93 114.06 21.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.788 -1.93 . . . . 50.0 105.788 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -59.52 141.16 55.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.882 0.849 . . . . 50.0 109.456 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.8 38.96 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-O 118.92 -0.933 . . . . 25.0 115.1 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.2 130.78 40.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.474 1.637 . . . . 50.0 110.422 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -119.92 149.39 42.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.593 -0.521 . . . . 50.0 109.593 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.1 tp -89.8 120.46 31.07 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 106.436 -1.69 . . . . 50.0 106.436 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -122.23 155.64 35.45 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 121.026 -0.269 . . . . 25.0 110.568 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 p -111.69 125.81 54.36 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.362 -0.607 . . . . 50.0 109.362 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -152.93 143.62 22.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.834 -1.172 . . . . 50.0 107.834 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.87 26.1 12.86 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.582 0.706 . . . . 25.0 112.73 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.21 9.17 87.18 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.491 -0.861 . . . . 25.0 114.474 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -128.24 163.25 25.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.693 -0.484 . . . . 50.0 109.693 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.05 149.54 38.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.088 -1.079 . . . . 50.0 108.088 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 171.21 42.86 Favored Glycine 0 C--O 1.241 0.561 0 N-CA-C 108.887 -1.685 . . . . 50.0 108.887 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -86.81 146.4 6.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.67 0.748 . . . . 50.0 110.226 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.405 HG11 ' CE1' ' A' ' 26' ' ' PHE . 54.7 t -139.42 133.67 16.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.412 -0.813 . . . . 25.0 109.067 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.99 115.49 4.01 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 115.278 -2.682 . . . . 50.0 110.536 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.6 -17.56 66.96 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 115.051 0.78 . . . . 50.0 115.051 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.16 -17.92 64.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.258 1.029 . . . . 50.0 111.436 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -90.78 5.61 47.61 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.81 -0.556 . . . . 50.0 110.658 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.29 151.58 37.41 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.541 0.525 . . . . 50.0 111.328 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -122.1 117.46 26.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.419 -0.956 . . . . 50.0 108.419 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm -59.52 133.72 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.86 -1.163 . . . . 50.0 107.86 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.4 -170.68 2.05 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.007 0.817 . . . . 50.0 108.936 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -63.58 147.67 12.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.884 -0.326 . . . . 25.0 111.706 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.73 104.93 0.53 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.224 -0.513 . . . . 25.0 113.317 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -139.45 152.86 47.36 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.551 -1.648 . . . . 25.0 106.551 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -80.9 125.48 30.17 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -153.06 161.0 43.02 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 107.136 -1.431 . . . . 25.0 107.136 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 90.7 mttt 62.19 -167.68 0.2 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.63 1.205 . . . . 25.0 113.819 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -67.39 155.1 91.7 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.474 -1.239 . . . . 25.0 108.479 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.77 169.75 15.44 Favored 'Trans proline' 0 C--N 1.348 0.551 0 O-C-N 122.431 0.701 . . . . 25.0 113.627 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.37 146.56 47.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.384 -0.826 . . . . 25.0 111.134 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.49 56.29 2.72 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.56 -0.745 . . . . 25.0 114.478 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -85.42 118.42 24.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.532 0.666 . . . . 25.0 109.596 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -150.73 -2.22 0.36 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.077 0.769 . . . . 25.0 113.077 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.6 mt -96.23 123.42 48.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.065 -1.087 . . . . 50.0 108.065 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 m -92.34 150.67 3.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 t -154.24 -51.44 0.09 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.064 0.459 . . . . 25.0 109.942 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 124.557 2.123 . . . . 25.0 111.561 178.186 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.007 0 CA-C-O 123.346 1.526 . . . . 25.0 114.596 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -144.45 142.58 30.39 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 120.948 -1.325 . . . . 25.0 108.664 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.0 ttp -154.0 156.98 38.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.499 -1.667 . . . . 25.0 106.499 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -117.3 127.91 54.54 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.568 -0.901 . . . . 25.0 108.568 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.0 173.74 7.59 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.086 -0.709 . . . . 50.0 109.086 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.57 -43.52 93.58 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.052 -0.721 . . . . 50.0 109.052 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 51.08 45.45 27.79 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.491 1.116 . . . . 50.0 112.906 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.72 163.48 6.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 105.478 -2.045 . . . . 50.0 105.478 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.13 148.57 52.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.235 1.017 . . . . 50.0 111.13 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.64 157.72 44.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.269 -1.332 . . . . 25.0 108.981 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -111.16 134.26 52.89 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.713 -0.847 . . . . 50.0 108.713 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.91 130.44 42.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.44 -26.8 19.66 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.857 -0.794 . . . . 50.0 108.857 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.05 158.33 35.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.545 -1.28 . . . . 50.0 107.545 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.4 p-10 -90.58 160.52 15.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.733 -1.581 . . . . 50.0 106.733 174.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -143.8 168.01 20.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 50.0 110.069 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.56 120.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 101.929 -3.359 . . . . 25.0 101.929 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 122.27 23.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.188 -1.042 . . . . 25.0 108.188 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -104.32 -21.14 13.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.888 -0.596 . . . . 50.0 111.325 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.3 m -102.26 150.35 37.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.443 -0.947 . . . . 50.0 108.443 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.83 -21.1 33.61 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 116.204 -2.064 . . . . 25.0 113.369 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.57 -8.02 58.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.177 -0.465 . . . . 50.0 111.477 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -90.05 140.93 29.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.672 0.273 . . . . 50.0 110.601 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mt -85.02 137.88 32.79 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.826 -0.546 . . . . 50.0 110.843 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -91.67 118.46 30.66 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.916 -1.142 . . . . 50.0 107.916 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.67 170.9 14.84 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.079 -0.712 . . . . 25.0 109.079 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.5 158.13 40.78 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 109.175 -0.676 . . . . 50.0 109.175 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.8 pttp -59.27 129.81 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.064 -0.717 . . . . 50.0 109.064 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -20.8 42.9 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.507 -0.77 . . . . 25.0 113.293 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.0 149.42 50.27 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 117.599 0.7 . . . . 50.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -114.13 127.68 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.457 -0.942 . . . . 50.0 108.457 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.8 ptp -137.81 147.7 44.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.824 0.345 . . . . 50.0 110.368 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 m -84.38 130.82 34.75 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 107.912 -1.144 . . . . 25.0 107.912 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.22 125.92 47.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 N-CA-C 107.39 -1.337 . . . . 50.0 107.39 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.77 -39.04 7.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.595 -0.729 . . . . 50.0 112.253 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -146.0 161.61 39.7 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.071 -0.715 . . . . 50.0 109.071 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -125.78 150.42 47.78 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 109.139 -0.689 . . . . 50.0 109.139 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 54.2 37.19 26.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.496 1.617 . . . . 50.0 108.889 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -69.55 -12.67 61.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 112.842 -1.981 . . . . 25.0 114.188 -169.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 7.91 17.21 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.219 -0.659 . . . . 50.0 109.219 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.42 -17.42 13.97 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.882 -0.887 . . . . 25.0 110.882 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.98 127.13 31.59 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.343 -1.355 . . . . 50.0 107.343 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.8 135.11 57.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.733 0.778 . . . . 50.0 110.459 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 -0.07 89.02 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-O 119.181 -0.788 . . . . 25.0 114.805 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -97.95 104.76 16.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.221 1.51 . . . . 50.0 110.534 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -94.82 147.59 23.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 50.0 111.371 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -85.99 117.27 24.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.948 -1.871 . . . . 50.0 105.948 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.7 m -115.89 162.14 17.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -122.64 124.94 44.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.519 -0.919 . . . . 50.0 108.519 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 tp -155.65 139.81 16.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.989 -0.745 . . . . 50.0 108.989 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 54.48 38.16 29.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.943 0.877 . . . . 25.0 113.049 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.07 0.7 77.39 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 115.129 0.812 . . . . 25.0 115.129 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -119.25 154.41 33.49 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.135 -0.691 . . . . 50.0 109.135 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -110.35 148.12 32.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 104.441 -2.429 . . . . 50.0 104.441 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.72 168.82 41.64 Favored Glycine 0 C--O 1.243 0.706 0 N-CA-C 111.39 -0.684 . . . . 50.0 111.39 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -78.26 142.91 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.877 0.846 . . . . 50.0 109.964 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.17 134.57 14.61 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.39 114.69 4.01 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 114.659 -3.094 . . . . 50.0 112.319 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 -23.07 63.49 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 114.263 0.465 . . . . 50.0 114.263 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.0 -25.46 67.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.267 -0.549 . . . . 50.0 111.206 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -92.19 8.34 38.5 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 112.266 0.469 . . . . 50.0 112.266 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -116.71 149.99 38.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 50.0 112.326 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.47 118.77 28.18 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.408 -0.59 . . . . 50.0 109.408 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.09 138.31 20.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.634 -0.876 . . . . 50.0 108.634 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.55 70.11 2.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.522 0.677 . . . . 50.0 111.46 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.56 124.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.814 -1.18 . . . . 25.0 107.814 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.15 22.06 62.42 Favored Glycine 0 C--O 1.217 -0.909 0 CA-C-O 119.608 -0.551 . . . . 25.0 113.028 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 79.1 mtp 51.02 37.11 16.9 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.926 0.49 . . . . 25.0 111.452 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.7 t80 64.29 58.77 1.08 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.694 0.759 . . . . 25.0 110.975 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -56.04 119.02 5.21 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 107.982 -1.118 . . . . 25.0 107.982 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -118.9 113.68 21.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.253 -0.885 . . . . 25.0 110.323 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -71.31 150.34 94.21 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 106.345 -1.724 . . . . 25.0 106.345 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.32 -27.01 20.04 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 117.358 -1.294 . . . . 25.0 114.158 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 140.86 44.6 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.784 -0.821 . . . . 25.0 108.784 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.03 176.54 48.11 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.575 -1.41 . . . . 25.0 109.575 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.93 173.78 11.85 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 103.305 -2.85 . . . . 25.0 103.305 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.6 t80 58.72 84.1 0.11 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.511 1.148 . . . . 25.0 112.101 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.7 pt -127.96 159.06 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.277 -1.009 . . . . 50.0 108.277 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.88 81.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 104.372 -2.455 . . . . 25.0 104.372 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.3 m -123.17 -50.82 1.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.287 -0.869 . . . . 25.0 110.928 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 C--O 1.209 -1.028 0 CA-C-O 124.631 2.158 . . . . 25.0 111.6 -177.041 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 CA-C-O 122.791 1.217 . . . . 25.0 115.308 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -62.04 129.25 40.0 Favored 'General case' 0 C--O 1.231 0.095 0 O-C-N 121.318 -1.107 . . . . 25.0 110.855 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.6 ttm -64.22 142.45 58.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.09 0.471 . . . . 25.0 111.938 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -153.77 -45.01 0.09 Allowed 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 123.253 0.621 . . . . 25.0 109.734 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.62 159.04 16.08 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.697 -1.594 . . . . 50.0 106.697 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt -65.31 -46.96 78.26 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.377 0.423 . . . . 50.0 111.44 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.7 t30 49.33 46.93 22.85 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.153 1.168 . . . . 50.0 114.153 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.6 m -109.81 169.98 3.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 104.581 -2.377 . . . . 50.0 104.581 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.97 158.76 43.62 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.382 -0.599 . . . . 50.0 109.382 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 149.64 34.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.746 -0.661 . . . . 25.0 112.091 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.18 134.38 37.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.964 -0.562 . . . . 50.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.78 132.0 42.14 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.209 0.528 . . . . 25.0 109.676 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 mt -96.9 -23.95 16.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.636 -0.711 . . . . 50.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.06 161.45 26.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.274 -1.38 . . . . 50.0 107.274 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.56 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.4 p-10 -102.16 162.37 12.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 50.0 109.269 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -151.96 159.11 43.86 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.507 0.504 . . . . 50.0 111.163 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.62 133.2 68.83 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 110.6 7.03 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -78.46 -35.4 46.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.012 -1.449 . . . . 50.0 107.708 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -119.36 154.55 54.08 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 50.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.5 -15.94 34.37 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.661 -1.093 . . . . 25.0 113.697 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.79 -10.2 58.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 50.0 110.698 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -94.29 144.16 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.039 -0.726 . . . . 50.0 109.039 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.46 135.24 33.57 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.774 -0.77 . . . . 50.0 110.21 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -85.27 125.08 32.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.842 -1.91 . . . . 50.0 105.842 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -148.81 163.72 36.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.028 -1.471 . . . . 25.0 107.028 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -129.52 159.03 37.59 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.224 0.535 . . . . 50.0 110.803 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.56 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.9 pttp -59.2 132.5 54.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.816 -1.179 . . . . 50.0 107.816 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.99 -23.34 32.52 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.783 -0.644 . . . . 25.0 113.06 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.35 163.28 26.58 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.073 0.437 . . . . 50.0 110.207 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.01 132.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.642 -0.873 . . . . 50.0 108.642 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -133.4 153.5 51.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 50.0 110.585 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -88.18 131.02 34.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.289 -0.634 . . . . 25.0 109.289 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.3 t -96.06 124.18 48.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.08 -1.081 . . . . 50.0 108.08 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.09 -42.2 8.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.771 -0.649 . . . . 50.0 112.096 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.38 159.75 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 50.0 109.009 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -129.91 151.28 50.65 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 107.894 -1.15 . . . . 50.0 107.894 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t0 58.83 39.6 23.83 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.144 1.45 . . . . 50.0 107.973 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -71.29 -13.8 62.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.854 -1.521 . . . . 25.0 112.859 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -119.46 4.88 11.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.961 0.726 . . . . 50.0 112.961 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.37 20.34 69.58 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 110.086 -1.206 . . . . 25.0 110.086 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.57 113.76 15.23 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.337 -1.727 . . . . 50.0 106.337 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -64.84 141.78 58.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.483 -1.302 . . . . 50.0 107.483 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.57 -15.43 63.33 Favored Glycine 0 C--O 1.209 -1.406 0 CA-C-O 118.441 -1.199 . . . . 25.0 113.377 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -98.57 125.23 43.74 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.658 1.729 . . . . 50.0 109.798 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -119.61 146.96 45.06 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.941 -0.392 . . . . 50.0 109.941 -172.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.1 tp -85.43 116.2 23.6 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.624 -1.251 . . . . 50.0 107.624 176.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -115.31 167.19 11.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.641 0.258 . . . . 25.0 110.652 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 m -131.62 132.94 44.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.448 -0.575 . . . . 50.0 109.448 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 tp -160.24 146.29 15.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.446 -0.946 . . . . 50.0 108.446 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 58.5 24.4 11.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.004 1.113 . . . . 25.0 114.004 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.44 4.66 87.68 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.909 -0.662 . . . . 25.0 113.228 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -122.83 163.89 19.42 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 122.947 0.499 . . . . 50.0 109.669 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -118.1 154.55 31.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.942 -1.873 . . . . 50.0 105.942 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.6 162.66 31.33 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 111.779 -0.528 . . . . 50.0 111.779 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.4 pt -78.12 145.64 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.557 . . . . 50.0 110.682 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -144.84 133.69 11.07 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 108.492 -0.929 . . . . 25.0 108.492 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.6 121.21 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 115.534 -2.511 . . . . 50.0 112.02 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.62 -22.36 65.91 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-N 115.342 -0.845 . . . . 50.0 114.188 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -70.47 -2.4 13.82 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.089 -0.654 . . . . 50.0 111.675 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.0 11.23 17.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.917 -0.401 . . . . 50.0 109.917 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.95 152.63 38.29 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.367 0.417 . . . . 50.0 111.078 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -117.88 117.81 30.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.08 -1.081 . . . . 50.0 108.08 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.35 134.67 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 123.821 0.7 . . . . 50.0 109.254 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.94 108.5 18.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 50.0 111.427 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.5 t -124.68 126.12 71.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.215 -1.402 . . . . 25.0 107.215 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.54 5.95 38.21 Favored Glycine 0 C--O 1.22 -0.742 0 O-C-N 123.269 0.356 . . . . 25.0 112.761 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.9 mtt -79.18 83.1 5.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.413 0.625 . . . . 25.0 111.325 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -117.61 23.84 11.47 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.168 -1.79 . . . . 25.0 106.168 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -73.33 152.16 41.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.462 -1.245 . . . . 25.0 108.88 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.65 166.31 30.9 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.17 -0.331 . . . . 25.0 110.212 -175.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -115.19 158.49 40.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 107.453 -1.314 . . . . 25.0 107.453 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.29 154.67 65.46 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 116.299 -2.001 . . . . 25.0 110.71 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.98 75.78 1.26 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.335 -0.393 . . . . 25.0 110.038 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.9 54.65 4.05 Favored Glycine 0 C--O 1.216 -0.98 0 CA-C-O 119.171 -0.794 . . . . 25.0 112.798 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 51.32 74.38 0.25 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.487 1.137 . . . . 25.0 113.003 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -69.13 123.48 21.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.507 -0.77 . . . . 25.0 111.566 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.61 150.9 19.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 104.801 -2.296 . . . . 50.0 104.801 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.9 p -142.84 144.43 24.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 105.583 -2.006 . . . . 25.0 105.583 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.3 p -126.19 109.0 11.84 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.88 -0.415 . . . . 25.0 109.88 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.0 t0 . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 125.174 1.389 . . . . 25.0 113.179 179.332 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.979 0 CA-C-O 124.023 1.902 . . . . 25.0 115.484 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -142.34 127.42 18.49 Favored 'General case' 0 CA--C 1.514 -0.435 0 O-C-N 121.349 -1.089 . . . . 25.0 109.809 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.2 mtt -142.28 120.74 12.43 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.094 0.247 . . . . 25.0 110.361 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 tptt 50.85 33.81 9.25 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 117.167 2.284 . . . . 25.0 117.167 169.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -65.25 158.96 24.86 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.129 -0.357 . . . . 50.0 110.242 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.19 -40.5 81.68 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.804 0.442 . . . . 50.0 111.564 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 51.44 43.78 29.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.4 1.259 . . . . 50.0 114.4 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.63 164.34 13.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 103.025 -2.954 . . . . 50.0 103.025 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.61 160.85 37.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.714 0.688 . . . . 50.0 110.386 -174.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.45 163.24 33.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.448 -0.796 . . . . 25.0 110.887 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.58 134.4 52.43 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.042 -1.466 . . . . 50.0 107.042 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.87 136.11 43.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.721 0.772 . . . . 25.0 109.231 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.82 -24.62 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.489 -0.778 . . . . 50.0 109.63 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -128.98 162.75 26.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.818 -1.178 . . . . 50.0 107.818 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.17 156.69 17.06 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.857 -1.164 . . . . 50.0 107.857 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -156.49 135.77 12.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.357 0.503 . . . . 50.0 112.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -100.64 146.92 8.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.98 -1.859 . . . . 25.0 105.98 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.93 133.54 37.26 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.255 -0.276 . . . . 25.0 110.255 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.55 -7.17 23.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.666 0.745 . . . . 50.0 109.117 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.7 t -129.46 148.65 70.18 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.631 -0.713 . . . . 50.0 109.347 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.32 -16.84 35.3 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.716 -1.722 . . . . 25.0 113.3 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -82.17 -15.56 52.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.471 0.653 . . . . 50.0 110.674 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -92.5 140.85 29.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.628 -0.879 . . . . 50.0 108.628 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 132.56 36.04 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.123 -0.631 . . . . 50.0 110.044 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p -84.53 133.08 34.47 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.394 -2.076 . . . . 50.0 105.394 171.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -150.64 166.12 31.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.933 -0.766 . . . . 25.0 108.933 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -127.04 152.99 46.53 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.872 -0.518 . . . . 50.0 110.696 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -59.49 138.37 57.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.651 -0.704 . . . . 50.0 109.279 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.5 -16.02 57.27 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.503 -0.771 . . . . 25.0 114.035 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -76.89 159.76 29.76 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 117.387 0.593 . . . . 50.0 109.93 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.51 130.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.983 0.513 . . . . 50.0 109.638 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.12 147.07 45.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.972 0.415 . . . . 50.0 110.728 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -85.66 130.74 34.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.6 t -88.83 116.41 30.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.809 -1.923 . . . . 50.0 105.809 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.24 -37.76 13.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.309 -0.859 . . . . 50.0 111.147 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -147.43 156.18 42.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.597 -1.26 . . . . 50.0 107.597 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -124.51 147.43 48.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.621 -0.511 . . . . 50.0 109.621 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 57.25 38.21 28.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.745 1.736 . . . . 50.0 107.618 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.5 t -70.56 -11.4 60.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 112.283 -2.235 . . . . 25.0 115.699 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.06 10.07 13.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.145 0.497 . . . . 50.0 110.028 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.62 66.79 Favored Glycine 0 C--O 1.225 -0.425 0 N-CA-C 109.688 -1.365 . . . . 25.0 109.688 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.69 116.74 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.643 -1.614 . . . . 50.0 106.643 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.42 133.82 55.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.795 -0.639 . . . . 50.0 109.457 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.29 -0.43 85.58 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.506 0.962 . . . . 25.0 115.506 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -102.92 116.57 32.8 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.127 1.464 . . . . 50.0 110.538 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -108.59 145.0 35.54 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.208 -0.308 . . . . 50.0 111.09 -174.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.52 120.98 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.473 -1.677 . . . . 50.0 106.473 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.2 m -119.86 165.22 14.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.697 -0.483 . . . . 25.0 109.697 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 p -122.95 131.66 53.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.059 0.457 . . . . 50.0 110.027 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 tp -160.27 148.61 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.664 -1.235 . . . . 50.0 107.664 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 59.64 23.25 12.01 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.272 0.841 . . . . 25.0 113.272 176.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.07 81.08 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.842 -0.694 . . . . 25.0 112.686 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -130.76 164.21 25.6 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.48 -0.933 . . . . 50.0 108.48 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -117.77 152.91 34.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.941 -1.874 . . . . 50.0 105.941 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.04 163.98 36.44 Favored Glycine 0 C--O 1.239 0.462 0 N-CA-C 110.387 -1.085 . . . . 50.0 110.387 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.8 pt -79.43 145.19 9.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.611 . . . . 50.0 110.062 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.4 t -140.74 133.7 14.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 107.64 -1.244 . . . . 25.0 107.64 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.41 121.57 8.11 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 114.667 -3.089 . . . . 50.0 111.212 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.16 -25.67 62.59 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 116.015 -0.539 . . . . 50.0 114.263 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -65.48 -18.52 65.38 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.23 -0.57 . . . . 50.0 112.374 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.84 8.0 41.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.888 -0.507 . . . . 50.0 111.232 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.0 mt -122.41 156.79 33.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.903 0.383 . . . . 50.0 110.786 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -131.62 120.07 22.32 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.512 -0.551 . . . . 50.0 109.512 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.1 mm -61.32 136.21 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.67 0.606 . . . . 50.0 110.358 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.53 124.41 44.69 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.376 -1.712 . . . . 50.0 106.376 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -142.18 146.7 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.12 94.18 0.12 Allowed Glycine 0 C--O 1.216 -0.974 0 C-N-CA 120.912 -0.661 . . . . 25.0 114.484 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 36.1 ttm 49.84 67.21 0.94 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.443 1.646 . . . . 25.0 115.443 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -105.0 154.55 19.97 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 50.65 41.09 25.41 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.995 1.479 . . . . 25.0 114.995 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -89.71 109.76 20.71 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.908 -0.495 . . . . 25.0 111.365 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 163.21 31.18 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.62 -0.881 . . . . 25.0 108.62 176.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.87 -178.23 2.65 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 117.618 -1.121 . . . . 25.0 110.106 170.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.28 55.62 4.95 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.497 0.665 . . . . 25.0 111.37 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.28 178.08 16.43 Favored Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.345 -1.102 . . . . 25.0 110.345 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.28 163.73 24.39 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 113.635 0.976 . . . . 25.0 113.635 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -140.48 141.77 35.37 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.268 -0.424 . . . . 25.0 110.364 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.88 126.92 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.945 -0.761 . . . . 50.0 108.945 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.73 164.41 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.35 . . . . 25.0 110.822 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 m -70.84 150.42 45.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.946 -0.57 . . . . 25.0 110.192 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 C--O 1.217 -0.626 0 CA-C-O 125.792 2.711 . . . . 25.0 111.998 173.712 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.52 0 CA-C-O 123.015 1.341 . . . . 25.0 113.741 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m 59.89 20.44 9.4 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.015 1.726 . . . . 25.0 112.602 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.9 mtt -79.79 -14.84 58.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.948 -0.569 . . . . 25.0 112.189 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -141.86 148.8 39.38 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.809 -0.812 . . . . 25.0 108.809 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -147.18 177.27 9.32 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 102.901 -3.0 . . . . 50.0 102.901 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.7 mt -55.92 -45.81 78.62 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.892 1.441 . . . . 50.0 114.892 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.4 43.26 26.88 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.042 1.497 . . . . 50.0 115.042 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.2 163.63 8.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 104.297 -2.483 . . . . 50.0 104.297 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.17 154.06 47.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 118.891 0.769 . . . . 50.0 110.63 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.91 143.79 34.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.657 -0.701 . . . . 25.0 111.36 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -95.19 132.42 40.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.083 -0.71 . . . . 50.0 109.083 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 134.88 41.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.392 0.615 . . . . 25.0 109.417 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.27 -25.1 17.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.578 -0.737 . . . . 50.0 109.488 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -131.22 157.65 42.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.512 -1.292 . . . . 50.0 107.512 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.556 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -95.35 161.65 14.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.667 -0.494 . . . . 50.0 109.667 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -152.92 149.84 28.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.444 -0.576 . . . . 50.0 109.444 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -124.1 128.74 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 103.773 -2.677 . . . . 25.0 103.773 173.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.91 136.09 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.913 -0.585 . . . . 25.0 109.923 -176.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -102.94 -12.9 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.332 -0.988 . . . . 50.0 108.332 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.35 155.66 53.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 50.0 110.312 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.23 -19.31 20.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 117.71 -1.06 . . . . 25.0 114.418 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -86.37 -15.03 41.71 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.985 0.898 . . . . 50.0 109.591 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -89.89 145.6 25.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.418 -0.81 . . . . 50.0 108.897 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.44 135.79 40.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.795 0.665 . . . . 50.0 112.795 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.31 138.67 32.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.068 -1.827 . . . . 50.0 106.068 170.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -157.4 164.01 37.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -124.15 153.06 42.07 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.618 -0.676 . . . . 50.0 112.197 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 46.2 pttt -58.3 132.43 53.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.543 -1.28 . . . . 50.0 107.543 175.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.21 -14.52 65.15 Favored Glycine 0 C--O 1.226 -0.348 0 CA-C-O 118.79 -1.005 . . . . 25.0 114.089 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.53 163.02 20.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.686 0.743 . . . . 50.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.49 132.11 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.026 -0.731 . . . . 50.0 109.026 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -129.13 151.37 49.88 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 116.055 -0.521 . . . . 50.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.1 m -85.42 129.08 34.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.259 -1.015 . . . . 25.0 108.259 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 83.7 t -91.87 119.62 39.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.684 -1.598 . . . . 50.0 106.684 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -97.87 -40.45 8.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.303 -0.862 . . . . 50.0 111.129 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -148.03 164.68 33.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.888 -1.523 . . . . 50.0 106.888 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -130.56 152.88 49.46 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.507 -1.294 . . . . 50.0 107.507 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 56.57 37.17 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.884 1.365 . . . . 50.0 108.166 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -69.34 -17.39 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 113.631 -1.622 . . . . 25.0 112.857 -169.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.17 6.48 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.721 -0.672 . . . . 50.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 -8.22 67.42 Favored Glycine 0 C--O 1.228 -0.257 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt -83.63 117.27 23.07 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.713 . . . . 50.0 109.076 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -60.39 128.27 35.88 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 50.0 109.412 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.22 -1.3 82.41 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 115.461 0.944 . . . . 25.0 115.461 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -100.63 122.59 43.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.926 1.363 . . . . 50.0 109.247 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -112.49 145.42 40.26 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.993 -0.442 . . . . 50.0 111.162 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.9 tp -83.57 115.07 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.545 -1.65 . . . . 50.0 106.545 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.6 m -122.45 164.84 17.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.536 0.208 . . . . 25.0 110.857 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.5 p -123.18 131.36 53.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.224 -0.658 . . . . 50.0 109.224 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -157.93 139.71 13.93 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.357 -0.979 . . . . 50.0 108.357 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 57.45 32.98 22.64 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.732 0.777 . . . . 25.0 112.632 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.08 4.47 63.18 Favored Glycine 0 CA--C 1.522 0.491 0 O-C-N 121.567 -0.708 . . . . 25.0 113.427 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.73 164.1 13.77 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.014 -1.476 . . . . 50.0 107.014 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -132.19 146.0 51.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 104.22 -2.511 . . . . 50.0 104.22 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.62 177.87 48.55 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 111.11 -0.796 . . . . 50.0 111.11 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.34 143.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.387 0.613 . . . . 50.0 110.299 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.7 t -139.33 134.18 16.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.75 118.54 5.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 115.015 -2.857 . . . . 50.0 110.749 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -23.92 70.78 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.706 -0.679 . . . . 50.0 113.988 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.59 -16.47 64.19 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.289 -0.536 . . . . 50.0 111.62 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -90.06 1.14 56.68 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.93 -0.481 . . . . 50.0 110.918 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.58 150.64 36.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.306 0.574 . . . . 50.0 111.343 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -121.96 113.86 20.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.331 -0.988 . . . . 50.0 108.331 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.0 mt -67.63 134.27 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 120.754 0.311 . . . . 50.0 110.848 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.9 mt -117.68 136.94 53.0 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.5 t 25.44 82.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 116.268 1.951 . . . . 25.0 116.268 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.1 -72.6 1.11 Allowed Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.596 -0.811 . . . . 25.0 113.612 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.34 161.41 37.6 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -161.06 164.52 30.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.22 -0.659 . . . . 25.0 109.22 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -135.53 -174.13 3.55 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.294 0.638 . . . . 25.0 111.245 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -114.67 141.21 48.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 120.945 0.403 . . . . 25.0 110.227 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -71.79 146.35 90.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.51 -19.86 21.28 Favored 'Trans proline' 0 C--N 1.349 0.566 0 N-CA-C 114.09 0.765 . . . . 25.0 114.09 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 55.48 25.52 7.91 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.787 1.773 . . . . 25.0 115.787 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.35 7.94 66.62 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 115.296 0.879 . . . . 25.0 115.296 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -121.02 64.89 0.86 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.396 0.617 . . . . 25.0 112.088 -174.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.53 118.21 9.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.154 -0.684 . . . . 25.0 109.154 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.5 tt -144.56 134.82 19.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.371 -0.974 . . . . 50.0 108.371 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.41 11.22 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.416 0.627 . . . . 25.0 109.516 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 53.83 51.18 15.34 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.53 1.157 . . . . 25.0 112.65 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.9 t0 . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 123.026 1.393 . . . . 25.0 110.595 175.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 114.832 0.693 . . . . 25.0 114.832 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 t 57.68 16.53 3.51 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.001 1.32 . . . . 25.0 114.027 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.0 ptp -102.9 -12.64 17.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.117 0.784 . . . . 25.0 113.117 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -146.88 157.79 43.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.742 0.306 . . . . 25.0 110.216 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -147.18 -179.45 6.84 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 101.878 -3.378 . . . . 50.0 101.878 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.3 mt -54.29 -37.43 64.77 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.699 1.37 . . . . 50.0 114.699 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.06 30.24 19.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.816 1.413 . . . . 50.0 114.816 173.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -115.94 164.01 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.175 -1.787 . . . . 50.0 106.175 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.95 164.11 23.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.207 -0.664 . . . . 50.0 109.207 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.28 145.21 30.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 25.0 110.857 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -95.05 134.49 37.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.31 136.55 40.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.274 0.559 . . . . 25.0 109.616 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.26 -26.22 17.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 50.0 110.071 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -130.24 162.78 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.41 -1.33 . . . . 50.0 107.41 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.511 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.9 p-10 -101.71 157.07 17.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.888 -0.412 . . . . 50.0 109.888 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -157.87 122.78 4.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.575 -0.739 . . . . 50.0 110.099 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 138.93 19.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.13 148.97 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -111.22 -20.41 12.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.639 -0.504 . . . . 50.0 109.639 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -105.09 152.46 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.49 -0.323 . . . . 50.0 110.265 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.6 -20.91 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 117.1 -1.466 . . . . 25.0 114.013 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.35 -4.79 59.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.536 0.684 . . . . 50.0 110.599 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -99.26 141.73 31.66 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.18 -1.044 . . . . 50.0 108.18 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.97 134.14 35.06 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.674 -0.641 . . . . 50.0 111.724 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.8 m -84.16 119.44 25.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.526 -1.657 . . . . 50.0 106.526 170.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -136.16 161.62 35.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.55 -0.537 . . . . 25.0 109.55 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -123.43 153.74 40.02 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.062 0.458 . . . . 50.0 110.079 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.511 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 14.0 ptmt -59.6 133.74 56.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.208 -1.034 . . . . 50.0 108.208 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 -10.81 72.17 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-O 119.102 -0.832 . . . . 25.0 114.302 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.65 158.29 25.68 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.916 0.858 . . . . 50.0 109.207 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.86 129.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.453 -0.573 . . . . 50.0 109.453 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -130.76 153.23 49.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 50.0 109.899 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 m -87.53 132.32 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.68 -1.229 . . . . 25.0 107.68 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.12 125.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.864 -1.532 . . . . 50.0 106.864 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -92.95 -47.78 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.04 -0.527 . . . . 50.0 111.183 -175.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.74 171.92 18.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.538 -1.282 . . . . 50.0 107.538 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -121.9 155.0 36.38 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.234 -0.654 . . . . 50.0 109.234 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 57.51 38.6 28.1 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.64 1.213 . . . . 50.0 109.924 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -69.88 -18.59 63.42 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.067 -1.424 . . . . 25.0 114.374 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -110.97 9.73 22.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.265 -0.643 . . . . 50.0 109.265 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.58 1.84 89.26 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.445 -1.062 . . . . 25.0 110.445 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.38 122.36 35.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.144 -1.058 . . . . 50.0 108.144 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -61.45 129.36 40.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.419 0.628 . . . . 50.0 109.98 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 0.45 87.96 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -101.58 108.43 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 118.827 1.313 . . . . 50.0 110.227 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.718 -0.475 . . . . 50.0 109.718 -173.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -82.41 120.1 25.02 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.671 -1.974 . . . . 50.0 105.671 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.71 160.68 24.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 25.0 109.236 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -121.47 132.53 54.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.435 0.636 . . . . 50.0 109.746 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.22 141.38 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.157 -0.928 . . . . 50.0 108.617 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 58.79 26.75 15.12 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.677 0.992 . . . . 25.0 113.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.74 6.06 89.61 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 121.097 -0.573 . . . . 25.0 113.293 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -122.11 167.33 13.28 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.05 -1.463 . . . . 50.0 107.05 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -135.41 154.32 51.5 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.777 -1.564 . . . . 50.0 106.777 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.7 171.33 44.27 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.856 -0.898 . . . . 50.0 110.856 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.5 143.3 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.506 0.67 . . . . 50.0 110.587 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.4 t -141.9 132.42 12.86 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.255 -1.017 . . . . 25.0 108.255 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.77 119.52 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 115.178 -2.748 . . . . 50.0 111.582 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.45 -21.77 62.77 Favored Glycine 0 C--O 1.221 -0.678 0 CA-C-N 115.888 -0.597 . . . . 50.0 114.473 -175.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -61.25 -28.12 68.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.267 -0.549 . . . . 50.0 111.37 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -89.15 6.28 40.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.869 0.322 . . . . 50.0 111.869 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.73 143.97 44.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.6 . . . . 50.0 111.913 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -117.75 117.69 30.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.807 -1.183 . . . . 50.0 107.807 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm -55.32 127.63 14.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 121.202 0.525 . . . . 50.0 110.157 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -107.45 92.98 4.3 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 107.79 -1.189 . . . . 50.0 107.79 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t 53.87 79.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 122.167 0.984 . . . . 25.0 111.678 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.57 49.65 3.91 Favored Glycine 0 C--O 1.225 -0.425 0 CA-C-N 115.374 -0.83 . . . . 25.0 113.446 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 162.6 19.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.137 -0.69 . . . . 25.0 109.137 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.68 148.86 51.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.365 0.603 . . . . 25.0 111.545 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.35 174.73 7.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.963 0.887 . . . . 25.0 112.008 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.92 157.26 17.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.222 -1.769 . . . . 25.0 106.222 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -58.32 143.25 80.23 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.382 -0.599 . . . . 25.0 109.382 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -70.22 156.91 61.07 Favored 'Trans proline' 0 C--N 1.347 0.474 0 O-C-N 122.3 0.632 . . . . 25.0 112.925 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.69 6.55 48.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.839 -0.619 . . . . 25.0 112.27 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.62 3.66 66.36 Favored Glycine 0 C--O 1.219 -0.798 0 C-N-CA 121.235 -0.507 . . . . 25.0 112.784 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -77.45 124.66 28.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.686 -0.487 . . . . 25.0 109.686 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -160.06 168.15 26.23 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.688 -0.856 . . . . 25.0 108.688 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 pt -128.21 166.05 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 108.708 -0.849 . . . . 50.0 108.708 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.7 m -86.62 160.78 3.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.637 -0.875 . . . . 25.0 108.637 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.2 p -78.2 150.99 33.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.685 -0.487 . . . . 25.0 109.685 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.213 -0.84 0 CA-C-O 123.068 1.413 . . . . 25.0 112.19 176.635 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 CA-C-O 122.698 1.165 . . . . 25.0 115.346 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 p -78.76 59.3 2.5 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.457 -1.025 . . . . 25.0 110.889 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.0 mmt -70.41 101.76 2.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.299 -0.41 . . . . 25.0 112.037 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 61.39 17.2 8.14 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.224 1.194 . . . . 25.0 114.224 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -75.31 164.89 25.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.458 -0.941 . . . . 50.0 108.458 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.68 -37.95 88.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.826 -0.435 . . . . 50.0 109.826 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 t30 56.17 36.83 28.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.464 -0.789 . . . . 50.0 112.284 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.16 129.75 55.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 106.728 -1.582 . . . . 50.0 106.728 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.47 153.85 19.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.738 0.78 . . . . 50.0 110.101 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.23 152.13 42.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.826 -1.079 . . . . 25.0 109.948 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -103.49 135.09 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.558 -0.904 . . . . 50.0 108.558 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 135.54 43.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.361 0.601 . . . . 25.0 110.169 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.44 -27.19 17.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.5 -0.773 . . . . 50.0 110.68 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.51 158.26 33.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.35 -1.722 . . . . 50.0 106.35 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 12.0 p-10 -97.95 146.16 25.76 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.296 -1.372 . . . . 50.0 107.296 174.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -144.6 129.99 18.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.776 -0.647 . . . . 50.0 110.741 -174.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -103.91 121.3 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.403 -1.703 . . . . 25.0 106.403 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.66 35.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.911 -0.586 . . . . 25.0 110.108 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -99.55 -17.26 17.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.158 0.504 . . . . 50.0 109.941 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 143.32 40.61 Favored Pre-proline 0 CA--C 1.513 -0.455 0 N-CA-C 107.722 -1.214 . . . . 50.0 107.722 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 -15.61 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 116.937 -1.576 . . . . 25.0 114.023 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -94.48 -9.0 36.83 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.315 0.579 . . . . 50.0 110.964 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.62 140.82 30.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.776 -0.824 . . . . 50.0 108.776 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.38 132.3 34.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.432 0.634 . . . . 50.0 111.169 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -86.93 136.32 32.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.14 -1.8 . . . . 50.0 106.14 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -156.55 166.78 32.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.978 0.418 . . . . 25.0 110.441 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -121.44 154.88 35.97 Favored 'General case' 0 C--O 1.213 -0.868 0 O-C-N 121.909 -0.495 . . . . 50.0 110.683 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.468 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.3 pttt -60.56 131.79 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.946 -1.131 . . . . 50.0 107.946 174.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.91 -20.57 49.81 Favored Glycine 0 C--O 1.224 -0.515 0 CA-C-N 115.903 -0.589 . . . . 25.0 113.026 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -71.49 154.19 41.67 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.326 0.563 . . . . 50.0 110.117 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -117.47 126.96 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.109 -0.7 . . . . 50.0 109.109 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.7 ptp -134.89 157.73 46.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.937 -0.764 . . . . 50.0 108.937 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.6 m -107.03 126.75 52.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.233 -0.284 . . . . 25.0 110.233 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -79.95 123.55 36.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.434 -1.321 . . . . 50.0 107.434 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.92 -46.62 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.92 -0.771 . . . . 50.0 108.92 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.26 169.25 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.165 -1.42 . . . . 50.0 107.165 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -124.16 157.14 35.39 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 110.259 -0.274 . . . . 50.0 110.259 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 56.53 41.42 28.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.74 1.275 . . . . 50.0 108.681 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.47 -16.26 62.9 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.704 1.372 . . . . 25.0 114.704 -167.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -111.94 9.0 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.509 -0.552 . . . . 50.0 109.509 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.11 -9.78 59.83 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 110.864 -0.894 . . . . 25.0 110.864 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.92 124.53 28.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.932 -1.136 . . . . 50.0 107.932 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -61.08 131.32 50.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.449 0.642 . . . . 50.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.45 89.58 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 118.566 -1.13 . . . . 25.0 115.482 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -99.02 105.44 17.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.755 1.777 . . . . 50.0 109.817 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -102.34 143.37 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.038 -0.528 . . . . 50.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.0 tp -83.66 112.78 20.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.673 -1.603 . . . . 50.0 106.673 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 67.3 m -112.08 163.14 14.63 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.555 -0.906 . . . . 25.0 108.555 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.2 p -123.74 130.7 53.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 50.0 109.048 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 tp -162.26 146.56 12.21 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.572 -0.899 . . . . 50.0 108.572 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 57.43 30.74 19.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.785 1.032 . . . . 25.0 113.785 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.56 11.44 82.81 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 120.702 -0.761 . . . . 25.0 113.161 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -124.55 165.51 17.71 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.44 -1.318 . . . . 50.0 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.36 152.61 47.97 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 103.448 -2.797 . . . . 50.0 103.448 167.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.59 167.09 38.82 Favored Glycine 0 C--O 1.24 0.508 0 N-CA-C 110.262 -1.135 . . . . 50.0 110.262 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.9 pt -75.48 143.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.548 0.69 . . . . 50.0 110.509 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -141.62 132.27 13.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.959 -1.126 . . . . 25.0 107.959 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.07 120.29 6.73 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 115.185 -2.743 . . . . 50.0 111.737 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.38 -25.8 60.97 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-N 115.742 -0.663 . . . . 50.0 114.397 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -63.42 -22.94 67.18 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.191 0.52 . . . . 50.0 111.646 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -91.56 5.5 49.33 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.757 -0.59 . . . . 50.0 111.667 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.5 mt -115.4 156.28 25.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 50.0 111.458 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -122.8 117.7 26.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.114 . . . . 50.0 107.991 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.63 132.51 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.891 -1.151 . . . . 50.0 107.891 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.06 -165.14 1.28 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.156 -0.475 . . . . 50.0 110.344 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.9 p -61.38 142.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.237 0.541 . . . . 25.0 109.603 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.56 -175.82 45.95 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 106.277 -2.729 . . . . 25.0 106.277 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.3 mtt -82.51 126.95 32.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.118 0.959 . . . . 25.0 110.123 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.47 150.88 9.18 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.476 -2.046 . . . . 25.0 105.476 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.24 -44.34 59.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.411 0.624 . . . . 25.0 109.673 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 tptt 55.61 -166.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.827 -1.078 . . . . 25.0 110.484 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -122.16 158.17 56.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 103.784 -2.673 . . . . 25.0 103.784 170.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -65.69 147.34 85.85 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 115.638 -2.441 . . . . 25.0 111.204 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.81 173.06 16.55 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.683 -1.229 . . . . 25.0 107.683 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.39 -119.93 0.61 Allowed Glycine 0 C--O 1.225 -0.448 0 N-CA-C 107.105 -2.398 . . . . 25.0 107.105 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 59.44 49.3 8.86 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.733 1.012 . . . . 25.0 113.733 172.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -148.54 163.05 38.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.931 -1.137 . . . . 25.0 107.931 174.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.8 pt -139.86 158.94 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.718 -1.956 . . . . 50.0 105.718 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 p -162.95 157.19 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.821 -1.918 . . . . 25.0 105.821 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m 51.43 77.27 0.14 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.482 1.289 . . . . 25.0 114.482 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 123.881 1.8 . . . . 25.0 114.174 178.769 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 115.381 0.912 . . . . 25.0 115.381 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 t 55.83 33.46 21.58 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.624 1.17 . . . . 25.0 113.218 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 ptp -125.66 17.32 8.1 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.228 0.825 . . . . 25.0 113.228 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -84.89 125.65 32.82 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.593 0.96 . . . . 25.0 113.593 -176.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -147.22 -178.64 6.33 Favored 'General case' 0 C--N 1.319 -0.723 1 N-CA-C 99.323 -4.325 . . . . 50.0 99.323 170.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt -51.36 -41.43 60.63 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.92 1.236 . . . . 50.0 113.949 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.88 38.51 29.47 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.89 0.853 . . . . 50.0 111.967 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.0 t -107.52 149.09 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 104.527 -2.398 . . . . 50.0 104.527 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.69 153.28 50.93 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.251 -1.018 . . . . 50.0 108.251 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.57 149.68 36.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.912 -0.585 . . . . 25.0 111.2 -172.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -96.3 136.44 36.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.596 -0.52 . . . . 50.0 109.596 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.81 134.18 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.203 0.525 . . . . 25.0 109.717 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.86 -32.73 15.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.351 0.596 . . . . 50.0 109.768 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.86 164.7 17.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.068 -1.456 . . . . 50.0 107.068 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.498 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.7 p-10 -98.9 163.06 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.676 -0.861 . . . . 50.0 108.676 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -151.62 144.66 24.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.181 -0.463 . . . . 50.0 111.626 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.14 125.33 73.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.214 -2.884 . . . . 25.0 103.214 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.03 146.22 41.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 25.0 110.147 -175.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -31.29 7.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.465 -0.568 . . . . 50.0 109.465 173.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -94.93 150.34 37.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.261 -0.644 . . . . 50.0 109.261 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.58 -16.96 26.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.734 -1.044 . . . . 25.0 113.303 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.94 -9.5 58.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 50.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.18 144.53 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.17 0.588 . . . . 50.0 110.236 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mt -94.9 134.55 37.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.56 0.695 . . . . 50.0 112.645 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.3 m -88.3 140.71 29.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.289 -1.374 . . . . 50.0 107.289 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -160.19 167.17 28.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -118.56 156.51 29.02 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.635 -0.665 . . . . 50.0 110.911 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 11.0 ptmm? -59.58 129.68 43.13 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.494 -0.928 . . . . 50.0 108.494 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.05 67.83 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 115.836 -0.62 . . . . 25.0 113.937 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.36 161.24 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.892 -0.781 . . . . 50.0 108.892 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.07 134.05 65.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.353 -0.98 . . . . 50.0 108.353 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -135.48 152.82 51.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.669 -0.696 . . . . 50.0 110.614 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.7 m -89.04 131.9 35.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 25.0 108.031 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.59 120.6 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.748 -1.575 . . . . 50.0 106.748 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.4 mt -92.37 -42.35 9.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 50.0 110.065 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.98 166.23 29.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.984 -0.747 . . . . 50.0 108.984 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -133.38 152.76 51.95 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 117.936 0.334 . . . . 50.0 110.236 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 57.32 36.36 27.15 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.95 1.357 . . . . 50.0 107.766 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.48 -7.1 40.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.17 -1.832 . . . . 25.0 115.644 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -126.87 12.36 7.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.82 -5.78 68.84 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.712 -0.955 . . . . 25.0 110.712 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.99 120.98 25.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.329 -0.989 . . . . 50.0 108.329 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -61.88 127.43 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.706 -0.679 . . . . 50.0 109.939 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.58 1.5 90.1 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.754 1.062 . . . . 25.0 115.754 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -98.68 119.09 36.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.301 1.551 . . . . 50.0 109.898 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -110.0 143.8 39.47 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.185 -0.322 . . . . 50.0 111.304 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.7 tp -81.57 111.59 18.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.614 -1.995 . . . . 50.0 105.614 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.2 m -115.34 164.15 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.834 -0.802 . . . . 25.0 108.834 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -139.26 130.7 27.03 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.758 0.313 . . . . 50.0 111.738 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.21 152.16 25.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 50.0 109.644 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.4 t60 53.07 36.45 22.25 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.83 7.24 74.86 Favored Glycine 0 C--O 1.226 -0.394 0 N-CA-C 114.874 0.71 . . . . 25.0 114.874 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -120.82 156.57 31.64 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.096 -1.446 . . . . 50.0 107.096 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -134.34 145.74 49.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.765 -1.939 . . . . 50.0 105.765 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.61 44.2 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.743 -0.943 . . . . 50.0 110.743 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 pt -76.29 143.89 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.614 0.721 . . . . 50.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.8 t -141.91 133.34 13.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.35 119.15 6.13 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 114.974 -2.884 . . . . 50.0 110.984 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.09 -18.02 66.41 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.703 -0.681 . . . . 50.0 113.781 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.07 -28.65 69.76 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.513 -0.404 . . . . 50.0 110.883 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -87.7 7.17 31.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.074 0.398 . . . . 50.0 112.074 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -118.92 147.91 43.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.111 0.481 . . . . 50.0 111.091 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -116.21 117.59 30.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.582 -0.895 . . . . 50.0 108.582 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm -60.72 130.74 25.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.417 0.687 . . . . 50.0 110.103 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.6 mt -92.09 164.94 13.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.382 -0.969 . . . . 50.0 108.382 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -71.27 149.53 9.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.122 -0.945 . . . . 25.0 108.955 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.91 -43.78 0.1 Allowed Glycine 0 C--O 1.227 -0.324 0 N-CA-C 111.598 -0.601 . . . . 25.0 111.598 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.34 146.72 46.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -113.75 152.85 29.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.73 0.644 . . . . 25.0 110.6 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 t0 57.59 -154.36 0.35 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.182 -0.917 . . . . 25.0 111.946 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -145.83 166.95 24.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.349 -0.611 . . . . 25.0 109.349 -171.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -83.01 155.62 67.45 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 107.13 -1.433 . . . . 25.0 107.13 176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.54 167.41 25.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 117.109 -1.461 . . . . 25.0 111.031 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.44 147.1 30.88 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.08 43.11 0.12 Allowed Glycine 0 C--O 1.221 -0.662 0 C-N-CA 120.97 -0.633 . . . . 25.0 112.914 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -64.23 133.3 52.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.205 0.502 . . . . 25.0 110.78 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -146.41 110.86 5.13 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.286 -0.635 . . . . 25.0 109.286 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.4 tt -141.74 120.31 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.799 -0.815 . . . . 50.0 108.799 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.7 m -85.54 -8.31 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.984 1.105 . . . . 25.0 113.984 -171.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.1 p -87.79 -22.42 24.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.291 0.567 . . . . 25.0 111.009 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 C--O 1.21 -0.978 0 CA-C-O 123.823 1.773 . . . . 25.0 112.789 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.682 0 CA-C-O 123.669 1.705 . . . . 25.0 115.561 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.4 m -94.18 98.51 11.01 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.73 -1.453 . . . . 25.0 110.697 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.2 ptt? -112.8 75.73 0.93 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.995 0.902 . . . . 25.0 109.49 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.22 97.51 9.96 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.022 -0.733 . . . . 25.0 109.022 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.38 162.97 15.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.613 -0.514 . . . . 50.0 109.613 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.16 -47.02 72.25 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.109 0.781 . . . . 50.0 113.109 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 54.69 24.53 5.62 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.361 1.245 . . . . 50.0 114.361 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.63 174.28 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 106.911 -1.514 . . . . 50.0 106.911 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.22 152.38 49.81 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.765 -0.584 . . . . 50.0 110.55 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.59 146.67 42.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 25.0 111.628 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -95.17 134.57 37.76 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.167 -1.049 . . . . 50.0 108.167 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.35 135.03 39.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.529 0.681 . . . . 25.0 110.676 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.0 mt -94.92 -23.05 17.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.12 -0.945 . . . . 50.0 109.531 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -127.61 159.04 35.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.098 -1.075 . . . . 50.0 108.098 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.499 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -99.39 145.35 27.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.531 -0.544 . . . . 50.0 109.531 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.58 109.89 3.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 50.0 110.299 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.52 138.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 105.335 -2.098 . . . . 25.0 105.335 175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.86 122.38 24.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -101.27 -17.66 16.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.969 -0.752 . . . . 50.0 108.969 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -109.63 151.59 42.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.99 -0.744 . . . . 50.0 108.99 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.48 -20.91 20.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.015 -1.523 . . . . 25.0 114.467 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -84.91 -9.54 58.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.693 0.759 . . . . 50.0 110.601 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -88.51 140.81 29.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.36 -0.836 . . . . 50.0 110.35 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.39 134.45 34.33 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.497 -0.557 . . . . 50.0 109.497 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -95.18 131.51 41.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.44 -0.578 . . . . 50.0 109.44 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -157.14 168.03 28.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.869 0.366 . . . . 25.0 110.03 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -127.14 158.37 37.22 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.807 -0.558 . . . . 50.0 110.33 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.499 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 13.7 pttt -60.86 133.67 56.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.418 -1.327 . . . . 50.0 107.418 174.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.28 55.24 Favored Glycine 0 C--O 1.223 -0.541 0 CA-C-O 119.357 -0.69 . . . . 25.0 113.358 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -81.57 163.02 22.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.218 0.509 . . . . 50.0 109.668 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.8 132.01 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.459 -0.571 . . . . 50.0 109.459 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.86 156.35 41.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 50.0 110.064 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -84.27 133.56 34.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.91 121.81 49.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 50.0 106.462 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.71 -49.62 5.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.237 -0.892 . . . . 50.0 111.695 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.19 162.98 34.19 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.622 0.576 . . . . 50.0 109.564 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -132.17 151.58 51.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.518 -0.919 . . . . 50.0 108.518 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t0 56.84 40.29 29.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.325 1.536 . . . . 50.0 107.663 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 t -70.58 -6.12 34.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.784 -1.553 . . . . 25.0 114.202 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -136.16 10.93 3.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.969 0.729 . . . . 50.0 112.969 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.79 20.31 73.93 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 109.201 -1.56 . . . . 25.0 109.201 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.5 mt -122.32 109.92 15.03 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 105.557 -2.016 . . . . 50.0 105.557 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -68.65 149.07 49.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.645 -1.242 . . . . 50.0 107.645 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.18 -14.21 58.0 Favored Glycine 0 C--O 1.222 -0.611 0 CA-C-O 119.068 -0.851 . . . . 25.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -97.94 134.22 41.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.678 1.239 . . . . 50.0 109.782 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -121.13 147.58 45.37 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.034 -0.728 . . . . 50.0 109.034 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 tp -85.89 115.48 23.54 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 105.907 -1.886 . . . . 50.0 105.907 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.3 m -118.08 160.63 21.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.391 -0.226 . . . . 25.0 110.391 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -131.18 132.2 44.56 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.137 0.494 . . . . 50.0 111.699 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tt -150.49 141.17 22.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.058 -0.974 . . . . 50.0 108.682 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 56.86 33.37 23.02 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.159 0.8 . . . . 25.0 113.159 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.1 10.75 81.49 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.731 -0.747 . . . . 25.0 113.686 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -118.45 162.76 17.8 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 105.564 -2.013 . . . . 50.0 105.564 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.37 149.48 41.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.466 -1.309 . . . . 50.0 107.466 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.64 -179.14 43.23 Favored Glycine 0 C--O 1.239 0.435 0 N-CA-C 110.97 -0.852 . . . . 50.0 110.97 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.14 146.14 7.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.345 0.593 . . . . 50.0 112.244 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -142.72 134.66 13.2 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.397 -0.819 . . . . 25.0 108.813 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.36 115.89 4.38 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 114.64 -3.107 . . . . 50.0 110.178 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.59 -17.01 66.29 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.277 0.471 . . . . 50.0 114.277 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -70.24 -4.13 20.34 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.415 -0.462 . . . . 50.0 111.661 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -104.69 10.28 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.226 -0.296 . . . . 50.0 110.629 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.4 153.27 40.62 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.88 0.326 . . . . 50.0 111.88 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.24 117.68 24.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.532 -0.914 . . . . 50.0 108.532 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.4 mm -63.35 133.13 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.778 0.431 . . . . 50.0 111.359 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 114.43 19.29 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 106.413 -1.699 . . . . 50.0 106.413 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.0 t 63.91 104.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 124.62 1.2 . . . . 25.0 112.095 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.63 -166.38 33.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.258 -1.137 . . . . 25.0 110.258 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.0 tpt -73.3 18.78 0.11 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.74 1.015 . . . . 25.0 113.74 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -148.37 114.45 5.81 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.895 -0.503 . . . . 25.0 111.704 -175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -137.77 52.69 1.86 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.366 1.079 . . . . 25.0 112.654 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -74.44 135.29 42.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 105.828 -1.916 . . . . 25.0 105.828 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.29 152.98 74.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 105.57 -2.011 . . . . 25.0 105.57 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.14 -18.93 26.75 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 115.927 1.472 . . . . 25.0 115.927 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 51.76 47.19 25.27 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.962 1.097 . . . . 25.0 113.962 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.78 160.83 28.79 Favored Glycine 0 CA--C 1.511 -0.202 0 N-CA-C 108.821 -1.712 . . . . 25.0 108.821 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -144.57 153.53 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.73 11.23 1.63 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.543 0.572 . . . . 25.0 112.543 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 tt -93.09 147.71 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.426 -1.324 . . . . 50.0 107.426 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.2 t -126.23 130.44 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.5 m -115.88 -42.7 3.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.555 -0.905 . . . . 25.0 108.555 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.8 t0 . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 124.878 1.271 . . . . 25.0 109.536 176.771 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.804 0 CA-C-O 123.375 1.542 . . . . 25.0 115.683 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -75.92 -26.84 57.3 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.689 -0.889 . . . . 25.0 112.353 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.7 ptp -155.37 172.96 17.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.804 -1.554 . . . . 25.0 106.804 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -110.43 -39.67 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.684 -0.487 . . . . 25.0 109.684 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -147.2 172.32 14.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 102.34 -3.208 . . . . 50.0 102.34 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.36 -45.99 80.23 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.849 1.425 . . . . 50.0 114.849 -171.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t30 50.75 45.24 27.39 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.76 1.393 . . . . 50.0 114.76 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.65 147.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.169 -1.789 . . . . 50.0 106.169 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.66 162.84 13.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.566 0.698 . . . . 75.0 110.136 -174.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.47 138.7 29.44 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.394 -0.821 . . . . 25.0 109.92 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -95.28 134.99 37.44 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.648 -0.871 . . . . 50.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.25 134.59 42.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.247 0.546 . . . . 25.0 110.548 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.06 -30.56 15.96 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.646 . . . . 50.0 109.352 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -126.44 163.66 22.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.219 -1.4 . . . . 50.0 107.219 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.8 p-10 -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.665 -0.865 . . . . 50.0 108.665 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -151.46 129.87 12.11 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.697 0.629 . . . . 50.0 112.697 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -98.62 128.15 50.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.174 -2.899 . . . . 25.0 103.174 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.59 117.49 9.6 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.819 -0.808 . . . . 25.0 108.819 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -95.1 -13.34 25.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.536 0.684 . . . . 50.0 109.286 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 m -120.41 150.7 52.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 50.0 108.507 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.81 -20.43 26.14 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 117.636 -1.109 . . . . 25.0 114.487 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -82.13 -15.45 53.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.763 0.792 . . . . 50.0 109.801 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -84.05 147.18 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.48 -0.782 . . . . 50.0 110.517 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 tp -97.92 132.52 43.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.95 0.405 . . . . 50.0 109.941 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -89.34 143.21 27.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.991 -1.115 . . . . 50.0 107.991 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -160.93 170.17 21.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.151 -1.796 . . . . 25.0 106.151 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtm-85 -124.26 159.29 30.55 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.928 -0.483 . . . . 50.0 111.087 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 10.6 ptmm? -59.09 133.44 56.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.042 -0.725 . . . . 50.0 109.042 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.1 -11.39 72.07 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.57 -0.741 . . . . 25.0 113.635 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -80.93 161.31 24.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.454 -0.943 . . . . 50.0 108.454 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.37 134.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.965 -0.754 . . . . 50.0 108.965 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.0 ptp -130.61 158.71 39.27 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.617 -0.883 . . . . 50.0 108.617 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 m -97.86 125.43 42.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.241 -0.652 . . . . 25.0 109.241 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.5 t -82.62 127.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.478 -1.305 . . . . 50.0 107.478 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -102.34 -41.09 6.46 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 50.0 110.454 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -146.67 164.58 32.23 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.772 -1.196 . . . . 50.0 107.772 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -132.69 152.39 51.72 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.505 -1.294 . . . . 50.0 107.505 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 31.04 20.81 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 123.052 1.406 . . . . 50.0 108.42 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.1 t -70.5 -20.43 62.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 113.311 -1.768 . . . . 25.0 114.701 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -102.85 3.82 37.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.29 0.567 . . . . 50.0 109.873 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.51 85.81 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 109.052 -1.619 . . . . 25.0 109.052 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.0 mt -111.26 122.8 48.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.394 -1.706 . . . . 50.0 106.394 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.7 132.69 54.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.695 0.759 . . . . 50.0 110.08 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -1.11 89.22 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-O 118.767 -1.018 . . . . 25.0 115.506 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.359 1.58 . . . . 50.0 108.712 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -110.23 142.5 41.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.202 -0.311 . . . . 50.0 110.921 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.73 114.83 20.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.336 -2.098 . . . . 50.0 105.336 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -117.89 162.96 17.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -129.68 138.63 51.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.96 0.41 . . . . 50.0 110.265 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.66 140.19 15.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.586 -1.264 . . . . 50.0 107.586 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 55.65 29.27 13.34 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.422 1.267 . . . . 25.0 114.422 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.92 1.87 90.64 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.952 -0.642 . . . . 25.0 114.351 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -114.06 162.8 16.01 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 106.883 -1.525 . . . . 50.0 106.883 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -131.83 138.51 48.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.901 -1.518 . . . . 50.0 106.901 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.53 164.46 28.07 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.378 -1.089 . . . . 50.0 110.378 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.6 pt -81.63 145.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.094 -1.076 . . . . 50.0 108.094 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.8 t -141.62 135.29 14.62 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.13 113.32 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 115.765 -2.357 . . . . 50.0 111.641 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.1 -20.0 59.89 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 114.545 0.578 . . . . 50.0 114.545 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.22 -30.11 68.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.932 0.396 . . . . 50.0 111.373 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -89.53 8.82 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.213 0.449 . . . . 50.0 112.213 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.69 153.67 36.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.149 0.499 . . . . 50.0 112.298 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -125.09 117.58 24.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.198 -0.667 . . . . 50.0 109.198 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm -64.31 136.46 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.179 0.592 . . . . 50.0 110.535 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.7 158.09 43.74 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 122.545 0.338 . . . . 50.0 110.455 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t 52.5 90.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 114.816 1.413 . . . . 25.0 114.816 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.75 45.01 2.02 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 115.157 -0.929 . . . . 25.0 111.371 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.1 mpt? 54.19 -119.26 1.44 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.436 0.694 . . . . 25.0 110.426 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -154.55 155.51 34.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.919 0.781 . . . . 25.0 110.285 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.53 -43.75 7.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.2 0.524 . . . . 25.0 111.179 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 52.37 -105.31 0.22 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.471 0.708 . . . . 25.0 111.126 -175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -122.01 148.03 50.48 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.681 -0.859 . . . . 25.0 108.681 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.85 9.72 2.58 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 N-CA-C 114.21 0.812 . . . . 25.0 114.21 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.19 144.93 31.12 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.034 -1.098 . . . . 25.0 108.034 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.89 -27.22 0.09 OUTLIER Glycine 0 C--O 1.224 -0.518 0 C-N-CA 121.488 -0.387 . . . . 25.0 112.354 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -123.84 167.05 14.59 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -73.18 164.54 26.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.409 . . . . 25.0 110.103 177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.4 pt -115.52 162.57 13.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.245 -0.65 . . . . 50.0 109.245 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.37 91.63 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.0 t -93.61 -1.68 55.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.686 0.755 . . . . 25.0 110.528 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.2 t0 . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 123.774 1.749 . . . . 25.0 111.641 179.446 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.091 0 CA-C-O 123.57 1.65 . . . . 25.0 114.8 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 m -81.43 -13.28 58.42 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.844 -1.386 . . . . 25.0 111.138 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 mmt -79.37 138.76 37.79 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.301 -0.629 . . . . 25.0 109.301 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -78.26 133.83 37.63 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -134.51 173.92 11.12 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 105.857 -1.905 . . . . 50.0 105.857 174.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -58.24 -46.04 86.66 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.677 1.362 . . . . 50.0 114.677 -170.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.9 t30 53.87 41.65 31.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.771 1.026 . . . . 50.0 113.771 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -120.12 151.98 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 105.901 -1.888 . . . . 50.0 105.901 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.73 151.97 37.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.128 0.489 . . . . 50.0 111.614 -174.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.63 148.62 51.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.54 -0.755 . . . . 25.0 112.465 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.31 132.61 40.13 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 114.988 -1.005 . . . . 50.0 108.295 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.97 125.4 28.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.2 mt -91.64 -26.99 18.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 50.0 110.752 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -127.96 163.03 25.38 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.411 -1.329 . . . . 50.0 107.411 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.62 165.63 12.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.273 -0.639 . . . . 50.0 109.273 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -148.61 156.55 42.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.608 -0.516 . . . . 50.0 109.608 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.36 105.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.41 30.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.167 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -104.91 -12.31 16.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 50.0 111.753 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -122.39 149.83 55.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.984 -0.553 . . . . 50.0 110.511 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.89 -16.07 40.89 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 117.393 -1.271 . . . . 25.0 114.583 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -76.86 -19.64 57.24 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.77 0.795 . . . . 50.0 109.945 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -94.18 137.89 32.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.805 0.812 . . . . 50.0 110.49 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.62 131.48 35.21 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.83 -0.748 . . . . 50.0 111.276 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.7 t -78.72 109.98 13.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.781 -1.192 . . . . 50.0 107.781 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.16 162.46 35.43 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.461 -0.94 . . . . 25.0 108.461 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.47 167.49 20.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.879 . . . . 50.0 108.625 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -61.92 140.66 58.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.522 -0.547 . . . . 50.0 109.522 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.51 -15.0 62.43 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-O 118.792 -1.004 . . . . 25.0 113.272 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -73.07 155.74 39.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.505 1.152 . . . . 50.0 110.697 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.9 mm -122.38 126.14 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.371 -1.344 . . . . 50.0 107.371 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.4 ptp -135.97 154.92 50.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.18 0.192 . . . . 50.0 111.31 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 m -92.96 129.8 38.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.625 -0.879 . . . . 25.0 108.625 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.95 125.74 40.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.502 -1.295 . . . . 50.0 107.502 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.3 mt -94.74 -48.11 6.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.046 -0.524 . . . . 50.0 110.442 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.2 167.12 22.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.237 0.96 . . . . 50.0 109.11 -174.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -129.92 155.46 46.02 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 57.5 36.02 26.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 123.55 1.643 . . . . 50.0 107.914 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -70.17 -12.5 61.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.835 -1.529 . . . . 25.0 114.089 -171.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.474 ' C ' ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -110.46 4.79 20.83 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.42 0.628 . . . . 50.0 109.337 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 -20.29 11.17 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 109.431 -1.468 . . . . 25.0 109.431 -173.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 40' ' ' GLN . 91.7 mt -81.02 123.77 28.62 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.751 -1.574 . . . . 50.0 106.751 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.7 135.46 57.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.511 -0.922 . . . . 50.0 108.511 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.75 -3.65 83.24 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 115.878 1.111 . . . . 25.0 115.878 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -96.35 121.56 38.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.635 1.218 . . . . 50.0 108.078 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -111.87 143.99 41.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.728 -0.389 . . . . 50.0 110.55 -172.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -85.37 120.77 27.2 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.818 -2.29 . . . . 50.0 104.818 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.4 m -121.68 161.78 21.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.59 -0.522 . . . . 25.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -123.44 129.87 51.88 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.525 -0.917 . . . . 50.0 108.525 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.88 142.22 14.82 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.918 -1.142 . . . . 50.0 107.918 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 58.57 29.95 19.15 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.355 0.662 . . . . 25.0 112.662 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.0 7.77 88.25 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.766 -0.731 . . . . 25.0 114.706 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.9 164.9 25.88 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.669 -1.234 . . . . 50.0 107.669 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -124.43 153.7 41.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.51 -1.293 . . . . 50.0 107.51 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 169.4 42.4 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 110.441 -1.064 . . . . 50.0 110.441 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 pt -78.22 147.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 117.742 0.771 . . . . 50.0 111.995 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.92 135.42 13.49 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.749 -1.204 . . . . 25.0 107.749 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.15 116.57 4.56 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 115.844 -2.304 . . . . 50.0 111.489 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.88 -25.49 69.27 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 115.935 1.134 . . . . 50.0 115.935 -172.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -69.07 -12.4 61.65 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.874 -0.78 . . . . 50.0 112.043 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.58 5.77 50.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.356 -0.84 . . . . 50.0 110.252 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -116.94 154.8 30.22 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 122.61 0.364 . . . . 50.0 111.462 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -126.86 114.5 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.165 -1.05 . . . . 50.0 108.165 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.3 mm -67.73 141.82 17.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.145 -1.058 . . . . 50.0 108.145 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.06 -159.64 0.48 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.828 0.451 . . . . 50.0 109.967 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.05 141.21 18.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 122.869 0.467 . . . . 25.0 109.771 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.15 37.14 1.39 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-O 119.999 -0.334 . . . . 25.0 113.3 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.42 162.85 39.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.618 0.709 . . . . 25.0 111.499 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.7 t80 54.61 52.86 11.51 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.356 1.074 . . . . 25.0 113.809 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.94 -22.02 66.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.321 -0.854 . . . . 25.0 112.928 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -99.73 111.85 24.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.412 0.625 . . . . 25.0 111.718 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.64 155.41 50.76 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 114.686 -1.143 . . . . 25.0 110.143 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.0 175.04 11.77 Favored 'Trans proline' 0 C--O 1.243 0.727 0 N-CA-C 113.722 0.624 . . . . 25.0 113.722 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.8 163.88 35.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 104.665 -2.346 . . . . 25.0 104.665 174.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.01 -171.78 44.29 Favored Glycine 0 C--O 1.218 -0.878 0 N-CA-C 108.073 -2.011 . . . . 25.0 108.073 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.63 172.65 7.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.082 -1.081 . . . . 25.0 108.082 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -126.04 161.63 27.13 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.702 0.287 . . . . 25.0 110.342 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.1 mt -109.55 134.02 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.826 -1.546 . . . . 50.0 106.826 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -118.78 169.01 10.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.374 -1.713 . . . . 25.0 106.374 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.84 120.9 15.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.175 0.512 . . . . 25.0 110.889 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 . . . . . 0 C--O 1.207 -1.133 0 CA-C-O 126.581 3.086 . . . . 25.0 113.938 178.443 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 115.314 0.886 . . . . 25.0 115.314 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m 56.5 18.08 3.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.98 1.474 . . . . 25.0 114.98 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.3 ttm -75.3 80.72 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.691 0.758 . . . . 25.0 110.44 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -163.17 -34.51 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.163 -0.926 . . . . 25.0 110.107 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -116.28 170.02 8.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.604 -1.258 . . . . 50.0 107.604 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -58.35 -42.62 87.33 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.294 0.371 . . . . 50.0 111.182 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 57.48 22.38 7.97 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.547 0.943 . . . . 50.0 113.547 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -89.7 132.94 33.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 N-CA-C 107.737 -1.209 . . . . 50.0 107.737 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.27 160.51 14.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.334 0.588 . . . . 75.0 109.747 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.09 150.75 34.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.616 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.79 133.5 39.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 50.0 109.649 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.95 134.13 38.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.391 0.615 . . . . 25.0 109.854 175.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.24 -21.55 19.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.524 -0.762 . . . . 50.0 110.152 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.88 159.88 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 50.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 17.3 p-10 -101.98 147.57 26.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.983 -0.747 . . . . 50.0 108.983 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -153.07 156.95 39.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.7 -0.682 . . . . 50.0 110.875 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -124.96 131.48 72.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 104.472 -2.418 . . . . 25.0 104.472 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 121.65 14.31 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.13 0.269 . . . . 25.0 110.406 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -94.6 -14.62 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.358 -0.978 . . . . 50.0 108.358 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.7 155.44 59.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.471 -0.786 . . . . 50.0 109.774 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.16 -19.86 25.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 117.31 -1.327 . . . . 25.0 113.753 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -15.57 49.1 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.618 0.723 . . . . 50.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.29 153.17 21.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 50.0 111.232 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.6 136.61 41.15 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.039 -0.413 . . . . 50.0 111.841 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.1 m -85.19 109.81 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.046 -1.094 . . . . 50.0 108.046 171.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -126.55 162.05 26.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.649 -0.871 . . . . 25.0 108.649 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 43.5 mtm105 -127.39 155.23 43.96 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.918 -0.488 . . . . 50.0 111.102 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.8 pttt -59.99 128.9 39.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.43 -0.952 . . . . 50.0 108.43 175.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.19 65.83 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.627 -0.715 . . . . 25.0 114.353 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.75 156.76 30.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.881 0.841 . . . . 50.0 109.872 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.16 130.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.676 -0.861 . . . . 50.0 108.676 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -135.28 160.6 37.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.584 -0.524 . . . . 50.0 109.584 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.4 m -101.85 127.15 48.79 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 25.0 109.824 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.93 125.53 40.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.886 -1.153 . . . . 50.0 107.886 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.7 mt -95.5 -41.57 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.607 -0.724 . . . . 50.0 110.237 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -148.23 164.17 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.324 -0.621 . . . . 50.0 109.324 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -135.11 151.88 51.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.494 -1.669 . . . . 50.0 106.494 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 59.39 34.45 22.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.175 1.464 . . . . 50.0 107.913 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -70.55 -16.54 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.829 -1.532 . . . . 25.0 112.613 -172.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -113.35 7.98 17.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 50.0 112.05 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.84 19.81 78.54 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 109.418 -1.473 . . . . 25.0 109.418 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.7 mt -130.05 114.86 16.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 106.97 -1.493 . . . . 50.0 106.97 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -65.7 149.93 49.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.68 -1.6 . . . . 50.0 106.68 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.86 -12.55 69.17 Favored Glycine 0 C--O 1.215 -1.07 0 CA-C-O 118.573 -1.126 . . . . 25.0 112.224 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -106.28 128.28 53.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.179 1.489 . . . . 50.0 110.337 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.16 142.34 50.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.77 -0.456 . . . . 50.0 109.77 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.2 tp -83.87 119.03 24.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.02 -1.474 . . . . 50.0 107.02 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.0 m -123.42 164.79 18.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.349 0.119 . . . . 25.0 111.209 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.7 p -121.94 124.13 43.34 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.032 0.444 . . . . 50.0 110.256 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 tp -162.17 164.64 27.75 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 106.076 -1.824 . . . . 50.0 106.076 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.19 17.63 7.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.789 1.403 . . . . 25.0 114.789 169.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.33 13.57 80.32 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.934 -0.65 . . . . 25.0 113.261 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.9 167.61 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.559 -0.534 . . . . 50.0 109.559 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -105.98 154.81 20.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 103.6 -2.741 . . . . 50.0 103.6 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.78 163.77 34.27 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 110.121 -1.192 . . . . 50.0 110.121 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 pt -79.61 141.93 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.877 0.846 . . . . 50.0 109.983 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.6 132.99 17.74 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.362 -1.347 . . . . 25.0 107.362 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.07 121.74 8.36 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 114.218 -3.388 . . . . 50.0 111.258 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.17 -19.07 69.86 Favored Glycine 0 C--O 1.22 -0.763 0 CA-C-N 115.801 -0.636 . . . . 50.0 112.121 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -69.73 -5.59 26.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.109 0.481 . . . . 50.0 111.378 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -114.4 11.43 17.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.748 -0.464 . . . . 50.0 109.748 175.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.0 mt -120.57 150.09 41.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.275 0.56 . . . . 50.0 110.779 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -120.45 119.75 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.349 -0.982 . . . . 50.0 108.349 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm -57.71 134.41 22.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.882 -0.599 . . . . 50.0 109.772 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.87 -166.97 1.72 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.661 -0.699 . . . . 50.0 110.367 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m -61.82 160.55 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 114.006 1.113 . . . . 25.0 114.006 -176.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.78 175.04 35.86 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 108.922 -1.671 . . . . 25.0 108.922 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.6 mtp -56.05 -30.64 62.25 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 116.148 1.907 . . . . 25.0 116.148 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.45 26.56 4.77 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.78 0.8 . . . . 25.0 110.313 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -68.78 156.01 39.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.203 -0.908 . . . . 25.0 109.746 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -118.32 111.65 19.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.461 0.648 . . . . 25.0 110.626 -175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -61.17 131.77 92.22 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.918 -1.037 . . . . 25.0 109.591 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.65 167.55 26.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 117.987 -0.875 . . . . 25.0 111.562 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.11 156.47 43.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.73 82.33 1.66 Allowed Glycine 0 C--O 1.219 -0.835 0 N-CA-C 110.939 -0.864 . . . . 25.0 110.939 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 57.21 29.98 17.61 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.828 1.047 . . . . 25.0 113.828 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -115.87 136.15 53.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.139 0.495 . . . . 25.0 110.225 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 79.9 mt -102.03 129.33 53.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.397 -1.705 . . . . 50.0 106.397 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.21 19.5 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.938 0.718 . . . . 25.0 112.938 -173.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.5 p -79.03 149.86 32.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.052 0.453 . . . . 25.0 110.423 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 C--O 1.21 -1.007 0 CA-C-O 124.641 2.162 . . . . 25.0 111.766 176.359 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.901 0 CA-C-O 122.815 1.231 . . . . 25.0 113.777 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -150.11 164.01 36.71 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 120.706 -1.467 . . . . 25.0 107.732 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.1 tpt 51.24 70.9 0.48 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.939 1.088 . . . . 25.0 113.939 177.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.2 tttm 62.81 58.62 1.52 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 122.223 1.011 . . . . 25.0 113.475 177.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -91.36 -179.47 5.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 105.927 -1.879 . . . . 50.0 105.927 171.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.6 mt -53.57 -49.87 66.79 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.191 1.182 . . . . 50.0 114.191 -175.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.7 t30 47.09 46.56 16.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.124 1.527 . . . . 50.0 115.124 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.7 m -111.25 169.5 4.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 104.483 -2.414 . . . . 50.0 104.483 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.41 164.38 29.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.527 -0.545 . . . . 50.0 109.527 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.42 28.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.496 -0.774 . . . . 25.0 109.75 -175.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.35 136.34 53.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.681 -1.229 . . . . 50.0 107.681 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 135.38 45.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.48 0.657 . . . . 25.0 109.727 177.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.01 -30.16 16.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.182 -0.917 . . . . 50.0 109.356 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.83 158.49 39.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.821 -1.177 . . . . 50.0 107.821 -177.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.1 p-10 -87.91 152.98 21.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.432 . . . . 50.0 110.08 177.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.76 87.25 1.41 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.711 -0.848 . . . . 50.0 108.711 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.16 121.55 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.59 51.64 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.379 0.424 . . . . 25.0 111.418 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.05 -18.18 12.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.361 -0.836 . . . . 50.0 110.184 175.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -104.93 150.79 39.1 Favored Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 109.613 -0.514 . . . . 50.0 109.613 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.62 -21.6 19.05 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 117.585 -1.144 . . . . 25.0 114.42 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.62 -14.95 56.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 50.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -89.15 140.61 29.29 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.91 . . . . 50.0 111.134 -176.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.87 124.74 34.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.674 -0.641 . . . . 50.0 111.147 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -80.45 121.22 25.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.544 -0.539 . . . . 50.0 109.544 174.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -143.26 168.56 19.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.306 -0.998 . . . . 25.0 108.306 178.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -129.28 164.82 22.69 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.973 -0.455 . . . . 50.0 111.23 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 34.9 pttt -62.03 134.27 56.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 50.0 109.729 -177.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.47 -13.38 67.45 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 115.524 -0.762 . . . . 25.0 113.407 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -75.87 157.64 33.05 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 117.419 0.609 . . . . 50.0 110.988 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.88 126.37 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.292 0.637 . . . . 50.0 111.042 -175.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -129.49 147.78 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.41 0.624 . . . . 50.0 111.43 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -87.97 130.25 35.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.24 124.13 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.773 -1.195 . . . . 50.0 107.773 177.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -99.59 -41.32 7.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.3 -0.864 . . . . 50.0 111.791 -174.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.06 160.41 42.43 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.88 -0.785 . . . . 50.0 108.88 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -128.36 154.58 45.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.899 -1.149 . . . . 50.0 107.899 176.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t0 55.67 40.57 30.92 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.547 1.642 . . . . 50.0 108.309 -175.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -70.86 -8.0 49.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.646 -1.616 . . . . 25.0 114.193 -171.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -135.86 12.49 3.39 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.811 0.671 . . . . 50.0 112.811 -175.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 15.96 74.41 Favored Glycine 0 N--CA 1.459 0.224 0 N-CA-C 110.692 -0.963 . . . . 25.0 110.692 -176.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.3 mt -122.52 110.68 15.88 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.479 -1.674 . . . . 50.0 106.479 176.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.9 144.07 57.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.559 -1.275 . . . . 50.0 107.559 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 -17.2 57.04 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 115.217 -0.902 . . . . 25.0 113.107 -177.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -94.33 128.2 40.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.96 1.38 . . . . 50.0 108.61 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -119.72 146.3 45.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.644 -0.502 . . . . 50.0 109.644 -174.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.2 tp -86.22 112.64 21.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.654 -1.61 . . . . 50.0 106.654 174.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -112.04 168.32 9.69 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.923 -0.399 . . . . 25.0 109.923 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -128.71 131.71 47.95 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.064 -1.088 . . . . 50.0 108.064 174.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -158.61 140.12 13.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.173 -0.677 . . . . 50.0 109.173 -176.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 56.43 33.2 22.05 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.547 0.689 . . . . 25.0 112.356 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.2 3.34 90.68 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 115.758 1.063 . . . . 25.0 115.758 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -127.85 161.48 28.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 118.503 1.152 . . . . 50.0 109.035 177.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -113.15 151.74 30.51 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 105.903 -1.888 . . . . 50.0 105.903 176.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.73 38.19 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.437 -1.065 . . . . 50.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -78.62 144.79 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.51 0.671 . . . . 50.0 109.217 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.55 134.12 15.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.314 -0.857 . . . . 25.0 109.106 -176.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.95 114.65 3.96 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 116.05 -2.167 . . . . 50.0 110.855 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.57 -18.28 63.4 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-N 116.066 -0.515 . . . . 50.0 113.07 -176.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.47 -31.13 67.52 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.53 0.332 . . . . 50.0 111.414 174.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -88.58 6.9 35.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.112 0.412 . . . . 50.0 112.112 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.9 mt -119.4 151.33 38.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.851 0.358 . . . . 50.0 111.818 -176.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -124.43 123.31 39.89 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.956 -0.757 . . . . 50.0 108.956 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.12 140.36 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.284 0.633 . . . . 50.0 110.388 -177.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.3 165.58 13.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.933 -0.765 . . . . 50.0 108.933 -179.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t 58.38 44.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.487 1.115 . . . . 25.0 112.385 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.34 -45.27 4.43 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.706 -0.759 . . . . 25.0 114.159 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 51.3 mtt 50.92 -137.37 1.16 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.092 0.557 . . . . 25.0 110.789 -176.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -154.19 146.97 24.29 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.265 -1.383 . . . . 25.0 107.265 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 49.42 -152.3 0.14 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 124.211 0.944 . . . . 25.0 112.917 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -145.93 144.98 30.5 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.143 -1.058 . . . . 25.0 108.143 -176.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -71.61 147.02 91.95 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.511 -1.663 . . . . 25.0 106.511 175.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.3 100.25 0.99 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 117.812 -0.992 . . . . 25.0 113.103 -178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.44 146.68 16.97 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.305 -0.628 . . . . 25.0 109.305 -179.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.97 -99.99 1.88 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 111.27 -0.732 . . . . 25.0 111.27 178.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.09 163.11 26.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.712 0.291 . . . . 25.0 110.945 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -103.58 139.8 38.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.995 -1.483 . . . . 25.0 106.995 175.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.5 pt -73.67 159.3 5.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.791 0.329 . . . . 50.0 111.74 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t 54.64 80.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 122.13 0.967 . . . . 25.0 113.051 179.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.0 t -132.48 168.8 17.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 105.155 -2.165 . . . . 25.0 105.155 175.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.215 -0.715 0 CA-C-O 124.85 2.262 . . . . 25.0 112.784 179.396 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.621 0 CA-C-O 124.943 2.413 . . . . 25.0 113.141 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -63.77 -20.7 65.97 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 112.066 -2.067 . . . . 25.0 113.308 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 91.0 mtp -104.36 -52.38 2.92 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 176.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -169.49 -47.87 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.28 0.562 . . . . 25.0 111.083 174.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -117.82 166.09 12.88 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.247 -1.02 . . . . 50.0 108.247 -178.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.42 -46.87 75.1 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 123.234 0.334 . . . . 50.0 111.144 -177.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.6 t30 48.55 47.35 20.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.352 1.241 . . . . 50.0 114.352 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 165.8 12.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 N-CA-C 105.334 -2.098 . . . . 50.0 105.334 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.23 159.64 39.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.524 -0.917 . . . . 50.0 108.524 -178.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.35 164.65 29.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.562 -0.744 . . . . 25.0 110.388 -172.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -114.81 135.15 54.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.75 -1.204 . . . . 50.0 107.75 175.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.99 124.49 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 25.0 110.7 178.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.42 -29.42 41.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.041 -0.527 . . . . 50.0 109.972 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -126.73 162.7 25.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.76 -0.83 . . . . 50.0 108.76 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 p-10 -98.29 160.38 14.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.613 -0.884 . . . . 50.0 108.613 175.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -144.14 175.0 10.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.462 0.648 . . . . 50.0 112.265 177.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.8 t -126.96 137.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 100.215 -3.994 . . . . 25.0 100.215 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.8 16.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.173 -1.047 . . . . 25.0 108.173 -178.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.64 -11.45 53.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.22 1.01 . . . . 50.0 109.354 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -138.33 152.52 71.57 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.02 -0.991 . . . . 50.0 109.088 -176.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.98 -15.78 29.25 Favored 'Trans proline' 0 C--N 1.35 0.608 0 N-CA-C 114.016 0.737 . . . . 25.0 114.016 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -84.35 -20.01 32.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.835 0.826 . . . . 50.0 109.621 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.56 135.73 35.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.662 -0.699 . . . . 50.0 110.199 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.95 138.46 36.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.108 -0.701 . . . . 50.0 109.108 177.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 p -90.03 131.74 35.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.194 -1.409 . . . . 50.0 107.194 172.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.39 169.02 22.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.716 -1.216 . . . . 25.0 107.716 -177.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -128.24 158.78 37.2 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 109.25 -0.648 . . . . 50.0 109.25 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.4 pttt -56.29 128.62 36.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.127 -1.064 . . . . 50.0 108.127 173.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.78 -20.84 42.5 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.944 -0.571 . . . . 25.0 113.868 -176.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -66.89 151.02 48.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.403 0.601 . . . . 50.0 109.989 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -115.42 128.38 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.541 -0.911 . . . . 50.0 108.541 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.5 148.61 50.58 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.455 0.645 . . . . 50.0 111.168 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 m -89.86 126.43 35.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.141 -1.429 . . . . 25.0 107.141 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.2 t -91.57 114.05 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.279 -1.748 . . . . 50.0 106.279 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.2 mt -88.77 -43.21 11.42 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.187 -0.915 . . . . 50.0 110.206 -176.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -145.72 161.19 40.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.499 -0.926 . . . . 50.0 108.499 -173.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -126.8 150.32 49.21 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.823 -1.547 . . . . 50.0 106.823 177.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 58.92 34.02 23.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.995 1.379 . . . . 50.0 108.267 177.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -69.61 -20.53 63.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.693 -1.594 . . . . 25.0 113.673 -169.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -102.46 6.22 39.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.701 -0.681 . . . . 50.0 110.144 -177.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 12.36 84.64 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 109.658 -1.377 . . . . 25.0 109.658 -173.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -113.36 121.02 43.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.783 -0.821 . . . . 50.0 108.783 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.4 128.51 37.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.54 0.686 . . . . 50.0 110.311 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.98 -0.92 84.63 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 115.766 1.066 . . . . 25.0 115.766 175.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -100.79 123.86 45.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.049 1.424 . . . . 50.0 109.237 177.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -113.3 143.02 45.14 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.251 -0.28 . . . . 50.0 111.133 -171.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.6 tp -81.99 112.98 19.57 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.661 -1.607 . . . . 50.0 106.661 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.3 m -114.11 159.05 20.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.901 0.382 . . . . 25.0 110.43 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -135.59 127.0 28.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.698 -0.683 . . . . 50.0 109.76 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.98 141.82 29.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.545 0.528 . . . . 50.0 110.889 176.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 48.08 38.57 9.87 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 178.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.61 89.82 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 115.019 0.768 . . . . 25.0 115.019 176.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -122.96 145.27 48.63 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.103 -0.703 . . . . 50.0 109.103 178.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -118.04 150.35 39.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.696 -0.853 . . . . 50.0 108.696 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.5 169.22 42.17 Favored Glycine 0 C--O 1.243 0.704 0 N-CA-C 109.789 -1.324 . . . . 50.0 109.789 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -82.27 146.89 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.504 0.652 . . . . 50.0 109.706 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.3 t -140.83 135.02 15.19 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 -177.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.06 119.76 6.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 115.323 -2.652 . . . . 50.0 110.776 174.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.63 -22.6 68.13 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 114.31 0.484 . . . . 50.0 114.31 -173.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.91 -26.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 122.524 -0.398 . . . . 50.0 111.932 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -85.71 6.62 26.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.84 0.681 . . . . 50.0 112.84 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -118.98 146.69 44.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.47 0.544 . . . . 50.0 112.47 -175.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -118.2 121.77 41.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 170.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm -59.71 136.74 23.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 O-C-N 123.982 0.801 . . . . 50.0 109.009 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.22 179.88 7.59 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.002 -0.74 . . . . 50.0 109.002 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 t 58.65 59.99 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 122.688 1.233 . . . . 25.0 108.937 -175.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.33 -178.34 32.26 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.702 -1.759 . . . . 25.0 108.702 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 76.9 mtm -67.36 130.51 43.29 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 118.245 1.022 . . . . 25.0 109.645 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -109.6 -18.59 13.45 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 -176.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t0 49.54 48.89 20.81 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.701 1.001 . . . . 25.0 113.701 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -157.64 167.99 28.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.358 -0.608 . . . . 25.0 109.358 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -82.3 156.1 69.06 Favored Pre-proline 0 C--O 1.243 0.723 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 173.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -67.79 155.9 68.09 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 116.762 -1.692 . . . . 25.0 110.125 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.42 59.82 0.82 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.945 0.402 . . . . 25.0 110.926 -177.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.49 161.65 26.75 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 108.721 -1.752 . . . . 25.0 108.721 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -79.03 84.19 5.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.862 -0.421 . . . . 25.0 109.862 -177.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 53.78 22.98 3.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.11 1.152 . . . . 25.0 114.11 -176.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp 56.36 46.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.164 0.986 . . . . 50.0 111.976 176.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.7 m -79.28 170.09 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.977 -1.12 . . . . 25.0 107.977 171.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.0 t -141.65 144.41 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.14 -0.689 . . . . 25.0 109.14 176.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 . . . . . 0 C--O 1.21 -1.009 0 CA-C-O 123.823 1.773 . . . . 25.0 112.858 -179.367 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.899 0 CA-C-O 124.167 1.981 . . . . 25.0 113.485 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -78.95 58.77 2.47 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.554 -1.323 . . . . 25.0 111.169 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.7 ttt -123.36 44.92 2.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.463 0.649 . . . . 25.0 109.924 -177.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.8 tttt 59.75 85.91 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 122.819 1.295 . . . . 25.0 113.744 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -124.15 176.74 6.21 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.523 -2.029 . . . . 50.0 105.523 177.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mp -51.48 -50.87 59.02 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.35 1.611 . . . . 50.0 115.35 -174.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.1 t30 51.77 41.69 29.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.402 1.63 . . . . 50.0 115.402 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 m -114.84 163.07 12.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.008 -1.849 . . . . 50.0 106.008 175.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 155.8 49.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.618 0.723 . . . . 50.0 111.839 -176.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.49 152.97 47.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.916 -1.038 . . . . 25.0 110.71 -173.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.41 139.23 37.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.708 -0.849 . . . . 50.0 108.708 174.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.98 130.34 41.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.419 -0.586 . . . . 25.0 109.419 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.31 -34.39 15.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.858 -0.793 . . . . 50.0 108.858 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -123.95 168.51 12.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.962 -1.125 . . . . 50.0 107.962 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.0 p-10 -103.77 158.77 16.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.054 0.454 . . . . 50.0 110.387 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -153.06 133.52 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 50.0 110.53 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.94 125.77 57.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 102.901 -2.999 . . . . 25.0 102.901 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.12 129.33 38.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -100.47 -9.69 21.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.688 1.232 . . . . 50.0 109.054 177.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 m -127.71 152.66 77.27 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.402 -1.272 . . . . 50.0 108.948 -177.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.46 -25.62 17.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 114.718 1.007 . . . . 25.0 114.718 -176.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.71 -19.44 60.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.51 0.672 . . . . 50.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -90.02 143.59 26.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.28 -0.873 . . . . 50.0 109.972 -175.06 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.37 137.11 33.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.222 -0.591 . . . . 50.0 111.428 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.0 m -85.6 128.02 34.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 106.32 -1.733 . . . . 50.0 106.32 171.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -149.43 156.69 42.42 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.67 152.78 41.66 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 119.962 -0.695 . . . . 50.0 110.009 179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.4 pttp -55.57 126.33 24.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.158 -178.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.39 -22.67 28.44 Favored Glycine 0 C--O 1.221 -0.662 0 CA-C-N 115.379 -0.828 . . . . 25.0 112.902 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -70.74 157.95 37.15 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.565 0.683 . . . . 50.0 112.044 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -118.03 126.61 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.334 0.653 . . . . 50.0 109.979 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.9 ptp -132.45 151.36 51.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.924 0.392 . . . . 50.0 111.131 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.2 m -92.79 128.11 38.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 25.0 107.808 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.17 124.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.524 -1.288 . . . . 50.0 107.524 178.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 mt -102.83 -33.14 9.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.665 0.617 . . . . 50.0 112.665 -176.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.84 162.01 41.13 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 124.247 0.967 . . . . 50.0 108.603 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -133.86 144.46 48.94 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 108.392 -0.966 . . . . 50.0 108.392 178.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.51 32.98 20.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.511 1.624 . . . . 50.0 107.521 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.41 -14.34 62.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.892 -1.958 . . . . 25.0 115.221 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -110.84 6.15 21.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.057 -0.72 . . . . 50.0 109.057 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.2 -6.88 73.99 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.578 -1.409 . . . . 25.0 109.578 -174.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.72 115.38 27.82 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.768 -0.827 . . . . 50.0 108.768 179.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -61.75 132.65 53.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.397 -0.964 . . . . 50.0 108.397 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.59 -0.49 67.92 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-O 118.908 -0.94 . . . . 25.0 114.497 176.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -106.11 124.23 49.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.663 1.231 . . . . 50.0 109.574 177.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -111.31 145.42 38.85 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 121.968 -0.457 . . . . 50.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.4 tp -85.02 114.56 22.27 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 105.547 -2.02 . . . . 50.0 105.547 175.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.1 m -119.92 157.05 29.59 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.842 -0.429 . . . . 25.0 109.842 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 p -123.74 130.58 52.86 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.954 -1.128 . . . . 50.0 107.954 177.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -151.79 137.72 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.787 -1.097 . . . . 50.0 108.618 -174.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.7 t60 55.48 33.99 22.13 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.819 1.044 . . . . 25.0 113.819 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.05 7.03 89.02 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.816 0.686 . . . . 25.0 114.816 177.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -128.42 163.82 24.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.735 -1.209 . . . . 50.0 107.735 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -124.98 157.99 34.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 50.0 108.062 173.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.26 172.61 45.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.463 -1.455 . . . . 50.0 109.463 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.2 pt -84.22 143.05 12.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-O 121.785 0.802 . . . . 50.0 109.653 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.83 134.05 16.88 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.676 -1.231 . . . . 25.0 107.676 -178.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.3 119.57 6.6 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 114.61 -3.126 . . . . 50.0 110.95 175.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -26.68 72.04 Favored Glycine 0 C--O 1.223 -0.576 0 CA-C-N 115.867 -0.606 . . . . 50.0 114.375 -173.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.33 -9.97 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.956 -0.732 . . . . 50.0 111.325 178.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -93.12 4.59 53.74 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.699 -0.626 . . . . 50.0 109.633 174.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.42 165.24 14.13 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.83 0.452 . . . . 50.0 111.032 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -137.31 118.18 14.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.929 -0.578 . . . . 50.0 109.991 173.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.19 134.31 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.639 -1.245 . . . . 50.0 107.639 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.3 mt -93.21 138.09 31.93 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.362 -0.977 . . . . 50.0 108.362 -178.032 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t 56.4 35.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.842 -1.072 . . . . 25.0 111.852 -178.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.89 -38.76 96.54 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 115.198 0.839 . . . . 25.0 115.198 -178.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -159.61 164.31 34.26 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.089 0.944 . . . . 25.0 109.493 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -86.36 179.15 6.93 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 106.597 -1.631 . . . . 25.0 106.597 172.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 52.8 48.74 21.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.318 1.056 . . . . 25.0 111.963 174.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -63.34 153.07 36.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.798 -1.092 . . . . 25.0 108.174 178.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.11 147.89 89.8 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 25.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 172.75 14.48 Favored 'Trans proline' 0 C--N 1.352 0.726 0 O-C-N 122.615 0.797 . . . . 25.0 112.77 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.73 166.62 23.3 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.699 -0.682 . . . . 25.0 109.802 177.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.7 -146.5 4.98 Favored Glycine 0 C--N 1.321 -0.302 0 N-CA-C 108.999 -1.64 . . . . 25.0 108.999 178.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 68.23 -168.15 0.19 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.541 1.136 . . . . 25.0 111.97 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.3 t80 47.82 78.81 0.07 Allowed 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.356 1.613 . . . . 25.0 115.356 -178.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.53 157.86 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.765 -1.198 . . . . 50.0 107.765 173.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.73 166.07 25.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.579 -0.526 . . . . 25.0 109.579 -178.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 p -90.82 153.43 20.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.975 -1.12 . . . . 25.0 107.975 177.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--O 1.211 -0.925 0 CA-C-O 124.886 2.279 . . . . 25.0 111.225 178.401 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.695 0 CA-C-O 125.069 2.483 . . . . 25.0 113.223 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 m -79.03 58.4 2.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 112.581 -1.81 . . . . 25.0 112.012 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.9 mtt -75.61 45.08 0.3 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.267 0.839 . . . . 25.0 113.267 -176.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -96.28 -23.68 16.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.347 -0.388 . . . . 25.0 109.97 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -109.94 168.59 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.789 -2.3 . . . . 50.0 104.789 173.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.1 mt -62.36 -38.51 89.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.283 -0.167 . . . . 50.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 55.26 30.03 13.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.792 0.837 . . . . 50.0 110.518 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.96 162.74 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 104.06 -2.57 . . . . 50.0 104.06 -179.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.15 160.94 38.61 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.383 -0.969 . . . . 50.0 108.383 -177.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.71 159.32 44.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.668 -0.696 . . . . 25.0 110.77 -174.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.88 135.59 48.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.722 -1.214 . . . . 50.0 107.722 174.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.24 135.84 46.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.371 0.605 . . . . 25.0 109.794 178.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.31 -25.79 16.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.469 -0.787 . . . . 50.0 110.041 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -124.01 158.51 31.94 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.632 -1.247 . . . . 50.0 107.632 -178.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 13.4 p-10 -101.52 159.12 15.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.335 -0.617 . . . . 50.0 109.335 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -150.78 158.34 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.355 0.409 . . . . 50.0 111.068 -173.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.71 125.38 65.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 103.076 -2.935 . . . . 25.0 103.076 173.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.81 121.73 17.84 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.74 -0.384 . . . . 25.0 110.029 -176.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -101.65 -15.1 17.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.383 0.611 . . . . 50.0 109.385 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 t -111.62 147.55 37.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 50.0 109.352 175.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.39 -15.4 34.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 117.775 -1.016 . . . . 25.0 113.491 175.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.47 -15.49 56.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.756 0.789 . . . . 50.0 110.19 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -92.62 143.29 26.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.178 -0.919 . . . . 50.0 112.803 -172.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.62 137.57 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.861 -0.524 . . . . 50.0 110.493 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 117.41 23.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.617 -1.253 . . . . 50.0 107.617 172.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 164.66 32.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 36.9 ptt-85 -137.01 164.03 29.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.68 -0.408 . . . . 50.0 111.985 177.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -60.01 136.81 58.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.193 0.52 . . . . 50.0 110.358 179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.36 -19.43 54.28 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.186 -0.915 . . . . 25.0 113.317 -178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -77.54 156.78 30.72 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 117.168 0.484 . . . . 50.0 110.412 -178.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.1 mm -115.18 130.5 69.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 123.332 0.653 . . . . 50.0 109.282 -174.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.9 ptp -138.94 151.83 47.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.949 0.404 . . . . 50.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 m -87.23 146.05 26.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.923 -1.51 . . . . 25.0 106.923 177.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.86 121.03 63.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 106.844 -1.539 . . . . 50.0 106.844 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.08 -49.44 8.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.596 . . . . 50.0 110.303 -177.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.55 170.84 19.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.208 -1.034 . . . . 50.0 108.208 -177.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -134.72 153.69 51.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.731 -0.176 . . . . 50.0 111.163 -175.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 60.46 38.75 19.01 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.298 1.523 . . . . 50.0 107.8 -177.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.45 -18.83 63.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.237 -1.802 . . . . 25.0 114.785 -167.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -111.4 6.38 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.497 0.665 . . . . 50.0 109.597 -177.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.53 -4.39 81.98 Favored Glycine 0 CA--C 1.518 0.241 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -174.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.4 127.02 35.49 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.274 -1.38 . . . . 50.0 107.274 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.53 132.41 52.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.297 0.57 . . . . 50.0 110.167 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.2 1.59 90.4 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 115.519 0.968 . . . . 25.0 115.519 174.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -100.94 115.41 30.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.143 1.472 . . . . 50.0 110.075 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -108.21 146.84 32.21 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.258 -0.276 . . . . 50.0 110.335 -172.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.1 tp -86.26 110.97 20.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.749 -1.575 . . . . 50.0 106.749 176.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -113.69 161.02 18.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.865 -0.42 . . . . 25.0 109.865 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.33 131.46 53.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.38 -0.6 . . . . 50.0 109.38 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.16 140.62 14.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 50.0 108.881 -177.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 56.96 35.06 25.88 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.074 1.138 . . . . 25.0 114.074 175.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.35 85.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.905 -0.664 . . . . 25.0 114.05 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.87 167.61 14.99 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.913 -1.143 . . . . 50.0 107.913 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -136.46 150.24 48.62 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.243 -1.762 . . . . 50.0 106.243 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.69 174.58 45.73 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 109.636 -1.386 . . . . 50.0 109.636 -176.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 pt -77.84 144.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.328 0.585 . . . . 50.0 110.437 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.0 t -144.26 136.19 13.04 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.34 112.05 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 116.009 -2.194 . . . . 50.0 111.662 174.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -24.86 73.29 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 115.902 -0.59 . . . . 50.0 113.941 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -70.44 -0.56 8.56 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 50.0 111.559 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -114.28 13.77 17.93 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.752 -0.462 . . . . 50.0 109.752 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.3 mt -118.75 155.19 31.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 50.0 109.928 178.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.81 117.76 27.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.179 -0.304 . . . . 50.0 110.179 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -54.68 130.56 16.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 O-C-N 123.773 0.671 . . . . 50.0 110.31 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 tp -114.62 113.66 24.66 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 115.692 -0.685 . . . . 50.0 110.264 -175.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t 58.08 5.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 114.702 1.371 . . . . 25.0 114.702 -178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.49 44.39 3.2 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 117.314 1.686 . . . . 25.0 117.314 -179.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 55.7 mtt 43.05 42.41 3.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.536 1.31 . . . . 25.0 114.536 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -50.69 -38.74 48.67 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.715 1.376 . . . . 25.0 114.715 -175.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -121.69 48.81 1.63 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.569 0.7 . . . . 25.0 109.172 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 tttp 46.85 46.35 15.33 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 123.294 1.521 . . . . 25.0 112.162 -177.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -74.54 146.32 83.46 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 114.084 -1.417 . . . . 25.0 110.191 -175.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.2 160.87 46.16 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 118.332 -0.645 . . . . 25.0 112.662 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -158.56 174.97 14.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.088 -2.19 . . . . 25.0 105.088 177.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.12 -175.09 49.82 Favored Glycine 0 C--O 1.227 -0.331 0 N-CA-C 108.628 -1.789 . . . . 25.0 108.628 174.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -66.83 -32.53 73.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.265 1.033 . . . . 25.0 110.198 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.45 92.79 5.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.8 0.81 . . . . 25.0 109.129 175.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 pt -93.65 165.6 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.147 -0.933 . . . . 50.0 109.859 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.9 t 72.95 130.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.238 1.415 . . . . 25.0 111.941 -178.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.1 p -133.38 156.85 46.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.454 -1.313 . . . . 25.0 107.454 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 124.778 2.228 . . . . 25.0 113.439 177.796 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.733 0 CA-C-O 123.615 1.675 . . . . 25.0 115.7 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 t -156.1 152.35 27.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.433 -1.321 . . . . 25.0 107.433 177.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -141.03 152.36 44.8 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.127 -2.546 . . . . 25.0 104.127 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.66 147.27 46.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.071 -0.714 . . . . 25.0 109.071 -178.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -82.97 172.95 12.24 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.876 -1.527 . . . . 50.0 106.876 175.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.18 -58.63 6.66 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.69 1.367 . . . . 50.0 114.69 -172.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t30 54.82 24.49 5.76 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.982 1.475 . . . . 50.0 114.982 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.81 174.16 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 N-CA-C 104.69 -2.337 . . . . 50.0 104.69 174.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.72 162.26 33.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.563 0.619 . . . . 50.0 109.961 -177.193 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.6 144.18 30.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.94 -0.573 . . . . 25.0 111.656 -177.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.24 135.09 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 50.0 109.837 176.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.04 131.05 40.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 25.0 110.062 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.41 -30.63 17.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 50.0 110.784 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -130.57 162.53 29.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.22 -1.771 . . . . 50.0 106.22 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.519 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.4 p-10 -96.83 160.37 14.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.977 0.353 . . . . 50.0 110.39 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -150.02 144.4 25.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.399 0.518 . . . . 50.0 112.399 -177.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 126.79 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.748 -2.315 . . . . 25.0 104.748 174.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.63 128.57 33.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 -178.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -97.2 -24.1 15.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.416 -0.957 . . . . 50.0 108.416 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -104.31 147.16 33.91 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.174 -0.676 . . . . 50.0 109.174 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.1 -14.81 35.47 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.118 -1.455 . . . . 25.0 113.932 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -81.89 -19.81 40.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.898 0.856 . . . . 50.0 110.289 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.07 144.6 25.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.496 -0.774 . . . . 50.0 109.526 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.69 132.92 44.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.189 0.519 . . . . 50.0 110.648 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t -88.86 145.16 25.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.949 -1.13 . . . . 50.0 107.949 175.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.36 165.58 32.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 -178.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -120.71 154.06 36.1 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 121.836 -0.54 . . . . 50.0 109.774 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 22.4 pttp -58.5 134.02 56.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.386 -0.968 . . . . 50.0 108.386 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.17 -14.01 65.93 Favored Glycine 0 C--O 1.221 -0.699 0 CA-C-O 119.209 -0.773 . . . . 25.0 112.996 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.21 159.8 28.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.02 0.91 . . . . 50.0 109.398 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.78 131.47 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.744 -0.465 . . . . 50.0 109.744 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.6 ptp -130.89 155.26 47.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.185 0.594 . . . . 50.0 110.051 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.3 m -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.825 -1.176 . . . . 25.0 107.825 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.7 125.63 54.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.757 -1.201 . . . . 50.0 107.757 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.0 mt -102.34 -36.59 8.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.554 -0.748 . . . . 50.0 111.876 -174.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.82 161.28 42.56 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.434 -1.321 . . . . 50.0 107.434 -178.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -129.41 150.25 50.85 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.553 -1.277 . . . . 50.0 107.553 177.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 59.09 35.64 23.9 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.287 1.617 . . . . 50.0 106.961 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.53 -10.48 59.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 112.546 -2.116 . . . . 25.0 115.923 -163.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -126.48 13.96 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.448 0.642 . . . . 50.0 109.611 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.58 -5.38 78.33 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 109.802 -1.319 . . . . 25.0 109.802 -175.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.18 115.59 26.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.041 -1.096 . . . . 50.0 108.041 178.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.33 130.83 48.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.793 0.806 . . . . 50.0 109.806 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 2.22 85.81 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-O 118.62 -1.1 . . . . 25.0 115.316 176.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -102.67 128.3 49.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.224 1.512 . . . . 50.0 108.442 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -117.1 144.43 44.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 50.0 109.647 -174.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.7 tp -84.34 117.38 23.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 106.061 -1.829 . . . . 50.0 106.061 175.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.92 158.08 27.44 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.34 129.93 52.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.248 -0.649 . . . . 50.0 109.248 177.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.08 137.76 19.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.509 -0.768 . . . . 50.0 109.173 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 54.99 30.94 15.06 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 176.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.33 13.02 82.45 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.138 -0.554 . . . . 25.0 113.991 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.37 165.3 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.243 -1.762 . . . . 50.0 106.243 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -137.23 140.61 41.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 118.471 0.578 . . . . 50.0 109.721 175.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.46 164.48 29.4 Favored Glycine 0 C--O 1.238 0.374 0 O-C-N 124.039 0.837 . . . . 50.0 111.574 -176.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.21 143.81 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.947 -1.131 . . . . 50.0 107.947 174.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.5 t -140.26 135.63 16.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 -175.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.58 116.99 4.8 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 115.21 -2.727 . . . . 50.0 110.385 174.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.05 -16.85 71.18 Favored Glycine 0 CA--C 1.508 -0.397 0 CA-C-N 116.163 -0.471 . . . . 50.0 112.948 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.49 -4.29 18.19 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.61 -0.347 . . . . 50.0 111.008 175.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -109.89 10.67 24.39 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.414 -0.179 . . . . 50.0 111.049 175.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.82 157.04 33.31 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.623 0.601 . . . . 50.0 112.623 -176.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -127.18 117.55 22.58 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.661 -0.866 . . . . 50.0 108.661 174.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.6 mm -63.75 139.43 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.614 0.245 . . . . 50.0 110.382 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.6 mt -121.05 149.8 42.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.431 -1.322 . . . . 50.0 107.431 176.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.35 169.32 19.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.683 -0.858 . . . . 25.0 108.683 -177.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.3 -64.37 0.38 Allowed Glycine 0 C--O 1.214 -1.147 0 C-N-CA 121.035 -0.602 . . . . 25.0 112.873 177.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 38.7 mmt -81.62 80.76 7.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.753 -0.263 . . . . 25.0 110.568 -178.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -75.91 -27.39 57.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.946 0.403 . . . . 25.0 110.234 178.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -84.97 88.02 7.41 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 175.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -131.9 122.02 24.97 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.317 -0.994 . . . . 25.0 108.317 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -70.49 138.99 86.37 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 107.417 -1.327 . . . . 25.0 107.417 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.97 -18.14 16.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 N-CA-C 114.895 1.075 . . . . 25.0 114.895 -177.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 52.62 40.28 29.79 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.562 0.745 . . . . 25.0 111.207 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.22 44.52 1.43 Allowed Glycine 0 C--O 1.225 -0.423 0 N-CA-C 110.794 -0.922 . . . . 25.0 110.794 -174.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -70.59 -16.92 62.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.029 0.442 . . . . 25.0 110.649 -177.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -115.07 129.7 56.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.342 -1.355 . . . . 25.0 107.342 170.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.0 pt -130.49 171.27 17.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.704 -0.85 . . . . 50.0 108.704 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.8 m -111.08 165.59 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 106.582 -1.636 . . . . 25.0 106.582 175.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.3 t -151.68 151.21 31.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.375 -1.343 . . . . 25.0 107.375 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 . . . . . 0 C--O 1.206 -1.224 0 CA-C-O 124.76 2.219 . . . . 25.0 111.986 -177.175 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.167 0 CA-C-O 123.374 1.541 . . . . 25.0 115.328 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 p -69.82 81.24 0.45 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.001 1.72 . . . . 25.0 112.653 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.6 mmm -75.32 -16.53 60.4 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.539 -0.726 . . . . 25.0 110.145 -179.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -161.43 151.38 17.06 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.688 0.795 . . . . 25.0 111.616 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -75.1 178.69 5.51 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.346 1.029 . . . . 50.0 110.459 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.4 -34.86 77.56 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.98 1.104 . . . . 50.0 113.98 -178.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 56.12 34.28 23.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.927 0.891 . . . . 50.0 112.67 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.87 135.49 39.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 104.153 -2.536 . . . . 50.0 104.153 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.75 161.47 29.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.991 0.814 . . . . 50.0 109.75 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.62 153.86 33.11 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.486 0.66 . . . . 25.0 112.768 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -91.64 134.58 34.57 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.167 -0.924 . . . . 50.0 109.962 176.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.97 127.56 32.98 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 108.33 -0.989 . . . . 25.0 108.33 173.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -87.03 -27.73 23.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.93 0.871 . . . . 50.0 109.602 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -124.97 160.0 29.94 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.926 -1.034 . . . . 50.0 108.972 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -98.76 158.22 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.586 -1.635 . . . . 50.0 106.586 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -142.91 159.84 41.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 112.703 0.631 . . . . 50.0 112.703 -174.132 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.63 119.77 55.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 102.535 -3.135 . . . . 25.0 102.535 172.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.07 113.25 13.39 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.354 -0.539 . . . . 25.0 109.593 -177.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -82.48 -15.52 52.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.937 0.875 . . . . 50.0 109.221 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.3 m -122.21 156.28 60.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.746 -0.661 . . . . 50.0 109.323 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.39 -14.13 22.77 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 117.548 -1.168 . . . . 25.0 112.739 175.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -84.85 -16.57 40.85 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.804 1.288 . . . . 50.0 110.962 178.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -91.59 140.93 29.25 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.32 134.32 34.11 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.675 0.75 . . . . 50.0 112.573 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -86.91 106.05 17.5 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.313 -0.858 . . . . 50.0 109.101 177.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -128.79 165.12 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.565 -0.709 . . . . 25.0 112.595 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 mtt85 -122.69 156.7 33.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.507 -0.183 . . . . 50.0 110.507 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -62.18 134.38 56.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 178.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.38 -11.54 68.73 Favored Glycine 0 C--O 1.214 -1.148 0 CA-C-N 115.484 -0.78 . . . . 25.0 112.559 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.16 159.82 32.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.342 1.071 . . . . 50.0 109.361 177.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.55 124.17 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.017 -0.734 . . . . 50.0 109.017 -176.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.6 ptp -131.86 152.35 51.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.26 0.837 . . . . 50.0 113.26 -176.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 m -92.83 131.24 38.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.22 -0.445 . . . . 25.0 110.223 -177.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.84 126.78 43.57 Favored 'Isoleucine or valine' 0 C--O 1.257 1.5 0 N-CA-C 108.104 -1.073 . . . . 50.0 108.104 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.8 mt -102.98 -38.75 7.21 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 114.735 -1.12 . . . . 50.0 111.889 -177.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -143.39 160.99 39.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.827 -1.078 . . . . 50.0 108.215 -176.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 -131.77 145.3 51.52 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.059 -1.83 . . . . 50.0 106.059 174.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 63.59 37.68 10.12 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 123.858 1.79 . . . . 50.0 108.305 -176.081 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -69.39 -19.63 63.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.03 -1.895 . . . . 25.0 116.054 -172.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -119.55 10.51 11.81 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.013 0.911 . . . . 50.0 108.82 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.23 79.64 Favored Glycine 0 CA--C 1.511 -0.16 0 CA-C-N 115.397 -0.819 . . . . 25.0 111.242 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.89 139.1 31.07 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 106.675 -1.602 . . . . 50.0 106.675 176.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.58 150.31 48.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.175 0.988 . . . . 50.0 110.404 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.4 -3.69 38.94 Favored Glycine 0 C--O 1.207 -1.572 0 O-C-N 120.873 -1.142 . . . . 25.0 115.329 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -99.73 131.04 45.97 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 118.967 1.384 . . . . 50.0 110.298 -179.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -125.82 142.34 51.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.97 -0.292 . . . . 50.0 111.389 -172.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp -82.77 120.73 26.0 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 106.618 -1.623 . . . . 50.0 106.618 176.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.46 164.13 15.72 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.386 0.275 . . . . 25.0 110.393 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 89.8 p -120.32 127.05 51.99 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.353 -0.61 . . . . 50.0 109.353 175.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 tp -153.1 146.24 24.68 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.391 -1.337 . . . . 50.0 107.391 -179.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.7 t60 60.92 10.86 2.97 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.406 1.261 . . . . 25.0 114.406 178.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 10.21 62.1 Favored Glycine 0 C--O 1.22 -0.761 0 C-N-CA 120.429 -0.891 . . . . 25.0 112.17 -179.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -124.39 165.76 17.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.677 -1.601 . . . . 50.0 106.677 178.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -118.82 156.88 28.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.026 -2.213 . . . . 50.0 105.026 172.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.72 162.87 31.55 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.879 -0.676 . . . . 50.0 111.865 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -77.02 141.97 14.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 122.313 1.054 . . . . 50.0 108.806 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.23 136.85 17.26 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.434 -1.257 . . . . 25.0 110.228 178.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.37 115.63 4.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 117.564 -1.157 . . . . 50.0 111.338 178.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.85 -25.46 70.63 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 115.996 -0.547 . . . . 50.0 113.576 -174.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -64.77 -22.85 67.07 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.899 0.849 . . . . 50.0 111.551 178.04 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -91.59 10.42 28.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.413 -0.358 . . . . 50.0 111.463 -178.073 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.9 144.87 45.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.528 0.68 . . . . 50.0 111.987 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -112.64 113.28 25.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 121.96 -0.463 . . . . 50.0 110.649 178.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mm -54.37 137.14 15.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 C-N-CA 123.063 0.545 . . . . 50.0 109.812 -174.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.46 173.54 6.55 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 105.923 -1.88 . . . . 50.0 105.923 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 m -80.14 163.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.305 -0.628 . . . . 25.0 109.305 179.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.96 149.39 42.78 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 120.316 -0.945 . . . . 25.0 112.542 -176.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.1 tpt -137.33 163.24 31.46 Favored 'General case' 0 C--O 1.205 -1.257 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 179.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.56 142.81 56.39 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 124.062 0.851 . . . . 25.0 110.953 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -134.53 163.77 28.97 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.041 -0.527 . . . . 25.0 110.409 177.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -89.05 140.55 29.33 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.317 -1.364 . . . . 25.0 107.317 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -54.8 135.09 65.53 Favored Pre-proline 0 N--CA 1.48 1.061 0 O-C-N 125.028 1.455 . . . . 25.0 110.394 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.44 173.57 14.03 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.881 2.388 . . . . 25.0 112.995 178.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.07 167.48 29.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.822 -1.547 . . . . 25.0 106.822 175.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.62 122.32 4.78 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 120.604 -0.808 . . . . 25.0 111.296 178.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.88 -25.11 23.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.18 1.178 . . . . 25.0 114.18 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 56.24 -164.98 0.14 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.397 1.079 . . . . 25.0 113.163 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.25 137.47 23.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 N-CA-C 103.398 -2.815 . . . . 50.0 103.398 172.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 m -74.66 156.22 6.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.669 0.747 . . . . 25.0 110.704 -175.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -81.84 117.12 21.86 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.109 -1.812 . . . . 25.0 106.109 172.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 C--O 1.193 -1.895 0 CA-C-O 124.369 2.033 . . . . 25.0 113.133 -172.104 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 CA-C-O 123.268 1.482 . . . . 25.0 115.079 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -65.72 -15.99 63.34 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.084 -1.245 . . . . 25.0 113.701 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.8 ttt 47.09 34.6 2.96 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.462 1.653 . . . . 25.0 115.462 176.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 60.59 15.79 5.99 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.201 1.556 . . . . 25.0 115.201 178.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.67 165.03 20.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.143 -1.058 . . . . 50.0 108.143 172.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.5 mt -64.02 -43.05 96.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 121.072 -0.251 . . . . 50.0 110.959 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 49.95 39.19 18.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.581 0.956 . . . . 50.0 113.581 176.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.55 141.56 32.18 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 107.335 -1.357 . . . . 50.0 107.335 -178.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.88 154.48 18.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.749 0.785 . . . . 50.0 111.879 -174.009 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.16 46.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.829 -1.078 . . . . 25.0 109.866 -179.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -97.02 134.62 40.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.024 -1.102 . . . . 50.0 108.024 175.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.85 136.79 45.4 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.638 0.732 . . . . 25.0 110.088 176.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.7 mt -94.61 -34.32 12.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 50.0 109.169 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -125.4 164.85 19.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.405 -1.702 . . . . 50.0 106.405 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.17 165.39 13.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.851 -0.796 . . . . 50.0 108.851 174.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.09 110.53 3.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.6 . . . . 50.0 109.787 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.57 131.87 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 174.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.92 15.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.478 -1.305 . . . . 25.0 107.478 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -96.84 -6.75 35.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.323 1.058 . . . . 50.0 108.296 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -132.31 149.58 73.56 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.194 -1.41 . . . . 50.0 107.194 178.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.38 -24.51 19.34 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 116.038 -2.175 . . . . 25.0 115.068 -174.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.62 -15.62 58.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.752 0.787 . . . . 50.0 110.617 -179.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -81.02 141.36 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.361 -1.348 . . . . 50.0 107.361 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.08 130.2 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.726 -0.609 . . . . 50.0 110.124 178.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.38 116.34 21.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.87 -1.159 . . . . 50.0 107.87 174.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -141.34 165.88 26.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.484 -0.562 . . . . 25.0 109.484 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.69 155.21 46.26 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.938 0.399 . . . . 50.0 111.921 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.5 129.84 37.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.981 -0.554 . . . . 50.0 110.594 176.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -21.74 44.32 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.435 -179.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -72.16 160.99 31.52 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 117.34 0.57 . . . . 50.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.7 mm -119.65 128.67 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.888 -0.782 . . . . 50.0 108.888 -176.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -135.87 148.45 48.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.068 0.461 . . . . 50.0 110.237 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -87.07 128.77 35.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.463 -0.94 . . . . 25.0 108.463 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.3 t -89.01 124.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.755 -1.572 . . . . 50.0 106.755 175.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.12 -45.29 7.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.624 -0.716 . . . . 50.0 110.247 -179.223 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.27 164.63 34.29 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.488 -0.56 . . . . 50.0 109.488 -175.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -129.88 152.66 49.12 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.402 -0.592 . . . . 50.0 109.402 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t0 56.53 39.43 29.91 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 123.608 1.67 . . . . 50.0 107.414 -175.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -70.48 -12.93 61.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.401 -1.727 . . . . 25.0 114.179 -169.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.05 9.85 5.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 50.0 111.472 -176.796 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.39 14.49 78.46 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 108.951 -1.66 . . . . 25.0 108.951 -174.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.92 111.25 23.82 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.172 -1.418 . . . . 50.0 107.172 177.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -63.78 141.75 58.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.814 -0.81 . . . . 50.0 108.814 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.04 -14.75 31.0 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-O 119.273 -0.737 . . . . 25.0 114.846 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -94.01 136.44 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.794 1.297 . . . . 50.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -121.83 146.14 47.37 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.232 -0.655 . . . . 50.0 109.232 -175.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -84.91 116.05 23.12 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.486 -1.672 . . . . 50.0 106.486 175.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.1 m -117.41 164.73 14.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.581 -0.526 . . . . 25.0 109.581 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -125.59 127.66 46.7 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.938 -0.764 . . . . 50.0 108.938 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.7 tp -161.11 152.36 18.87 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.01 -1.478 . . . . 50.0 107.01 -177.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.1 t60 58.95 28.23 17.33 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.64 0.733 . . . . 25.0 112.109 177.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.74 2.12 85.1 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 115.023 0.769 . . . . 25.0 115.023 178.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -133.86 164.21 27.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 117.866 0.833 . . . . 50.0 110.656 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -101.71 158.93 15.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.618 -1.623 . . . . 50.0 106.618 176.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 162.66 33.11 Favored Glycine 0 C--O 1.24 0.496 0 N-CA-C 109.872 -1.291 . . . . 50.0 109.872 178.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -81.88 145.7 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.514 0.673 . . . . 50.0 109.643 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.31 134.83 16.76 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 25.0 108.809 -176.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.22 109.19 2.15 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.079 -1.481 . . . . 50.0 110.696 172.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.15 61.84 Favored Glycine 0 C--O 1.22 -0.723 0 N-CA-C 115.394 0.918 . . . . 50.0 115.394 -172.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -16.99 64.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.874 -0.78 . . . . 50.0 111.464 177.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.53 3.83 51.2 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.908 -0.495 . . . . 50.0 111.002 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -118.51 157.59 26.99 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.613 0.365 . . . . 50.0 110.321 -178.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -127.49 117.82 22.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.381 -0.97 . . . . 50.0 108.381 171.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.0 mm -59.27 137.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.234 -1.024 . . . . 50.0 108.234 177.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.55 119.44 11.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.108 -1.071 . . . . 50.0 108.108 177.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -84.62 151.9 3.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.277 -0.874 . . . . 25.0 109.963 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.42 173.47 19.59 Favored Glycine 0 N--CA 1.454 -0.126 0 N-CA-C 110.539 -1.024 . . . . 25.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 57.8 mtt -83.25 161.47 21.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.89 -0.782 . . . . 25.0 108.89 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -80.67 38.79 0.45 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.007 0.743 . . . . 25.0 113.007 -177.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.27 -29.91 68.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.296 0.569 . . . . 25.0 112.167 -175.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -132.18 147.18 52.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.986 -0.446 . . . . 25.0 110.87 -178.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.73 150.01 47.51 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 106.808 -1.553 . . . . 25.0 106.808 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.39 -18.1 16.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 N-CA-C 114.775 1.029 . . . . 25.0 114.775 -178.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -160.64 168.35 25.11 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.382 -2.081 . . . . 25.0 105.382 -179.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.74 19.23 0.1 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.241 -0.504 . . . . 25.0 113.787 176.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -88.64 163.26 15.89 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.047 0.539 . . . . 25.0 111.003 -175.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -135.84 142.9 44.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.4 tt -127.65 138.48 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.442 -0.947 . . . . 50.0 108.442 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -86.7 -43.72 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.04 0.448 . . . . 25.0 110.385 -178.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -155.72 -59.31 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.376 0.608 . . . . 25.0 110.721 -179.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 124.266 1.984 . . . . 25.0 111.328 -178.194 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.87 0 CA-C-O 123.833 1.796 . . . . 25.0 113.475 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 m 56.14 28.18 12.65 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 112.348 -1.926 . . . . 25.0 112.457 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.1 mtt -69.24 143.21 54.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.137 -0.69 . . . . 25.0 109.137 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -134.64 -38.0 0.83 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 -178.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -137.63 156.36 48.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.127 -1.064 . . . . 50.0 108.127 -177.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt -68.69 -44.83 73.16 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.354 0.409 . . . . 50.0 111.141 -175.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 55.31 26.7 8.92 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.904 0.882 . . . . 50.0 113.214 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.73 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 N-CA-C 105.798 -1.927 . . . . 50.0 105.798 177.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.24 159.63 37.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.898 -0.779 . . . . 50.0 108.898 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.279 -0.419 . . . . 25.0 109.973 -178.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -95.42 133.86 38.91 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.108 -0.701 . . . . 50.0 109.108 178.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 132.18 42.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.199 0.523 . . . . 25.0 110.686 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.8 -32.8 15.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.78 -0.822 . . . . 50.0 108.78 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.65 162.18 18.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.073 -0.967 . . . . 50.0 108.825 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.34 148.99 22.19 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.339 -2.097 . . . . 50.0 105.339 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -148.28 130.51 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 50.0 111.672 -172.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.46 132.26 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 102.833 -3.025 . . . . 25.0 102.833 172.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.13 126.33 28.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.96 -0.755 . . . . 25.0 108.96 -178.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.33 -7.07 32.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.435 -0.95 . . . . 50.0 108.435 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.9 155.68 80.19 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.316 -0.856 . . . . 50.0 109.171 178.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.38 -24.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 116.994 -1.537 . . . . 25.0 113.591 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.76 -15.55 51.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.222 -0.444 . . . . 50.0 110.143 -178.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.74 147.06 29.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.602 0.715 . . . . 50.0 110.894 -178.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.89 134.24 36.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.102 -0.499 . . . . 50.0 110.224 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -84.62 142.84 29.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.758 -1.571 . . . . 50.0 106.758 172.027 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -158.24 166.35 32.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -126.14 155.5 41.59 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.942 -0.474 . . . . 50.0 110.653 -178.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.04 135.3 56.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.119 -0.697 . . . . 50.0 109.119 -179.027 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.68 -9.97 76.09 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.153 -0.804 . . . . 25.0 114.711 -178.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -81.42 162.98 23.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.966 0.883 . . . . 50.0 108.71 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.54 131.48 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.659 -0.867 . . . . 50.0 108.659 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.6 ptp -129.48 152.21 49.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.916 -0.584 . . . . 50.0 110.002 -178.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 m -82.31 131.64 35.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.217 -1.031 . . . . 25.0 108.217 178.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.4 t -100.03 121.07 50.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.658 -1.608 . . . . 50.0 106.658 176.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.5 mt -91.28 -52.36 4.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.724 -0.671 . . . . 50.0 110.689 -176.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -146.43 170.55 16.61 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.757 -0.831 . . . . 50.0 108.757 -177.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -128.27 157.04 42.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.154 -1.795 . . . . 50.0 106.154 -179.218 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.6 t0 62.17 35.56 15.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 123.397 1.57 . . . . 50.0 108.759 177.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -70.98 -12.59 61.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.476 -1.693 . . . . 25.0 112.349 -176.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -118.9 5.81 11.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.347 0.499 . . . . 50.0 112.347 -175.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.52 11.14 82.4 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.555 -1.418 . . . . 25.0 109.555 -174.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.65 114.91 16.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.301 -1.741 . . . . 50.0 106.301 176.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.95 156.88 31.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.82 -1.548 . . . . 50.0 106.82 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.56 -15.4 62.07 Favored Glycine 0 C--O 1.218 -0.848 0 N-CA-C 108.186 -1.966 . . . . 25.0 108.186 -173.054 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.91 126.41 52.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.196 -1.409 . . . . 50.0 107.196 173.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -119.79 143.07 48.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.266 -1.013 . . . . 50.0 108.266 -177.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.8 tp -82.97 107.86 15.87 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.377 -1.712 . . . . 50.0 106.377 177.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.7 m -108.65 163.81 12.92 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.371 -0.604 . . . . 25.0 109.371 179.383 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.5 t -130.1 129.67 43.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.313 -0.625 . . . . 50.0 109.313 175.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 tp -161.39 155.05 21.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.509 -1.663 . . . . 50.0 106.509 -175.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 58.8 23.83 11.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.438 0.903 . . . . 25.0 113.438 174.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.76 4.21 88.99 Favored Glycine 0 C--O 1.202 -1.904 0 N-CA-C 115.602 1.001 . . . . 25.0 115.602 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -129.36 166.16 20.07 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.372 1.069 . . . . 50.0 108.136 -178.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -118.44 158.2 25.76 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.986 -1.857 . . . . 50.0 105.986 169.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.67 167.37 39.95 Favored Glycine 0 CA--C 1.507 -0.435 0 N-CA-C 110.747 -0.941 . . . . 50.0 110.747 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 pt -75.86 145.56 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.291 -1.374 . . . . 50.0 107.291 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.26 133.6 15.09 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 -179.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.12 108.4 1.95 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 116.374 -1.951 . . . . 50.0 110.246 172.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.18 -18.62 58.15 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-N 115.565 -0.743 . . . . 50.0 114.112 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -65.19 -18.48 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.59 -0.359 . . . . 50.0 111.062 176.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -90.47 4.51 50.85 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.969 -0.457 . . . . 50.0 111.736 176.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.9 mt -122.85 157.23 32.94 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.628 0.603 . . . . 50.0 112.628 -173.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -125.08 117.78 24.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.88 -0.785 . . . . 50.0 108.88 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.49 135.93 27.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.105 -0.498 . . . . 50.0 112.171 -174.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -88.89 105.91 18.06 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 102.498 -3.149 . . . . 50.0 102.498 167.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.54 90.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.692 0.758 . . . . 25.0 112.058 -170.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.18 31.26 8.74 Favored Glycine 0 C--O 1.219 -0.808 0 N-CA-C 109.683 -1.367 . . . . 25.0 109.683 175.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.0 mtp -78.74 -10.28 59.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.355 0.872 . . . . 25.0 113.355 -175.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 t80 63.52 -174.84 0.16 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.561 -0.903 . . . . 25.0 108.561 -172.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -148.2 176.97 9.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.483 0.659 . . . . 25.0 110.375 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -69.73 163.94 24.6 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.067 0.947 . . . . 25.0 110.404 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -69.8 143.84 92.74 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 105.75 -1.945 . . . . 25.0 105.75 170.489 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.41 153.83 69.98 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 116.459 -1.894 . . . . 25.0 111.837 178.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.03 163.11 40.75 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.324 -2.102 . . . . 25.0 105.324 178.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.38 -176.14 47.55 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 107.929 -2.069 . . . . 25.0 107.929 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -138.5 159.2 42.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.233 -2.136 . . . . 25.0 105.233 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -118.17 4.32 11.98 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.75 0.648 . . . . 25.0 112.75 -173.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.7 pt -125.87 160.68 32.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 106.554 -1.647 . . . . 50.0 106.554 178.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.38 25.57 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.647 1.213 . . . . 25.0 108.395 -174.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.0 p -97.36 9.38 42.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.526 1.155 . . . . 25.0 108.176 177.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 125.389 2.519 . . . . 25.0 113.55 -175.767 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.815 0 CA-C-O 124.506 2.17 . . . . 25.0 113.097 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 t -78.42 -4.77 49.99 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 112.39 -1.905 . . . . 25.0 111.25 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 ttt -146.37 150.33 35.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.501 -2.037 . . . . 25.0 105.501 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -131.11 109.67 10.63 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.087 0.47 . . . . 25.0 111.359 178.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -147.03 170.77 16.43 Favored 'General case' 0 C--N 1.319 -0.749 1 N-CA-C 98.676 -4.564 . . . . 50.0 98.676 171.135 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.02 -44.03 97.08 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.186 1.55 . . . . 50.0 115.186 -170.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 t30 49.91 42.35 24.14 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.05 0.759 . . . . 50.0 113.05 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.1 p -116.4 161.95 14.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 103.685 -2.709 . . . . 50.0 103.685 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.52 156.93 45.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.179 0.899 . . . . 50.0 109.714 -177.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.85 151.78 43.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.654 -0.703 . . . . 25.0 110.4 -174.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -97.63 133.33 42.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.334 -1.358 . . . . 50.0 107.334 174.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.74 137.06 43.75 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.417 0.627 . . . . 25.0 109.378 176.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.29 -26.66 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.458 -0.792 . . . . 50.0 109.541 178.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -127.26 159.47 34.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.12 -1.067 . . . . 50.0 108.12 -178.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -100.06 163.5 12.4 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.29 0.636 . . . . 50.0 109.481 178.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.21 160.29 43.92 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.311 -0.996 . . . . 50.0 108.311 -178.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.15 133.42 68.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 102.391 -3.188 . . . . 25.0 102.391 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.94 143.47 27.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.96 -0.385 . . . . 25.0 109.96 -175.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -122.34 -23.97 5.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.553 0.533 . . . . 50.0 110.662 173.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.3 m -85.46 147.22 46.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 176.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -71.63 -20.36 26.85 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.968 -1.555 . . . . 25.0 113.718 -178.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -86.15 -4.5 59.18 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.763 0.425 . . . . 50.0 111.099 179.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.91 143.08 28.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.927 0.491 . . . . 50.0 111.128 -175.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mt -96.49 133.5 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.82 -0.55 . . . . 50.0 111.611 177.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.2 t -88.75 85.06 6.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.868 -1.16 . . . . 50.0 107.868 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -96.46 160.33 14.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.347 -0.612 . . . . 25.0 109.347 -179.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -129.56 152.87 48.61 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 122.202 -0.311 . . . . 50.0 110.742 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -60.11 136.25 57.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 50.0 109.813 178.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.35 -27.54 13.33 Favored Glycine 0 C--N 1.321 -0.286 0 CA-C-N 115.418 -0.81 . . . . 25.0 113.053 -178.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -73.57 162.53 29.13 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.075 0.437 . . . . 50.0 111.048 -178.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.67 129.54 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 122.91 0.484 . . . . 50.0 110.227 -174.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -132.24 146.22 51.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.088 0.471 . . . . 50.0 110.937 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.0 m -85.19 132.0 34.35 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.77 126.79 51.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.393 -1.336 . . . . 50.0 107.393 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -101.83 -50.7 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 50.0 111.1 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -136.3 170.45 16.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.34 0.656 . . . . 50.0 110.097 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -133.25 155.49 49.27 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.447 -1.686 . . . . 50.0 106.447 174.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.6 t0 56.89 41.95 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.133 1.444 . . . . 50.0 109.213 -177.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 t -76.29 4.58 8.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.235 -1.348 . . . . 25.0 113.507 -174.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -139.49 -0.68 1.75 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.956 0.724 . . . . 50.0 112.956 -177.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.32 -2.61 87.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 108.383 -1.887 . . . . 25.0 108.383 -170.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.7 mt -96.02 110.09 22.38 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.734 -1.951 . . . . 50.0 105.734 174.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.89 150.11 47.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.672 -1.233 . . . . 50.0 107.672 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.97 -16.12 44.29 Favored Glycine 0 C--O 1.222 -0.63 0 CA-C-O 119.089 -0.839 . . . . 25.0 113.337 -178.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -93.37 133.84 36.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.831 1.316 . . . . 50.0 108.877 177.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -118.94 146.28 45.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.195 -0.669 . . . . 50.0 109.195 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -84.07 113.97 21.41 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 106.052 -1.833 . . . . 50.0 106.052 176.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.5 m -116.9 166.22 12.42 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.977 -0.379 . . . . 25.0 109.977 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -129.28 132.22 47.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.795 -0.446 . . . . 50.0 109.795 175.127 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -150.95 137.57 18.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.414 -0.958 . . . . 50.0 108.414 -176.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 54.53 32.69 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.776 1.028 . . . . 25.0 113.776 177.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -0.54 89.24 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 114.825 0.69 . . . . 25.0 114.825 177.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -111.81 162.76 14.93 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.906 -1.146 . . . . 50.0 107.906 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -117.25 155.5 29.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.298 -2.482 . . . . 50.0 104.298 170.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.77 164.98 34.31 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.4 -0.68 . . . . 50.0 111.4 179.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -80.41 142.63 13.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.615 0.721 . . . . 50.0 110.239 -177.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.7 t -140.43 133.08 14.63 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.235 -1.024 . . . . 25.0 108.235 -177.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 115.046 -2.836 . . . . 50.0 110.449 174.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.72 -20.49 68.29 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 115.033 0.773 . . . . 50.0 115.033 -173.109 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.03 -8.44 49.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.369 0.584 . . . . 50.0 111.705 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -98.46 6.45 47.2 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.091 -0.381 . . . . 50.0 110.609 175.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.94 143.95 45.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.939 0.4 . . . . 50.0 111.487 -176.071 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -111.16 117.64 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.709 -1.589 . . . . 50.0 106.709 173.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 mp -67.41 133.37 31.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 116.19 -0.459 . . . . 50.0 111.039 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.5 mt -86.84 109.38 19.25 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.944 -1.873 . . . . 50.0 105.944 175.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.27 133.15 40.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.047 -1.094 . . . . 25.0 108.047 -175.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.29 174.39 52.1 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 121.289 -0.481 . . . . 25.0 112.208 -179.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.5 ttt -115.25 156.3 25.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.191 -1.411 . . . . 25.0 107.191 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.6 t80 68.19 2.1 3.09 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.945 1.091 . . . . 25.0 113.945 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -66.72 118.38 10.18 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.942 -0.762 . . . . 25.0 108.942 175.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -139.69 60.54 1.56 Allowed 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.026 -0.731 . . . . 25.0 109.026 -179.25 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.99 143.43 42.18 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 174.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.27 162.46 42.39 Favored 'Trans proline' 0 C--N 1.346 0.405 0 N-CA-C 114.805 1.04 . . . . 25.0 114.805 -173.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.55 164.42 29.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.21 -1.774 . . . . 25.0 106.21 177.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.71 -86.5 1.51 Allowed Glycine 0 C--O 1.225 -0.418 0 C-N-CA 121.284 -0.484 . . . . 25.0 112.747 177.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -79.53 130.89 35.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.84 0.352 . . . . 25.0 110.961 -178.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -142.86 64.61 1.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.494 -0.928 . . . . 25.0 108.494 176.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -102.16 141.17 18.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.287 0.565 . . . . 50.0 109.897 -177.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.47 -39.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.724 -0.671 . . . . 25.0 109.397 178.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.1 m -150.84 -72.11 0.17 Allowed 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.897 -0.779 . . . . 25.0 108.897 177.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.209 -1.034 0 CA-C-O 124.34 2.019 . . . . 25.0 110.945 177.741 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 CA-C-O 123.499 1.611 . . . . 25.0 115.646 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -78.15 157.73 29.32 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 121.053 -1.263 . . . . 25.0 111.745 -178.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.2 ptm -68.59 -6.47 25.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.915 0.709 . . . . 25.0 112.915 178.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -156.86 149.17 23.17 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.095 -1.076 . . . . 25.0 108.095 -178.264 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -116.51 168.59 10.03 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.632 -1.247 . . . . 50.0 107.632 175.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.3 -40.5 90.72 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.014 0.37 . . . . 50.0 110.958 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.0 t30 55.53 42.2 29.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.215 0.531 . . . . 50.0 111.934 178.018 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.92 172.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.998 -1.853 . . . . 50.0 105.998 176.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 162.53 34.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.423 0.63 . . . . 50.0 110.956 -177.304 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.69 150.09 36.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.016 -0.993 . . . . 25.0 110.42 -178.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -99.53 136.67 39.12 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.595 -0.891 . . . . 50.0 108.595 176.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.33 46.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.982 0.42 . . . . 25.0 109.995 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.98 -24.98 14.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.721 -0.672 . . . . 50.0 110.372 178.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -123.69 158.27 31.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.795 -1.928 . . . . 50.0 105.795 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.4 p-10 -103.02 144.33 31.42 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.089 -0.708 . . . . 50.0 109.089 175.399 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -148.9 122.29 9.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.375 -0.375 . . . . 50.0 110.421 -175.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.91 130.5 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 175.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.91 8.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.945 0.402 . . . . 25.0 111.477 -175.564 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -89.39 -11.54 42.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.435 0.636 . . . . 50.0 109.807 176.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 m -122.86 146.31 47.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.196 -1.409 . . . . 50.0 107.196 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -23.11 27.83 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 117.388 -1.275 . . . . 25.0 114.873 -174.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -77.66 -20.52 53.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.15 0.5 . . . . 50.0 110.567 -178.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.42 152.35 25.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.211 -1.033 . . . . 50.0 108.211 178.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 139.76 32.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.929 0.395 . . . . 50.0 111.093 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -84.66 126.56 33.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.956 -1.498 . . . . 50.0 106.956 172.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.18 163.98 37.6 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -129.78 154.23 47.43 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.762 -0.586 . . . . 50.0 109.943 176.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 53.3 pttt -56.97 135.12 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.379 0.609 . . . . 50.0 110.198 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.02 -25.66 27.43 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.127 -0.942 . . . . 25.0 112.669 -175.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -72.65 155.89 39.54 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.117 0.458 . . . . 50.0 110.33 -179.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.4 mm -117.06 129.02 74.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.375 0.67 . . . . 50.0 109.67 -175.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -130.89 149.61 52.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.579 0.705 . . . . 50.0 110.525 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.3 m -84.88 128.28 34.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.541 -0.911 . . . . 25.0 108.541 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.64 123.47 46.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.066 -1.457 . . . . 50.0 107.066 177.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.39 -42.94 9.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.6 -0.727 . . . . 50.0 111.787 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -156.31 171.31 20.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.123 -1.066 . . . . 50.0 108.123 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -134.21 157.13 47.05 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 107.287 -1.375 . . . . 50.0 107.287 -178.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t0 60.11 38.47 20.39 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 123.341 1.543 . . . . 50.0 107.691 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -70.51 -12.27 61.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.578 -1.646 . . . . 25.0 114.055 -171.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.16 13.88 6.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.836 0.31 . . . . 50.0 111.836 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.99 18.89 79.23 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.365 -1.094 . . . . 25.0 110.365 -176.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.44 114.84 22.93 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.883 -1.525 . . . . 50.0 106.883 178.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -62.18 144.32 55.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.124 0.964 . . . . 50.0 109.453 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 -16.16 40.89 Favored Glycine 0 C--O 1.217 -0.926 0 CA-C-O 118.876 -0.958 . . . . 25.0 114.112 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -89.58 131.12 35.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.325 1.563 . . . . 50.0 109.94 178.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -120.53 146.19 46.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.976 -0.749 . . . . 50.0 108.976 -175.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.1 tp -86.43 115.35 23.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.457 -1.683 . . . . 50.0 106.457 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -112.75 158.47 20.05 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 -178.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -124.99 126.24 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.756 -0.831 . . . . 50.0 108.756 178.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -159.23 148.42 18.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.316 -1.364 . . . . 50.0 107.316 -174.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 58.24 25.84 13.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.734 0.778 . . . . 25.0 112.494 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.68 88.98 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 114.834 0.693 . . . . 25.0 114.834 176.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -136.16 162.73 32.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 117.773 0.786 . . . . 50.0 110.636 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -96.08 160.61 14.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.242 -1.021 . . . . 50.0 108.242 175.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.75 161.97 34.91 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.917 -1.673 . . . . 50.0 108.917 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 pt -81.77 143.86 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.904 -0.776 . . . . 50.0 108.904 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.13 133.95 13.38 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.46 114.39 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 116.524 -1.85 . . . . 50.0 111.033 175.088 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.02 -21.79 66.12 Favored Glycine 0 C--O 1.223 -0.584 0 N-CA-C 116.165 1.226 . . . . 50.0 116.165 -173.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -67.54 -16.88 64.43 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.879 . . . . 50.0 110.542 177.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -93.1 9.33 36.33 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.451 -0.156 . . . . 50.0 110.83 177.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -121.34 154.69 36.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.168 0.509 . . . . 50.0 110.852 -178.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -119.07 116.28 26.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.086 -1.079 . . . . 50.0 108.086 175.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm -62.35 132.4 28.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.988 -1.486 . . . . 50.0 106.988 175.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.54 142.67 35.16 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.309 -0.997 . . . . 50.0 108.309 -179.408 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m -90.92 152.71 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 106.982 -1.488 . . . . 25.0 106.982 175.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.94 76.14 0.02 OUTLIER Glycine 0 C--O 1.223 -0.557 0 N-CA-C 110.708 -0.957 . . . . 25.0 110.708 -176.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -72.66 135.81 45.52 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.924 -1.139 . . . . 25.0 107.924 -179.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -79.77 74.36 6.48 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.35 0.406 . . . . 25.0 110.356 178.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 52.4 28.16 5.57 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.872 1.434 . . . . 25.0 114.872 175.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -71.59 143.35 49.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.442 0.639 . . . . 25.0 111.136 179.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -117.77 160.12 39.78 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.83 174.15 12.32 Favored 'Trans proline' 0 C--N 1.349 0.568 0 O-C-N 122.28 0.621 . . . . 25.0 111.426 177.117 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.61 161.27 40.88 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.124 -1.065 . . . . 25.0 108.124 178.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.8 85.1 0.24 Allowed Glycine 0 C--O 1.219 -0.832 0 N-CA-C 109.961 -1.256 . . . . 25.0 109.961 -178.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -102.34 -3.45 27.12 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.077 1.14 . . . . 25.0 114.077 -173.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -149.46 156.52 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.72 -0.845 . . . . 25.0 108.72 178.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.2 pt -128.67 14.95 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.895 -0.593 . . . . 50.0 111.273 -177.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.7 t 62.59 80.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 122.308 1.051 . . . . 25.0 110.081 -177.065 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.54 -42.04 71.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.885 -1.052 . . . . 25.0 111.055 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 CA--C 1.559 1.321 0 CA-C-O 122.498 1.142 . . . . 25.0 112.002 -178.933 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.282 0 N-CA-C 114.877 0.711 . . . . 25.0 114.877 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -68.43 -34.12 75.43 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.961 0.41 . . . . 25.0 111.419 -178.096 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.3 ttm -125.26 93.09 3.77 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 106.855 -1.535 . . . . 25.0 106.855 -179.435 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -152.08 -40.08 0.11 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.363 0.875 . . . . 25.0 113.363 -179.423 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -149.92 180.0 7.6 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 106.449 -1.685 . . . . 50.0 106.449 176.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.0 mt -61.14 -41.78 97.35 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.604 1.335 . . . . 50.0 114.604 -171.469 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.3 t30 49.91 42.32 24.08 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.574 2.064 . . . . 50.0 116.574 175.466 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -118.05 164.68 14.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 N-CA-C 105.227 -2.138 . . . . 50.0 105.227 170.357 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.57 157.86 42.51 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.681 0.753 . . . . 50.0 109.611 -173.767 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.37 162.59 32.61 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.423 -0.808 . . . . 25.0 110.119 -172.727 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.2 134.99 47.38 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.515 -1.291 . . . . 50.0 107.515 178.095 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 120.04 19.77 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.856 -1.164 . . . . 25.0 107.856 173.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.56 -16.86 31.49 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.946 -0.39 . . . . 50.0 109.946 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -138.75 169.25 18.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.156 -1.424 . . . . 50.0 107.156 -176.7 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -104.01 164.97 11.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.824 0.449 . . . . 50.0 111.958 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -156.31 156.73 34.5 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.435 0.694 . . . . 50.0 111.38 175.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -125.55 129.55 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.919 -2.623 . . . . 25.0 103.919 171.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.27 130.6 41.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.739 0.644 . . . . 25.0 112.739 -177.365 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -100.57 -41.53 6.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.59 -1.633 . . . . 50.0 106.59 175.685 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -85.33 147.97 48.6 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.178 -1.045 . . . . 50.0 108.178 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.51 -15.2 27.74 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 119.123 0.722 . . . . 25.0 113.346 175.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 -18.64 49.73 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 121.404 0.621 . . . . 50.0 110.504 177.938 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -87.5 154.08 20.92 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.643 1.211 . . . . 50.0 110.28 -173.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.81 136.92 42.58 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 120.691 -1.256 . . . . 50.0 110.551 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.28 125.13 31.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.119 -2.549 . . . . 50.0 104.119 169.176 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -137.72 159.33 42.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 177.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -124.49 152.12 43.77 Favored 'General case' 0 CA--C 1.491 -1.314 0 O-C-N 121.701 -0.624 . . . . 50.0 112.345 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -57.02 123.08 13.93 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.187 -0.915 . . . . 50.0 111.558 178.146 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -12.76 49.99 Favored Glycine 0 C--O 1.236 0.227 0 CA-C-O 118.944 -0.92 . . . . 25.0 113.859 179.908 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.65 160.13 25.13 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.253 0.62 . . . . 50.0 111.946 -176.382 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.14 136.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.385 0.674 . . . . 50.0 109.311 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -144.86 151.6 38.99 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.518 -0.739 . . . . 50.0 111.078 179.374 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -82.57 132.25 35.2 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.566 -0.288 . . . . 25.0 110.833 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.3 t -88.81 122.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.331 -0.989 . . . . 50.0 108.331 174.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.6 mt -92.67 -51.28 5.18 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.184 0.516 . . . . 50.0 110.402 -176.648 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -137.15 163.82 29.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.868 -1.901 . . . . 50.0 105.868 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -131.35 148.45 52.67 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 109.015 -0.735 . . . . 50.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.85 38.94 30.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.205 1.566 . . . . 50.0 108.133 -177.749 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -67.76 -13.45 62.13 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.012 -1.904 . . . . 25.0 115.359 -175.157 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.78 0.01 20.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.95 -0.389 . . . . 50.0 109.95 -179.248 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.77 77.72 Favored Glycine 0 CA--C 1.511 -0.196 0 N-CA-C 109.263 -1.535 . . . . 25.0 109.263 -174.524 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.39 116.72 29.07 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 106.53 -1.656 . . . . 50.0 106.53 177.045 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.67 138.77 58.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.22 -1.4 . . . . 50.0 107.22 178.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 0.74 72.36 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.43 -1.206 . . . . 25.0 113.54 178.616 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -109.59 115.92 30.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.733 1.766 . . . . 50.0 111.21 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -109.5 144.65 37.48 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.348 -0.845 . . . . 50.0 112.093 -173.535 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.5 tp -82.56 122.27 27.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.649 -1.982 . . . . 50.0 105.649 175.563 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.2 m -120.07 161.49 20.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 177.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.3 t -125.88 133.78 51.81 Favored 'General case' 0 C--O 1.256 1.425 0 C-N-CA 123.476 0.711 . . . . 50.0 109.729 177.258 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -160.88 138.52 9.36 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.888 -1.051 . . . . 50.0 108.884 -177.004 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 t60 58.24 34.9 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.525 0.679 . . . . 25.0 112.675 176.939 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.55 2.34 63.61 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 121.245 -0.502 . . . . 25.0 113.85 177.442 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -115.06 160.29 19.81 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.237 -2.135 . . . . 50.0 105.237 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -137.35 143.41 42.0 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 103.007 -2.96 . . . . 50.0 103.007 175.457 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 174.67 43.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.831 -1.308 . . . . 50.0 109.831 -174.501 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -83.12 140.44 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.675 0.75 . . . . 50.0 112.066 -172.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.4 131.3 15.07 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.044 -1.435 . . . . 25.0 108.843 -176.731 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.13 119.14 6.16 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 114.813 -2.992 . . . . 50.0 112.873 175.316 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.42 -16.84 69.89 Favored Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 119.466 -0.63 . . . . 50.0 114.175 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.82 -15.35 63.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 120.553 -0.459 . . . . 50.0 110.374 174.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -101.42 8.79 42.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.942 0.349 . . . . 50.0 111.942 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 mt -117.66 149.23 41.07 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.284 1.04 . . . . 50.0 111.818 -173.055 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -120.32 120.66 36.66 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.583 -1.266 . . . . 50.0 107.583 174.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.4 mm -64.72 138.98 22.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 O-C-N 123.656 0.598 . . . . 50.0 109.848 -179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -125.1 177.34 6.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.235 -1.394 . . . . 50.0 107.235 176.39 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t 58.56 70.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 122.563 1.173 . . . . 25.0 109.935 -176.835 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.53 46.94 1.09 Allowed Glycine 0 C--O 1.217 -0.927 0 CA-C-N 115.127 -0.942 . . . . 25.0 112.55 -179.662 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 53.1 tpp 56.65 87.49 0.06 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.456 1.122 . . . . 25.0 112.204 -175.33 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -138.23 144.45 40.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.573 -1.194 . . . . 25.0 108.016 -177.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -73.4 56.89 0.51 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.117 0.961 . . . . 25.0 113.389 -176.388 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -134.59 155.75 49.9 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.577 -1.638 . . . . 25.0 106.577 177.258 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -83.49 149.69 58.32 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 106.705 -1.591 . . . . 25.0 106.705 179.718 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.52 151.88 65.03 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 117.033 -1.511 . . . . 25.0 111.382 -175.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.69 172.19 9.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.947 -1.131 . . . . 25.0 107.947 175.72 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.76 -83.83 0.9 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.539 -1.024 . . . . 25.0 110.539 178.113 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 49.83 74.34 0.21 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 117.735 2.494 . . . . 25.0 117.735 174.424 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -71.51 137.84 48.46 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.914 -0.773 . . . . 25.0 108.914 171.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 pt -68.42 123.84 22.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-O 121.929 0.871 . . . . 50.0 110.609 176.444 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.44 23.53 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 122.827 1.299 . . . . 25.0 107.887 -176.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -72.7 135.14 45.33 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.072 -0.967 . . . . 25.0 108.776 -179.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--O 1.215 -0.734 0 CA-C-O 124.727 2.203 . . . . 25.0 111.848 179.545 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 122.513 1.063 . . . . 25.0 114.949 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.4 p -153.59 146.79 24.69 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 121.238 -1.154 . . . . 25.0 109.045 178.515 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.2 mtp -88.06 98.25 11.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.527 -1.286 . . . . 25.0 107.527 177.328 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -92.4 80.6 4.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.72 0.295 . . . . 25.0 111.638 -176.423 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -114.46 176.7 4.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.187 -2.523 . . . . 50.0 104.187 175.784 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.8 mt -61.76 -46.3 90.17 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.932 1.456 . . . . 50.0 114.932 -171.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 t30 51.66 40.38 27.22 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.103 1.149 . . . . 50.0 114.103 -178.476 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.72 172.54 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 105.563 -2.014 . . . . 50.0 105.563 177.08 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.7 156.69 48.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.705 0.684 . . . . 50.0 110.162 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.29 158.6 43.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.21 -0.904 . . . . 25.0 111.059 -173.633 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.8 134.65 48.57 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.367 -0.975 . . . . 50.0 108.367 175.231 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.77 130.29 39.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.742 -0.466 . . . . 25.0 109.742 178.026 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.35 -26.29 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.946 -0.57 . . . . 50.0 109.571 179.306 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -126.28 162.55 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.658 -1.238 . . . . 50.0 107.658 -179.399 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.533 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 25.3 p-10 -103.89 151.21 23.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.864 -0.421 . . . . 50.0 109.864 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -144.58 126.88 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.155 -0.475 . . . . 50.0 110.885 -176.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.7 t -92.04 126.99 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 102.983 -2.969 . . . . 25.0 102.983 174.277 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.46 114.85 5.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 -179.084 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -99.05 -10.97 21.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.724 0.773 . . . . 50.0 108.981 179.18 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 t -116.03 146.72 37.7 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 106.873 -1.528 . . . . 50.0 106.873 172.708 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.68 -18.71 32.47 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 115.819 -2.321 . . . . 25.0 113.618 177.328 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -79.96 -15.71 56.7 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.039 0.923 . . . . 50.0 110.348 179.304 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -86.38 142.68 28.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.653 -0.703 . . . . 50.0 110.19 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 134.25 34.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.741 -0.466 . . . . 50.0 109.741 178.25 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.39 118.67 25.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.101 -1.074 . . . . 50.0 108.101 175.343 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.91 164.57 30.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -178.481 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -131.58 157.1 44.52 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 121.254 0.55 . . . . 50.0 112.056 179.58 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.533 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.0 pttt -56.69 131.67 49.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.468 -0.787 . . . . 50.0 108.987 179.191 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.07 -25.7 25.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.692 -0.686 . . . . 25.0 113.321 -176.651 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.17 161.85 30.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.216 0.508 . . . . 50.0 111.826 -176.456 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.12 131.17 73.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.241 -1.022 . . . . 50.0 108.241 -177.427 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -139.81 154.02 47.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.058 -0.349 . . . . 50.0 110.058 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -87.79 131.02 34.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.583 -1.265 . . . . 25.0 107.583 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.9 t -95.48 116.27 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.327 -2.101 . . . . 50.0 105.327 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.45 -45.66 10.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.4 -0.818 . . . . 50.0 109.636 -176.475 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -146.09 169.47 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.96 -0.756 . . . . 50.0 108.96 -177.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -129.58 156.03 44.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.846 -0.798 . . . . 50.0 108.846 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.16 33.9 23.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.147 1.451 . . . . 50.0 109.286 174.629 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.8 t -70.53 -19.01 62.94 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.594 1.701 . . . . 25.0 115.594 -168.005 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -101.26 2.59 40.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.135 0.493 . . . . 50.0 110.362 -175.61 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.34 -2.36 87.25 Favored Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.003 -1.639 . . . . 25.0 109.003 -172.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -100.83 119.37 38.56 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.435 -1.691 . . . . 50.0 106.435 176.78 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -60.17 136.12 57.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.507 0.67 . . . . 50.0 109.218 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.3 -2.35 86.57 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 115.693 1.037 . . . . 25.0 115.693 177.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -99.94 116.91 33.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.312 1.556 . . . . 50.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -107.05 148.13 29.12 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.094 -0.379 . . . . 50.0 110.806 -171.644 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.0 tp -87.93 113.45 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.765 -1.569 . . . . 50.0 106.765 176.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.14 160.28 21.28 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.2 -0.2 . . . . 25.0 110.749 179.707 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -119.9 128.93 54.08 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.263 0.554 . . . . 50.0 109.594 175.344 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 tp -162.29 152.83 17.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.114 -1.81 . . . . 50.0 106.114 -177.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 58.57 27.75 16.12 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.459 0.647 . . . . 25.0 112.737 177.009 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.5 16.66 77.54 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.803 -0.713 . . . . 25.0 114.11 178.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.52 21.99 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.836 -0.802 . . . . 50.0 108.836 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -109.3 156.92 19.39 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.141 -2.17 . . . . 50.0 105.141 173.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.5 37.47 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 108.87 -1.692 . . . . 50.0 108.87 177.53 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.3 pt -78.83 145.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.504 0.669 . . . . 50.0 109.255 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.2 t -140.39 134.2 15.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 -178.491 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 106.49 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 117.261 -1.36 . . . . 50.0 110.559 174.258 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.21 69.83 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 116.176 1.23 . . . . 50.0 116.176 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -69.92 -8.44 48.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.534 0.667 . . . . 50.0 111.373 178.364 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -93.68 6.28 48.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.03 -0.419 . . . . 50.0 110.451 175.492 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.3 mt -119.15 155.2 32.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.633 -0.506 . . . . 50.0 109.633 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -122.34 121.57 37.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.128 -0.323 . . . . 50.0 110.128 171.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.27 137.58 20.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.278 0.631 . . . . 50.0 109.884 177.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -107.51 -173.07 2.2 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.227 -0.897 . . . . 50.0 108.807 -179.507 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 t 64.21 75.09 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-O 122.395 1.093 . . . . 25.0 111.208 179.353 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.58 95.98 0.1 Allowed Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 110.091 -1.204 . . . . 25.0 110.091 -179.791 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.4 ttm -160.83 157.74 27.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.33 -1.359 . . . . 25.0 107.33 -176.728 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -69.35 -41.78 76.14 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.601 0.715 . . . . 25.0 109.773 179.051 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -80.19 149.13 30.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.094 -0.957 . . . . 25.0 110.751 -179.294 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -94.46 149.72 20.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 -175.635 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -75.85 150.9 84.16 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.948 -1.13 . . . . 25.0 107.948 178.403 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.27 2.93 6.21 Favored 'Trans proline' 0 C--N 1.35 0.619 0 N-CA-C 113.842 0.67 . . . . 25.0 113.842 176.614 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.41 -152.13 0.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.897 0.879 . . . . 25.0 113.04 177.521 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.24 -143.5 4.27 Favored Glycine 0 C--O 1.224 -0.488 0 N-CA-C 105.561 -3.016 . . . . 25.0 105.561 -177.684 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.7 -25.89 68.4 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.84 0.82 . . . . 25.0 110.612 176.36 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.78 138.14 50.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.542 -0.91 . . . . 25.0 108.542 176.299 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.57 150.27 18.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.02 -1.844 . . . . 50.0 106.02 -179.145 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.32 158.51 38.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.892 -1.522 . . . . 25.0 106.892 178.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.9 p -130.92 161.79 31.1 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.577 -1.268 . . . . 25.0 107.577 179.168 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 C--O 1.212 -0.874 0 CA-C-O 125.417 2.532 . . . . 25.0 111.897 176.877 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.536 0 CA-C-O 124.015 1.897 . . . . 25.0 115.095 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -137.9 36.48 2.38 Favored 'General case' 0 C--O 1.244 0.801 0 O-C-N 121.214 -1.168 . . . . 25.0 111.283 -178.33 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -71.12 141.95 50.77 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 121.864 0.84 . . . . 25.0 108.759 -178.629 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -88.16 84.56 6.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.014 -0.539 . . . . 25.0 109.788 178.151 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.44 167.5 22.03 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 102.62 -3.104 . . . . 50.0 102.62 177.781 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.53 -51.65 67.74 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.556 1.071 . . . . 50.0 113.045 -173.308 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.57 48.47 16.93 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.777 1.028 . . . . 50.0 113.777 -179.123 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 m -112.79 172.7 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 103.469 -2.789 . . . . 50.0 103.469 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 155.42 50.23 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.61 0.719 . . . . 50.0 110.944 -177.822 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.71 153.08 44.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.781 -1.1 . . . . 25.0 110.901 -175.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -95.52 133.59 39.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.961 -0.755 . . . . 50.0 108.961 176.828 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.59 123.99 24.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.047 -0.723 . . . . 25.0 109.047 171.37 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.89 -25.98 21.84 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 108.946 -0.761 . . . . 50.0 108.946 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.27 166.51 20.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.277 -1.379 . . . . 50.0 107.277 -178.478 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.95 159.18 15.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.581 0.229 . . . . 50.0 110.71 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -151.49 143.61 23.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.989 -0.551 . . . . 50.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -117.41 126.17 74.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 102.591 -3.114 . . . . 25.0 102.591 174.219 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 127.92 34.07 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.812 0.339 . . . . 25.0 111.2 -174.352 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -97.84 -6.14 33.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.066 0.936 . . . . 50.0 109.193 179.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -141.55 153.15 65.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.773 . . . . 50.0 108.949 -177.082 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.13 -22.83 46.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 116.99 -1.54 . . . . 25.0 112.869 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -73.76 -19.75 60.69 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.482 0.489 . . . . 50.0 110.512 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -95.3 153.08 17.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.963 0.411 . . . . 50.0 111.939 -172.297 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.52 138.33 36.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.699 1.0 . . . . 50.0 113.699 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -87.02 136.87 32.77 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.838 -1.542 . . . . 50.0 106.838 172.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -160.81 162.35 32.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -129.19 158.34 39.29 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.387 -0.821 . . . . 50.0 111.319 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -53.77 131.97 40.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.18 -0.918 . . . . 50.0 109.951 178.725 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.01 -23.18 36.83 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.618 -0.719 . . . . 25.0 113.166 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.68 157.19 38.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.115 0.957 . . . . 50.0 110.791 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -120.79 131.02 73.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.376 -0.972 . . . . 50.0 108.376 -176.039 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -131.47 152.21 50.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.065 0.46 . . . . 50.0 111.332 178.186 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 m -84.76 132.02 34.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 25.0 107.972 177.293 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.9 t -96.03 123.05 48.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 106.282 -1.747 . . . . 50.0 106.282 176.093 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -93.42 -39.79 10.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.561 -0.745 . . . . 50.0 110.823 -174.2 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -159.81 171.92 18.6 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.608 -0.886 . . . . 50.0 108.608 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -120.92 160.98 22.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.97 -1.122 . . . . 50.0 107.97 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.3 42.73 22.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.34 1.067 . . . . 50.0 110.837 179.204 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -68.72 -22.02 64.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.491 -176.767 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.445 ' C ' ' H ' ' A' ' 42' ' ' LEU . 2.3 tp60 -97.83 1.02 47.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 50.0 110.133 179.603 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 -20.13 8.13 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.159 -1.176 . . . . 25.0 110.159 -172.542 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.445 ' H ' ' C ' ' A' ' 40' ' ' GLN . 95.8 mt -78.19 133.49 37.76 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.993 -1.854 . . . . 50.0 105.993 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.72 153.9 42.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.727 0.775 . . . . 50.0 110.702 -177.075 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.5 -19.65 4.7 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 115.557 0.983 . . . . 25.0 115.557 177.095 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -84.33 107.12 16.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.715 1.258 . . . . 50.0 111.291 -179.404 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -96.81 147.31 24.07 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.061 -0.348 . . . . 50.0 110.061 -176.007 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.1 tp -85.72 117.3 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.765 -1.939 . . . . 50.0 105.765 172.916 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 63.9 m -120.28 163.24 18.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.387 -0.597 . . . . 25.0 109.387 179.294 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -124.51 125.82 44.84 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.037 0.535 . . . . 50.0 111.774 -179.658 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.69 153.09 18.61 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 106.946 -1.501 . . . . 50.0 106.946 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 59.06 36.3 24.21 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.825 0.821 . . . . 25.0 110.912 178.575 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 14.32 59.3 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 115.518 0.967 . . . . 25.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -142.36 163.86 31.71 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 118.002 0.901 . . . . 50.0 109.195 177.591 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.85 154.73 26.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.807 -1.183 . . . . 50.0 107.807 173.987 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.13 169.56 41.51 Favored Glycine 0 C--O 1.248 0.971 0 N-CA-C 108.416 -1.873 . . . . 50.0 108.416 -177.684 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.03 143.08 13.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 117.217 0.508 . . . . 50.0 110.441 -177.764 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -140.07 131.53 14.4 Favored Pre-proline 0 C--O 1.242 0.681 0 C-N-CA 123.765 0.826 . . . . 25.0 108.833 178.583 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.09 119.4 6.33 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 115.29 -2.673 . . . . 50.0 111.156 177.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.55 -25.74 61.28 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 114.893 0.717 . . . . 50.0 114.893 -175.77 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.5 -21.3 66.25 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.865 0.364 . . . . 50.0 111.747 178.395 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.35 3.57 53.33 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.66 -0.65 . . . . 50.0 112.257 178.157 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.51 154.98 30.53 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.99 0.424 . . . . 50.0 112.031 -177.31 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -123.17 117.95 26.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.533 -0.303 . . . . 50.0 110.366 171.442 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm -60.33 140.08 18.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 O-C-N 123.88 0.738 . . . . 50.0 109.697 179.468 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.81 -178.41 3.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.446 -1.687 . . . . 50.0 106.446 176.715 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 t 67.8 94.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.374 1.069 . . . . 25.0 112.03 179.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.55 -44.93 0.61 Allowed Glycine 0 C--O 1.218 -0.891 0 N-CA-C 109.568 -1.413 . . . . 25.0 109.568 -178.75 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -147.57 120.08 8.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.806 -1.183 . . . . 25.0 107.806 174.49 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -163.89 152.29 13.29 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.9 -0.407 . . . . 25.0 109.9 177.593 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.27 166.35 18.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.346 -0.613 . . . . 25.0 109.346 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -55.19 144.87 22.9 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.084 0.401 . . . . 25.0 112.084 175.408 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.68 162.25 29.82 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 123.641 0.777 . . . . 25.0 108.979 -179.522 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.03 169.89 21.13 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 117.494 -1.204 . . . . 25.0 110.647 173.461 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.61 160.03 23.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.893 -0.41 . . . . 25.0 109.893 177.73 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.63 -61.2 0.04 OUTLIER Glycine 0 C--O 1.215 -1.035 0 C-N-CA 120.341 -0.933 . . . . 25.0 112.85 178.17 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 53.97 32.6 15.69 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.585 1.183 . . . . 25.0 112.735 178.237 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -78.47 137.58 38.02 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.72 -0.673 . . . . 25.0 112.016 -178.181 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.8 tt -119.85 153.22 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 105.736 -1.95 . . . . 50.0 105.736 175.036 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.8 t -106.4 -34.25 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.384 0.611 . . . . 25.0 111.827 -174.162 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 p -75.73 155.21 35.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.272 0.558 . . . . 25.0 111.125 179.76 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 125.35 2.5 . . . . 25.0 113.435 177.93 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.266 0 CA-C-O 122.564 1.091 . . . . 25.0 115.429 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 m -69.73 139.32 53.35 Favored 'General case' 0 CA--C 1.51 -0.558 0 O-C-N 120.97 -1.312 . . . . 25.0 108.51 179.387 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.6 mmm -130.35 -82.14 0.54 Allowed 'General case' 0 C--O 1.212 -0.893 0 O-C-N 124.106 0.879 . . . . 25.0 109.725 175.12 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -130.72 -26.8 2.18 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 -175.835 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -119.66 167.63 11.84 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.913 -1.143 . . . . 50.0 107.913 179.59 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.86 -35.5 78.66 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.698 -1.137 . . . . 50.0 112.983 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.4 m120 45.59 48.32 11.22 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.227 1.011 . . . . 50.0 113.471 178.014 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.96 151.92 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 106.605 -1.628 . . . . 50.0 106.605 179.449 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 162.43 13.41 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.137 0.494 . . . . 75.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.06 154.05 42.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.285 -0.87 . . . . 25.0 111.373 172.085 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -107.66 133.72 51.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.167 0.987 . . . . 50.0 109.628 -179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 134.95 45.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 124.525 1.141 . . . . 25.0 111.359 175.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.51 -34.06 12.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.832 0.825 . . . . 50.0 109.918 177.323 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.86 165.24 14.86 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 106.642 -1.614 . . . . 50.0 106.642 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.8 p-10 -103.48 155.85 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.992 0.36 . . . . 50.0 111.93 177.588 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.56 98.48 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.705 0.802 . . . . 50.0 108.953 -177.867 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -78.52 140.06 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 172.42 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.43 140.9 54.14 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 123.488 0.715 . . . . 25.0 112.395 -173.062 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.428 ' HG3' ' HG ' ' A' ' 20' ' ' SER . 18.7 pt-20 -110.74 -9.72 14.49 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 114.333 -1.303 . . . . 50.0 110.864 174.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.428 ' HG ' ' HG3' ' A' ' 19' ' ' GLU . 56.2 m -131.44 158.64 74.73 Favored Pre-proline 0 N--CA 1.475 0.81 0 O-C-N 121.248 -0.907 . . . . 50.0 110.707 -178.532 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -71.14 -21.98 26.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 116.69 -1.74 . . . . 25.0 113.995 -179.699 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -16.14 59.49 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 124.297 0.998 . . . . 50.0 109.491 -179.732 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -98.0 150.64 21.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 122.121 0.962 . . . . 50.0 110.28 -168.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.04 133.86 42.7 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.595 -0.691 . . . . 50.0 112.039 178.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.66 104.18 15.82 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.363 -0.606 . . . . 50.0 109.363 179.217 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -134.46 162.57 31.86 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.888 -0.782 . . . . 25.0 108.888 -178.709 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -126.84 162.47 25.82 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.946 -0.761 . . . . 50.0 108.946 -179.169 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 19.8 ptpt -56.01 139.86 45.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.682 -1.229 . . . . 50.0 107.682 178.233 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.11 -14.2 59.62 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 115.611 1.005 . . . . 25.0 115.611 177.943 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.69 163.85 27.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.268 -1.012 . . . . 50.0 108.268 176.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.17 131.12 73.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 N-CA-C 108.266 -1.013 . . . . 50.0 108.266 -178.705 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.7 ptp -130.85 155.49 46.63 Favored 'General case' 0 C--O 1.251 1.158 0 O-C-N 121.627 -0.671 . . . . 50.0 111.604 176.268 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -90.65 135.92 33.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.761 -1.94 . . . . 25.0 105.761 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -96.68 126.69 49.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.148 -1.427 . . . . 50.0 107.148 176.743 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 mt -97.7 -42.85 7.43 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.298 -0.865 . . . . 50.0 110.961 -176.569 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -143.21 161.63 37.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.313 -1.366 . . . . 50.0 107.313 -178.555 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -128.16 144.38 51.11 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.843 -0.799 . . . . 50.0 108.843 173.241 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 59.03 43.15 18.04 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.427 -1.323 . . . . 50.0 107.427 -177.739 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -68.99 -15.11 63.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.722 1.749 . . . . 25.0 115.722 -172.335 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.79 16.63 13.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 122.409 1.1 . . . . 50.0 109.157 178.252 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.98 -21.91 7.4 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.31 -0.859 . . . . 25.0 112.052 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.96 119.15 12.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.905 -0.569 . . . . 50.0 109.819 176.361 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -56.34 132.64 51.51 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.711 0.767 . . . . 50.0 110.132 178.826 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.02 89.66 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.722 -1.043 . . . . 25.0 115.239 175.659 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -96.35 102.19 13.94 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.718 1.759 . . . . 50.0 110.804 179.155 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -91.71 140.35 29.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.549 -0.75 . . . . 50.0 111.917 -172.848 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.21 115.52 21.98 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.405 -1.702 . . . . 50.0 106.405 174.213 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.4 m -112.0 166.87 10.84 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 25.0 110.39 -179.702 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -135.5 125.82 26.51 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.767 -0.457 . . . . 50.0 109.767 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tt -152.34 138.86 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.123 -0.944 . . . . 50.0 108.839 -174.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 53.82 38.51 28.76 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 113.557 0.947 . . . . 25.0 113.557 176.527 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.66 -0.51 85.74 Favored Glycine 0 C--O 1.217 -0.965 0 CA-C-O 118.467 -1.185 . . . . 25.0 115.765 175.773 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -126.07 164.53 20.68 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 118.849 1.324 . . . . 50.0 108.193 178.417 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -113.29 164.15 13.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.101 -1.444 . . . . 50.0 107.101 176.574 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.07 162.55 31.55 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.765 -0.934 . . . . 50.0 110.765 174.581 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 pt -79.38 142.32 14.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.78 -0.822 . . . . 50.0 108.78 175.698 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.6 t -139.64 133.65 15.79 Favored Pre-proline 0 C--N 1.311 -1.078 0 C-N-CA 123.407 0.683 . . . . 25.0 109.525 -175.363 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.2 114.79 3.17 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 116.471 -1.886 . . . . 50.0 112.161 175.937 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.66 -16.58 72.14 Favored Glycine 0 C--O 1.21 -1.352 0 C-N-CA 119.567 -1.301 . . . . 50.0 115.133 -173.552 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.8 -16.01 62.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.518 1.159 . . . . 50.0 111.722 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -94.65 8.48 42.24 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.594 -0.73 . . . . 50.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.08 157.06 29.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.118 0.961 . . . . 50.0 109.92 -177.047 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.05 122.31 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.346 -0.843 . . . . 50.0 108.758 174.382 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.7 mm -63.14 134.36 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 107.699 -1.223 . . . . 50.0 107.699 -179.839 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.61 177.35 8.75 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.767 0.794 . . . . 50.0 110.093 179.79 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.8 t -56.01 134.81 19.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 108.064 -1.088 . . . . 25.0 108.064 174.154 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.21 -38.82 0.1 Allowed Glycine 0 C--O 1.217 -0.929 0 O-C-N 123.685 0.616 . . . . 25.0 112.104 -177.519 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -108.77 157.45 18.55 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.833 -1.173 . . . . 25.0 107.833 176.309 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -96.22 21.31 9.1 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 107.66 -1.237 . . . . 25.0 107.66 178.243 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.89 -167.81 0.18 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.869 -1.514 . . . . 25.0 112.134 -175.815 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -116.83 162.63 17.41 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.065 -1.022 . . . . 25.0 110.112 -176.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -60.7 146.44 86.11 Favored Pre-proline 0 C--O 1.248 1.006 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 177.058 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.32 171.54 17.89 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 120.417 0.745 . . . . 25.0 113.412 178.51 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.47 -42.83 2.53 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 115.731 -0.668 . . . . 25.0 111.376 179.686 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.14 152.95 27.88 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.298 -0.477 . . . . 25.0 113.036 -177.166 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -149.32 84.94 1.44 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -178.287 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.98 160.92 28.28 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -177.226 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.4 pt -135.97 157.24 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 107.886 -1.153 . . . . 50.0 107.886 174.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.2 p -154.54 145.59 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 -176.777 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m 47.51 47.61 17.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.353 0.597 . . . . 25.0 112.325 -179.016 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t0 . . . . . 0 C--O 1.203 -1.392 0 C-N-CA 124.938 1.295 . . . . 25.0 113.059 -176.176 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.219 0 N-CA-C 116.837 1.495 . . . . 25.0 116.837 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.9 t -80.61 154.38 27.44 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 121.664 -0.903 . . . . 25.0 110.814 178.22 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 mtm -127.48 160.69 30.72 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 104.197 -2.52 . . . . 25.0 104.197 179.905 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -127.89 -44.46 1.47 Allowed 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 116.506 2.039 . . . . 25.0 116.506 -173.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.97 176.25 9.84 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 101.703 -3.443 . . . . 50.0 101.703 -174.342 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.2 mt -56.62 -43.69 80.46 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 113.71 1.004 . . . . 50.0 113.71 -173.703 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.0 t30 53.12 42.33 32.18 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 113.521 0.934 . . . . 50.0 113.521 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -112.44 147.17 16.37 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.718 0 N-CA-C 105.188 -2.153 . . . . 50.0 105.188 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.65 155.38 46.68 Favored 'General case' 0 C--O 1.267 2.024 0 CA-C-N 119.611 1.096 . . . . 50.0 112.521 177.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.5 161.72 36.8 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.897 -1.047 . . . . 25.0 111.021 -170.166 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -110.68 132.27 54.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.378 0.671 . . . . 50.0 110.574 177.261 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.66 127.52 33.32 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.544 0.688 . . . . 25.0 110.247 178.126 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.0 mt -93.44 -23.91 18.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.114 -1.069 . . . . 50.0 108.114 -179.255 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -126.4 165.36 19.19 Favored 'General case' 0 C--O 1.202 -1.432 0 N-CA-C 109.866 -0.42 . . . . 50.0 109.866 178.162 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -100.77 160.85 14.02 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.725 0.81 . . . . 50.0 109.742 178.274 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -148.2 135.79 20.7 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 113.158 0.799 . . . . 50.0 113.158 -177.731 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -94.89 119.81 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 168.159 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.68 116.93 12.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 -177.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.11 -21.28 29.35 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.714 1.245 . . . . 50.0 111.798 -178.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -133.44 154.13 80.75 Favored Pre-proline 0 C--O 1.215 -0.751 0 CA-C-N 115.477 -0.783 . . . . 50.0 109.948 -170.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.48 -21.54 60.13 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 116.22 1.585 . . . . 25.0 116.22 -178.981 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.24 -19.89 45.8 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.058 0.932 . . . . 50.0 110.273 176.425 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -81.87 140.33 34.18 Favored 'General case' 0 C--O 1.195 -1.771 0 O-C-N 121.022 -1.049 . . . . 50.0 112.246 -176.344 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.02 135.99 33.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 123.566 1.65 . . . . 50.0 110.627 177.725 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.28 110.17 18.88 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.801 -1.545 . . . . 50.0 108.192 176.212 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -135.87 166.39 23.41 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.405 0.621 . . . . 25.0 112.424 -176.282 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -128.4 152.79 47.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.594 -1.262 . . . . 50.0 107.594 -179.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -62.27 139.64 58.5 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.828 -1.175 . . . . 50.0 107.828 175.413 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -22.51 40.58 Favored Glycine 0 C--O 1.264 2.02 0 CA-C-O 117.843 -1.531 . . . . 25.0 110.284 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.19 166.17 23.06 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 119.468 1.634 . . . . 50.0 109.977 -176.616 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -121.71 132.24 71.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 114.781 -1.099 . . . . 50.0 110.253 -174.519 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.6 ptp -139.96 155.53 47.09 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 124.028 0.83 . . . . 50.0 112.071 -178.602 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -93.41 138.68 31.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 -179.406 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -103.02 119.22 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 106.787 -1.56 . . . . 50.0 106.787 177.744 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.9 mt -93.87 -41.04 9.84 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.341 -1.3 . . . . 50.0 111.555 -174.166 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -149.27 159.19 44.48 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 104.978 -2.23 . . . . 50.0 104.978 -177.479 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -130.73 149.11 52.53 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 101.496 -3.52 . . . . 50.0 101.496 178.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 t0 62.86 34.55 14.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.997 0.919 . . . . 50.0 108.583 -177.464 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -66.24 -20.63 66.17 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.363 1.616 . . . . 25.0 115.363 -177.387 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -5.97 21.76 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.239 -0.891 . . . . 50.0 112.292 -177.391 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.9 -6.47 83.44 Favored Glycine 0 N--CA 1.464 0.52 0 CA-C-O 122.597 1.11 . . . . 25.0 111.48 -170.388 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.1 mt -94.14 118.69 31.91 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 106.912 -1.514 . . . . 50.0 106.912 177.584 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -56.83 126.68 28.04 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 106.997 -1.483 . . . . 50.0 106.997 171.831 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.0 64.37 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-O 116.634 -2.203 . . . . 25.0 115.302 178.25 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -104.52 125.81 51.03 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 120.772 2.286 . . . . 50.0 110.025 171.235 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -116.61 148.68 40.72 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.438 -1.319 . . . . 50.0 107.438 -176.054 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.3 tp -92.33 113.35 25.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.847 -1.538 . . . . 50.0 106.847 178.276 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.2 m -121.94 157.1 31.98 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.47 0.652 . . . . 25.0 110.121 -177.539 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -118.64 133.43 55.86 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.063 0.945 . . . . 50.0 110.097 173.279 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.2 138.93 19.75 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 124.625 1.203 . . . . 50.0 109.45 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t60 57.86 29.35 17.4 Favored 'General case' 0 C--O 1.183 -2.428 0 O-C-N 124.218 0.949 . . . . 25.0 110.727 173.287 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.76 -2.24 74.76 Favored Glycine 0 N--CA 1.473 1.159 0 C-N-CA 118.922 -1.609 . . . . 25.0 113.443 -179.31 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -107.12 167.4 9.93 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.081 -1.822 . . . . 50.0 106.081 -179.919 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -141.34 144.5 34.59 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 103.493 -2.78 . . . . 50.0 103.493 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -177.85 47.53 Favored Glycine 0 CA--C 1.545 1.96 0 O-C-N 125.394 1.684 . . . . 50.0 110.208 179.291 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.06 143.08 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.29 0.545 . . . . 50.0 111.042 -174.331 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.3 t -139.08 136.21 18.03 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 -172.16 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.66 112.42 3.05 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 CA-C-O 122.819 1.091 . . . . 50.0 111.828 172.594 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -26.26 63.42 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-N 115.407 -0.815 . . . . 50.0 115.038 -179.313 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -68.89 -15.3 63.46 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.678 0.739 . . . . 50.0 109.913 179.622 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -92.18 3.46 55.29 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 120.655 -0.418 . . . . 50.0 110.896 175.505 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -117.33 157.13 26.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.002 0.521 . . . . 50.0 111.127 -177.188 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -124.02 129.08 50.31 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.082 -1.451 . . . . 50.0 107.082 172.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.1 mm -67.18 127.84 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 104.484 -2.413 . . . . 50.0 104.484 -179.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -157.75 109.99 2.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.258 -1.016 . . . . 50.0 108.258 -178.581 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -71.42 165.71 2.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 CA-C-O 121.43 0.633 . . . . 25.0 111.329 177.902 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.44 81.16 0.03 OUTLIER Glycine 0 C--O 1.215 -1.074 0 CA-C-N 116.042 -0.527 . . . . 25.0 111.998 177.742 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.32 153.84 45.68 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.963 -0.384 . . . . 25.0 109.963 -178.928 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -122.26 -39.45 2.58 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.329 1.062 . . . . 25.0 112.775 -175.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.07 174.82 8.12 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.185 -1.37 . . . . 25.0 113.437 179.616 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -117.36 158.15 24.92 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 120.555 -1.34 . . . . 25.0 111.183 -173.661 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -84.1 149.54 56.13 Favored Pre-proline 0 C--O 1.258 1.533 0 CA-C-N 114.036 -1.438 . . . . 25.0 109.008 176.219 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.54 161.18 40.33 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 117.917 -0.922 . . . . 25.0 109.859 178.671 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.74 150.33 29.3 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.019 -2.585 . . . . 25.0 104.019 179.01 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.28 7.72 61.9 Favored Glycine 0 C--O 1.258 1.618 0 CA-C-O 117.912 -1.493 . . . . 25.0 112.38 179.223 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -110.27 144.29 39.2 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 118.76 1.28 . . . . 25.0 109.377 -178.28 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -155.16 123.89 6.09 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 174.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 tt -146.75 143.99 20.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 O-C-N 120.94 -1.1 . . . . 50.0 109.562 -174.147 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.97 146.55 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.329 -0.619 . . . . 25.0 109.329 179.8 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -131.53 139.7 49.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.519 -1.659 . . . . 25.0 106.519 177.821 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t0 . . . . . 0 N--CA 1.493 1.707 0 C-N-CA 125.794 1.638 . . . . 25.0 111.455 -175.11 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 5.02 0 CA-C-O 123.948 1.86 . . . . 25.0 116.176 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 m -60.99 142.0 56.9 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 127.048 2.139 . . . . 25.0 111.923 177.684 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.6 mtt -123.94 91.34 3.44 Favored 'General case' 0 C--O 1.193 -1.907 0 CA-C-O 121.748 0.785 . . . . 25.0 109.628 -179.478 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 57.53 40.32 27.11 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 113.869 1.063 . . . . 25.0 113.869 178.182 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.61 166.75 16.87 Favored 'General case' 0 C--O 1.267 1.981 0 CA-C-N 113.867 -1.515 . . . . 50.0 109.812 169.879 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.05 -48.12 79.31 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.275 1.213 . . . . 50.0 114.275 -175.671 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.4 t30 45.81 47.36 12.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.32 0.648 . . . . 50.0 112.258 -178.073 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.97 165.35 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 105.751 -1.944 . . . . 50.0 105.751 165.673 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.32 156.2 45.24 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 115.507 -0.769 . . . . 50.0 109.518 -177.139 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.55 162.47 35.0 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 123.896 0.878 . . . . 25.0 110.894 -175.211 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -101.45 133.57 45.89 Favored 'General case' 0 C--O 1.206 -1.23 0 O-C-N 124.185 0.928 . . . . 50.0 108.631 172.246 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 130.5 39.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 105.616 -1.994 . . . . 25.0 105.616 174.731 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.32 -16.54 22.32 Favored 'General case' 0 C--O 1.264 1.82 0 O-C-N 121.439 -0.788 . . . . 50.0 110.44 -178.72 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -135.85 164.78 27.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.383 -1.339 . . . . 50.0 107.383 -178.847 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -100.5 161.01 13.88 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 109.036 -0.727 . . . . 50.0 109.036 -175.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -147.97 136.24 21.38 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 123.863 1.792 . . . . 50.0 111.922 178.731 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.85 122.38 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.8 -1.187 . . . . 25.0 108.719 169.72 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.27 115.41 22.45 Favored 'General case' 0 CA--C 1.565 1.558 0 O-C-N 124.041 0.838 . . . . 25.0 109.386 -177.657 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.54 -20.63 14.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.272 -0.876 . . . . 50.0 111.309 177.049 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -96.22 151.45 38.18 Favored Pre-proline 0 C--O 1.207 -1.14 0 CA-C-N 115.36 -0.836 . . . . 50.0 110.165 177.291 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.95 -19.66 13.74 Favored 'Trans proline' 0 C--O 1.205 -1.129 0 C-N-CA 117.184 -1.41 . . . . 25.0 113.241 -179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -86.08 -20.57 28.55 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.122 1.439 . . . . 50.0 109.838 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -77.5 143.95 38.08 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.947 1.092 . . . . 50.0 113.947 178.151 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.86 137.51 32.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.94 1.352 . . . . 50.0 112.522 176.231 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 p -82.06 125.09 30.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.486 -1.233 . . . . 50.0 109.653 171.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -150.96 172.75 15.2 Favored 'General case' 0 C--O 1.191 -2.002 0 CA-C-O 121.588 0.709 . . . . 25.0 112.449 175.676 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -134.19 163.72 28.97 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.716 -1.587 . . . . 50.0 106.716 -178.436 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -63.98 141.0 58.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.292 -1.373 . . . . 50.0 107.292 174.836 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.59 -15.36 51.79 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 117.302 1.681 . . . . 25.0 117.302 -177.01 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.5 156.81 34.78 Favored 'General case' 0 C--O 1.263 1.765 0 C-N-CA 120.522 -0.471 . . . . 50.0 110.652 173.648 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.96 130.02 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 107.553 -1.277 . . . . 50.0 107.553 -176.547 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.9 150.65 48.36 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 121.026 -1.046 . . . . 50.0 110.853 179.85 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 m -81.62 138.87 35.29 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.046 -0.979 . . . . 25.0 109.585 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.93 122.3 59.36 Favored 'Isoleucine or valine' 0 C--O 1.254 1.314 0 N-CA-C 105.759 -1.941 . . . . 50.0 105.759 178.274 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.52 -36.91 12.19 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 124.329 1.018 . . . . 50.0 113.14 -177.709 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -155.79 149.08 24.68 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.757 -0.831 . . . . 50.0 108.757 -174.515 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.13 147.87 36.47 Favored 'General case' 0 C--O 1.197 -1.669 0 CA-C-O 117.086 -1.435 . . . . 50.0 107.677 -178.645 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 55.81 44.08 26.63 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 125.252 1.595 . . . . 50.0 109.104 179.104 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -72.38 -12.92 61.33 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 116.269 1.952 . . . . 25.0 116.269 -173.7 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -115.39 3.12 14.09 Favored 'General case' 0 C--O 1.256 1.439 0 CA-C-O 121.748 0.785 . . . . 50.0 109.693 -174.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.41 -15.77 59.25 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.05 -1.432 . . . . 25.0 109.925 -178.401 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.34 127.07 32.87 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.462 1.331 . . . . 50.0 111.111 176.336 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.06 129.05 38.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.849 1.309 . . . . 50.0 109.776 -177.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.63 10.16 73.7 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 174.882 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -107.77 103.3 12.54 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 123.778 1.751 . . . . 50.0 113.019 171.346 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -97.86 152.98 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.729 -1.232 . . . . 50.0 110.744 -174.527 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.54 119.93 29.46 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.541 1.15 . . . . 50.0 108.004 174.144 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -122.09 162.58 20.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.347 -0.983 . . . . 25.0 108.347 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.1 t -127.04 133.74 50.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.637 -1.245 . . . . 50.0 107.637 174.591 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 tp -154.89 136.69 14.46 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.752 1.283 . . . . 50.0 110.287 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 59.39 31.76 21.32 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-N 114.428 -1.26 . . . . 25.0 109.771 179.249 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.67 4.69 85.44 Favored Glycine 0 CA--C 1.545 1.937 0 C-N-CA 119.816 -1.183 . . . . 25.0 113.568 -179.775 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.7 mtp85 -117.66 140.11 50.1 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.746 1.773 . . . . 50.0 107.673 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -103.51 151.93 22.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.716 -1.587 . . . . 50.0 106.716 176.118 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.15 172.29 45.21 Favored Glycine 0 C--O 1.263 1.921 0 C-N-CA 118.714 -1.708 . . . . 50.0 113.9 175.051 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -79.83 142.74 13.54 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 117.448 0.624 . . . . 50.0 109.922 -177.888 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.09 132.05 14.58 Favored Pre-proline 0 C--O 1.263 1.764 0 O-C-N 122.014 -0.429 . . . . 25.0 110.588 -174.27 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 125.89 11.69 Favored 'Trans proline' 0 C--O 1.208 -0.985 1 C-N-CA 111.387 -5.275 . . . . 50.0 111.464 178.791 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.06 -21.53 67.69 Favored Glycine 0 C--N 1.306 -1.09 0 CA-C-N 114.75 -1.114 . . . . 50.0 113.756 -171.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.98 -3.65 33.57 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 120.199 -1.765 . . . . 50.0 108.031 178.123 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -109.38 12.21 24.76 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.673 0.749 . . . . 50.0 110.222 176.473 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.8 mt -120.02 154.28 34.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 122.344 1.069 . . . . 50.0 111.508 177.218 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -126.89 113.85 17.09 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.412 -0.813 . . . . 50.0 109.488 171.219 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.3 mm -54.77 136.38 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 O-C-N 124.787 1.305 . . . . 50.0 108.965 175.592 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -171.26 1.79 Allowed 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 124.107 0.879 . . . . 50.0 113.098 -177.912 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.4 m -58.17 162.53 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.419 0.628 . . . . 25.0 112.283 178.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.02 -33.29 2.62 Favored Glycine 0 C--O 1.265 2.076 0 N-CA-C 110.921 -0.872 . . . . 25.0 110.921 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -157.89 153.65 26.62 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.555 -1.276 . . . . 25.0 107.555 179.314 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -145.92 118.4 8.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 118.681 -0.676 . . . . 25.0 111.703 179.523 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -138.32 69.2 1.38 Allowed 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 107.063 -1.458 . . . . 25.0 107.063 -179.587 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -142.74 152.31 42.18 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.356 -1.465 . . . . 25.0 113.5 -179.452 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -77.6 144.73 70.04 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 106.003 -1.851 . . . . 25.0 106.003 179.038 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -69.46 149.35 68.68 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 117.156 -1.429 . . . . 25.0 112.548 178.273 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.05 147.69 32.73 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.301 -0.999 . . . . 25.0 108.301 -178.169 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.25 142.87 9.15 Favored Glycine 0 C--O 1.248 0.992 0 CA-C-O 119.14 -0.811 . . . . 25.0 111.73 -179.785 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -70.28 169.18 14.29 Favored 'General case' 0 C--O 1.199 -1.56 0 CA-C-O 121.46 0.648 . . . . 25.0 110.492 172.977 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -129.98 165.53 21.95 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 125.055 1.342 . . . . 25.0 110.586 179.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.4 pt -104.05 164.5 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 118.732 -0.651 . . . . 50.0 110.705 176.847 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.8 165.44 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 107.424 -1.325 . . . . 25.0 107.424 175.357 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.51 162.05 27.33 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 106.602 -1.629 . . . . 25.0 106.602 -173.227 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t0 . . . . . 0 N--CA 1.507 2.402 0 C-N-CA 125.133 1.373 . . . . 25.0 113.98 179.641 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.482 0 N-CA-C 118.323 2.089 . . . . 25.0 118.323 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -69.14 135.81 51.25 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.686 -0.891 . . . . 25.0 110.018 -179.079 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -72.93 154.65 40.46 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 116.084 1.883 . . . . 25.0 116.084 -173.225 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -93.68 -35.88 12.61 Favored 'General case' 0 C--O 1.202 -1.447 0 CA-C-N 111.941 -2.39 . . . . 25.0 112.503 -177.786 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -115.45 161.12 19.01 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.374 -1.713 . . . . 50.0 106.374 -177.755 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.44 -43.24 93.18 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 123.917 0.76 . . . . 50.0 111.379 -177.537 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.87 37.64 17.79 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.356 -1.293 . . . . 50.0 113.662 174.598 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 p -109.34 160.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 103.49 -2.782 . . . . 50.0 103.49 175.299 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 159.03 28.67 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 107.064 -1.458 . . . . 75.0 107.064 -177.869 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.88 155.71 49.9 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 124.194 0.934 . . . . 25.0 109.597 -176.299 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -98.65 137.03 37.87 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 122.789 0.435 . . . . 50.0 110.86 169.207 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.9 130.6 36.8 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.209 0.448 . . . . 25.0 112.209 172.695 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.69 -22.1 17.77 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.091 -1.078 . . . . 50.0 108.091 -177.017 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -130.99 162.79 28.99 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 125.168 1.542 . . . . 50.0 111.869 178.42 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.53 161.83 13.55 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.781 -0.574 . . . . 50.0 109.782 -179.141 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -151.52 153.85 35.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.871 0.468 . . . . 50.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.1 t -116.87 123.55 71.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.551 -1.648 . . . . 25.0 106.551 167.302 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.35 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.128 -0.983 . . . . 25.0 113.227 -178.376 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -81.9 -15.4 54.06 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.983 -1.008 . . . . 50.0 110.72 176.387 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -134.25 151.67 76.81 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 108.685 -0.857 . . . . 50.0 108.685 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.62 -11.38 26.12 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 117.722 -1.052 . . . . 25.0 112.115 -178.332 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.91 -12.33 55.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.06 0.944 . . . . 50.0 110.531 175.287 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.6 149.49 22.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.233 -0.44 . . . . 50.0 111.554 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.28 139.93 31.7 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 114.189 1.181 . . . . 50.0 114.189 177.071 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 m -85.1 80.44 9.25 Favored 'General case' 0 C--O 1.271 2.206 0 N-CA-C 109.062 -0.718 . . . . 50.0 109.062 169.381 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -86.7 157.75 19.58 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.578 -1.638 . . . . 25.0 106.578 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.66 146.51 50.53 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 107.063 -1.458 . . . . 50.0 107.063 -174.776 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.54 138.07 57.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.133 -0.627 . . . . 50.0 111.246 177.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.44 -16.74 47.68 Favored Glycine 0 C--O 1.255 1.437 0 CA-C-O 117.319 -1.823 . . . . 25.0 112.351 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.75 163.68 26.58 Favored 'General case' 0 C--O 1.269 2.086 0 CA-C-N 119.06 1.43 . . . . 50.0 110.642 179.884 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.5 mm -122.41 128.01 75.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.005 -1.109 . . . . 50.0 108.005 -176.057 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.73 148.12 52.55 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.654 0.74 . . . . 50.0 112.329 177.257 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -81.27 131.24 35.28 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.265 -0.88 . . . . 25.0 110.976 175.545 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.25 128.59 45.44 Favored 'Isoleucine or valine' 0 C--O 1.273 2.29 0 N-CA-C 106.771 -1.566 . . . . 50.0 106.771 179.585 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.73 -38.52 7.04 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 113.442 0.904 . . . . 50.0 113.442 -173.856 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -151.12 147.79 27.49 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.359 -0.837 . . . . 50.0 109.613 -177.131 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -113.66 156.08 24.36 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.859 -1.163 . . . . 50.0 107.859 175.377 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t0 58.34 39.83 25.03 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.187 1.47 . . . . 50.0 109.163 -177.53 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -70.04 -20.11 63.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 121.185 -0.947 . . . . 25.0 113.554 -168.3 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 42' ' ' LEU . 1.4 tp60 -115.73 6.9 14.53 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-N 118.294 0.497 . . . . 50.0 111.851 -174.193 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.98 -18.21 32.6 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.757 -1.337 . . . . 25.0 109.757 -172.922 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 40' ' ' GLN . 90.6 mt -83.97 117.77 23.59 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.535 -2.024 . . . . 50.0 105.535 178.072 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.94 144.12 56.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.999 -1.111 . . . . 50.0 107.999 -175.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.58 81.58 Favored Glycine 0 N--CA 1.437 -1.266 0 O-C-N 121.062 -1.023 . . . . 25.0 114.971 179.798 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -97.39 116.42 29.57 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 118.328 1.064 . . . . 50.0 109.794 177.085 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -108.36 148.53 29.96 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.843 1.783 . . . . 50.0 108.914 -174.753 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -87.78 117.93 26.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.316 -1.311 . . . . 50.0 109.155 172.499 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -121.06 162.84 19.29 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.527 0.566 . . . . 25.0 112.527 -179.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.4 t -121.78 131.24 53.96 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.522 -0.751 . . . . 50.0 110.179 175.519 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 tp -161.49 142.88 11.39 Favored 'General case' 0 C--O 1.181 -2.541 0 CA-C-O 118.121 -0.942 . . . . 50.0 110.487 -175.887 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t60 54.18 29.76 11.06 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.917 1.081 . . . . 25.0 113.917 178.743 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.38 7.04 87.08 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 115.65 1.02 . . . . 25.0 115.65 175.571 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -123.94 164.89 18.39 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 107.458 -1.312 . . . . 50.0 107.458 175.214 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -124.97 150.75 46.33 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 105.264 -2.124 . . . . 50.0 105.264 166.548 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.0 175.0 47.51 Favored Glycine 0 C--O 1.283 3.157 0 N-CA-C 108.522 -1.831 . . . . 50.0 108.522 -178.54 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.2 pt -78.9 140.11 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 124.832 2.253 . . . . 50.0 112.066 -179.378 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -137.32 133.45 18.26 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-N 113.34 -1.755 . . . . 25.0 107.258 -178.722 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.58 118.9 5.95 Favored 'Trans proline' 0 CA--C 1.56 1.816 0 C-N-CA 114.217 -3.389 . . . . 50.0 113.068 172.631 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.65 -21.9 65.49 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 115.023 0.769 . . . . 50.0 115.023 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -56.57 -32.59 65.34 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.234 0.54 . . . . 50.0 111.417 173.179 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -92.06 5.14 51.35 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 113.838 1.051 . . . . 50.0 113.838 179.498 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.9 mt -110.0 155.98 21.09 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.454 1.121 . . . . 50.0 113.288 177.42 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -125.82 115.28 19.75 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.626 -0.879 . . . . 50.0 108.626 174.164 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm -61.14 126.17 18.63 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 CA-C-N 116.165 -0.47 . . . . 50.0 111.406 176.605 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.8 mt -78.74 90.83 4.64 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.642 -0.873 . . . . 50.0 108.642 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 m -81.22 161.61 3.72 Favored 'Isoleucine or valine' 0 C--O 1.255 1.391 0 N-CA-C 106.402 -1.703 . . . . 25.0 106.402 -178.937 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.7 -178.64 47.95 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 118.117 -1.38 . . . . 25.0 111.689 179.475 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.8 mtp -97.45 18.36 15.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.675 1.19 . . . . 25.0 111.989 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -81.94 122.38 27.7 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 120.989 -1.069 . . . . 25.0 112.83 -177.452 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -146.99 163.49 36.03 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.262 -1.384 . . . . 25.0 107.262 176.571 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 40.69 64.76 0.89 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.707 1.002 . . . . 25.0 113.707 -174.69 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.69 160.99 56.93 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-N 114.78 -1.1 . . . . 25.0 109.57 174.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.87 -23.77 40.87 Favored 'Trans proline' 0 C--N 1.357 0.974 0 N-CA-C 117.695 2.152 . . . . 25.0 117.695 -168.229 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 53.45 41.82 32.06 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.417 -0.802 . . . . 25.0 110.541 174.111 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.8 111.41 0.6 Allowed Glycine 0 N--CA 1.44 -1.084 0 O-C-N 125.505 1.753 . . . . 25.0 111.001 178.732 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -128.37 -163.69 1.3 Allowed 'General case' 0 C--O 1.208 -1.125 0 N-CA-C 106.196 -1.779 . . . . 25.0 106.196 175.725 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.9 t80 65.19 38.05 6.21 Favored 'General case' 0 C--O 1.25 1.098 0 C-N-CA 125.349 1.46 . . . . 25.0 113.445 173.351 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.0 pt -130.85 162.4 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.02 1.328 . . . . 50.0 107.576 178.607 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.0 t -77.33 129.84 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.117 0.484 . . . . 25.0 111.481 -179.701 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 p -74.53 -47.5 32.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.479 -0.782 . . . . 25.0 110.832 174.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 C--O 1.198 -1.643 0 CA-C-O 124.977 2.323 . . . . 25.0 113.562 -175.744 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.197 -2.184 0 CA-C-O 120.009 -0.328 . . . . 25.0 113.512 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m 57.5 29.83 17.7 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.579 1.696 . . . . 25.0 115.579 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 33.0 ttm -64.6 -16.33 62.53 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 124.544 2.116 . . . . 25.0 114.57 178.278 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -75.99 -8.97 58.19 Favored 'General case' 0 C--O 1.2 -1.505 0 CA-C-N 114.529 -1.214 . . . . 25.0 112.23 179.27 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -124.19 173.76 8.12 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.272 -1.381 . . . . 50.0 107.272 172.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.4 mt -64.86 -39.63 93.86 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 109.27 -0.641 . . . . 50.0 109.27 -177.774 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 59.01 36.86 24.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 125.041 1.463 . . . . 50.0 111.041 177.624 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t -104.87 146.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 106.065 -1.828 . . . . 50.0 106.065 177.252 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 153.4 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 119.304 0.957 . . . . 50.0 111.395 -179.299 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.3 162.34 33.81 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 116.115 -0.493 . . . . 25.0 109.929 -172.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -110.65 140.8 44.66 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.797 -2.297 . . . . 50.0 104.797 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.87 124.98 28.77 Favored 'General case' 0 C--O 1.2 -1.509 0 O-C-N 125.275 1.609 . . . . 25.0 111.09 176.836 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -92.94 -18.83 22.27 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.665 -0.698 . . . . 50.0 110.241 -176.542 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -134.79 163.73 29.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.147 -1.798 . . . . 50.0 106.147 178.883 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -93.47 168.69 10.88 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 119.625 -0.83 . . . . 50.0 110.078 177.809 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -150.29 144.69 25.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.527 0.936 . . . . 50.0 113.527 -179.865 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -116.38 103.78 15.65 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.004 0 N-CA-C 104.082 -2.562 . . . . 25.0 104.082 176.034 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.91 127.38 32.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.076 -1.42 . . . . 25.0 111.268 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.48 -19.96 15.31 Favored 'General case' 0 C--O 1.262 1.759 0 CA-C-O 121.104 0.478 . . . . 50.0 109.715 -176.877 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -107.95 153.49 41.64 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 121.838 -0.539 . . . . 50.0 110.922 -176.467 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.06 -14.66 23.51 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 N-CA-C 113.92 0.7 . . . . 25.0 113.92 178.262 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -85.88 -10.64 54.96 Favored 'General case' 0 C--O 1.209 -1.036 0 O-C-N 124.895 1.372 . . . . 50.0 109.569 176.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.41 144.1 30.63 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.987 0.899 . . . . 50.0 111.137 -174.2 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -92.12 130.61 37.8 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 120.197 -1.564 . . . . 50.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 t -78.18 132.29 37.55 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.584 -0.895 . . . . 50.0 108.584 167.726 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -157.83 166.79 31.78 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.436 -1.69 . . . . 25.0 106.436 176.343 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -133.65 163.99 28.2 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.602 1.191 . . . . 50.0 109.212 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -60.28 132.72 54.79 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 114.683 -1.144 . . . . 50.0 109.952 -176.622 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.46 -5.86 84.23 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 118.286 -1.285 . . . . 25.0 115.863 -171.383 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.56 155.42 28.18 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.003 1.901 . . . . 50.0 110.501 175.436 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.05 122.54 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 123.536 0.523 . . . . 50.0 109.899 -176.491 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.2 ptp -130.69 156.5 44.82 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.983 -0.747 . . . . 50.0 108.983 -175.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -93.99 125.82 38.84 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.264 0.626 . . . . 25.0 111.716 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.67 121.21 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.362 -1.347 . . . . 50.0 107.362 177.532 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.3 -40.33 11.55 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.768 -0.651 . . . . 50.0 110.51 178.82 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.42 168.14 27.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.606 0.763 . . . . 50.0 110.051 178.867 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -122.2 155.13 36.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.923 -1.51 . . . . 50.0 106.923 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 56.13 38.36 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.506 1.753 . . . . 50.0 111.454 177.5 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -66.36 -15.67 63.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.693 2.108 . . . . 25.0 116.693 -167.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -116.63 13.11 15.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 108.321 -0.992 . . . . 50.0 108.321 -178.999 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.22 78.08 Favored Glycine 0 C--O 1.203 -1.785 0 CA-C-O 122.706 1.17 . . . . 25.0 111.025 -177.016 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.28 116.51 21.83 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.762 -1.199 . . . . 50.0 107.762 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -65.2 115.34 5.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.306 -0.861 . . . . 50.0 108.758 176.218 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.23 0.97 47.76 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 117.554 -1.692 . . . . 25.0 115.287 178.322 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -109.45 117.95 35.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 120.452 2.126 . . . . 50.0 110.586 175.594 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -105.82 154.51 20.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.387 -1.279 . . . . 50.0 108.178 -170.8 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.5 tp -93.99 119.54 33.01 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 106.636 -1.616 . . . . 50.0 106.636 177.032 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.4 m -118.01 163.25 16.87 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 119.554 -0.859 . . . . 25.0 110.392 178.398 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.5 t -118.85 129.04 55.0 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 124.076 0.86 . . . . 50.0 112.166 173.673 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 tp -157.55 142.22 16.54 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-N 114.056 -1.429 . . . . 50.0 109.033 -176.225 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.4 t60 56.71 27.31 12.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.176 0.436 . . . . 25.0 112.176 -178.37 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.71 -3.41 74.84 Favored Glycine 0 C--O 1.246 0.856 0 CA-C-O 116.54 -2.255 . . . . 25.0 115.018 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -113.48 160.35 18.56 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.5 1.15 . . . . 50.0 108.267 -178.128 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -109.82 149.25 30.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.322 -2.103 . . . . 50.0 105.322 175.922 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.22 163.33 36.78 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.883 -1.287 . . . . 50.0 109.883 177.471 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 pt -82.64 141.54 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.419 1.104 . . . . 50.0 108.812 -179.174 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.75 137.69 20.36 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.189 -2.152 . . . . 25.0 105.189 -175.334 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -72.69 122.49 8.26 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 113.723 -3.718 . . . . 50.0 115.384 175.391 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.61 -19.95 78.19 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.509 -1.223 . . . . 50.0 113.918 -177.419 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -70.45 -8.95 54.95 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 118.716 -1.194 . . . . 50.0 112.215 172.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -108.93 4.37 23.3 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.589 0.709 . . . . 50.0 109.857 -179.601 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.3 mt -111.85 146.35 37.85 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-O 123.069 1.414 . . . . 50.0 112.186 179.919 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -114.65 116.92 29.49 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.525 -1.216 . . . . 50.0 111.089 170.649 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mm -59.62 128.27 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 107.327 -1.36 . . . . 50.0 107.327 178.727 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.1 173.56 7.78 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.158 -1.053 . . . . 50.0 108.158 -172.037 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.0 t 67.7 136.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.187 -2.218 0 O-C-N 124.86 1.35 . . . . 25.0 112.555 -176.142 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.62 -152.75 7.49 Favored Glycine 0 C--O 1.21 -1.359 0 N-CA-C 115.446 0.938 . . . . 25.0 115.446 -178.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 mmt -68.45 -35.48 77.65 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.576 -0.85 . . . . 25.0 110.103 -176.363 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -77.69 120.51 22.72 Favored 'General case' 0 C--O 1.26 1.638 0 N-CA-C 107.324 -1.361 . . . . 25.0 107.324 179.888 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -77.51 99.49 5.7 Favored 'General case' 0 C--O 1.199 -1.563 0 CA-C-N 114.677 -1.147 . . . . 25.0 110.243 -174.551 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt 68.27 115.6 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.693 1.197 . . . . 25.0 112.816 177.786 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -58.99 146.09 78.11 Favored Pre-proline 0 CA--C 1.558 1.274 0 O-C-N 121.327 -0.858 . . . . 25.0 109.854 177.088 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.08 86.41 1.43 Allowed 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.474 2.116 . . . . 25.0 112.588 176.59 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.49 159.28 44.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.706 -1.961 . . . . 25.0 105.706 176.59 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.45 131.4 3.26 Favored Glycine 0 C--N 1.338 0.68 0 O-C-N 122.093 -0.379 . . . . 25.0 113.672 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -79.64 132.99 36.39 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.246 -0.65 . . . . 25.0 109.246 -174.471 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -81.42 59.96 4.26 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.121 0.568 . . . . 25.0 109.987 -179.641 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.1 pt -64.42 150.79 9.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.779 -0.646 . . . . 50.0 109.336 174.627 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.8 m -140.3 164.02 22.78 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.268 0 CA-C-O 122.906 1.336 . . . . 25.0 108.442 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.64 18.32 9.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.548 -0.751 . . . . 25.0 109.474 175.481 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 . . . . . 0 C--N 1.311 -1.105 0 CA-C-O 124.091 1.9 . . . . 25.0 112.242 -179.074 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.194 -2.384 0 CA-C-O 121.47 0.483 . . . . 25.0 113.905 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m 51.65 50.48 18.66 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.364 0.875 . . . . 25.0 113.364 175.656 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 ttp -113.83 41.19 2.27 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.859 0.688 . . . . 25.0 112.859 -176.378 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -135.88 112.92 10.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.042 0.925 . . . . 25.0 111.64 178.396 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -143.22 177.08 8.65 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 102.752 -3.055 . . . . 50.0 102.752 174.812 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.14 -40.96 91.63 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 114.639 1.348 . . . . 50.0 114.639 -173.387 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.4 t30 44.36 46.42 7.75 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.566 1.321 . . . . 50.0 114.566 -179.143 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.86 157.11 35.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 N-CA-C 103.596 -2.742 . . . . 50.0 103.596 -177.06 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.11 163.36 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.446 -0.946 . . . . 50.0 108.446 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.16 156.36 43.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 25.0 110.938 -177.533 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.14 137.36 37.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.217 -1.031 . . . . 50.0 108.217 174.629 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.82 135.04 43.44 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 172.63 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -94.24 -33.18 13.36 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 125.122 1.514 . . . . 50.0 112.103 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -121.57 162.2 21.02 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.553 -1.647 . . . . 50.0 106.553 -177.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.04 149.25 23.67 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 121.896 -0.502 . . . . 50.0 110.806 177.423 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -145.42 122.47 11.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.144 0.974 . . . . 50.0 111.942 -172.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -84.21 132.1 32.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 105.76 -1.941 . . . . 25.0 105.76 171.983 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.18 122.1 26.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.216 -0.994 . . . . 25.0 108.674 178.629 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.44 -12.15 18.79 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.504 0.722 . . . . 50.0 110.101 -178.858 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 m -127.78 152.68 77.43 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 107.391 -1.337 . . . . 50.0 107.391 -176.13 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.01 -15.19 23.5 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 114.866 -2.956 . . . . 25.0 112.672 -179.662 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.48 -15.06 57.66 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.578 -1.267 . . . . 50.0 107.578 -179.476 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -89.88 144.47 25.91 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.29 -0.868 . . . . 50.0 112.65 -173.387 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 128.81 37.94 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.836 -0.745 . . . . 50.0 110.607 177.52 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -73.31 131.21 41.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.834 -2.284 . . . . 50.0 104.834 171.995 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.75 167.46 30.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.089 0.471 . . . . 25.0 110.048 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -133.37 159.88 39.0 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.222 -0.659 . . . . 50.0 109.222 -178.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -63.0 139.62 58.79 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 107.593 -1.262 . . . . 50.0 107.593 -179.877 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -12.3 68.53 Favored Glycine 0 CA--C 1.498 -0.974 0 CA-C-N 115.209 -0.905 . . . . 25.0 112.626 179.007 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -84.75 157.54 21.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.158 -0.682 . . . . 50.0 109.158 -179.489 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 mp -128.28 131.24 69.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-O 122.03 0.919 . . . . 50.0 109.383 -176.419 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.13 144.37 50.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.661 -0.699 . . . . 50.0 111.287 -177.126 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 m -75.14 134.11 41.34 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.13 -1.063 . . . . 25.0 108.13 175.728 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.48 124.82 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.024 -1.102 . . . . 50.0 108.024 174.301 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.0 mt -96.54 -47.25 6.02 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 123.9 0.75 . . . . 50.0 112.13 -174.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.69 168.37 23.04 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.75 -1.944 . . . . 50.0 105.75 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -120.55 160.29 23.5 Favored 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 108.92 -0.771 . . . . 50.0 108.92 -179.261 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 51.32 42.51 29.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 123.496 1.617 . . . . 50.0 111.038 179.925 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -67.4 -21.87 65.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 115.305 1.594 . . . . 25.0 115.305 -168.18 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -109.08 8.14 25.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.398 -0.521 . . . . 50.0 111.019 178.732 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.17 -1.8 86.57 Favored Glycine 0 C--O 1.215 -1.04 0 CA-C-O 122.901 1.278 . . . . 25.0 110.257 -175.797 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.92 122.13 37.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.697 -1.594 . . . . 50.0 106.697 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.34 132.36 49.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.174 -1.417 . . . . 50.0 107.174 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.75 -12.85 61.08 Favored Glycine 0 CA--C 1.485 -1.797 0 O-C-N 121.722 -0.611 . . . . 25.0 114.348 174.29 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.451 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 92.8 m95 -97.43 110.26 22.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.16 -0.612 . . . . 50.0 111.7 177.769 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -101.81 145.39 29.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.732 -0.84 . . . . 50.0 108.732 -174.709 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.09 121.8 28.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.363 -1.347 . . . . 50.0 107.363 173.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.3 m -123.94 164.65 18.88 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.4 -0.963 . . . . 25.0 108.4 178.541 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -124.27 128.06 48.59 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.003 -1.061 . . . . 50.0 109.23 -178.227 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -158.23 151.45 23.01 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 125.202 1.564 . . . . 50.0 110.548 -176.908 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 55.24 31.84 17.37 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.761 0.791 . . . . 25.0 110.545 -179.586 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.22 21.95 66.69 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 117.906 1.922 . . . . 25.0 117.906 -176.101 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -143.7 165.66 27.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.199 -1.778 . . . . 50.0 106.199 -177.912 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -117.72 161.03 20.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.7 -1.593 . . . . 50.0 106.7 -176.648 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.73 166.35 36.58 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.736 -0.745 . . . . 50.0 112.763 176.57 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 pt -73.71 144.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 122.788 1.28 . . . . 50.0 109.675 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.8 t -142.84 134.32 12.91 Favored Pre-proline 0 C--O 1.217 -0.643 0 O-C-N 120.408 -1.433 . . . . 25.0 107.695 179.489 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HD3' ' CZ3' ' A' ' 45' ' ' TRP . 79.1 Cg_endo -73.58 116.98 4.87 Favored 'Trans proline' 0 C--O 1.255 1.344 0 C-N-CA 115.87 -2.286 . . . . 50.0 113.038 176.86 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.05 -23.25 59.21 Favored Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 120.666 -0.778 . . . . 50.0 114.711 -175.241 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.91 -4.9 14.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 120.606 -1.526 . . . . 50.0 112.527 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -114.94 11.97 16.69 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 122.842 0.457 . . . . 50.0 110.403 178.522 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.4 mt -118.33 153.86 33.29 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.33 -0.85 . . . . 50.0 111.181 -179.293 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -121.1 127.17 51.37 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.502 -0.555 . . . . 50.0 109.502 169.815 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.6 mm -59.57 133.88 24.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 121.792 0.806 . . . . 50.0 110.686 179.058 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mp -126.64 159.83 32.47 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 124.767 1.227 . . . . 50.0 108.364 179.253 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.4 t 56.0 76.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.241 0.543 . . . . 25.0 111.758 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -165.82 73.59 0.16 Allowed Glycine 0 C--O 1.206 -1.648 0 C-N-CA 120.331 -0.938 . . . . 25.0 110.877 175.496 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 5.6 ttt 54.51 40.43 31.82 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.958 1.096 . . . . 25.0 113.958 -177.785 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -102.33 157.81 16.64 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.961 -1.018 . . . . 25.0 108.384 176.5 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -67.89 151.32 47.34 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.582 0.753 . . . . 25.0 110.469 -179.803 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -144.09 161.39 38.93 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 -178.242 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -70.72 153.05 95.09 Favored Pre-proline 0 N--CA 1.475 0.811 0 N-CA-C 102.038 -3.319 . . . . 25.0 102.038 175.272 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.45 114.93 4.09 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 114.02 -3.52 . . . . 25.0 112.493 -176.738 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.04 164.4 35.48 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.167 -1.42 . . . . 25.0 107.167 177.743 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.62 -130.5 5.66 Favored Glycine 0 C--O 1.241 0.591 0 N-CA-C 109.486 -1.446 . . . . 25.0 109.486 176.692 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.24 171.84 0.09 Allowed 'General case' 0 C--O 1.2 -1.504 0 N-CA-C 115.544 1.683 . . . . 25.0 115.544 178.172 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 52.52 39.79 28.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.149 0.976 . . . . 25.0 111.164 -178.598 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 tt -123.45 144.55 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.482 -0.932 . . . . 50.0 108.482 -176.176 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 m -65.37 152.6 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 108.782 -0.821 . . . . 25.0 108.782 -176.415 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.8 p -118.67 -39.33 3.0 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.426 0.899 . . . . 25.0 113.426 175.678 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 . . . . . 0 C--N 1.352 0.688 0 CA-C-O 125.996 2.807 . . . . 25.0 110.4 176.717 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.532 5.084 0 N-CA-C 114.94 0.736 . . . . 25.0 114.94 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 p -61.64 -37.21 83.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 120.816 -0.354 . . . . 25.0 110.502 -179.151 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 ptm -156.17 -47.27 0.08 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.399 0.619 . . . . 25.0 111.141 172.032 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 91.9 mttt 55.65 -162.26 0.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.385 1.074 . . . . 25.0 109.969 -175.194 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -139.04 174.25 10.7 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.162 -1.792 . . . . 50.0 106.162 -177.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.31 -46.44 86.13 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 121.869 0.842 . . . . 50.0 109.405 177.197 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.3 m120 53.54 32.78 14.88 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-O 122.685 1.231 . . . . 50.0 111.366 -178.239 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.45 147.1 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 101.686 -3.45 . . . . 50.0 101.686 179.168 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.49 163.53 28.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.235 -0.654 . . . . 50.0 109.235 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.14 153.63 38.01 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 122.025 -0.422 . . . . 25.0 109.962 -175.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -101.41 137.28 39.96 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.088 -1.449 . . . . 50.0 107.088 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.63 128.72 33.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 112.917 0.71 . . . . 25.0 112.917 179.157 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.4 mt -89.2 -18.2 27.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.918 0.887 . . . . 50.0 111.218 179.765 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.9 169.49 17.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.271 -1.381 . . . . 50.0 107.271 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.89 154.4 25.25 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.675 0.79 . . . . 50.0 111.523 179.089 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.5 162.56 40.68 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-O 122.118 0.961 . . . . 50.0 110.996 -174.018 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.42 129.21 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.081 -2.933 . . . . 25.0 103.081 173.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.43 126.54 30.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.286 -0.635 . . . . 25.0 109.286 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.47 -14.27 33.12 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.998 0.904 . . . . 50.0 111.178 176.385 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -131.03 155.25 81.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.079 -1.082 . . . . 50.0 108.079 -175.983 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.26 -10.23 20.72 Favored 'Trans proline' 0 C--O 1.205 -1.132 0 CA-C-N 119.967 1.024 . . . . 25.0 113.343 176.013 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -85.29 -4.6 59.21 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.503 -1.295 . . . . 50.0 107.503 178.661 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -118.24 149.37 41.23 Favored 'General case' 0 C--O 1.252 1.217 0 N-CA-C 105.464 -2.05 . . . . 50.0 105.464 -170.654 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -102.97 133.8 47.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.468 1.128 . . . . 50.0 113.579 -178.435 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.8 82.72 8.0 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 121.015 -1.053 . . . . 50.0 113.154 170.341 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -97.21 154.67 17.24 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.882 -1.508 . . . . 25.0 112.698 176.856 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -125.84 152.95 44.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.16 -1.793 . . . . 50.0 106.16 -178.376 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -59.19 135.0 57.5 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 120.303 -0.559 . . . . 50.0 111.455 -179.117 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.07 -14.84 62.42 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 115.43 -0.804 . . . . 25.0 114.231 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -73.39 158.86 34.22 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 121.735 -0.862 . . . . 50.0 112.563 173.359 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -117.46 133.61 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 O-C-N 124.363 1.039 . . . . 50.0 110.295 -178.912 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 ptp -140.84 147.98 39.83 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.36 1.076 . . . . 50.0 111.578 177.636 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 m -86.34 130.57 34.47 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.007 -1.451 . . . . 25.0 111.181 -177.764 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t -90.77 126.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.25 -1.759 . . . . 50.0 106.25 -179.736 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.8 mt -101.06 -35.99 9.15 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 124.255 0.972 . . . . 50.0 112.412 -178.644 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -147.53 145.48 29.11 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.836 -1.172 . . . . 50.0 107.836 177.688 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -112.48 151.01 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 104.003 -2.591 . . . . 50.0 104.003 173.843 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 59.61 42.16 17.67 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.952 0.882 . . . . 50.0 110.66 -175.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.71 -18.44 62.81 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 116.866 2.173 . . . . 25.0 116.866 -169.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.76 5.06 13.06 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.169 0.985 . . . . 50.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.69 -17.41 25.84 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.184 -0.916 . . . . 25.0 112.349 -168.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.4 126.61 28.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.632 -0.507 . . . . 50.0 109.632 172.254 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.0 124.04 19.72 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 122.666 1.222 . . . . 50.0 112.821 -179.852 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.59 79.0 Favored Glycine 0 CA--C 1.503 -0.716 0 N-CA-C 118.094 1.998 . . . . 25.0 118.094 176.903 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -104.82 119.14 38.29 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.912 1.356 . . . . 50.0 108.694 178.552 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -106.12 142.64 35.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.872 -0.604 . . . . 50.0 111.588 -169.404 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -82.31 120.67 25.69 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.431 -0.581 . . . . 50.0 109.431 171.226 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 m -126.17 160.72 29.45 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 112.837 0.68 . . . . 25.0 112.837 -179.217 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.0 t -120.2 135.35 55.01 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 123.731 0.644 . . . . 50.0 110.758 174.906 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 tp -150.58 137.04 18.79 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.927 -1.508 . . . . 50.0 106.927 178.073 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.5 m170 57.44 30.88 19.35 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.361 0.875 . . . . 25.0 113.361 179.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.84 9.43 79.33 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 117.22 1.648 . . . . 25.0 117.22 -175.461 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -110.03 158.99 17.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.81 -1.181 . . . . 50.0 107.81 177.53 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -123.73 142.76 50.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.632 -1.293 . . . . 50.0 108.059 171.887 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.94 161.36 35.05 Favored Glycine 0 CA--C 1.491 -1.43 0 O-C-N 124.294 0.996 . . . . 50.0 111.117 177.6 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.9 pt -77.53 149.74 5.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.539 1.161 . . . . 50.0 108.727 -176.08 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.2 t -145.66 134.91 11.3 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 -176.933 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.21 119.47 6.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 117.188 -1.408 . . . . 50.0 113.114 179.33 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -24.1 63.34 Favored Glycine 0 C--O 1.198 -2.127 0 N-CA-C 117.249 1.66 . . . . 50.0 117.249 -177.463 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.06 -16.33 62.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 118.088 0.944 . . . . 50.0 109.623 178.553 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -94.42 9.53 37.98 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.15 0.976 . . . . 50.0 111.341 178.255 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.6 mt -124.86 147.63 48.68 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.603 -0.686 . . . . 50.0 111.006 -176.918 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -116.34 125.21 51.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.748 -1.114 . . . . 50.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.71 130.08 26.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 118.452 0.569 . . . . 50.0 110.973 177.375 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -112.26 124.97 53.62 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.768 0.827 . . . . 50.0 109.496 179.354 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.3 t -117.65 124.95 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-O 121.315 0.578 . . . . 25.0 110.506 -175.324 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.44 54.98 0.08 OUTLIER Glycine 0 C--O 1.198 -2.105 0 C-N-CA 119.186 -1.483 . . . . 25.0 111.901 -170.886 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.5 tpt -135.15 153.11 52.1 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-N 118.504 1.152 . . . . 25.0 109.391 -174.77 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.63 143.66 40.02 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.098 -1.445 . . . . 25.0 107.098 179.098 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.84 -37.77 79.36 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.855 0.687 . . . . 25.0 112.855 -176.965 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 40.73 55.11 3.04 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 113.382 0.882 . . . . 25.0 113.382 -179.016 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -68.3 138.27 91.72 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 174.989 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.35 146.5 80.85 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 117.235 -1.377 . . . . 25.0 113.738 -170.895 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.64 -6.82 57.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.386 -0.825 . . . . 25.0 109.953 176.69 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.49 -37.34 1.56 Allowed Glycine 0 C--O 1.21 -1.354 0 C-N-CA 121.332 -0.461 . . . . 25.0 113.533 176.6 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 54.09 31.87 14.63 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.562 0.345 . . . . 25.0 111.005 178.558 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -79.33 3.09 19.2 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.166 0.802 . . . . 25.0 113.166 -174.569 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -69.11 122.17 19.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 N-CA-C 106.735 -1.58 . . . . 50.0 106.735 -176.883 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t 52.22 77.83 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.301 0 O-C-N 126.258 2.224 . . . . 25.0 110.279 178.628 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.9 p -66.26 147.07 53.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.943 0.402 . . . . 25.0 111.96 178.132 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.447 -0.587 0 CA-C-O 127.034 3.302 . . . . 25.0 113.958 -174.001 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 112.392 0.515 . . . . 25.0 112.392 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.5 t30 55.0 39.61 31.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.09 0.774 . . . . 25.0 113.09 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 m -113.75 155.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.282 -2.488 . . . . 25.0 104.282 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.51 172.02 8.13 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 107.007 -1.479 . . . . 25.0 107.007 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.73 144.87 29.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.317 -0.401 . . . . 25.0 110.811 173.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -95.36 135.76 36.58 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.0 -0.741 . . . . 25.0 109.0 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 130.36 39.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.548 0.69 . . . . 25.0 109.367 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.53 -28.08 15.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.78 -0.645 . . . . 25.0 109.466 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -129.77 160.52 33.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.365 -1.346 . . . . 25.0 107.365 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.508 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.0 p-10 -101.76 159.88 14.95 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.581 0.752 . . . . 25.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.83 -177.99 5.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.013 0.435 . . . . 25.0 110.583 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.89 147.81 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.696 -3.816 . . . . 25.0 100.696 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.97 139.61 38.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -99.55 -13.3 19.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.245 0.545 . . . . 25.0 110.295 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -128.8 151.11 76.71 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.518 . . . . 25.0 109.865 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.01 -15.14 36.03 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 117.046 -1.502 . . . . 25.0 113.687 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.63 -7.72 59.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.701 0.763 . . . . 25.0 110.294 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -106.62 143.86 34.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 134.88 34.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.425 0.631 . . . . 25.0 111.89 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.0 p -93.09 122.6 35.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.459 ' CE2' HG13 ' A' ' 57' ' ' VAL . 40.9 p90 -141.21 164.76 29.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.379 -1.341 . . . . 25.0 107.379 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -132.3 154.51 49.63 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.842 -0.799 . . . . 25.0 108.842 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.508 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 64.0 pttt -56.37 137.32 52.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.375 0.607 . . . . 25.0 109.685 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.42 45.98 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.551 -0.749 . . . . 25.0 112.869 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -77.89 160.63 28.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.221 0.51 . . . . 25.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -130.44 132.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.6 ptp -131.59 151.12 51.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.454 . . . . 25.0 110.634 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -85.02 130.47 34.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.872 -0.418 . . . . 25.0 109.872 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.6 t -90.23 124.38 42.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.577 -1.268 . . . . 25.0 107.577 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.54 -43.15 8.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 25.0 110.862 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -156.42 171.79 19.64 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -127.38 154.73 44.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.754 -0.461 . . . . 25.0 109.754 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 58.81 39.01 24.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 25.0 108.9 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -65.54 -20.47 66.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.982 -1.917 . . . . 25.0 114.96 -168.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -114.76 13.05 17.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.661 -0.649 . . . . 25.0 110.265 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 -3.59 81.73 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.582 -1.007 . . . . 25.0 110.582 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.42 118.61 30.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.052 -0.721 . . . . 25.0 109.052 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -60.34 130.33 46.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.584 -0.735 . . . . 25.0 109.269 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.75 -1.71 83.81 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 114.982 0.753 . . . . 25.0 114.982 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -101.05 121.66 42.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.677 1.239 . . . . 25.0 108.762 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -111.07 146.49 36.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 25.0 109.493 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.8 tp -85.13 111.84 20.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.034 -2.21 . . . . 25.0 105.034 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.31 164.9 12.69 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.79 -0.819 . . . . 25.0 108.79 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -127.65 130.55 49.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -159.29 142.79 14.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 53.61 38.94 29.41 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.097 1.147 . . . . 25.0 114.097 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 2.93 89.56 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 115.289 0.876 . . . . 25.0 115.289 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -125.9 165.46 18.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -127.2 148.2 50.2 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 104.113 -2.551 . . . . 25.0 104.113 167.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.58 172.57 45.04 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 110.043 -1.223 . . . . 25.0 110.043 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 pt -75.27 141.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 25.0 110.308 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.459 HG13 ' CE2' ' A' ' 26' ' ' PHE . 74.0 t -140.67 133.9 14.79 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 108.877 -0.786 . . . . 25.0 108.877 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 112.97 3.45 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 117.339 -1.307 . . . . 25.0 111.751 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.75 -19.11 69.05 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.997 -0.547 . . . . 25.0 112.949 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.18 -5.86 7.91 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.351 0.5 . . . . 25.0 112.351 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -116.64 11.27 14.63 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.914 -0.491 . . . . 25.0 110.642 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.3 mt -122.33 155.2 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.035 0.445 . . . . 25.0 111.332 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -121.55 118.06 28.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.677 0.275 . . . . 25.0 110.537 179.554 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 115.058 1.503 . . . . 25.0 115.058 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 t30 50.15 42.44 25.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.197 0.814 . . . . 25.0 113.197 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.74 157.74 32.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 N-CA-C 105.887 -1.894 . . . . 25.0 105.887 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 161.66 36.48 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.325 0.583 . . . . 25.0 110.941 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.34 163.27 33.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.196 -0.911 . . . . 25.0 110.869 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -111.27 133.35 53.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.997 -1.112 . . . . 25.0 107.997 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.67 133.54 43.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.313 0.578 . . . . 25.0 109.585 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.46 -25.81 17.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.669 -0.696 . . . . 25.0 109.814 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -129.9 160.66 32.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.281 -1.007 . . . . 25.0 108.281 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.6 p-10 -98.15 158.54 15.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.325 -0.62 . . . . 25.0 109.325 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -156.42 135.84 12.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.909 -0.587 . . . . 25.0 112.168 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.32 127.03 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 127.14 30.41 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.143 -0.317 . . . . 25.0 110.143 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -100.08 -8.59 23.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.961 0.886 . . . . 25.0 108.615 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.1 m -128.4 152.33 78.01 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.783 -1.099 . . . . 25.0 108.655 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.24 -25.62 21.87 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 117.043 -1.504 . . . . 25.0 114.374 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -83.98 -9.92 58.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.195 0.521 . . . . 25.0 110.77 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -87.11 148.5 25.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.497 -0.557 . . . . 25.0 109.497 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.64 134.73 38.2 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.072 -0.392 . . . . 25.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 m -85.04 124.9 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.814 -1.55 . . . . 25.0 106.814 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.434 ' CE2' HG13 ' A' ' 57' ' ' VAL . 49.0 p90 -145.57 167.93 21.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.341 -0.985 . . . . 25.0 108.341 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -128.99 154.45 46.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 121.972 -0.455 . . . . 25.0 111.509 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.8 pttp -57.75 131.27 49.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.89 46.42 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-O 119.351 -0.694 . . . . 25.0 113.973 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -73.19 161.72 30.23 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.345 0.573 . . . . 25.0 111.035 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -121.84 130.15 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.22 -0.659 . . . . 25.0 109.22 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.39 147.81 47.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.551 . . . . 25.0 111.439 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -82.59 132.79 35.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.0 t -94.12 121.37 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.111 -1.811 . . . . 25.0 106.111 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.45 -46.73 9.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.654 -0.703 . . . . 25.0 110.191 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -154.7 163.05 40.82 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.554 -0.906 . . . . 25.0 108.554 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.6 154.09 37.22 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.989 0.516 . . . . 25.0 110.024 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.4 t0 54.66 45.85 25.94 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 123.454 1.597 . . . . 25.0 108.719 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.55 -6.34 35.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.776 -1.556 . . . . 25.0 114.347 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -136.57 6.15 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.294 1.22 . . . . 25.0 114.294 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.14 22.82 64.72 Favored Glycine 0 CA--C 1.517 0.209 0 N-CA-C 108.578 -1.809 . . . . 25.0 108.578 -174.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt -122.72 110.01 14.95 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 104.619 -2.363 . . . . 25.0 104.619 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -65.1 144.15 57.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.954 0.883 . . . . 25.0 109.053 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.34 -16.49 43.9 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-O 118.456 -1.191 . . . . 25.0 114.033 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -88.65 132.28 34.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.596 1.698 . . . . 25.0 109.998 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -120.19 144.22 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.63 118.6 25.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.933 -1.877 . . . . 25.0 105.933 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.1 m -120.46 164.43 16.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.292 -0.262 . . . . 25.0 110.292 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.6 t -125.62 130.48 51.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.364 -0.606 . . . . 25.0 109.364 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.7 tp -161.61 146.63 13.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.493 -0.928 . . . . 25.0 108.493 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 58.18 32.73 22.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.281 0.845 . . . . 25.0 113.281 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 6.56 88.79 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.877 -0.677 . . . . 25.0 114.735 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -133.31 162.9 30.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 117.839 0.82 . . . . 25.0 109.863 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -105.36 158.28 16.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 104.265 -2.494 . . . . 25.0 104.265 172.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.01 161.1 29.47 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.852 -0.689 . . . . 25.0 111.557 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -78.58 141.82 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG13 ' CE2' ' A' ' 26' ' ' PHE . 74.9 t -140.1 133.89 15.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.38 117.04 4.89 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 114.93 -2.913 . . . . 25.0 110.758 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -19.52 70.0 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 116.068 -0.514 . . . . 25.0 113.607 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -72.8 -3.23 24.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.264 -0.55 . . . . 25.0 111.767 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -108.71 8.95 27.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.09 -0.708 . . . . 25.0 109.09 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.18 155.3 34.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -126.12 120.75 30.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.801 -0.814 . . . . 25.0 108.801 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 mm . . . . . 0 C--O 1.242 0.663 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 179.009 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 114.24 1.2 . . . . 25.0 114.24 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t30 53.84 31.86 13.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.456 0.91 . . . . 25.0 113.456 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -119.53 156.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.29 158.82 43.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.816 -0.438 . . . . 25.0 109.816 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.21 151.18 44.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 25.0 110.983 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -97.24 134.29 40.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.771 -0.825 . . . . 25.0 108.771 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.82 130.52 40.09 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.717 -0.475 . . . . 25.0 109.717 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.2 mt -92.07 -28.1 17.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 25.0 109.593 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -129.28 162.21 28.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.3 p-10 -98.72 163.01 12.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.791 0.329 . . . . 25.0 110.699 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -150.42 153.39 35.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 25.0 110.784 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.09 118.12 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.614 -2.365 . . . . 25.0 104.614 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.57 30.41 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.217 0.323 . . . . 25.0 110.511 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.7 -22.05 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.559 174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.9 m -97.79 151.02 37.37 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.243 -0.28 . . . . 25.0 110.243 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.82 -17.99 25.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 117.697 -1.069 . . . . 25.0 113.297 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -85.53 -7.58 58.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.09 -0.505 . . . . 25.0 110.436 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -103.39 146.47 28.45 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.64 0.776 . . . . 25.0 110.007 -176.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -100.26 135.65 41.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.608 0.595 . . . . 25.0 112.608 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -84.95 139.85 31.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.387 -2.079 . . . . 25.0 105.387 168.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.449 ' CE1' HG13 ' A' ' 57' ' ' VAL . 44.7 p90 -159.11 163.7 35.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.593 -2.003 . . . . 25.0 105.593 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -129.77 154.81 46.85 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 120.222 -0.591 . . . . 25.0 111.855 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.485 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.0 pttp -55.73 130.34 42.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.413 -0.812 . . . . 25.0 109.621 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.52 22.74 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.397 -0.819 . . . . 25.0 113.082 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -73.37 162.15 29.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 122.731 0.413 . . . . 25.0 111.745 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -121.47 130.97 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.545 0.738 . . . . 25.0 109.34 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -135.44 145.79 47.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.787 0.327 . . . . 25.0 110.344 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -84.77 131.26 34.57 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.124 -1.065 . . . . 25.0 108.124 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -90.05 124.68 42.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.6 mt -91.75 -49.18 6.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 25.0 110.156 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -153.58 171.92 18.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.529 -1.285 . . . . 25.0 107.529 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -126.88 157.18 40.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 110.203 -0.295 . . . . 25.0 110.203 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 60.17 32.58 20.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 123.129 1.442 . . . . 25.0 109.467 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.57 -20.52 62.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.356 -1.747 . . . . 25.0 114.544 -170.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -100.99 3.09 41.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.367 0.603 . . . . 25.0 109.713 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.66 79.76 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 109.489 -1.444 . . . . 25.0 109.489 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.33 124.35 39.32 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.33 -1.359 . . . . 25.0 107.33 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.02 133.86 55.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.24 -0.652 . . . . 25.0 109.24 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 1.03 88.94 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 115.352 0.901 . . . . 25.0 115.352 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -99.04 124.13 43.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.173 1.486 . . . . 25.0 108.635 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -113.89 143.84 44.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.03 -0.419 . . . . 25.0 110.329 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.6 tp -82.87 118.07 23.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.417 -2.068 . . . . 25.0 105.417 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.63 163.84 16.76 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.255 -0.646 . . . . 25.0 109.255 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -122.91 137.81 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.118 0.485 . . . . 25.0 110.765 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 tp -159.46 143.4 14.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.94 -1.504 . . . . 25.0 106.94 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 58.99 22.25 10.21 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.606 0.965 . . . . 25.0 113.606 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.8 89.44 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.996 -0.621 . . . . 25.0 112.509 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -112.09 167.28 10.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.168 -1.79 . . . . 25.0 106.168 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.58 150.88 50.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.65 167.06 39.87 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 109.525 -1.43 . . . . 25.0 109.525 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.87 144.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.811 0.815 . . . . 25.0 111.131 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' CE1' ' A' ' 26' ' ' PHE . 64.4 t -140.2 134.18 15.44 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.66 117.99 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 114.621 -3.12 . . . . 25.0 110.696 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.0 -21.61 69.83 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 116.143 -0.48 . . . . 25.0 113.491 -174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -67.67 -14.5 63.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.533 -0.392 . . . . 25.0 111.696 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -94.63 6.72 48.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.037 -0.414 . . . . 25.0 111.123 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.82 154.33 34.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 25.0 111.751 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -123.97 117.72 25.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 25.0 108.969 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 25.0 111.177 -177.461 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 109.361 -0.607 . . . . 25.0 109.361 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 t30 51.36 40.25 26.06 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.484 1.291 . . . . 25.0 114.484 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.34 166.16 11.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 N-CA-C 105.03 -2.211 . . . . 25.0 105.03 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.62 157.52 43.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.536 0.684 . . . . 25.0 111.495 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.58 152.3 43.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.008 -0.996 . . . . 25.0 110.46 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.45 137.43 35.54 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 131.99 42.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.1 mt -86.59 -25.8 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.48 161.21 35.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 25.0 109.081 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.585 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.6 p-10 -99.91 155.79 17.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.429 -0.952 . . . . 25.0 108.429 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.13 172.96 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.674 0.749 . . . . 25.0 112.729 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.71 135.93 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 1 N-CA-C 100.141 -4.022 . . . . 25.0 100.141 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.38 47.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.396 -0.965 . . . . 25.0 108.396 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.63 -25.07 8.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.585 0.553 . . . . 25.0 112.055 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -93.88 148.36 35.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.339 -0.225 . . . . 25.0 110.876 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.3 -15.7 38.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 116.762 -1.692 . . . . 25.0 112.614 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -83.73 -15.56 48.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.862 0.363 . . . . 25.0 110.103 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -95.34 135.06 37.42 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.946 0.498 . . . . 25.0 111.532 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 136.53 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.508 -0.477 . . . . 25.0 110.954 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -91.23 118.47 30.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -136.13 166.33 23.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.316 0.579 . . . . 25.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -125.2 152.27 44.74 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.771 -0.455 . . . . 25.0 109.771 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.585 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.9 pttt -56.61 132.62 52.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.746 . . . . 25.0 108.987 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -13.04 66.98 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 119.247 -0.751 . . . . 25.0 114.265 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -76.28 158.04 31.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 117.936 0.868 . . . . 25.0 110.126 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mm -116.66 125.1 73.46 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 123.061 0.544 . . . . 25.0 109.868 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -131.42 147.25 52.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 25.0 111.376 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -89.0 127.12 35.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.084 -0.71 . . . . 25.0 109.084 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.3 t -86.73 123.13 39.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.77 -40.9 8.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 25.0 110.81 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.83 158.59 44.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.33 -0.618 . . . . 25.0 109.33 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -129.6 148.61 51.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.733 -0.84 . . . . 25.0 108.733 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.3 t0 55.38 43.6 28.59 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.361 1.553 . . . . 25.0 107.1 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -70.63 -6.34 36.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.568 -1.651 . . . . 25.0 114.352 -170.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.08 6.76 3.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.718 0.636 . . . . 25.0 112.718 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.86 9.65 85.13 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 109.496 -1.441 . . . . 25.0 109.496 -174.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -109.43 110.04 21.06 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 105.509 -2.034 . . . . 25.0 105.509 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.36 145.86 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.083 0.944 . . . . 25.0 108.701 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.4 48.12 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-O 118.624 -1.098 . . . . 25.0 113.749 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -93.5 129.7 39.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 119.367 1.583 . . . . 25.0 110.007 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -119.07 143.72 46.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.33 116.4 22.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 105.614 -1.995 . . . . 25.0 105.614 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -118.18 164.24 15.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.9 p -129.72 132.98 46.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.98 -0.748 . . . . 25.0 108.98 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.1 tp -159.31 141.56 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 25.0 109.252 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 57.35 31.18 19.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.282 1.216 . . . . 25.0 114.282 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.26 85.98 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 115.239 0.856 . . . . 25.0 115.239 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -135.01 162.81 31.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.726 -0.842 . . . . 25.0 108.726 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -117.75 160.23 21.69 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.25 167.55 39.64 Favored Glycine 0 C--O 1.238 0.374 0 N-CA-C 110.316 -1.114 . . . . 25.0 110.316 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -78.25 142.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.371 0.605 . . . . 25.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -141.68 134.63 14.16 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.994 -1.113 . . . . 25.0 107.994 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.58 119.72 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 114.672 -3.086 . . . . 25.0 111.182 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.68 -18.4 65.98 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.088 -0.506 . . . . 25.0 114.155 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.1 -29.98 70.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.424 -0.457 . . . . 25.0 110.282 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.53 10.28 26.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.377 -0.374 . . . . 25.0 111.983 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.8 mt -117.68 152.59 34.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.326 0.584 . . . . 25.0 111.078 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -124.72 117.99 25.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.121 -0.696 . . . . 25.0 109.121 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.4 mm . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 109.453 -0.573 . . . . 25.0 109.453 -179.824 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 110.927 -0.027 . . . . 25.0 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.1 t30 46.9 46.05 15.43 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.071 1.137 . . . . 25.0 114.071 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -125.29 149.04 29.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.549 -1.649 . . . . 25.0 106.549 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 155.33 30.75 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.248 0.547 . . . . 25.0 110.511 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 154.73 49.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.04 -0.982 . . . . 25.0 108.703 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -105.67 135.45 47.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.03 131.39 42.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.191 0.52 . . . . 25.0 109.74 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.68 -26.9 18.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.573 0.702 . . . . 25.0 109.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -130.58 158.72 39.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.508 -1.293 . . . . 25.0 107.508 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.6 p-10 -97.42 160.05 14.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.242 -0.651 . . . . 25.0 109.242 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.38 171.88 13.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 25.0 110.563 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.2 124.59 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 101.029 -3.693 . . . . 25.0 101.029 172.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.51 140.17 29.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -119.12 -29.37 5.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.658 0.599 . . . . 25.0 111.553 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -89.21 148.98 42.03 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.764 -0.828 . . . . 25.0 108.764 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.77 -18.22 32.41 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 116.746 -1.703 . . . . 25.0 112.797 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.84 -13.8 59.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 25.0 110.744 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -96.08 142.51 28.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.199 0.523 . . . . 25.0 110.94 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.47 137.7 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.867 -0.333 . . . . 25.0 110.605 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -93.23 124.5 37.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.268 -1.382 . . . . 25.0 107.268 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.88 168.25 24.3 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.361 -1.348 . . . . 25.0 107.361 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -133.02 159.32 40.38 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.964 -0.46 . . . . 25.0 110.229 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.489 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 27.0 pttt -56.57 136.35 54.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.584 0.707 . . . . 25.0 110.078 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.63 -24.04 31.28 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.08 -0.964 . . . . 25.0 113.303 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.61 159.39 34.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 117.141 0.47 . . . . 25.0 110.219 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.9 127.95 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.193 0.597 . . . . 25.0 110.101 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.63 148.52 50.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.366 0.603 . . . . 25.0 110.094 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -87.45 126.83 35.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.52 127.18 41.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 106.632 -1.618 . . . . 25.0 106.632 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -108.42 -33.36 7.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.82 -0.627 . . . . 25.0 112.52 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -151.68 163.76 38.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.383 -1.34 . . . . 25.0 107.383 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -126.08 152.29 46.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.582 0.628 . . . . 25.0 110.823 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 55.25 38.77 30.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.745 1.259 . . . . 25.0 109.382 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.54 -12.68 61.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 -165.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -116.07 6.67 14.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.287 0.565 . . . . 25.0 109.617 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.12 -5.93 69.57 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.731 -0.948 . . . . 25.0 110.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.09 124.84 30.2 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.539 -1.652 . . . . 25.0 106.539 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.47 132.25 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.635 0.731 . . . . 25.0 110.964 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.36 -0.12 85.37 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 115.38 0.912 . . . . 25.0 115.38 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -95.39 108.59 20.8 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.767 1.784 . . . . 25.0 110.21 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -97.8 144.28 27.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.158 -0.473 . . . . 25.0 110.977 -172.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.8 111.76 19.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.582 -2.007 . . . . 25.0 105.582 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.1 m -114.85 163.33 15.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.479 -0.934 . . . . 25.0 108.479 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -125.1 132.22 53.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.457 -0.572 . . . . 25.0 109.457 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.99 140.17 13.0 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.226 -1.027 . . . . 25.0 108.226 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 57.74 27.6 14.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.823 0.82 . . . . 25.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.94 -0.63 86.72 Favored Glycine 0 N--CA 1.458 0.152 0 N-CA-C 114.445 0.538 . . . . 25.0 114.445 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -107.08 153.98 21.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -116.22 140.02 49.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 103.507 -2.775 . . . . 25.0 103.507 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.43 168.07 40.7 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.959 -0.639 . . . . 25.0 112.126 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -76.48 141.22 16.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.771 0.796 . . . . 25.0 110.005 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.21 132.99 13.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.2 114.47 3.78 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 116.564 -1.824 . . . . 25.0 111.548 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.4 -22.35 65.46 Favored Glycine 0 C--O 1.219 -0.838 0 N-CA-C 114.667 0.627 . . . . 25.0 114.667 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.67 -23.42 67.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.739 0.78 . . . . 25.0 111.21 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.92 6.41 46.33 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 121.513 -0.742 . . . . 25.0 111.377 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -118.47 152.72 35.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.2 0.524 . . . . 25.0 111.183 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -123.28 117.46 25.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.738 -0.467 . . . . 25.0 109.738 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.2 mm . . . . . 0 C--O 1.238 0.451 0 N-CA-C 108.838 -0.801 . . . . 25.0 108.838 -179.781 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 110.102 -0.333 . . . . 25.0 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.1 t30 50.86 46.12 26.54 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.069 0.856 . . . . 25.0 113.089 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.8 m -111.46 169.99 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 103.717 -2.697 . . . . 25.0 103.717 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.97 159.81 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.181 0.901 . . . . 25.0 111.178 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.03 40.27 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.063 -0.971 . . . . 25.0 111.404 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -97.39 131.62 43.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.306 -1.368 . . . . 25.0 107.306 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.16 138.62 43.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.649 0.738 . . . . 25.0 109.544 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -96.38 -21.4 17.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.41 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -128.33 160.17 33.02 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.435 -1.32 . . . . 25.0 107.435 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.7 p-10 -100.5 153.03 19.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -156.37 151.6 26.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.568 -0.742 . . . . 25.0 110.937 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -116.13 150.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.62 110.51 16.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -93.89 -8.84 39.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 t -134.8 149.02 69.52 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.734 -1.58 . . . . 25.0 106.734 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.76 -18.9 41.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 116.687 -1.742 . . . . 25.0 113.666 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.57 -15.7 58.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.194 0.521 . . . . 25.0 110.817 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -92.39 143.21 26.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.041 0.536 . . . . 25.0 110.703 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.08 133.83 35.85 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.706 -0.798 . . . . 25.0 111.098 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.2 p -82.29 137.59 34.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 25.0 106.974 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.406 ' CE2' HG13 ' A' ' 57' ' ' VAL . 36.8 p90 -156.49 165.77 35.36 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -124.78 155.13 39.86 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.574 -0.703 . . . . 25.0 110.932 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.3 pttp -59.1 128.05 35.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.91 -12.19 68.8 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.703 -0.68 . . . . 25.0 113.903 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -79.37 158.02 27.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.039 -0.726 . . . . 25.0 109.039 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -120.66 127.63 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.957 -0.386 . . . . 25.0 109.957 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.69 152.27 51.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 25.0 111.873 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 m -86.84 133.86 33.6 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.5 t -98.72 121.42 49.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -93.64 -42.31 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.682 -0.69 . . . . 25.0 110.988 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.11 164.61 30.71 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 -173.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -132.01 150.04 52.26 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.466 -1.679 . . . . 25.0 106.466 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 58.28 39.91 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.81 1.319 . . . . 25.0 108.675 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -70.46 -14.22 62.45 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.808 -1.542 . . . . 25.0 114.35 -169.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -116.39 11.13 14.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.996 -0.547 . . . . 25.0 109.704 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.43 -6.8 63.11 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.806 -0.918 . . . . 25.0 110.806 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -86.0 118.13 25.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.429 -0.952 . . . . 25.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.5 128.78 38.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.793 -0.818 . . . . 25.0 108.793 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.12 78.55 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 115.779 1.071 . . . . 25.0 115.779 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -104.13 112.83 26.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.541 1.671 . . . . 25.0 110.046 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -107.82 142.73 37.42 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.228 -0.295 . . . . 25.0 111.643 -170.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.95 116.09 22.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.43 -1.322 . . . . 25.0 107.43 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.5 m -117.97 169.53 9.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.727 -0.215 . . . . 25.0 110.443 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -133.11 129.1 37.5 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.66 -0.496 . . . . 25.0 109.66 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.2 tp -161.04 155.47 23.22 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.4 t60 60.03 23.55 12.72 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.801 0.667 . . . . 25.0 112.801 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.08 11.56 85.25 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 25.0 114.051 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -142.28 162.84 34.44 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.0 -0.37 . . . . 25.0 110.0 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -110.72 155.85 21.89 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.224 -1.028 . . . . 25.0 108.224 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.45 165.97 37.15 Favored Glycine 0 C--O 1.24 0.523 0 N-CA-C 110.179 -1.168 . . . . 25.0 110.179 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -79.25 147.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 25.0 109.851 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 26' ' ' PHE . 86.5 t -142.46 131.81 12.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 25.0 107.289 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 121.84 8.69 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 114.882 -2.945 . . . . 25.0 111.326 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -22.8 61.74 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 115.954 -0.566 . . . . 25.0 113.686 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -65.67 -13.01 58.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.091 -0.652 . . . . 25.0 112.418 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -103.18 7.98 38.57 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 25.0 110.747 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -118.64 152.82 35.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.612 0.72 . . . . 25.0 111.044 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -126.87 117.72 23.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.646 -1.242 . . . . 25.0 107.646 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 108.705 -0.85 . . . . 25.0 108.705 -179.872 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 109.369 -0.604 . . . . 25.0 109.369 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 t30 46.91 46.91 15.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.988 1.107 . . . . 25.0 113.988 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.93 125.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.671 -1.233 . . . . 25.0 107.671 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -82.01 154.4 25.7 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.81 0.814 . . . . 25.0 108.975 -175.129 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.62 161.63 35.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.498 -1.228 . . . . 25.0 108.231 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -113.11 133.87 54.81 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.112 -1.07 . . . . 25.0 108.112 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.76 123.44 24.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.433 0.635 . . . . 25.0 109.797 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -82.46 -29.96 30.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.783 -0.644 . . . . 25.0 109.989 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -132.4 164.06 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 25.0 107.38 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.599 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.3 p-10 -99.22 166.62 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.487 -0.19 . . . . 25.0 110.487 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -148.15 160.53 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 25.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.54 118.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 102.855 -3.017 . . . . 25.0 102.855 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 144.27 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.9 -0.407 . . . . 25.0 109.9 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -33.89 3.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 25.0 110.002 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 t -81.03 146.75 59.69 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.969 -1.122 . . . . 25.0 107.969 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.88 -13.76 29.32 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 117.493 -1.205 . . . . 25.0 114.058 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -86.79 -15.65 38.65 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.875 0.845 . . . . 25.0 109.762 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -85.24 137.31 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 25.0 111.253 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.56 134.69 34.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.33 0.586 . . . . 25.0 111.105 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -84.29 114.05 21.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE2' HG13 ' A' ' 57' ' ' VAL . 55.2 p90 -140.14 161.06 38.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -131.08 164.11 26.16 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.936 0.398 . . . . 25.0 111.887 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.599 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 49.5 pttt -60.23 137.68 58.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.179 0.514 . . . . 25.0 110.712 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.96 -23.82 31.36 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.236 -0.893 . . . . 25.0 112.679 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -70.47 157.67 37.43 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 122.572 0.349 . . . . 25.0 111.407 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.13 127.47 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.308 0.643 . . . . 25.0 110.017 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.46 146.91 46.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.308 -0.256 . . . . 25.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 37.4 m -90.1 122.94 33.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 25.0 110.081 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -82.95 121.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 107.297 -1.371 . . . . 25.0 107.297 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -90.16 -45.91 8.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.751 -0.659 . . . . 25.0 110.067 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -153.5 171.89 18.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 25.0 109.388 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -130.19 155.53 46.1 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.884 -1.895 . . . . 25.0 105.884 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.3 t0 60.57 41.12 15.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 123.19 1.471 . . . . 25.0 108.905 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -70.72 -18.53 62.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.806 -1.543 . . . . 25.0 114.181 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -120.27 8.88 10.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.182 0.438 . . . . 25.0 112.182 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.79 7.88 85.2 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 109.642 -1.383 . . . . 25.0 109.642 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.9 mt -113.54 110.03 19.6 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.066 -1.457 . . . . 25.0 107.066 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -66.77 147.83 52.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.6 -22.27 40.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.457 -0.792 . . . . 25.0 112.466 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -93.18 132.01 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.208 1.004 . . . . 25.0 108.95 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -119.4 139.7 51.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.596 -0.89 . . . . 25.0 108.596 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.08 121.86 28.0 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.257 -1.757 . . . . 25.0 106.257 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.8 m -123.04 156.31 35.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.944 -0.391 . . . . 25.0 109.944 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.0 p -117.18 131.15 56.93 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.708 -1.219 . . . . 25.0 107.708 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.83 131.78 13.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.419 -0.81 . . . . 25.0 108.856 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 52.91 37.41 24.27 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.659 0.985 . . . . 25.0 113.659 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.36 3.45 85.94 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.096 -0.573 . . . . 25.0 114.476 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -118.08 167.2 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.495 -1.668 . . . . 25.0 106.495 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -134.03 157.37 46.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.024 -1.473 . . . . 25.0 107.024 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.1 171.49 43.95 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 109.315 -1.514 . . . . 25.0 109.315 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.85 144.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.703 0.763 . . . . 25.0 110.507 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG13 ' CE2' ' A' ' 26' ' ' PHE . 79.0 t -138.62 134.82 17.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 119.48 6.34 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 115.1 -2.8 . . . . 25.0 110.812 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.31 62.48 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 115.009 0.764 . . . . 25.0 115.009 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.99 -28.58 67.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 25.0 111.281 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -89.39 8.98 27.96 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.718 0.636 . . . . 25.0 112.718 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.23 151.51 39.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.249 0.547 . . . . 25.0 112.394 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -122.93 117.67 26.08 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.75 -0.833 . . . . 25.0 108.75 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 C--N 1.324 -0.512 0 N-CA-C 108.015 -1.106 . . . . 25.0 108.015 175.852 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--O 1.226 -0.178 0 N-CA-C 109.852 -0.425 . . . . 25.0 109.852 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.0 t30 51.23 38.85 22.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.283 -0.871 . . . . 25.0 112.485 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.19 170.5 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 104.327 -2.472 . . . . 25.0 104.327 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.85 153.46 51.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 118.879 0.763 . . . . 25.0 110.54 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -134.67 149.47 50.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.998 -1.001 . . . . 25.0 110.93 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -95.34 131.39 41.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.529 -1.285 . . . . 25.0 107.529 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.41 136.63 42.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.43 -20.59 18.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.441 -0.799 . . . . 25.0 109.64 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -134.03 159.66 40.1 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.636 -0.876 . . . . 25.0 108.636 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 5.6 p-10 -100.36 156.66 17.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.013 0.525 . . . . 25.0 109.663 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -155.34 161.13 41.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.738 -0.665 . . . . 25.0 110.577 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 p -122.72 147.76 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.97 114.91 22.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.778 -0.823 . . . . 25.0 108.778 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -93.2 -8.49 42.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.231 -1.025 . . . . 25.0 108.231 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -129.85 148.14 68.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.53 -12.45 31.46 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 117.211 -1.393 . . . . 25.0 113.248 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -85.89 -14.19 45.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.932 0.872 . . . . 25.0 110.013 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -94.41 147.84 22.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 25.0 109.931 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.08 137.79 34.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.149 0.5 . . . . 25.0 111.233 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -87.37 116.7 25.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.691 -1.226 . . . . 25.0 107.691 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.423 ' CE1' HG13 ' A' ' 57' ' ' VAL . 47.9 p90 -135.07 162.56 32.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 80.0 mtm-85 -131.38 154.01 49.07 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.958 -0.463 . . . . 25.0 111.009 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.455 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.1 pttp -58.89 131.89 52.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 25.0 109.938 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.92 -19.52 53.57 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.426 -0.806 . . . . 25.0 113.374 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -75.35 159.11 31.81 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.275 0.537 . . . . 25.0 110.312 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.5 mm -119.38 127.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.123 -0.695 . . . . 25.0 109.123 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptp -133.83 149.35 51.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.0 0.429 . . . . 25.0 111.767 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.7 m -79.9 136.31 36.63 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.301 -1.0 . . . . 25.0 108.301 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -104.38 120.8 55.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.79 -45.64 10.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 25.0 111.322 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.27 171.84 18.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.459 -1.312 . . . . 25.0 107.459 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.66 154.75 44.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 110.302 -0.259 . . . . 25.0 110.302 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 57.57 35.53 25.85 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 125.032 1.458 . . . . 25.0 109.472 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -70.48 -20.48 62.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.676 -1.602 . . . . 25.0 113.513 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -99.4 0.98 43.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.376 0.608 . . . . 25.0 110.193 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 -6.02 67.48 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 109.787 -1.325 . . . . 25.0 109.787 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.7 mt -88.25 126.81 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.827 -1.546 . . . . 25.0 106.827 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -61.02 131.15 49.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.375 0.607 . . . . 25.0 109.899 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.69 0.66 90.24 Favored Glycine 0 C--O 1.219 -0.788 0 CA-C-O 118.428 -1.207 . . . . 25.0 116.055 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -97.43 110.76 23.25 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.125 1.962 . . . . 25.0 110.93 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.78 144.85 30.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 25.0 111.058 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.95 118.0 23.17 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.3 m -119.86 167.76 11.79 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.479 -0.563 . . . . 25.0 109.479 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -134.0 130.86 38.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.851 0.358 . . . . 25.0 110.238 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 tp -160.75 152.34 19.5 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 106.976 -1.49 . . . . 25.0 106.976 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.2 m80 58.69 24.16 11.86 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.76 82.4 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.665 -0.779 . . . . 25.0 112.295 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -125.13 167.13 15.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.629 -1.619 . . . . 25.0 106.629 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.78 150.55 50.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 105.123 -2.176 . . . . 25.0 105.123 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.1 171.08 43.93 Favored Glycine 0 C--O 1.241 0.532 0 N-CA-C 110.682 -0.967 . . . . 25.0 110.682 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -78.41 143.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 25.0 111.157 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 26' ' ' PHE . 71.0 t -141.44 134.23 14.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.81 118.69 5.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 114.987 -2.875 . . . . 25.0 111.472 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.55 -21.24 66.68 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 114.772 0.669 . . . . 25.0 114.772 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -64.42 -21.81 66.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.571 . . . . 25.0 110.83 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -91.91 9.86 31.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.992 -0.443 . . . . 25.0 111.152 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.1 mt -125.36 155.04 40.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.78 0.432 . . . . 25.0 110.404 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -129.19 117.68 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.497 HD13 ' HB2' ' A' ' 10' ' ' ALA . 9.7 mm . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 109.247 -0.649 . . . . 25.0 109.247 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.8 mt . . . . . 0 C--O 1.217 -0.647 0 N-CA-C 115.14 1.534 . . . . 25.0 115.14 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.9 t30 49.52 41.99 22.06 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.316 1.228 . . . . 25.0 114.316 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.82 166.38 5.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 105.186 -2.153 . . . . 25.0 105.186 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 155.98 45.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.147 0.499 . . . . 25.0 110.108 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.45 144.69 33.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.75 -0.659 . . . . 25.0 112.107 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -90.84 135.45 33.72 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.56 121.27 22.16 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.89 0.744 . . . . 25.0 109.118 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.98 -26.43 27.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.147 -0.479 . . . . 25.0 110.324 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.29 163.87 26.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.0 p-10 -97.21 157.66 15.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.975 -0.75 . . . . 25.0 108.975 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -147.17 131.14 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.936 0.495 . . . . 25.0 110.492 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -100.87 121.97 52.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 101.616 -3.475 . . . . 25.0 101.616 168.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 143.09 48.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.977 -0.749 . . . . 25.0 108.977 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -110.92 -26.29 9.38 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 123.479 0.487 . . . . 25.0 110.058 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.6 t -97.02 146.26 31.0 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 108.366 -0.976 . . . . 25.0 108.366 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.55 -14.95 27.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 116.763 -1.691 . . . . 25.0 113.153 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.47 -15.54 57.6 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 122.969 0.508 . . . . 25.0 110.58 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -93.73 143.46 26.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.318 0.647 . . . . 25.0 111.864 -171.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.15 133.13 35.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 25.0 110.729 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 84.0 6.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.849 0.833 . . . . 25.0 108.947 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.522 ' CE1' HG13 ' A' ' 57' ' ' VAL . 36.3 p90 -93.88 162.99 13.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.636 -0.875 . . . . 25.0 108.636 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -126.26 155.96 41.07 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.252 0.549 . . . . 25.0 110.795 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.7 ptmt -57.95 132.85 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 25.0 109.922 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.05 -21.44 46.01 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-O 119.014 -0.881 . . . . 25.0 114.245 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -74.93 160.59 30.42 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.61 133.51 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.284 -1.006 . . . . 25.0 108.284 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.67 148.68 52.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 25.0 110.889 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -81.0 127.26 32.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -91.15 122.17 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 mt -96.93 -41.09 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.123 -0.944 . . . . 25.0 111.884 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.46 157.69 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -134.29 147.26 50.59 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.013 -1.477 . . . . 25.0 107.013 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 t0 59.29 38.93 23.03 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 123.98 1.848 . . . . 25.0 107.335 -170.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -69.32 -11.8 61.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.322 -1.763 . . . . 25.0 114.626 -169.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -129.77 15.11 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.131 0.491 . . . . 25.0 110.806 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.83 22.26 77.23 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 109.514 -1.434 . . . . 25.0 109.514 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.93 114.06 21.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.788 -1.93 . . . . 25.0 105.788 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -59.52 141.16 55.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.882 0.849 . . . . 25.0 109.456 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.8 38.96 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-O 118.92 -0.933 . . . . 25.0 115.1 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.2 130.78 40.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.474 1.637 . . . . 25.0 110.422 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -119.92 149.39 42.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.593 -0.521 . . . . 25.0 109.593 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.1 tp -89.8 120.46 31.07 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 106.436 -1.69 . . . . 25.0 106.436 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -122.23 155.64 35.45 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 121.026 -0.269 . . . . 25.0 110.568 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 p -111.69 125.81 54.36 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.362 -0.607 . . . . 25.0 109.362 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -152.93 143.62 22.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.834 -1.172 . . . . 25.0 107.834 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.87 26.1 12.86 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.582 0.706 . . . . 25.0 112.73 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.21 9.17 87.18 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.491 -0.861 . . . . 25.0 114.474 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -128.24 163.25 25.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.693 -0.484 . . . . 25.0 109.693 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.05 149.54 38.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.088 -1.079 . . . . 25.0 108.088 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 171.21 42.86 Favored Glycine 0 C--O 1.241 0.561 0 N-CA-C 108.887 -1.685 . . . . 25.0 108.887 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -86.81 146.4 6.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.67 0.748 . . . . 25.0 110.226 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.522 HG13 ' CE1' ' A' ' 26' ' ' PHE . 54.7 t -139.42 133.67 16.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.412 -0.813 . . . . 25.0 109.067 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.99 115.49 4.01 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 115.278 -2.682 . . . . 25.0 110.536 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.6 -17.56 66.96 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 115.051 0.78 . . . . 25.0 115.051 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.16 -17.92 64.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.258 1.029 . . . . 25.0 111.436 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -90.78 5.61 47.61 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.81 -0.556 . . . . 25.0 110.658 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.29 151.58 37.41 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.541 0.525 . . . . 25.0 111.328 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -122.1 117.46 26.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.419 -0.956 . . . . 25.0 108.419 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 107.86 -1.163 . . . . 25.0 107.86 177.294 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.215 -0.724 0 N-CA-C 109.052 -0.721 . . . . 25.0 109.052 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 51.08 45.45 27.79 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.491 1.116 . . . . 25.0 112.906 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.72 163.48 6.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 105.478 -2.045 . . . . 25.0 105.478 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.13 148.57 52.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.235 1.017 . . . . 25.0 111.13 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.64 157.72 44.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.269 -1.332 . . . . 25.0 108.981 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -111.16 134.26 52.89 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.713 -0.847 . . . . 25.0 108.713 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.91 130.44 42.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.44 -26.8 19.66 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.857 -0.794 . . . . 25.0 108.857 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.05 158.33 35.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.545 -1.28 . . . . 25.0 107.545 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.4 p-10 -90.58 160.52 15.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.733 -1.581 . . . . 25.0 106.733 174.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -143.8 168.01 20.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 25.0 110.069 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.56 120.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 101.929 -3.359 . . . . 25.0 101.929 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 122.27 23.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.188 -1.042 . . . . 25.0 108.188 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -104.32 -21.14 13.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.888 -0.596 . . . . 25.0 111.325 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.3 m -102.26 150.35 37.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.83 -21.1 33.61 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 116.204 -2.064 . . . . 25.0 113.369 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.57 -8.02 58.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.177 -0.465 . . . . 25.0 111.477 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -90.05 140.93 29.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.672 0.273 . . . . 25.0 110.601 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mt -85.02 137.88 32.79 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.826 -0.546 . . . . 25.0 110.843 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -91.67 118.46 30.66 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.916 -1.142 . . . . 25.0 107.916 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.67 170.9 14.84 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.079 -0.712 . . . . 25.0 109.079 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.5 158.13 40.78 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 109.175 -0.676 . . . . 25.0 109.175 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.8 pttp -59.27 129.81 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -20.8 42.9 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.507 -0.77 . . . . 25.0 113.293 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.0 149.42 50.27 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 117.599 0.7 . . . . 25.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -114.13 127.68 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.457 -0.942 . . . . 25.0 108.457 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.8 ptp -137.81 147.7 44.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.824 0.345 . . . . 25.0 110.368 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 m -84.38 130.82 34.75 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 107.912 -1.144 . . . . 25.0 107.912 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.22 125.92 47.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 N-CA-C 107.39 -1.337 . . . . 25.0 107.39 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.77 -39.04 7.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.595 -0.729 . . . . 25.0 112.253 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -146.0 161.61 39.7 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.071 -0.715 . . . . 25.0 109.071 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -125.78 150.42 47.78 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 109.139 -0.689 . . . . 25.0 109.139 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 54.2 37.19 26.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.496 1.617 . . . . 25.0 108.889 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -69.55 -12.67 61.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 112.842 -1.981 . . . . 25.0 114.188 -169.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 7.91 17.21 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.219 -0.659 . . . . 25.0 109.219 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.42 -17.42 13.97 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.882 -0.887 . . . . 25.0 110.882 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.98 127.13 31.59 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.343 -1.355 . . . . 25.0 107.343 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.8 135.11 57.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.733 0.778 . . . . 25.0 110.459 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 -0.07 89.02 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-O 119.181 -0.788 . . . . 25.0 114.805 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -97.95 104.76 16.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.221 1.51 . . . . 25.0 110.534 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -94.82 147.59 23.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 25.0 111.371 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -85.99 117.27 24.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.948 -1.871 . . . . 25.0 105.948 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.7 m -115.89 162.14 17.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -122.64 124.94 44.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.519 -0.919 . . . . 25.0 108.519 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 tp -155.65 139.81 16.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.989 -0.745 . . . . 25.0 108.989 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 54.48 38.16 29.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.943 0.877 . . . . 25.0 113.049 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.07 0.7 77.39 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 115.129 0.812 . . . . 25.0 115.129 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -119.25 154.41 33.49 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.135 -0.691 . . . . 25.0 109.135 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -110.35 148.12 32.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 104.441 -2.429 . . . . 25.0 104.441 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.72 168.82 41.64 Favored Glycine 0 C--O 1.243 0.706 0 N-CA-C 111.39 -0.684 . . . . 25.0 111.39 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -78.26 142.91 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.877 0.846 . . . . 25.0 109.964 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.17 134.57 14.61 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.39 114.69 4.01 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 114.659 -3.094 . . . . 25.0 112.319 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 -23.07 63.49 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 114.263 0.465 . . . . 25.0 114.263 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.0 -25.46 67.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.267 -0.549 . . . . 25.0 111.206 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -92.19 8.34 38.5 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 112.266 0.469 . . . . 25.0 112.266 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -116.71 149.99 38.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 25.0 112.326 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.47 118.77 28.18 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.408 -0.59 . . . . 25.0 109.408 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.1 mm . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 108.634 -0.876 . . . . 25.0 108.634 177.672 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--O 1.224 -0.247 0 CA-C-O 120.627 0.251 . . . . 25.0 111.44 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.7 t30 49.33 46.93 22.85 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.6 m -109.81 169.98 3.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.97 158.76 43.62 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.382 -0.599 . . . . 25.0 109.382 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 149.64 34.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.746 -0.661 . . . . 25.0 112.091 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.18 134.38 37.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.964 -0.562 . . . . 25.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.78 132.0 42.14 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.209 0.528 . . . . 25.0 109.676 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 mt -96.9 -23.95 16.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.636 -0.711 . . . . 25.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.06 161.45 26.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.274 -1.38 . . . . 25.0 107.274 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.567 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.4 p-10 -102.16 162.37 12.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 25.0 109.269 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -151.96 159.11 43.86 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.507 0.504 . . . . 25.0 111.163 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.62 133.2 68.83 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 110.6 7.03 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -78.46 -35.4 46.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.012 -1.449 . . . . 25.0 107.708 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -119.36 154.55 54.08 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 25.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.5 -15.94 34.37 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.661 -1.093 . . . . 25.0 113.697 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.79 -10.2 58.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 25.0 110.698 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -94.29 144.16 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.039 -0.726 . . . . 25.0 109.039 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.46 135.24 33.57 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.774 -0.77 . . . . 25.0 110.21 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -85.27 125.08 32.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.842 -1.91 . . . . 25.0 105.842 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -148.81 163.72 36.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.028 -1.471 . . . . 25.0 107.028 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -129.52 159.03 37.59 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.224 0.535 . . . . 25.0 110.803 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.9 pttp -59.2 132.5 54.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.816 -1.179 . . . . 25.0 107.816 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.99 -23.34 32.52 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.783 -0.644 . . . . 25.0 113.06 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.35 163.28 26.58 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.073 0.437 . . . . 25.0 110.207 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.01 132.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -133.4 153.5 51.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 25.0 110.585 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -88.18 131.02 34.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.289 -0.634 . . . . 25.0 109.289 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.3 t -96.06 124.18 48.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.09 -42.2 8.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.771 -0.649 . . . . 25.0 112.096 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.38 159.75 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 25.0 109.009 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -129.91 151.28 50.65 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t0 58.83 39.6 23.83 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.144 1.45 . . . . 25.0 107.973 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -71.29 -13.8 62.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.854 -1.521 . . . . 25.0 112.859 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -119.46 4.88 11.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.961 0.726 . . . . 25.0 112.961 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.37 20.34 69.58 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 110.086 -1.206 . . . . 25.0 110.086 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.57 113.76 15.23 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.337 -1.727 . . . . 25.0 106.337 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -64.84 141.78 58.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.483 -1.302 . . . . 25.0 107.483 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.57 -15.43 63.33 Favored Glycine 0 C--O 1.209 -1.406 0 CA-C-O 118.441 -1.199 . . . . 25.0 113.377 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -98.57 125.23 43.74 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.658 1.729 . . . . 25.0 109.798 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -119.61 146.96 45.06 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.941 -0.392 . . . . 25.0 109.941 -172.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.1 tp -85.43 116.2 23.6 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.624 -1.251 . . . . 25.0 107.624 176.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -115.31 167.19 11.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.641 0.258 . . . . 25.0 110.652 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 m -131.62 132.94 44.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.448 -0.575 . . . . 25.0 109.448 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 tp -160.24 146.29 15.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 58.5 24.4 11.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.004 1.113 . . . . 25.0 114.004 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.44 4.66 87.68 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.909 -0.662 . . . . 25.0 113.228 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -122.83 163.89 19.42 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 122.947 0.499 . . . . 25.0 109.669 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -118.1 154.55 31.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.942 -1.873 . . . . 25.0 105.942 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.6 162.66 31.33 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 111.779 -0.528 . . . . 25.0 111.779 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.4 pt -78.12 145.64 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.557 . . . . 25.0 110.682 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -144.84 133.69 11.07 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 108.492 -0.929 . . . . 25.0 108.492 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.6 121.21 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 115.534 -2.511 . . . . 25.0 112.02 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.62 -22.36 65.91 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-N 115.342 -0.845 . . . . 25.0 114.188 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -70.47 -2.4 13.82 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.089 -0.654 . . . . 25.0 111.675 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.0 11.23 17.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.917 -0.401 . . . . 25.0 109.917 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.95 152.63 38.29 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.367 0.417 . . . . 25.0 111.078 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -117.88 117.81 30.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 N--CA 1.471 0.581 0 O-C-N 123.821 0.7 . . . . 25.0 109.254 177.088 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 120.544 0.211 . . . . 25.0 111.564 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 51.44 43.78 29.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.4 1.259 . . . . 25.0 114.4 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.63 164.34 13.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 103.025 -2.954 . . . . 25.0 103.025 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.61 160.85 37.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.714 0.688 . . . . 25.0 110.386 -174.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.45 163.24 33.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.448 -0.796 . . . . 25.0 110.887 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.58 134.4 52.43 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.042 -1.466 . . . . 25.0 107.042 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.87 136.11 43.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.721 0.772 . . . . 25.0 109.231 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.82 -24.62 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.489 -0.778 . . . . 25.0 109.63 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -128.98 162.75 26.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.818 -1.178 . . . . 25.0 107.818 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.17 156.69 17.06 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -156.49 135.77 12.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.357 0.503 . . . . 25.0 112.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -100.64 146.92 8.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.98 -1.859 . . . . 25.0 105.98 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.93 133.54 37.26 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.255 -0.276 . . . . 25.0 110.255 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.55 -7.17 23.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.666 0.745 . . . . 25.0 109.117 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.7 t -129.46 148.65 70.18 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.631 -0.713 . . . . 25.0 109.347 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.32 -16.84 35.3 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.716 -1.722 . . . . 25.0 113.3 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -82.17 -15.56 52.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.471 0.653 . . . . 25.0 110.674 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -92.5 140.85 29.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.628 -0.879 . . . . 25.0 108.628 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 132.56 36.04 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.123 -0.631 . . . . 25.0 110.044 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p -84.53 133.08 34.47 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.394 -2.076 . . . . 25.0 105.394 171.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.413 ' CE1' HG13 ' A' ' 57' ' ' VAL . 45.8 p90 -150.64 166.12 31.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.933 -0.766 . . . . 25.0 108.933 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -127.04 152.99 46.53 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.872 -0.518 . . . . 25.0 110.696 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -59.49 138.37 57.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.651 -0.704 . . . . 25.0 109.279 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.5 -16.02 57.27 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.503 -0.771 . . . . 25.0 114.035 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -76.89 159.76 29.76 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 117.387 0.593 . . . . 25.0 109.93 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.51 130.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.983 0.513 . . . . 25.0 109.638 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.12 147.07 45.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.972 0.415 . . . . 25.0 110.728 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -85.66 130.74 34.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.6 t -88.83 116.41 30.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.809 -1.923 . . . . 25.0 105.809 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.24 -37.76 13.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.309 -0.859 . . . . 25.0 111.147 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -147.43 156.18 42.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.597 -1.26 . . . . 25.0 107.597 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -124.51 147.43 48.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.621 -0.511 . . . . 25.0 109.621 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 57.25 38.21 28.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.745 1.736 . . . . 25.0 107.618 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.5 t -70.56 -11.4 60.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 112.283 -2.235 . . . . 25.0 115.699 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.06 10.07 13.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.145 0.497 . . . . 25.0 110.028 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.62 66.79 Favored Glycine 0 C--O 1.225 -0.425 0 N-CA-C 109.688 -1.365 . . . . 25.0 109.688 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.69 116.74 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.643 -1.614 . . . . 25.0 106.643 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.42 133.82 55.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.795 -0.639 . . . . 25.0 109.457 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.29 -0.43 85.58 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.506 0.962 . . . . 25.0 115.506 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -102.92 116.57 32.8 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.127 1.464 . . . . 25.0 110.538 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -108.59 145.0 35.54 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.208 -0.308 . . . . 25.0 111.09 -174.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.52 120.98 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.473 -1.677 . . . . 25.0 106.473 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.2 m -119.86 165.22 14.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.697 -0.483 . . . . 25.0 109.697 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 p -122.95 131.66 53.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.059 0.457 . . . . 25.0 110.027 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 tp -160.27 148.61 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.664 -1.235 . . . . 25.0 107.664 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 59.64 23.25 12.01 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.272 0.841 . . . . 25.0 113.272 176.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.07 81.08 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.842 -0.694 . . . . 25.0 112.686 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -130.76 164.21 25.6 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.48 -0.933 . . . . 25.0 108.48 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -117.77 152.91 34.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.941 -1.874 . . . . 25.0 105.941 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.04 163.98 36.44 Favored Glycine 0 C--O 1.239 0.462 0 N-CA-C 110.387 -1.085 . . . . 25.0 110.387 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.8 pt -79.43 145.19 9.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.611 . . . . 25.0 110.062 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.413 HG13 ' CE1' ' A' ' 26' ' ' PHE . 71.4 t -140.74 133.7 14.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 107.64 -1.244 . . . . 25.0 107.64 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.41 121.57 8.11 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 114.667 -3.089 . . . . 25.0 111.212 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.16 -25.67 62.59 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 116.015 -0.539 . . . . 25.0 114.263 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -65.48 -18.52 65.38 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.23 -0.57 . . . . 25.0 112.374 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.84 8.0 41.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.888 -0.507 . . . . 25.0 111.232 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.0 mt -122.41 156.79 33.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.903 0.383 . . . . 25.0 110.786 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -131.62 120.07 22.32 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.1 mm . . . . . 0 N--CA 1.469 0.519 0 O-C-N 123.67 0.606 . . . . 25.0 110.358 -179.071 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.892 1.441 . . . . 25.0 114.892 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.4 43.26 26.88 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.042 1.497 . . . . 25.0 115.042 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.2 163.63 8.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 104.297 -2.483 . . . . 25.0 104.297 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.17 154.06 47.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 118.891 0.769 . . . . 25.0 110.63 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.91 143.79 34.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.657 -0.701 . . . . 25.0 111.36 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -95.19 132.42 40.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.083 -0.71 . . . . 25.0 109.083 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 134.88 41.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.392 0.615 . . . . 25.0 109.417 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.27 -25.1 17.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.578 -0.737 . . . . 25.0 109.488 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -131.22 157.65 42.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.512 -1.292 . . . . 25.0 107.512 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -95.35 161.65 14.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.667 -0.494 . . . . 25.0 109.667 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -152.92 149.84 28.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -124.1 128.74 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 103.773 -2.677 . . . . 25.0 103.773 173.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.91 136.09 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.913 -0.585 . . . . 25.0 109.923 -176.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -102.94 -12.9 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.35 155.66 53.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 25.0 110.312 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.23 -19.31 20.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 117.71 -1.06 . . . . 25.0 114.418 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -86.37 -15.03 41.71 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.985 0.898 . . . . 25.0 109.591 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -89.89 145.6 25.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.418 -0.81 . . . . 25.0 108.897 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.44 135.79 40.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.31 138.67 32.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 170.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.442 ' CE1' HG13 ' A' ' 57' ' ' VAL . 42.3 p90 -157.4 164.01 37.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -124.15 153.06 42.07 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.618 -0.676 . . . . 25.0 112.197 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.543 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 46.2 pttt -58.3 132.43 53.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.543 -1.28 . . . . 25.0 107.543 175.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.21 -14.52 65.15 Favored Glycine 0 C--O 1.226 -0.348 0 CA-C-O 118.79 -1.005 . . . . 25.0 114.089 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.53 163.02 20.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.686 0.743 . . . . 25.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.49 132.11 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.026 -0.731 . . . . 25.0 109.026 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -129.13 151.37 49.88 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 116.055 -0.521 . . . . 25.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.1 m -85.42 129.08 34.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.259 -1.015 . . . . 25.0 108.259 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 83.7 t -91.87 119.62 39.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.684 -1.598 . . . . 25.0 106.684 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -97.87 -40.45 8.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.303 -0.862 . . . . 25.0 111.129 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -148.03 164.68 33.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -130.56 152.88 49.46 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 56.57 37.17 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.884 1.365 . . . . 25.0 108.166 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -69.34 -17.39 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 113.631 -1.622 . . . . 25.0 112.857 -169.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.17 6.48 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.721 -0.672 . . . . 25.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 -8.22 67.42 Favored Glycine 0 C--O 1.228 -0.257 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt -83.63 117.27 23.07 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.713 . . . . 25.0 109.076 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -60.39 128.27 35.88 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 25.0 109.412 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.22 -1.3 82.41 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 115.461 0.944 . . . . 25.0 115.461 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -100.63 122.59 43.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.926 1.363 . . . . 25.0 109.247 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -112.49 145.42 40.26 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.993 -0.442 . . . . 25.0 111.162 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.9 tp -83.57 115.07 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.545 -1.65 . . . . 25.0 106.545 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.6 m -122.45 164.84 17.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.536 0.208 . . . . 25.0 110.857 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.5 p -123.18 131.36 53.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -157.93 139.71 13.93 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 57.45 32.98 22.64 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.732 0.777 . . . . 25.0 112.632 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.08 4.47 63.18 Favored Glycine 0 CA--C 1.522 0.491 0 O-C-N 121.567 -0.708 . . . . 25.0 113.427 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.73 164.1 13.77 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -132.19 146.0 51.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 104.22 -2.511 . . . . 25.0 104.22 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.62 177.87 48.55 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 111.11 -0.796 . . . . 25.0 111.11 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.34 143.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.387 0.613 . . . . 25.0 110.299 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 26' ' ' PHE . 72.7 t -139.33 134.18 16.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.75 118.54 5.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 115.015 -2.857 . . . . 25.0 110.749 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -23.92 70.78 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.706 -0.679 . . . . 25.0 113.988 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.59 -16.47 64.19 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.289 -0.536 . . . . 25.0 111.62 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -90.06 1.14 56.68 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.93 -0.481 . . . . 25.0 110.918 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.58 150.64 36.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.306 0.574 . . . . 25.0 111.343 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -121.96 113.86 20.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.331 -0.988 . . . . 25.0 108.331 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.754 0.311 . . . . 25.0 110.848 -177.138 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 114.699 1.37 . . . . 25.0 114.699 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.06 30.24 19.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.816 1.413 . . . . 25.0 114.816 173.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -115.94 164.01 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.175 -1.787 . . . . 25.0 106.175 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.95 164.11 23.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.28 145.21 30.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 25.0 110.857 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -95.05 134.49 37.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.31 136.55 40.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.274 0.559 . . . . 25.0 109.616 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.26 -26.22 17.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 25.0 110.071 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -130.24 162.78 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.55 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.9 p-10 -101.71 157.07 17.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.888 -0.412 . . . . 25.0 109.888 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -157.87 122.78 4.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.575 -0.739 . . . . 25.0 110.099 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 138.93 19.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.13 148.97 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -111.22 -20.41 12.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.639 -0.504 . . . . 25.0 109.639 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -105.09 152.46 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.49 -0.323 . . . . 25.0 110.265 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.6 -20.91 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 117.1 -1.466 . . . . 25.0 114.013 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.35 -4.79 59.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.536 0.684 . . . . 25.0 110.599 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -99.26 141.73 31.66 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.18 -1.044 . . . . 25.0 108.18 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.97 134.14 35.06 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.674 -0.641 . . . . 25.0 111.724 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.8 m -84.16 119.44 25.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.526 -1.657 . . . . 25.0 106.526 170.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -136.16 161.62 35.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.55 -0.537 . . . . 25.0 109.55 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -123.43 153.74 40.02 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.062 0.458 . . . . 25.0 110.079 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.55 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 14.0 ptmt -59.6 133.74 56.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 -10.81 72.17 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-O 119.102 -0.832 . . . . 25.0 114.302 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.65 158.29 25.68 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.916 0.858 . . . . 25.0 109.207 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.86 129.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.453 -0.573 . . . . 25.0 109.453 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -130.76 153.23 49.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 25.0 109.899 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 m -87.53 132.32 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.68 -1.229 . . . . 25.0 107.68 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.12 125.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -92.95 -47.78 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.04 -0.527 . . . . 25.0 111.183 -175.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.74 171.92 18.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -121.9 155.0 36.38 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.234 -0.654 . . . . 25.0 109.234 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 57.51 38.6 28.1 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.64 1.213 . . . . 25.0 109.924 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -69.88 -18.59 63.42 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.067 -1.424 . . . . 25.0 114.374 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -110.97 9.73 22.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.265 -0.643 . . . . 25.0 109.265 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.58 1.84 89.26 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.445 -1.062 . . . . 25.0 110.445 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.38 122.36 35.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.144 -1.058 . . . . 25.0 108.144 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -61.45 129.36 40.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.419 0.628 . . . . 25.0 109.98 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 0.45 87.96 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -101.58 108.43 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 118.827 1.313 . . . . 25.0 110.227 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.718 -0.475 . . . . 25.0 109.718 -173.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -82.41 120.1 25.02 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.671 -1.974 . . . . 25.0 105.671 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.71 160.68 24.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 25.0 109.236 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -121.47 132.53 54.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.435 0.636 . . . . 25.0 109.746 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.22 141.38 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.157 -0.928 . . . . 25.0 108.617 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 58.79 26.75 15.12 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.677 0.992 . . . . 25.0 113.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.74 6.06 89.61 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 121.097 -0.573 . . . . 25.0 113.293 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -122.11 167.33 13.28 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.05 -1.463 . . . . 25.0 107.05 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -135.41 154.32 51.5 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.777 -1.564 . . . . 25.0 106.777 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.7 171.33 44.27 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.856 -0.898 . . . . 25.0 110.856 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.5 143.3 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.506 0.67 . . . . 25.0 110.587 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.4 t -141.9 132.42 12.86 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.255 -1.017 . . . . 25.0 108.255 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.77 119.52 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 115.178 -2.748 . . . . 25.0 111.582 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.45 -21.77 62.77 Favored Glycine 0 C--O 1.221 -0.678 0 CA-C-N 115.888 -0.597 . . . . 25.0 114.473 -175.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -61.25 -28.12 68.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.267 -0.549 . . . . 25.0 111.37 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -89.15 6.28 40.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.869 0.322 . . . . 25.0 111.869 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.73 143.97 44.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.6 . . . . 25.0 111.913 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -117.75 117.69 30.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm . . . . . 0 C--O 1.24 0.563 0 CA-C-O 121.202 0.525 . . . . 25.0 110.157 -177.517 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.826 -0.435 . . . . 25.0 109.826 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 t30 56.17 36.83 28.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.464 -0.789 . . . . 25.0 112.284 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.16 129.75 55.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 106.728 -1.582 . . . . 25.0 106.728 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -100.47 153.85 19.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.738 0.78 . . . . 25.0 110.101 -179.106 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.23 152.13 42.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.826 -1.079 . . . . 25.0 109.948 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -103.49 135.09 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.558 -0.904 . . . . 25.0 108.558 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 135.54 43.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.361 0.601 . . . . 25.0 110.169 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.44 -27.19 17.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.5 -0.773 . . . . 25.0 110.68 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.51 158.26 33.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.35 -1.722 . . . . 25.0 106.35 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 12.0 p-10 -97.95 146.16 25.76 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.296 -1.372 . . . . 25.0 107.296 174.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -144.6 129.99 18.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.776 -0.647 . . . . 25.0 110.741 -174.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -103.91 121.3 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.403 -1.703 . . . . 25.0 106.403 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.66 35.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.911 -0.586 . . . . 25.0 110.108 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -99.55 -17.26 17.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.158 0.504 . . . . 25.0 109.941 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 143.32 40.61 Favored Pre-proline 0 CA--C 1.513 -0.455 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 -15.61 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 116.937 -1.576 . . . . 25.0 114.023 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -94.48 -9.0 36.83 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.315 0.579 . . . . 25.0 110.964 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.62 140.82 30.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.776 -0.824 . . . . 25.0 108.776 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.38 132.3 34.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.432 0.634 . . . . 25.0 111.169 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -86.93 136.32 32.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.14 -1.8 . . . . 25.0 106.14 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -156.55 166.78 32.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.978 0.418 . . . . 25.0 110.441 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -121.44 154.88 35.97 Favored 'General case' 0 C--O 1.213 -0.868 0 O-C-N 121.909 -0.495 . . . . 25.0 110.683 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.3 pttt -60.56 131.79 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 174.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.91 -20.57 49.81 Favored Glycine 0 C--O 1.224 -0.515 0 CA-C-N 115.903 -0.589 . . . . 25.0 113.026 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -71.49 154.19 41.67 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.326 0.563 . . . . 25.0 110.117 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -117.47 126.96 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.109 -0.7 . . . . 25.0 109.109 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.7 ptp -134.89 157.73 46.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 31.6 m -107.03 126.75 52.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.233 -0.284 . . . . 25.0 110.233 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -79.95 123.55 36.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.434 -1.321 . . . . 25.0 107.434 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.92 -46.62 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.92 -0.771 . . . . 25.0 108.92 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.26 169.25 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.165 -1.42 . . . . 25.0 107.165 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -124.16 157.14 35.39 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 110.259 -0.274 . . . . 25.0 110.259 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 56.53 41.42 28.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.74 1.275 . . . . 25.0 108.681 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.47 -16.26 62.9 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.704 1.372 . . . . 25.0 114.704 -167.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -111.94 9.0 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.509 -0.552 . . . . 25.0 109.509 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.11 -9.78 59.83 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 110.864 -0.894 . . . . 25.0 110.864 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.92 124.53 28.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -61.08 131.32 50.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.449 0.642 . . . . 25.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.45 89.58 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 118.566 -1.13 . . . . 25.0 115.482 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -99.02 105.44 17.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.755 1.777 . . . . 25.0 109.817 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -102.34 143.37 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.038 -0.528 . . . . 25.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.0 tp -83.66 112.78 20.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.673 -1.603 . . . . 25.0 106.673 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 67.3 m -112.08 163.14 14.63 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.555 -0.906 . . . . 25.0 108.555 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.2 p -123.74 130.7 53.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 25.0 109.048 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 tp -162.26 146.56 12.21 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 57.43 30.74 19.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.785 1.032 . . . . 25.0 113.785 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.56 11.44 82.81 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 120.702 -0.761 . . . . 25.0 113.161 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -124.55 165.51 17.71 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.44 -1.318 . . . . 25.0 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.36 152.61 47.97 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 103.448 -2.797 . . . . 25.0 103.448 167.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.59 167.09 38.82 Favored Glycine 0 C--O 1.24 0.508 0 N-CA-C 110.262 -1.135 . . . . 25.0 110.262 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.9 pt -75.48 143.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.548 0.69 . . . . 25.0 110.509 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -141.62 132.27 13.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.959 -1.126 . . . . 25.0 107.959 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.07 120.29 6.73 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 115.185 -2.743 . . . . 25.0 111.737 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.38 -25.8 60.97 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-N 115.742 -0.663 . . . . 25.0 114.397 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -63.42 -22.94 67.18 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.191 0.52 . . . . 25.0 111.646 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -91.56 5.5 49.33 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.757 -0.59 . . . . 25.0 111.667 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.5 mt -115.4 156.28 25.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 25.0 111.458 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -122.8 117.7 26.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.114 . . . . 25.0 107.991 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 178.93 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 113.949 1.092 . . . . 25.0 113.949 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.88 38.51 29.47 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.89 0.853 . . . . 25.0 111.967 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.0 t -107.52 149.09 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 104.527 -2.398 . . . . 25.0 104.527 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.69 153.28 50.93 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.251 -1.018 . . . . 25.0 108.251 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.57 149.68 36.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.912 -0.585 . . . . 25.0 111.2 -172.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -96.3 136.44 36.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.81 134.18 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.203 0.525 . . . . 25.0 109.717 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.86 -32.73 15.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.351 0.596 . . . . 25.0 109.768 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.86 164.7 17.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.528 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.7 p-10 -98.9 163.06 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -151.62 144.66 24.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.181 -0.463 . . . . 25.0 111.626 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.14 125.33 73.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.214 -2.884 . . . . 25.0 103.214 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.03 146.22 41.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 25.0 110.147 -175.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -31.29 7.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.465 -0.568 . . . . 25.0 109.465 173.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -94.93 150.34 37.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.58 -16.96 26.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.734 -1.044 . . . . 25.0 113.303 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.94 -9.5 58.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 25.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.18 144.53 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.17 0.588 . . . . 25.0 110.236 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mt -94.9 134.55 37.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.56 0.695 . . . . 25.0 112.645 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.3 m -88.3 140.71 29.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.289 -1.374 . . . . 25.0 107.289 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.42 ' CE2' HG13 ' A' ' 57' ' ' VAL . 40.4 p90 -160.19 167.17 28.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -118.56 156.51 29.02 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.635 -0.665 . . . . 25.0 110.911 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 11.0 ptmm? -59.58 129.68 43.13 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.494 -0.928 . . . . 25.0 108.494 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.05 67.83 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 115.836 -0.62 . . . . 25.0 113.937 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.36 161.24 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.892 -0.781 . . . . 25.0 108.892 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.07 134.05 65.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.353 -0.98 . . . . 25.0 108.353 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -135.48 152.82 51.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.669 -0.696 . . . . 25.0 110.614 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.7 m -89.04 131.9 35.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 25.0 108.031 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.59 120.6 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.748 -1.575 . . . . 25.0 106.748 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.4 mt -92.37 -42.35 9.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 25.0 110.065 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.98 166.23 29.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.984 -0.747 . . . . 25.0 108.984 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -133.38 152.76 51.95 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 117.936 0.334 . . . . 25.0 110.236 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 57.32 36.36 27.15 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.95 1.357 . . . . 25.0 107.766 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.48 -7.1 40.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.17 -1.832 . . . . 25.0 115.644 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -126.87 12.36 7.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.82 -5.78 68.84 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.712 -0.955 . . . . 25.0 110.712 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.99 120.98 25.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.329 -0.989 . . . . 25.0 108.329 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -61.88 127.43 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.706 -0.679 . . . . 25.0 109.939 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.58 1.5 90.1 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.754 1.062 . . . . 25.0 115.754 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -98.68 119.09 36.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.301 1.551 . . . . 25.0 109.898 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -110.0 143.8 39.47 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.185 -0.322 . . . . 25.0 111.304 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.7 tp -81.57 111.59 18.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.614 -1.995 . . . . 25.0 105.614 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.2 m -115.34 164.15 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.834 -0.802 . . . . 25.0 108.834 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -139.26 130.7 27.03 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.758 0.313 . . . . 25.0 111.738 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.21 152.16 25.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 25.0 109.644 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.4 t60 53.07 36.45 22.25 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.83 7.24 74.86 Favored Glycine 0 C--O 1.226 -0.394 0 N-CA-C 114.874 0.71 . . . . 25.0 114.874 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -120.82 156.57 31.64 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.096 -1.446 . . . . 25.0 107.096 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -134.34 145.74 49.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.765 -1.939 . . . . 25.0 105.765 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.61 44.2 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.743 -0.943 . . . . 25.0 110.743 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 pt -76.29 143.89 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.614 0.721 . . . . 25.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 26' ' ' PHE . 71.8 t -141.91 133.34 13.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.35 119.15 6.13 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 114.974 -2.884 . . . . 25.0 110.984 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.09 -18.02 66.41 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.703 -0.681 . . . . 25.0 113.781 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.07 -28.65 69.76 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.513 -0.404 . . . . 25.0 110.883 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -87.7 7.17 31.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.074 0.398 . . . . 25.0 112.074 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -118.92 147.91 43.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.111 0.481 . . . . 25.0 111.091 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -116.21 117.59 30.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.582 -0.895 . . . . 25.0 108.582 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm . . . . . 0 C--O 1.242 0.686 0 C-N-CA 123.417 0.687 . . . . 25.0 110.103 178.308 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 mt . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 113.109 0.781 . . . . 25.0 113.109 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 54.69 24.53 5.62 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.361 1.245 . . . . 25.0 114.361 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.63 174.28 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 106.911 -1.514 . . . . 25.0 106.911 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.22 152.38 49.81 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.765 -0.584 . . . . 25.0 110.55 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.419 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -138.59 146.67 42.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 25.0 111.628 -175.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -95.17 134.57 37.76 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.35 135.03 39.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.529 0.681 . . . . 25.0 110.676 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.0 mt -94.92 -23.05 17.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.12 -0.945 . . . . 25.0 109.531 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -127.61 159.04 35.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -99.39 145.35 27.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.531 -0.544 . . . . 25.0 109.531 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.58 109.89 3.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 25.0 110.299 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.52 138.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 105.335 -2.098 . . . . 25.0 105.335 175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.86 122.38 24.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -101.27 -17.66 16.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.969 -0.752 . . . . 25.0 108.969 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -109.63 151.59 42.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.99 -0.744 . . . . 25.0 108.99 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.48 -20.91 20.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.015 -1.523 . . . . 25.0 114.467 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -84.91 -9.54 58.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.693 0.759 . . . . 25.0 110.601 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -88.51 140.81 29.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.36 -0.836 . . . . 25.0 110.35 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.39 134.45 34.33 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.497 -0.557 . . . . 25.0 109.497 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -95.18 131.51 41.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.44 -0.578 . . . . 25.0 109.44 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -157.14 168.03 28.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.869 0.366 . . . . 25.0 110.03 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -127.14 158.37 37.22 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.807 -0.558 . . . . 25.0 110.33 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.503 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 13.7 pttt -60.86 133.67 56.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.418 -1.327 . . . . 25.0 107.418 174.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.28 55.24 Favored Glycine 0 C--O 1.223 -0.541 0 CA-C-O 119.357 -0.69 . . . . 25.0 113.358 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -81.57 163.02 22.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.218 0.509 . . . . 25.0 109.668 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.8 132.01 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.459 -0.571 . . . . 25.0 109.459 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.86 156.35 41.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.064 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -84.27 133.56 34.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.91 121.81 49.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 25.0 106.462 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.71 -49.62 5.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.237 -0.892 . . . . 25.0 111.695 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.19 162.98 34.19 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.622 0.576 . . . . 25.0 109.564 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -132.17 151.58 51.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.518 -0.919 . . . . 25.0 108.518 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t0 56.84 40.29 29.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.325 1.536 . . . . 25.0 107.663 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 t -70.58 -6.12 34.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.784 -1.553 . . . . 25.0 114.202 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -136.16 10.93 3.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.969 0.729 . . . . 25.0 112.969 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.79 20.31 73.93 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 109.201 -1.56 . . . . 25.0 109.201 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.5 mt -122.32 109.92 15.03 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 105.557 -2.016 . . . . 25.0 105.557 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -68.65 149.07 49.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.645 -1.242 . . . . 25.0 107.645 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.18 -14.21 58.0 Favored Glycine 0 C--O 1.222 -0.611 0 CA-C-O 119.068 -0.851 . . . . 25.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -97.94 134.22 41.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.678 1.239 . . . . 25.0 109.782 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -121.13 147.58 45.37 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.034 -0.728 . . . . 25.0 109.034 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 tp -85.89 115.48 23.54 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 105.907 -1.886 . . . . 25.0 105.907 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.3 m -118.08 160.63 21.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.391 -0.226 . . . . 25.0 110.391 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -131.18 132.2 44.56 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.137 0.494 . . . . 25.0 111.699 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tt -150.49 141.17 22.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.058 -0.974 . . . . 25.0 108.682 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 56.86 33.37 23.02 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.159 0.8 . . . . 25.0 113.159 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.1 10.75 81.49 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.731 -0.747 . . . . 25.0 113.686 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -118.45 162.76 17.8 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.37 149.48 41.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.466 -1.309 . . . . 25.0 107.466 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.64 -179.14 43.23 Favored Glycine 0 C--O 1.239 0.435 0 N-CA-C 110.97 -0.852 . . . . 25.0 110.97 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.14 146.14 7.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.345 0.593 . . . . 25.0 112.244 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -142.72 134.66 13.2 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.397 -0.819 . . . . 25.0 108.813 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.36 115.89 4.38 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 114.64 -3.107 . . . . 25.0 110.178 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.59 -17.01 66.29 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.277 0.471 . . . . 25.0 114.277 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -70.24 -4.13 20.34 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.415 -0.462 . . . . 25.0 111.661 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -104.69 10.28 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.226 -0.296 . . . . 25.0 110.629 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.4 153.27 40.62 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.88 0.326 . . . . 25.0 111.88 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.24 117.68 24.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.419 HD13 ' HB2' ' A' ' 10' ' ' ALA . 25.4 mm . . . . . 0 N--CA 1.476 0.825 0 C-N-CA 122.778 0.431 . . . . 25.0 111.359 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 114.849 1.425 . . . . 25.0 114.849 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t30 50.75 45.24 27.39 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.76 1.393 . . . . 25.0 114.76 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.65 147.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.169 -1.789 . . . . 25.0 106.169 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.66 162.84 13.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.566 0.698 . . . . 25.0 110.136 -174.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.47 138.7 29.44 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.394 -0.821 . . . . 25.0 109.92 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -95.28 134.99 37.44 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.648 -0.871 . . . . 25.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.25 134.59 42.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.247 0.546 . . . . 25.0 110.548 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.06 -30.56 15.96 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.646 . . . . 25.0 109.352 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -126.44 163.66 22.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.219 -1.4 . . . . 25.0 107.219 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.8 p-10 -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.665 -0.865 . . . . 25.0 108.665 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -151.46 129.87 12.11 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.697 0.629 . . . . 25.0 112.697 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -98.62 128.15 50.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.174 -2.899 . . . . 25.0 103.174 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.59 117.49 9.6 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.819 -0.808 . . . . 25.0 108.819 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -95.1 -13.34 25.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.536 0.684 . . . . 25.0 109.286 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 m -120.41 150.7 52.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.81 -20.43 26.14 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 117.636 -1.109 . . . . 25.0 114.487 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -82.13 -15.45 53.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.763 0.792 . . . . 25.0 109.801 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -84.05 147.18 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.48 -0.782 . . . . 25.0 110.517 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.432 HD22 ' H ' ' A' ' 55' ' ' GLY . 4.9 tp -97.92 132.52 43.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.95 0.405 . . . . 25.0 109.941 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -89.34 143.21 27.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.991 -1.115 . . . . 25.0 107.991 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 57' ' ' VAL . 38.8 p90 -160.93 170.17 21.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.151 -1.796 . . . . 25.0 106.151 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtm-85 -124.26 159.29 30.55 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.928 -0.483 . . . . 25.0 111.087 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 10.6 ptmm? -59.09 133.44 56.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.042 -0.725 . . . . 25.0 109.042 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.1 -11.39 72.07 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.57 -0.741 . . . . 25.0 113.635 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -80.93 161.31 24.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.37 134.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.965 -0.754 . . . . 25.0 108.965 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.0 ptp -130.61 158.71 39.27 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 m -97.86 125.43 42.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.241 -0.652 . . . . 25.0 109.241 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.5 t -82.62 127.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.478 -1.305 . . . . 25.0 107.478 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -102.34 -41.09 6.46 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 25.0 110.454 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -146.67 164.58 32.23 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.772 -1.196 . . . . 25.0 107.772 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -132.69 152.39 51.72 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.505 -1.294 . . . . 25.0 107.505 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 31.04 20.81 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 123.052 1.406 . . . . 25.0 108.42 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.1 t -70.5 -20.43 62.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 113.311 -1.768 . . . . 25.0 114.701 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -102.85 3.82 37.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.29 0.567 . . . . 25.0 109.873 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.51 85.81 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 109.052 -1.619 . . . . 25.0 109.052 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.0 mt -111.26 122.8 48.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.394 -1.706 . . . . 25.0 106.394 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.7 132.69 54.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.695 0.759 . . . . 25.0 110.08 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -1.11 89.22 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-O 118.767 -1.018 . . . . 25.0 115.506 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.359 1.58 . . . . 25.0 108.712 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -110.23 142.5 41.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.202 -0.311 . . . . 25.0 110.921 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.73 114.83 20.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.336 -2.098 . . . . 25.0 105.336 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -117.89 162.96 17.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -129.68 138.63 51.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.96 0.41 . . . . 25.0 110.265 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.66 140.19 15.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.586 -1.264 . . . . 25.0 107.586 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 55.65 29.27 13.34 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.422 1.267 . . . . 25.0 114.422 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.92 1.87 90.64 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.952 -0.642 . . . . 25.0 114.351 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -114.06 162.8 16.01 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -131.83 138.51 48.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.901 -1.518 . . . . 25.0 106.901 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -145.53 164.46 28.07 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.378 -1.089 . . . . 25.0 110.378 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.6 pt -81.63 145.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG13 ' CE1' ' A' ' 26' ' ' PHE . 76.8 t -141.62 135.29 14.62 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -176.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.13 113.32 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 115.765 -2.357 . . . . 25.0 111.641 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.1 -20.0 59.89 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 114.545 0.578 . . . . 25.0 114.545 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.22 -30.11 68.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.932 0.396 . . . . 25.0 111.373 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -89.53 8.82 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.213 0.449 . . . . 25.0 112.213 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.69 153.67 36.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.149 0.499 . . . . 25.0 112.298 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -125.09 117.58 24.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.198 -0.667 . . . . 25.0 109.198 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 123.179 0.592 . . . . 25.0 110.535 179.86 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 114.677 1.362 . . . . 25.0 114.677 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.9 t30 53.87 41.65 31.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.771 1.026 . . . . 25.0 113.771 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -120.12 151.98 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 105.901 -1.888 . . . . 25.0 105.901 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.73 151.97 37.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.128 0.489 . . . . 25.0 111.614 -174.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -133.63 148.62 51.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.54 -0.755 . . . . 25.0 112.465 -175.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.31 132.61 40.13 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 114.988 -1.005 . . . . 25.0 108.295 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.97 125.4 28.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.2 mt -91.64 -26.99 18.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 25.0 110.752 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -127.96 163.03 25.38 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.411 -1.329 . . . . 25.0 107.411 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.62 165.63 12.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.273 -0.639 . . . . 25.0 109.273 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -148.61 156.55 42.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.608 -0.516 . . . . 25.0 109.608 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.36 105.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.41 30.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.167 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -104.91 -12.31 16.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 25.0 111.753 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -122.39 149.83 55.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.984 -0.553 . . . . 25.0 110.511 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.89 -16.07 40.89 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 117.393 -1.271 . . . . 25.0 114.583 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -76.86 -19.64 57.24 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.77 0.795 . . . . 25.0 109.945 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -94.18 137.89 32.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.805 0.812 . . . . 25.0 110.49 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.62 131.48 35.21 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.83 -0.748 . . . . 25.0 111.276 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.7 t -78.72 109.98 13.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.16 162.46 35.43 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.461 -0.94 . . . . 25.0 108.461 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.47 167.49 20.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.879 . . . . 25.0 108.625 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -61.92 140.66 58.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.522 -0.547 . . . . 25.0 109.522 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.51 -15.0 62.43 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-O 118.792 -1.004 . . . . 25.0 113.272 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -73.07 155.74 39.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.505 1.152 . . . . 25.0 110.697 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.9 mm -122.38 126.14 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.371 -1.344 . . . . 25.0 107.371 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.4 ptp -135.97 154.92 50.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.18 0.192 . . . . 25.0 111.31 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 m -92.96 129.8 38.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.625 -0.879 . . . . 25.0 108.625 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.95 125.74 40.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.502 -1.295 . . . . 25.0 107.502 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.3 mt -94.74 -48.11 6.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.046 -0.524 . . . . 25.0 110.442 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.2 167.12 22.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.237 0.96 . . . . 25.0 109.11 -174.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -129.92 155.46 46.02 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 57.5 36.02 26.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 123.55 1.643 . . . . 25.0 107.914 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -70.17 -12.5 61.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.835 -1.529 . . . . 25.0 114.089 -171.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -110.46 4.79 20.83 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.42 0.628 . . . . 25.0 109.337 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 -20.29 11.17 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 109.431 -1.468 . . . . 25.0 109.431 -173.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 40' ' ' GLN . 91.7 mt -81.02 123.77 28.62 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.751 -1.574 . . . . 25.0 106.751 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.7 135.46 57.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.511 -0.922 . . . . 25.0 108.511 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.75 -3.65 83.24 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 115.878 1.111 . . . . 25.0 115.878 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -96.35 121.56 38.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.635 1.218 . . . . 25.0 108.078 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -111.87 143.99 41.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.728 -0.389 . . . . 25.0 110.55 -172.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -85.37 120.77 27.2 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.818 -2.29 . . . . 25.0 104.818 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.4 m -121.68 161.78 21.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.59 -0.522 . . . . 25.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -123.44 129.87 51.88 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.88 142.22 14.82 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.918 -1.142 . . . . 25.0 107.918 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 58.57 29.95 19.15 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.355 0.662 . . . . 25.0 112.662 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.0 7.77 88.25 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.766 -0.731 . . . . 25.0 114.706 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.9 164.9 25.88 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -124.43 153.7 41.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.51 -1.293 . . . . 25.0 107.51 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 169.4 42.4 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 110.441 -1.064 . . . . 25.0 110.441 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 pt -78.22 147.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 117.742 0.771 . . . . 25.0 111.995 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.92 135.42 13.49 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.749 -1.204 . . . . 25.0 107.749 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.15 116.57 4.56 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 115.844 -2.304 . . . . 25.0 111.489 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.88 -25.49 69.27 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 115.935 1.134 . . . . 25.0 115.935 -172.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -69.07 -12.4 61.65 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.874 -0.78 . . . . 25.0 112.043 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.58 5.77 50.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.356 -0.84 . . . . 25.0 110.252 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -116.94 154.8 30.22 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 122.61 0.364 . . . . 25.0 111.462 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -126.86 114.5 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.547 HD13 ' HB2' ' A' ' 10' ' ' ALA . 11.3 mm . . . . . 0 C--N 1.321 -0.649 0 N-CA-C 108.145 -1.058 . . . . 25.0 108.145 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.47 0.176 . . . . 25.0 111.182 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 39.8 t30 57.48 22.38 7.97 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.547 0.943 . . . . 25.0 113.547 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -89.7 132.94 33.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -95.27 160.51 14.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.334 0.588 . . . . 25.0 109.747 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.09 150.75 34.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.616 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.79 133.5 39.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 25.0 109.649 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.42 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -76.95 134.13 38.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.391 0.615 . . . . 25.0 109.854 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.24 -21.55 19.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.524 -0.762 . . . . 25.0 110.152 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.88 159.88 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 25.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 17.3 p-10 -101.98 147.57 26.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -153.07 156.95 39.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.7 -0.682 . . . . 25.0 110.875 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -124.96 131.48 72.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 104.472 -2.418 . . . . 25.0 104.472 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 121.65 14.31 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.13 0.269 . . . . 25.0 110.406 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -94.6 -14.62 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.358 -0.978 . . . . 25.0 108.358 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.7 155.44 59.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.471 -0.786 . . . . 25.0 109.774 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.16 -19.86 25.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 117.31 -1.327 . . . . 25.0 113.753 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -15.57 49.1 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.618 0.723 . . . . 25.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.29 153.17 21.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 25.0 111.232 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.6 136.61 41.15 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.039 -0.413 . . . . 25.0 111.841 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.1 m -85.19 109.81 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 171.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -126.55 162.05 26.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.649 -0.871 . . . . 25.0 108.649 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 43.5 mtm105 -127.39 155.23 43.96 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.918 -0.488 . . . . 25.0 111.102 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.8 pttt -59.99 128.9 39.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 175.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.19 65.83 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.627 -0.715 . . . . 25.0 114.353 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.75 156.76 30.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.881 0.841 . . . . 25.0 109.872 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.16 130.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -135.28 160.6 37.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.584 -0.524 . . . . 25.0 109.584 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 33.4 m -101.85 127.15 48.79 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 25.0 109.824 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.93 125.53 40.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.7 mt -95.5 -41.57 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.607 -0.724 . . . . 25.0 110.237 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -148.23 164.17 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.324 -0.621 . . . . 25.0 109.324 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -135.11 151.88 51.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.494 -1.669 . . . . 25.0 106.494 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 59.39 34.45 22.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.175 1.464 . . . . 25.0 107.913 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -70.55 -16.54 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.829 -1.532 . . . . 25.0 112.613 -172.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -113.35 7.98 17.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 25.0 112.05 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.84 19.81 78.54 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 109.418 -1.473 . . . . 25.0 109.418 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.7 mt -130.05 114.86 16.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -65.7 149.93 49.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.68 -1.6 . . . . 25.0 106.68 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.86 -12.55 69.17 Favored Glycine 0 C--O 1.215 -1.07 0 CA-C-O 118.573 -1.126 . . . . 25.0 112.224 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -106.28 128.28 53.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.179 1.489 . . . . 25.0 110.337 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.16 142.34 50.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.77 -0.456 . . . . 25.0 109.77 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.2 tp -83.87 119.03 24.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.0 m -123.42 164.79 18.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.349 0.119 . . . . 25.0 111.209 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.7 p -121.94 124.13 43.34 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.032 0.444 . . . . 25.0 110.256 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 tp -162.17 164.64 27.75 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 106.076 -1.824 . . . . 25.0 106.076 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.19 17.63 7.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.789 1.403 . . . . 25.0 114.789 169.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.33 13.57 80.32 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.934 -0.65 . . . . 25.0 113.261 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.9 167.61 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.559 -0.534 . . . . 25.0 109.559 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -105.98 154.81 20.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 103.6 -2.741 . . . . 25.0 103.6 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.78 163.77 34.27 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 110.121 -1.192 . . . . 25.0 110.121 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 pt -79.61 141.93 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.877 0.846 . . . . 25.0 109.983 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.6 132.99 17.74 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.362 -1.347 . . . . 25.0 107.362 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.07 121.74 8.36 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 114.218 -3.388 . . . . 25.0 111.258 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.17 -19.07 69.86 Favored Glycine 0 C--O 1.22 -0.763 0 CA-C-N 115.801 -0.636 . . . . 25.0 112.121 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -69.73 -5.59 26.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.109 0.481 . . . . 25.0 111.378 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -114.4 11.43 17.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.748 -0.464 . . . . 25.0 109.748 175.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 12' ' ' ALA . 89.0 mt -120.57 150.09 41.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.275 0.56 . . . . 25.0 110.779 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -120.45 119.75 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.882 -0.599 . . . . 25.0 109.772 179.138 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 114.191 1.182 . . . . 25.0 114.191 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.7 t30 47.09 46.56 16.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.124 1.527 . . . . 25.0 115.124 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.7 m -111.25 169.5 4.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 104.483 -2.414 . . . . 25.0 104.483 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.41 164.38 29.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.42 28.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.496 -0.774 . . . . 25.0 109.75 -175.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.35 136.34 53.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.681 -1.229 . . . . 25.0 107.681 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 135.38 45.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.48 0.657 . . . . 25.0 109.727 177.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.01 -30.16 16.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.182 -0.917 . . . . 25.0 109.356 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.83 158.49 39.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 -177.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.1 p-10 -87.91 152.98 21.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.432 . . . . 25.0 110.08 177.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.76 87.25 1.41 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.16 121.55 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.59 51.64 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.379 0.424 . . . . 25.0 111.418 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.05 -18.18 12.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.361 -0.836 . . . . 25.0 110.184 175.333 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -104.93 150.79 39.1 Favored Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 109.613 -0.514 . . . . 25.0 109.613 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.62 -21.6 19.05 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 117.585 -1.144 . . . . 25.0 114.42 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.62 -14.95 56.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 25.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -89.15 140.61 29.29 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.91 . . . . 25.0 111.134 -176.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.87 124.74 34.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.674 -0.641 . . . . 25.0 111.147 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -80.45 121.22 25.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.544 -0.539 . . . . 25.0 109.544 174.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.503 ' CE1' HG13 ' A' ' 57' ' ' VAL . 52.7 p90 -143.26 168.56 19.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.306 -0.998 . . . . 25.0 108.306 178.305 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -129.28 164.82 22.69 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.973 -0.455 . . . . 25.0 111.23 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 34.9 pttt -62.03 134.27 56.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 25.0 109.729 -177.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.47 -13.38 67.45 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 115.524 -0.762 . . . . 25.0 113.407 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -75.87 157.64 33.05 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 117.419 0.609 . . . . 25.0 110.988 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.88 126.37 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.292 0.637 . . . . 25.0 111.042 -175.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -129.49 147.78 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.41 0.624 . . . . 25.0 111.43 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -87.97 130.25 35.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.21 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.24 124.13 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 177.545 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -99.59 -41.32 7.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.3 -0.864 . . . . 25.0 111.791 -174.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.06 160.41 42.43 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.88 -0.785 . . . . 25.0 108.88 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -128.36 154.58 45.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.899 -1.149 . . . . 25.0 107.899 176.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t0 55.67 40.57 30.92 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.547 1.642 . . . . 25.0 108.309 -175.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -70.86 -8.0 49.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.646 -1.616 . . . . 25.0 114.193 -171.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -135.86 12.49 3.39 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.811 0.671 . . . . 25.0 112.811 -175.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 15.96 74.41 Favored Glycine 0 N--CA 1.459 0.224 0 N-CA-C 110.692 -0.963 . . . . 25.0 110.692 -176.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.3 mt -122.52 110.68 15.88 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.479 -1.674 . . . . 25.0 106.479 176.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.9 144.07 57.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.559 -1.275 . . . . 25.0 107.559 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 -17.2 57.04 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 115.217 -0.902 . . . . 25.0 113.107 -177.289 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -94.33 128.2 40.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.96 1.38 . . . . 25.0 108.61 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -119.72 146.3 45.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 -174.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.2 tp -86.22 112.64 21.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.654 -1.61 . . . . 25.0 106.654 174.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -112.04 168.32 9.69 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.923 -0.399 . . . . 25.0 109.923 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -128.71 131.71 47.95 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.064 -1.088 . . . . 25.0 108.064 174.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -158.61 140.12 13.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 -176.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 56.43 33.2 22.05 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.547 0.689 . . . . 25.0 112.356 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.2 3.34 90.68 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 115.758 1.063 . . . . 25.0 115.758 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -127.85 161.48 28.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 118.503 1.152 . . . . 25.0 109.035 177.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -113.15 151.74 30.51 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 105.903 -1.888 . . . . 25.0 105.903 176.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.73 38.19 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.437 -1.065 . . . . 25.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -78.62 144.79 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.51 0.671 . . . . 25.0 109.217 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.503 HG13 ' CE1' ' A' ' 26' ' ' PHE . 46.3 t -140.55 134.12 15.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.314 -0.857 . . . . 25.0 109.106 -176.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.95 114.65 3.96 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 116.05 -2.167 . . . . 25.0 110.855 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.57 -18.28 63.4 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-N 116.066 -0.515 . . . . 25.0 113.07 -176.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.47 -31.13 67.52 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.53 0.332 . . . . 25.0 111.414 174.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -88.58 6.9 35.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.112 0.412 . . . . 25.0 112.112 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.9 mt -119.4 151.33 38.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.851 0.358 . . . . 25.0 111.818 -176.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -124.43 123.31 39.89 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.956 -0.757 . . . . 25.0 108.956 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.471 0.593 0 C-N-CA 123.284 0.633 . . . . 25.0 110.388 -177.84 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 120.257 0.075 . . . . 25.0 111.144 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.6 t30 48.55 47.35 20.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.352 1.241 . . . . 25.0 114.352 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 165.8 12.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 N-CA-C 105.334 -2.098 . . . . 25.0 105.334 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.23 159.64 39.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.524 -0.917 . . . . 25.0 108.524 -178.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.35 164.65 29.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.562 -0.744 . . . . 25.0 110.388 -172.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -114.81 135.15 54.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.75 -1.204 . . . . 25.0 107.75 175.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.99 124.49 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 25.0 110.7 178.026 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.42 -29.42 41.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.041 -0.527 . . . . 25.0 109.972 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -126.73 162.7 25.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.76 -0.83 . . . . 25.0 108.76 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.498 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 p-10 -98.29 160.38 14.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 175.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -144.14 175.0 10.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.462 0.648 . . . . 25.0 112.265 177.192 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.8 t -126.96 137.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 100.215 -3.994 . . . . 25.0 100.215 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.8 16.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.173 -1.047 . . . . 25.0 108.173 -178.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.64 -11.45 53.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.22 1.01 . . . . 25.0 109.354 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -138.33 152.52 71.57 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.02 -0.991 . . . . 25.0 109.088 -176.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.98 -15.78 29.25 Favored 'Trans proline' 0 C--N 1.35 0.608 0 N-CA-C 114.016 0.737 . . . . 25.0 114.016 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -84.35 -20.01 32.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.835 0.826 . . . . 25.0 109.621 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.56 135.73 35.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.662 -0.699 . . . . 25.0 110.199 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.95 138.46 36.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.108 -0.701 . . . . 25.0 109.108 177.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 p -90.03 131.74 35.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.194 -1.409 . . . . 25.0 107.194 172.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.39 169.02 22.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.716 -1.216 . . . . 25.0 107.716 -177.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -128.24 158.78 37.2 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 109.25 -0.648 . . . . 25.0 109.25 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.4 pttt -56.29 128.62 36.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 173.454 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.78 -20.84 42.5 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.944 -0.571 . . . . 25.0 113.868 -176.352 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -66.89 151.02 48.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.403 0.601 . . . . 25.0 109.989 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -115.42 128.38 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.541 -0.911 . . . . 25.0 108.541 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.5 148.61 50.58 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.455 0.645 . . . . 25.0 111.168 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 m -89.86 126.43 35.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.141 -1.429 . . . . 25.0 107.141 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.2 t -91.57 114.05 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.279 -1.748 . . . . 25.0 106.279 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.2 mt -88.77 -43.21 11.42 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.187 -0.915 . . . . 25.0 110.206 -176.483 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -145.72 161.19 40.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.499 -0.926 . . . . 25.0 108.499 -173.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -126.8 150.32 49.21 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.823 -1.547 . . . . 25.0 106.823 177.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 58.92 34.02 23.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.995 1.379 . . . . 25.0 108.267 177.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -69.61 -20.53 63.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.693 -1.594 . . . . 25.0 113.673 -169.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -102.46 6.22 39.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.701 -0.681 . . . . 25.0 110.144 -177.315 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 12.36 84.64 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 109.658 -1.377 . . . . 25.0 109.658 -173.35 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -113.36 121.02 43.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.783 -0.821 . . . . 25.0 108.783 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.4 128.51 37.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.54 0.686 . . . . 25.0 110.311 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.98 -0.92 84.63 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 115.766 1.066 . . . . 25.0 115.766 175.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -100.79 123.86 45.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.049 1.424 . . . . 25.0 109.237 177.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -113.3 143.02 45.14 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.251 -0.28 . . . . 25.0 111.133 -171.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.6 tp -81.99 112.98 19.57 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.661 -1.607 . . . . 25.0 106.661 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.3 m -114.11 159.05 20.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.901 0.382 . . . . 25.0 110.43 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -135.59 127.0 28.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.698 -0.683 . . . . 25.0 109.76 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.98 141.82 29.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.545 0.528 . . . . 25.0 110.889 176.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 48.08 38.57 9.87 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 178.355 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.61 89.82 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 115.019 0.768 . . . . 25.0 115.019 176.591 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -122.96 145.27 48.63 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.103 -0.703 . . . . 25.0 109.103 178.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -118.04 150.35 39.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.696 -0.853 . . . . 25.0 108.696 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.5 169.22 42.17 Favored Glycine 0 C--O 1.243 0.704 0 N-CA-C 109.789 -1.324 . . . . 25.0 109.789 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -82.27 146.89 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.504 0.652 . . . . 25.0 109.706 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.3 t -140.83 135.02 15.19 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 -177.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.06 119.76 6.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 115.323 -2.652 . . . . 25.0 110.776 174.43 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.63 -22.6 68.13 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 114.31 0.484 . . . . 25.0 114.31 -173.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.91 -26.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 122.524 -0.398 . . . . 25.0 111.932 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -85.71 6.62 26.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -118.98 146.69 44.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.47 0.544 . . . . 25.0 112.47 -175.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -118.2 121.77 41.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.497 -1.297 . . . . 25.0 107.497 170.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm . . . . . 0 C--O 1.24 0.56 0 O-C-N 123.982 0.801 . . . . 25.0 109.009 -179.805 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 115.35 1.611 . . . . 25.0 115.35 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.1 t30 51.77 41.69 29.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.402 1.63 . . . . 25.0 115.402 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 m -114.84 163.07 12.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 175.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 155.8 49.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.618 0.723 . . . . 25.0 111.839 -176.083 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.49 152.97 47.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.916 -1.038 . . . . 25.0 110.71 -173.191 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.41 139.23 37.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.708 -0.849 . . . . 25.0 108.708 174.128 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.98 130.34 41.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.419 -0.586 . . . . 25.0 109.419 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.31 -34.39 15.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -123.95 168.51 12.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.0 p-10 -103.77 158.77 16.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.054 0.454 . . . . 25.0 110.387 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -153.06 133.52 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 25.0 110.53 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.94 125.77 57.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 102.901 -2.999 . . . . 25.0 102.901 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.12 129.33 38.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -100.47 -9.69 21.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.688 1.232 . . . . 25.0 109.054 177.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 m -127.71 152.66 77.27 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.402 -1.272 . . . . 25.0 108.948 -177.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.46 -25.62 17.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 114.718 1.007 . . . . 25.0 114.718 -176.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.71 -19.44 60.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.51 0.672 . . . . 25.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -90.02 143.59 26.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.28 -0.873 . . . . 25.0 109.972 -175.06 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.37 137.11 33.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.222 -0.591 . . . . 25.0 111.428 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.0 m -85.6 128.02 34.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 106.32 -1.733 . . . . 25.0 106.32 171.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.451 ' CE2' HG13 ' A' ' 57' ' ' VAL . 48.3 p90 -149.43 156.69 42.42 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.67 152.78 41.66 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 119.962 -0.695 . . . . 25.0 110.009 179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.525 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.4 pttp -55.57 126.33 24.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.158 -178.307 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.39 -22.67 28.44 Favored Glycine 0 C--O 1.221 -0.662 0 CA-C-N 115.379 -0.828 . . . . 25.0 112.902 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -70.74 157.95 37.15 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.565 0.683 . . . . 25.0 112.044 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -118.03 126.61 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.334 0.653 . . . . 25.0 109.979 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.9 ptp -132.45 151.36 51.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.924 0.392 . . . . 25.0 111.131 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.2 m -92.79 128.11 38.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 25.0 107.808 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.17 124.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 178.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 mt -102.83 -33.14 9.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.665 0.617 . . . . 25.0 112.665 -176.458 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.84 162.01 41.13 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 124.247 0.967 . . . . 25.0 108.603 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -133.86 144.46 48.94 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 108.392 -0.966 . . . . 25.0 108.392 178.344 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.51 32.98 20.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.511 1.624 . . . . 25.0 107.521 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.41 -14.34 62.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.892 -1.958 . . . . 25.0 115.221 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -110.84 6.15 21.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.2 -6.88 73.99 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.578 -1.409 . . . . 25.0 109.578 -174.145 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.72 115.38 27.82 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.768 -0.827 . . . . 25.0 108.768 179.001 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -61.75 132.65 53.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.397 -0.964 . . . . 25.0 108.397 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.59 -0.49 67.92 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-O 118.908 -0.94 . . . . 25.0 114.497 176.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -106.11 124.23 49.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.663 1.231 . . . . 25.0 109.574 177.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -111.31 145.42 38.85 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 121.968 -0.457 . . . . 25.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.4 tp -85.02 114.56 22.27 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 105.547 -2.02 . . . . 25.0 105.547 175.08 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.1 m -119.92 157.05 29.59 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.842 -0.429 . . . . 25.0 109.842 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 p -123.74 130.58 52.86 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.954 -1.128 . . . . 25.0 107.954 177.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -151.79 137.72 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.787 -1.097 . . . . 25.0 108.618 -174.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.7 t60 55.48 33.99 22.13 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.819 1.044 . . . . 25.0 113.819 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.05 7.03 89.02 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.816 0.686 . . . . 25.0 114.816 177.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -128.42 163.82 24.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.735 -1.209 . . . . 25.0 107.735 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -124.98 157.99 34.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 173.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.26 172.61 45.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.463 -1.455 . . . . 25.0 109.463 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.2 pt -84.22 143.05 12.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-O 121.785 0.802 . . . . 25.0 109.653 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 26' ' ' PHE . 58.1 t -138.83 134.05 16.88 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.676 -1.231 . . . . 25.0 107.676 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.3 119.57 6.6 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 114.61 -3.126 . . . . 25.0 110.95 175.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -26.68 72.04 Favored Glycine 0 C--O 1.223 -0.576 0 CA-C-N 115.867 -0.606 . . . . 25.0 114.375 -173.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.33 -9.97 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.956 -0.732 . . . . 25.0 111.325 178.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -93.12 4.59 53.74 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.699 -0.626 . . . . 25.0 109.633 174.495 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.42 165.24 14.13 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.83 0.452 . . . . 25.0 111.032 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -137.31 118.18 14.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.929 -0.578 . . . . 25.0 109.991 173.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 107.639 -1.245 . . . . 25.0 107.639 178.752 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--O 1.224 -0.253 0 CA-C-O 120.227 0.061 . . . . 25.0 110.925 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 55.26 30.03 13.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.792 0.837 . . . . 25.0 110.518 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.96 162.74 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 104.06 -2.57 . . . . 25.0 104.06 -179.209 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.15 160.94 38.61 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.383 -0.969 . . . . 25.0 108.383 -177.568 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.71 159.32 44.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.668 -0.696 . . . . 25.0 110.77 -174.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.88 135.59 48.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 174.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.24 135.84 46.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.371 0.605 . . . . 25.0 109.794 178.658 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.31 -25.79 16.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.041 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -124.01 158.51 31.94 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.632 -1.247 . . . . 25.0 107.632 -178.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 13.4 p-10 -101.52 159.12 15.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -150.78 158.34 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.355 0.409 . . . . 25.0 111.068 -173.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.71 125.38 65.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 103.076 -2.935 . . . . 25.0 103.076 173.246 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.81 121.73 17.84 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.74 -0.384 . . . . 25.0 110.029 -176.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -101.65 -15.1 17.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.383 0.611 . . . . 25.0 109.385 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 t -111.62 147.55 37.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 25.0 109.352 175.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.39 -15.4 34.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 117.775 -1.016 . . . . 25.0 113.491 175.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.47 -15.49 56.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.756 0.789 . . . . 25.0 110.19 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -92.62 143.29 26.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.178 -0.919 . . . . 25.0 112.803 -172.458 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.62 137.57 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.861 -0.524 . . . . 25.0 110.493 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 117.41 23.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 172.618 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 164.66 32.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 36.9 ptt-85 -137.01 164.03 29.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.68 -0.408 . . . . 25.0 111.985 177.554 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.6 pttt -60.01 136.81 58.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.193 0.52 . . . . 25.0 110.358 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.36 -19.43 54.28 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.186 -0.915 . . . . 25.0 113.317 -178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -77.54 156.78 30.72 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 117.168 0.484 . . . . 25.0 110.412 -178.544 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.1 mm -115.18 130.5 69.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 123.332 0.653 . . . . 25.0 109.282 -174.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.9 ptp -138.94 151.83 47.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.949 0.404 . . . . 25.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 m -87.23 146.05 26.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.923 -1.51 . . . . 25.0 106.923 177.3 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.86 121.03 63.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 106.844 -1.539 . . . . 25.0 106.844 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.08 -49.44 8.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.596 . . . . 25.0 110.303 -177.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.55 170.84 19.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 -177.565 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -134.72 153.69 51.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.731 -0.176 . . . . 25.0 111.163 -175.33 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 60.46 38.75 19.01 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.298 1.523 . . . . 25.0 107.8 -177.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.45 -18.83 63.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.237 -1.802 . . . . 25.0 114.785 -167.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -111.4 6.38 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.497 0.665 . . . . 25.0 109.597 -177.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.53 -4.39 81.98 Favored Glycine 0 CA--C 1.518 0.241 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -174.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.4 127.02 35.49 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.274 -1.38 . . . . 25.0 107.274 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.53 132.41 52.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.297 0.57 . . . . 25.0 110.167 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.2 1.59 90.4 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 115.519 0.968 . . . . 25.0 115.519 174.709 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -100.94 115.41 30.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.143 1.472 . . . . 25.0 110.075 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -108.21 146.84 32.21 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.258 -0.276 . . . . 25.0 110.335 -172.082 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.1 tp -86.26 110.97 20.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.749 -1.575 . . . . 25.0 106.749 176.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -113.69 161.02 18.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.865 -0.42 . . . . 25.0 109.865 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.33 131.46 53.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.16 140.62 14.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 25.0 108.881 -177.266 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 56.96 35.06 25.88 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.074 1.138 . . . . 25.0 114.074 175.618 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.35 85.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.905 -0.664 . . . . 25.0 114.05 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.87 167.61 14.99 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -136.46 150.24 48.62 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.243 -1.762 . . . . 25.0 106.243 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.69 174.58 45.73 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 109.636 -1.386 . . . . 25.0 109.636 -176.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 pt -77.84 144.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.328 0.585 . . . . 25.0 110.437 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.0 t -144.26 136.19 13.04 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.34 112.05 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 116.009 -2.194 . . . . 25.0 111.662 174.579 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -24.86 73.29 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 115.902 -0.59 . . . . 25.0 113.941 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -70.44 -0.56 8.56 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 25.0 111.559 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -114.28 13.77 17.93 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.3 mt -118.75 155.19 31.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 25.0 109.928 178.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.81 117.76 27.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.179 -0.304 . . . . 25.0 110.179 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm . . . . . 0 C--O 1.24 0.558 0 O-C-N 123.773 0.671 . . . . 25.0 110.31 -179.285 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 114.69 1.367 . . . . 25.0 114.69 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t30 54.82 24.49 5.76 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.982 1.475 . . . . 25.0 114.982 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.81 174.16 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 N-CA-C 104.69 -2.337 . . . . 25.0 104.69 174.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.72 162.26 33.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.563 0.619 . . . . 25.0 109.961 -177.193 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.6 144.18 30.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.94 -0.573 . . . . 25.0 111.656 -177.077 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.24 135.09 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 25.0 109.837 176.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.04 131.05 40.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 25.0 110.062 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.41 -30.63 17.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 25.0 110.784 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -130.57 162.53 29.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.22 -1.771 . . . . 25.0 106.22 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.53 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.4 p-10 -96.83 160.37 14.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.977 0.353 . . . . 25.0 110.39 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -150.02 144.4 25.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.399 0.518 . . . . 25.0 112.399 -177.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 126.79 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.748 -2.315 . . . . 25.0 104.748 174.228 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.63 128.57 33.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 -178.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -97.2 -24.1 15.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -104.31 147.16 33.91 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.174 -0.676 . . . . 25.0 109.174 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.1 -14.81 35.47 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.118 -1.455 . . . . 25.0 113.932 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -81.89 -19.81 40.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.898 0.856 . . . . 25.0 110.289 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.07 144.6 25.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.496 -0.774 . . . . 25.0 109.526 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.69 132.92 44.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.189 0.519 . . . . 25.0 110.648 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t -88.86 145.16 25.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 175.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 57' ' ' VAL . 35.6 p90 -159.36 165.58 32.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 -178.388 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -120.71 154.06 36.1 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 121.836 -0.54 . . . . 25.0 109.774 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 22.4 pttp -58.5 134.02 56.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.17 -14.01 65.93 Favored Glycine 0 C--O 1.221 -0.699 0 CA-C-O 119.209 -0.773 . . . . 25.0 112.996 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.21 159.8 28.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.02 0.91 . . . . 25.0 109.398 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.78 131.47 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.6 ptp -130.89 155.26 47.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.185 0.594 . . . . 25.0 110.051 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.3 m -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.825 -1.176 . . . . 25.0 107.825 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.7 125.63 54.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.757 -1.201 . . . . 25.0 107.757 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.0 mt -102.34 -36.59 8.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.554 -0.748 . . . . 25.0 111.876 -174.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.82 161.28 42.56 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.434 -1.321 . . . . 25.0 107.434 -178.096 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -129.41 150.25 50.85 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.553 -1.277 . . . . 25.0 107.553 177.065 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 59.09 35.64 23.9 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.287 1.617 . . . . 25.0 106.961 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.53 -10.48 59.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 112.546 -2.116 . . . . 25.0 115.923 -163.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -126.48 13.96 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.448 0.642 . . . . 25.0 109.611 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.58 -5.38 78.33 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 109.802 -1.319 . . . . 25.0 109.802 -175.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.18 115.59 26.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.041 -1.096 . . . . 25.0 108.041 178.066 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.33 130.83 48.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.793 0.806 . . . . 25.0 109.806 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 2.22 85.81 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-O 118.62 -1.1 . . . . 25.0 115.316 176.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -102.67 128.3 49.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.224 1.512 . . . . 25.0 108.442 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -117.1 144.43 44.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 25.0 109.647 -174.042 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.7 tp -84.34 117.38 23.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 175.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.92 158.08 27.44 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.34 129.93 52.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 177.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.08 137.76 19.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.509 -0.768 . . . . 25.0 109.173 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 54.99 30.94 15.06 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 176.246 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.33 13.02 82.45 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.138 -0.554 . . . . 25.0 113.991 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.37 165.3 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.243 -1.762 . . . . 25.0 106.243 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -137.23 140.61 41.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 118.471 0.578 . . . . 25.0 109.721 175.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.46 164.48 29.4 Favored Glycine 0 C--O 1.238 0.374 0 O-C-N 124.039 0.837 . . . . 25.0 111.574 -176.16 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.21 143.81 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.947 -1.131 . . . . 25.0 107.947 174.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG13 ' CE1' ' A' ' 26' ' ' PHE . 53.5 t -140.26 135.63 16.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 -175.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.58 116.99 4.8 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 115.21 -2.727 . . . . 25.0 110.385 174.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.05 -16.85 71.18 Favored Glycine 0 CA--C 1.508 -0.397 0 CA-C-N 116.163 -0.471 . . . . 25.0 112.948 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.49 -4.29 18.19 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.61 -0.347 . . . . 25.0 111.008 175.053 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -109.89 10.67 24.39 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.414 -0.179 . . . . 25.0 111.049 175.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.82 157.04 33.31 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.623 0.601 . . . . 25.0 112.623 -176.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -127.18 117.55 22.58 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.661 -0.866 . . . . 25.0 108.661 174.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.6 mm . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.614 0.245 . . . . 25.0 110.382 -177.963 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.98 1.104 . . . . 25.0 113.98 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 56.12 34.28 23.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.927 0.891 . . . . 25.0 112.67 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.87 135.49 39.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 104.153 -2.536 . . . . 25.0 104.153 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.75 161.47 29.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.991 0.814 . . . . 25.0 109.75 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.62 153.86 33.11 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.486 0.66 . . . . 25.0 112.768 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -91.64 134.58 34.57 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.167 -0.924 . . . . 25.0 109.962 176.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.97 127.56 32.98 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 108.33 -0.989 . . . . 25.0 108.33 173.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -87.03 -27.73 23.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.93 0.871 . . . . 25.0 109.602 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -124.97 160.0 29.94 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.926 -1.034 . . . . 25.0 108.972 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -98.76 158.22 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.586 -1.635 . . . . 25.0 106.586 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -142.91 159.84 41.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 112.703 0.631 . . . . 25.0 112.703 -174.132 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.63 119.77 55.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 102.535 -3.135 . . . . 25.0 102.535 172.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.07 113.25 13.39 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.354 -0.539 . . . . 25.0 109.593 -177.569 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -82.48 -15.52 52.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.937 0.875 . . . . 25.0 109.221 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.3 m -122.21 156.28 60.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.746 -0.661 . . . . 25.0 109.323 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.39 -14.13 22.77 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 117.548 -1.168 . . . . 25.0 112.739 175.571 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -84.85 -16.57 40.85 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.804 1.288 . . . . 25.0 110.962 178.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -91.59 140.93 29.25 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.32 134.32 34.11 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.675 0.75 . . . . 25.0 112.573 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -86.91 106.05 17.5 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.313 -0.858 . . . . 25.0 109.101 177.226 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -128.79 165.12 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.565 -0.709 . . . . 25.0 112.595 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 mtt85 -122.69 156.7 33.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.507 -0.183 . . . . 25.0 110.507 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -62.18 134.38 56.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 178.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.38 -11.54 68.73 Favored Glycine 0 C--O 1.214 -1.148 0 CA-C-N 115.484 -0.78 . . . . 25.0 112.559 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.16 159.82 32.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.342 1.071 . . . . 25.0 109.361 177.182 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.55 124.17 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.017 -0.734 . . . . 25.0 109.017 -176.331 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.6 ptp -131.86 152.35 51.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.26 0.837 . . . . 25.0 113.26 -176.683 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 m -92.83 131.24 38.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.22 -0.445 . . . . 25.0 110.223 -177.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.84 126.78 43.57 Favored 'Isoleucine or valine' 0 C--O 1.257 1.5 0 N-CA-C 108.104 -1.073 . . . . 25.0 108.104 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.8 mt -102.98 -38.75 7.21 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 114.735 -1.12 . . . . 25.0 111.889 -177.44 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -143.39 160.99 39.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.827 -1.078 . . . . 25.0 108.215 -176.557 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 -131.77 145.3 51.52 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.059 -1.83 . . . . 25.0 106.059 174.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 63.59 37.68 10.12 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 123.858 1.79 . . . . 25.0 108.305 -176.081 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -69.39 -19.63 63.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.03 -1.895 . . . . 25.0 116.054 -172.417 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -119.55 10.51 11.81 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.013 0.911 . . . . 25.0 108.82 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.23 79.64 Favored Glycine 0 CA--C 1.511 -0.16 0 CA-C-N 115.397 -0.819 . . . . 25.0 111.242 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.89 139.1 31.07 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 106.675 -1.602 . . . . 25.0 106.675 176.69 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.58 150.31 48.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.175 0.988 . . . . 25.0 110.404 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.4 -3.69 38.94 Favored Glycine 0 C--O 1.207 -1.572 0 O-C-N 120.873 -1.142 . . . . 25.0 115.329 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -99.73 131.04 45.97 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 118.967 1.384 . . . . 25.0 110.298 -179.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -125.82 142.34 51.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.97 -0.292 . . . . 25.0 111.389 -172.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp -82.77 120.73 26.0 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 106.618 -1.623 . . . . 25.0 106.618 176.6 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.46 164.13 15.72 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.386 0.275 . . . . 25.0 110.393 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 89.8 p -120.32 127.05 51.99 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.353 -0.61 . . . . 25.0 109.353 175.817 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 tp -153.1 146.24 24.68 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 -179.149 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.7 t60 60.92 10.86 2.97 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.406 1.261 . . . . 25.0 114.406 178.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 10.21 62.1 Favored Glycine 0 C--O 1.22 -0.761 0 C-N-CA 120.429 -0.891 . . . . 25.0 112.17 -179.108 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -124.39 165.76 17.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 178.16 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -118.82 156.88 28.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.026 -2.213 . . . . 25.0 105.026 172.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.72 162.87 31.55 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.879 -0.676 . . . . 25.0 111.865 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -77.02 141.97 14.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 122.313 1.054 . . . . 25.0 108.806 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.23 136.85 17.26 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.434 -1.257 . . . . 25.0 110.228 178.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.37 115.63 4.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 117.564 -1.157 . . . . 25.0 111.338 178.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.85 -25.46 70.63 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 115.996 -0.547 . . . . 25.0 113.576 -174.292 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -64.77 -22.85 67.07 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.899 0.849 . . . . 25.0 111.551 178.04 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -91.59 10.42 28.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.413 -0.358 . . . . 25.0 111.463 -178.073 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.9 144.87 45.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.528 0.68 . . . . 25.0 111.987 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -112.64 113.28 25.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 121.96 -0.463 . . . . 25.0 110.649 178.324 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mm . . . . . 0 C--O 1.214 -0.785 0 C-N-CA 123.063 0.545 . . . . 25.0 109.812 -174.645 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.347 0.117 . . . . 25.0 110.959 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 49.95 39.19 18.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.581 0.956 . . . . 25.0 113.581 176.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.55 141.56 32.18 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 -178.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.88 154.48 18.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.749 0.785 . . . . 25.0 111.879 -174.009 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.16 46.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.829 -1.078 . . . . 25.0 109.866 -179.446 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -97.02 134.62 40.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.024 -1.102 . . . . 25.0 108.024 175.518 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.85 136.79 45.4 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.638 0.732 . . . . 25.0 110.088 176.668 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.7 mt -94.61 -34.32 12.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 25.0 109.169 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -125.4 164.85 19.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.405 -1.702 . . . . 25.0 106.405 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.17 165.39 13.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.851 -0.796 . . . . 25.0 108.851 174.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.09 110.53 3.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.6 . . . . 25.0 109.787 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.57 131.87 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 174.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.92 15.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.478 -1.305 . . . . 25.0 107.478 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -96.84 -6.75 35.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.323 1.058 . . . . 25.0 108.296 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -132.31 149.58 73.56 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.194 -1.41 . . . . 25.0 107.194 178.29 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.38 -24.51 19.34 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 116.038 -2.175 . . . . 25.0 115.068 -174.551 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.62 -15.62 58.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.752 0.787 . . . . 25.0 110.617 -179.635 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -81.02 141.36 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.361 -1.348 . . . . 25.0 107.361 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.08 130.2 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.726 -0.609 . . . . 25.0 110.124 178.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.38 116.34 21.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.87 -1.159 . . . . 25.0 107.87 174.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.546 ' CE1' HG13 ' A' ' 57' ' ' VAL . 52.1 p90 -141.34 165.88 26.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.484 -0.562 . . . . 25.0 109.484 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.69 155.21 46.26 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.938 0.399 . . . . 25.0 111.921 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.5 129.84 37.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.981 -0.554 . . . . 25.0 110.594 176.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -21.74 44.32 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.435 -179.177 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -72.16 160.99 31.52 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 117.34 0.57 . . . . 25.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.7 mm -119.65 128.67 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.888 -0.782 . . . . 25.0 108.888 -176.715 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -135.87 148.45 48.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.068 0.461 . . . . 25.0 110.237 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -87.07 128.77 35.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.463 -0.94 . . . . 25.0 108.463 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.3 t -89.01 124.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.755 -1.572 . . . . 25.0 106.755 175.486 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.12 -45.29 7.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.624 -0.716 . . . . 25.0 110.247 -179.223 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.27 164.63 34.29 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.488 -0.56 . . . . 25.0 109.488 -175.599 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -129.88 152.66 49.12 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.402 -0.592 . . . . 25.0 109.402 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t0 56.53 39.43 29.91 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 123.608 1.67 . . . . 25.0 107.414 -175.642 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -70.48 -12.93 61.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.401 -1.727 . . . . 25.0 114.179 -169.714 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.05 9.85 5.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 25.0 111.472 -176.796 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.39 14.49 78.46 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 108.951 -1.66 . . . . 25.0 108.951 -174.041 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.92 111.25 23.82 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 177.813 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -63.78 141.75 58.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.814 -0.81 . . . . 25.0 108.814 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.04 -14.75 31.0 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-O 119.273 -0.737 . . . . 25.0 114.846 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -94.01 136.44 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.794 1.297 . . . . 25.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -121.83 146.14 47.37 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.232 -0.655 . . . . 25.0 109.232 -175.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -84.91 116.05 23.12 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.486 -1.672 . . . . 25.0 106.486 175.715 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.1 m -117.41 164.73 14.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.581 -0.526 . . . . 25.0 109.581 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -125.59 127.66 46.7 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.7 tp -161.11 152.36 18.87 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 -177.393 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.1 t60 58.95 28.23 17.33 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.64 0.733 . . . . 25.0 112.109 177.331 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.74 2.12 85.1 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 115.023 0.769 . . . . 25.0 115.023 178.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -133.86 164.21 27.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 117.866 0.833 . . . . 25.0 110.656 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -101.71 158.93 15.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.618 -1.623 . . . . 25.0 106.618 176.565 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 162.66 33.11 Favored Glycine 0 C--O 1.24 0.496 0 N-CA-C 109.872 -1.291 . . . . 25.0 109.872 178.308 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -81.88 145.7 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.514 0.673 . . . . 25.0 109.643 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.546 HG13 ' CE1' ' A' ' 26' ' ' PHE . 40.5 t -139.31 134.83 16.76 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 25.0 108.809 -176.841 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.22 109.19 2.15 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.079 -1.481 . . . . 25.0 110.696 172.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.15 61.84 Favored Glycine 0 C--O 1.22 -0.723 0 N-CA-C 115.394 0.918 . . . . 25.0 115.394 -172.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -16.99 64.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.874 -0.78 . . . . 25.0 111.464 177.444 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.53 3.83 51.2 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.908 -0.495 . . . . 25.0 111.002 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.436 HD11 HG11 ' A' ' 57' ' ' VAL . 80.1 mt -118.51 157.59 26.99 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.613 0.365 . . . . 25.0 110.321 -178.377 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -127.49 117.82 22.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.381 -0.97 . . . . 25.0 108.381 171.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.0 mm . . . . . 0 C--N 1.32 -0.683 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 177.926 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.549 0.214 . . . . 25.0 111.141 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 55.31 26.7 8.92 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.904 0.882 . . . . 25.0 113.214 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.73 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 N-CA-C 105.798 -1.927 . . . . 25.0 105.798 177.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.24 159.63 37.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.279 -0.419 . . . . 25.0 109.973 -178.662 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -95.42 133.86 38.91 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.108 -0.701 . . . . 25.0 109.108 178.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 132.18 42.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.199 0.523 . . . . 25.0 110.686 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.8 -32.8 15.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.65 162.18 18.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.073 -0.967 . . . . 25.0 108.825 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.34 148.99 22.19 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.339 -2.097 . . . . 25.0 105.339 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -148.28 130.51 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 25.0 111.672 -172.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.46 132.26 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 102.833 -3.025 . . . . 25.0 102.833 172.561 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.13 126.33 28.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.96 -0.755 . . . . 25.0 108.96 -178.709 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.33 -7.07 32.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.9 155.68 80.19 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.316 -0.856 . . . . 25.0 109.171 178.678 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.38 -24.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 116.994 -1.537 . . . . 25.0 113.591 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.76 -15.55 51.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.222 -0.444 . . . . 25.0 110.143 -178.372 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.74 147.06 29.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.602 0.715 . . . . 25.0 110.894 -178.069 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.89 134.24 36.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.102 -0.499 . . . . 25.0 110.224 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -84.62 142.84 29.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.758 -1.571 . . . . 25.0 106.758 172.027 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.472 ' CE2' HG13 ' A' ' 57' ' ' VAL . 36.5 p90 -158.24 166.35 32.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.776 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -126.14 155.5 41.59 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.942 -0.474 . . . . 25.0 110.653 -178.361 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.04 135.3 56.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.119 -0.697 . . . . 25.0 109.119 -179.027 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.68 -9.97 76.09 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.153 -0.804 . . . . 25.0 114.711 -178.653 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -81.42 162.98 23.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.966 0.883 . . . . 25.0 108.71 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.54 131.48 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.659 -0.867 . . . . 25.0 108.659 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.6 ptp -129.48 152.21 49.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.002 -178.694 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 m -82.31 131.64 35.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.217 -1.031 . . . . 25.0 108.217 178.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.4 t -100.03 121.07 50.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.658 -1.608 . . . . 25.0 106.658 176.053 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.5 mt -91.28 -52.36 4.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.724 -0.671 . . . . 25.0 110.689 -176.591 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -146.43 170.55 16.61 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 -177.561 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -128.27 157.04 42.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.154 -1.795 . . . . 25.0 106.154 -179.218 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.6 t0 62.17 35.56 15.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 123.397 1.57 . . . . 25.0 108.759 177.313 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -70.98 -12.59 61.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.476 -1.693 . . . . 25.0 112.349 -176.03 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -118.9 5.81 11.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.347 0.499 . . . . 25.0 112.347 -175.347 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.52 11.14 82.4 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.555 -1.418 . . . . 25.0 109.555 -174.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.65 114.91 16.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.301 -1.741 . . . . 25.0 106.301 176.601 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.95 156.88 31.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.82 -1.548 . . . . 25.0 106.82 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.56 -15.4 62.07 Favored Glycine 0 C--O 1.218 -0.848 0 N-CA-C 108.186 -1.966 . . . . 25.0 108.186 -173.054 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.91 126.41 52.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 173.642 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -119.79 143.07 48.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -177.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.8 tp -82.97 107.86 15.87 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.377 -1.712 . . . . 25.0 106.377 177.038 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.7 m -108.65 163.81 12.92 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.371 -0.604 . . . . 25.0 109.371 179.383 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 48.5 t -130.1 129.67 43.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 175.109 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 tp -161.39 155.05 21.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 -175.445 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 58.8 23.83 11.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.438 0.903 . . . . 25.0 113.438 174.545 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.76 4.21 88.99 Favored Glycine 0 C--O 1.202 -1.904 0 N-CA-C 115.602 1.001 . . . . 25.0 115.602 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -129.36 166.16 20.07 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.372 1.069 . . . . 25.0 108.136 -178.616 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 21.7 pt20 -118.44 158.2 25.76 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.986 -1.857 . . . . 25.0 105.986 169.011 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.67 167.37 39.95 Favored Glycine 0 CA--C 1.507 -0.435 0 N-CA-C 110.747 -0.941 . . . . 25.0 110.747 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 pt -75.86 145.56 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.291 -1.374 . . . . 25.0 107.291 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 26' ' ' PHE . 40.9 t -140.26 133.6 15.09 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 -179.298 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.12 108.4 1.95 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 116.374 -1.951 . . . . 25.0 110.246 172.779 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.18 -18.62 58.15 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-N 115.565 -0.743 . . . . 25.0 114.112 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -65.19 -18.48 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.59 -0.359 . . . . 25.0 111.062 176.65 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -90.47 4.51 50.85 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.969 -0.457 . . . . 25.0 111.736 176.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.422 HD11 HG11 ' A' ' 57' ' ' VAL . 59.9 mt -122.85 157.23 32.94 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.628 0.603 . . . . 25.0 112.628 -173.302 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -125.08 117.78 24.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.88 -0.785 . . . . 25.0 108.88 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 116.105 -0.498 . . . . 25.0 112.171 -174.75 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 115.186 1.55 . . . . 25.0 115.186 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 t30 49.91 42.35 24.14 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.1 p -116.4 161.95 14.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 103.685 -2.709 . . . . 25.0 103.685 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.52 156.93 45.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.179 0.899 . . . . 25.0 109.714 -177.918 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.85 151.78 43.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.654 -0.703 . . . . 25.0 110.4 -174.578 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -97.63 133.33 42.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 174.828 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.74 137.06 43.75 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.417 0.627 . . . . 25.0 109.378 176.331 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.29 -26.66 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.458 -0.792 . . . . 25.0 109.541 178.203 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -127.26 159.47 34.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 -178.335 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -100.06 163.5 12.4 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.29 0.636 . . . . 25.0 109.481 178.636 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.21 160.29 43.92 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.311 -0.996 . . . . 25.0 108.311 -178.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.15 133.42 68.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 102.391 -3.188 . . . . 25.0 102.391 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.94 143.47 27.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.96 -0.385 . . . . 25.0 109.96 -175.143 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -122.34 -23.97 5.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.553 0.533 . . . . 25.0 110.662 173.507 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.3 m -85.46 147.22 46.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 176.574 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -71.63 -20.36 26.85 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.968 -1.555 . . . . 25.0 113.718 -178.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -86.15 -4.5 59.18 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.763 0.425 . . . . 25.0 111.099 179.436 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.91 143.08 28.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.927 0.491 . . . . 25.0 111.128 -175.196 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mt -96.49 133.5 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.82 -0.55 . . . . 25.0 111.611 177.474 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.2 t -88.75 85.06 6.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.446 ' CE1' HG13 ' A' ' 57' ' ' VAL . 47.7 p90 -96.46 160.33 14.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.347 -0.612 . . . . 25.0 109.347 -179.063 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -129.56 152.87 48.61 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 122.202 -0.311 . . . . 25.0 110.742 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -60.11 136.25 57.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 25.0 109.813 178.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.35 -27.54 13.33 Favored Glycine 0 C--N 1.321 -0.286 0 CA-C-N 115.418 -0.81 . . . . 25.0 113.053 -178.092 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -73.57 162.53 29.13 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.075 0.437 . . . . 25.0 111.048 -178.063 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.67 129.54 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 122.91 0.484 . . . . 25.0 110.227 -174.096 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -132.24 146.22 51.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.088 0.471 . . . . 25.0 110.937 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.0 m -85.19 132.0 34.35 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.77 126.79 51.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -101.83 -50.7 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 25.0 111.1 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -136.3 170.45 16.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.34 0.656 . . . . 25.0 110.097 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -133.25 155.49 49.27 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.447 -1.686 . . . . 25.0 106.447 174.704 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.6 t0 56.89 41.95 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.133 1.444 . . . . 25.0 109.213 -177.481 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 t -76.29 4.58 8.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.235 -1.348 . . . . 25.0 113.507 -174.196 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -139.49 -0.68 1.75 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.956 0.724 . . . . 25.0 112.956 -177.304 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.32 -2.61 87.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 108.383 -1.887 . . . . 25.0 108.383 -170.248 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.7 mt -96.02 110.09 22.38 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.734 -1.951 . . . . 25.0 105.734 174.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.89 150.11 47.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.672 -1.233 . . . . 25.0 107.672 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.97 -16.12 44.29 Favored Glycine 0 C--O 1.222 -0.63 0 CA-C-O 119.089 -0.839 . . . . 25.0 113.337 -178.3 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -93.37 133.84 36.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.831 1.316 . . . . 25.0 108.877 177.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -118.94 146.28 45.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.195 -0.669 . . . . 25.0 109.195 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -84.07 113.97 21.41 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 106.052 -1.833 . . . . 25.0 106.052 176.138 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.5 m -116.9 166.22 12.42 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.977 -0.379 . . . . 25.0 109.977 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -129.28 132.22 47.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.795 -0.446 . . . . 25.0 109.795 175.127 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -150.95 137.57 18.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.414 -0.958 . . . . 25.0 108.414 -176.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 54.53 32.69 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.776 1.028 . . . . 25.0 113.776 177.106 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -0.54 89.24 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 114.825 0.69 . . . . 25.0 114.825 177.727 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -111.81 162.76 14.93 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.906 -1.146 . . . . 25.0 107.906 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -117.25 155.5 29.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.298 -2.482 . . . . 25.0 104.298 170.158 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.77 164.98 34.31 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.4 -0.68 . . . . 25.0 111.4 179.118 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -80.41 142.63 13.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.615 0.721 . . . . 25.0 110.239 -177.824 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.446 HG13 ' CE1' ' A' ' 26' ' ' PHE . 77.7 t -140.43 133.08 14.63 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.235 -1.024 . . . . 25.0 108.235 -177.665 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 115.046 -2.836 . . . . 25.0 110.449 174.794 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.72 -20.49 68.29 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 115.033 0.773 . . . . 25.0 115.033 -173.109 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.03 -8.44 49.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.369 0.584 . . . . 25.0 111.705 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -98.46 6.45 47.2 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.091 -0.381 . . . . 25.0 110.609 175.549 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.94 143.95 45.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.939 0.4 . . . . 25.0 111.487 -176.071 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -111.16 117.64 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.709 -1.589 . . . . 25.0 106.709 173.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 ' H ' ' A' ' 64' ' ' ILE . 4.0 mp . . . . . 0 C--O 1.242 0.71 0 CA-C-N 116.19 -0.459 . . . . 25.0 111.039 -177.882 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 119.841 -0.123 . . . . 25.0 110.958 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.0 t30 55.53 42.2 29.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.215 0.531 . . . . 25.0 111.934 178.018 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.92 172.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.998 -1.853 . . . . 25.0 105.998 176.885 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 162.53 34.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.423 0.63 . . . . 25.0 110.956 -177.304 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.69 150.09 36.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.016 -0.993 . . . . 25.0 110.42 -178.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -99.53 136.67 39.12 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.595 -0.891 . . . . 25.0 108.595 176.35 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.33 46.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.982 0.42 . . . . 25.0 109.995 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.98 -24.98 14.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.721 -0.672 . . . . 25.0 110.372 178.428 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -123.69 158.27 31.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.795 -1.928 . . . . 25.0 105.795 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.512 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.4 p-10 -103.02 144.33 31.42 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 175.399 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -148.9 122.29 9.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.375 -0.375 . . . . 25.0 110.421 -175.447 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.91 130.5 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 175.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.91 8.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.945 0.402 . . . . 25.0 111.477 -175.564 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -89.39 -11.54 42.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.435 0.636 . . . . 25.0 109.807 176.714 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 m -122.86 146.31 47.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -23.11 27.83 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 117.388 -1.275 . . . . 25.0 114.873 -174.794 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -77.66 -20.52 53.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.15 0.5 . . . . 25.0 110.567 -178.035 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.42 152.35 25.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.211 -1.033 . . . . 25.0 108.211 178.847 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 139.76 32.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.929 0.395 . . . . 25.0 111.093 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -84.66 126.56 33.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 172.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.18 163.98 37.6 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -129.78 154.23 47.43 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.762 -0.586 . . . . 25.0 109.943 176.266 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.512 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 53.3 pttt -56.97 135.12 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.379 0.609 . . . . 25.0 110.198 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.02 -25.66 27.43 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.127 -0.942 . . . . 25.0 112.669 -175.311 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -72.65 155.89 39.54 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.117 0.458 . . . . 25.0 110.33 -179.283 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.4 mm -117.06 129.02 74.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.375 0.67 . . . . 25.0 109.67 -175.552 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -130.89 149.61 52.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.579 0.705 . . . . 25.0 110.525 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.3 m -84.88 128.28 34.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.541 -0.911 . . . . 25.0 108.541 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.64 123.47 46.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.066 -1.457 . . . . 25.0 107.066 177.098 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.39 -42.94 9.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.6 -0.727 . . . . 25.0 111.787 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -156.31 171.31 20.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.123 -1.066 . . . . 25.0 108.123 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -134.21 157.13 47.05 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 107.287 -1.375 . . . . 25.0 107.287 -178.106 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t0 60.11 38.47 20.39 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 123.341 1.543 . . . . 25.0 107.691 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -70.51 -12.27 61.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.578 -1.646 . . . . 25.0 114.055 -171.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.16 13.88 6.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.836 0.31 . . . . 25.0 111.836 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.99 18.89 79.23 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.365 -1.094 . . . . 25.0 110.365 -176.504 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.44 114.84 22.93 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 178.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -62.18 144.32 55.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.124 0.964 . . . . 25.0 109.453 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 -16.16 40.89 Favored Glycine 0 C--O 1.217 -0.926 0 CA-C-O 118.876 -0.958 . . . . 25.0 114.112 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -89.58 131.12 35.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.325 1.563 . . . . 25.0 109.94 178.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -120.53 146.19 46.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.976 -0.749 . . . . 25.0 108.976 -175.647 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.1 tp -86.43 115.35 23.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.457 -1.683 . . . . 25.0 106.457 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -112.75 158.47 20.05 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 -178.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -124.99 126.24 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 178.239 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -159.23 148.42 18.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.316 -1.364 . . . . 25.0 107.316 -174.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 58.24 25.84 13.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.734 0.778 . . . . 25.0 112.494 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.68 88.98 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 114.834 0.693 . . . . 25.0 114.834 176.301 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -136.16 162.73 32.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 117.773 0.786 . . . . 25.0 110.636 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -96.08 160.61 14.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.242 -1.021 . . . . 25.0 108.242 175.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.75 161.97 34.91 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.917 -1.673 . . . . 25.0 108.917 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 pt -81.77 143.86 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.13 133.95 13.38 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.46 114.39 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 116.524 -1.85 . . . . 25.0 111.033 175.088 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.02 -21.79 66.12 Favored Glycine 0 C--O 1.223 -0.584 0 N-CA-C 116.165 1.226 . . . . 25.0 116.165 -173.344 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -67.54 -16.88 64.43 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.879 . . . . 25.0 110.542 177.145 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -93.1 9.33 36.33 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.451 -0.156 . . . . 25.0 110.83 177.554 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -121.34 154.69 36.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.168 0.509 . . . . 25.0 110.852 -178.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -119.07 116.28 26.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.086 -1.079 . . . . 25.0 108.086 175.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 175.972 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 114.604 1.335 . . . . 25.0 114.604 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.3 t30 49.91 42.32 24.08 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.574 2.064 . . . . 25.0 116.574 175.466 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -118.05 164.68 14.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 N-CA-C 105.227 -2.138 . . . . 25.0 105.227 170.357 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.57 157.86 42.51 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.681 0.753 . . . . 25.0 109.611 -173.767 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.37 162.59 32.61 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.423 -0.808 . . . . 25.0 110.119 -172.727 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.2 134.99 47.38 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.515 -1.291 . . . . 25.0 107.515 178.095 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 120.04 19.77 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.856 -1.164 . . . . 25.0 107.856 173.85 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.56 -16.86 31.49 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.946 -0.39 . . . . 25.0 109.946 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -138.75 169.25 18.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.156 -1.424 . . . . 25.0 107.156 -176.7 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -104.01 164.97 11.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.824 0.449 . . . . 25.0 111.958 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -156.31 156.73 34.5 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.435 0.694 . . . . 25.0 111.38 175.983 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -125.55 129.55 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.919 -2.623 . . . . 25.0 103.919 171.737 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.27 130.6 41.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.739 0.644 . . . . 25.0 112.739 -177.365 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -100.57 -41.53 6.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.59 -1.633 . . . . 25.0 106.59 175.685 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -85.33 147.97 48.6 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.51 -15.2 27.74 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 119.123 0.722 . . . . 25.0 113.346 175.82 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 -18.64 49.73 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 121.404 0.621 . . . . 25.0 110.504 177.938 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -87.5 154.08 20.92 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.643 1.211 . . . . 25.0 110.28 -173.523 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.81 136.92 42.58 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 120.691 -1.256 . . . . 25.0 110.551 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.28 125.13 31.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.119 -2.549 . . . . 25.0 104.119 169.176 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -137.72 159.33 42.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 177.846 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -124.49 152.12 43.77 Favored 'General case' 0 CA--C 1.491 -1.314 0 O-C-N 121.701 -0.624 . . . . 25.0 112.345 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -57.02 123.08 13.93 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.187 -0.915 . . . . 25.0 111.558 178.146 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -12.76 49.99 Favored Glycine 0 C--O 1.236 0.227 0 CA-C-O 118.944 -0.92 . . . . 25.0 113.859 179.908 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.65 160.13 25.13 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.253 0.62 . . . . 25.0 111.946 -176.382 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.14 136.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.385 0.674 . . . . 25.0 109.311 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -144.86 151.6 38.99 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.518 -0.739 . . . . 25.0 111.078 179.374 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -82.57 132.25 35.2 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.566 -0.288 . . . . 25.0 110.833 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.3 t -88.81 122.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 174.77 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.6 mt -92.67 -51.28 5.18 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.184 0.516 . . . . 25.0 110.402 -176.648 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -137.15 163.82 29.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.868 -1.901 . . . . 25.0 105.868 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -131.35 148.45 52.67 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.85 38.94 30.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.205 1.566 . . . . 25.0 108.133 -177.749 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -67.76 -13.45 62.13 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.012 -1.904 . . . . 25.0 115.359 -175.157 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.78 0.01 20.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.95 -0.389 . . . . 25.0 109.95 -179.248 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.77 77.72 Favored Glycine 0 CA--C 1.511 -0.196 0 N-CA-C 109.263 -1.535 . . . . 25.0 109.263 -174.524 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.39 116.72 29.07 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 106.53 -1.656 . . . . 25.0 106.53 177.045 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.67 138.77 58.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 178.588 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 0.74 72.36 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.43 -1.206 . . . . 25.0 113.54 178.616 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -109.59 115.92 30.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.733 1.766 . . . . 25.0 111.21 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -109.5 144.65 37.48 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.348 -0.845 . . . . 25.0 112.093 -173.535 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.5 tp -82.56 122.27 27.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.649 -1.982 . . . . 25.0 105.649 175.563 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.2 m -120.07 161.49 20.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 177.495 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.3 t -125.88 133.78 51.81 Favored 'General case' 0 C--O 1.256 1.425 0 C-N-CA 123.476 0.711 . . . . 25.0 109.729 177.258 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -160.88 138.52 9.36 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.888 -1.051 . . . . 25.0 108.884 -177.004 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 t60 58.24 34.9 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.525 0.679 . . . . 25.0 112.675 176.939 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.55 2.34 63.61 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 121.245 -0.502 . . . . 25.0 113.85 177.442 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -115.06 160.29 19.81 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.237 -2.135 . . . . 25.0 105.237 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -137.35 143.41 42.0 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 103.007 -2.96 . . . . 25.0 103.007 175.457 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 174.67 43.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.831 -1.308 . . . . 25.0 109.831 -174.501 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -83.12 140.44 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.675 0.75 . . . . 25.0 112.066 -172.759 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.4 131.3 15.07 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.044 -1.435 . . . . 25.0 108.843 -176.731 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.13 119.14 6.16 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 114.813 -2.992 . . . . 25.0 112.873 175.316 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.42 -16.84 69.89 Favored Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 119.466 -0.63 . . . . 25.0 114.175 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.82 -15.35 63.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 120.553 -0.459 . . . . 25.0 110.374 174.518 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -101.42 8.79 42.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.942 0.349 . . . . 25.0 111.942 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 mt -117.66 149.23 41.07 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.284 1.04 . . . . 25.0 111.818 -173.055 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -120.32 120.66 36.66 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.583 -1.266 . . . . 25.0 107.583 174.236 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 C--O 1.247 0.972 0 O-C-N 123.656 0.598 . . . . 25.0 109.848 -179.952 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 114.932 1.456 . . . . 25.0 114.932 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 t30 51.66 40.38 27.22 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.103 1.149 . . . . 25.0 114.103 -178.476 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.72 172.54 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 105.563 -2.014 . . . . 25.0 105.563 177.08 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.7 156.69 48.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.705 0.684 . . . . 25.0 110.162 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.29 158.6 43.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.21 -0.904 . . . . 25.0 111.059 -173.633 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.8 134.65 48.57 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.367 -0.975 . . . . 25.0 108.367 175.231 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.77 130.29 39.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.742 -0.466 . . . . 25.0 109.742 178.026 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.35 -26.29 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.946 -0.57 . . . . 25.0 109.571 179.306 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -126.28 162.55 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 -179.399 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 25.3 p-10 -103.89 151.21 23.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.864 -0.421 . . . . 25.0 109.864 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -144.58 126.88 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.155 -0.475 . . . . 25.0 110.885 -176.921 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.7 t -92.04 126.99 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 102.983 -2.969 . . . . 25.0 102.983 174.277 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.46 114.85 5.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 -179.084 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -99.05 -10.97 21.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.724 0.773 . . . . 25.0 108.981 179.18 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 t -116.03 146.72 37.7 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 106.873 -1.528 . . . . 25.0 106.873 172.708 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.68 -18.71 32.47 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 115.819 -2.321 . . . . 25.0 113.618 177.328 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -79.96 -15.71 56.7 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.039 0.923 . . . . 25.0 110.348 179.304 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -86.38 142.68 28.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.653 -0.703 . . . . 25.0 110.19 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 134.25 34.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.741 -0.466 . . . . 25.0 109.741 178.25 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.39 118.67 25.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 175.343 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.445 ' CE2' HG13 ' A' ' 57' ' ' VAL . 53.9 p90 -143.91 164.57 30.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -178.481 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -131.58 157.1 44.52 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 121.254 0.55 . . . . 25.0 112.056 179.58 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.542 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.0 pttt -56.69 131.67 49.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.468 -0.787 . . . . 25.0 108.987 179.191 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.07 -25.7 25.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.692 -0.686 . . . . 25.0 113.321 -176.651 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.17 161.85 30.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.216 0.508 . . . . 25.0 111.826 -176.456 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.12 131.17 73.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.241 -1.022 . . . . 25.0 108.241 -177.427 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -139.81 154.02 47.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.058 -0.349 . . . . 25.0 110.058 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -87.79 131.02 34.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.583 -1.265 . . . . 25.0 107.583 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.9 t -95.48 116.27 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.327 -2.101 . . . . 25.0 105.327 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.45 -45.66 10.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.4 -0.818 . . . . 25.0 109.636 -176.475 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -146.09 169.47 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.96 -0.756 . . . . 25.0 108.96 -177.458 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -129.58 156.03 44.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.16 33.9 23.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.147 1.451 . . . . 25.0 109.286 174.629 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.8 t -70.53 -19.01 62.94 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.594 1.701 . . . . 25.0 115.594 -168.005 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -101.26 2.59 40.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.135 0.493 . . . . 25.0 110.362 -175.61 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.34 -2.36 87.25 Favored Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.003 -1.639 . . . . 25.0 109.003 -172.503 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -100.83 119.37 38.56 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 176.78 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -60.17 136.12 57.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.507 0.67 . . . . 25.0 109.218 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.3 -2.35 86.57 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 115.693 1.037 . . . . 25.0 115.693 177.828 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -99.94 116.91 33.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.312 1.556 . . . . 25.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -107.05 148.13 29.12 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.094 -0.379 . . . . 25.0 110.806 -171.644 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.0 tp -87.93 113.45 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.765 -1.569 . . . . 25.0 106.765 176.727 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.14 160.28 21.28 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.2 -0.2 . . . . 25.0 110.749 179.707 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -119.9 128.93 54.08 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.263 0.554 . . . . 25.0 109.594 175.344 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 tp -162.29 152.83 17.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.114 -1.81 . . . . 25.0 106.114 -177.735 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 58.57 27.75 16.12 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.459 0.647 . . . . 25.0 112.737 177.009 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.5 16.66 77.54 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.803 -0.713 . . . . 25.0 114.11 178.347 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.52 21.99 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.836 -0.802 . . . . 25.0 108.836 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -109.3 156.92 19.39 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.141 -2.17 . . . . 25.0 105.141 173.232 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.5 37.47 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 108.87 -1.692 . . . . 25.0 108.87 177.53 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.3 pt -78.83 145.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.504 0.669 . . . . 25.0 109.255 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.445 HG13 ' CE2' ' A' ' 26' ' ' PHE . 55.2 t -140.39 134.2 15.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 -178.491 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 106.49 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 117.261 -1.36 . . . . 25.0 110.559 174.258 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.21 69.83 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 116.176 1.23 . . . . 25.0 116.176 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -69.92 -8.44 48.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.534 0.667 . . . . 25.0 111.373 178.364 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -93.68 6.28 48.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.03 -0.419 . . . . 25.0 110.451 175.492 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.3 mt -119.15 155.2 32.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.633 -0.506 . . . . 25.0 109.633 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -122.34 121.57 37.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.128 -0.323 . . . . 25.0 110.128 171.347 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.6 mm . . . . . 0 C--O 1.245 0.855 0 C-N-CA 123.278 0.631 . . . . 25.0 109.884 177.924 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 113.045 0.757 . . . . 25.0 113.045 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.57 48.47 16.93 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.777 1.028 . . . . 25.0 113.777 -179.123 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 m -112.79 172.7 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 103.469 -2.789 . . . . 25.0 103.469 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 155.42 50.23 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.61 0.719 . . . . 25.0 110.944 -177.822 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.71 153.08 44.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.781 -1.1 . . . . 25.0 110.901 -175.951 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -95.52 133.59 39.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 176.828 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.59 123.99 24.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.047 -0.723 . . . . 25.0 109.047 171.37 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.89 -25.98 21.84 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 108.946 -0.761 . . . . 25.0 108.946 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.27 166.51 20.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 -178.478 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.95 159.18 15.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.581 0.229 . . . . 25.0 110.71 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -151.49 143.61 23.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.989 -0.551 . . . . 25.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -117.41 126.17 74.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 102.591 -3.114 . . . . 25.0 102.591 174.219 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 127.92 34.07 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.812 0.339 . . . . 25.0 111.2 -174.352 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -97.84 -6.14 33.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.066 0.936 . . . . 25.0 109.193 179.816 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -141.55 153.15 65.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.773 . . . . 25.0 108.949 -177.082 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.13 -22.83 46.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 116.99 -1.54 . . . . 25.0 112.869 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -73.76 -19.75 60.69 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.482 0.489 . . . . 25.0 110.512 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -95.3 153.08 17.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.963 0.411 . . . . 25.0 111.939 -172.297 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.52 138.33 36.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.699 1.0 . . . . 25.0 113.699 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -87.02 136.87 32.77 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.838 -1.542 . . . . 25.0 106.838 172.376 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -160.81 162.35 32.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -129.19 158.34 39.29 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.387 -0.821 . . . . 25.0 111.319 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -53.77 131.97 40.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.18 -0.918 . . . . 25.0 109.951 178.725 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.01 -23.18 36.83 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.618 -0.719 . . . . 25.0 113.166 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.68 157.19 38.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.115 0.957 . . . . 25.0 110.791 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -120.79 131.02 73.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 -176.039 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -131.47 152.21 50.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.065 0.46 . . . . 25.0 111.332 178.186 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 m -84.76 132.02 34.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 25.0 107.972 177.293 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.9 t -96.03 123.05 48.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 106.282 -1.747 . . . . 25.0 106.282 176.093 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -93.42 -39.79 10.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.561 -0.745 . . . . 25.0 110.823 -174.2 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -159.81 171.92 18.6 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.608 -0.886 . . . . 25.0 108.608 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -120.92 160.98 22.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.97 -1.122 . . . . 25.0 107.97 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.3 42.73 22.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.34 1.067 . . . . 25.0 110.837 179.204 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -68.72 -22.02 64.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.491 -176.767 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' C ' ' H ' ' A' ' 42' ' ' LEU . 2.3 tp60 -97.83 1.02 47.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 25.0 110.133 179.603 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 -20.13 8.13 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.159 -1.176 . . . . 25.0 110.159 -172.542 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 40' ' ' GLN . 95.8 mt -78.19 133.49 37.76 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.993 -1.854 . . . . 25.0 105.993 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.72 153.9 42.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.727 0.775 . . . . 25.0 110.702 -177.075 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.5 -19.65 4.7 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 115.557 0.983 . . . . 25.0 115.557 177.095 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -84.33 107.12 16.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.715 1.258 . . . . 25.0 111.291 -179.404 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -96.81 147.31 24.07 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.061 -0.348 . . . . 25.0 110.061 -176.007 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.1 tp -85.72 117.3 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.765 -1.939 . . . . 25.0 105.765 172.916 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 63.9 m -120.28 163.24 18.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.387 -0.597 . . . . 25.0 109.387 179.294 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -124.51 125.82 44.84 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.037 0.535 . . . . 25.0 111.774 -179.658 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.69 153.09 18.61 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 106.946 -1.501 . . . . 25.0 106.946 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 59.06 36.3 24.21 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.825 0.821 . . . . 25.0 110.912 178.575 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 14.32 59.3 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 115.518 0.967 . . . . 25.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -142.36 163.86 31.71 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 118.002 0.901 . . . . 25.0 109.195 177.591 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.85 154.73 26.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 173.987 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.13 169.56 41.51 Favored Glycine 0 C--O 1.248 0.971 0 N-CA-C 108.416 -1.873 . . . . 25.0 108.416 -177.684 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.03 143.08 13.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 117.217 0.508 . . . . 25.0 110.441 -177.764 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -140.07 131.53 14.4 Favored Pre-proline 0 C--O 1.242 0.681 0 C-N-CA 123.765 0.826 . . . . 25.0 108.833 178.583 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.09 119.4 6.33 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 115.29 -2.673 . . . . 25.0 111.156 177.054 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.55 -25.74 61.28 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 114.893 0.717 . . . . 25.0 114.893 -175.77 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.5 -21.3 66.25 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.865 0.364 . . . . 25.0 111.747 178.395 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.35 3.57 53.33 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.66 -0.65 . . . . 25.0 112.257 178.157 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.51 154.98 30.53 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.99 0.424 . . . . 25.0 112.031 -177.31 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -123.17 117.95 26.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.533 -0.303 . . . . 25.0 110.366 171.442 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 C--N 1.321 -0.634 0 O-C-N 123.88 0.738 . . . . 25.0 109.697 179.468 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 112.983 0.734 . . . . 25.0 112.983 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.4 m120 45.59 48.32 11.22 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.227 1.011 . . . . 25.0 113.471 178.014 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.96 151.92 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 106.605 -1.628 . . . . 25.0 106.605 179.449 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 162.43 13.41 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.137 0.494 . . . . 25.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.06 154.05 42.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.285 -0.87 . . . . 25.0 111.373 172.085 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -107.66 133.72 51.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.167 0.987 . . . . 25.0 109.628 -179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 134.95 45.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 124.525 1.141 . . . . 25.0 111.359 175.902 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.51 -34.06 12.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.832 0.825 . . . . 25.0 109.918 177.323 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.86 165.24 14.86 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 106.642 -1.614 . . . . 25.0 106.642 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.494 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.8 p-10 -103.48 155.85 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.992 0.36 . . . . 25.0 111.93 177.588 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.56 98.48 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.705 0.802 . . . . 25.0 108.953 -177.867 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -78.52 140.06 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 172.42 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.43 140.9 54.14 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 123.488 0.715 . . . . 25.0 112.395 -173.062 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -110.74 -9.72 14.49 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 114.333 -1.303 . . . . 25.0 110.864 174.93 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -131.44 158.64 74.73 Favored Pre-proline 0 N--CA 1.475 0.81 0 O-C-N 121.248 -0.907 . . . . 25.0 110.707 -178.532 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -71.14 -21.98 26.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 116.69 -1.74 . . . . 25.0 113.995 -179.699 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -16.14 59.49 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 124.297 0.998 . . . . 25.0 109.491 -179.732 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -98.0 150.64 21.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 122.121 0.962 . . . . 25.0 110.28 -168.857 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.04 133.86 42.7 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.595 -0.691 . . . . 25.0 112.039 178.899 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.66 104.18 15.82 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.363 -0.606 . . . . 25.0 109.363 179.217 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.447 ' CE2' HG13 ' A' ' 57' ' ' VAL . 52.5 p90 -134.46 162.57 31.86 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.888 -0.782 . . . . 25.0 108.888 -178.709 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -126.84 162.47 25.82 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.946 -0.761 . . . . 25.0 108.946 -179.169 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.494 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 19.8 ptpt -56.01 139.86 45.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 178.233 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.11 -14.2 59.62 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 115.611 1.005 . . . . 25.0 115.611 177.943 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.69 163.85 27.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.268 -1.012 . . . . 25.0 108.268 176.849 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.17 131.12 73.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -178.705 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.7 ptp -130.85 155.49 46.63 Favored 'General case' 0 C--O 1.251 1.158 0 O-C-N 121.627 -0.671 . . . . 25.0 111.604 176.268 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -90.65 135.92 33.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.761 -1.94 . . . . 25.0 105.761 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -96.68 126.69 49.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.148 -1.427 . . . . 25.0 107.148 176.743 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 mt -97.7 -42.85 7.43 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.298 -0.865 . . . . 25.0 110.961 -176.569 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -143.21 161.63 37.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.313 -1.366 . . . . 25.0 107.313 -178.555 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -128.16 144.38 51.11 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.843 -0.799 . . . . 25.0 108.843 173.241 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 59.03 43.15 18.04 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.427 -1.323 . . . . 25.0 107.427 -177.739 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -68.99 -15.11 63.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.722 1.749 . . . . 25.0 115.722 -172.335 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.79 16.63 13.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 122.409 1.1 . . . . 25.0 109.157 178.252 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.98 -21.91 7.4 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.31 -0.859 . . . . 25.0 112.052 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.96 119.15 12.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.905 -0.569 . . . . 25.0 109.819 176.361 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -56.34 132.64 51.51 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.711 0.767 . . . . 25.0 110.132 178.826 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.02 89.66 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.722 -1.043 . . . . 25.0 115.239 175.659 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -96.35 102.19 13.94 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.718 1.759 . . . . 25.0 110.804 179.155 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -91.71 140.35 29.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.549 -0.75 . . . . 25.0 111.917 -172.848 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.21 115.52 21.98 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.405 -1.702 . . . . 25.0 106.405 174.213 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.4 m -112.0 166.87 10.84 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 25.0 110.39 -179.702 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -135.5 125.82 26.51 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.767 -0.457 . . . . 25.0 109.767 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tt -152.34 138.86 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.123 -0.944 . . . . 25.0 108.839 -174.994 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 53.82 38.51 28.76 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 113.557 0.947 . . . . 25.0 113.557 176.527 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.66 -0.51 85.74 Favored Glycine 0 C--O 1.217 -0.965 0 CA-C-O 118.467 -1.185 . . . . 25.0 115.765 175.773 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -126.07 164.53 20.68 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 118.849 1.324 . . . . 25.0 108.193 178.417 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -113.29 164.15 13.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.101 -1.444 . . . . 25.0 107.101 176.574 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.07 162.55 31.55 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.765 -0.934 . . . . 25.0 110.765 174.581 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 pt -79.38 142.32 14.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 175.698 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.447 HG13 ' CE2' ' A' ' 26' ' ' PHE . 82.6 t -139.64 133.65 15.79 Favored Pre-proline 0 C--N 1.311 -1.078 0 C-N-CA 123.407 0.683 . . . . 25.0 109.525 -175.363 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.2 114.79 3.17 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 116.471 -1.886 . . . . 25.0 112.161 175.937 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.66 -16.58 72.14 Favored Glycine 0 C--O 1.21 -1.352 0 C-N-CA 119.567 -1.301 . . . . 25.0 115.133 -173.552 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.8 -16.01 62.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.518 1.159 . . . . 25.0 111.722 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -94.65 8.48 42.24 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.594 -0.73 . . . . 25.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.08 157.06 29.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.118 0.961 . . . . 25.0 109.92 -177.047 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.05 122.31 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.346 -0.843 . . . . 25.0 108.758 174.382 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.7 mm . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -179.839 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 C--O 1.204 -1.311 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.0 t30 53.12 42.33 32.18 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 113.521 0.934 . . . . 25.0 113.521 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -112.44 147.17 16.37 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.718 0 N-CA-C 105.188 -2.153 . . . . 25.0 105.188 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.65 155.38 46.68 Favored 'General case' 0 C--O 1.267 2.024 0 CA-C-N 119.611 1.096 . . . . 25.0 112.521 177.906 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.5 161.72 36.8 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.897 -1.047 . . . . 25.0 111.021 -170.166 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -110.68 132.27 54.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.378 0.671 . . . . 25.0 110.574 177.261 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.66 127.52 33.32 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.544 0.688 . . . . 25.0 110.247 178.126 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.0 mt -93.44 -23.91 18.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 -179.255 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -126.4 165.36 19.19 Favored 'General case' 0 C--O 1.202 -1.432 0 N-CA-C 109.866 -0.42 . . . . 25.0 109.866 178.162 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -100.77 160.85 14.02 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.725 0.81 . . . . 25.0 109.742 178.274 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -148.2 135.79 20.7 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 113.158 0.799 . . . . 25.0 113.158 -177.731 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -94.89 119.81 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 168.159 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.68 116.93 12.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 -177.945 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.11 -21.28 29.35 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.714 1.245 . . . . 25.0 111.798 -178.98 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -133.44 154.13 80.75 Favored Pre-proline 0 C--O 1.215 -0.751 0 CA-C-N 115.477 -0.783 . . . . 25.0 109.948 -170.762 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.48 -21.54 60.13 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 116.22 1.585 . . . . 25.0 116.22 -178.981 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.24 -19.89 45.8 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.058 0.932 . . . . 25.0 110.273 176.425 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -81.87 140.33 34.18 Favored 'General case' 0 C--O 1.195 -1.771 0 O-C-N 121.022 -1.049 . . . . 25.0 112.246 -176.344 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.02 135.99 33.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 123.566 1.65 . . . . 25.0 110.627 177.725 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.28 110.17 18.88 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.801 -1.545 . . . . 25.0 108.192 176.212 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 57' ' ' VAL . 53.8 p90 -135.87 166.39 23.41 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.405 0.621 . . . . 25.0 112.424 -176.282 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -128.4 152.79 47.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 -179.203 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -62.27 139.64 58.5 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.828 -1.175 . . . . 25.0 107.828 175.413 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -22.51 40.58 Favored Glycine 0 C--O 1.264 2.02 0 CA-C-O 117.843 -1.531 . . . . 25.0 110.284 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.19 166.17 23.06 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 119.468 1.634 . . . . 25.0 109.977 -176.616 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -121.71 132.24 71.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 114.781 -1.099 . . . . 25.0 110.253 -174.519 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.6 ptp -139.96 155.53 47.09 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 124.028 0.83 . . . . 25.0 112.071 -178.602 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -93.41 138.68 31.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 -179.406 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -103.02 119.22 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 106.787 -1.56 . . . . 25.0 106.787 177.744 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.9 mt -93.87 -41.04 9.84 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.341 -1.3 . . . . 25.0 111.555 -174.166 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -149.27 159.19 44.48 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 104.978 -2.23 . . . . 25.0 104.978 -177.479 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -130.73 149.11 52.53 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 101.496 -3.52 . . . . 25.0 101.496 178.795 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 t0 62.86 34.55 14.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.997 0.919 . . . . 25.0 108.583 -177.464 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -66.24 -20.63 66.17 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.363 1.616 . . . . 25.0 115.363 -177.387 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -5.97 21.76 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.239 -0.891 . . . . 25.0 112.292 -177.391 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.9 -6.47 83.44 Favored Glycine 0 N--CA 1.464 0.52 0 CA-C-O 122.597 1.11 . . . . 25.0 111.48 -170.388 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.1 mt -94.14 118.69 31.91 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 106.912 -1.514 . . . . 25.0 106.912 177.584 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -56.83 126.68 28.04 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 106.997 -1.483 . . . . 25.0 106.997 171.831 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.0 64.37 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-O 116.634 -2.203 . . . . 25.0 115.302 178.25 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -104.52 125.81 51.03 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 120.772 2.286 . . . . 25.0 110.025 171.235 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -116.61 148.68 40.72 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.438 -1.319 . . . . 25.0 107.438 -176.054 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.3 tp -92.33 113.35 25.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.847 -1.538 . . . . 25.0 106.847 178.276 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.2 m -121.94 157.1 31.98 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.47 0.652 . . . . 25.0 110.121 -177.539 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -118.64 133.43 55.86 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.063 0.945 . . . . 25.0 110.097 173.279 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.2 138.93 19.75 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 124.625 1.203 . . . . 25.0 109.45 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t60 57.86 29.35 17.4 Favored 'General case' 0 C--O 1.183 -2.428 0 O-C-N 124.218 0.949 . . . . 25.0 110.727 173.287 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.76 -2.24 74.76 Favored Glycine 0 N--CA 1.473 1.159 0 C-N-CA 118.922 -1.609 . . . . 25.0 113.443 -179.31 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -107.12 167.4 9.93 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.081 -1.822 . . . . 25.0 106.081 -179.919 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -141.34 144.5 34.59 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 103.493 -2.78 . . . . 25.0 103.493 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -177.85 47.53 Favored Glycine 0 CA--C 1.545 1.96 0 O-C-N 125.394 1.684 . . . . 25.0 110.208 179.291 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.06 143.08 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.29 0.545 . . . . 25.0 111.042 -174.331 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 26' ' ' PHE . 79.3 t -139.08 136.21 18.03 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 -172.16 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.66 112.42 3.05 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 CA-C-O 122.819 1.091 . . . . 25.0 111.828 172.594 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -26.26 63.42 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-N 115.407 -0.815 . . . . 25.0 115.038 -179.313 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -68.89 -15.3 63.46 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.678 0.739 . . . . 25.0 109.913 179.622 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -92.18 3.46 55.29 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 120.655 -0.418 . . . . 25.0 110.896 175.505 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -117.33 157.13 26.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.002 0.521 . . . . 25.0 111.127 -177.188 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -124.02 129.08 50.31 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.082 -1.451 . . . . 25.0 107.082 172.795 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.1 mm . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 104.484 -2.413 . . . . 25.0 104.484 -179.762 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 114.275 1.213 . . . . 25.0 114.275 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.4 t30 45.81 47.36 12.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.32 0.648 . . . . 25.0 112.258 -178.073 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.97 165.35 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 105.751 -1.944 . . . . 25.0 105.751 165.673 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.32 156.2 45.24 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 115.507 -0.769 . . . . 25.0 109.518 -177.139 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.55 162.47 35.0 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 123.896 0.878 . . . . 25.0 110.894 -175.211 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -101.45 133.57 45.89 Favored 'General case' 0 C--O 1.206 -1.23 0 O-C-N 124.185 0.928 . . . . 25.0 108.631 172.246 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 130.5 39.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 105.616 -1.994 . . . . 25.0 105.616 174.731 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.32 -16.54 22.32 Favored 'General case' 0 C--O 1.264 1.82 0 O-C-N 121.439 -0.788 . . . . 25.0 110.44 -178.72 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -135.85 164.78 27.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.383 -1.339 . . . . 25.0 107.383 -178.847 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -100.5 161.01 13.88 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 109.036 -0.727 . . . . 25.0 109.036 -175.995 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -147.97 136.24 21.38 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 123.863 1.792 . . . . 25.0 111.922 178.731 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.85 122.38 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.8 -1.187 . . . . 25.0 108.719 169.72 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.27 115.41 22.45 Favored 'General case' 0 CA--C 1.565 1.558 0 O-C-N 124.041 0.838 . . . . 25.0 109.386 -177.657 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.54 -20.63 14.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.272 -0.876 . . . . 25.0 111.309 177.049 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -96.22 151.45 38.18 Favored Pre-proline 0 C--O 1.207 -1.14 0 CA-C-N 115.36 -0.836 . . . . 25.0 110.165 177.291 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.95 -19.66 13.74 Favored 'Trans proline' 0 C--O 1.205 -1.129 0 C-N-CA 117.184 -1.41 . . . . 25.0 113.241 -179.926 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -86.08 -20.57 28.55 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.122 1.439 . . . . 25.0 109.838 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -77.5 143.95 38.08 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.947 1.092 . . . . 25.0 113.947 178.151 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.86 137.51 32.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.94 1.352 . . . . 25.0 112.522 176.231 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 p -82.06 125.09 30.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.486 -1.233 . . . . 25.0 109.653 171.957 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -150.96 172.75 15.2 Favored 'General case' 0 C--O 1.191 -2.002 0 CA-C-O 121.588 0.709 . . . . 25.0 112.449 175.676 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -134.19 163.72 28.97 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.716 -1.587 . . . . 25.0 106.716 -178.436 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -63.98 141.0 58.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.292 -1.373 . . . . 25.0 107.292 174.836 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.59 -15.36 51.79 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 117.302 1.681 . . . . 25.0 117.302 -177.01 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.5 156.81 34.78 Favored 'General case' 0 C--O 1.263 1.765 0 C-N-CA 120.522 -0.471 . . . . 25.0 110.652 173.648 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.96 130.02 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 107.553 -1.277 . . . . 25.0 107.553 -176.547 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.9 150.65 48.36 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 121.026 -1.046 . . . . 25.0 110.853 179.85 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 m -81.62 138.87 35.29 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.046 -0.979 . . . . 25.0 109.585 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.93 122.3 59.36 Favored 'Isoleucine or valine' 0 C--O 1.254 1.314 0 N-CA-C 105.759 -1.941 . . . . 25.0 105.759 178.274 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.52 -36.91 12.19 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 124.329 1.018 . . . . 25.0 113.14 -177.709 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -155.79 149.08 24.68 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 -174.515 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.13 147.87 36.47 Favored 'General case' 0 C--O 1.197 -1.669 0 CA-C-O 117.086 -1.435 . . . . 25.0 107.677 -178.645 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 55.81 44.08 26.63 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 125.252 1.595 . . . . 25.0 109.104 179.104 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -72.38 -12.92 61.33 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 116.269 1.952 . . . . 25.0 116.269 -173.7 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -115.39 3.12 14.09 Favored 'General case' 0 C--O 1.256 1.439 0 CA-C-O 121.748 0.785 . . . . 25.0 109.693 -174.795 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.41 -15.77 59.25 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.05 -1.432 . . . . 25.0 109.925 -178.401 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.34 127.07 32.87 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.462 1.331 . . . . 25.0 111.111 176.336 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.06 129.05 38.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.849 1.309 . . . . 25.0 109.776 -177.776 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.63 10.16 73.7 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 174.882 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -107.77 103.3 12.54 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 123.778 1.751 . . . . 25.0 113.019 171.346 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -97.86 152.98 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.729 -1.232 . . . . 25.0 110.744 -174.527 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.54 119.93 29.46 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.541 1.15 . . . . 25.0 108.004 174.144 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -122.09 162.58 20.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.347 -0.983 . . . . 25.0 108.347 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.1 t -127.04 133.74 50.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.637 -1.245 . . . . 25.0 107.637 174.591 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 tp -154.89 136.69 14.46 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.752 1.283 . . . . 25.0 110.287 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 59.39 31.76 21.32 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-N 114.428 -1.26 . . . . 25.0 109.771 179.249 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.67 4.69 85.44 Favored Glycine 0 CA--C 1.545 1.937 0 C-N-CA 119.816 -1.183 . . . . 25.0 113.568 -179.775 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.7 mtp85 -117.66 140.11 50.1 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.746 1.773 . . . . 25.0 107.673 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -103.51 151.93 22.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.716 -1.587 . . . . 25.0 106.716 176.118 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.15 172.29 45.21 Favored Glycine 0 C--O 1.263 1.921 0 C-N-CA 118.714 -1.708 . . . . 25.0 113.9 175.051 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -79.83 142.74 13.54 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 117.448 0.624 . . . . 25.0 109.922 -177.888 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.09 132.05 14.58 Favored Pre-proline 0 C--O 1.263 1.764 0 O-C-N 122.014 -0.429 . . . . 25.0 110.588 -174.27 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 125.89 11.69 Favored 'Trans proline' 0 C--O 1.208 -0.985 1 C-N-CA 111.387 -5.275 . . . . 25.0 111.464 178.791 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.06 -21.53 67.69 Favored Glycine 0 C--N 1.306 -1.09 0 CA-C-N 114.75 -1.114 . . . . 25.0 113.756 -171.922 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.98 -3.65 33.57 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 120.199 -1.765 . . . . 25.0 108.031 178.123 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -109.38 12.21 24.76 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.673 0.749 . . . . 25.0 110.222 176.473 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.8 mt -120.02 154.28 34.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 122.344 1.069 . . . . 25.0 111.508 177.218 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -126.89 113.85 17.09 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.412 -0.813 . . . . 25.0 109.488 171.219 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.3 mm . . . . . 0 N--CA 1.516 2.836 0 O-C-N 124.787 1.305 . . . . 25.0 108.965 175.592 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--O 1.216 -0.674 0 CA-C-O 121.184 0.516 . . . . 25.0 111.379 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.87 37.64 17.79 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.356 -1.293 . . . . 25.0 113.662 174.598 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 p -109.34 160.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 103.49 -2.782 . . . . 25.0 103.49 175.299 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 159.03 28.67 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 107.064 -1.458 . . . . 25.0 107.064 -177.869 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.88 155.71 49.9 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 124.194 0.934 . . . . 25.0 109.597 -176.299 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -98.65 137.03 37.87 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 122.789 0.435 . . . . 25.0 110.86 169.207 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.9 130.6 36.8 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.209 0.448 . . . . 25.0 112.209 172.695 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.69 -22.1 17.77 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.091 -1.078 . . . . 25.0 108.091 -177.017 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -130.99 162.79 28.99 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 125.168 1.542 . . . . 25.0 111.869 178.42 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.53 161.83 13.55 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.781 -0.574 . . . . 25.0 109.782 -179.141 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -151.52 153.85 35.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.871 0.468 . . . . 25.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.1 t -116.87 123.55 71.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.551 -1.648 . . . . 25.0 106.551 167.302 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.35 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.128 -0.983 . . . . 25.0 113.227 -178.376 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -81.9 -15.4 54.06 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.983 -1.008 . . . . 25.0 110.72 176.387 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -134.25 151.67 76.81 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 108.685 -0.857 . . . . 25.0 108.685 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.62 -11.38 26.12 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 117.722 -1.052 . . . . 25.0 112.115 -178.332 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.91 -12.33 55.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.06 0.944 . . . . 25.0 110.531 175.287 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.6 149.49 22.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.233 -0.44 . . . . 25.0 111.554 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.28 139.93 31.7 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 114.189 1.181 . . . . 25.0 114.189 177.071 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 m -85.1 80.44 9.25 Favored 'General case' 0 C--O 1.271 2.206 0 N-CA-C 109.062 -0.718 . . . . 25.0 109.062 169.381 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -86.7 157.75 19.58 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.578 -1.638 . . . . 25.0 106.578 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.66 146.51 50.53 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 107.063 -1.458 . . . . 25.0 107.063 -174.776 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.54 138.07 57.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.133 -0.627 . . . . 25.0 111.246 177.996 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.44 -16.74 47.68 Favored Glycine 0 C--O 1.255 1.437 0 CA-C-O 117.319 -1.823 . . . . 25.0 112.351 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.75 163.68 26.58 Favored 'General case' 0 C--O 1.269 2.086 0 CA-C-N 119.06 1.43 . . . . 25.0 110.642 179.884 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.5 mm -122.41 128.01 75.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.005 -1.109 . . . . 25.0 108.005 -176.057 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.73 148.12 52.55 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.654 0.74 . . . . 25.0 112.329 177.257 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -81.27 131.24 35.28 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.265 -0.88 . . . . 25.0 110.976 175.545 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.25 128.59 45.44 Favored 'Isoleucine or valine' 0 C--O 1.273 2.29 0 N-CA-C 106.771 -1.566 . . . . 25.0 106.771 179.585 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.73 -38.52 7.04 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 113.442 0.904 . . . . 25.0 113.442 -173.856 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -151.12 147.79 27.49 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.359 -0.837 . . . . 25.0 109.613 -177.131 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -113.66 156.08 24.36 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.859 -1.163 . . . . 25.0 107.859 175.377 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t0 58.34 39.83 25.03 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.187 1.47 . . . . 25.0 109.163 -177.53 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -70.04 -20.11 63.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 121.185 -0.947 . . . . 25.0 113.554 -168.3 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -115.73 6.9 14.53 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-N 118.294 0.497 . . . . 25.0 111.851 -174.193 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.98 -18.21 32.6 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.757 -1.337 . . . . 25.0 109.757 -172.922 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.6 mt -83.97 117.77 23.59 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.535 -2.024 . . . . 25.0 105.535 178.072 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.94 144.12 56.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.999 -1.111 . . . . 25.0 107.999 -175.859 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.58 81.58 Favored Glycine 0 N--CA 1.437 -1.266 0 O-C-N 121.062 -1.023 . . . . 25.0 114.971 179.798 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -97.39 116.42 29.57 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 118.328 1.064 . . . . 25.0 109.794 177.085 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -108.36 148.53 29.96 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.843 1.783 . . . . 25.0 108.914 -174.753 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -87.78 117.93 26.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.316 -1.311 . . . . 25.0 109.155 172.499 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -121.06 162.84 19.29 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.527 0.566 . . . . 25.0 112.527 -179.756 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.4 t -121.78 131.24 53.96 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.522 -0.751 . . . . 25.0 110.179 175.519 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 tp -161.49 142.88 11.39 Favored 'General case' 0 C--O 1.181 -2.541 0 CA-C-O 118.121 -0.942 . . . . 25.0 110.487 -175.887 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t60 54.18 29.76 11.06 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.917 1.081 . . . . 25.0 113.917 178.743 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.38 7.04 87.08 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 115.65 1.02 . . . . 25.0 115.65 175.571 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -123.94 164.89 18.39 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 107.458 -1.312 . . . . 25.0 107.458 175.214 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -124.97 150.75 46.33 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 105.264 -2.124 . . . . 25.0 105.264 166.548 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.0 175.0 47.51 Favored Glycine 0 C--O 1.283 3.157 0 N-CA-C 108.522 -1.831 . . . . 25.0 108.522 -178.54 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.2 pt -78.9 140.11 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 124.832 2.253 . . . . 25.0 112.066 -179.378 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -137.32 133.45 18.26 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-N 113.34 -1.755 . . . . 25.0 107.258 -178.722 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.58 118.9 5.95 Favored 'Trans proline' 0 CA--C 1.56 1.816 0 C-N-CA 114.217 -3.389 . . . . 25.0 113.068 172.631 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.65 -21.9 65.49 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 115.023 0.769 . . . . 25.0 115.023 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -56.57 -32.59 65.34 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.234 0.54 . . . . 25.0 111.417 173.179 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -92.06 5.14 51.35 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 113.838 1.051 . . . . 25.0 113.838 179.498 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.9 mt -110.0 155.98 21.09 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.454 1.121 . . . . 25.0 113.288 177.42 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -125.82 115.28 19.75 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 174.164 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm . . . . . 0 C--O 1.256 1.447 0 CA-C-N 116.165 -0.47 . . . . 25.0 111.406 176.605 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.4 mt . . . . . 0 C--O 1.249 1.063 0 N-CA-C 109.27 -0.641 . . . . 25.0 109.27 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 59.01 36.86 24.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 125.041 1.463 . . . . 25.0 111.041 177.624 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t -104.87 146.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 177.252 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 153.4 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 119.304 0.957 . . . . 25.0 111.395 -179.299 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.3 162.34 33.81 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 116.115 -0.493 . . . . 25.0 109.929 -172.92 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -110.65 140.8 44.66 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.797 -2.297 . . . . 25.0 104.797 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.87 124.98 28.77 Favored 'General case' 0 C--O 1.2 -1.509 0 O-C-N 125.275 1.609 . . . . 25.0 111.09 176.836 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -92.94 -18.83 22.27 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.665 -0.698 . . . . 25.0 110.241 -176.542 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -134.79 163.73 29.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.147 -1.798 . . . . 25.0 106.147 178.883 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -93.47 168.69 10.88 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 119.625 -0.83 . . . . 25.0 110.078 177.809 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -150.29 144.69 25.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.527 0.936 . . . . 25.0 113.527 -179.865 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -116.38 103.78 15.65 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.004 0 N-CA-C 104.082 -2.562 . . . . 25.0 104.082 176.034 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.91 127.38 32.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.076 -1.42 . . . . 25.0 111.268 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.48 -19.96 15.31 Favored 'General case' 0 C--O 1.262 1.759 0 CA-C-O 121.104 0.478 . . . . 25.0 109.715 -176.877 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -107.95 153.49 41.64 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 121.838 -0.539 . . . . 25.0 110.922 -176.467 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.06 -14.66 23.51 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 N-CA-C 113.92 0.7 . . . . 25.0 113.92 178.262 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -85.88 -10.64 54.96 Favored 'General case' 0 C--O 1.209 -1.036 0 O-C-N 124.895 1.372 . . . . 25.0 109.569 176.963 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.41 144.1 30.63 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.987 0.899 . . . . 25.0 111.137 -174.2 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -92.12 130.61 37.8 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 120.197 -1.564 . . . . 25.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 t -78.18 132.29 37.55 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 167.726 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -157.83 166.79 31.78 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.436 -1.69 . . . . 25.0 106.436 176.343 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -133.65 163.99 28.2 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.602 1.191 . . . . 25.0 109.212 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -60.28 132.72 54.79 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 114.683 -1.144 . . . . 25.0 109.952 -176.622 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.46 -5.86 84.23 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 118.286 -1.285 . . . . 25.0 115.863 -171.383 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.56 155.42 28.18 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.003 1.901 . . . . 25.0 110.501 175.436 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.05 122.54 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 123.536 0.523 . . . . 25.0 109.899 -176.491 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.2 ptp -130.69 156.5 44.82 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -175.96 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -93.99 125.82 38.84 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.264 0.626 . . . . 25.0 111.716 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.67 121.21 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.362 -1.347 . . . . 25.0 107.362 177.532 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.3 -40.33 11.55 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.768 -0.651 . . . . 25.0 110.51 178.82 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.42 168.14 27.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.606 0.763 . . . . 25.0 110.051 178.867 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -122.2 155.13 36.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.923 -1.51 . . . . 25.0 106.923 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 56.13 38.36 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.506 1.753 . . . . 25.0 111.454 177.5 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -66.36 -15.67 63.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.693 2.108 . . . . 25.0 116.693 -167.973 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -116.63 13.11 15.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 -178.999 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.22 78.08 Favored Glycine 0 C--O 1.203 -1.785 0 CA-C-O 122.706 1.17 . . . . 25.0 111.025 -177.016 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.28 116.51 21.83 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.762 -1.199 . . . . 25.0 107.762 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -65.2 115.34 5.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.306 -0.861 . . . . 25.0 108.758 176.218 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.23 0.97 47.76 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 117.554 -1.692 . . . . 25.0 115.287 178.322 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -109.45 117.95 35.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 120.452 2.126 . . . . 25.0 110.586 175.594 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -105.82 154.51 20.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.387 -1.279 . . . . 25.0 108.178 -170.8 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.5 tp -93.99 119.54 33.01 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 106.636 -1.616 . . . . 25.0 106.636 177.032 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.4 m -118.01 163.25 16.87 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 119.554 -0.859 . . . . 25.0 110.392 178.398 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.5 t -118.85 129.04 55.0 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 124.076 0.86 . . . . 25.0 112.166 173.673 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 tp -157.55 142.22 16.54 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-N 114.056 -1.429 . . . . 25.0 109.033 -176.225 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.4 t60 56.71 27.31 12.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.176 0.436 . . . . 25.0 112.176 -178.37 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.71 -3.41 74.84 Favored Glycine 0 C--O 1.246 0.856 0 CA-C-O 116.54 -2.255 . . . . 25.0 115.018 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -113.48 160.35 18.56 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.5 1.15 . . . . 25.0 108.267 -178.128 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -109.82 149.25 30.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.322 -2.103 . . . . 25.0 105.322 175.922 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.22 163.33 36.78 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.883 -1.287 . . . . 25.0 109.883 177.471 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 pt -82.64 141.54 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.419 1.104 . . . . 25.0 108.812 -179.174 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.75 137.69 20.36 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.189 -2.152 . . . . 25.0 105.189 -175.334 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -72.69 122.49 8.26 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 113.723 -3.718 . . . . 25.0 115.384 175.391 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.61 -19.95 78.19 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.509 -1.223 . . . . 25.0 113.918 -177.419 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -70.45 -8.95 54.95 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 118.716 -1.194 . . . . 25.0 112.215 172.598 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -108.93 4.37 23.3 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.589 0.709 . . . . 25.0 109.857 -179.601 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.3 mt -111.85 146.35 37.85 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-O 123.069 1.414 . . . . 25.0 112.186 179.919 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -114.65 116.92 29.49 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.525 -1.216 . . . . 25.0 111.089 170.649 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mm . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 178.727 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 CA--C 1.497 -1.074 0 N-CA-C 114.639 1.348 . . . . 25.0 114.639 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.4 t30 44.36 46.42 7.75 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.566 1.321 . . . . 25.0 114.566 -179.143 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.86 157.11 35.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 N-CA-C 103.596 -2.742 . . . . 25.0 103.596 -177.06 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.11 163.36 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.16 156.36 43.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 25.0 110.938 -177.533 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.14 137.36 37.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.217 -1.031 . . . . 25.0 108.217 174.629 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -73.82 135.04 43.44 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 172.63 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -94.24 -33.18 13.36 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 125.122 1.514 . . . . 25.0 112.103 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -121.57 162.2 21.02 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.553 -1.647 . . . . 25.0 106.553 -177.574 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.04 149.25 23.67 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 121.896 -0.502 . . . . 25.0 110.806 177.423 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -145.42 122.47 11.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.144 0.974 . . . . 25.0 111.942 -172.943 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -84.21 132.1 32.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 105.76 -1.941 . . . . 25.0 105.76 171.983 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.18 122.1 26.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.216 -0.994 . . . . 25.0 108.674 178.629 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.44 -12.15 18.79 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.504 0.722 . . . . 25.0 110.101 -178.858 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 m -127.78 152.68 77.43 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 -176.13 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.01 -15.19 23.5 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 114.866 -2.956 . . . . 25.0 112.672 -179.662 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.48 -15.06 57.66 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.578 -1.267 . . . . 25.0 107.578 -179.476 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -89.88 144.47 25.91 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.29 -0.868 . . . . 25.0 112.65 -173.387 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 128.81 37.94 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.836 -0.745 . . . . 25.0 110.607 177.52 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -73.31 131.21 41.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.834 -2.284 . . . . 25.0 104.834 171.995 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.75 167.46 30.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.089 0.471 . . . . 25.0 110.048 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -133.37 159.88 39.0 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 -178.81 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -63.0 139.62 58.79 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 107.593 -1.262 . . . . 25.0 107.593 -179.877 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -12.3 68.53 Favored Glycine 0 CA--C 1.498 -0.974 0 CA-C-N 115.209 -0.905 . . . . 25.0 112.626 179.007 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -84.75 157.54 21.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.158 -0.682 . . . . 25.0 109.158 -179.489 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 mp -128.28 131.24 69.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-O 122.03 0.919 . . . . 25.0 109.383 -176.419 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.13 144.37 50.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.661 -0.699 . . . . 25.0 111.287 -177.126 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 m -75.14 134.11 41.34 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.13 -1.063 . . . . 25.0 108.13 175.728 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.48 124.82 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.024 -1.102 . . . . 25.0 108.024 174.301 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.0 mt -96.54 -47.25 6.02 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 123.9 0.75 . . . . 25.0 112.13 -174.751 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.69 168.37 23.04 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.75 -1.944 . . . . 25.0 105.75 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -120.55 160.29 23.5 Favored 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 108.92 -0.771 . . . . 25.0 108.92 -179.261 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 51.32 42.51 29.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 123.496 1.617 . . . . 25.0 111.038 179.925 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -67.4 -21.87 65.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 115.305 1.594 . . . . 25.0 115.305 -168.18 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -109.08 8.14 25.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.398 -0.521 . . . . 25.0 111.019 178.732 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.17 -1.8 86.57 Favored Glycine 0 C--O 1.215 -1.04 0 CA-C-O 122.901 1.278 . . . . 25.0 110.257 -175.797 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.92 122.13 37.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.34 132.36 49.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.174 -1.417 . . . . 25.0 107.174 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.75 -12.85 61.08 Favored Glycine 0 CA--C 1.485 -1.797 0 O-C-N 121.722 -0.611 . . . . 25.0 114.348 174.29 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.462 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 92.8 m95 -97.43 110.26 22.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.16 -0.612 . . . . 25.0 111.7 177.769 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -101.81 145.39 29.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -174.709 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.09 121.8 28.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.363 -1.347 . . . . 25.0 107.363 173.822 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.3 m -123.94 164.65 18.88 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.4 -0.963 . . . . 25.0 108.4 178.541 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -124.27 128.06 48.59 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.003 -1.061 . . . . 25.0 109.23 -178.227 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -158.23 151.45 23.01 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 125.202 1.564 . . . . 25.0 110.548 -176.908 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 55.24 31.84 17.37 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.761 0.791 . . . . 25.0 110.545 -179.586 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.22 21.95 66.69 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 117.906 1.922 . . . . 25.0 117.906 -176.101 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -143.7 165.66 27.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.199 -1.778 . . . . 25.0 106.199 -177.912 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -117.72 161.03 20.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.7 -1.593 . . . . 25.0 106.7 -176.648 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.73 166.35 36.58 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.736 -0.745 . . . . 25.0 112.763 176.57 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 pt -73.71 144.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 122.788 1.28 . . . . 25.0 109.675 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.8 t -142.84 134.32 12.91 Favored Pre-proline 0 C--O 1.217 -0.643 0 O-C-N 120.408 -1.433 . . . . 25.0 107.695 179.489 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD3' ' CZ3' ' A' ' 45' ' ' TRP . 79.1 Cg_endo -73.58 116.98 4.87 Favored 'Trans proline' 0 C--O 1.255 1.344 0 C-N-CA 115.87 -2.286 . . . . 25.0 113.038 176.86 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.05 -23.25 59.21 Favored Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 120.666 -0.778 . . . . 25.0 114.711 -175.241 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.91 -4.9 14.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 120.606 -1.526 . . . . 25.0 112.527 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -114.94 11.97 16.69 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 122.842 0.457 . . . . 25.0 110.403 178.522 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 12' ' ' ALA . 92.4 mt -118.33 153.86 33.29 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.33 -0.85 . . . . 25.0 111.181 -179.293 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -121.1 127.17 51.37 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.502 -0.555 . . . . 25.0 109.502 169.815 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.6 mm . . . . . 0 C--O 1.24 0.576 0 CA-C-O 121.792 0.806 . . . . 25.0 110.686 179.058 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 121.869 0.842 . . . . 25.0 109.405 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.3 m120 53.54 32.78 14.88 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-O 122.685 1.231 . . . . 25.0 111.366 -178.239 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.45 147.1 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 101.686 -3.45 . . . . 25.0 101.686 179.168 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.49 163.53 28.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.235 -0.654 . . . . 25.0 109.235 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.14 153.63 38.01 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 122.025 -0.422 . . . . 25.0 109.962 -175.956 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -101.41 137.28 39.96 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.088 -1.449 . . . . 25.0 107.088 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.63 128.72 33.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 112.917 0.71 . . . . 25.0 112.917 179.157 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.4 mt -89.2 -18.2 27.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.918 0.887 . . . . 25.0 111.218 179.765 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.9 169.49 17.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.89 154.4 25.25 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.675 0.79 . . . . 25.0 111.523 179.089 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.5 162.56 40.68 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-O 122.118 0.961 . . . . 25.0 110.996 -174.018 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.42 129.21 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.081 -2.933 . . . . 25.0 103.081 173.979 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.43 126.54 30.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.286 -0.635 . . . . 25.0 109.286 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.47 -14.27 33.12 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.998 0.904 . . . . 25.0 111.178 176.385 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -131.03 155.25 81.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.079 -1.082 . . . . 25.0 108.079 -175.983 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.26 -10.23 20.72 Favored 'Trans proline' 0 C--O 1.205 -1.132 0 CA-C-N 119.967 1.024 . . . . 25.0 113.343 176.013 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -85.29 -4.6 59.21 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.503 -1.295 . . . . 25.0 107.503 178.661 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -118.24 149.37 41.23 Favored 'General case' 0 C--O 1.252 1.217 0 N-CA-C 105.464 -2.05 . . . . 25.0 105.464 -170.654 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -102.97 133.8 47.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.468 1.128 . . . . 25.0 113.579 -178.435 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.8 82.72 8.0 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 121.015 -1.053 . . . . 25.0 113.154 170.341 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -97.21 154.67 17.24 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.882 -1.508 . . . . 25.0 112.698 176.856 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -125.84 152.95 44.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 -178.376 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -59.19 135.0 57.5 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 120.303 -0.559 . . . . 25.0 111.455 -179.117 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.07 -14.84 62.42 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 115.43 -0.804 . . . . 25.0 114.231 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -73.39 158.86 34.22 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 121.735 -0.862 . . . . 25.0 112.563 173.359 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -117.46 133.61 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 O-C-N 124.363 1.039 . . . . 25.0 110.295 -178.912 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 ptp -140.84 147.98 39.83 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.36 1.076 . . . . 25.0 111.578 177.636 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 m -86.34 130.57 34.47 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.007 -1.451 . . . . 25.0 111.181 -177.764 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t -90.77 126.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 -179.736 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.8 mt -101.06 -35.99 9.15 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 124.255 0.972 . . . . 25.0 112.412 -178.644 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -147.53 145.48 29.11 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.836 -1.172 . . . . 25.0 107.836 177.688 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -112.48 151.01 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 104.003 -2.591 . . . . 25.0 104.003 173.843 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 59.61 42.16 17.67 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.952 0.882 . . . . 25.0 110.66 -175.533 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.71 -18.44 62.81 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 116.866 2.173 . . . . 25.0 116.866 -169.855 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.76 5.06 13.06 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.169 0.985 . . . . 25.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.69 -17.41 25.84 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.184 -0.916 . . . . 25.0 112.349 -168.978 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.4 126.61 28.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 172.254 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.0 124.04 19.72 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 122.666 1.222 . . . . 25.0 112.821 -179.852 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.59 79.0 Favored Glycine 0 CA--C 1.503 -0.716 0 N-CA-C 118.094 1.998 . . . . 25.0 118.094 176.903 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -104.82 119.14 38.29 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.912 1.356 . . . . 25.0 108.694 178.552 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -106.12 142.64 35.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.872 -0.604 . . . . 25.0 111.588 -169.404 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -82.31 120.67 25.69 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.431 -0.581 . . . . 25.0 109.431 171.226 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 m -126.17 160.72 29.45 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 112.837 0.68 . . . . 25.0 112.837 -179.217 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.0 t -120.2 135.35 55.01 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 123.731 0.644 . . . . 25.0 110.758 174.906 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 tp -150.58 137.04 18.79 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.927 -1.508 . . . . 25.0 106.927 178.073 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.5 m170 57.44 30.88 19.35 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.361 0.875 . . . . 25.0 113.361 179.855 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.84 9.43 79.33 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 117.22 1.648 . . . . 25.0 117.22 -175.461 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -110.03 158.99 17.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.81 -1.181 . . . . 25.0 107.81 177.53 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -123.73 142.76 50.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.632 -1.293 . . . . 25.0 108.059 171.887 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.94 161.36 35.05 Favored Glycine 0 CA--C 1.491 -1.43 0 O-C-N 124.294 0.996 . . . . 25.0 111.117 177.6 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.9 pt -77.53 149.74 5.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.539 1.161 . . . . 25.0 108.727 -176.08 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.2 t -145.66 134.91 11.3 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 -176.933 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.21 119.47 6.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 117.188 -1.408 . . . . 25.0 113.114 179.33 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -24.1 63.34 Favored Glycine 0 C--O 1.198 -2.127 0 N-CA-C 117.249 1.66 . . . . 25.0 117.249 -177.463 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.06 -16.33 62.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 118.088 0.944 . . . . 25.0 109.623 178.553 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -94.42 9.53 37.98 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.15 0.976 . . . . 25.0 111.341 178.255 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.6 mt -124.86 147.63 48.68 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.603 -0.686 . . . . 25.0 111.006 -176.918 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -116.34 125.21 51.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.748 -1.114 . . . . 25.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 118.452 0.569 . . . . 25.0 110.973 177.375 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.637 0 N-CA-C 116.807 1.483 . . . . 25.0 116.807 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 p -85.74 165.11 17.18 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.985 -1.303 . . . . 25.0 111.811 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 tpt 49.76 49.15 20.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.667 1.729 . . . . 25.0 115.667 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -91.95 144.77 25.13 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.05 -0.523 . . . . 25.0 110.812 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -87.36 165.76 15.36 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.598 -0.519 . . . . 25.0 109.598 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.95 -41.59 99.56 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.392 0.515 . . . . 25.0 112.392 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.5 t30 55.0 39.61 31.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.09 0.774 . . . . 25.0 113.09 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 m -113.75 155.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.282 -2.488 . . . . 25.0 104.282 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.51 172.02 8.13 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 107.007 -1.479 . . . . 25.0 107.007 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.73 144.87 29.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.317 -0.401 . . . . 25.0 110.811 173.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -95.36 135.76 36.58 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.0 -0.741 . . . . 25.0 109.0 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 130.36 39.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.548 0.69 . . . . 25.0 109.367 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.53 -28.08 15.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.78 -0.645 . . . . 25.0 109.466 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -129.77 160.52 33.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.365 -1.346 . . . . 25.0 107.365 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.508 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.0 p-10 -101.76 159.88 14.95 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.581 0.752 . . . . 25.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.83 -177.99 5.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.013 0.435 . . . . 25.0 110.583 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.89 147.81 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.696 -3.816 . . . . 25.0 100.696 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.97 139.61 38.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -99.55 -13.3 19.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.245 0.545 . . . . 25.0 110.295 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -128.8 151.11 76.71 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.518 . . . . 25.0 109.865 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.01 -15.14 36.03 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 117.046 -1.502 . . . . 25.0 113.687 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.63 -7.72 59.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.701 0.763 . . . . 25.0 110.294 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -106.62 143.86 34.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 134.88 34.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.425 0.631 . . . . 25.0 111.89 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.0 p -93.09 122.6 35.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.459 ' CE2' HG13 ' A' ' 57' ' ' VAL . 40.9 p90 -141.21 164.76 29.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.379 -1.341 . . . . 25.0 107.379 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -132.3 154.51 49.63 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.842 -0.799 . . . . 25.0 108.842 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.508 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 64.0 pttt -56.37 137.32 52.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.375 0.607 . . . . 25.0 109.685 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.42 45.98 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.551 -0.749 . . . . 25.0 112.869 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -77.89 160.63 28.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.221 0.51 . . . . 25.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -130.44 132.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.6 ptp -131.59 151.12 51.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.454 . . . . 25.0 110.634 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -85.02 130.47 34.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.872 -0.418 . . . . 25.0 109.872 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.6 t -90.23 124.38 42.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.577 -1.268 . . . . 25.0 107.577 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.54 -43.15 8.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 25.0 110.862 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -156.42 171.79 19.64 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -127.38 154.73 44.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.754 -0.461 . . . . 25.0 109.754 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 58.81 39.01 24.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 25.0 108.9 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -65.54 -20.47 66.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.982 -1.917 . . . . 25.0 114.96 -168.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -114.76 13.05 17.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.661 -0.649 . . . . 25.0 110.265 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 -3.59 81.73 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.582 -1.007 . . . . 25.0 110.582 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.42 118.61 30.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.052 -0.721 . . . . 25.0 109.052 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -60.34 130.33 46.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.584 -0.735 . . . . 25.0 109.269 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.75 -1.71 83.81 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 114.982 0.753 . . . . 25.0 114.982 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -101.05 121.66 42.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.677 1.239 . . . . 25.0 108.762 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -111.07 146.49 36.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 25.0 109.493 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.8 tp -85.13 111.84 20.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.034 -2.21 . . . . 25.0 105.034 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.31 164.9 12.69 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.79 -0.819 . . . . 25.0 108.79 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -127.65 130.55 49.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -159.29 142.79 14.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 53.61 38.94 29.41 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.097 1.147 . . . . 25.0 114.097 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 2.93 89.56 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 115.289 0.876 . . . . 25.0 115.289 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -125.9 165.46 18.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -127.2 148.2 50.2 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 104.113 -2.551 . . . . 25.0 104.113 167.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.58 172.57 45.04 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 110.043 -1.223 . . . . 25.0 110.043 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 pt -75.27 141.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 25.0 110.308 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.459 HG13 ' CE2' ' A' ' 26' ' ' PHE . 74.0 t -140.67 133.9 14.79 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 108.877 -0.786 . . . . 25.0 108.877 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 112.97 3.45 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 117.339 -1.307 . . . . 25.0 111.751 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.75 -19.11 69.05 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.997 -0.547 . . . . 25.0 112.949 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.18 -5.86 7.91 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.351 0.5 . . . . 25.0 112.351 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -116.64 11.27 14.63 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.914 -0.491 . . . . 25.0 110.642 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.3 mt -122.33 155.2 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.035 0.445 . . . . 25.0 111.332 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -121.55 118.06 28.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mm -60.27 132.24 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 120.677 0.275 . . . . 25.0 110.537 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.8 mt -137.24 133.1 34.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.983 -1.118 . . . . 25.0 107.983 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.2 t -86.84 89.43 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.615 -1.254 . . . . 25.0 107.615 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.16 -19.66 56.83 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.514 -0.851 . . . . 25.0 113.661 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.84 135.23 45.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.979 0.419 . . . . 25.0 110.085 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -110.15 -45.74 3.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.187 -1.412 . . . . 25.0 107.187 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -71.19 143.77 50.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.267 -1.383 . . . . 25.0 107.267 172.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -171.16 171.47 5.72 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.984 -1.487 . . . . 25.0 106.984 -172.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -60.28 142.42 90.16 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.117 -0.697 . . . . 25.0 109.117 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -70.8 -24.28 25.09 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 117.239 -1.374 . . . . 25.0 113.046 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.08 -154.18 0.36 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.662 0.785 . . . . 25.0 110.061 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.86 -14.74 62.58 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-O 120.076 -0.291 . . . . 25.0 112.951 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -72.98 90.72 1.5 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.234 -0.654 . . . . 25.0 109.234 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -161.12 165.39 29.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.262 -1.014 . . . . 25.0 108.262 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 pt -72.84 162.88 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.481 0.658 . . . . 25.0 110.046 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.5 m -66.27 148.6 12.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.52 -0.548 . . . . 25.0 109.52 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.49 150.76 33.97 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.897 -1.149 . . . . 25.0 107.897 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 C--O 1.21 -0.982 0 CA-C-O 123.734 1.73 . . . . 25.0 112.873 179.384 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.799 0 CA-C-O 124.007 1.893 . . . . 25.0 114.045 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -74.48 161.46 29.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.229 -1.485 . . . . 25.0 111.256 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.3 mtm 54.77 54.98 8.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.535 0.734 . . . . 25.0 112.545 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -97.72 165.86 11.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.308 -0.627 . . . . 25.0 109.308 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -139.73 133.15 30.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.287 -1.746 . . . . 25.0 106.287 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.7 mt -95.81 -16.31 21.96 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 115.058 1.503 . . . . 25.0 115.058 -172.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 t30 50.15 42.44 25.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.197 0.814 . . . . 25.0 113.197 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.74 157.74 32.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 N-CA-C 105.887 -1.894 . . . . 25.0 105.887 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 161.66 36.48 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.325 0.583 . . . . 25.0 110.941 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.34 163.27 33.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.196 -0.911 . . . . 25.0 110.869 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -111.27 133.35 53.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.997 -1.112 . . . . 25.0 107.997 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.67 133.54 43.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.313 0.578 . . . . 25.0 109.585 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.46 -25.81 17.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.669 -0.696 . . . . 25.0 109.814 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -129.9 160.66 32.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.281 -1.007 . . . . 25.0 108.281 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.6 p-10 -98.15 158.54 15.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.325 -0.62 . . . . 25.0 109.325 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -156.42 135.84 12.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.909 -0.587 . . . . 25.0 112.168 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.32 127.03 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 127.14 30.41 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.143 -0.317 . . . . 25.0 110.143 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -100.08 -8.59 23.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.961 0.886 . . . . 25.0 108.615 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.1 m -128.4 152.33 78.01 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.783 -1.099 . . . . 25.0 108.655 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.24 -25.62 21.87 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 117.043 -1.504 . . . . 25.0 114.374 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -83.98 -9.92 58.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.195 0.521 . . . . 25.0 110.77 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -87.11 148.5 25.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.497 -0.557 . . . . 25.0 109.497 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.64 134.73 38.2 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.072 -0.392 . . . . 25.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 m -85.04 124.9 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.814 -1.55 . . . . 25.0 106.814 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.434 ' CE2' HG13 ' A' ' 57' ' ' VAL . 49.0 p90 -145.57 167.93 21.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.341 -0.985 . . . . 25.0 108.341 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -128.99 154.45 46.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 121.972 -0.455 . . . . 25.0 111.509 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.8 pttp -57.75 131.27 49.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.89 46.42 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-O 119.351 -0.694 . . . . 25.0 113.973 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -73.19 161.72 30.23 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.345 0.573 . . . . 25.0 111.035 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -121.84 130.15 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.22 -0.659 . . . . 25.0 109.22 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.39 147.81 47.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.551 . . . . 25.0 111.439 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -82.59 132.79 35.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.0 t -94.12 121.37 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.111 -1.811 . . . . 25.0 106.111 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.45 -46.73 9.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.654 -0.703 . . . . 25.0 110.191 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -154.7 163.05 40.82 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.554 -0.906 . . . . 25.0 108.554 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.6 154.09 37.22 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.989 0.516 . . . . 25.0 110.024 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.4 t0 54.66 45.85 25.94 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 123.454 1.597 . . . . 25.0 108.719 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.55 -6.34 35.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.776 -1.556 . . . . 25.0 114.347 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -136.57 6.15 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.294 1.22 . . . . 25.0 114.294 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.14 22.82 64.72 Favored Glycine 0 CA--C 1.517 0.209 0 N-CA-C 108.578 -1.809 . . . . 25.0 108.578 -174.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt -122.72 110.01 14.95 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 104.619 -2.363 . . . . 25.0 104.619 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -65.1 144.15 57.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.954 0.883 . . . . 25.0 109.053 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.34 -16.49 43.9 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-O 118.456 -1.191 . . . . 25.0 114.033 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -88.65 132.28 34.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.596 1.698 . . . . 25.0 109.998 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -120.19 144.22 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.63 118.6 25.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.933 -1.877 . . . . 25.0 105.933 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.1 m -120.46 164.43 16.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.292 -0.262 . . . . 25.0 110.292 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.6 t -125.62 130.48 51.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.364 -0.606 . . . . 25.0 109.364 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.7 tp -161.61 146.63 13.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.493 -0.928 . . . . 25.0 108.493 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 58.18 32.73 22.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.281 0.845 . . . . 25.0 113.281 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 6.56 88.79 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.877 -0.677 . . . . 25.0 114.735 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -133.31 162.9 30.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 117.839 0.82 . . . . 25.0 109.863 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -105.36 158.28 16.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 104.265 -2.494 . . . . 25.0 104.265 172.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.01 161.1 29.47 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.852 -0.689 . . . . 25.0 111.557 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -78.58 141.82 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG13 ' CE2' ' A' ' 26' ' ' PHE . 74.9 t -140.1 133.89 15.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.38 117.04 4.89 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 114.93 -2.913 . . . . 25.0 110.758 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -19.52 70.0 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 116.068 -0.514 . . . . 25.0 113.607 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -72.8 -3.23 24.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.264 -0.55 . . . . 25.0 111.767 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -108.71 8.95 27.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.09 -0.708 . . . . 25.0 109.09 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.18 155.3 34.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -126.12 120.75 30.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.801 -0.814 . . . . 25.0 108.801 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 mm -58.58 129.26 20.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.7 tp -154.18 105.85 2.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.577 -0.738 . . . . 25.0 109.178 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.9 t -110.36 112.05 38.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.157 -1.423 . . . . 25.0 107.157 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.83 4.46 2.7 Favored Glycine 0 C--O 1.227 -0.316 0 CA-C-N 116.158 -0.474 . . . . 25.0 112.444 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 27.6 ttt -104.13 148.18 26.57 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.856 -2.275 . . . . 25.0 104.856 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -59.43 125.74 24.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.549 0.214 . . . . 25.0 110.625 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -69.72 127.99 34.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.397 -1.334 . . . . 25.0 107.397 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.51 143.06 30.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -66.41 146.9 99.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.291 -1.374 . . . . 25.0 107.291 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.73 159.63 52.73 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 117.838 -0.975 . . . . 25.0 112.13 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.38 -21.79 58.02 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.108 0.48 . . . . 25.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.73 178.81 23.24 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 106.165 -2.774 . . . . 25.0 106.165 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.16 -53.3 3.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.853 0.826 . . . . 25.0 110.744 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 58.3 -169.67 0.12 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.163 0.985 . . . . 25.0 112.153 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.7 pt -134.74 157.94 41.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -109.23 -13.12 10.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.056 0.455 . . . . 25.0 111.134 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.7 p -145.53 145.06 30.89 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.315 -2.106 . . . . 25.0 105.315 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 C--O 1.208 -1.13 0 CA-C-O 124.929 2.3 . . . . 25.0 112.345 178.611 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 122.785 1.214 . . . . 25.0 115.269 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -151.46 153.71 35.16 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.726 -1.213 . . . . 25.0 107.726 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.14 164.28 37.63 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.17 47.54 2.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.353 1.073 . . . . 25.0 109.153 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -144.55 133.12 22.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.441 -1.254 . . . . 25.0 107.653 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.4 mt -110.85 -11.03 14.4 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.24 1.2 . . . . 25.0 114.24 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t30 53.84 31.86 13.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.456 0.91 . . . . 25.0 113.456 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -119.53 156.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.29 158.82 43.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.816 -0.438 . . . . 25.0 109.816 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.21 151.18 44.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 25.0 110.983 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -97.24 134.29 40.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.771 -0.825 . . . . 25.0 108.771 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.82 130.52 40.09 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.717 -0.475 . . . . 25.0 109.717 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.2 mt -92.07 -28.1 17.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 25.0 109.593 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -129.28 162.21 28.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.3 p-10 -98.72 163.01 12.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.791 0.329 . . . . 25.0 110.699 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -150.42 153.39 35.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 25.0 110.784 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.09 118.12 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.614 -2.365 . . . . 25.0 104.614 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.57 30.41 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.217 0.323 . . . . 25.0 110.511 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.7 -22.05 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.559 174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.9 m -97.79 151.02 37.37 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.243 -0.28 . . . . 25.0 110.243 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.82 -17.99 25.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 117.697 -1.069 . . . . 25.0 113.297 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -85.53 -7.58 58.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.09 -0.505 . . . . 25.0 110.436 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -103.39 146.47 28.45 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.64 0.776 . . . . 25.0 110.007 -176.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -100.26 135.65 41.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.608 0.595 . . . . 25.0 112.608 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -84.95 139.85 31.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.387 -2.079 . . . . 25.0 105.387 168.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.449 ' CE1' HG13 ' A' ' 57' ' ' VAL . 44.7 p90 -159.11 163.7 35.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.593 -2.003 . . . . 25.0 105.593 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -129.77 154.81 46.85 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 120.222 -0.591 . . . . 25.0 111.855 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.485 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.0 pttp -55.73 130.34 42.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.413 -0.812 . . . . 25.0 109.621 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.52 22.74 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.397 -0.819 . . . . 25.0 113.082 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -73.37 162.15 29.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 122.731 0.413 . . . . 25.0 111.745 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -121.47 130.97 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.545 0.738 . . . . 25.0 109.34 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -135.44 145.79 47.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.787 0.327 . . . . 25.0 110.344 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -84.77 131.26 34.57 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.124 -1.065 . . . . 25.0 108.124 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -90.05 124.68 42.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.6 mt -91.75 -49.18 6.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 25.0 110.156 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -153.58 171.92 18.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.529 -1.285 . . . . 25.0 107.529 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -126.88 157.18 40.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 110.203 -0.295 . . . . 25.0 110.203 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 60.17 32.58 20.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 123.129 1.442 . . . . 25.0 109.467 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.57 -20.52 62.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.356 -1.747 . . . . 25.0 114.544 -170.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -100.99 3.09 41.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.367 0.603 . . . . 25.0 109.713 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.66 79.76 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 109.489 -1.444 . . . . 25.0 109.489 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.33 124.35 39.32 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.33 -1.359 . . . . 25.0 107.33 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.02 133.86 55.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.24 -0.652 . . . . 25.0 109.24 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 1.03 88.94 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 115.352 0.901 . . . . 25.0 115.352 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -99.04 124.13 43.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.173 1.486 . . . . 25.0 108.635 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -113.89 143.84 44.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.03 -0.419 . . . . 25.0 110.329 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.6 tp -82.87 118.07 23.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.417 -2.068 . . . . 25.0 105.417 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.63 163.84 16.76 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.255 -0.646 . . . . 25.0 109.255 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -122.91 137.81 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.118 0.485 . . . . 25.0 110.765 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 tp -159.46 143.4 14.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.94 -1.504 . . . . 25.0 106.94 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 58.99 22.25 10.21 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.606 0.965 . . . . 25.0 113.606 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.8 89.44 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.996 -0.621 . . . . 25.0 112.509 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -112.09 167.28 10.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.168 -1.79 . . . . 25.0 106.168 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.58 150.88 50.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.65 167.06 39.87 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 109.525 -1.43 . . . . 25.0 109.525 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.87 144.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.811 0.815 . . . . 25.0 111.131 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' CE1' ' A' ' 26' ' ' PHE . 64.4 t -140.2 134.18 15.44 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.66 117.99 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 114.621 -3.12 . . . . 25.0 110.696 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.0 -21.61 69.83 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 116.143 -0.48 . . . . 25.0 113.491 -174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -67.67 -14.5 63.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.533 -0.392 . . . . 25.0 111.696 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -94.63 6.72 48.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.037 -0.414 . . . . 25.0 111.123 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.82 154.33 34.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 25.0 111.751 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -123.97 117.72 25.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 25.0 108.969 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.6 mt -66.78 136.51 26.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 25.0 111.177 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.42 144.14 26.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.459 -2.793 . . . . 25.0 103.459 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.6 t -46.39 109.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 114.073 1.138 . . . . 25.0 114.073 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.39 39.03 0.04 OUTLIER Glycine 0 C--O 1.225 -0.46 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.7 ttm -68.03 113.19 5.5 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.118 -0.637 . . . . 25.0 111.323 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 53.77 46.73 25.23 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.176 0.922 . . . . 25.0 112.013 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -61.65 138.17 58.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.971 -0.559 . . . . 25.0 109.823 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -146.09 153.11 40.33 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.265 -0.643 . . . . 25.0 109.265 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -71.91 147.35 91.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 105.502 -2.036 . . . . 25.0 105.502 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.01 -3.22 13.52 Favored 'Trans proline' 0 C--N 1.346 0.408 0 N-CA-C 114.492 0.92 . . . . 25.0 114.492 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.32 168.82 22.97 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.725 -1.583 . . . . 25.0 106.725 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.93 -179.93 27.09 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 108.572 -1.811 . . . . 25.0 108.572 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.01 161.02 28.67 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.786 -0.45 . . . . 25.0 109.786 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -83.93 138.47 33.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.777 0.322 . . . . 25.0 110.143 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.4 tt -84.46 143.57 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.137 -1.431 . . . . 25.0 107.137 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.09 -4.52 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.42 0.629 . . . . 25.0 111.564 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.9 m -63.49 -44.19 95.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.403 0.621 . . . . 25.0 112.242 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 C--O 1.211 -0.933 0 CA-C-O 125.458 2.551 . . . . 25.0 112.105 -174.858 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.671 0 CA-C-O 122.867 1.259 . . . . 25.0 114.319 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -140.92 132.02 26.32 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.4 -1.647 . . . . 25.0 109.979 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.8 mtm 51.07 37.23 17.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.071 0.548 . . . . 25.0 112.041 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 65.78 3.58 2.57 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.432 1.641 . . . . 25.0 115.432 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -93.69 159.66 15.11 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.206 -0.665 . . . . 25.0 109.206 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.54 -46.71 88.09 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.361 -0.607 . . . . 25.0 109.361 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 t30 51.36 40.25 26.06 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.484 1.291 . . . . 25.0 114.484 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.34 166.16 11.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 N-CA-C 105.03 -2.211 . . . . 25.0 105.03 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.62 157.52 43.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.536 0.684 . . . . 25.0 111.495 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.58 152.3 43.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.008 -0.996 . . . . 25.0 110.46 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.45 137.43 35.54 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 131.99 42.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.1 mt -86.59 -25.8 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.48 161.21 35.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 25.0 109.081 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.585 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.6 p-10 -99.91 155.79 17.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.429 -0.952 . . . . 25.0 108.429 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.13 172.96 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.674 0.749 . . . . 25.0 112.729 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.71 135.93 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 1 N-CA-C 100.141 -4.022 . . . . 25.0 100.141 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.38 47.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.396 -0.965 . . . . 25.0 108.396 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.63 -25.07 8.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.585 0.553 . . . . 25.0 112.055 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -93.88 148.36 35.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.339 -0.225 . . . . 25.0 110.876 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.3 -15.7 38.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 116.762 -1.692 . . . . 25.0 112.614 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -83.73 -15.56 48.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.862 0.363 . . . . 25.0 110.103 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -95.34 135.06 37.42 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.946 0.498 . . . . 25.0 111.532 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 136.53 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.508 -0.477 . . . . 25.0 110.954 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -91.23 118.47 30.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -136.13 166.33 23.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.316 0.579 . . . . 25.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -125.2 152.27 44.74 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.771 -0.455 . . . . 25.0 109.771 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.585 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.9 pttt -56.61 132.62 52.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.746 . . . . 25.0 108.987 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -13.04 66.98 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 119.247 -0.751 . . . . 25.0 114.265 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -76.28 158.04 31.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 117.936 0.868 . . . . 25.0 110.126 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mm -116.66 125.1 73.46 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 123.061 0.544 . . . . 25.0 109.868 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -131.42 147.25 52.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 25.0 111.376 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -89.0 127.12 35.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.084 -0.71 . . . . 25.0 109.084 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.3 t -86.73 123.13 39.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.77 -40.9 8.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 25.0 110.81 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.83 158.59 44.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.33 -0.618 . . . . 25.0 109.33 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -129.6 148.61 51.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.733 -0.84 . . . . 25.0 108.733 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.3 t0 55.38 43.6 28.59 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.361 1.553 . . . . 25.0 107.1 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -70.63 -6.34 36.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.568 -1.651 . . . . 25.0 114.352 -170.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.08 6.76 3.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.718 0.636 . . . . 25.0 112.718 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.86 9.65 85.13 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 109.496 -1.441 . . . . 25.0 109.496 -174.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -109.43 110.04 21.06 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 105.509 -2.034 . . . . 25.0 105.509 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.36 145.86 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.083 0.944 . . . . 25.0 108.701 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.4 48.12 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-O 118.624 -1.098 . . . . 25.0 113.749 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -93.5 129.7 39.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 119.367 1.583 . . . . 25.0 110.007 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -119.07 143.72 46.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.33 116.4 22.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 105.614 -1.995 . . . . 25.0 105.614 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -118.18 164.24 15.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.9 p -129.72 132.98 46.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.98 -0.748 . . . . 25.0 108.98 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.1 tp -159.31 141.56 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 25.0 109.252 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 57.35 31.18 19.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.282 1.216 . . . . 25.0 114.282 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.26 85.98 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 115.239 0.856 . . . . 25.0 115.239 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -135.01 162.81 31.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.726 -0.842 . . . . 25.0 108.726 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -117.75 160.23 21.69 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.25 167.55 39.64 Favored Glycine 0 C--O 1.238 0.374 0 N-CA-C 110.316 -1.114 . . . . 25.0 110.316 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -78.25 142.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.371 0.605 . . . . 25.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -141.68 134.63 14.16 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.994 -1.113 . . . . 25.0 107.994 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.58 119.72 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 114.672 -3.086 . . . . 25.0 111.182 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.68 -18.4 65.98 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.088 -0.506 . . . . 25.0 114.155 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.1 -29.98 70.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.424 -0.457 . . . . 25.0 110.282 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.53 10.28 26.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.377 -0.374 . . . . 25.0 111.983 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.8 mt -117.68 152.59 34.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.326 0.584 . . . . 25.0 111.078 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -124.72 117.99 25.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.121 -0.696 . . . . 25.0 109.121 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.4 mm -57.62 137.81 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.453 -0.573 . . . . 25.0 109.453 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.62 173.41 8.53 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.238 -0.653 . . . . 25.0 109.238 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t 60.25 79.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-O 122.258 1.028 . . . . 25.0 112.297 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.23 47.21 0.92 Allowed Glycine 0 C--O 1.223 -0.532 0 CA-C-N 115.217 -0.901 . . . . 25.0 112.164 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.5 tpt -114.71 123.33 49.0 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.573 -0.529 . . . . 25.0 109.573 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -80.29 -45.44 17.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.46 0.648 . . . . 25.0 110.294 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -73.93 138.66 44.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.629 -0.714 . . . . 25.0 110.181 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -154.26 161.95 41.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.251 -0.648 . . . . 25.0 109.251 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -93.31 151.63 40.48 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.627 -1.249 . . . . 25.0 107.627 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.86 163.46 38.33 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 117.489 -1.207 . . . . 25.0 111.538 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.28 163.43 35.52 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.191 -1.411 . . . . 25.0 107.191 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.76 86.95 0.54 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 109.391 -1.484 . . . . 25.0 109.391 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -118.43 146.5 44.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 -175.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -135.55 143.52 45.75 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.2 pt -88.59 161.62 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.434 0.159 . . . . 25.0 110.892 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 t 38.5 75.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.736 1.384 . . . . 25.0 114.736 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -129.73 133.98 47.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.668 -1.605 . . . . 25.0 106.668 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 124.522 2.106 . . . . 25.0 111.513 -174.552 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.857 0 CA-C-O 124.02 1.9 . . . . 25.0 115.382 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 p -82.66 149.76 27.18 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.461 -1.023 . . . . 25.0 108.945 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 ttm -81.64 -73.31 0.39 Allowed 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 120.771 -0.372 . . . . 25.0 110.372 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -157.54 152.43 25.54 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.282 -1.377 . . . . 25.0 107.282 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.12 175.8 11.4 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 103.392 -2.818 . . . . 25.0 103.392 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.39 -45.92 72.99 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.926 0.784 . . . . 25.0 110.927 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.1 t30 46.9 46.05 15.43 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.071 1.137 . . . . 25.0 114.071 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -125.29 149.04 29.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.549 -1.649 . . . . 25.0 106.549 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 155.33 30.75 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.248 0.547 . . . . 25.0 110.511 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 154.73 49.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.04 -0.982 . . . . 25.0 108.703 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -105.67 135.45 47.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.03 131.39 42.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.191 0.52 . . . . 25.0 109.74 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.68 -26.9 18.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.573 0.702 . . . . 25.0 109.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -130.58 158.72 39.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.508 -1.293 . . . . 25.0 107.508 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.6 p-10 -97.42 160.05 14.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.242 -0.651 . . . . 25.0 109.242 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.38 171.88 13.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 25.0 110.563 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.2 124.59 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 101.029 -3.693 . . . . 25.0 101.029 172.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.51 140.17 29.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -119.12 -29.37 5.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.658 0.599 . . . . 25.0 111.553 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -89.21 148.98 42.03 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.764 -0.828 . . . . 25.0 108.764 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.77 -18.22 32.41 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 116.746 -1.703 . . . . 25.0 112.797 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.84 -13.8 59.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 25.0 110.744 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -96.08 142.51 28.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.199 0.523 . . . . 25.0 110.94 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.47 137.7 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.867 -0.333 . . . . 25.0 110.605 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -93.23 124.5 37.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.268 -1.382 . . . . 25.0 107.268 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.88 168.25 24.3 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.361 -1.348 . . . . 25.0 107.361 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -133.02 159.32 40.38 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.964 -0.46 . . . . 25.0 110.229 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.489 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 27.0 pttt -56.57 136.35 54.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.584 0.707 . . . . 25.0 110.078 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.63 -24.04 31.28 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.08 -0.964 . . . . 25.0 113.303 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.61 159.39 34.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 117.141 0.47 . . . . 25.0 110.219 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.9 127.95 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.193 0.597 . . . . 25.0 110.101 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.63 148.52 50.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.366 0.603 . . . . 25.0 110.094 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -87.45 126.83 35.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.52 127.18 41.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 106.632 -1.618 . . . . 25.0 106.632 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -108.42 -33.36 7.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.82 -0.627 . . . . 25.0 112.52 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -151.68 163.76 38.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.383 -1.34 . . . . 25.0 107.383 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -126.08 152.29 46.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.582 0.628 . . . . 25.0 110.823 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 55.25 38.77 30.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.745 1.259 . . . . 25.0 109.382 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.54 -12.68 61.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 -165.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -116.07 6.67 14.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.287 0.565 . . . . 25.0 109.617 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.12 -5.93 69.57 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.731 -0.948 . . . . 25.0 110.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.09 124.84 30.2 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.539 -1.652 . . . . 25.0 106.539 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.47 132.25 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.635 0.731 . . . . 25.0 110.964 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.36 -0.12 85.37 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 115.38 0.912 . . . . 25.0 115.38 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -95.39 108.59 20.8 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.767 1.784 . . . . 25.0 110.21 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -97.8 144.28 27.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.158 -0.473 . . . . 25.0 110.977 -172.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.8 111.76 19.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.582 -2.007 . . . . 25.0 105.582 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.1 m -114.85 163.33 15.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.479 -0.934 . . . . 25.0 108.479 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -125.1 132.22 53.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.457 -0.572 . . . . 25.0 109.457 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.99 140.17 13.0 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.226 -1.027 . . . . 25.0 108.226 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 57.74 27.6 14.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.823 0.82 . . . . 25.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.94 -0.63 86.72 Favored Glycine 0 N--CA 1.458 0.152 0 N-CA-C 114.445 0.538 . . . . 25.0 114.445 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -107.08 153.98 21.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -116.22 140.02 49.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 103.507 -2.775 . . . . 25.0 103.507 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.43 168.07 40.7 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.959 -0.639 . . . . 25.0 112.126 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -76.48 141.22 16.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.771 0.796 . . . . 25.0 110.005 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.21 132.99 13.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.2 114.47 3.78 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 116.564 -1.824 . . . . 25.0 111.548 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.4 -22.35 65.46 Favored Glycine 0 C--O 1.219 -0.838 0 N-CA-C 114.667 0.627 . . . . 25.0 114.667 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.67 -23.42 67.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.739 0.78 . . . . 25.0 111.21 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.92 6.41 46.33 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 121.513 -0.742 . . . . 25.0 111.377 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -118.47 152.72 35.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.2 0.524 . . . . 25.0 111.183 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -123.28 117.46 25.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.738 -0.467 . . . . 25.0 109.738 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.12 135.63 27.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.838 -0.801 . . . . 25.0 108.838 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.98 109.11 10.53 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 t 59.22 72.13 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -149.76 116.55 0.79 Allowed Glycine 0 N--CA 1.459 0.174 0 N-CA-C 110.961 -0.855 . . . . 25.0 110.961 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.3 ttm -169.59 173.49 6.36 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.01 116.49 0.05 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.565 1.691 . . . . 25.0 115.565 173.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.91 -36.59 3.25 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 114.636 1.347 . . . . 25.0 114.636 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 89.7 mttt 46.55 66.63 0.93 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.546 0.943 . . . . 25.0 113.546 -174.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -59.27 155.48 35.33 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.123 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.56 172.23 16.59 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 N-CA-C 113.293 0.459 . . . . 25.0 113.293 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.13 170.89 18.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.546 -1.649 . . . . 25.0 106.546 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.1 118.79 0.92 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 110.127 -1.189 . . . . 25.0 110.127 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.69 -15.71 41.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.032 0.444 . . . . 25.0 111.869 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -115.72 112.09 21.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.114 0.783 . . . . 25.0 113.114 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.4 pt -131.81 155.22 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 104.636 -2.357 . . . . 25.0 104.636 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m -141.39 156.9 21.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.717 -1.216 . . . . 25.0 107.717 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.1 p -135.12 -69.6 0.5 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.409 0.623 . . . . 25.0 110.14 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 C--O 1.204 -1.3 0 CA-C-O 124.162 1.934 . . . . 25.0 112.244 -173.963 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 CA-C-O 124.96 2.422 . . . . 25.0 113.659 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -83.93 95.22 8.44 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 113.159 -1.521 . . . . 25.0 111.544 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.6 ttt -126.36 137.78 53.49 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -164.04 116.16 1.37 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.487 0.315 . . . . 25.0 111.224 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -147.23 165.92 28.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.136 -2.172 . . . . 25.0 105.136 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.14 -42.98 83.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.419 0.554 . . . . 25.0 110.102 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.1 t30 50.86 46.12 26.54 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.069 0.856 . . . . 25.0 113.089 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.8 m -111.46 169.99 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 103.717 -2.697 . . . . 25.0 103.717 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.97 159.81 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.181 0.901 . . . . 25.0 111.178 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.03 40.27 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.063 -0.971 . . . . 25.0 111.404 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -97.39 131.62 43.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.306 -1.368 . . . . 25.0 107.306 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.16 138.62 43.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.649 0.738 . . . . 25.0 109.544 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -96.38 -21.4 17.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.41 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -128.33 160.17 33.02 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.435 -1.32 . . . . 25.0 107.435 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.7 p-10 -100.5 153.03 19.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -156.37 151.6 26.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.568 -0.742 . . . . 25.0 110.937 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -116.13 150.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.62 110.51 16.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -93.89 -8.84 39.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 t -134.8 149.02 69.52 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.734 -1.58 . . . . 25.0 106.734 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.76 -18.9 41.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 116.687 -1.742 . . . . 25.0 113.666 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.57 -15.7 58.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.194 0.521 . . . . 25.0 110.817 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -92.39 143.21 26.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.041 0.536 . . . . 25.0 110.703 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.08 133.83 35.85 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.706 -0.798 . . . . 25.0 111.098 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.2 p -82.29 137.59 34.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 25.0 106.974 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.406 ' CE2' HG13 ' A' ' 57' ' ' VAL . 36.8 p90 -156.49 165.77 35.36 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -124.78 155.13 39.86 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.574 -0.703 . . . . 25.0 110.932 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.3 pttp -59.1 128.05 35.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.91 -12.19 68.8 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.703 -0.68 . . . . 25.0 113.903 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -79.37 158.02 27.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.039 -0.726 . . . . 25.0 109.039 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -120.66 127.63 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.957 -0.386 . . . . 25.0 109.957 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.69 152.27 51.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 25.0 111.873 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 m -86.84 133.86 33.6 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.5 t -98.72 121.42 49.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -93.64 -42.31 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.682 -0.69 . . . . 25.0 110.988 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.11 164.61 30.71 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 -173.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -132.01 150.04 52.26 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.466 -1.679 . . . . 25.0 106.466 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 58.28 39.91 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.81 1.319 . . . . 25.0 108.675 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -70.46 -14.22 62.45 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.808 -1.542 . . . . 25.0 114.35 -169.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -116.39 11.13 14.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.996 -0.547 . . . . 25.0 109.704 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.43 -6.8 63.11 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.806 -0.918 . . . . 25.0 110.806 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -86.0 118.13 25.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.429 -0.952 . . . . 25.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.5 128.78 38.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.793 -0.818 . . . . 25.0 108.793 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.12 78.55 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 115.779 1.071 . . . . 25.0 115.779 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -104.13 112.83 26.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.541 1.671 . . . . 25.0 110.046 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -107.82 142.73 37.42 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.228 -0.295 . . . . 25.0 111.643 -170.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.95 116.09 22.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.43 -1.322 . . . . 25.0 107.43 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.5 m -117.97 169.53 9.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.727 -0.215 . . . . 25.0 110.443 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -133.11 129.1 37.5 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.66 -0.496 . . . . 25.0 109.66 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.2 tp -161.04 155.47 23.22 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.4 t60 60.03 23.55 12.72 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.801 0.667 . . . . 25.0 112.801 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.08 11.56 85.25 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 25.0 114.051 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -142.28 162.84 34.44 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.0 -0.37 . . . . 25.0 110.0 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -110.72 155.85 21.89 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.224 -1.028 . . . . 25.0 108.224 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.45 165.97 37.15 Favored Glycine 0 C--O 1.24 0.523 0 N-CA-C 110.179 -1.168 . . . . 25.0 110.179 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -79.25 147.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 25.0 109.851 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 26' ' ' PHE . 86.5 t -142.46 131.81 12.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 25.0 107.289 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 121.84 8.69 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 114.882 -2.945 . . . . 25.0 111.326 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -22.8 61.74 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 115.954 -0.566 . . . . 25.0 113.686 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -65.67 -13.01 58.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.091 -0.652 . . . . 25.0 112.418 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -103.18 7.98 38.57 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 25.0 110.747 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -118.64 152.82 35.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.612 0.72 . . . . 25.0 111.044 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -126.87 117.72 23.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.646 -1.242 . . . . 25.0 107.646 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.1 mm -57.8 135.41 21.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.705 -0.85 . . . . 25.0 108.705 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mt -106.1 -176.24 3.02 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t 73.6 92.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.434 1.494 . . . . 25.0 111.622 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.9 -38.73 0.97 Allowed Glycine 0 C--O 1.226 -0.403 0 CA-C-N 114.993 -1.003 . . . . 25.0 114.419 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 20.8 mmt -139.27 114.92 9.96 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 52.72 45.25 29.06 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.645 -0.707 . . . . 25.0 112.34 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.49 -40.73 87.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.804 1.409 . . . . 25.0 114.804 -171.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -156.2 166.11 34.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.096 0.474 . . . . 25.0 110.896 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.09 158.17 32.29 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.441 -2.059 . . . . 25.0 105.441 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.75 149.88 67.53 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 116.396 -1.936 . . . . 25.0 112.74 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.1 165.63 29.32 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.839 -2.652 . . . . 25.0 103.839 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.97 155.62 35.16 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.001 -2.039 . . . . 25.0 108.001 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -89.24 141.57 28.41 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.69 131.94 35.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.953 -0.567 . . . . 25.0 112.404 -173.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.95 131.68 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 105.554 -2.017 . . . . 25.0 105.554 174.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.7 m -105.95 146.67 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.243 -1.392 . . . . 25.0 107.243 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.9 m -154.0 95.88 1.9 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.707 0.765 . . . . 25.0 109.137 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.213 -0.851 0 CA-C-O 124.037 1.875 . . . . 25.0 112.62 -178.405 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.041 0 CA-C-O 124.51 2.172 . . . . 25.0 113.733 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -148.71 126.02 11.53 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 113.384 -1.408 . . . . 25.0 108.269 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.5 mmm -76.4 118.35 19.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.82 -0.437 . . . . 25.0 109.82 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -157.77 162.65 38.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.168 -0.308 . . . . 25.0 110.168 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -146.81 168.13 22.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 103.666 -2.716 . . . . 25.0 103.666 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.61 -42.65 74.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.754 0.706 . . . . 25.0 109.369 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 t30 46.91 46.91 15.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.988 1.107 . . . . 25.0 113.988 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.93 125.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.671 -1.233 . . . . 25.0 107.671 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -82.01 154.4 25.7 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.81 0.814 . . . . 25.0 108.975 -175.129 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.62 161.63 35.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.498 -1.228 . . . . 25.0 108.231 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -113.11 133.87 54.81 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.112 -1.07 . . . . 25.0 108.112 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.76 123.44 24.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.433 0.635 . . . . 25.0 109.797 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -82.46 -29.96 30.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.783 -0.644 . . . . 25.0 109.989 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -132.4 164.06 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 25.0 107.38 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.599 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.3 p-10 -99.22 166.62 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.487 -0.19 . . . . 25.0 110.487 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -148.15 160.53 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 25.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.54 118.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 102.855 -3.017 . . . . 25.0 102.855 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 144.27 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.9 -0.407 . . . . 25.0 109.9 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -33.89 3.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 25.0 110.002 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 t -81.03 146.75 59.69 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.969 -1.122 . . . . 25.0 107.969 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.88 -13.76 29.32 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 117.493 -1.205 . . . . 25.0 114.058 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -86.79 -15.65 38.65 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.875 0.845 . . . . 25.0 109.762 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -85.24 137.31 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 25.0 111.253 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.56 134.69 34.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.33 0.586 . . . . 25.0 111.105 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -84.29 114.05 21.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE2' HG13 ' A' ' 57' ' ' VAL . 55.2 p90 -140.14 161.06 38.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -131.08 164.11 26.16 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.936 0.398 . . . . 25.0 111.887 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.599 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 49.5 pttt -60.23 137.68 58.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.179 0.514 . . . . 25.0 110.712 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.96 -23.82 31.36 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.236 -0.893 . . . . 25.0 112.679 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -70.47 157.67 37.43 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 122.572 0.349 . . . . 25.0 111.407 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.13 127.47 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.308 0.643 . . . . 25.0 110.017 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.46 146.91 46.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.308 -0.256 . . . . 25.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 37.4 m -90.1 122.94 33.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 25.0 110.081 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -82.95 121.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 107.297 -1.371 . . . . 25.0 107.297 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -90.16 -45.91 8.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.751 -0.659 . . . . 25.0 110.067 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -153.5 171.89 18.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 25.0 109.388 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -130.19 155.53 46.1 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.884 -1.895 . . . . 25.0 105.884 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.3 t0 60.57 41.12 15.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 123.19 1.471 . . . . 25.0 108.905 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -70.72 -18.53 62.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.806 -1.543 . . . . 25.0 114.181 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -120.27 8.88 10.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.182 0.438 . . . . 25.0 112.182 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.79 7.88 85.2 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 109.642 -1.383 . . . . 25.0 109.642 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.9 mt -113.54 110.03 19.6 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.066 -1.457 . . . . 25.0 107.066 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -66.77 147.83 52.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.6 -22.27 40.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.457 -0.792 . . . . 25.0 112.466 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -93.18 132.01 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.208 1.004 . . . . 25.0 108.95 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -119.4 139.7 51.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.596 -0.89 . . . . 25.0 108.596 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.08 121.86 28.0 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.257 -1.757 . . . . 25.0 106.257 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.8 m -123.04 156.31 35.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.944 -0.391 . . . . 25.0 109.944 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.0 p -117.18 131.15 56.93 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.708 -1.219 . . . . 25.0 107.708 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.83 131.78 13.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.419 -0.81 . . . . 25.0 108.856 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 52.91 37.41 24.27 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.659 0.985 . . . . 25.0 113.659 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.36 3.45 85.94 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.096 -0.573 . . . . 25.0 114.476 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -118.08 167.2 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.495 -1.668 . . . . 25.0 106.495 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -134.03 157.37 46.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.024 -1.473 . . . . 25.0 107.024 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.1 171.49 43.95 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 109.315 -1.514 . . . . 25.0 109.315 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.85 144.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.703 0.763 . . . . 25.0 110.507 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG13 ' CE2' ' A' ' 26' ' ' PHE . 79.0 t -138.62 134.82 17.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 119.48 6.34 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 115.1 -2.8 . . . . 25.0 110.812 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.31 62.48 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 115.009 0.764 . . . . 25.0 115.009 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.99 -28.58 67.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 25.0 111.281 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -89.39 8.98 27.96 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.718 0.636 . . . . 25.0 112.718 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.23 151.51 39.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.249 0.547 . . . . 25.0 112.394 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -122.93 117.67 26.08 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.75 -0.833 . . . . 25.0 108.75 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.0 mm -63.19 134.13 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.015 -1.106 . . . . 25.0 108.015 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.84 116.8 24.31 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.549 -0.908 . . . . 25.0 108.549 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.4 t -95.77 128.45 46.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.157 -1.053 . . . . 25.0 108.157 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.64 42.0 0.33 Allowed Glycine 0 C--O 1.225 -0.428 0 C-N-CA 121.433 -0.413 . . . . 25.0 112.288 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -133.8 165.65 24.49 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.94 -0.763 . . . . 25.0 108.94 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -65.63 148.93 50.94 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.153 0.283 . . . . 25.0 110.943 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.01 148.47 50.07 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.636 0.731 . . . . 25.0 110.704 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -72.17 161.72 30.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.257 -0.883 . . . . 25.0 112.71 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.52 168.9 15.69 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.904 -1.517 . . . . 25.0 106.904 172.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.52 171.02 13.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 115.91 -2.26 . . . . 25.0 110.043 170.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.37 136.33 43.31 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 106.87 -1.53 . . . . 25.0 106.87 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.87 164.32 38.2 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 108.767 -1.733 . . . . 25.0 108.767 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -154.74 -48.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.922 0.342 . . . . 25.0 111.922 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -133.18 163.87 28.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.786 0.326 . . . . 25.0 110.481 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.9 tt -82.91 155.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.018 -0.734 . . . . 25.0 109.018 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.64 133.77 65.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.374 -1.343 . . . . 25.0 107.374 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.2 m 56.67 66.07 1.27 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.307 1.051 . . . . 25.0 113.629 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 124.718 2.199 . . . . 25.0 111.141 173.844 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 CA-C-O 123.364 1.535 . . . . 25.0 115.644 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -77.09 18.75 0.35 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 114.874 1.435 . . . . 25.0 114.874 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.8 ttt -124.58 131.2 53.49 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.311 -0.626 . . . . 25.0 109.311 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt 54.88 59.36 4.11 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 123.818 0.699 . . . . 25.0 112.618 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -65.33 159.44 23.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.494 -0.928 . . . . 25.0 108.494 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.3 mt -63.72 -42.04 97.98 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.852 -0.425 . . . . 25.0 109.852 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.0 t30 51.23 38.85 22.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.283 -0.871 . . . . 25.0 112.485 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.19 170.5 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 104.327 -2.472 . . . . 25.0 104.327 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.85 153.46 51.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 118.879 0.763 . . . . 25.0 110.54 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -134.67 149.47 50.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.998 -1.001 . . . . 25.0 110.93 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -95.34 131.39 41.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.529 -1.285 . . . . 25.0 107.529 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.41 136.63 42.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.43 -20.59 18.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.441 -0.799 . . . . 25.0 109.64 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -134.03 159.66 40.1 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.636 -0.876 . . . . 25.0 108.636 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 5.6 p-10 -100.36 156.66 17.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.013 0.525 . . . . 25.0 109.663 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -155.34 161.13 41.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.738 -0.665 . . . . 25.0 110.577 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 p -122.72 147.76 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.97 114.91 22.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.778 -0.823 . . . . 25.0 108.778 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -93.2 -8.49 42.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.231 -1.025 . . . . 25.0 108.231 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -129.85 148.14 68.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.53 -12.45 31.46 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 117.211 -1.393 . . . . 25.0 113.248 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -85.89 -14.19 45.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.932 0.872 . . . . 25.0 110.013 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -94.41 147.84 22.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 25.0 109.931 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.08 137.79 34.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.149 0.5 . . . . 25.0 111.233 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -87.37 116.7 25.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.691 -1.226 . . . . 25.0 107.691 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.423 ' CE1' HG13 ' A' ' 57' ' ' VAL . 47.9 p90 -135.07 162.56 32.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 80.0 mtm-85 -131.38 154.01 49.07 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.958 -0.463 . . . . 25.0 111.009 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.455 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.1 pttp -58.89 131.89 52.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 25.0 109.938 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.92 -19.52 53.57 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.426 -0.806 . . . . 25.0 113.374 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -75.35 159.11 31.81 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.275 0.537 . . . . 25.0 110.312 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.5 mm -119.38 127.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.123 -0.695 . . . . 25.0 109.123 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptp -133.83 149.35 51.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.0 0.429 . . . . 25.0 111.767 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.7 m -79.9 136.31 36.63 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.301 -1.0 . . . . 25.0 108.301 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -104.38 120.8 55.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.79 -45.64 10.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 25.0 111.322 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.27 171.84 18.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.459 -1.312 . . . . 25.0 107.459 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.66 154.75 44.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 110.302 -0.259 . . . . 25.0 110.302 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 57.57 35.53 25.85 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 125.032 1.458 . . . . 25.0 109.472 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -70.48 -20.48 62.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.676 -1.602 . . . . 25.0 113.513 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -99.4 0.98 43.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.376 0.608 . . . . 25.0 110.193 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 -6.02 67.48 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 109.787 -1.325 . . . . 25.0 109.787 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.7 mt -88.25 126.81 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.827 -1.546 . . . . 25.0 106.827 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -61.02 131.15 49.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.375 0.607 . . . . 25.0 109.899 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.69 0.66 90.24 Favored Glycine 0 C--O 1.219 -0.788 0 CA-C-O 118.428 -1.207 . . . . 25.0 116.055 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -97.43 110.76 23.25 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.125 1.962 . . . . 25.0 110.93 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.78 144.85 30.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 25.0 111.058 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.95 118.0 23.17 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.3 m -119.86 167.76 11.79 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.479 -0.563 . . . . 25.0 109.479 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -134.0 130.86 38.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.851 0.358 . . . . 25.0 110.238 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 tp -160.75 152.34 19.5 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 106.976 -1.49 . . . . 25.0 106.976 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.2 m80 58.69 24.16 11.86 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.76 82.4 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.665 -0.779 . . . . 25.0 112.295 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -125.13 167.13 15.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.629 -1.619 . . . . 25.0 106.629 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.78 150.55 50.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 105.123 -2.176 . . . . 25.0 105.123 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.1 171.08 43.93 Favored Glycine 0 C--O 1.241 0.532 0 N-CA-C 110.682 -0.967 . . . . 25.0 110.682 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -78.41 143.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 25.0 111.157 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 26' ' ' PHE . 71.0 t -141.44 134.23 14.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.81 118.69 5.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 114.987 -2.875 . . . . 25.0 111.472 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.55 -21.24 66.68 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 114.772 0.669 . . . . 25.0 114.772 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -64.42 -21.81 66.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.571 . . . . 25.0 110.83 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -91.91 9.86 31.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.992 -0.443 . . . . 25.0 111.152 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.1 mt -125.36 155.04 40.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.78 0.432 . . . . 25.0 110.404 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -129.19 117.68 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.497 HD13 ' HB2' ' A' ' 10' ' ' ALA . 9.7 mm -67.88 133.72 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.247 -0.649 . . . . 25.0 109.247 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.88 121.59 22.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.0 t 50.48 45.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 115.093 -0.958 . . . . 25.0 111.862 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.81 7.67 8.94 Favored Glycine 0 C--O 1.225 -0.446 0 N-CA-C 116.815 1.486 . . . . 25.0 116.815 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 54.6 ttp -148.62 101.95 3.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.781 0.791 . . . . 25.0 109.33 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -157.36 111.41 2.63 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 112.154 0.427 . . . . 25.0 112.154 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -76.65 152.27 35.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.71 0.29 . . . . 25.0 111.675 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -142.33 -37.94 0.38 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.643 1.349 . . . . 25.0 114.643 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.66 151.95 57.92 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 122.122 -0.361 . . . . 25.0 110.134 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.14 170.54 19.91 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 117.939 -0.907 . . . . 25.0 110.51 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.28 147.83 51.64 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.758 -0.83 . . . . 25.0 108.758 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.96 -179.93 45.85 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 108.8 -1.72 . . . . 25.0 108.8 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.83 164.08 26.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.73 125.05 49.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.42 -0.956 . . . . 25.0 108.42 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.1 pt -79.43 161.87 4.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.794 -0.639 . . . . 25.0 111.849 -175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.32 19.02 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.28 -0.873 . . . . 25.0 109.39 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.9 p -117.61 124.29 48.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 25.0 110.697 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 C--O 1.215 -0.733 0 CA-C-O 124.245 1.974 . . . . 25.0 111.249 178.045 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.101 0 N-CA-C 115.817 1.087 . . . . 25.0 115.817 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m 60.87 2.01 0.5 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.672 1.989 . . . . 25.0 116.049 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.3 ttt -146.62 124.13 11.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -111.74 -31.7 6.88 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.114 0.483 . . . . 25.0 110.095 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -147.81 173.23 13.01 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 102.403 -3.184 . . . . 25.0 102.403 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.8 mt -58.43 -47.56 83.55 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 115.14 1.534 . . . . 25.0 115.14 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.9 t30 49.52 41.99 22.06 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.316 1.228 . . . . 25.0 114.316 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.82 166.38 5.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 105.186 -2.153 . . . . 25.0 105.186 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 155.98 45.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.147 0.499 . . . . 25.0 110.108 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.45 144.69 33.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.75 -0.659 . . . . 25.0 112.107 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -90.84 135.45 33.72 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.56 121.27 22.16 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.89 0.744 . . . . 25.0 109.118 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.98 -26.43 27.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.147 -0.479 . . . . 25.0 110.324 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.29 163.87 26.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.0 p-10 -97.21 157.66 15.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.975 -0.75 . . . . 25.0 108.975 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -147.17 131.14 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.936 0.495 . . . . 25.0 110.492 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -100.87 121.97 52.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 101.616 -3.475 . . . . 25.0 101.616 168.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 143.09 48.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.977 -0.749 . . . . 25.0 108.977 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -110.92 -26.29 9.38 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 123.479 0.487 . . . . 25.0 110.058 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.6 t -97.02 146.26 31.0 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 108.366 -0.976 . . . . 25.0 108.366 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.55 -14.95 27.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 116.763 -1.691 . . . . 25.0 113.153 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.47 -15.54 57.6 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 122.969 0.508 . . . . 25.0 110.58 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -93.73 143.46 26.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.318 0.647 . . . . 25.0 111.864 -171.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.15 133.13 35.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 25.0 110.729 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 84.0 6.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.849 0.833 . . . . 25.0 108.947 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.522 ' CE1' HG13 ' A' ' 57' ' ' VAL . 36.3 p90 -93.88 162.99 13.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.636 -0.875 . . . . 25.0 108.636 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -126.26 155.96 41.07 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.252 0.549 . . . . 25.0 110.795 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.7 ptmt -57.95 132.85 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 25.0 109.922 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.05 -21.44 46.01 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-O 119.014 -0.881 . . . . 25.0 114.245 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -74.93 160.59 30.42 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.61 133.51 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.284 -1.006 . . . . 25.0 108.284 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.67 148.68 52.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 25.0 110.889 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -81.0 127.26 32.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -91.15 122.17 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 mt -96.93 -41.09 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.123 -0.944 . . . . 25.0 111.884 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.46 157.69 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -134.29 147.26 50.59 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.013 -1.477 . . . . 25.0 107.013 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 t0 59.29 38.93 23.03 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 123.98 1.848 . . . . 25.0 107.335 -170.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -69.32 -11.8 61.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.322 -1.763 . . . . 25.0 114.626 -169.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -129.77 15.11 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.131 0.491 . . . . 25.0 110.806 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.83 22.26 77.23 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 109.514 -1.434 . . . . 25.0 109.514 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.93 114.06 21.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.788 -1.93 . . . . 25.0 105.788 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -59.52 141.16 55.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.882 0.849 . . . . 25.0 109.456 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.8 38.96 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-O 118.92 -0.933 . . . . 25.0 115.1 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.2 130.78 40.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.474 1.637 . . . . 25.0 110.422 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -119.92 149.39 42.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.593 -0.521 . . . . 25.0 109.593 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.1 tp -89.8 120.46 31.07 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 106.436 -1.69 . . . . 25.0 106.436 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -122.23 155.64 35.45 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 121.026 -0.269 . . . . 25.0 110.568 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 p -111.69 125.81 54.36 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.362 -0.607 . . . . 25.0 109.362 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -152.93 143.62 22.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.834 -1.172 . . . . 25.0 107.834 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.87 26.1 12.86 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.582 0.706 . . . . 25.0 112.73 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.21 9.17 87.18 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.491 -0.861 . . . . 25.0 114.474 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -128.24 163.25 25.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.693 -0.484 . . . . 25.0 109.693 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.05 149.54 38.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.088 -1.079 . . . . 25.0 108.088 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 171.21 42.86 Favored Glycine 0 C--O 1.241 0.561 0 N-CA-C 108.887 -1.685 . . . . 25.0 108.887 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -86.81 146.4 6.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.67 0.748 . . . . 25.0 110.226 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.522 HG13 ' CE1' ' A' ' 26' ' ' PHE . 54.7 t -139.42 133.67 16.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.412 -0.813 . . . . 25.0 109.067 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.99 115.49 4.01 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 115.278 -2.682 . . . . 25.0 110.536 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.6 -17.56 66.96 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 115.051 0.78 . . . . 25.0 115.051 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.16 -17.92 64.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.258 1.029 . . . . 25.0 111.436 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -90.78 5.61 47.61 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.81 -0.556 . . . . 25.0 110.658 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.29 151.58 37.41 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.541 0.525 . . . . 25.0 111.328 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -122.1 117.46 26.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.419 -0.956 . . . . 25.0 108.419 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm -59.52 133.72 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.86 -1.163 . . . . 25.0 107.86 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.4 -170.68 2.05 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.007 0.817 . . . . 25.0 108.936 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -63.58 147.67 12.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.884 -0.326 . . . . 25.0 111.706 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.73 104.93 0.53 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.224 -0.513 . . . . 25.0 113.317 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -139.45 152.86 47.36 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.551 -1.648 . . . . 25.0 106.551 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -80.9 125.48 30.17 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -153.06 161.0 43.02 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 107.136 -1.431 . . . . 25.0 107.136 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 90.7 mttt 62.19 -167.68 0.2 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.63 1.205 . . . . 25.0 113.819 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -67.39 155.1 91.7 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.474 -1.239 . . . . 25.0 108.479 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.77 169.75 15.44 Favored 'Trans proline' 0 C--N 1.348 0.551 0 O-C-N 122.431 0.701 . . . . 25.0 113.627 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.37 146.56 47.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.384 -0.826 . . . . 25.0 111.134 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.49 56.29 2.72 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.56 -0.745 . . . . 25.0 114.478 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -85.42 118.42 24.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.532 0.666 . . . . 25.0 109.596 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -150.73 -2.22 0.36 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.077 0.769 . . . . 25.0 113.077 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.6 mt -96.23 123.42 48.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.065 -1.087 . . . . 25.0 108.065 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 m -92.34 150.67 3.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 t -154.24 -51.44 0.09 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.064 0.459 . . . . 25.0 109.942 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 124.557 2.123 . . . . 25.0 111.561 178.186 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.007 0 CA-C-O 123.346 1.526 . . . . 25.0 114.596 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -144.45 142.58 30.39 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 120.948 -1.325 . . . . 25.0 108.664 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.0 ttp -154.0 156.98 38.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.499 -1.667 . . . . 25.0 106.499 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -117.3 127.91 54.54 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.568 -0.901 . . . . 25.0 108.568 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.0 173.74 7.59 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.086 -0.709 . . . . 25.0 109.086 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.57 -43.52 93.58 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.052 -0.721 . . . . 25.0 109.052 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 51.08 45.45 27.79 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.491 1.116 . . . . 25.0 112.906 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.72 163.48 6.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 105.478 -2.045 . . . . 25.0 105.478 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.13 148.57 52.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.235 1.017 . . . . 25.0 111.13 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.64 157.72 44.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.269 -1.332 . . . . 25.0 108.981 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -111.16 134.26 52.89 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.713 -0.847 . . . . 25.0 108.713 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.91 130.44 42.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.44 -26.8 19.66 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.857 -0.794 . . . . 25.0 108.857 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.05 158.33 35.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.545 -1.28 . . . . 25.0 107.545 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.4 p-10 -90.58 160.52 15.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.733 -1.581 . . . . 25.0 106.733 174.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -143.8 168.01 20.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 25.0 110.069 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.56 120.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 101.929 -3.359 . . . . 25.0 101.929 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 122.27 23.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.188 -1.042 . . . . 25.0 108.188 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -104.32 -21.14 13.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.888 -0.596 . . . . 25.0 111.325 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.3 m -102.26 150.35 37.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.83 -21.1 33.61 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 116.204 -2.064 . . . . 25.0 113.369 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.57 -8.02 58.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.177 -0.465 . . . . 25.0 111.477 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -90.05 140.93 29.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.672 0.273 . . . . 25.0 110.601 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mt -85.02 137.88 32.79 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.826 -0.546 . . . . 25.0 110.843 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -91.67 118.46 30.66 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.916 -1.142 . . . . 25.0 107.916 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.67 170.9 14.84 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.079 -0.712 . . . . 25.0 109.079 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.5 158.13 40.78 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 109.175 -0.676 . . . . 25.0 109.175 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.8 pttp -59.27 129.81 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -20.8 42.9 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.507 -0.77 . . . . 25.0 113.293 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.0 149.42 50.27 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 117.599 0.7 . . . . 25.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -114.13 127.68 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.457 -0.942 . . . . 25.0 108.457 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.8 ptp -137.81 147.7 44.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.824 0.345 . . . . 25.0 110.368 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 m -84.38 130.82 34.75 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 107.912 -1.144 . . . . 25.0 107.912 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.22 125.92 47.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 N-CA-C 107.39 -1.337 . . . . 25.0 107.39 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.77 -39.04 7.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.595 -0.729 . . . . 25.0 112.253 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -146.0 161.61 39.7 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.071 -0.715 . . . . 25.0 109.071 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -125.78 150.42 47.78 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 109.139 -0.689 . . . . 25.0 109.139 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 54.2 37.19 26.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.496 1.617 . . . . 25.0 108.889 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -69.55 -12.67 61.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 112.842 -1.981 . . . . 25.0 114.188 -169.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 7.91 17.21 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.219 -0.659 . . . . 25.0 109.219 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.42 -17.42 13.97 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.882 -0.887 . . . . 25.0 110.882 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.98 127.13 31.59 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.343 -1.355 . . . . 25.0 107.343 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.8 135.11 57.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.733 0.778 . . . . 25.0 110.459 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 -0.07 89.02 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-O 119.181 -0.788 . . . . 25.0 114.805 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -97.95 104.76 16.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.221 1.51 . . . . 25.0 110.534 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -94.82 147.59 23.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 25.0 111.371 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -85.99 117.27 24.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.948 -1.871 . . . . 25.0 105.948 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.7 m -115.89 162.14 17.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -122.64 124.94 44.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.519 -0.919 . . . . 25.0 108.519 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 tp -155.65 139.81 16.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.989 -0.745 . . . . 25.0 108.989 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 54.48 38.16 29.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.943 0.877 . . . . 25.0 113.049 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.07 0.7 77.39 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 115.129 0.812 . . . . 25.0 115.129 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -119.25 154.41 33.49 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.135 -0.691 . . . . 25.0 109.135 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -110.35 148.12 32.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 104.441 -2.429 . . . . 25.0 104.441 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.72 168.82 41.64 Favored Glycine 0 C--O 1.243 0.706 0 N-CA-C 111.39 -0.684 . . . . 25.0 111.39 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -78.26 142.91 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.877 0.846 . . . . 25.0 109.964 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.17 134.57 14.61 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.39 114.69 4.01 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 114.659 -3.094 . . . . 25.0 112.319 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 -23.07 63.49 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 114.263 0.465 . . . . 25.0 114.263 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.0 -25.46 67.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.267 -0.549 . . . . 25.0 111.206 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -92.19 8.34 38.5 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 112.266 0.469 . . . . 25.0 112.266 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -116.71 149.99 38.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 25.0 112.326 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.47 118.77 28.18 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.408 -0.59 . . . . 25.0 109.408 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.09 138.31 20.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.634 -0.876 . . . . 25.0 108.634 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.55 70.11 2.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.522 0.677 . . . . 25.0 111.46 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.56 124.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.814 -1.18 . . . . 25.0 107.814 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.15 22.06 62.42 Favored Glycine 0 C--O 1.217 -0.909 0 CA-C-O 119.608 -0.551 . . . . 25.0 113.028 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 79.1 mtp 51.02 37.11 16.9 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.926 0.49 . . . . 25.0 111.452 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.7 t80 64.29 58.77 1.08 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.694 0.759 . . . . 25.0 110.975 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -56.04 119.02 5.21 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 107.982 -1.118 . . . . 25.0 107.982 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -118.9 113.68 21.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.253 -0.885 . . . . 25.0 110.323 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -71.31 150.34 94.21 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 106.345 -1.724 . . . . 25.0 106.345 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.32 -27.01 20.04 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 117.358 -1.294 . . . . 25.0 114.158 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 140.86 44.6 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.784 -0.821 . . . . 25.0 108.784 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.03 176.54 48.11 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.575 -1.41 . . . . 25.0 109.575 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.93 173.78 11.85 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 103.305 -2.85 . . . . 25.0 103.305 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.6 t80 58.72 84.1 0.11 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.511 1.148 . . . . 25.0 112.101 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.7 pt -127.96 159.06 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.277 -1.009 . . . . 25.0 108.277 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.88 81.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 104.372 -2.455 . . . . 25.0 104.372 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.3 m -123.17 -50.82 1.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.287 -0.869 . . . . 25.0 110.928 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 C--O 1.209 -1.028 0 CA-C-O 124.631 2.158 . . . . 25.0 111.6 -177.041 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 CA-C-O 122.791 1.217 . . . . 25.0 115.308 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -62.04 129.25 40.0 Favored 'General case' 0 C--O 1.231 0.095 0 O-C-N 121.318 -1.107 . . . . 25.0 110.855 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.6 ttm -64.22 142.45 58.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.09 0.471 . . . . 25.0 111.938 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -153.77 -45.01 0.09 Allowed 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 123.253 0.621 . . . . 25.0 109.734 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.62 159.04 16.08 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt -65.31 -46.96 78.26 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.377 0.423 . . . . 25.0 111.44 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.7 t30 49.33 46.93 22.85 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.6 m -109.81 169.98 3.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.97 158.76 43.62 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.382 -0.599 . . . . 25.0 109.382 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 149.64 34.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.746 -0.661 . . . . 25.0 112.091 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.18 134.38 37.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.964 -0.562 . . . . 25.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.78 132.0 42.14 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.209 0.528 . . . . 25.0 109.676 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 mt -96.9 -23.95 16.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.636 -0.711 . . . . 25.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.06 161.45 26.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.274 -1.38 . . . . 25.0 107.274 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.567 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.4 p-10 -102.16 162.37 12.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 25.0 109.269 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -151.96 159.11 43.86 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.507 0.504 . . . . 25.0 111.163 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.62 133.2 68.83 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 110.6 7.03 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -78.46 -35.4 46.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.012 -1.449 . . . . 25.0 107.708 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -119.36 154.55 54.08 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 25.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.5 -15.94 34.37 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.661 -1.093 . . . . 25.0 113.697 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.79 -10.2 58.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 25.0 110.698 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -94.29 144.16 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.039 -0.726 . . . . 25.0 109.039 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.46 135.24 33.57 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.774 -0.77 . . . . 25.0 110.21 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -85.27 125.08 32.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.842 -1.91 . . . . 25.0 105.842 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -148.81 163.72 36.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.028 -1.471 . . . . 25.0 107.028 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -129.52 159.03 37.59 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.224 0.535 . . . . 25.0 110.803 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.9 pttp -59.2 132.5 54.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.816 -1.179 . . . . 25.0 107.816 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.99 -23.34 32.52 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.783 -0.644 . . . . 25.0 113.06 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.35 163.28 26.58 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.073 0.437 . . . . 25.0 110.207 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.01 132.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -133.4 153.5 51.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 25.0 110.585 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -88.18 131.02 34.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.289 -0.634 . . . . 25.0 109.289 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.3 t -96.06 124.18 48.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.09 -42.2 8.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.771 -0.649 . . . . 25.0 112.096 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.38 159.75 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 25.0 109.009 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -129.91 151.28 50.65 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t0 58.83 39.6 23.83 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.144 1.45 . . . . 25.0 107.973 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -71.29 -13.8 62.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.854 -1.521 . . . . 25.0 112.859 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -119.46 4.88 11.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.961 0.726 . . . . 25.0 112.961 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.37 20.34 69.58 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 110.086 -1.206 . . . . 25.0 110.086 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.57 113.76 15.23 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.337 -1.727 . . . . 25.0 106.337 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -64.84 141.78 58.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.483 -1.302 . . . . 25.0 107.483 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.57 -15.43 63.33 Favored Glycine 0 C--O 1.209 -1.406 0 CA-C-O 118.441 -1.199 . . . . 25.0 113.377 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -98.57 125.23 43.74 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.658 1.729 . . . . 25.0 109.798 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -119.61 146.96 45.06 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.941 -0.392 . . . . 25.0 109.941 -172.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.1 tp -85.43 116.2 23.6 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.624 -1.251 . . . . 25.0 107.624 176.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -115.31 167.19 11.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.641 0.258 . . . . 25.0 110.652 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 m -131.62 132.94 44.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.448 -0.575 . . . . 25.0 109.448 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 tp -160.24 146.29 15.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 58.5 24.4 11.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.004 1.113 . . . . 25.0 114.004 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.44 4.66 87.68 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.909 -0.662 . . . . 25.0 113.228 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -122.83 163.89 19.42 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 122.947 0.499 . . . . 25.0 109.669 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -118.1 154.55 31.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.942 -1.873 . . . . 25.0 105.942 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.6 162.66 31.33 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 111.779 -0.528 . . . . 25.0 111.779 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.4 pt -78.12 145.64 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.557 . . . . 25.0 110.682 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -144.84 133.69 11.07 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 108.492 -0.929 . . . . 25.0 108.492 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.6 121.21 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 115.534 -2.511 . . . . 25.0 112.02 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.62 -22.36 65.91 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-N 115.342 -0.845 . . . . 25.0 114.188 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -70.47 -2.4 13.82 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.089 -0.654 . . . . 25.0 111.675 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.0 11.23 17.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.917 -0.401 . . . . 25.0 109.917 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.95 152.63 38.29 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.367 0.417 . . . . 25.0 111.078 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -117.88 117.81 30.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.35 134.67 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 123.821 0.7 . . . . 25.0 109.254 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.94 108.5 18.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 25.0 111.427 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.5 t -124.68 126.12 71.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.215 -1.402 . . . . 25.0 107.215 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.54 5.95 38.21 Favored Glycine 0 C--O 1.22 -0.742 0 O-C-N 123.269 0.356 . . . . 25.0 112.761 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.9 mtt -79.18 83.1 5.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.413 0.625 . . . . 25.0 111.325 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -117.61 23.84 11.47 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.168 -1.79 . . . . 25.0 106.168 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -73.33 152.16 41.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.462 -1.245 . . . . 25.0 108.88 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.65 166.31 30.9 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.17 -0.331 . . . . 25.0 110.212 -175.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -115.19 158.49 40.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 107.453 -1.314 . . . . 25.0 107.453 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.29 154.67 65.46 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 116.299 -2.001 . . . . 25.0 110.71 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.98 75.78 1.26 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.335 -0.393 . . . . 25.0 110.038 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.9 54.65 4.05 Favored Glycine 0 C--O 1.216 -0.98 0 CA-C-O 119.171 -0.794 . . . . 25.0 112.798 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 51.32 74.38 0.25 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.487 1.137 . . . . 25.0 113.003 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -69.13 123.48 21.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.507 -0.77 . . . . 25.0 111.566 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.61 150.9 19.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 104.801 -2.296 . . . . 25.0 104.801 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.9 p -142.84 144.43 24.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 105.583 -2.006 . . . . 25.0 105.583 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.3 p -126.19 109.0 11.84 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.88 -0.415 . . . . 25.0 109.88 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.0 t0 . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 125.174 1.389 . . . . 25.0 113.179 179.332 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.979 0 CA-C-O 124.023 1.902 . . . . 25.0 115.484 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -142.34 127.42 18.49 Favored 'General case' 0 CA--C 1.514 -0.435 0 O-C-N 121.349 -1.089 . . . . 25.0 109.809 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.2 mtt -142.28 120.74 12.43 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.094 0.247 . . . . 25.0 110.361 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 tptt 50.85 33.81 9.25 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 117.167 2.284 . . . . 25.0 117.167 169.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -65.25 158.96 24.86 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.129 -0.357 . . . . 25.0 110.242 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.19 -40.5 81.68 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.804 0.442 . . . . 25.0 111.564 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 51.44 43.78 29.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.4 1.259 . . . . 25.0 114.4 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.63 164.34 13.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 103.025 -2.954 . . . . 25.0 103.025 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.61 160.85 37.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.714 0.688 . . . . 25.0 110.386 -174.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.45 163.24 33.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.448 -0.796 . . . . 25.0 110.887 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.58 134.4 52.43 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.042 -1.466 . . . . 25.0 107.042 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.87 136.11 43.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.721 0.772 . . . . 25.0 109.231 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.82 -24.62 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.489 -0.778 . . . . 25.0 109.63 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -128.98 162.75 26.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.818 -1.178 . . . . 25.0 107.818 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.17 156.69 17.06 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -156.49 135.77 12.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.357 0.503 . . . . 25.0 112.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -100.64 146.92 8.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.98 -1.859 . . . . 25.0 105.98 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.93 133.54 37.26 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.255 -0.276 . . . . 25.0 110.255 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.55 -7.17 23.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.666 0.745 . . . . 25.0 109.117 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.7 t -129.46 148.65 70.18 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.631 -0.713 . . . . 25.0 109.347 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.32 -16.84 35.3 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.716 -1.722 . . . . 25.0 113.3 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -82.17 -15.56 52.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.471 0.653 . . . . 25.0 110.674 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -92.5 140.85 29.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.628 -0.879 . . . . 25.0 108.628 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 132.56 36.04 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.123 -0.631 . . . . 25.0 110.044 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p -84.53 133.08 34.47 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.394 -2.076 . . . . 25.0 105.394 171.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.413 ' CE1' HG13 ' A' ' 57' ' ' VAL . 45.8 p90 -150.64 166.12 31.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.933 -0.766 . . . . 25.0 108.933 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -127.04 152.99 46.53 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.872 -0.518 . . . . 25.0 110.696 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -59.49 138.37 57.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.651 -0.704 . . . . 25.0 109.279 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.5 -16.02 57.27 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.503 -0.771 . . . . 25.0 114.035 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -76.89 159.76 29.76 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 117.387 0.593 . . . . 25.0 109.93 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.51 130.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.983 0.513 . . . . 25.0 109.638 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.12 147.07 45.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.972 0.415 . . . . 25.0 110.728 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -85.66 130.74 34.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.6 t -88.83 116.41 30.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.809 -1.923 . . . . 25.0 105.809 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.24 -37.76 13.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.309 -0.859 . . . . 25.0 111.147 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -147.43 156.18 42.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.597 -1.26 . . . . 25.0 107.597 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -124.51 147.43 48.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.621 -0.511 . . . . 25.0 109.621 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 57.25 38.21 28.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.745 1.736 . . . . 25.0 107.618 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.5 t -70.56 -11.4 60.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 112.283 -2.235 . . . . 25.0 115.699 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.06 10.07 13.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.145 0.497 . . . . 25.0 110.028 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.62 66.79 Favored Glycine 0 C--O 1.225 -0.425 0 N-CA-C 109.688 -1.365 . . . . 25.0 109.688 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.69 116.74 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.643 -1.614 . . . . 25.0 106.643 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.42 133.82 55.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.795 -0.639 . . . . 25.0 109.457 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.29 -0.43 85.58 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.506 0.962 . . . . 25.0 115.506 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -102.92 116.57 32.8 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.127 1.464 . . . . 25.0 110.538 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -108.59 145.0 35.54 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.208 -0.308 . . . . 25.0 111.09 -174.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.52 120.98 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.473 -1.677 . . . . 25.0 106.473 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.2 m -119.86 165.22 14.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.697 -0.483 . . . . 25.0 109.697 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 p -122.95 131.66 53.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.059 0.457 . . . . 25.0 110.027 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 tp -160.27 148.61 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.664 -1.235 . . . . 25.0 107.664 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 59.64 23.25 12.01 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.272 0.841 . . . . 25.0 113.272 176.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.07 81.08 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.842 -0.694 . . . . 25.0 112.686 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -130.76 164.21 25.6 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.48 -0.933 . . . . 25.0 108.48 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -117.77 152.91 34.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.941 -1.874 . . . . 25.0 105.941 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.04 163.98 36.44 Favored Glycine 0 C--O 1.239 0.462 0 N-CA-C 110.387 -1.085 . . . . 25.0 110.387 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.8 pt -79.43 145.19 9.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.611 . . . . 25.0 110.062 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.413 HG13 ' CE1' ' A' ' 26' ' ' PHE . 71.4 t -140.74 133.7 14.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 107.64 -1.244 . . . . 25.0 107.64 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.41 121.57 8.11 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 114.667 -3.089 . . . . 25.0 111.212 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.16 -25.67 62.59 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 116.015 -0.539 . . . . 25.0 114.263 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -65.48 -18.52 65.38 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.23 -0.57 . . . . 25.0 112.374 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.84 8.0 41.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.888 -0.507 . . . . 25.0 111.232 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.0 mt -122.41 156.79 33.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.903 0.383 . . . . 25.0 110.786 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -131.62 120.07 22.32 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.1 mm -61.32 136.21 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.67 0.606 . . . . 25.0 110.358 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.53 124.41 44.69 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.376 -1.712 . . . . 25.0 106.376 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -142.18 146.7 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.12 94.18 0.12 Allowed Glycine 0 C--O 1.216 -0.974 0 C-N-CA 120.912 -0.661 . . . . 25.0 114.484 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 36.1 ttm 49.84 67.21 0.94 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.443 1.646 . . . . 25.0 115.443 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -105.0 154.55 19.97 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 50.65 41.09 25.41 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.995 1.479 . . . . 25.0 114.995 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -89.71 109.76 20.71 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.908 -0.495 . . . . 25.0 111.365 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 163.21 31.18 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.62 -0.881 . . . . 25.0 108.62 176.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.87 -178.23 2.65 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 117.618 -1.121 . . . . 25.0 110.106 170.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.28 55.62 4.95 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.497 0.665 . . . . 25.0 111.37 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.28 178.08 16.43 Favored Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.345 -1.102 . . . . 25.0 110.345 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.28 163.73 24.39 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 113.635 0.976 . . . . 25.0 113.635 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -140.48 141.77 35.37 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.268 -0.424 . . . . 25.0 110.364 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.88 126.92 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.73 164.41 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.35 . . . . 25.0 110.822 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 m -70.84 150.42 45.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.946 -0.57 . . . . 25.0 110.192 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 C--O 1.217 -0.626 0 CA-C-O 125.792 2.711 . . . . 25.0 111.998 173.712 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.52 0 CA-C-O 123.015 1.341 . . . . 25.0 113.741 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m 59.89 20.44 9.4 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.015 1.726 . . . . 25.0 112.602 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.9 mtt -79.79 -14.84 58.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.948 -0.569 . . . . 25.0 112.189 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -141.86 148.8 39.38 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.809 -0.812 . . . . 25.0 108.809 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -147.18 177.27 9.32 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 102.901 -3.0 . . . . 25.0 102.901 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.7 mt -55.92 -45.81 78.62 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.892 1.441 . . . . 25.0 114.892 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.4 43.26 26.88 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.042 1.497 . . . . 25.0 115.042 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.2 163.63 8.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 104.297 -2.483 . . . . 25.0 104.297 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.17 154.06 47.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 118.891 0.769 . . . . 25.0 110.63 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.91 143.79 34.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.657 -0.701 . . . . 25.0 111.36 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -95.19 132.42 40.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.083 -0.71 . . . . 25.0 109.083 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 134.88 41.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.392 0.615 . . . . 25.0 109.417 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.27 -25.1 17.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.578 -0.737 . . . . 25.0 109.488 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -131.22 157.65 42.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.512 -1.292 . . . . 25.0 107.512 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -95.35 161.65 14.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.667 -0.494 . . . . 25.0 109.667 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -152.92 149.84 28.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -124.1 128.74 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 103.773 -2.677 . . . . 25.0 103.773 173.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.91 136.09 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.913 -0.585 . . . . 25.0 109.923 -176.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -102.94 -12.9 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.35 155.66 53.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 25.0 110.312 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.23 -19.31 20.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 117.71 -1.06 . . . . 25.0 114.418 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -86.37 -15.03 41.71 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.985 0.898 . . . . 25.0 109.591 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -89.89 145.6 25.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.418 -0.81 . . . . 25.0 108.897 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.44 135.79 40.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.31 138.67 32.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 170.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.442 ' CE1' HG13 ' A' ' 57' ' ' VAL . 42.3 p90 -157.4 164.01 37.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -124.15 153.06 42.07 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.618 -0.676 . . . . 25.0 112.197 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.543 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 46.2 pttt -58.3 132.43 53.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.543 -1.28 . . . . 25.0 107.543 175.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.21 -14.52 65.15 Favored Glycine 0 C--O 1.226 -0.348 0 CA-C-O 118.79 -1.005 . . . . 25.0 114.089 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.53 163.02 20.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.686 0.743 . . . . 25.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.49 132.11 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.026 -0.731 . . . . 25.0 109.026 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -129.13 151.37 49.88 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 116.055 -0.521 . . . . 25.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.1 m -85.42 129.08 34.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.259 -1.015 . . . . 25.0 108.259 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 83.7 t -91.87 119.62 39.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.684 -1.598 . . . . 25.0 106.684 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -97.87 -40.45 8.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.303 -0.862 . . . . 25.0 111.129 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -148.03 164.68 33.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -130.56 152.88 49.46 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 56.57 37.17 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.884 1.365 . . . . 25.0 108.166 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -69.34 -17.39 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 113.631 -1.622 . . . . 25.0 112.857 -169.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.17 6.48 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.721 -0.672 . . . . 25.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 -8.22 67.42 Favored Glycine 0 C--O 1.228 -0.257 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt -83.63 117.27 23.07 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.713 . . . . 25.0 109.076 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -60.39 128.27 35.88 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 25.0 109.412 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.22 -1.3 82.41 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 115.461 0.944 . . . . 25.0 115.461 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -100.63 122.59 43.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.926 1.363 . . . . 25.0 109.247 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -112.49 145.42 40.26 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.993 -0.442 . . . . 25.0 111.162 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.9 tp -83.57 115.07 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.545 -1.65 . . . . 25.0 106.545 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.6 m -122.45 164.84 17.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.536 0.208 . . . . 25.0 110.857 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.5 p -123.18 131.36 53.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -157.93 139.71 13.93 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 57.45 32.98 22.64 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.732 0.777 . . . . 25.0 112.632 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.08 4.47 63.18 Favored Glycine 0 CA--C 1.522 0.491 0 O-C-N 121.567 -0.708 . . . . 25.0 113.427 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.73 164.1 13.77 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -132.19 146.0 51.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 104.22 -2.511 . . . . 25.0 104.22 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.62 177.87 48.55 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 111.11 -0.796 . . . . 25.0 111.11 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.34 143.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.387 0.613 . . . . 25.0 110.299 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 26' ' ' PHE . 72.7 t -139.33 134.18 16.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.75 118.54 5.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 115.015 -2.857 . . . . 25.0 110.749 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -23.92 70.78 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.706 -0.679 . . . . 25.0 113.988 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.59 -16.47 64.19 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.289 -0.536 . . . . 25.0 111.62 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -90.06 1.14 56.68 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.93 -0.481 . . . . 25.0 110.918 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.58 150.64 36.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.306 0.574 . . . . 25.0 111.343 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -121.96 113.86 20.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.331 -0.988 . . . . 25.0 108.331 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.0 mt -67.63 134.27 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 120.754 0.311 . . . . 25.0 110.848 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.9 mt -117.68 136.94 53.0 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.692 -0.855 . . . . 25.0 108.692 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.5 t 25.44 82.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 116.268 1.951 . . . . 25.0 116.268 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.1 -72.6 1.11 Allowed Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.596 -0.811 . . . . 25.0 113.612 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.34 161.41 37.6 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -161.06 164.52 30.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.22 -0.659 . . . . 25.0 109.22 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -135.53 -174.13 3.55 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.294 0.638 . . . . 25.0 111.245 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -114.67 141.21 48.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 120.945 0.403 . . . . 25.0 110.227 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -71.79 146.35 90.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.51 -19.86 21.28 Favored 'Trans proline' 0 C--N 1.349 0.566 0 N-CA-C 114.09 0.765 . . . . 25.0 114.09 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 55.48 25.52 7.91 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.787 1.773 . . . . 25.0 115.787 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.35 7.94 66.62 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 115.296 0.879 . . . . 25.0 115.296 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -121.02 64.89 0.86 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.396 0.617 . . . . 25.0 112.088 -174.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.53 118.21 9.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.154 -0.684 . . . . 25.0 109.154 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.5 tt -144.56 134.82 19.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.371 -0.974 . . . . 25.0 108.371 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.41 11.22 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.416 0.627 . . . . 25.0 109.516 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 53.83 51.18 15.34 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.53 1.157 . . . . 25.0 112.65 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.9 t0 . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 123.026 1.393 . . . . 25.0 110.595 175.993 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 114.832 0.693 . . . . 25.0 114.832 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 t 57.68 16.53 3.51 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.001 1.32 . . . . 25.0 114.027 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.0 ptp -102.9 -12.64 17.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.117 0.784 . . . . 25.0 113.117 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -146.88 157.79 43.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.742 0.306 . . . . 25.0 110.216 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -147.18 -179.45 6.84 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 101.878 -3.378 . . . . 25.0 101.878 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.3 mt -54.29 -37.43 64.77 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.699 1.37 . . . . 25.0 114.699 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.06 30.24 19.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.816 1.413 . . . . 25.0 114.816 173.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -115.94 164.01 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.175 -1.787 . . . . 25.0 106.175 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.95 164.11 23.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.28 145.21 30.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 25.0 110.857 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -95.05 134.49 37.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.31 136.55 40.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.274 0.559 . . . . 25.0 109.616 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.26 -26.22 17.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 25.0 110.071 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -130.24 162.78 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.55 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.9 p-10 -101.71 157.07 17.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.888 -0.412 . . . . 25.0 109.888 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -157.87 122.78 4.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.575 -0.739 . . . . 25.0 110.099 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 138.93 19.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.13 148.97 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -111.22 -20.41 12.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.639 -0.504 . . . . 25.0 109.639 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -105.09 152.46 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.49 -0.323 . . . . 25.0 110.265 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.6 -20.91 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 117.1 -1.466 . . . . 25.0 114.013 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.35 -4.79 59.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.536 0.684 . . . . 25.0 110.599 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -99.26 141.73 31.66 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.18 -1.044 . . . . 25.0 108.18 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.97 134.14 35.06 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.674 -0.641 . . . . 25.0 111.724 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.8 m -84.16 119.44 25.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.526 -1.657 . . . . 25.0 106.526 170.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -136.16 161.62 35.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.55 -0.537 . . . . 25.0 109.55 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -123.43 153.74 40.02 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.062 0.458 . . . . 25.0 110.079 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.55 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 14.0 ptmt -59.6 133.74 56.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 -10.81 72.17 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-O 119.102 -0.832 . . . . 25.0 114.302 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.65 158.29 25.68 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.916 0.858 . . . . 25.0 109.207 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.86 129.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.453 -0.573 . . . . 25.0 109.453 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -130.76 153.23 49.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 25.0 109.899 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 m -87.53 132.32 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.68 -1.229 . . . . 25.0 107.68 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.12 125.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -92.95 -47.78 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.04 -0.527 . . . . 25.0 111.183 -175.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.74 171.92 18.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -121.9 155.0 36.38 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.234 -0.654 . . . . 25.0 109.234 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 57.51 38.6 28.1 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.64 1.213 . . . . 25.0 109.924 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -69.88 -18.59 63.42 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.067 -1.424 . . . . 25.0 114.374 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -110.97 9.73 22.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.265 -0.643 . . . . 25.0 109.265 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.58 1.84 89.26 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.445 -1.062 . . . . 25.0 110.445 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.38 122.36 35.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.144 -1.058 . . . . 25.0 108.144 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -61.45 129.36 40.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.419 0.628 . . . . 25.0 109.98 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 0.45 87.96 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -101.58 108.43 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 118.827 1.313 . . . . 25.0 110.227 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.718 -0.475 . . . . 25.0 109.718 -173.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -82.41 120.1 25.02 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.671 -1.974 . . . . 25.0 105.671 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.71 160.68 24.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 25.0 109.236 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -121.47 132.53 54.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.435 0.636 . . . . 25.0 109.746 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.22 141.38 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.157 -0.928 . . . . 25.0 108.617 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 58.79 26.75 15.12 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.677 0.992 . . . . 25.0 113.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.74 6.06 89.61 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 121.097 -0.573 . . . . 25.0 113.293 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -122.11 167.33 13.28 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.05 -1.463 . . . . 25.0 107.05 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -135.41 154.32 51.5 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.777 -1.564 . . . . 25.0 106.777 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.7 171.33 44.27 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.856 -0.898 . . . . 25.0 110.856 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.5 143.3 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.506 0.67 . . . . 25.0 110.587 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.4 t -141.9 132.42 12.86 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.255 -1.017 . . . . 25.0 108.255 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.77 119.52 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 115.178 -2.748 . . . . 25.0 111.582 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.45 -21.77 62.77 Favored Glycine 0 C--O 1.221 -0.678 0 CA-C-N 115.888 -0.597 . . . . 25.0 114.473 -175.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -61.25 -28.12 68.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.267 -0.549 . . . . 25.0 111.37 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -89.15 6.28 40.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.869 0.322 . . . . 25.0 111.869 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.73 143.97 44.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.6 . . . . 25.0 111.913 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -117.75 117.69 30.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm -55.32 127.63 14.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 121.202 0.525 . . . . 25.0 110.157 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -107.45 92.98 4.3 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 107.79 -1.189 . . . . 25.0 107.79 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t 53.87 79.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 122.167 0.984 . . . . 25.0 111.678 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.57 49.65 3.91 Favored Glycine 0 C--O 1.225 -0.425 0 CA-C-N 115.374 -0.83 . . . . 25.0 113.446 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 162.6 19.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.137 -0.69 . . . . 25.0 109.137 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.68 148.86 51.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.365 0.603 . . . . 25.0 111.545 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.35 174.73 7.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.963 0.887 . . . . 25.0 112.008 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.92 157.26 17.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.222 -1.769 . . . . 25.0 106.222 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -58.32 143.25 80.23 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.382 -0.599 . . . . 25.0 109.382 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -70.22 156.91 61.07 Favored 'Trans proline' 0 C--N 1.347 0.474 0 O-C-N 122.3 0.632 . . . . 25.0 112.925 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.69 6.55 48.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.839 -0.619 . . . . 25.0 112.27 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.62 3.66 66.36 Favored Glycine 0 C--O 1.219 -0.798 0 C-N-CA 121.235 -0.507 . . . . 25.0 112.784 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -77.45 124.66 28.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.686 -0.487 . . . . 25.0 109.686 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -160.06 168.15 26.23 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.688 -0.856 . . . . 25.0 108.688 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 pt -128.21 166.05 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 108.708 -0.849 . . . . 25.0 108.708 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.7 m -86.62 160.78 3.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.637 -0.875 . . . . 25.0 108.637 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.2 p -78.2 150.99 33.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.685 -0.487 . . . . 25.0 109.685 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.213 -0.84 0 CA-C-O 123.068 1.413 . . . . 25.0 112.19 176.635 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 CA-C-O 122.698 1.165 . . . . 25.0 115.346 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 p -78.76 59.3 2.5 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.457 -1.025 . . . . 25.0 110.889 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.0 mmt -70.41 101.76 2.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.299 -0.41 . . . . 25.0 112.037 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 61.39 17.2 8.14 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.224 1.194 . . . . 25.0 114.224 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -75.31 164.89 25.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.458 -0.941 . . . . 25.0 108.458 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.68 -37.95 88.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.826 -0.435 . . . . 25.0 109.826 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 t30 56.17 36.83 28.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.464 -0.789 . . . . 25.0 112.284 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.16 129.75 55.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 106.728 -1.582 . . . . 25.0 106.728 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -100.47 153.85 19.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.738 0.78 . . . . 25.0 110.101 -179.106 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.23 152.13 42.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.826 -1.079 . . . . 25.0 109.948 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -103.49 135.09 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.558 -0.904 . . . . 25.0 108.558 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 135.54 43.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.361 0.601 . . . . 25.0 110.169 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.44 -27.19 17.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.5 -0.773 . . . . 25.0 110.68 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.51 158.26 33.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.35 -1.722 . . . . 25.0 106.35 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 12.0 p-10 -97.95 146.16 25.76 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.296 -1.372 . . . . 25.0 107.296 174.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -144.6 129.99 18.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.776 -0.647 . . . . 25.0 110.741 -174.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -103.91 121.3 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.403 -1.703 . . . . 25.0 106.403 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.66 35.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.911 -0.586 . . . . 25.0 110.108 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -99.55 -17.26 17.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.158 0.504 . . . . 25.0 109.941 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 143.32 40.61 Favored Pre-proline 0 CA--C 1.513 -0.455 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 -15.61 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 116.937 -1.576 . . . . 25.0 114.023 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -94.48 -9.0 36.83 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.315 0.579 . . . . 25.0 110.964 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.62 140.82 30.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.776 -0.824 . . . . 25.0 108.776 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.38 132.3 34.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.432 0.634 . . . . 25.0 111.169 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -86.93 136.32 32.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.14 -1.8 . . . . 25.0 106.14 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -156.55 166.78 32.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.978 0.418 . . . . 25.0 110.441 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -121.44 154.88 35.97 Favored 'General case' 0 C--O 1.213 -0.868 0 O-C-N 121.909 -0.495 . . . . 25.0 110.683 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.3 pttt -60.56 131.79 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 174.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.91 -20.57 49.81 Favored Glycine 0 C--O 1.224 -0.515 0 CA-C-N 115.903 -0.589 . . . . 25.0 113.026 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -71.49 154.19 41.67 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.326 0.563 . . . . 25.0 110.117 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -117.47 126.96 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.109 -0.7 . . . . 25.0 109.109 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.7 ptp -134.89 157.73 46.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 31.6 m -107.03 126.75 52.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.233 -0.284 . . . . 25.0 110.233 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -79.95 123.55 36.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.434 -1.321 . . . . 25.0 107.434 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.92 -46.62 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.92 -0.771 . . . . 25.0 108.92 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.26 169.25 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.165 -1.42 . . . . 25.0 107.165 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -124.16 157.14 35.39 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 110.259 -0.274 . . . . 25.0 110.259 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 56.53 41.42 28.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.74 1.275 . . . . 25.0 108.681 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.47 -16.26 62.9 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.704 1.372 . . . . 25.0 114.704 -167.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -111.94 9.0 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.509 -0.552 . . . . 25.0 109.509 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.11 -9.78 59.83 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 110.864 -0.894 . . . . 25.0 110.864 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.92 124.53 28.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -61.08 131.32 50.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.449 0.642 . . . . 25.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.45 89.58 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 118.566 -1.13 . . . . 25.0 115.482 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -99.02 105.44 17.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.755 1.777 . . . . 25.0 109.817 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -102.34 143.37 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.038 -0.528 . . . . 25.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.0 tp -83.66 112.78 20.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.673 -1.603 . . . . 25.0 106.673 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 67.3 m -112.08 163.14 14.63 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.555 -0.906 . . . . 25.0 108.555 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.2 p -123.74 130.7 53.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 25.0 109.048 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 tp -162.26 146.56 12.21 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 57.43 30.74 19.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.785 1.032 . . . . 25.0 113.785 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.56 11.44 82.81 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 120.702 -0.761 . . . . 25.0 113.161 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -124.55 165.51 17.71 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.44 -1.318 . . . . 25.0 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.36 152.61 47.97 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 103.448 -2.797 . . . . 25.0 103.448 167.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.59 167.09 38.82 Favored Glycine 0 C--O 1.24 0.508 0 N-CA-C 110.262 -1.135 . . . . 25.0 110.262 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.9 pt -75.48 143.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.548 0.69 . . . . 25.0 110.509 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -141.62 132.27 13.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.959 -1.126 . . . . 25.0 107.959 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.07 120.29 6.73 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 115.185 -2.743 . . . . 25.0 111.737 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.38 -25.8 60.97 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-N 115.742 -0.663 . . . . 25.0 114.397 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -63.42 -22.94 67.18 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.191 0.52 . . . . 25.0 111.646 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -91.56 5.5 49.33 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.757 -0.59 . . . . 25.0 111.667 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.5 mt -115.4 156.28 25.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 25.0 111.458 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -122.8 117.7 26.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.114 . . . . 25.0 107.991 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.63 132.51 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.06 -165.14 1.28 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.156 -0.475 . . . . 25.0 110.344 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.9 p -61.38 142.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.237 0.541 . . . . 25.0 109.603 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.56 -175.82 45.95 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 106.277 -2.729 . . . . 25.0 106.277 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.3 mtt -82.51 126.95 32.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.118 0.959 . . . . 25.0 110.123 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.47 150.88 9.18 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.476 -2.046 . . . . 25.0 105.476 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.24 -44.34 59.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.411 0.624 . . . . 25.0 109.673 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 tptt 55.61 -166.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.827 -1.078 . . . . 25.0 110.484 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -122.16 158.17 56.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 103.784 -2.673 . . . . 25.0 103.784 170.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -65.69 147.34 85.85 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 115.638 -2.441 . . . . 25.0 111.204 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.81 173.06 16.55 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.683 -1.229 . . . . 25.0 107.683 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.39 -119.93 0.61 Allowed Glycine 0 C--O 1.225 -0.448 0 N-CA-C 107.105 -2.398 . . . . 25.0 107.105 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 59.44 49.3 8.86 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.733 1.012 . . . . 25.0 113.733 172.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -148.54 163.05 38.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.931 -1.137 . . . . 25.0 107.931 174.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.8 pt -139.86 158.94 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.718 -1.956 . . . . 25.0 105.718 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 p -162.95 157.19 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.821 -1.918 . . . . 25.0 105.821 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m 51.43 77.27 0.14 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.482 1.289 . . . . 25.0 114.482 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 123.881 1.8 . . . . 25.0 114.174 178.769 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 115.381 0.912 . . . . 25.0 115.381 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 t 55.83 33.46 21.58 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.624 1.17 . . . . 25.0 113.218 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 ptp -125.66 17.32 8.1 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.228 0.825 . . . . 25.0 113.228 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -84.89 125.65 32.82 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.593 0.96 . . . . 25.0 113.593 -176.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -147.22 -178.64 6.33 Favored 'General case' 0 C--N 1.319 -0.723 1 N-CA-C 99.323 -4.325 . . . . 25.0 99.323 170.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt -51.36 -41.43 60.63 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.92 1.236 . . . . 25.0 113.949 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.88 38.51 29.47 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.89 0.853 . . . . 25.0 111.967 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.0 t -107.52 149.09 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 104.527 -2.398 . . . . 25.0 104.527 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.69 153.28 50.93 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.251 -1.018 . . . . 25.0 108.251 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.57 149.68 36.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.912 -0.585 . . . . 25.0 111.2 -172.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -96.3 136.44 36.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.81 134.18 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.203 0.525 . . . . 25.0 109.717 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.86 -32.73 15.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.351 0.596 . . . . 25.0 109.768 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.86 164.7 17.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.528 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.7 p-10 -98.9 163.06 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -151.62 144.66 24.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.181 -0.463 . . . . 25.0 111.626 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.14 125.33 73.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.214 -2.884 . . . . 25.0 103.214 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.03 146.22 41.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 25.0 110.147 -175.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -31.29 7.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.465 -0.568 . . . . 25.0 109.465 173.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -94.93 150.34 37.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.58 -16.96 26.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.734 -1.044 . . . . 25.0 113.303 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.94 -9.5 58.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 25.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.18 144.53 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.17 0.588 . . . . 25.0 110.236 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mt -94.9 134.55 37.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.56 0.695 . . . . 25.0 112.645 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.3 m -88.3 140.71 29.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.289 -1.374 . . . . 25.0 107.289 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.42 ' CE2' HG13 ' A' ' 57' ' ' VAL . 40.4 p90 -160.19 167.17 28.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -118.56 156.51 29.02 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.635 -0.665 . . . . 25.0 110.911 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 11.0 ptmm? -59.58 129.68 43.13 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.494 -0.928 . . . . 25.0 108.494 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.05 67.83 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 115.836 -0.62 . . . . 25.0 113.937 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.36 161.24 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.892 -0.781 . . . . 25.0 108.892 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.07 134.05 65.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.353 -0.98 . . . . 25.0 108.353 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -135.48 152.82 51.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.669 -0.696 . . . . 25.0 110.614 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.7 m -89.04 131.9 35.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 25.0 108.031 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.59 120.6 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.748 -1.575 . . . . 25.0 106.748 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.4 mt -92.37 -42.35 9.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 25.0 110.065 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.98 166.23 29.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.984 -0.747 . . . . 25.0 108.984 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -133.38 152.76 51.95 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 117.936 0.334 . . . . 25.0 110.236 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 57.32 36.36 27.15 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.95 1.357 . . . . 25.0 107.766 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.48 -7.1 40.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.17 -1.832 . . . . 25.0 115.644 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -126.87 12.36 7.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.82 -5.78 68.84 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.712 -0.955 . . . . 25.0 110.712 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.99 120.98 25.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.329 -0.989 . . . . 25.0 108.329 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -61.88 127.43 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.706 -0.679 . . . . 25.0 109.939 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.58 1.5 90.1 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.754 1.062 . . . . 25.0 115.754 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -98.68 119.09 36.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.301 1.551 . . . . 25.0 109.898 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -110.0 143.8 39.47 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.185 -0.322 . . . . 25.0 111.304 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.7 tp -81.57 111.59 18.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.614 -1.995 . . . . 25.0 105.614 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.2 m -115.34 164.15 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.834 -0.802 . . . . 25.0 108.834 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -139.26 130.7 27.03 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.758 0.313 . . . . 25.0 111.738 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.21 152.16 25.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 25.0 109.644 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.4 t60 53.07 36.45 22.25 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.83 7.24 74.86 Favored Glycine 0 C--O 1.226 -0.394 0 N-CA-C 114.874 0.71 . . . . 25.0 114.874 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -120.82 156.57 31.64 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.096 -1.446 . . . . 25.0 107.096 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -134.34 145.74 49.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.765 -1.939 . . . . 25.0 105.765 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.61 44.2 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.743 -0.943 . . . . 25.0 110.743 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 pt -76.29 143.89 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.614 0.721 . . . . 25.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 26' ' ' PHE . 71.8 t -141.91 133.34 13.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.35 119.15 6.13 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 114.974 -2.884 . . . . 25.0 110.984 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.09 -18.02 66.41 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.703 -0.681 . . . . 25.0 113.781 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.07 -28.65 69.76 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.513 -0.404 . . . . 25.0 110.883 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -87.7 7.17 31.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.074 0.398 . . . . 25.0 112.074 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -118.92 147.91 43.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.111 0.481 . . . . 25.0 111.091 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -116.21 117.59 30.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.582 -0.895 . . . . 25.0 108.582 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm -60.72 130.74 25.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.417 0.687 . . . . 25.0 110.103 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.6 mt -92.09 164.94 13.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.382 -0.969 . . . . 25.0 108.382 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -71.27 149.53 9.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.122 -0.945 . . . . 25.0 108.955 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.91 -43.78 0.1 Allowed Glycine 0 C--O 1.227 -0.324 0 N-CA-C 111.598 -0.601 . . . . 25.0 111.598 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.34 146.72 46.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -113.75 152.85 29.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.73 0.644 . . . . 25.0 110.6 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 t0 57.59 -154.36 0.35 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.182 -0.917 . . . . 25.0 111.946 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -145.83 166.95 24.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.349 -0.611 . . . . 25.0 109.349 -171.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -83.01 155.62 67.45 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 107.13 -1.433 . . . . 25.0 107.13 176.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.54 167.41 25.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 117.109 -1.461 . . . . 25.0 111.031 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.44 147.1 30.88 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.08 43.11 0.12 Allowed Glycine 0 C--O 1.221 -0.662 0 C-N-CA 120.97 -0.633 . . . . 25.0 112.914 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -64.23 133.3 52.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.205 0.502 . . . . 25.0 110.78 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -146.41 110.86 5.13 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.286 -0.635 . . . . 25.0 109.286 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.4 tt -141.74 120.31 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.799 -0.815 . . . . 25.0 108.799 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.7 m -85.54 -8.31 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.984 1.105 . . . . 25.0 113.984 -171.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.1 p -87.79 -22.42 24.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.291 0.567 . . . . 25.0 111.009 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 C--O 1.21 -0.978 0 CA-C-O 123.823 1.773 . . . . 25.0 112.789 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.682 0 CA-C-O 123.669 1.705 . . . . 25.0 115.561 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.4 m -94.18 98.51 11.01 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.73 -1.453 . . . . 25.0 110.697 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.2 ptt? -112.8 75.73 0.93 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.995 0.902 . . . . 25.0 109.49 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.22 97.51 9.96 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.022 -0.733 . . . . 25.0 109.022 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.38 162.97 15.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.613 -0.514 . . . . 25.0 109.613 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.16 -47.02 72.25 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.109 0.781 . . . . 25.0 113.109 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 54.69 24.53 5.62 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.361 1.245 . . . . 25.0 114.361 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.63 174.28 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 106.911 -1.514 . . . . 25.0 106.911 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.22 152.38 49.81 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.765 -0.584 . . . . 25.0 110.55 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.419 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -138.59 146.67 42.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 25.0 111.628 -175.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -95.17 134.57 37.76 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.35 135.03 39.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.529 0.681 . . . . 25.0 110.676 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.0 mt -94.92 -23.05 17.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.12 -0.945 . . . . 25.0 109.531 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -127.61 159.04 35.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -99.39 145.35 27.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.531 -0.544 . . . . 25.0 109.531 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.58 109.89 3.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 25.0 110.299 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.52 138.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 105.335 -2.098 . . . . 25.0 105.335 175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.86 122.38 24.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -101.27 -17.66 16.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.969 -0.752 . . . . 25.0 108.969 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -109.63 151.59 42.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.99 -0.744 . . . . 25.0 108.99 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.48 -20.91 20.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.015 -1.523 . . . . 25.0 114.467 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -84.91 -9.54 58.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.693 0.759 . . . . 25.0 110.601 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -88.51 140.81 29.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.36 -0.836 . . . . 25.0 110.35 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.39 134.45 34.33 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.497 -0.557 . . . . 25.0 109.497 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -95.18 131.51 41.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.44 -0.578 . . . . 25.0 109.44 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -157.14 168.03 28.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.869 0.366 . . . . 25.0 110.03 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -127.14 158.37 37.22 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.807 -0.558 . . . . 25.0 110.33 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.503 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 13.7 pttt -60.86 133.67 56.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.418 -1.327 . . . . 25.0 107.418 174.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.28 55.24 Favored Glycine 0 C--O 1.223 -0.541 0 CA-C-O 119.357 -0.69 . . . . 25.0 113.358 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -81.57 163.02 22.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.218 0.509 . . . . 25.0 109.668 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.8 132.01 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.459 -0.571 . . . . 25.0 109.459 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.86 156.35 41.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.064 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -84.27 133.56 34.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.91 121.81 49.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 25.0 106.462 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.71 -49.62 5.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.237 -0.892 . . . . 25.0 111.695 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.19 162.98 34.19 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.622 0.576 . . . . 25.0 109.564 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -132.17 151.58 51.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.518 -0.919 . . . . 25.0 108.518 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t0 56.84 40.29 29.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.325 1.536 . . . . 25.0 107.663 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 t -70.58 -6.12 34.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.784 -1.553 . . . . 25.0 114.202 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -136.16 10.93 3.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.969 0.729 . . . . 25.0 112.969 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.79 20.31 73.93 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 109.201 -1.56 . . . . 25.0 109.201 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.5 mt -122.32 109.92 15.03 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 105.557 -2.016 . . . . 25.0 105.557 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -68.65 149.07 49.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.645 -1.242 . . . . 25.0 107.645 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.18 -14.21 58.0 Favored Glycine 0 C--O 1.222 -0.611 0 CA-C-O 119.068 -0.851 . . . . 25.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -97.94 134.22 41.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.678 1.239 . . . . 25.0 109.782 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -121.13 147.58 45.37 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.034 -0.728 . . . . 25.0 109.034 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 tp -85.89 115.48 23.54 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 105.907 -1.886 . . . . 25.0 105.907 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.3 m -118.08 160.63 21.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.391 -0.226 . . . . 25.0 110.391 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -131.18 132.2 44.56 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.137 0.494 . . . . 25.0 111.699 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tt -150.49 141.17 22.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.058 -0.974 . . . . 25.0 108.682 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 56.86 33.37 23.02 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.159 0.8 . . . . 25.0 113.159 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.1 10.75 81.49 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.731 -0.747 . . . . 25.0 113.686 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -118.45 162.76 17.8 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.37 149.48 41.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.466 -1.309 . . . . 25.0 107.466 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.64 -179.14 43.23 Favored Glycine 0 C--O 1.239 0.435 0 N-CA-C 110.97 -0.852 . . . . 25.0 110.97 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.14 146.14 7.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.345 0.593 . . . . 25.0 112.244 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -142.72 134.66 13.2 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.397 -0.819 . . . . 25.0 108.813 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.36 115.89 4.38 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 114.64 -3.107 . . . . 25.0 110.178 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.59 -17.01 66.29 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.277 0.471 . . . . 25.0 114.277 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -70.24 -4.13 20.34 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.415 -0.462 . . . . 25.0 111.661 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -104.69 10.28 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.226 -0.296 . . . . 25.0 110.629 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.4 153.27 40.62 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.88 0.326 . . . . 25.0 111.88 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.24 117.68 24.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.419 HD13 ' HB2' ' A' ' 10' ' ' ALA . 25.4 mm -63.35 133.13 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.778 0.431 . . . . 25.0 111.359 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 114.43 19.29 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 106.413 -1.699 . . . . 25.0 106.413 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.0 t 63.91 104.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 124.62 1.2 . . . . 25.0 112.095 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.63 -166.38 33.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.258 -1.137 . . . . 25.0 110.258 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.0 tpt -73.3 18.78 0.11 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.74 1.015 . . . . 25.0 113.74 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -148.37 114.45 5.81 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.895 -0.503 . . . . 25.0 111.704 -175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -137.77 52.69 1.86 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.366 1.079 . . . . 25.0 112.654 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -74.44 135.29 42.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 105.828 -1.916 . . . . 25.0 105.828 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.29 152.98 74.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 105.57 -2.011 . . . . 25.0 105.57 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.14 -18.93 26.75 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 115.927 1.472 . . . . 25.0 115.927 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 51.76 47.19 25.27 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.962 1.097 . . . . 25.0 113.962 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.78 160.83 28.79 Favored Glycine 0 CA--C 1.511 -0.202 0 N-CA-C 108.821 -1.712 . . . . 25.0 108.821 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -144.57 153.53 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.73 11.23 1.63 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.543 0.572 . . . . 25.0 112.543 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 tt -93.09 147.71 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.426 -1.324 . . . . 25.0 107.426 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.2 t -126.23 130.44 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.5 m -115.88 -42.7 3.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.555 -0.905 . . . . 25.0 108.555 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.8 t0 . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 124.878 1.271 . . . . 25.0 109.536 176.771 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.804 0 CA-C-O 123.375 1.542 . . . . 25.0 115.683 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -75.92 -26.84 57.3 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.689 -0.889 . . . . 25.0 112.353 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.7 ptp -155.37 172.96 17.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.804 -1.554 . . . . 25.0 106.804 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -110.43 -39.67 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.684 -0.487 . . . . 25.0 109.684 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -147.2 172.32 14.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 102.34 -3.208 . . . . 25.0 102.34 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.36 -45.99 80.23 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.849 1.425 . . . . 25.0 114.849 -171.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t30 50.75 45.24 27.39 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.76 1.393 . . . . 25.0 114.76 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.65 147.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.169 -1.789 . . . . 25.0 106.169 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.66 162.84 13.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.566 0.698 . . . . 25.0 110.136 -174.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.47 138.7 29.44 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.394 -0.821 . . . . 25.0 109.92 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -95.28 134.99 37.44 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.648 -0.871 . . . . 25.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.25 134.59 42.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.247 0.546 . . . . 25.0 110.548 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.06 -30.56 15.96 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.646 . . . . 25.0 109.352 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -126.44 163.66 22.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.219 -1.4 . . . . 25.0 107.219 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.8 p-10 -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.665 -0.865 . . . . 25.0 108.665 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -151.46 129.87 12.11 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.697 0.629 . . . . 25.0 112.697 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -98.62 128.15 50.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.174 -2.899 . . . . 25.0 103.174 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.59 117.49 9.6 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.819 -0.808 . . . . 25.0 108.819 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -95.1 -13.34 25.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.536 0.684 . . . . 25.0 109.286 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 m -120.41 150.7 52.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.81 -20.43 26.14 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 117.636 -1.109 . . . . 25.0 114.487 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -82.13 -15.45 53.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.763 0.792 . . . . 25.0 109.801 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -84.05 147.18 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.48 -0.782 . . . . 25.0 110.517 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.432 HD22 ' H ' ' A' ' 55' ' ' GLY . 4.9 tp -97.92 132.52 43.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.95 0.405 . . . . 25.0 109.941 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -89.34 143.21 27.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.991 -1.115 . . . . 25.0 107.991 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 57' ' ' VAL . 38.8 p90 -160.93 170.17 21.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.151 -1.796 . . . . 25.0 106.151 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtm-85 -124.26 159.29 30.55 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.928 -0.483 . . . . 25.0 111.087 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 10.6 ptmm? -59.09 133.44 56.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.042 -0.725 . . . . 25.0 109.042 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.1 -11.39 72.07 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.57 -0.741 . . . . 25.0 113.635 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -80.93 161.31 24.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.37 134.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.965 -0.754 . . . . 25.0 108.965 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.0 ptp -130.61 158.71 39.27 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 m -97.86 125.43 42.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.241 -0.652 . . . . 25.0 109.241 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.5 t -82.62 127.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.478 -1.305 . . . . 25.0 107.478 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -102.34 -41.09 6.46 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 25.0 110.454 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -146.67 164.58 32.23 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.772 -1.196 . . . . 25.0 107.772 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -132.69 152.39 51.72 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.505 -1.294 . . . . 25.0 107.505 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 31.04 20.81 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 123.052 1.406 . . . . 25.0 108.42 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.1 t -70.5 -20.43 62.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 113.311 -1.768 . . . . 25.0 114.701 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -102.85 3.82 37.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.29 0.567 . . . . 25.0 109.873 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.51 85.81 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 109.052 -1.619 . . . . 25.0 109.052 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.0 mt -111.26 122.8 48.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.394 -1.706 . . . . 25.0 106.394 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.7 132.69 54.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.695 0.759 . . . . 25.0 110.08 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -1.11 89.22 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-O 118.767 -1.018 . . . . 25.0 115.506 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.359 1.58 . . . . 25.0 108.712 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -110.23 142.5 41.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.202 -0.311 . . . . 25.0 110.921 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.73 114.83 20.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.336 -2.098 . . . . 25.0 105.336 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -117.89 162.96 17.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -129.68 138.63 51.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.96 0.41 . . . . 25.0 110.265 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.66 140.19 15.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.586 -1.264 . . . . 25.0 107.586 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 55.65 29.27 13.34 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.422 1.267 . . . . 25.0 114.422 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.92 1.87 90.64 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.952 -0.642 . . . . 25.0 114.351 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -114.06 162.8 16.01 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -131.83 138.51 48.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.901 -1.518 . . . . 25.0 106.901 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -145.53 164.46 28.07 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.378 -1.089 . . . . 25.0 110.378 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.6 pt -81.63 145.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG13 ' CE1' ' A' ' 26' ' ' PHE . 76.8 t -141.62 135.29 14.62 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -176.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.13 113.32 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 115.765 -2.357 . . . . 25.0 111.641 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.1 -20.0 59.89 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 114.545 0.578 . . . . 25.0 114.545 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.22 -30.11 68.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.932 0.396 . . . . 25.0 111.373 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -89.53 8.82 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.213 0.449 . . . . 25.0 112.213 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.69 153.67 36.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.149 0.499 . . . . 25.0 112.298 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -125.09 117.58 24.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.198 -0.667 . . . . 25.0 109.198 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm -64.31 136.46 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.179 0.592 . . . . 25.0 110.535 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.7 158.09 43.74 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 122.545 0.338 . . . . 25.0 110.455 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t 52.5 90.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 114.816 1.413 . . . . 25.0 114.816 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.75 45.01 2.02 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 115.157 -0.929 . . . . 25.0 111.371 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.1 mpt? 54.19 -119.26 1.44 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.436 0.694 . . . . 25.0 110.426 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -154.55 155.51 34.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.919 0.781 . . . . 25.0 110.285 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.53 -43.75 7.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.2 0.524 . . . . 25.0 111.179 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 52.37 -105.31 0.22 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.471 0.708 . . . . 25.0 111.126 -175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -122.01 148.03 50.48 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.681 -0.859 . . . . 25.0 108.681 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.85 9.72 2.58 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 N-CA-C 114.21 0.812 . . . . 25.0 114.21 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.19 144.93 31.12 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.034 -1.098 . . . . 25.0 108.034 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.89 -27.22 0.09 OUTLIER Glycine 0 C--O 1.224 -0.518 0 C-N-CA 121.488 -0.387 . . . . 25.0 112.354 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -123.84 167.05 14.59 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -73.18 164.54 26.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.409 . . . . 25.0 110.103 177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.4 pt -115.52 162.57 13.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.37 91.63 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.0 t -93.61 -1.68 55.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.686 0.755 . . . . 25.0 110.528 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.2 t0 . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 123.774 1.749 . . . . 25.0 111.641 179.446 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.091 0 CA-C-O 123.57 1.65 . . . . 25.0 114.8 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 m -81.43 -13.28 58.42 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.844 -1.386 . . . . 25.0 111.138 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 mmt -79.37 138.76 37.79 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.301 -0.629 . . . . 25.0 109.301 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -78.26 133.83 37.63 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -134.51 173.92 11.12 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 105.857 -1.905 . . . . 25.0 105.857 174.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -58.24 -46.04 86.66 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.677 1.362 . . . . 25.0 114.677 -170.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.9 t30 53.87 41.65 31.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.771 1.026 . . . . 25.0 113.771 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -120.12 151.98 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 105.901 -1.888 . . . . 25.0 105.901 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.73 151.97 37.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.128 0.489 . . . . 25.0 111.614 -174.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -133.63 148.62 51.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.54 -0.755 . . . . 25.0 112.465 -175.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.31 132.61 40.13 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 114.988 -1.005 . . . . 25.0 108.295 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.97 125.4 28.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.2 mt -91.64 -26.99 18.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 25.0 110.752 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -127.96 163.03 25.38 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.411 -1.329 . . . . 25.0 107.411 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.62 165.63 12.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.273 -0.639 . . . . 25.0 109.273 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -148.61 156.55 42.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.608 -0.516 . . . . 25.0 109.608 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.36 105.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.41 30.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.167 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -104.91 -12.31 16.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 25.0 111.753 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -122.39 149.83 55.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.984 -0.553 . . . . 25.0 110.511 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.89 -16.07 40.89 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 117.393 -1.271 . . . . 25.0 114.583 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -76.86 -19.64 57.24 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.77 0.795 . . . . 25.0 109.945 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -94.18 137.89 32.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.805 0.812 . . . . 25.0 110.49 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.62 131.48 35.21 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.83 -0.748 . . . . 25.0 111.276 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.7 t -78.72 109.98 13.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.16 162.46 35.43 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.461 -0.94 . . . . 25.0 108.461 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.47 167.49 20.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.879 . . . . 25.0 108.625 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -61.92 140.66 58.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.522 -0.547 . . . . 25.0 109.522 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.51 -15.0 62.43 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-O 118.792 -1.004 . . . . 25.0 113.272 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -73.07 155.74 39.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.505 1.152 . . . . 25.0 110.697 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.9 mm -122.38 126.14 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.371 -1.344 . . . . 25.0 107.371 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.4 ptp -135.97 154.92 50.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.18 0.192 . . . . 25.0 111.31 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 m -92.96 129.8 38.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.625 -0.879 . . . . 25.0 108.625 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.95 125.74 40.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.502 -1.295 . . . . 25.0 107.502 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.3 mt -94.74 -48.11 6.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.046 -0.524 . . . . 25.0 110.442 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.2 167.12 22.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.237 0.96 . . . . 25.0 109.11 -174.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -129.92 155.46 46.02 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 57.5 36.02 26.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 123.55 1.643 . . . . 25.0 107.914 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -70.17 -12.5 61.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.835 -1.529 . . . . 25.0 114.089 -171.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -110.46 4.79 20.83 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.42 0.628 . . . . 25.0 109.337 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 -20.29 11.17 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 109.431 -1.468 . . . . 25.0 109.431 -173.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 40' ' ' GLN . 91.7 mt -81.02 123.77 28.62 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.751 -1.574 . . . . 25.0 106.751 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.7 135.46 57.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.511 -0.922 . . . . 25.0 108.511 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.75 -3.65 83.24 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 115.878 1.111 . . . . 25.0 115.878 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -96.35 121.56 38.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.635 1.218 . . . . 25.0 108.078 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -111.87 143.99 41.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.728 -0.389 . . . . 25.0 110.55 -172.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -85.37 120.77 27.2 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.818 -2.29 . . . . 25.0 104.818 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.4 m -121.68 161.78 21.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.59 -0.522 . . . . 25.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -123.44 129.87 51.88 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.88 142.22 14.82 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.918 -1.142 . . . . 25.0 107.918 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 58.57 29.95 19.15 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.355 0.662 . . . . 25.0 112.662 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.0 7.77 88.25 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.766 -0.731 . . . . 25.0 114.706 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.9 164.9 25.88 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -124.43 153.7 41.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.51 -1.293 . . . . 25.0 107.51 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 169.4 42.4 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 110.441 -1.064 . . . . 25.0 110.441 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 pt -78.22 147.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 117.742 0.771 . . . . 25.0 111.995 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.92 135.42 13.49 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.749 -1.204 . . . . 25.0 107.749 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.15 116.57 4.56 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 115.844 -2.304 . . . . 25.0 111.489 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.88 -25.49 69.27 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 115.935 1.134 . . . . 25.0 115.935 -172.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -69.07 -12.4 61.65 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.874 -0.78 . . . . 25.0 112.043 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.58 5.77 50.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.356 -0.84 . . . . 25.0 110.252 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -116.94 154.8 30.22 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 122.61 0.364 . . . . 25.0 111.462 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -126.86 114.5 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.547 HD13 ' HB2' ' A' ' 10' ' ' ALA . 11.3 mm -67.73 141.82 17.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.145 -1.058 . . . . 25.0 108.145 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.06 -159.64 0.48 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.828 0.451 . . . . 25.0 109.967 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.05 141.21 18.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 122.869 0.467 . . . . 25.0 109.771 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.15 37.14 1.39 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-O 119.999 -0.334 . . . . 25.0 113.3 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.42 162.85 39.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.618 0.709 . . . . 25.0 111.499 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.7 t80 54.61 52.86 11.51 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.356 1.074 . . . . 25.0 113.809 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.94 -22.02 66.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.321 -0.854 . . . . 25.0 112.928 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -99.73 111.85 24.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.412 0.625 . . . . 25.0 111.718 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.64 155.41 50.76 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 114.686 -1.143 . . . . 25.0 110.143 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.0 175.04 11.77 Favored 'Trans proline' 0 C--O 1.243 0.727 0 N-CA-C 113.722 0.624 . . . . 25.0 113.722 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.8 163.88 35.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 104.665 -2.346 . . . . 25.0 104.665 174.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.01 -171.78 44.29 Favored Glycine 0 C--O 1.218 -0.878 0 N-CA-C 108.073 -2.011 . . . . 25.0 108.073 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.63 172.65 7.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.082 -1.081 . . . . 25.0 108.082 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -126.04 161.63 27.13 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.702 0.287 . . . . 25.0 110.342 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.1 mt -109.55 134.02 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.826 -1.546 . . . . 25.0 106.826 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -118.78 169.01 10.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.374 -1.713 . . . . 25.0 106.374 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.84 120.9 15.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.175 0.512 . . . . 25.0 110.889 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 . . . . . 0 C--O 1.207 -1.133 0 CA-C-O 126.581 3.086 . . . . 25.0 113.938 178.443 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 115.314 0.886 . . . . 25.0 115.314 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m 56.5 18.08 3.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.98 1.474 . . . . 25.0 114.98 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.3 ttm -75.3 80.72 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.691 0.758 . . . . 25.0 110.44 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -163.17 -34.51 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.163 -0.926 . . . . 25.0 110.107 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -116.28 170.02 8.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.604 -1.258 . . . . 25.0 107.604 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -58.35 -42.62 87.33 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.294 0.371 . . . . 25.0 111.182 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 39.8 t30 57.48 22.38 7.97 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.547 0.943 . . . . 25.0 113.547 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -89.7 132.94 33.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -95.27 160.51 14.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.334 0.588 . . . . 25.0 109.747 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.09 150.75 34.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.616 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.79 133.5 39.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 25.0 109.649 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.42 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -76.95 134.13 38.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.391 0.615 . . . . 25.0 109.854 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.24 -21.55 19.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.524 -0.762 . . . . 25.0 110.152 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.88 159.88 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 25.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 17.3 p-10 -101.98 147.57 26.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -153.07 156.95 39.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.7 -0.682 . . . . 25.0 110.875 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -124.96 131.48 72.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 104.472 -2.418 . . . . 25.0 104.472 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 121.65 14.31 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.13 0.269 . . . . 25.0 110.406 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -94.6 -14.62 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.358 -0.978 . . . . 25.0 108.358 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.7 155.44 59.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.471 -0.786 . . . . 25.0 109.774 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.16 -19.86 25.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 117.31 -1.327 . . . . 25.0 113.753 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -15.57 49.1 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.618 0.723 . . . . 25.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.29 153.17 21.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 25.0 111.232 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.6 136.61 41.15 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.039 -0.413 . . . . 25.0 111.841 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.1 m -85.19 109.81 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 171.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -126.55 162.05 26.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.649 -0.871 . . . . 25.0 108.649 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 43.5 mtm105 -127.39 155.23 43.96 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.918 -0.488 . . . . 25.0 111.102 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.8 pttt -59.99 128.9 39.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 175.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.19 65.83 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.627 -0.715 . . . . 25.0 114.353 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.75 156.76 30.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.881 0.841 . . . . 25.0 109.872 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.16 130.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -135.28 160.6 37.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.584 -0.524 . . . . 25.0 109.584 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 33.4 m -101.85 127.15 48.79 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 25.0 109.824 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.93 125.53 40.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.7 mt -95.5 -41.57 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.607 -0.724 . . . . 25.0 110.237 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -148.23 164.17 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.324 -0.621 . . . . 25.0 109.324 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -135.11 151.88 51.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.494 -1.669 . . . . 25.0 106.494 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 59.39 34.45 22.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.175 1.464 . . . . 25.0 107.913 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -70.55 -16.54 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.829 -1.532 . . . . 25.0 112.613 -172.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -113.35 7.98 17.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 25.0 112.05 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.84 19.81 78.54 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 109.418 -1.473 . . . . 25.0 109.418 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.7 mt -130.05 114.86 16.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -65.7 149.93 49.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.68 -1.6 . . . . 25.0 106.68 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.86 -12.55 69.17 Favored Glycine 0 C--O 1.215 -1.07 0 CA-C-O 118.573 -1.126 . . . . 25.0 112.224 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -106.28 128.28 53.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.179 1.489 . . . . 25.0 110.337 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.16 142.34 50.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.77 -0.456 . . . . 25.0 109.77 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.2 tp -83.87 119.03 24.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.0 m -123.42 164.79 18.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.349 0.119 . . . . 25.0 111.209 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.7 p -121.94 124.13 43.34 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.032 0.444 . . . . 25.0 110.256 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 tp -162.17 164.64 27.75 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 106.076 -1.824 . . . . 25.0 106.076 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.19 17.63 7.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.789 1.403 . . . . 25.0 114.789 169.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.33 13.57 80.32 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.934 -0.65 . . . . 25.0 113.261 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.9 167.61 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.559 -0.534 . . . . 25.0 109.559 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -105.98 154.81 20.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 103.6 -2.741 . . . . 25.0 103.6 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.78 163.77 34.27 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 110.121 -1.192 . . . . 25.0 110.121 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 pt -79.61 141.93 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.877 0.846 . . . . 25.0 109.983 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.6 132.99 17.74 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.362 -1.347 . . . . 25.0 107.362 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.07 121.74 8.36 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 114.218 -3.388 . . . . 25.0 111.258 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.17 -19.07 69.86 Favored Glycine 0 C--O 1.22 -0.763 0 CA-C-N 115.801 -0.636 . . . . 25.0 112.121 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -69.73 -5.59 26.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.109 0.481 . . . . 25.0 111.378 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -114.4 11.43 17.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.748 -0.464 . . . . 25.0 109.748 175.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 12' ' ' ALA . 89.0 mt -120.57 150.09 41.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.275 0.56 . . . . 25.0 110.779 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -120.45 119.75 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm -57.71 134.41 22.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.882 -0.599 . . . . 25.0 109.772 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.87 -166.97 1.72 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.661 -0.699 . . . . 25.0 110.367 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m -61.82 160.55 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 114.006 1.113 . . . . 25.0 114.006 -176.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.78 175.04 35.86 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 108.922 -1.671 . . . . 25.0 108.922 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.6 mtp -56.05 -30.64 62.25 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 116.148 1.907 . . . . 25.0 116.148 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.45 26.56 4.77 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.78 0.8 . . . . 25.0 110.313 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -68.78 156.01 39.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.203 -0.908 . . . . 25.0 109.746 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -118.32 111.65 19.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.461 0.648 . . . . 25.0 110.626 -175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -61.17 131.77 92.22 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.918 -1.037 . . . . 25.0 109.591 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.65 167.55 26.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 117.987 -0.875 . . . . 25.0 111.562 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.11 156.47 43.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.73 82.33 1.66 Allowed Glycine 0 C--O 1.219 -0.835 0 N-CA-C 110.939 -0.864 . . . . 25.0 110.939 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 57.21 29.98 17.61 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.828 1.047 . . . . 25.0 113.828 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -115.87 136.15 53.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.139 0.495 . . . . 25.0 110.225 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 79.9 mt -102.03 129.33 53.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.397 -1.705 . . . . 25.0 106.397 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.21 19.5 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.938 0.718 . . . . 25.0 112.938 -173.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.5 p -79.03 149.86 32.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.052 0.453 . . . . 25.0 110.423 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 C--O 1.21 -1.007 0 CA-C-O 124.641 2.162 . . . . 25.0 111.766 176.359 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.901 0 CA-C-O 122.815 1.231 . . . . 25.0 113.777 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -150.11 164.01 36.71 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 120.706 -1.467 . . . . 25.0 107.732 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.1 tpt 51.24 70.9 0.48 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.939 1.088 . . . . 25.0 113.939 177.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.2 tttm 62.81 58.62 1.52 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 122.223 1.011 . . . . 25.0 113.475 177.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -91.36 -179.47 5.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 105.927 -1.879 . . . . 25.0 105.927 171.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.6 mt -53.57 -49.87 66.79 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.191 1.182 . . . . 25.0 114.191 -175.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.7 t30 47.09 46.56 16.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.124 1.527 . . . . 25.0 115.124 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.7 m -111.25 169.5 4.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 104.483 -2.414 . . . . 25.0 104.483 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.41 164.38 29.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.42 28.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.496 -0.774 . . . . 25.0 109.75 -175.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.35 136.34 53.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.681 -1.229 . . . . 25.0 107.681 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 135.38 45.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.48 0.657 . . . . 25.0 109.727 177.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.01 -30.16 16.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.182 -0.917 . . . . 25.0 109.356 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.83 158.49 39.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 -177.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.1 p-10 -87.91 152.98 21.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.432 . . . . 25.0 110.08 177.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.76 87.25 1.41 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.16 121.55 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.59 51.64 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.379 0.424 . . . . 25.0 111.418 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.05 -18.18 12.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.361 -0.836 . . . . 25.0 110.184 175.333 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -104.93 150.79 39.1 Favored Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 109.613 -0.514 . . . . 25.0 109.613 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.62 -21.6 19.05 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 117.585 -1.144 . . . . 25.0 114.42 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.62 -14.95 56.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 25.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -89.15 140.61 29.29 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.91 . . . . 25.0 111.134 -176.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.87 124.74 34.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.674 -0.641 . . . . 25.0 111.147 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -80.45 121.22 25.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.544 -0.539 . . . . 25.0 109.544 174.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.503 ' CE1' HG13 ' A' ' 57' ' ' VAL . 52.7 p90 -143.26 168.56 19.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.306 -0.998 . . . . 25.0 108.306 178.305 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -129.28 164.82 22.69 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.973 -0.455 . . . . 25.0 111.23 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 34.9 pttt -62.03 134.27 56.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 25.0 109.729 -177.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.47 -13.38 67.45 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 115.524 -0.762 . . . . 25.0 113.407 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -75.87 157.64 33.05 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 117.419 0.609 . . . . 25.0 110.988 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.88 126.37 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.292 0.637 . . . . 25.0 111.042 -175.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -129.49 147.78 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.41 0.624 . . . . 25.0 111.43 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -87.97 130.25 35.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.21 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.24 124.13 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 177.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -99.59 -41.32 7.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.3 -0.864 . . . . 25.0 111.791 -174.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.06 160.41 42.43 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.88 -0.785 . . . . 25.0 108.88 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -128.36 154.58 45.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.899 -1.149 . . . . 25.0 107.899 176.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t0 55.67 40.57 30.92 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.547 1.642 . . . . 25.0 108.309 -175.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -70.86 -8.0 49.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.646 -1.616 . . . . 25.0 114.193 -171.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -135.86 12.49 3.39 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.811 0.671 . . . . 25.0 112.811 -175.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 15.96 74.41 Favored Glycine 0 N--CA 1.459 0.224 0 N-CA-C 110.692 -0.963 . . . . 25.0 110.692 -176.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.3 mt -122.52 110.68 15.88 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.479 -1.674 . . . . 25.0 106.479 176.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.9 144.07 57.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.559 -1.275 . . . . 25.0 107.559 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 -17.2 57.04 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 115.217 -0.902 . . . . 25.0 113.107 -177.289 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -94.33 128.2 40.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.96 1.38 . . . . 25.0 108.61 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -119.72 146.3 45.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 -174.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.2 tp -86.22 112.64 21.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.654 -1.61 . . . . 25.0 106.654 174.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -112.04 168.32 9.69 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.923 -0.399 . . . . 25.0 109.923 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -128.71 131.71 47.95 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.064 -1.088 . . . . 25.0 108.064 174.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -158.61 140.12 13.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 -176.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 56.43 33.2 22.05 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.547 0.689 . . . . 25.0 112.356 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.2 3.34 90.68 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 115.758 1.063 . . . . 25.0 115.758 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -127.85 161.48 28.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 118.503 1.152 . . . . 25.0 109.035 177.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -113.15 151.74 30.51 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 105.903 -1.888 . . . . 25.0 105.903 176.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.73 38.19 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.437 -1.065 . . . . 25.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -78.62 144.79 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.51 0.671 . . . . 25.0 109.217 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.503 HG13 ' CE1' ' A' ' 26' ' ' PHE . 46.3 t -140.55 134.12 15.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.314 -0.857 . . . . 25.0 109.106 -176.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.95 114.65 3.96 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 116.05 -2.167 . . . . 25.0 110.855 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.57 -18.28 63.4 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-N 116.066 -0.515 . . . . 25.0 113.07 -176.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.47 -31.13 67.52 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.53 0.332 . . . . 25.0 111.414 174.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -88.58 6.9 35.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.112 0.412 . . . . 25.0 112.112 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.9 mt -119.4 151.33 38.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.851 0.358 . . . . 25.0 111.818 -176.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -124.43 123.31 39.89 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.956 -0.757 . . . . 25.0 108.956 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.12 140.36 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.284 0.633 . . . . 25.0 110.388 -177.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.3 165.58 13.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.933 -0.765 . . . . 25.0 108.933 -179.216 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t 58.38 44.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.487 1.115 . . . . 25.0 112.385 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.34 -45.27 4.43 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.706 -0.759 . . . . 25.0 114.159 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 51.3 mtt 50.92 -137.37 1.16 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.092 0.557 . . . . 25.0 110.789 -176.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -154.19 146.97 24.29 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.265 -1.383 . . . . 25.0 107.265 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 49.42 -152.3 0.14 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 124.211 0.944 . . . . 25.0 112.917 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -145.93 144.98 30.5 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.143 -1.058 . . . . 25.0 108.143 -176.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -71.61 147.02 91.95 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.511 -1.663 . . . . 25.0 106.511 175.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.3 100.25 0.99 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 117.812 -0.992 . . . . 25.0 113.103 -178.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.44 146.68 16.97 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.305 -0.628 . . . . 25.0 109.305 -179.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.97 -99.99 1.88 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 111.27 -0.732 . . . . 25.0 111.27 178.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.09 163.11 26.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.712 0.291 . . . . 25.0 110.945 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -103.58 139.8 38.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.995 -1.483 . . . . 25.0 106.995 175.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.5 pt -73.67 159.3 5.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.791 0.329 . . . . 25.0 111.74 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t 54.64 80.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 122.13 0.967 . . . . 25.0 113.051 179.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.0 t -132.48 168.8 17.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 105.155 -2.165 . . . . 25.0 105.155 175.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.215 -0.715 0 CA-C-O 124.85 2.262 . . . . 25.0 112.784 179.396 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.621 0 CA-C-O 124.943 2.413 . . . . 25.0 113.141 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -63.77 -20.7 65.97 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 112.066 -2.067 . . . . 25.0 113.308 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 91.0 mtp -104.36 -52.38 2.92 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 176.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -169.49 -47.87 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.28 0.562 . . . . 25.0 111.083 174.087 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -117.82 166.09 12.88 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 -178.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.42 -46.87 75.1 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 123.234 0.334 . . . . 25.0 111.144 -177.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.6 t30 48.55 47.35 20.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.352 1.241 . . . . 25.0 114.352 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 165.8 12.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 N-CA-C 105.334 -2.098 . . . . 25.0 105.334 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.23 159.64 39.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.524 -0.917 . . . . 25.0 108.524 -178.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.35 164.65 29.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.562 -0.744 . . . . 25.0 110.388 -172.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -114.81 135.15 54.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.75 -1.204 . . . . 25.0 107.75 175.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.99 124.49 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 25.0 110.7 178.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.42 -29.42 41.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.041 -0.527 . . . . 25.0 109.972 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -126.73 162.7 25.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.76 -0.83 . . . . 25.0 108.76 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.498 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 p-10 -98.29 160.38 14.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 175.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -144.14 175.0 10.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.462 0.648 . . . . 25.0 112.265 177.192 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.8 t -126.96 137.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 100.215 -3.994 . . . . 25.0 100.215 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.8 16.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.173 -1.047 . . . . 25.0 108.173 -178.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.64 -11.45 53.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.22 1.01 . . . . 25.0 109.354 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -138.33 152.52 71.57 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.02 -0.991 . . . . 25.0 109.088 -176.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.98 -15.78 29.25 Favored 'Trans proline' 0 C--N 1.35 0.608 0 N-CA-C 114.016 0.737 . . . . 25.0 114.016 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -84.35 -20.01 32.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.835 0.826 . . . . 25.0 109.621 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.56 135.73 35.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.662 -0.699 . . . . 25.0 110.199 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.95 138.46 36.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.108 -0.701 . . . . 25.0 109.108 177.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 p -90.03 131.74 35.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.194 -1.409 . . . . 25.0 107.194 172.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.39 169.02 22.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.716 -1.216 . . . . 25.0 107.716 -177.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -128.24 158.78 37.2 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 109.25 -0.648 . . . . 25.0 109.25 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.4 pttt -56.29 128.62 36.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 173.454 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.78 -20.84 42.5 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.944 -0.571 . . . . 25.0 113.868 -176.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -66.89 151.02 48.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.403 0.601 . . . . 25.0 109.989 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -115.42 128.38 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.541 -0.911 . . . . 25.0 108.541 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.5 148.61 50.58 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.455 0.645 . . . . 25.0 111.168 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 m -89.86 126.43 35.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.141 -1.429 . . . . 25.0 107.141 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.2 t -91.57 114.05 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.279 -1.748 . . . . 25.0 106.279 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.2 mt -88.77 -43.21 11.42 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.187 -0.915 . . . . 25.0 110.206 -176.483 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -145.72 161.19 40.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.499 -0.926 . . . . 25.0 108.499 -173.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -126.8 150.32 49.21 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.823 -1.547 . . . . 25.0 106.823 177.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 58.92 34.02 23.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.995 1.379 . . . . 25.0 108.267 177.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -69.61 -20.53 63.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.693 -1.594 . . . . 25.0 113.673 -169.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -102.46 6.22 39.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.701 -0.681 . . . . 25.0 110.144 -177.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 12.36 84.64 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 109.658 -1.377 . . . . 25.0 109.658 -173.35 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -113.36 121.02 43.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.783 -0.821 . . . . 25.0 108.783 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.4 128.51 37.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.54 0.686 . . . . 25.0 110.311 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.98 -0.92 84.63 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 115.766 1.066 . . . . 25.0 115.766 175.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -100.79 123.86 45.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.049 1.424 . . . . 25.0 109.237 177.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -113.3 143.02 45.14 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.251 -0.28 . . . . 25.0 111.133 -171.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.6 tp -81.99 112.98 19.57 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.661 -1.607 . . . . 25.0 106.661 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.3 m -114.11 159.05 20.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.901 0.382 . . . . 25.0 110.43 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -135.59 127.0 28.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.698 -0.683 . . . . 25.0 109.76 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.98 141.82 29.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.545 0.528 . . . . 25.0 110.889 176.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 48.08 38.57 9.87 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 178.355 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.61 89.82 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 115.019 0.768 . . . . 25.0 115.019 176.591 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -122.96 145.27 48.63 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.103 -0.703 . . . . 25.0 109.103 178.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -118.04 150.35 39.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.696 -0.853 . . . . 25.0 108.696 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.5 169.22 42.17 Favored Glycine 0 C--O 1.243 0.704 0 N-CA-C 109.789 -1.324 . . . . 25.0 109.789 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -82.27 146.89 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.504 0.652 . . . . 25.0 109.706 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.3 t -140.83 135.02 15.19 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 -177.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.06 119.76 6.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 115.323 -2.652 . . . . 25.0 110.776 174.43 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.63 -22.6 68.13 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 114.31 0.484 . . . . 25.0 114.31 -173.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.91 -26.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 122.524 -0.398 . . . . 25.0 111.932 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -85.71 6.62 26.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -118.98 146.69 44.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.47 0.544 . . . . 25.0 112.47 -175.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -118.2 121.77 41.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.497 -1.297 . . . . 25.0 107.497 170.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm -59.71 136.74 23.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 O-C-N 123.982 0.801 . . . . 25.0 109.009 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.22 179.88 7.59 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.002 -0.74 . . . . 25.0 109.002 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 t 58.65 59.99 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 122.688 1.233 . . . . 25.0 108.937 -175.013 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.33 -178.34 32.26 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.702 -1.759 . . . . 25.0 108.702 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 76.9 mtm -67.36 130.51 43.29 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 118.245 1.022 . . . . 25.0 109.645 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -109.6 -18.59 13.45 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 -176.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t0 49.54 48.89 20.81 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.701 1.001 . . . . 25.0 113.701 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -157.64 167.99 28.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.358 -0.608 . . . . 25.0 109.358 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -82.3 156.1 69.06 Favored Pre-proline 0 C--O 1.243 0.723 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 173.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -67.79 155.9 68.09 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 116.762 -1.692 . . . . 25.0 110.125 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.42 59.82 0.82 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.945 0.402 . . . . 25.0 110.926 -177.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.49 161.65 26.75 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 108.721 -1.752 . . . . 25.0 108.721 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -79.03 84.19 5.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.862 -0.421 . . . . 25.0 109.862 -177.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 53.78 22.98 3.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.11 1.152 . . . . 25.0 114.11 -176.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp 56.36 46.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.164 0.986 . . . . 25.0 111.976 176.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.7 m -79.28 170.09 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.977 -1.12 . . . . 25.0 107.977 171.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.0 t -141.65 144.41 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.14 -0.689 . . . . 25.0 109.14 176.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 . . . . . 0 C--O 1.21 -1.009 0 CA-C-O 123.823 1.773 . . . . 25.0 112.858 -179.367 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.899 0 CA-C-O 124.167 1.981 . . . . 25.0 113.485 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -78.95 58.77 2.47 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.554 -1.323 . . . . 25.0 111.169 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.7 ttt -123.36 44.92 2.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.463 0.649 . . . . 25.0 109.924 -177.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.8 tttt 59.75 85.91 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 122.819 1.295 . . . . 25.0 113.744 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -124.15 176.74 6.21 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 177.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mp -51.48 -50.87 59.02 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.35 1.611 . . . . 25.0 115.35 -174.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.1 t30 51.77 41.69 29.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.402 1.63 . . . . 25.0 115.402 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 m -114.84 163.07 12.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 175.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 155.8 49.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.618 0.723 . . . . 25.0 111.839 -176.083 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.49 152.97 47.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.916 -1.038 . . . . 25.0 110.71 -173.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.41 139.23 37.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.708 -0.849 . . . . 25.0 108.708 174.128 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.98 130.34 41.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.419 -0.586 . . . . 25.0 109.419 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.31 -34.39 15.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -123.95 168.51 12.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.0 p-10 -103.77 158.77 16.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.054 0.454 . . . . 25.0 110.387 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -153.06 133.52 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 25.0 110.53 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.94 125.77 57.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 102.901 -2.999 . . . . 25.0 102.901 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.12 129.33 38.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -100.47 -9.69 21.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.688 1.232 . . . . 25.0 109.054 177.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 m -127.71 152.66 77.27 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.402 -1.272 . . . . 25.0 108.948 -177.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.46 -25.62 17.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 114.718 1.007 . . . . 25.0 114.718 -176.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.71 -19.44 60.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.51 0.672 . . . . 25.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -90.02 143.59 26.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.28 -0.873 . . . . 25.0 109.972 -175.06 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.37 137.11 33.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.222 -0.591 . . . . 25.0 111.428 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.0 m -85.6 128.02 34.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 106.32 -1.733 . . . . 25.0 106.32 171.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.451 ' CE2' HG13 ' A' ' 57' ' ' VAL . 48.3 p90 -149.43 156.69 42.42 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.67 152.78 41.66 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 119.962 -0.695 . . . . 25.0 110.009 179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.525 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.4 pttp -55.57 126.33 24.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.158 -178.307 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.39 -22.67 28.44 Favored Glycine 0 C--O 1.221 -0.662 0 CA-C-N 115.379 -0.828 . . . . 25.0 112.902 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -70.74 157.95 37.15 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.565 0.683 . . . . 25.0 112.044 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -118.03 126.61 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.334 0.653 . . . . 25.0 109.979 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.9 ptp -132.45 151.36 51.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.924 0.392 . . . . 25.0 111.131 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.2 m -92.79 128.11 38.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 25.0 107.808 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.17 124.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 178.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 mt -102.83 -33.14 9.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.665 0.617 . . . . 25.0 112.665 -176.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.84 162.01 41.13 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 124.247 0.967 . . . . 25.0 108.603 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -133.86 144.46 48.94 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 108.392 -0.966 . . . . 25.0 108.392 178.344 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.51 32.98 20.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.511 1.624 . . . . 25.0 107.521 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.41 -14.34 62.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.892 -1.958 . . . . 25.0 115.221 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -110.84 6.15 21.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.2 -6.88 73.99 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.578 -1.409 . . . . 25.0 109.578 -174.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.72 115.38 27.82 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.768 -0.827 . . . . 25.0 108.768 179.001 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -61.75 132.65 53.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.397 -0.964 . . . . 25.0 108.397 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.59 -0.49 67.92 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-O 118.908 -0.94 . . . . 25.0 114.497 176.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -106.11 124.23 49.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.663 1.231 . . . . 25.0 109.574 177.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -111.31 145.42 38.85 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 121.968 -0.457 . . . . 25.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.4 tp -85.02 114.56 22.27 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 105.547 -2.02 . . . . 25.0 105.547 175.08 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.1 m -119.92 157.05 29.59 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.842 -0.429 . . . . 25.0 109.842 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 p -123.74 130.58 52.86 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.954 -1.128 . . . . 25.0 107.954 177.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -151.79 137.72 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.787 -1.097 . . . . 25.0 108.618 -174.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.7 t60 55.48 33.99 22.13 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.819 1.044 . . . . 25.0 113.819 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.05 7.03 89.02 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.816 0.686 . . . . 25.0 114.816 177.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -128.42 163.82 24.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.735 -1.209 . . . . 25.0 107.735 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -124.98 157.99 34.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 173.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.26 172.61 45.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.463 -1.455 . . . . 25.0 109.463 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.2 pt -84.22 143.05 12.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-O 121.785 0.802 . . . . 25.0 109.653 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 26' ' ' PHE . 58.1 t -138.83 134.05 16.88 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.676 -1.231 . . . . 25.0 107.676 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.3 119.57 6.6 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 114.61 -3.126 . . . . 25.0 110.95 175.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -26.68 72.04 Favored Glycine 0 C--O 1.223 -0.576 0 CA-C-N 115.867 -0.606 . . . . 25.0 114.375 -173.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.33 -9.97 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.956 -0.732 . . . . 25.0 111.325 178.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -93.12 4.59 53.74 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.699 -0.626 . . . . 25.0 109.633 174.495 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.42 165.24 14.13 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.83 0.452 . . . . 25.0 111.032 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -137.31 118.18 14.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.929 -0.578 . . . . 25.0 109.991 173.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.19 134.31 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.639 -1.245 . . . . 25.0 107.639 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.3 mt -93.21 138.09 31.93 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.362 -0.977 . . . . 25.0 108.362 -178.032 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t 56.4 35.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.842 -1.072 . . . . 25.0 111.852 -178.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.89 -38.76 96.54 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 115.198 0.839 . . . . 25.0 115.198 -178.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -159.61 164.31 34.26 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.089 0.944 . . . . 25.0 109.493 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -86.36 179.15 6.93 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 106.597 -1.631 . . . . 25.0 106.597 172.069 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 52.8 48.74 21.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.318 1.056 . . . . 25.0 111.963 174.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -63.34 153.07 36.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.798 -1.092 . . . . 25.0 108.174 178.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.11 147.89 89.8 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 25.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 172.75 14.48 Favored 'Trans proline' 0 C--N 1.352 0.726 0 O-C-N 122.615 0.797 . . . . 25.0 112.77 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.73 166.62 23.3 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.699 -0.682 . . . . 25.0 109.802 177.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.7 -146.5 4.98 Favored Glycine 0 C--N 1.321 -0.302 0 N-CA-C 108.999 -1.64 . . . . 25.0 108.999 178.288 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 68.23 -168.15 0.19 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.541 1.136 . . . . 25.0 111.97 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.3 t80 47.82 78.81 0.07 Allowed 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.356 1.613 . . . . 25.0 115.356 -178.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.53 157.86 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.765 -1.198 . . . . 25.0 107.765 173.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.73 166.07 25.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.579 -0.526 . . . . 25.0 109.579 -178.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 p -90.82 153.43 20.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.975 -1.12 . . . . 25.0 107.975 177.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--O 1.211 -0.925 0 CA-C-O 124.886 2.279 . . . . 25.0 111.225 178.401 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.695 0 CA-C-O 125.069 2.483 . . . . 25.0 113.223 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 m -79.03 58.4 2.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 112.581 -1.81 . . . . 25.0 112.012 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.9 mtt -75.61 45.08 0.3 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.267 0.839 . . . . 25.0 113.267 -176.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -96.28 -23.68 16.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.347 -0.388 . . . . 25.0 109.97 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -109.94 168.59 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.789 -2.3 . . . . 25.0 104.789 173.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.1 mt -62.36 -38.51 89.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.283 -0.167 . . . . 25.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 55.26 30.03 13.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.792 0.837 . . . . 25.0 110.518 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.96 162.74 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 104.06 -2.57 . . . . 25.0 104.06 -179.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.15 160.94 38.61 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.383 -0.969 . . . . 25.0 108.383 -177.568 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.71 159.32 44.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.668 -0.696 . . . . 25.0 110.77 -174.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.88 135.59 48.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 174.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.24 135.84 46.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.371 0.605 . . . . 25.0 109.794 178.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.31 -25.79 16.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.041 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -124.01 158.51 31.94 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.632 -1.247 . . . . 25.0 107.632 -178.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 13.4 p-10 -101.52 159.12 15.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -150.78 158.34 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.355 0.409 . . . . 25.0 111.068 -173.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.71 125.38 65.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 103.076 -2.935 . . . . 25.0 103.076 173.246 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.81 121.73 17.84 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.74 -0.384 . . . . 25.0 110.029 -176.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -101.65 -15.1 17.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.383 0.611 . . . . 25.0 109.385 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 t -111.62 147.55 37.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 25.0 109.352 175.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.39 -15.4 34.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 117.775 -1.016 . . . . 25.0 113.491 175.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.47 -15.49 56.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.756 0.789 . . . . 25.0 110.19 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -92.62 143.29 26.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.178 -0.919 . . . . 25.0 112.803 -172.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.62 137.57 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.861 -0.524 . . . . 25.0 110.493 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 117.41 23.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 172.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 164.66 32.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 36.9 ptt-85 -137.01 164.03 29.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.68 -0.408 . . . . 25.0 111.985 177.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.6 pttt -60.01 136.81 58.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.193 0.52 . . . . 25.0 110.358 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.36 -19.43 54.28 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.186 -0.915 . . . . 25.0 113.317 -178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -77.54 156.78 30.72 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 117.168 0.484 . . . . 25.0 110.412 -178.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.1 mm -115.18 130.5 69.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 123.332 0.653 . . . . 25.0 109.282 -174.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.9 ptp -138.94 151.83 47.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.949 0.404 . . . . 25.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 m -87.23 146.05 26.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.923 -1.51 . . . . 25.0 106.923 177.3 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.86 121.03 63.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 106.844 -1.539 . . . . 25.0 106.844 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.08 -49.44 8.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.596 . . . . 25.0 110.303 -177.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.55 170.84 19.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 -177.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -134.72 153.69 51.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.731 -0.176 . . . . 25.0 111.163 -175.33 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 60.46 38.75 19.01 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.298 1.523 . . . . 25.0 107.8 -177.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.45 -18.83 63.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.237 -1.802 . . . . 25.0 114.785 -167.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -111.4 6.38 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.497 0.665 . . . . 25.0 109.597 -177.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.53 -4.39 81.98 Favored Glycine 0 CA--C 1.518 0.241 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -174.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.4 127.02 35.49 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.274 -1.38 . . . . 25.0 107.274 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.53 132.41 52.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.297 0.57 . . . . 25.0 110.167 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.2 1.59 90.4 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 115.519 0.968 . . . . 25.0 115.519 174.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -100.94 115.41 30.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.143 1.472 . . . . 25.0 110.075 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -108.21 146.84 32.21 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.258 -0.276 . . . . 25.0 110.335 -172.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.1 tp -86.26 110.97 20.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.749 -1.575 . . . . 25.0 106.749 176.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -113.69 161.02 18.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.865 -0.42 . . . . 25.0 109.865 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.33 131.46 53.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.16 140.62 14.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 25.0 108.881 -177.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 56.96 35.06 25.88 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.074 1.138 . . . . 25.0 114.074 175.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.35 85.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.905 -0.664 . . . . 25.0 114.05 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.87 167.61 14.99 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -136.46 150.24 48.62 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.243 -1.762 . . . . 25.0 106.243 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.69 174.58 45.73 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 109.636 -1.386 . . . . 25.0 109.636 -176.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 pt -77.84 144.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.328 0.585 . . . . 25.0 110.437 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.0 t -144.26 136.19 13.04 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.34 112.05 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 116.009 -2.194 . . . . 25.0 111.662 174.579 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -24.86 73.29 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 115.902 -0.59 . . . . 25.0 113.941 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -70.44 -0.56 8.56 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 25.0 111.559 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -114.28 13.77 17.93 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.3 mt -118.75 155.19 31.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 25.0 109.928 178.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.81 117.76 27.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.179 -0.304 . . . . 25.0 110.179 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -54.68 130.56 16.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 O-C-N 123.773 0.671 . . . . 25.0 110.31 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 tp -114.62 113.66 24.66 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 115.692 -0.685 . . . . 25.0 110.264 -175.275 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t 58.08 5.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 114.702 1.371 . . . . 25.0 114.702 -178.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.49 44.39 3.2 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 117.314 1.686 . . . . 25.0 117.314 -179.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 55.7 mtt 43.05 42.41 3.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.536 1.31 . . . . 25.0 114.536 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -50.69 -38.74 48.67 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.715 1.376 . . . . 25.0 114.715 -175.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -121.69 48.81 1.63 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.569 0.7 . . . . 25.0 109.172 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 tttp 46.85 46.35 15.33 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 123.294 1.521 . . . . 25.0 112.162 -177.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -74.54 146.32 83.46 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 114.084 -1.417 . . . . 25.0 110.191 -175.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.2 160.87 46.16 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 118.332 -0.645 . . . . 25.0 112.662 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -158.56 174.97 14.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.088 -2.19 . . . . 25.0 105.088 177.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.12 -175.09 49.82 Favored Glycine 0 C--O 1.227 -0.331 0 N-CA-C 108.628 -1.789 . . . . 25.0 108.628 174.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -66.83 -32.53 73.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.265 1.033 . . . . 25.0 110.198 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.45 92.79 5.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.8 0.81 . . . . 25.0 109.129 175.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 pt -93.65 165.6 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.147 -0.933 . . . . 25.0 109.859 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.9 t 72.95 130.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.238 1.415 . . . . 25.0 111.941 -178.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.1 p -133.38 156.85 46.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.454 -1.313 . . . . 25.0 107.454 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 124.778 2.228 . . . . 25.0 113.439 177.796 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.733 0 CA-C-O 123.615 1.675 . . . . 25.0 115.7 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 t -156.1 152.35 27.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.433 -1.321 . . . . 25.0 107.433 177.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -141.03 152.36 44.8 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.127 -2.546 . . . . 25.0 104.127 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.66 147.27 46.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.071 -0.714 . . . . 25.0 109.071 -178.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -82.97 172.95 12.24 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.876 -1.527 . . . . 25.0 106.876 175.415 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.18 -58.63 6.66 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.69 1.367 . . . . 25.0 114.69 -172.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t30 54.82 24.49 5.76 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.982 1.475 . . . . 25.0 114.982 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.81 174.16 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 N-CA-C 104.69 -2.337 . . . . 25.0 104.69 174.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.72 162.26 33.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.563 0.619 . . . . 25.0 109.961 -177.193 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.6 144.18 30.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.94 -0.573 . . . . 25.0 111.656 -177.077 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.24 135.09 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 25.0 109.837 176.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.04 131.05 40.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 25.0 110.062 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.41 -30.63 17.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 25.0 110.784 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -130.57 162.53 29.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.22 -1.771 . . . . 25.0 106.22 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.53 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.4 p-10 -96.83 160.37 14.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.977 0.353 . . . . 25.0 110.39 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -150.02 144.4 25.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.399 0.518 . . . . 25.0 112.399 -177.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 126.79 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.748 -2.315 . . . . 25.0 104.748 174.228 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.63 128.57 33.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 -178.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -97.2 -24.1 15.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -104.31 147.16 33.91 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.174 -0.676 . . . . 25.0 109.174 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.1 -14.81 35.47 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.118 -1.455 . . . . 25.0 113.932 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -81.89 -19.81 40.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.898 0.856 . . . . 25.0 110.289 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.07 144.6 25.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.496 -0.774 . . . . 25.0 109.526 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.69 132.92 44.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.189 0.519 . . . . 25.0 110.648 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t -88.86 145.16 25.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 175.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 57' ' ' VAL . 35.6 p90 -159.36 165.58 32.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 -178.388 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -120.71 154.06 36.1 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 121.836 -0.54 . . . . 25.0 109.774 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 22.4 pttp -58.5 134.02 56.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.17 -14.01 65.93 Favored Glycine 0 C--O 1.221 -0.699 0 CA-C-O 119.209 -0.773 . . . . 25.0 112.996 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.21 159.8 28.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.02 0.91 . . . . 25.0 109.398 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.78 131.47 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.6 ptp -130.89 155.26 47.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.185 0.594 . . . . 25.0 110.051 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.3 m -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.825 -1.176 . . . . 25.0 107.825 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.7 125.63 54.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.757 -1.201 . . . . 25.0 107.757 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.0 mt -102.34 -36.59 8.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.554 -0.748 . . . . 25.0 111.876 -174.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.82 161.28 42.56 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.434 -1.321 . . . . 25.0 107.434 -178.096 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -129.41 150.25 50.85 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.553 -1.277 . . . . 25.0 107.553 177.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 59.09 35.64 23.9 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.287 1.617 . . . . 25.0 106.961 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.53 -10.48 59.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 112.546 -2.116 . . . . 25.0 115.923 -163.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -126.48 13.96 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.448 0.642 . . . . 25.0 109.611 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.58 -5.38 78.33 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 109.802 -1.319 . . . . 25.0 109.802 -175.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.18 115.59 26.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.041 -1.096 . . . . 25.0 108.041 178.066 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.33 130.83 48.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.793 0.806 . . . . 25.0 109.806 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 2.22 85.81 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-O 118.62 -1.1 . . . . 25.0 115.316 176.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -102.67 128.3 49.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.224 1.512 . . . . 25.0 108.442 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -117.1 144.43 44.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 25.0 109.647 -174.042 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.7 tp -84.34 117.38 23.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 175.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.92 158.08 27.44 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.34 129.93 52.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 177.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.08 137.76 19.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.509 -0.768 . . . . 25.0 109.173 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 54.99 30.94 15.06 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 176.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.33 13.02 82.45 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.138 -0.554 . . . . 25.0 113.991 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.37 165.3 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.243 -1.762 . . . . 25.0 106.243 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -137.23 140.61 41.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 118.471 0.578 . . . . 25.0 109.721 175.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.46 164.48 29.4 Favored Glycine 0 C--O 1.238 0.374 0 O-C-N 124.039 0.837 . . . . 25.0 111.574 -176.16 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.21 143.81 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.947 -1.131 . . . . 25.0 107.947 174.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG13 ' CE1' ' A' ' 26' ' ' PHE . 53.5 t -140.26 135.63 16.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 -175.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.58 116.99 4.8 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 115.21 -2.727 . . . . 25.0 110.385 174.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.05 -16.85 71.18 Favored Glycine 0 CA--C 1.508 -0.397 0 CA-C-N 116.163 -0.471 . . . . 25.0 112.948 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.49 -4.29 18.19 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.61 -0.347 . . . . 25.0 111.008 175.053 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -109.89 10.67 24.39 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.414 -0.179 . . . . 25.0 111.049 175.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.82 157.04 33.31 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.623 0.601 . . . . 25.0 112.623 -176.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -127.18 117.55 22.58 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.661 -0.866 . . . . 25.0 108.661 174.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.6 mm -63.75 139.43 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.614 0.245 . . . . 25.0 110.382 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.6 mt -121.05 149.8 42.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.431 -1.322 . . . . 25.0 107.431 176.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.35 169.32 19.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.683 -0.858 . . . . 25.0 108.683 -177.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.3 -64.37 0.38 Allowed Glycine 0 C--O 1.214 -1.147 0 C-N-CA 121.035 -0.602 . . . . 25.0 112.873 177.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 38.7 mmt -81.62 80.76 7.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.753 -0.263 . . . . 25.0 110.568 -178.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -75.91 -27.39 57.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.946 0.403 . . . . 25.0 110.234 178.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -84.97 88.02 7.41 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 175.092 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -131.9 122.02 24.97 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.317 -0.994 . . . . 25.0 108.317 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -70.49 138.99 86.37 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 107.417 -1.327 . . . . 25.0 107.417 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.97 -18.14 16.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 N-CA-C 114.895 1.075 . . . . 25.0 114.895 -177.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 52.62 40.28 29.79 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.562 0.745 . . . . 25.0 111.207 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.22 44.52 1.43 Allowed Glycine 0 C--O 1.225 -0.423 0 N-CA-C 110.794 -0.922 . . . . 25.0 110.794 -174.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -70.59 -16.92 62.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.029 0.442 . . . . 25.0 110.649 -177.016 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -115.07 129.7 56.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.342 -1.355 . . . . 25.0 107.342 170.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.0 pt -130.49 171.27 17.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.704 -0.85 . . . . 25.0 108.704 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.8 m -111.08 165.59 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 106.582 -1.636 . . . . 25.0 106.582 175.01 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.3 t -151.68 151.21 31.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.375 -1.343 . . . . 25.0 107.375 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 . . . . . 0 C--O 1.206 -1.224 0 CA-C-O 124.76 2.219 . . . . 25.0 111.986 -177.175 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.167 0 CA-C-O 123.374 1.541 . . . . 25.0 115.328 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 p -69.82 81.24 0.45 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.001 1.72 . . . . 25.0 112.653 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.6 mmm -75.32 -16.53 60.4 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.539 -0.726 . . . . 25.0 110.145 -179.7 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -161.43 151.38 17.06 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.688 0.795 . . . . 25.0 111.616 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -75.1 178.69 5.51 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.346 1.029 . . . . 25.0 110.459 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.4 -34.86 77.56 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.98 1.104 . . . . 25.0 113.98 -178.769 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 56.12 34.28 23.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.927 0.891 . . . . 25.0 112.67 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.87 135.49 39.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 104.153 -2.536 . . . . 25.0 104.153 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.75 161.47 29.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.991 0.814 . . . . 25.0 109.75 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.62 153.86 33.11 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.486 0.66 . . . . 25.0 112.768 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -91.64 134.58 34.57 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.167 -0.924 . . . . 25.0 109.962 176.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.97 127.56 32.98 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 108.33 -0.989 . . . . 25.0 108.33 173.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -87.03 -27.73 23.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.93 0.871 . . . . 25.0 109.602 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -124.97 160.0 29.94 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.926 -1.034 . . . . 25.0 108.972 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -98.76 158.22 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.586 -1.635 . . . . 25.0 106.586 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -142.91 159.84 41.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 112.703 0.631 . . . . 25.0 112.703 -174.132 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.63 119.77 55.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 102.535 -3.135 . . . . 25.0 102.535 172.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.07 113.25 13.39 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.354 -0.539 . . . . 25.0 109.593 -177.569 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -82.48 -15.52 52.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.937 0.875 . . . . 25.0 109.221 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.3 m -122.21 156.28 60.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.746 -0.661 . . . . 25.0 109.323 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.39 -14.13 22.77 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 117.548 -1.168 . . . . 25.0 112.739 175.571 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -84.85 -16.57 40.85 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.804 1.288 . . . . 25.0 110.962 178.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -91.59 140.93 29.25 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.32 134.32 34.11 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.675 0.75 . . . . 25.0 112.573 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -86.91 106.05 17.5 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.313 -0.858 . . . . 25.0 109.101 177.226 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -128.79 165.12 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.565 -0.709 . . . . 25.0 112.595 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 mtt85 -122.69 156.7 33.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.507 -0.183 . . . . 25.0 110.507 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -62.18 134.38 56.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 178.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.38 -11.54 68.73 Favored Glycine 0 C--O 1.214 -1.148 0 CA-C-N 115.484 -0.78 . . . . 25.0 112.559 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.16 159.82 32.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.342 1.071 . . . . 25.0 109.361 177.182 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.55 124.17 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.017 -0.734 . . . . 25.0 109.017 -176.331 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.6 ptp -131.86 152.35 51.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.26 0.837 . . . . 25.0 113.26 -176.683 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 m -92.83 131.24 38.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.22 -0.445 . . . . 25.0 110.223 -177.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.84 126.78 43.57 Favored 'Isoleucine or valine' 0 C--O 1.257 1.5 0 N-CA-C 108.104 -1.073 . . . . 25.0 108.104 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.8 mt -102.98 -38.75 7.21 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 114.735 -1.12 . . . . 25.0 111.889 -177.44 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -143.39 160.99 39.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.827 -1.078 . . . . 25.0 108.215 -176.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 -131.77 145.3 51.52 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.059 -1.83 . . . . 25.0 106.059 174.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 63.59 37.68 10.12 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 123.858 1.79 . . . . 25.0 108.305 -176.081 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -69.39 -19.63 63.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.03 -1.895 . . . . 25.0 116.054 -172.417 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -119.55 10.51 11.81 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.013 0.911 . . . . 25.0 108.82 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.23 79.64 Favored Glycine 0 CA--C 1.511 -0.16 0 CA-C-N 115.397 -0.819 . . . . 25.0 111.242 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.89 139.1 31.07 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 106.675 -1.602 . . . . 25.0 106.675 176.69 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.58 150.31 48.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.175 0.988 . . . . 25.0 110.404 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.4 -3.69 38.94 Favored Glycine 0 C--O 1.207 -1.572 0 O-C-N 120.873 -1.142 . . . . 25.0 115.329 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -99.73 131.04 45.97 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 118.967 1.384 . . . . 25.0 110.298 -179.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -125.82 142.34 51.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.97 -0.292 . . . . 25.0 111.389 -172.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp -82.77 120.73 26.0 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 106.618 -1.623 . . . . 25.0 106.618 176.6 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.46 164.13 15.72 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.386 0.275 . . . . 25.0 110.393 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 89.8 p -120.32 127.05 51.99 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.353 -0.61 . . . . 25.0 109.353 175.817 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 tp -153.1 146.24 24.68 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 -179.149 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.7 t60 60.92 10.86 2.97 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.406 1.261 . . . . 25.0 114.406 178.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 10.21 62.1 Favored Glycine 0 C--O 1.22 -0.761 0 C-N-CA 120.429 -0.891 . . . . 25.0 112.17 -179.108 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -124.39 165.76 17.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 178.16 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -118.82 156.88 28.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.026 -2.213 . . . . 25.0 105.026 172.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.72 162.87 31.55 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.879 -0.676 . . . . 25.0 111.865 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -77.02 141.97 14.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 122.313 1.054 . . . . 25.0 108.806 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.23 136.85 17.26 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.434 -1.257 . . . . 25.0 110.228 178.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.37 115.63 4.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 117.564 -1.157 . . . . 25.0 111.338 178.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.85 -25.46 70.63 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 115.996 -0.547 . . . . 25.0 113.576 -174.292 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -64.77 -22.85 67.07 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.899 0.849 . . . . 25.0 111.551 178.04 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -91.59 10.42 28.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.413 -0.358 . . . . 25.0 111.463 -178.073 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.9 144.87 45.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.528 0.68 . . . . 25.0 111.987 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -112.64 113.28 25.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 121.96 -0.463 . . . . 25.0 110.649 178.324 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mm -54.37 137.14 15.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 C-N-CA 123.063 0.545 . . . . 25.0 109.812 -174.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.46 173.54 6.55 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 105.923 -1.88 . . . . 25.0 105.923 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 m -80.14 163.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.305 -0.628 . . . . 25.0 109.305 179.245 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.96 149.39 42.78 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 120.316 -0.945 . . . . 25.0 112.542 -176.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.1 tpt -137.33 163.24 31.46 Favored 'General case' 0 C--O 1.205 -1.257 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 179.001 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.56 142.81 56.39 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 124.062 0.851 . . . . 25.0 110.953 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -134.53 163.77 28.97 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.041 -0.527 . . . . 25.0 110.409 177.553 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -89.05 140.55 29.33 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.317 -1.364 . . . . 25.0 107.317 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -54.8 135.09 65.53 Favored Pre-proline 0 N--CA 1.48 1.061 0 O-C-N 125.028 1.455 . . . . 25.0 110.394 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.44 173.57 14.03 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.881 2.388 . . . . 25.0 112.995 178.301 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.07 167.48 29.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.822 -1.547 . . . . 25.0 106.822 175.001 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.62 122.32 4.78 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 120.604 -0.808 . . . . 25.0 111.296 178.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.88 -25.11 23.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.18 1.178 . . . . 25.0 114.18 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 56.24 -164.98 0.14 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.397 1.079 . . . . 25.0 113.163 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.25 137.47 23.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 N-CA-C 103.398 -2.815 . . . . 25.0 103.398 172.592 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 m -74.66 156.22 6.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.669 0.747 . . . . 25.0 110.704 -175.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -81.84 117.12 21.86 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.109 -1.812 . . . . 25.0 106.109 172.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 C--O 1.193 -1.895 0 CA-C-O 124.369 2.033 . . . . 25.0 113.133 -172.104 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 CA-C-O 123.268 1.482 . . . . 25.0 115.079 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -65.72 -15.99 63.34 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.084 -1.245 . . . . 25.0 113.701 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.8 ttt 47.09 34.6 2.96 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.462 1.653 . . . . 25.0 115.462 176.291 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 60.59 15.79 5.99 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.201 1.556 . . . . 25.0 115.201 178.145 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.67 165.03 20.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.143 -1.058 . . . . 25.0 108.143 172.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.5 mt -64.02 -43.05 96.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 121.072 -0.251 . . . . 25.0 110.959 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 49.95 39.19 18.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.581 0.956 . . . . 25.0 113.581 176.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.55 141.56 32.18 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 -178.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.88 154.48 18.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.749 0.785 . . . . 25.0 111.879 -174.009 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.16 46.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.829 -1.078 . . . . 25.0 109.866 -179.446 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -97.02 134.62 40.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.024 -1.102 . . . . 25.0 108.024 175.518 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.85 136.79 45.4 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.638 0.732 . . . . 25.0 110.088 176.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.7 mt -94.61 -34.32 12.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 25.0 109.169 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -125.4 164.85 19.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.405 -1.702 . . . . 25.0 106.405 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.17 165.39 13.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.851 -0.796 . . . . 25.0 108.851 174.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.09 110.53 3.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.6 . . . . 25.0 109.787 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.57 131.87 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 174.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.92 15.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.478 -1.305 . . . . 25.0 107.478 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -96.84 -6.75 35.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.323 1.058 . . . . 25.0 108.296 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -132.31 149.58 73.56 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.194 -1.41 . . . . 25.0 107.194 178.29 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.38 -24.51 19.34 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 116.038 -2.175 . . . . 25.0 115.068 -174.551 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.62 -15.62 58.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.752 0.787 . . . . 25.0 110.617 -179.635 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -81.02 141.36 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.361 -1.348 . . . . 25.0 107.361 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.08 130.2 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.726 -0.609 . . . . 25.0 110.124 178.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.38 116.34 21.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.87 -1.159 . . . . 25.0 107.87 174.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.546 ' CE1' HG13 ' A' ' 57' ' ' VAL . 52.1 p90 -141.34 165.88 26.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.484 -0.562 . . . . 25.0 109.484 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.69 155.21 46.26 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.938 0.399 . . . . 25.0 111.921 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.5 129.84 37.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.981 -0.554 . . . . 25.0 110.594 176.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -21.74 44.32 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.435 -179.177 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -72.16 160.99 31.52 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 117.34 0.57 . . . . 25.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.7 mm -119.65 128.67 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.888 -0.782 . . . . 25.0 108.888 -176.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -135.87 148.45 48.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.068 0.461 . . . . 25.0 110.237 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -87.07 128.77 35.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.463 -0.94 . . . . 25.0 108.463 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.3 t -89.01 124.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.755 -1.572 . . . . 25.0 106.755 175.486 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.12 -45.29 7.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.624 -0.716 . . . . 25.0 110.247 -179.223 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.27 164.63 34.29 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.488 -0.56 . . . . 25.0 109.488 -175.599 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -129.88 152.66 49.12 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.402 -0.592 . . . . 25.0 109.402 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t0 56.53 39.43 29.91 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 123.608 1.67 . . . . 25.0 107.414 -175.642 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -70.48 -12.93 61.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.401 -1.727 . . . . 25.0 114.179 -169.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.05 9.85 5.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 25.0 111.472 -176.796 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.39 14.49 78.46 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 108.951 -1.66 . . . . 25.0 108.951 -174.041 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.92 111.25 23.82 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 177.813 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -63.78 141.75 58.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.814 -0.81 . . . . 25.0 108.814 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.04 -14.75 31.0 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-O 119.273 -0.737 . . . . 25.0 114.846 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -94.01 136.44 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.794 1.297 . . . . 25.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -121.83 146.14 47.37 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.232 -0.655 . . . . 25.0 109.232 -175.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -84.91 116.05 23.12 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.486 -1.672 . . . . 25.0 106.486 175.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.1 m -117.41 164.73 14.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.581 -0.526 . . . . 25.0 109.581 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -125.59 127.66 46.7 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.7 tp -161.11 152.36 18.87 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 -177.393 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.1 t60 58.95 28.23 17.33 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.64 0.733 . . . . 25.0 112.109 177.331 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.74 2.12 85.1 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 115.023 0.769 . . . . 25.0 115.023 178.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -133.86 164.21 27.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 117.866 0.833 . . . . 25.0 110.656 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -101.71 158.93 15.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.618 -1.623 . . . . 25.0 106.618 176.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 162.66 33.11 Favored Glycine 0 C--O 1.24 0.496 0 N-CA-C 109.872 -1.291 . . . . 25.0 109.872 178.308 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -81.88 145.7 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.514 0.673 . . . . 25.0 109.643 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.546 HG13 ' CE1' ' A' ' 26' ' ' PHE . 40.5 t -139.31 134.83 16.76 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 25.0 108.809 -176.841 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.22 109.19 2.15 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.079 -1.481 . . . . 25.0 110.696 172.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.15 61.84 Favored Glycine 0 C--O 1.22 -0.723 0 N-CA-C 115.394 0.918 . . . . 25.0 115.394 -172.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -16.99 64.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.874 -0.78 . . . . 25.0 111.464 177.444 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.53 3.83 51.2 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.908 -0.495 . . . . 25.0 111.002 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.436 HD11 HG11 ' A' ' 57' ' ' VAL . 80.1 mt -118.51 157.59 26.99 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.613 0.365 . . . . 25.0 110.321 -178.377 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -127.49 117.82 22.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.381 -0.97 . . . . 25.0 108.381 171.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.0 mm -59.27 137.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 177.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.55 119.44 11.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.108 -1.071 . . . . 25.0 108.108 177.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -84.62 151.9 3.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.277 -0.874 . . . . 25.0 109.963 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.42 173.47 19.59 Favored Glycine 0 N--CA 1.454 -0.126 0 N-CA-C 110.539 -1.024 . . . . 25.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 57.8 mtt -83.25 161.47 21.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.89 -0.782 . . . . 25.0 108.89 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -80.67 38.79 0.45 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.007 0.743 . . . . 25.0 113.007 -177.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.27 -29.91 68.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.296 0.569 . . . . 25.0 112.167 -175.218 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -132.18 147.18 52.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.986 -0.446 . . . . 25.0 110.87 -178.407 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.73 150.01 47.51 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 106.808 -1.553 . . . . 25.0 106.808 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.39 -18.1 16.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 N-CA-C 114.775 1.029 . . . . 25.0 114.775 -178.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -160.64 168.35 25.11 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.382 -2.081 . . . . 25.0 105.382 -179.089 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.74 19.23 0.1 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.241 -0.504 . . . . 25.0 113.787 176.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -88.64 163.26 15.89 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.047 0.539 . . . . 25.0 111.003 -175.021 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -135.84 142.9 44.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.4 tt -127.65 138.48 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.442 -0.947 . . . . 25.0 108.442 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -86.7 -43.72 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.04 0.448 . . . . 25.0 110.385 -178.1 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -155.72 -59.31 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.376 0.608 . . . . 25.0 110.721 -179.332 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 124.266 1.984 . . . . 25.0 111.328 -178.194 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.87 0 CA-C-O 123.833 1.796 . . . . 25.0 113.475 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 m 56.14 28.18 12.65 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 112.348 -1.926 . . . . 25.0 112.457 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.1 mtt -69.24 143.21 54.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.137 -0.69 . . . . 25.0 109.137 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -134.64 -38.0 0.83 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 -178.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -137.63 156.36 48.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 -177.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt -68.69 -44.83 73.16 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.354 0.409 . . . . 25.0 111.141 -175.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 55.31 26.7 8.92 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.904 0.882 . . . . 25.0 113.214 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.73 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 N-CA-C 105.798 -1.927 . . . . 25.0 105.798 177.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.24 159.63 37.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.279 -0.419 . . . . 25.0 109.973 -178.662 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -95.42 133.86 38.91 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.108 -0.701 . . . . 25.0 109.108 178.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 132.18 42.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.199 0.523 . . . . 25.0 110.686 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.8 -32.8 15.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.65 162.18 18.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.073 -0.967 . . . . 25.0 108.825 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.34 148.99 22.19 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.339 -2.097 . . . . 25.0 105.339 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -148.28 130.51 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 25.0 111.672 -172.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.46 132.26 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 102.833 -3.025 . . . . 25.0 102.833 172.561 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.13 126.33 28.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.96 -0.755 . . . . 25.0 108.96 -178.709 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.33 -7.07 32.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.9 155.68 80.19 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.316 -0.856 . . . . 25.0 109.171 178.678 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.38 -24.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 116.994 -1.537 . . . . 25.0 113.591 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.76 -15.55 51.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.222 -0.444 . . . . 25.0 110.143 -178.372 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.74 147.06 29.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.602 0.715 . . . . 25.0 110.894 -178.069 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.89 134.24 36.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.102 -0.499 . . . . 25.0 110.224 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -84.62 142.84 29.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.758 -1.571 . . . . 25.0 106.758 172.027 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.472 ' CE2' HG13 ' A' ' 57' ' ' VAL . 36.5 p90 -158.24 166.35 32.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.776 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -126.14 155.5 41.59 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.942 -0.474 . . . . 25.0 110.653 -178.361 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.04 135.3 56.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.119 -0.697 . . . . 25.0 109.119 -179.027 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.68 -9.97 76.09 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.153 -0.804 . . . . 25.0 114.711 -178.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -81.42 162.98 23.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.966 0.883 . . . . 25.0 108.71 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.54 131.48 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.659 -0.867 . . . . 25.0 108.659 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.6 ptp -129.48 152.21 49.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.002 -178.694 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 m -82.31 131.64 35.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.217 -1.031 . . . . 25.0 108.217 178.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.4 t -100.03 121.07 50.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.658 -1.608 . . . . 25.0 106.658 176.053 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.5 mt -91.28 -52.36 4.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.724 -0.671 . . . . 25.0 110.689 -176.591 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -146.43 170.55 16.61 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 -177.561 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -128.27 157.04 42.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.154 -1.795 . . . . 25.0 106.154 -179.218 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.6 t0 62.17 35.56 15.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 123.397 1.57 . . . . 25.0 108.759 177.313 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -70.98 -12.59 61.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.476 -1.693 . . . . 25.0 112.349 -176.03 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -118.9 5.81 11.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.347 0.499 . . . . 25.0 112.347 -175.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.52 11.14 82.4 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.555 -1.418 . . . . 25.0 109.555 -174.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.65 114.91 16.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.301 -1.741 . . . . 25.0 106.301 176.601 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.95 156.88 31.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.82 -1.548 . . . . 25.0 106.82 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.56 -15.4 62.07 Favored Glycine 0 C--O 1.218 -0.848 0 N-CA-C 108.186 -1.966 . . . . 25.0 108.186 -173.054 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.91 126.41 52.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 173.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -119.79 143.07 48.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -177.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.8 tp -82.97 107.86 15.87 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.377 -1.712 . . . . 25.0 106.377 177.038 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.7 m -108.65 163.81 12.92 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.371 -0.604 . . . . 25.0 109.371 179.383 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 48.5 t -130.1 129.67 43.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 175.109 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 tp -161.39 155.05 21.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 -175.445 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 58.8 23.83 11.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.438 0.903 . . . . 25.0 113.438 174.545 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.76 4.21 88.99 Favored Glycine 0 C--O 1.202 -1.904 0 N-CA-C 115.602 1.001 . . . . 25.0 115.602 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -129.36 166.16 20.07 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.372 1.069 . . . . 25.0 108.136 -178.616 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 21.7 pt20 -118.44 158.2 25.76 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.986 -1.857 . . . . 25.0 105.986 169.011 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.67 167.37 39.95 Favored Glycine 0 CA--C 1.507 -0.435 0 N-CA-C 110.747 -0.941 . . . . 25.0 110.747 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 pt -75.86 145.56 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.291 -1.374 . . . . 25.0 107.291 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 26' ' ' PHE . 40.9 t -140.26 133.6 15.09 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 -179.298 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.12 108.4 1.95 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 116.374 -1.951 . . . . 25.0 110.246 172.779 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.18 -18.62 58.15 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-N 115.565 -0.743 . . . . 25.0 114.112 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -65.19 -18.48 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.59 -0.359 . . . . 25.0 111.062 176.65 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -90.47 4.51 50.85 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.969 -0.457 . . . . 25.0 111.736 176.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.422 HD11 HG11 ' A' ' 57' ' ' VAL . 59.9 mt -122.85 157.23 32.94 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.628 0.603 . . . . 25.0 112.628 -173.302 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -125.08 117.78 24.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.88 -0.785 . . . . 25.0 108.88 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.49 135.93 27.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.105 -0.498 . . . . 25.0 112.171 -174.75 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -88.89 105.91 18.06 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 102.498 -3.149 . . . . 25.0 102.498 167.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.54 90.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.692 0.758 . . . . 25.0 112.058 -170.077 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.18 31.26 8.74 Favored Glycine 0 C--O 1.219 -0.808 0 N-CA-C 109.683 -1.367 . . . . 25.0 109.683 175.425 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.0 mtp -78.74 -10.28 59.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.355 0.872 . . . . 25.0 113.355 -175.183 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 t80 63.52 -174.84 0.16 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.561 -0.903 . . . . 25.0 108.561 -172.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -148.2 176.97 9.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.483 0.659 . . . . 25.0 110.375 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -69.73 163.94 24.6 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.067 0.947 . . . . 25.0 110.404 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -69.8 143.84 92.74 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 105.75 -1.945 . . . . 25.0 105.75 170.489 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.41 153.83 69.98 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 116.459 -1.894 . . . . 25.0 111.837 178.318 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.03 163.11 40.75 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.324 -2.102 . . . . 25.0 105.324 178.699 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.38 -176.14 47.55 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 107.929 -2.069 . . . . 25.0 107.929 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -138.5 159.2 42.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.233 -2.136 . . . . 25.0 105.233 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -118.17 4.32 11.98 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.75 0.648 . . . . 25.0 112.75 -173.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.7 pt -125.87 160.68 32.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 106.554 -1.647 . . . . 25.0 106.554 178.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.38 25.57 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.647 1.213 . . . . 25.0 108.395 -174.656 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.0 p -97.36 9.38 42.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.526 1.155 . . . . 25.0 108.176 177.773 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 125.389 2.519 . . . . 25.0 113.55 -175.767 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.815 0 CA-C-O 124.506 2.17 . . . . 25.0 113.097 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 t -78.42 -4.77 49.99 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 112.39 -1.905 . . . . 25.0 111.25 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 ttt -146.37 150.33 35.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.501 -2.037 . . . . 25.0 105.501 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -131.11 109.67 10.63 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.087 0.47 . . . . 25.0 111.359 178.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -147.03 170.77 16.43 Favored 'General case' 0 C--N 1.319 -0.749 1 N-CA-C 98.676 -4.564 . . . . 25.0 98.676 171.135 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.02 -44.03 97.08 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.186 1.55 . . . . 25.0 115.186 -170.593 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 t30 49.91 42.35 24.14 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.1 p -116.4 161.95 14.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 103.685 -2.709 . . . . 25.0 103.685 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.52 156.93 45.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.179 0.899 . . . . 25.0 109.714 -177.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.85 151.78 43.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.654 -0.703 . . . . 25.0 110.4 -174.578 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -97.63 133.33 42.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 174.828 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.74 137.06 43.75 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.417 0.627 . . . . 25.0 109.378 176.331 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.29 -26.66 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.458 -0.792 . . . . 25.0 109.541 178.203 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -127.26 159.47 34.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 -178.335 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -100.06 163.5 12.4 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.29 0.636 . . . . 25.0 109.481 178.636 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.21 160.29 43.92 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.311 -0.996 . . . . 25.0 108.311 -178.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.15 133.42 68.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 102.391 -3.188 . . . . 25.0 102.391 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.94 143.47 27.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.96 -0.385 . . . . 25.0 109.96 -175.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -122.34 -23.97 5.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.553 0.533 . . . . 25.0 110.662 173.507 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.3 m -85.46 147.22 46.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 176.574 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -71.63 -20.36 26.85 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.968 -1.555 . . . . 25.0 113.718 -178.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -86.15 -4.5 59.18 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.763 0.425 . . . . 25.0 111.099 179.436 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.91 143.08 28.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.927 0.491 . . . . 25.0 111.128 -175.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mt -96.49 133.5 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.82 -0.55 . . . . 25.0 111.611 177.474 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.2 t -88.75 85.06 6.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.446 ' CE1' HG13 ' A' ' 57' ' ' VAL . 47.7 p90 -96.46 160.33 14.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.347 -0.612 . . . . 25.0 109.347 -179.063 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -129.56 152.87 48.61 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 122.202 -0.311 . . . . 25.0 110.742 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -60.11 136.25 57.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 25.0 109.813 178.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.35 -27.54 13.33 Favored Glycine 0 C--N 1.321 -0.286 0 CA-C-N 115.418 -0.81 . . . . 25.0 113.053 -178.092 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -73.57 162.53 29.13 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.075 0.437 . . . . 25.0 111.048 -178.063 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.67 129.54 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 122.91 0.484 . . . . 25.0 110.227 -174.096 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -132.24 146.22 51.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.088 0.471 . . . . 25.0 110.937 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.0 m -85.19 132.0 34.35 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.77 126.79 51.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -101.83 -50.7 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 25.0 111.1 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -136.3 170.45 16.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.34 0.656 . . . . 25.0 110.097 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -133.25 155.49 49.27 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.447 -1.686 . . . . 25.0 106.447 174.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.6 t0 56.89 41.95 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.133 1.444 . . . . 25.0 109.213 -177.481 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 t -76.29 4.58 8.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.235 -1.348 . . . . 25.0 113.507 -174.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -139.49 -0.68 1.75 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.956 0.724 . . . . 25.0 112.956 -177.304 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.32 -2.61 87.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 108.383 -1.887 . . . . 25.0 108.383 -170.248 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.7 mt -96.02 110.09 22.38 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.734 -1.951 . . . . 25.0 105.734 174.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.89 150.11 47.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.672 -1.233 . . . . 25.0 107.672 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.97 -16.12 44.29 Favored Glycine 0 C--O 1.222 -0.63 0 CA-C-O 119.089 -0.839 . . . . 25.0 113.337 -178.3 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -93.37 133.84 36.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.831 1.316 . . . . 25.0 108.877 177.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -118.94 146.28 45.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.195 -0.669 . . . . 25.0 109.195 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -84.07 113.97 21.41 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 106.052 -1.833 . . . . 25.0 106.052 176.138 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.5 m -116.9 166.22 12.42 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.977 -0.379 . . . . 25.0 109.977 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -129.28 132.22 47.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.795 -0.446 . . . . 25.0 109.795 175.127 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -150.95 137.57 18.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.414 -0.958 . . . . 25.0 108.414 -176.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 54.53 32.69 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.776 1.028 . . . . 25.0 113.776 177.106 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -0.54 89.24 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 114.825 0.69 . . . . 25.0 114.825 177.727 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -111.81 162.76 14.93 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.906 -1.146 . . . . 25.0 107.906 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -117.25 155.5 29.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.298 -2.482 . . . . 25.0 104.298 170.158 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.77 164.98 34.31 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.4 -0.68 . . . . 25.0 111.4 179.118 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -80.41 142.63 13.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.615 0.721 . . . . 25.0 110.239 -177.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG13 ' CE1' ' A' ' 26' ' ' PHE . 77.7 t -140.43 133.08 14.63 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.235 -1.024 . . . . 25.0 108.235 -177.665 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 115.046 -2.836 . . . . 25.0 110.449 174.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.72 -20.49 68.29 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 115.033 0.773 . . . . 25.0 115.033 -173.109 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.03 -8.44 49.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.369 0.584 . . . . 25.0 111.705 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -98.46 6.45 47.2 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.091 -0.381 . . . . 25.0 110.609 175.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.94 143.95 45.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.939 0.4 . . . . 25.0 111.487 -176.071 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -111.16 117.64 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.709 -1.589 . . . . 25.0 106.709 173.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 ' H ' ' A' ' 64' ' ' ILE . 4.0 mp -67.41 133.37 31.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 116.19 -0.459 . . . . 25.0 111.039 -177.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.5 mt -86.84 109.38 19.25 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.944 -1.873 . . . . 25.0 105.944 175.192 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.27 133.15 40.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.047 -1.094 . . . . 25.0 108.047 -175.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.29 174.39 52.1 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 121.289 -0.481 . . . . 25.0 112.208 -179.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.5 ttt -115.25 156.3 25.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.191 -1.411 . . . . 25.0 107.191 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.6 t80 68.19 2.1 3.09 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.945 1.091 . . . . 25.0 113.945 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -66.72 118.38 10.18 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.942 -0.762 . . . . 25.0 108.942 175.256 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -139.69 60.54 1.56 Allowed 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.026 -0.731 . . . . 25.0 109.026 -179.25 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.99 143.43 42.18 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 174.805 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.27 162.46 42.39 Favored 'Trans proline' 0 C--N 1.346 0.405 0 N-CA-C 114.805 1.04 . . . . 25.0 114.805 -173.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.55 164.42 29.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.21 -1.774 . . . . 25.0 106.21 177.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.71 -86.5 1.51 Allowed Glycine 0 C--O 1.225 -0.418 0 C-N-CA 121.284 -0.484 . . . . 25.0 112.747 177.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -79.53 130.89 35.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.84 0.352 . . . . 25.0 110.961 -178.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -142.86 64.61 1.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.494 -0.928 . . . . 25.0 108.494 176.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -102.16 141.17 18.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.287 0.565 . . . . 25.0 109.897 -177.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.47 -39.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.724 -0.671 . . . . 25.0 109.397 178.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.1 m -150.84 -72.11 0.17 Allowed 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.897 -0.779 . . . . 25.0 108.897 177.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.209 -1.034 0 CA-C-O 124.34 2.019 . . . . 25.0 110.945 177.741 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 CA-C-O 123.499 1.611 . . . . 25.0 115.646 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -78.15 157.73 29.32 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 121.053 -1.263 . . . . 25.0 111.745 -178.442 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.2 ptm -68.59 -6.47 25.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.915 0.709 . . . . 25.0 112.915 178.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -156.86 149.17 23.17 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.095 -1.076 . . . . 25.0 108.095 -178.264 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -116.51 168.59 10.03 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.632 -1.247 . . . . 25.0 107.632 175.425 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.3 -40.5 90.72 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.014 0.37 . . . . 25.0 110.958 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.0 t30 55.53 42.2 29.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.215 0.531 . . . . 25.0 111.934 178.018 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.92 172.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.998 -1.853 . . . . 25.0 105.998 176.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 162.53 34.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.423 0.63 . . . . 25.0 110.956 -177.304 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.69 150.09 36.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.016 -0.993 . . . . 25.0 110.42 -178.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -99.53 136.67 39.12 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.595 -0.891 . . . . 25.0 108.595 176.35 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.33 46.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.982 0.42 . . . . 25.0 109.995 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.98 -24.98 14.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.721 -0.672 . . . . 25.0 110.372 178.428 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -123.69 158.27 31.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.795 -1.928 . . . . 25.0 105.795 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.512 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.4 p-10 -103.02 144.33 31.42 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 175.399 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -148.9 122.29 9.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.375 -0.375 . . . . 25.0 110.421 -175.447 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.91 130.5 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 175.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.91 8.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.945 0.402 . . . . 25.0 111.477 -175.564 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -89.39 -11.54 42.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.435 0.636 . . . . 25.0 109.807 176.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 m -122.86 146.31 47.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -23.11 27.83 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 117.388 -1.275 . . . . 25.0 114.873 -174.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -77.66 -20.52 53.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.15 0.5 . . . . 25.0 110.567 -178.035 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.42 152.35 25.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.211 -1.033 . . . . 25.0 108.211 178.847 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 139.76 32.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.929 0.395 . . . . 25.0 111.093 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -84.66 126.56 33.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 172.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.18 163.98 37.6 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -129.78 154.23 47.43 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.762 -0.586 . . . . 25.0 109.943 176.266 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.512 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 53.3 pttt -56.97 135.12 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.379 0.609 . . . . 25.0 110.198 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.02 -25.66 27.43 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.127 -0.942 . . . . 25.0 112.669 -175.311 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -72.65 155.89 39.54 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.117 0.458 . . . . 25.0 110.33 -179.283 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.4 mm -117.06 129.02 74.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.375 0.67 . . . . 25.0 109.67 -175.552 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -130.89 149.61 52.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.579 0.705 . . . . 25.0 110.525 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.3 m -84.88 128.28 34.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.541 -0.911 . . . . 25.0 108.541 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.64 123.47 46.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.066 -1.457 . . . . 25.0 107.066 177.098 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.39 -42.94 9.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.6 -0.727 . . . . 25.0 111.787 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -156.31 171.31 20.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.123 -1.066 . . . . 25.0 108.123 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -134.21 157.13 47.05 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 107.287 -1.375 . . . . 25.0 107.287 -178.106 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t0 60.11 38.47 20.39 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 123.341 1.543 . . . . 25.0 107.691 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -70.51 -12.27 61.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.578 -1.646 . . . . 25.0 114.055 -171.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.16 13.88 6.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.836 0.31 . . . . 25.0 111.836 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.99 18.89 79.23 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.365 -1.094 . . . . 25.0 110.365 -176.504 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.44 114.84 22.93 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 178.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -62.18 144.32 55.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.124 0.964 . . . . 25.0 109.453 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 -16.16 40.89 Favored Glycine 0 C--O 1.217 -0.926 0 CA-C-O 118.876 -0.958 . . . . 25.0 114.112 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -89.58 131.12 35.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.325 1.563 . . . . 25.0 109.94 178.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -120.53 146.19 46.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.976 -0.749 . . . . 25.0 108.976 -175.647 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.1 tp -86.43 115.35 23.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.457 -1.683 . . . . 25.0 106.457 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -112.75 158.47 20.05 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 -178.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -124.99 126.24 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 178.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -159.23 148.42 18.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.316 -1.364 . . . . 25.0 107.316 -174.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 58.24 25.84 13.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.734 0.778 . . . . 25.0 112.494 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.68 88.98 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 114.834 0.693 . . . . 25.0 114.834 176.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -136.16 162.73 32.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 117.773 0.786 . . . . 25.0 110.636 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -96.08 160.61 14.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.242 -1.021 . . . . 25.0 108.242 175.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.75 161.97 34.91 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.917 -1.673 . . . . 25.0 108.917 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 pt -81.77 143.86 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.13 133.95 13.38 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.46 114.39 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 116.524 -1.85 . . . . 25.0 111.033 175.088 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.02 -21.79 66.12 Favored Glycine 0 C--O 1.223 -0.584 0 N-CA-C 116.165 1.226 . . . . 25.0 116.165 -173.344 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -67.54 -16.88 64.43 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.879 . . . . 25.0 110.542 177.145 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -93.1 9.33 36.33 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.451 -0.156 . . . . 25.0 110.83 177.554 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -121.34 154.69 36.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.168 0.509 . . . . 25.0 110.852 -178.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -119.07 116.28 26.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.086 -1.079 . . . . 25.0 108.086 175.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm -62.35 132.4 28.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 175.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.54 142.67 35.16 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 -179.408 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m -90.92 152.71 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 106.982 -1.488 . . . . 25.0 106.982 175.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.94 76.14 0.02 OUTLIER Glycine 0 C--O 1.223 -0.557 0 N-CA-C 110.708 -0.957 . . . . 25.0 110.708 -176.617 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -72.66 135.81 45.52 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.924 -1.139 . . . . 25.0 107.924 -179.247 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -79.77 74.36 6.48 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.35 0.406 . . . . 25.0 110.356 178.64 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 52.4 28.16 5.57 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.872 1.434 . . . . 25.0 114.872 175.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -71.59 143.35 49.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.442 0.639 . . . . 25.0 111.136 179.394 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -117.77 160.12 39.78 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.83 174.15 12.32 Favored 'Trans proline' 0 C--N 1.349 0.568 0 O-C-N 122.28 0.621 . . . . 25.0 111.426 177.117 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.61 161.27 40.88 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.124 -1.065 . . . . 25.0 108.124 178.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.8 85.1 0.24 Allowed Glycine 0 C--O 1.219 -0.832 0 N-CA-C 109.961 -1.256 . . . . 25.0 109.961 -178.675 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -102.34 -3.45 27.12 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.077 1.14 . . . . 25.0 114.077 -173.312 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -149.46 156.52 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.72 -0.845 . . . . 25.0 108.72 178.345 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.2 pt -128.67 14.95 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.895 -0.593 . . . . 25.0 111.273 -177.594 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.7 t 62.59 80.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 122.308 1.051 . . . . 25.0 110.081 -177.065 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.54 -42.04 71.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.885 -1.052 . . . . 25.0 111.055 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 CA--C 1.559 1.321 0 CA-C-O 122.498 1.142 . . . . 25.0 112.002 -178.933 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.282 0 N-CA-C 114.877 0.711 . . . . 25.0 114.877 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -68.43 -34.12 75.43 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.961 0.41 . . . . 25.0 111.419 -178.096 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.3 ttm -125.26 93.09 3.77 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 106.855 -1.535 . . . . 25.0 106.855 -179.435 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -152.08 -40.08 0.11 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.363 0.875 . . . . 25.0 113.363 -179.423 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -149.92 180.0 7.6 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 176.8 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.0 mt -61.14 -41.78 97.35 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.604 1.335 . . . . 25.0 114.604 -171.469 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.3 t30 49.91 42.32 24.08 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.574 2.064 . . . . 25.0 116.574 175.466 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -118.05 164.68 14.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 N-CA-C 105.227 -2.138 . . . . 25.0 105.227 170.357 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.57 157.86 42.51 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.681 0.753 . . . . 25.0 109.611 -173.767 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.37 162.59 32.61 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.423 -0.808 . . . . 25.0 110.119 -172.727 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.2 134.99 47.38 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.515 -1.291 . . . . 25.0 107.515 178.095 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 120.04 19.77 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.856 -1.164 . . . . 25.0 107.856 173.85 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.56 -16.86 31.49 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.946 -0.39 . . . . 25.0 109.946 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -138.75 169.25 18.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.156 -1.424 . . . . 25.0 107.156 -176.7 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -104.01 164.97 11.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.824 0.449 . . . . 25.0 111.958 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -156.31 156.73 34.5 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.435 0.694 . . . . 25.0 111.38 175.983 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -125.55 129.55 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.919 -2.623 . . . . 25.0 103.919 171.737 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.27 130.6 41.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.739 0.644 . . . . 25.0 112.739 -177.365 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -100.57 -41.53 6.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.59 -1.633 . . . . 25.0 106.59 175.685 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -85.33 147.97 48.6 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.51 -15.2 27.74 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 119.123 0.722 . . . . 25.0 113.346 175.82 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 -18.64 49.73 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 121.404 0.621 . . . . 25.0 110.504 177.938 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -87.5 154.08 20.92 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.643 1.211 . . . . 25.0 110.28 -173.523 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.81 136.92 42.58 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 120.691 -1.256 . . . . 25.0 110.551 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.28 125.13 31.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.119 -2.549 . . . . 25.0 104.119 169.176 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -137.72 159.33 42.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 177.846 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -124.49 152.12 43.77 Favored 'General case' 0 CA--C 1.491 -1.314 0 O-C-N 121.701 -0.624 . . . . 25.0 112.345 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -57.02 123.08 13.93 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.187 -0.915 . . . . 25.0 111.558 178.146 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -12.76 49.99 Favored Glycine 0 C--O 1.236 0.227 0 CA-C-O 118.944 -0.92 . . . . 25.0 113.859 179.908 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.65 160.13 25.13 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.253 0.62 . . . . 25.0 111.946 -176.382 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.14 136.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.385 0.674 . . . . 25.0 109.311 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -144.86 151.6 38.99 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.518 -0.739 . . . . 25.0 111.078 179.374 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -82.57 132.25 35.2 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.566 -0.288 . . . . 25.0 110.833 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.3 t -88.81 122.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 174.77 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.6 mt -92.67 -51.28 5.18 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.184 0.516 . . . . 25.0 110.402 -176.648 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -137.15 163.82 29.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.868 -1.901 . . . . 25.0 105.868 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -131.35 148.45 52.67 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.85 38.94 30.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.205 1.566 . . . . 25.0 108.133 -177.749 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -67.76 -13.45 62.13 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.012 -1.904 . . . . 25.0 115.359 -175.157 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.78 0.01 20.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.95 -0.389 . . . . 25.0 109.95 -179.248 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.77 77.72 Favored Glycine 0 CA--C 1.511 -0.196 0 N-CA-C 109.263 -1.535 . . . . 25.0 109.263 -174.524 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.39 116.72 29.07 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 106.53 -1.656 . . . . 25.0 106.53 177.045 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.67 138.77 58.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 178.588 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 0.74 72.36 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.43 -1.206 . . . . 25.0 113.54 178.616 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -109.59 115.92 30.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.733 1.766 . . . . 25.0 111.21 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -109.5 144.65 37.48 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.348 -0.845 . . . . 25.0 112.093 -173.535 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.5 tp -82.56 122.27 27.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.649 -1.982 . . . . 25.0 105.649 175.563 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.2 m -120.07 161.49 20.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 177.495 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.3 t -125.88 133.78 51.81 Favored 'General case' 0 C--O 1.256 1.425 0 C-N-CA 123.476 0.711 . . . . 25.0 109.729 177.258 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -160.88 138.52 9.36 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.888 -1.051 . . . . 25.0 108.884 -177.004 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 t60 58.24 34.9 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.525 0.679 . . . . 25.0 112.675 176.939 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.55 2.34 63.61 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 121.245 -0.502 . . . . 25.0 113.85 177.442 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -115.06 160.29 19.81 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.237 -2.135 . . . . 25.0 105.237 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -137.35 143.41 42.0 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 103.007 -2.96 . . . . 25.0 103.007 175.457 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 174.67 43.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.831 -1.308 . . . . 25.0 109.831 -174.501 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -83.12 140.44 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.675 0.75 . . . . 25.0 112.066 -172.759 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.4 131.3 15.07 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.044 -1.435 . . . . 25.0 108.843 -176.731 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.13 119.14 6.16 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 114.813 -2.992 . . . . 25.0 112.873 175.316 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.42 -16.84 69.89 Favored Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 119.466 -0.63 . . . . 25.0 114.175 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.82 -15.35 63.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 120.553 -0.459 . . . . 25.0 110.374 174.518 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -101.42 8.79 42.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.942 0.349 . . . . 25.0 111.942 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 mt -117.66 149.23 41.07 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.284 1.04 . . . . 25.0 111.818 -173.055 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -120.32 120.66 36.66 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.583 -1.266 . . . . 25.0 107.583 174.236 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.4 mm -64.72 138.98 22.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 O-C-N 123.656 0.598 . . . . 25.0 109.848 -179.952 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -125.1 177.34 6.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.235 -1.394 . . . . 25.0 107.235 176.39 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t 58.56 70.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 122.563 1.173 . . . . 25.0 109.935 -176.835 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.53 46.94 1.09 Allowed Glycine 0 C--O 1.217 -0.927 0 CA-C-N 115.127 -0.942 . . . . 25.0 112.55 -179.662 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 53.1 tpp 56.65 87.49 0.06 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.456 1.122 . . . . 25.0 112.204 -175.33 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -138.23 144.45 40.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.573 -1.194 . . . . 25.0 108.016 -177.434 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -73.4 56.89 0.51 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.117 0.961 . . . . 25.0 113.389 -176.388 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -134.59 155.75 49.9 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.577 -1.638 . . . . 25.0 106.577 177.258 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -83.49 149.69 58.32 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 106.705 -1.591 . . . . 25.0 106.705 179.718 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.52 151.88 65.03 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 117.033 -1.511 . . . . 25.0 111.382 -175.598 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.69 172.19 9.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.947 -1.131 . . . . 25.0 107.947 175.72 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.76 -83.83 0.9 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.539 -1.024 . . . . 25.0 110.539 178.113 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 49.83 74.34 0.21 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 117.735 2.494 . . . . 25.0 117.735 174.424 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -71.51 137.84 48.46 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.914 -0.773 . . . . 25.0 108.914 171.954 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 pt -68.42 123.84 22.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-O 121.929 0.871 . . . . 25.0 110.609 176.444 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.44 23.53 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 122.827 1.299 . . . . 25.0 107.887 -176.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -72.7 135.14 45.33 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.072 -0.967 . . . . 25.0 108.776 -179.885 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--O 1.215 -0.734 0 CA-C-O 124.727 2.203 . . . . 25.0 111.848 179.545 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 122.513 1.063 . . . . 25.0 114.949 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.4 p -153.59 146.79 24.69 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 121.238 -1.154 . . . . 25.0 109.045 178.515 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.2 mtp -88.06 98.25 11.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.527 -1.286 . . . . 25.0 107.527 177.328 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -92.4 80.6 4.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.72 0.295 . . . . 25.0 111.638 -176.423 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -114.46 176.7 4.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.187 -2.523 . . . . 25.0 104.187 175.784 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.8 mt -61.76 -46.3 90.17 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.932 1.456 . . . . 25.0 114.932 -171.99 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 t30 51.66 40.38 27.22 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.103 1.149 . . . . 25.0 114.103 -178.476 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.72 172.54 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 105.563 -2.014 . . . . 25.0 105.563 177.08 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.7 156.69 48.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.705 0.684 . . . . 25.0 110.162 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.29 158.6 43.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.21 -0.904 . . . . 25.0 111.059 -173.633 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.8 134.65 48.57 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.367 -0.975 . . . . 25.0 108.367 175.231 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.77 130.29 39.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.742 -0.466 . . . . 25.0 109.742 178.026 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.35 -26.29 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.946 -0.57 . . . . 25.0 109.571 179.306 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -126.28 162.55 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 -179.399 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 25.3 p-10 -103.89 151.21 23.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.864 -0.421 . . . . 25.0 109.864 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -144.58 126.88 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.155 -0.475 . . . . 25.0 110.885 -176.921 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.7 t -92.04 126.99 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 102.983 -2.969 . . . . 25.0 102.983 174.277 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.46 114.85 5.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 -179.084 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -99.05 -10.97 21.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.724 0.773 . . . . 25.0 108.981 179.18 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 t -116.03 146.72 37.7 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 106.873 -1.528 . . . . 25.0 106.873 172.708 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.68 -18.71 32.47 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 115.819 -2.321 . . . . 25.0 113.618 177.328 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -79.96 -15.71 56.7 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.039 0.923 . . . . 25.0 110.348 179.304 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -86.38 142.68 28.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.653 -0.703 . . . . 25.0 110.19 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 134.25 34.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.741 -0.466 . . . . 25.0 109.741 178.25 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.39 118.67 25.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 175.343 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.445 ' CE2' HG13 ' A' ' 57' ' ' VAL . 53.9 p90 -143.91 164.57 30.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -178.481 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -131.58 157.1 44.52 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 121.254 0.55 . . . . 25.0 112.056 179.58 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.542 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.0 pttt -56.69 131.67 49.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.468 -0.787 . . . . 25.0 108.987 179.191 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.07 -25.7 25.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.692 -0.686 . . . . 25.0 113.321 -176.651 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.17 161.85 30.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.216 0.508 . . . . 25.0 111.826 -176.456 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.12 131.17 73.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.241 -1.022 . . . . 25.0 108.241 -177.427 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -139.81 154.02 47.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.058 -0.349 . . . . 25.0 110.058 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -87.79 131.02 34.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.583 -1.265 . . . . 25.0 107.583 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.9 t -95.48 116.27 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.327 -2.101 . . . . 25.0 105.327 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.45 -45.66 10.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.4 -0.818 . . . . 25.0 109.636 -176.475 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -146.09 169.47 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.96 -0.756 . . . . 25.0 108.96 -177.458 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -129.58 156.03 44.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.16 33.9 23.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.147 1.451 . . . . 25.0 109.286 174.629 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.8 t -70.53 -19.01 62.94 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.594 1.701 . . . . 25.0 115.594 -168.005 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -101.26 2.59 40.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.135 0.493 . . . . 25.0 110.362 -175.61 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.34 -2.36 87.25 Favored Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.003 -1.639 . . . . 25.0 109.003 -172.503 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -100.83 119.37 38.56 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 176.78 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -60.17 136.12 57.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.507 0.67 . . . . 25.0 109.218 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.3 -2.35 86.57 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 115.693 1.037 . . . . 25.0 115.693 177.828 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -99.94 116.91 33.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.312 1.556 . . . . 25.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -107.05 148.13 29.12 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.094 -0.379 . . . . 25.0 110.806 -171.644 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.0 tp -87.93 113.45 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.765 -1.569 . . . . 25.0 106.765 176.727 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.14 160.28 21.28 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.2 -0.2 . . . . 25.0 110.749 179.707 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -119.9 128.93 54.08 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.263 0.554 . . . . 25.0 109.594 175.344 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 tp -162.29 152.83 17.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.114 -1.81 . . . . 25.0 106.114 -177.735 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 58.57 27.75 16.12 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.459 0.647 . . . . 25.0 112.737 177.009 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.5 16.66 77.54 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.803 -0.713 . . . . 25.0 114.11 178.347 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.52 21.99 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.836 -0.802 . . . . 25.0 108.836 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -109.3 156.92 19.39 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.141 -2.17 . . . . 25.0 105.141 173.232 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.5 37.47 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 108.87 -1.692 . . . . 25.0 108.87 177.53 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.3 pt -78.83 145.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.504 0.669 . . . . 25.0 109.255 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.445 HG13 ' CE2' ' A' ' 26' ' ' PHE . 55.2 t -140.39 134.2 15.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 -178.491 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 106.49 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 117.261 -1.36 . . . . 25.0 110.559 174.258 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.21 69.83 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 116.176 1.23 . . . . 25.0 116.176 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -69.92 -8.44 48.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.534 0.667 . . . . 25.0 111.373 178.364 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -93.68 6.28 48.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.03 -0.419 . . . . 25.0 110.451 175.492 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.3 mt -119.15 155.2 32.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.633 -0.506 . . . . 25.0 109.633 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -122.34 121.57 37.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.128 -0.323 . . . . 25.0 110.128 171.347 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.27 137.58 20.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.278 0.631 . . . . 25.0 109.884 177.924 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -107.51 -173.07 2.2 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.227 -0.897 . . . . 25.0 108.807 -179.507 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 t 64.21 75.09 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-O 122.395 1.093 . . . . 25.0 111.208 179.353 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.58 95.98 0.1 Allowed Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 110.091 -1.204 . . . . 25.0 110.091 -179.791 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.4 ttm -160.83 157.74 27.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.33 -1.359 . . . . 25.0 107.33 -176.728 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -69.35 -41.78 76.14 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.601 0.715 . . . . 25.0 109.773 179.051 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -80.19 149.13 30.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.094 -0.957 . . . . 25.0 110.751 -179.294 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -94.46 149.72 20.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 -175.635 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -75.85 150.9 84.16 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.948 -1.13 . . . . 25.0 107.948 178.403 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.27 2.93 6.21 Favored 'Trans proline' 0 C--N 1.35 0.619 0 N-CA-C 113.842 0.67 . . . . 25.0 113.842 176.614 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.41 -152.13 0.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.897 0.879 . . . . 25.0 113.04 177.521 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.24 -143.5 4.27 Favored Glycine 0 C--O 1.224 -0.488 0 N-CA-C 105.561 -3.016 . . . . 25.0 105.561 -177.684 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.7 -25.89 68.4 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.84 0.82 . . . . 25.0 110.612 176.36 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.78 138.14 50.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.542 -0.91 . . . . 25.0 108.542 176.299 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.57 150.27 18.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.02 -1.844 . . . . 25.0 106.02 -179.145 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.32 158.51 38.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.892 -1.522 . . . . 25.0 106.892 178.96 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.9 p -130.92 161.79 31.1 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.577 -1.268 . . . . 25.0 107.577 179.168 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 C--O 1.212 -0.874 0 CA-C-O 125.417 2.532 . . . . 25.0 111.897 176.877 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.536 0 CA-C-O 124.015 1.897 . . . . 25.0 115.095 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -137.9 36.48 2.38 Favored 'General case' 0 C--O 1.244 0.801 0 O-C-N 121.214 -1.168 . . . . 25.0 111.283 -178.33 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -71.12 141.95 50.77 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 121.864 0.84 . . . . 25.0 108.759 -178.629 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -88.16 84.56 6.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.014 -0.539 . . . . 25.0 109.788 178.151 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.44 167.5 22.03 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 102.62 -3.104 . . . . 25.0 102.62 177.781 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.53 -51.65 67.74 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.556 1.071 . . . . 25.0 113.045 -173.308 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.57 48.47 16.93 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.777 1.028 . . . . 25.0 113.777 -179.123 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 m -112.79 172.7 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 103.469 -2.789 . . . . 25.0 103.469 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 155.42 50.23 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.61 0.719 . . . . 25.0 110.944 -177.822 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.71 153.08 44.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.781 -1.1 . . . . 25.0 110.901 -175.951 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -95.52 133.59 39.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 176.828 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.59 123.99 24.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.047 -0.723 . . . . 25.0 109.047 171.37 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.89 -25.98 21.84 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 108.946 -0.761 . . . . 25.0 108.946 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.27 166.51 20.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 -178.478 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.95 159.18 15.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.581 0.229 . . . . 25.0 110.71 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -151.49 143.61 23.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.989 -0.551 . . . . 25.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -117.41 126.17 74.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 102.591 -3.114 . . . . 25.0 102.591 174.219 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 127.92 34.07 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.812 0.339 . . . . 25.0 111.2 -174.352 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -97.84 -6.14 33.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.066 0.936 . . . . 25.0 109.193 179.816 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -141.55 153.15 65.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.773 . . . . 25.0 108.949 -177.082 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.13 -22.83 46.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 116.99 -1.54 . . . . 25.0 112.869 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -73.76 -19.75 60.69 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.482 0.489 . . . . 25.0 110.512 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -95.3 153.08 17.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.963 0.411 . . . . 25.0 111.939 -172.297 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.52 138.33 36.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.699 1.0 . . . . 25.0 113.699 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -87.02 136.87 32.77 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.838 -1.542 . . . . 25.0 106.838 172.376 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -160.81 162.35 32.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -129.19 158.34 39.29 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.387 -0.821 . . . . 25.0 111.319 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -53.77 131.97 40.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.18 -0.918 . . . . 25.0 109.951 178.725 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.01 -23.18 36.83 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.618 -0.719 . . . . 25.0 113.166 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.68 157.19 38.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.115 0.957 . . . . 25.0 110.791 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -120.79 131.02 73.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 -176.039 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -131.47 152.21 50.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.065 0.46 . . . . 25.0 111.332 178.186 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 m -84.76 132.02 34.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 25.0 107.972 177.293 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.9 t -96.03 123.05 48.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 106.282 -1.747 . . . . 25.0 106.282 176.093 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -93.42 -39.79 10.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.561 -0.745 . . . . 25.0 110.823 -174.2 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -159.81 171.92 18.6 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.608 -0.886 . . . . 25.0 108.608 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -120.92 160.98 22.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.97 -1.122 . . . . 25.0 107.97 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.3 42.73 22.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.34 1.067 . . . . 25.0 110.837 179.204 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -68.72 -22.02 64.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.491 -176.767 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' C ' ' H ' ' A' ' 42' ' ' LEU . 2.3 tp60 -97.83 1.02 47.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 25.0 110.133 179.603 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 -20.13 8.13 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.159 -1.176 . . . . 25.0 110.159 -172.542 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 40' ' ' GLN . 95.8 mt -78.19 133.49 37.76 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.993 -1.854 . . . . 25.0 105.993 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.72 153.9 42.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.727 0.775 . . . . 25.0 110.702 -177.075 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.5 -19.65 4.7 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 115.557 0.983 . . . . 25.0 115.557 177.095 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -84.33 107.12 16.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.715 1.258 . . . . 25.0 111.291 -179.404 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -96.81 147.31 24.07 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.061 -0.348 . . . . 25.0 110.061 -176.007 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.1 tp -85.72 117.3 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.765 -1.939 . . . . 25.0 105.765 172.916 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 63.9 m -120.28 163.24 18.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.387 -0.597 . . . . 25.0 109.387 179.294 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -124.51 125.82 44.84 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.037 0.535 . . . . 25.0 111.774 -179.658 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.69 153.09 18.61 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 106.946 -1.501 . . . . 25.0 106.946 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 59.06 36.3 24.21 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.825 0.821 . . . . 25.0 110.912 178.575 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 14.32 59.3 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 115.518 0.967 . . . . 25.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -142.36 163.86 31.71 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 118.002 0.901 . . . . 25.0 109.195 177.591 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.85 154.73 26.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 173.987 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.13 169.56 41.51 Favored Glycine 0 C--O 1.248 0.971 0 N-CA-C 108.416 -1.873 . . . . 25.0 108.416 -177.684 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.03 143.08 13.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 117.217 0.508 . . . . 25.0 110.441 -177.764 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -140.07 131.53 14.4 Favored Pre-proline 0 C--O 1.242 0.681 0 C-N-CA 123.765 0.826 . . . . 25.0 108.833 178.583 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.09 119.4 6.33 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 115.29 -2.673 . . . . 25.0 111.156 177.054 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.55 -25.74 61.28 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 114.893 0.717 . . . . 25.0 114.893 -175.77 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.5 -21.3 66.25 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.865 0.364 . . . . 25.0 111.747 178.395 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.35 3.57 53.33 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.66 -0.65 . . . . 25.0 112.257 178.157 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.51 154.98 30.53 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.99 0.424 . . . . 25.0 112.031 -177.31 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -123.17 117.95 26.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.533 -0.303 . . . . 25.0 110.366 171.442 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm -60.33 140.08 18.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 O-C-N 123.88 0.738 . . . . 25.0 109.697 179.468 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.81 -178.41 3.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.446 -1.687 . . . . 25.0 106.446 176.715 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 t 67.8 94.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.374 1.069 . . . . 25.0 112.03 179.391 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.55 -44.93 0.61 Allowed Glycine 0 C--O 1.218 -0.891 0 N-CA-C 109.568 -1.413 . . . . 25.0 109.568 -178.75 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -147.57 120.08 8.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.806 -1.183 . . . . 25.0 107.806 174.49 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -163.89 152.29 13.29 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.9 -0.407 . . . . 25.0 109.9 177.593 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.27 166.35 18.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.346 -0.613 . . . . 25.0 109.346 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -55.19 144.87 22.9 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.084 0.401 . . . . 25.0 112.084 175.408 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.68 162.25 29.82 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 123.641 0.777 . . . . 25.0 108.979 -179.522 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.03 169.89 21.13 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 117.494 -1.204 . . . . 25.0 110.647 173.461 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.61 160.03 23.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.893 -0.41 . . . . 25.0 109.893 177.73 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.63 -61.2 0.04 OUTLIER Glycine 0 C--O 1.215 -1.035 0 C-N-CA 120.341 -0.933 . . . . 25.0 112.85 178.17 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 53.97 32.6 15.69 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.585 1.183 . . . . 25.0 112.735 178.237 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -78.47 137.58 38.02 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.72 -0.673 . . . . 25.0 112.016 -178.181 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.8 tt -119.85 153.22 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 105.736 -1.95 . . . . 25.0 105.736 175.036 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.8 t -106.4 -34.25 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.384 0.611 . . . . 25.0 111.827 -174.162 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 p -75.73 155.21 35.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.272 0.558 . . . . 25.0 111.125 179.76 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 125.35 2.5 . . . . 25.0 113.435 177.93 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.266 0 CA-C-O 122.564 1.091 . . . . 25.0 115.429 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 m -69.73 139.32 53.35 Favored 'General case' 0 CA--C 1.51 -0.558 0 O-C-N 120.97 -1.312 . . . . 25.0 108.51 179.387 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.6 mmm -130.35 -82.14 0.54 Allowed 'General case' 0 C--O 1.212 -0.893 0 O-C-N 124.106 0.879 . . . . 25.0 109.725 175.12 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -130.72 -26.8 2.18 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 -175.835 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -119.66 167.63 11.84 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 179.59 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.86 -35.5 78.66 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.698 -1.137 . . . . 25.0 112.983 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.4 m120 45.59 48.32 11.22 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.227 1.011 . . . . 25.0 113.471 178.014 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.96 151.92 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 106.605 -1.628 . . . . 25.0 106.605 179.449 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 162.43 13.41 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.137 0.494 . . . . 25.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.06 154.05 42.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.285 -0.87 . . . . 25.0 111.373 172.085 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -107.66 133.72 51.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.167 0.987 . . . . 25.0 109.628 -179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 134.95 45.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 124.525 1.141 . . . . 25.0 111.359 175.902 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.51 -34.06 12.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.832 0.825 . . . . 25.0 109.918 177.323 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.86 165.24 14.86 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 106.642 -1.614 . . . . 25.0 106.642 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.494 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.8 p-10 -103.48 155.85 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.992 0.36 . . . . 25.0 111.93 177.588 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.56 98.48 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.705 0.802 . . . . 25.0 108.953 -177.867 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -78.52 140.06 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 172.42 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.43 140.9 54.14 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 123.488 0.715 . . . . 25.0 112.395 -173.062 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -110.74 -9.72 14.49 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 114.333 -1.303 . . . . 25.0 110.864 174.93 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -131.44 158.64 74.73 Favored Pre-proline 0 N--CA 1.475 0.81 0 O-C-N 121.248 -0.907 . . . . 25.0 110.707 -178.532 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -71.14 -21.98 26.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 116.69 -1.74 . . . . 25.0 113.995 -179.699 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -16.14 59.49 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 124.297 0.998 . . . . 25.0 109.491 -179.732 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -98.0 150.64 21.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 122.121 0.962 . . . . 25.0 110.28 -168.857 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.04 133.86 42.7 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.595 -0.691 . . . . 25.0 112.039 178.899 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.66 104.18 15.82 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.363 -0.606 . . . . 25.0 109.363 179.217 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.447 ' CE2' HG13 ' A' ' 57' ' ' VAL . 52.5 p90 -134.46 162.57 31.86 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.888 -0.782 . . . . 25.0 108.888 -178.709 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -126.84 162.47 25.82 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.946 -0.761 . . . . 25.0 108.946 -179.169 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.494 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 19.8 ptpt -56.01 139.86 45.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 178.233 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.11 -14.2 59.62 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 115.611 1.005 . . . . 25.0 115.611 177.943 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.69 163.85 27.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.268 -1.012 . . . . 25.0 108.268 176.849 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.17 131.12 73.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -178.705 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.7 ptp -130.85 155.49 46.63 Favored 'General case' 0 C--O 1.251 1.158 0 O-C-N 121.627 -0.671 . . . . 25.0 111.604 176.268 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -90.65 135.92 33.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.761 -1.94 . . . . 25.0 105.761 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -96.68 126.69 49.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.148 -1.427 . . . . 25.0 107.148 176.743 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 mt -97.7 -42.85 7.43 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.298 -0.865 . . . . 25.0 110.961 -176.569 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -143.21 161.63 37.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.313 -1.366 . . . . 25.0 107.313 -178.555 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -128.16 144.38 51.11 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.843 -0.799 . . . . 25.0 108.843 173.241 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 59.03 43.15 18.04 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.427 -1.323 . . . . 25.0 107.427 -177.739 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -68.99 -15.11 63.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.722 1.749 . . . . 25.0 115.722 -172.335 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.79 16.63 13.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 122.409 1.1 . . . . 25.0 109.157 178.252 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.98 -21.91 7.4 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.31 -0.859 . . . . 25.0 112.052 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.96 119.15 12.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.905 -0.569 . . . . 25.0 109.819 176.361 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -56.34 132.64 51.51 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.711 0.767 . . . . 25.0 110.132 178.826 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.02 89.66 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.722 -1.043 . . . . 25.0 115.239 175.659 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -96.35 102.19 13.94 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.718 1.759 . . . . 25.0 110.804 179.155 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -91.71 140.35 29.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.549 -0.75 . . . . 25.0 111.917 -172.848 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.21 115.52 21.98 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.405 -1.702 . . . . 25.0 106.405 174.213 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.4 m -112.0 166.87 10.84 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 25.0 110.39 -179.702 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -135.5 125.82 26.51 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.767 -0.457 . . . . 25.0 109.767 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tt -152.34 138.86 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.123 -0.944 . . . . 25.0 108.839 -174.994 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 53.82 38.51 28.76 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 113.557 0.947 . . . . 25.0 113.557 176.527 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.66 -0.51 85.74 Favored Glycine 0 C--O 1.217 -0.965 0 CA-C-O 118.467 -1.185 . . . . 25.0 115.765 175.773 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -126.07 164.53 20.68 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 118.849 1.324 . . . . 25.0 108.193 178.417 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -113.29 164.15 13.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.101 -1.444 . . . . 25.0 107.101 176.574 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.07 162.55 31.55 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.765 -0.934 . . . . 25.0 110.765 174.581 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 pt -79.38 142.32 14.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 175.698 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.447 HG13 ' CE2' ' A' ' 26' ' ' PHE . 82.6 t -139.64 133.65 15.79 Favored Pre-proline 0 C--N 1.311 -1.078 0 C-N-CA 123.407 0.683 . . . . 25.0 109.525 -175.363 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.2 114.79 3.17 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 116.471 -1.886 . . . . 25.0 112.161 175.937 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.66 -16.58 72.14 Favored Glycine 0 C--O 1.21 -1.352 0 C-N-CA 119.567 -1.301 . . . . 25.0 115.133 -173.552 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.8 -16.01 62.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.518 1.159 . . . . 25.0 111.722 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -94.65 8.48 42.24 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.594 -0.73 . . . . 25.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.08 157.06 29.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.118 0.961 . . . . 25.0 109.92 -177.047 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.05 122.31 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.346 -0.843 . . . . 25.0 108.758 174.382 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.7 mm -63.14 134.36 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -179.839 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.61 177.35 8.75 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.767 0.794 . . . . 25.0 110.093 179.79 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.8 t -56.01 134.81 19.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 108.064 -1.088 . . . . 25.0 108.064 174.154 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.21 -38.82 0.1 Allowed Glycine 0 C--O 1.217 -0.929 0 O-C-N 123.685 0.616 . . . . 25.0 112.104 -177.519 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -108.77 157.45 18.55 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.833 -1.173 . . . . 25.0 107.833 176.309 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -96.22 21.31 9.1 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 107.66 -1.237 . . . . 25.0 107.66 178.243 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.89 -167.81 0.18 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.869 -1.514 . . . . 25.0 112.134 -175.815 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -116.83 162.63 17.41 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.065 -1.022 . . . . 25.0 110.112 -176.19 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -60.7 146.44 86.11 Favored Pre-proline 0 C--O 1.248 1.006 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 177.058 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.32 171.54 17.89 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 120.417 0.745 . . . . 25.0 113.412 178.51 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.47 -42.83 2.53 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 115.731 -0.668 . . . . 25.0 111.376 179.686 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.14 152.95 27.88 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.298 -0.477 . . . . 25.0 113.036 -177.166 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -149.32 84.94 1.44 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -178.287 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.98 160.92 28.28 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -177.226 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.4 pt -135.97 157.24 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 174.94 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.2 p -154.54 145.59 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 -176.777 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m 47.51 47.61 17.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.353 0.597 . . . . 25.0 112.325 -179.016 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t0 . . . . . 0 C--O 1.203 -1.392 0 C-N-CA 124.938 1.295 . . . . 25.0 113.059 -176.176 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.219 0 N-CA-C 116.837 1.495 . . . . 25.0 116.837 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.9 t -80.61 154.38 27.44 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 121.664 -0.903 . . . . 25.0 110.814 178.22 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 mtm -127.48 160.69 30.72 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 104.197 -2.52 . . . . 25.0 104.197 179.905 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -127.89 -44.46 1.47 Allowed 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 116.506 2.039 . . . . 25.0 116.506 -173.91 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.97 176.25 9.84 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 101.703 -3.443 . . . . 25.0 101.703 -174.342 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.2 mt -56.62 -43.69 80.46 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 -173.703 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.0 t30 53.12 42.33 32.18 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 113.521 0.934 . . . . 25.0 113.521 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -112.44 147.17 16.37 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.718 0 N-CA-C 105.188 -2.153 . . . . 25.0 105.188 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.65 155.38 46.68 Favored 'General case' 0 C--O 1.267 2.024 0 CA-C-N 119.611 1.096 . . . . 25.0 112.521 177.906 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.5 161.72 36.8 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.897 -1.047 . . . . 25.0 111.021 -170.166 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -110.68 132.27 54.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.378 0.671 . . . . 25.0 110.574 177.261 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.66 127.52 33.32 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.544 0.688 . . . . 25.0 110.247 178.126 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.0 mt -93.44 -23.91 18.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 -179.255 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -126.4 165.36 19.19 Favored 'General case' 0 C--O 1.202 -1.432 0 N-CA-C 109.866 -0.42 . . . . 25.0 109.866 178.162 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -100.77 160.85 14.02 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.725 0.81 . . . . 25.0 109.742 178.274 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -148.2 135.79 20.7 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 113.158 0.799 . . . . 25.0 113.158 -177.731 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -94.89 119.81 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 168.159 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.68 116.93 12.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 -177.945 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.11 -21.28 29.35 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.714 1.245 . . . . 25.0 111.798 -178.98 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -133.44 154.13 80.75 Favored Pre-proline 0 C--O 1.215 -0.751 0 CA-C-N 115.477 -0.783 . . . . 25.0 109.948 -170.762 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.48 -21.54 60.13 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 116.22 1.585 . . . . 25.0 116.22 -178.981 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.24 -19.89 45.8 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.058 0.932 . . . . 25.0 110.273 176.425 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -81.87 140.33 34.18 Favored 'General case' 0 C--O 1.195 -1.771 0 O-C-N 121.022 -1.049 . . . . 25.0 112.246 -176.344 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.02 135.99 33.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 123.566 1.65 . . . . 25.0 110.627 177.725 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.28 110.17 18.88 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.801 -1.545 . . . . 25.0 108.192 176.212 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 57' ' ' VAL . 53.8 p90 -135.87 166.39 23.41 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.405 0.621 . . . . 25.0 112.424 -176.282 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -128.4 152.79 47.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 -179.203 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -62.27 139.64 58.5 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.828 -1.175 . . . . 25.0 107.828 175.413 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -22.51 40.58 Favored Glycine 0 C--O 1.264 2.02 0 CA-C-O 117.843 -1.531 . . . . 25.0 110.284 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.19 166.17 23.06 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 119.468 1.634 . . . . 25.0 109.977 -176.616 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -121.71 132.24 71.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 114.781 -1.099 . . . . 25.0 110.253 -174.519 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.6 ptp -139.96 155.53 47.09 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 124.028 0.83 . . . . 25.0 112.071 -178.602 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -93.41 138.68 31.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 -179.406 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -103.02 119.22 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 106.787 -1.56 . . . . 25.0 106.787 177.744 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.9 mt -93.87 -41.04 9.84 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.341 -1.3 . . . . 25.0 111.555 -174.166 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -149.27 159.19 44.48 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 104.978 -2.23 . . . . 25.0 104.978 -177.479 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -130.73 149.11 52.53 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 101.496 -3.52 . . . . 25.0 101.496 178.795 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 t0 62.86 34.55 14.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.997 0.919 . . . . 25.0 108.583 -177.464 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -66.24 -20.63 66.17 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.363 1.616 . . . . 25.0 115.363 -177.387 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -5.97 21.76 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.239 -0.891 . . . . 25.0 112.292 -177.391 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.9 -6.47 83.44 Favored Glycine 0 N--CA 1.464 0.52 0 CA-C-O 122.597 1.11 . . . . 25.0 111.48 -170.388 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.1 mt -94.14 118.69 31.91 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 106.912 -1.514 . . . . 25.0 106.912 177.584 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -56.83 126.68 28.04 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 106.997 -1.483 . . . . 25.0 106.997 171.831 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.0 64.37 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-O 116.634 -2.203 . . . . 25.0 115.302 178.25 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -104.52 125.81 51.03 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 120.772 2.286 . . . . 25.0 110.025 171.235 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -116.61 148.68 40.72 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.438 -1.319 . . . . 25.0 107.438 -176.054 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.3 tp -92.33 113.35 25.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.847 -1.538 . . . . 25.0 106.847 178.276 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.2 m -121.94 157.1 31.98 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.47 0.652 . . . . 25.0 110.121 -177.539 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -118.64 133.43 55.86 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.063 0.945 . . . . 25.0 110.097 173.279 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.2 138.93 19.75 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 124.625 1.203 . . . . 25.0 109.45 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t60 57.86 29.35 17.4 Favored 'General case' 0 C--O 1.183 -2.428 0 O-C-N 124.218 0.949 . . . . 25.0 110.727 173.287 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.76 -2.24 74.76 Favored Glycine 0 N--CA 1.473 1.159 0 C-N-CA 118.922 -1.609 . . . . 25.0 113.443 -179.31 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -107.12 167.4 9.93 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.081 -1.822 . . . . 25.0 106.081 -179.919 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -141.34 144.5 34.59 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 103.493 -2.78 . . . . 25.0 103.493 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -177.85 47.53 Favored Glycine 0 CA--C 1.545 1.96 0 O-C-N 125.394 1.684 . . . . 25.0 110.208 179.291 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.06 143.08 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.29 0.545 . . . . 25.0 111.042 -174.331 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 26' ' ' PHE . 79.3 t -139.08 136.21 18.03 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 -172.16 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.66 112.42 3.05 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 CA-C-O 122.819 1.091 . . . . 25.0 111.828 172.594 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -26.26 63.42 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-N 115.407 -0.815 . . . . 25.0 115.038 -179.313 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -68.89 -15.3 63.46 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.678 0.739 . . . . 25.0 109.913 179.622 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -92.18 3.46 55.29 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 120.655 -0.418 . . . . 25.0 110.896 175.505 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -117.33 157.13 26.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.002 0.521 . . . . 25.0 111.127 -177.188 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -124.02 129.08 50.31 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.082 -1.451 . . . . 25.0 107.082 172.795 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.1 mm -67.18 127.84 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 104.484 -2.413 . . . . 25.0 104.484 -179.762 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -157.75 109.99 2.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.258 -1.016 . . . . 25.0 108.258 -178.581 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -71.42 165.71 2.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 CA-C-O 121.43 0.633 . . . . 25.0 111.329 177.902 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.44 81.16 0.03 OUTLIER Glycine 0 C--O 1.215 -1.074 0 CA-C-N 116.042 -0.527 . . . . 25.0 111.998 177.742 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.32 153.84 45.68 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.963 -0.384 . . . . 25.0 109.963 -178.928 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -122.26 -39.45 2.58 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.329 1.062 . . . . 25.0 112.775 -175.432 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.07 174.82 8.12 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.185 -1.37 . . . . 25.0 113.437 179.616 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -117.36 158.15 24.92 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 120.555 -1.34 . . . . 25.0 111.183 -173.661 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -84.1 149.54 56.13 Favored Pre-proline 0 C--O 1.258 1.533 0 CA-C-N 114.036 -1.438 . . . . 25.0 109.008 176.219 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.54 161.18 40.33 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 117.917 -0.922 . . . . 25.0 109.859 178.671 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.74 150.33 29.3 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.019 -2.585 . . . . 25.0 104.019 179.01 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.28 7.72 61.9 Favored Glycine 0 C--O 1.258 1.618 0 CA-C-O 117.912 -1.493 . . . . 25.0 112.38 179.223 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -110.27 144.29 39.2 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 118.76 1.28 . . . . 25.0 109.377 -178.28 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -155.16 123.89 6.09 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 174.961 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 tt -146.75 143.99 20.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 O-C-N 120.94 -1.1 . . . . 25.0 109.562 -174.147 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.97 146.55 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.329 -0.619 . . . . 25.0 109.329 179.8 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -131.53 139.7 49.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.519 -1.659 . . . . 25.0 106.519 177.821 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t0 . . . . . 0 N--CA 1.493 1.707 0 C-N-CA 125.794 1.638 . . . . 25.0 111.455 -175.11 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 5.02 0 CA-C-O 123.948 1.86 . . . . 25.0 116.176 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 m -60.99 142.0 56.9 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 127.048 2.139 . . . . 25.0 111.923 177.684 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.6 mtt -123.94 91.34 3.44 Favored 'General case' 0 C--O 1.193 -1.907 0 CA-C-O 121.748 0.785 . . . . 25.0 109.628 -179.478 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 57.53 40.32 27.11 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 113.869 1.063 . . . . 25.0 113.869 178.182 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.61 166.75 16.87 Favored 'General case' 0 C--O 1.267 1.981 0 CA-C-N 113.867 -1.515 . . . . 25.0 109.812 169.879 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.05 -48.12 79.31 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.275 1.213 . . . . 25.0 114.275 -175.671 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.4 t30 45.81 47.36 12.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.32 0.648 . . . . 25.0 112.258 -178.073 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.97 165.35 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 105.751 -1.944 . . . . 25.0 105.751 165.673 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.32 156.2 45.24 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 115.507 -0.769 . . . . 25.0 109.518 -177.139 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.55 162.47 35.0 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 123.896 0.878 . . . . 25.0 110.894 -175.211 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -101.45 133.57 45.89 Favored 'General case' 0 C--O 1.206 -1.23 0 O-C-N 124.185 0.928 . . . . 25.0 108.631 172.246 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 130.5 39.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 105.616 -1.994 . . . . 25.0 105.616 174.731 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.32 -16.54 22.32 Favored 'General case' 0 C--O 1.264 1.82 0 O-C-N 121.439 -0.788 . . . . 25.0 110.44 -178.72 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -135.85 164.78 27.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.383 -1.339 . . . . 25.0 107.383 -178.847 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -100.5 161.01 13.88 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 109.036 -0.727 . . . . 25.0 109.036 -175.995 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -147.97 136.24 21.38 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 123.863 1.792 . . . . 25.0 111.922 178.731 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.85 122.38 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.8 -1.187 . . . . 25.0 108.719 169.72 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.27 115.41 22.45 Favored 'General case' 0 CA--C 1.565 1.558 0 O-C-N 124.041 0.838 . . . . 25.0 109.386 -177.657 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.54 -20.63 14.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.272 -0.876 . . . . 25.0 111.309 177.049 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -96.22 151.45 38.18 Favored Pre-proline 0 C--O 1.207 -1.14 0 CA-C-N 115.36 -0.836 . . . . 25.0 110.165 177.291 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.95 -19.66 13.74 Favored 'Trans proline' 0 C--O 1.205 -1.129 0 C-N-CA 117.184 -1.41 . . . . 25.0 113.241 -179.926 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -86.08 -20.57 28.55 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.122 1.439 . . . . 25.0 109.838 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -77.5 143.95 38.08 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.947 1.092 . . . . 25.0 113.947 178.151 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.86 137.51 32.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.94 1.352 . . . . 25.0 112.522 176.231 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 p -82.06 125.09 30.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.486 -1.233 . . . . 25.0 109.653 171.957 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -150.96 172.75 15.2 Favored 'General case' 0 C--O 1.191 -2.002 0 CA-C-O 121.588 0.709 . . . . 25.0 112.449 175.676 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -134.19 163.72 28.97 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.716 -1.587 . . . . 25.0 106.716 -178.436 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -63.98 141.0 58.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.292 -1.373 . . . . 25.0 107.292 174.836 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.59 -15.36 51.79 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 117.302 1.681 . . . . 25.0 117.302 -177.01 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.5 156.81 34.78 Favored 'General case' 0 C--O 1.263 1.765 0 C-N-CA 120.522 -0.471 . . . . 25.0 110.652 173.648 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.96 130.02 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 107.553 -1.277 . . . . 25.0 107.553 -176.547 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.9 150.65 48.36 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 121.026 -1.046 . . . . 25.0 110.853 179.85 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 m -81.62 138.87 35.29 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.046 -0.979 . . . . 25.0 109.585 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.93 122.3 59.36 Favored 'Isoleucine or valine' 0 C--O 1.254 1.314 0 N-CA-C 105.759 -1.941 . . . . 25.0 105.759 178.274 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.52 -36.91 12.19 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 124.329 1.018 . . . . 25.0 113.14 -177.709 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -155.79 149.08 24.68 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 -174.515 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.13 147.87 36.47 Favored 'General case' 0 C--O 1.197 -1.669 0 CA-C-O 117.086 -1.435 . . . . 25.0 107.677 -178.645 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 55.81 44.08 26.63 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 125.252 1.595 . . . . 25.0 109.104 179.104 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -72.38 -12.92 61.33 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 116.269 1.952 . . . . 25.0 116.269 -173.7 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -115.39 3.12 14.09 Favored 'General case' 0 C--O 1.256 1.439 0 CA-C-O 121.748 0.785 . . . . 25.0 109.693 -174.795 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.41 -15.77 59.25 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.05 -1.432 . . . . 25.0 109.925 -178.401 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.34 127.07 32.87 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.462 1.331 . . . . 25.0 111.111 176.336 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.06 129.05 38.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.849 1.309 . . . . 25.0 109.776 -177.776 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.63 10.16 73.7 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 174.882 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -107.77 103.3 12.54 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 123.778 1.751 . . . . 25.0 113.019 171.346 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -97.86 152.98 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.729 -1.232 . . . . 25.0 110.744 -174.527 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.54 119.93 29.46 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.541 1.15 . . . . 25.0 108.004 174.144 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -122.09 162.58 20.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.347 -0.983 . . . . 25.0 108.347 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.1 t -127.04 133.74 50.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.637 -1.245 . . . . 25.0 107.637 174.591 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 tp -154.89 136.69 14.46 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.752 1.283 . . . . 25.0 110.287 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 59.39 31.76 21.32 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-N 114.428 -1.26 . . . . 25.0 109.771 179.249 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.67 4.69 85.44 Favored Glycine 0 CA--C 1.545 1.937 0 C-N-CA 119.816 -1.183 . . . . 25.0 113.568 -179.775 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.7 mtp85 -117.66 140.11 50.1 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.746 1.773 . . . . 25.0 107.673 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -103.51 151.93 22.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.716 -1.587 . . . . 25.0 106.716 176.118 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.15 172.29 45.21 Favored Glycine 0 C--O 1.263 1.921 0 C-N-CA 118.714 -1.708 . . . . 25.0 113.9 175.051 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -79.83 142.74 13.54 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 117.448 0.624 . . . . 25.0 109.922 -177.888 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.09 132.05 14.58 Favored Pre-proline 0 C--O 1.263 1.764 0 O-C-N 122.014 -0.429 . . . . 25.0 110.588 -174.27 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 125.89 11.69 Favored 'Trans proline' 0 C--O 1.208 -0.985 1 C-N-CA 111.387 -5.275 . . . . 25.0 111.464 178.791 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.06 -21.53 67.69 Favored Glycine 0 C--N 1.306 -1.09 0 CA-C-N 114.75 -1.114 . . . . 25.0 113.756 -171.922 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.98 -3.65 33.57 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 120.199 -1.765 . . . . 25.0 108.031 178.123 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -109.38 12.21 24.76 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.673 0.749 . . . . 25.0 110.222 176.473 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.8 mt -120.02 154.28 34.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 122.344 1.069 . . . . 25.0 111.508 177.218 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -126.89 113.85 17.09 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.412 -0.813 . . . . 25.0 109.488 171.219 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.3 mm -54.77 136.38 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 O-C-N 124.787 1.305 . . . . 25.0 108.965 175.592 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -171.26 1.79 Allowed 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 124.107 0.879 . . . . 25.0 113.098 -177.912 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.4 m -58.17 162.53 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.419 0.628 . . . . 25.0 112.283 178.978 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.02 -33.29 2.62 Favored Glycine 0 C--O 1.265 2.076 0 N-CA-C 110.921 -0.872 . . . . 25.0 110.921 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -157.89 153.65 26.62 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.555 -1.276 . . . . 25.0 107.555 179.314 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -145.92 118.4 8.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 118.681 -0.676 . . . . 25.0 111.703 179.523 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -138.32 69.2 1.38 Allowed 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 107.063 -1.458 . . . . 25.0 107.063 -179.587 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -142.74 152.31 42.18 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.356 -1.465 . . . . 25.0 113.5 -179.452 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -77.6 144.73 70.04 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 106.003 -1.851 . . . . 25.0 106.003 179.038 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -69.46 149.35 68.68 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 117.156 -1.429 . . . . 25.0 112.548 178.273 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.05 147.69 32.73 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.301 -0.999 . . . . 25.0 108.301 -178.169 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.25 142.87 9.15 Favored Glycine 0 C--O 1.248 0.992 0 CA-C-O 119.14 -0.811 . . . . 25.0 111.73 -179.785 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -70.28 169.18 14.29 Favored 'General case' 0 C--O 1.199 -1.56 0 CA-C-O 121.46 0.648 . . . . 25.0 110.492 172.977 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -129.98 165.53 21.95 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 125.055 1.342 . . . . 25.0 110.586 179.859 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.4 pt -104.05 164.5 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 118.732 -0.651 . . . . 25.0 110.705 176.847 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.8 165.44 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 107.424 -1.325 . . . . 25.0 107.424 175.357 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.51 162.05 27.33 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 106.602 -1.629 . . . . 25.0 106.602 -173.227 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t0 . . . . . 0 N--CA 1.507 2.402 0 C-N-CA 125.133 1.373 . . . . 25.0 113.98 179.641 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.482 0 N-CA-C 118.323 2.089 . . . . 25.0 118.323 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -69.14 135.81 51.25 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.686 -0.891 . . . . 25.0 110.018 -179.079 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -72.93 154.65 40.46 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 116.084 1.883 . . . . 25.0 116.084 -173.225 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -93.68 -35.88 12.61 Favored 'General case' 0 C--O 1.202 -1.447 0 CA-C-N 111.941 -2.39 . . . . 25.0 112.503 -177.786 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -115.45 161.12 19.01 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.374 -1.713 . . . . 25.0 106.374 -177.755 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.44 -43.24 93.18 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 123.917 0.76 . . . . 25.0 111.379 -177.537 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.87 37.64 17.79 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.356 -1.293 . . . . 25.0 113.662 174.598 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 p -109.34 160.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 103.49 -2.782 . . . . 25.0 103.49 175.299 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 159.03 28.67 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 107.064 -1.458 . . . . 25.0 107.064 -177.869 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.88 155.71 49.9 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 124.194 0.934 . . . . 25.0 109.597 -176.299 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -98.65 137.03 37.87 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 122.789 0.435 . . . . 25.0 110.86 169.207 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.9 130.6 36.8 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.209 0.448 . . . . 25.0 112.209 172.695 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.69 -22.1 17.77 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.091 -1.078 . . . . 25.0 108.091 -177.017 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -130.99 162.79 28.99 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 125.168 1.542 . . . . 25.0 111.869 178.42 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.53 161.83 13.55 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.781 -0.574 . . . . 25.0 109.782 -179.141 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -151.52 153.85 35.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.871 0.468 . . . . 25.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.1 t -116.87 123.55 71.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.551 -1.648 . . . . 25.0 106.551 167.302 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.35 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.128 -0.983 . . . . 25.0 113.227 -178.376 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -81.9 -15.4 54.06 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.983 -1.008 . . . . 25.0 110.72 176.387 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -134.25 151.67 76.81 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 108.685 -0.857 . . . . 25.0 108.685 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.62 -11.38 26.12 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 117.722 -1.052 . . . . 25.0 112.115 -178.332 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.91 -12.33 55.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.06 0.944 . . . . 25.0 110.531 175.287 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.6 149.49 22.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.233 -0.44 . . . . 25.0 111.554 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.28 139.93 31.7 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 114.189 1.181 . . . . 25.0 114.189 177.071 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 m -85.1 80.44 9.25 Favored 'General case' 0 C--O 1.271 2.206 0 N-CA-C 109.062 -0.718 . . . . 25.0 109.062 169.381 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -86.7 157.75 19.58 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.578 -1.638 . . . . 25.0 106.578 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.66 146.51 50.53 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 107.063 -1.458 . . . . 25.0 107.063 -174.776 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.54 138.07 57.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.133 -0.627 . . . . 25.0 111.246 177.996 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.44 -16.74 47.68 Favored Glycine 0 C--O 1.255 1.437 0 CA-C-O 117.319 -1.823 . . . . 25.0 112.351 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.75 163.68 26.58 Favored 'General case' 0 C--O 1.269 2.086 0 CA-C-N 119.06 1.43 . . . . 25.0 110.642 179.884 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.5 mm -122.41 128.01 75.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.005 -1.109 . . . . 25.0 108.005 -176.057 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.73 148.12 52.55 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.654 0.74 . . . . 25.0 112.329 177.257 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -81.27 131.24 35.28 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.265 -0.88 . . . . 25.0 110.976 175.545 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.25 128.59 45.44 Favored 'Isoleucine or valine' 0 C--O 1.273 2.29 0 N-CA-C 106.771 -1.566 . . . . 25.0 106.771 179.585 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.73 -38.52 7.04 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 113.442 0.904 . . . . 25.0 113.442 -173.856 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -151.12 147.79 27.49 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.359 -0.837 . . . . 25.0 109.613 -177.131 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -113.66 156.08 24.36 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.859 -1.163 . . . . 25.0 107.859 175.377 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t0 58.34 39.83 25.03 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.187 1.47 . . . . 25.0 109.163 -177.53 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -70.04 -20.11 63.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 121.185 -0.947 . . . . 25.0 113.554 -168.3 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -115.73 6.9 14.53 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-N 118.294 0.497 . . . . 25.0 111.851 -174.193 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.98 -18.21 32.6 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.757 -1.337 . . . . 25.0 109.757 -172.922 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.6 mt -83.97 117.77 23.59 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.535 -2.024 . . . . 25.0 105.535 178.072 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.94 144.12 56.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.999 -1.111 . . . . 25.0 107.999 -175.859 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.58 81.58 Favored Glycine 0 N--CA 1.437 -1.266 0 O-C-N 121.062 -1.023 . . . . 25.0 114.971 179.798 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -97.39 116.42 29.57 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 118.328 1.064 . . . . 25.0 109.794 177.085 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -108.36 148.53 29.96 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.843 1.783 . . . . 25.0 108.914 -174.753 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -87.78 117.93 26.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.316 -1.311 . . . . 25.0 109.155 172.499 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -121.06 162.84 19.29 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.527 0.566 . . . . 25.0 112.527 -179.756 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.4 t -121.78 131.24 53.96 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.522 -0.751 . . . . 25.0 110.179 175.519 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 tp -161.49 142.88 11.39 Favored 'General case' 0 C--O 1.181 -2.541 0 CA-C-O 118.121 -0.942 . . . . 25.0 110.487 -175.887 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t60 54.18 29.76 11.06 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.917 1.081 . . . . 25.0 113.917 178.743 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.38 7.04 87.08 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 115.65 1.02 . . . . 25.0 115.65 175.571 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -123.94 164.89 18.39 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 107.458 -1.312 . . . . 25.0 107.458 175.214 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -124.97 150.75 46.33 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 105.264 -2.124 . . . . 25.0 105.264 166.548 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.0 175.0 47.51 Favored Glycine 0 C--O 1.283 3.157 0 N-CA-C 108.522 -1.831 . . . . 25.0 108.522 -178.54 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.2 pt -78.9 140.11 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 124.832 2.253 . . . . 25.0 112.066 -179.378 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -137.32 133.45 18.26 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-N 113.34 -1.755 . . . . 25.0 107.258 -178.722 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.58 118.9 5.95 Favored 'Trans proline' 0 CA--C 1.56 1.816 0 C-N-CA 114.217 -3.389 . . . . 25.0 113.068 172.631 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.65 -21.9 65.49 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 115.023 0.769 . . . . 25.0 115.023 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -56.57 -32.59 65.34 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.234 0.54 . . . . 25.0 111.417 173.179 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -92.06 5.14 51.35 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 113.838 1.051 . . . . 25.0 113.838 179.498 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.9 mt -110.0 155.98 21.09 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.454 1.121 . . . . 25.0 113.288 177.42 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -125.82 115.28 19.75 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 174.164 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm -61.14 126.17 18.63 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 CA-C-N 116.165 -0.47 . . . . 25.0 111.406 176.605 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.8 mt -78.74 90.83 4.64 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 m -81.22 161.61 3.72 Favored 'Isoleucine or valine' 0 C--O 1.255 1.391 0 N-CA-C 106.402 -1.703 . . . . 25.0 106.402 -178.937 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.7 -178.64 47.95 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 118.117 -1.38 . . . . 25.0 111.689 179.475 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.8 mtp -97.45 18.36 15.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.675 1.19 . . . . 25.0 111.989 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -81.94 122.38 27.7 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 120.989 -1.069 . . . . 25.0 112.83 -177.452 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -146.99 163.49 36.03 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.262 -1.384 . . . . 25.0 107.262 176.571 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 40.69 64.76 0.89 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.707 1.002 . . . . 25.0 113.707 -174.69 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.69 160.99 56.93 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-N 114.78 -1.1 . . . . 25.0 109.57 174.99 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.87 -23.77 40.87 Favored 'Trans proline' 0 C--N 1.357 0.974 0 N-CA-C 117.695 2.152 . . . . 25.0 117.695 -168.229 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 53.45 41.82 32.06 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.417 -0.802 . . . . 25.0 110.541 174.111 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.8 111.41 0.6 Allowed Glycine 0 N--CA 1.44 -1.084 0 O-C-N 125.505 1.753 . . . . 25.0 111.001 178.732 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -128.37 -163.69 1.3 Allowed 'General case' 0 C--O 1.208 -1.125 0 N-CA-C 106.196 -1.779 . . . . 25.0 106.196 175.725 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.9 t80 65.19 38.05 6.21 Favored 'General case' 0 C--O 1.25 1.098 0 C-N-CA 125.349 1.46 . . . . 25.0 113.445 173.351 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.0 pt -130.85 162.4 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.02 1.328 . . . . 25.0 107.576 178.607 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.0 t -77.33 129.84 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.117 0.484 . . . . 25.0 111.481 -179.701 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 p -74.53 -47.5 32.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.479 -0.782 . . . . 25.0 110.832 174.895 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 C--O 1.198 -1.643 0 CA-C-O 124.977 2.323 . . . . 25.0 113.562 -175.744 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.197 -2.184 0 CA-C-O 120.009 -0.328 . . . . 25.0 113.512 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m 57.5 29.83 17.7 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.579 1.696 . . . . 25.0 115.579 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 33.0 ttm -64.6 -16.33 62.53 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 124.544 2.116 . . . . 25.0 114.57 178.278 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -75.99 -8.97 58.19 Favored 'General case' 0 C--O 1.2 -1.505 0 CA-C-N 114.529 -1.214 . . . . 25.0 112.23 179.27 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -124.19 173.76 8.12 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.272 -1.381 . . . . 25.0 107.272 172.722 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.4 mt -64.86 -39.63 93.86 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 109.27 -0.641 . . . . 25.0 109.27 -177.774 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 59.01 36.86 24.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 125.041 1.463 . . . . 25.0 111.041 177.624 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t -104.87 146.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 177.252 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 153.4 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 119.304 0.957 . . . . 25.0 111.395 -179.299 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.3 162.34 33.81 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 116.115 -0.493 . . . . 25.0 109.929 -172.92 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -110.65 140.8 44.66 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.797 -2.297 . . . . 25.0 104.797 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.87 124.98 28.77 Favored 'General case' 0 C--O 1.2 -1.509 0 O-C-N 125.275 1.609 . . . . 25.0 111.09 176.836 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -92.94 -18.83 22.27 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.665 -0.698 . . . . 25.0 110.241 -176.542 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -134.79 163.73 29.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.147 -1.798 . . . . 25.0 106.147 178.883 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -93.47 168.69 10.88 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 119.625 -0.83 . . . . 25.0 110.078 177.809 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -150.29 144.69 25.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.527 0.936 . . . . 25.0 113.527 -179.865 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -116.38 103.78 15.65 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.004 0 N-CA-C 104.082 -2.562 . . . . 25.0 104.082 176.034 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.91 127.38 32.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.076 -1.42 . . . . 25.0 111.268 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.48 -19.96 15.31 Favored 'General case' 0 C--O 1.262 1.759 0 CA-C-O 121.104 0.478 . . . . 25.0 109.715 -176.877 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -107.95 153.49 41.64 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 121.838 -0.539 . . . . 25.0 110.922 -176.467 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.06 -14.66 23.51 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 N-CA-C 113.92 0.7 . . . . 25.0 113.92 178.262 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -85.88 -10.64 54.96 Favored 'General case' 0 C--O 1.209 -1.036 0 O-C-N 124.895 1.372 . . . . 25.0 109.569 176.963 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.41 144.1 30.63 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.987 0.899 . . . . 25.0 111.137 -174.2 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -92.12 130.61 37.8 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 120.197 -1.564 . . . . 25.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 t -78.18 132.29 37.55 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 167.726 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -157.83 166.79 31.78 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.436 -1.69 . . . . 25.0 106.436 176.343 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -133.65 163.99 28.2 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.602 1.191 . . . . 25.0 109.212 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -60.28 132.72 54.79 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 114.683 -1.144 . . . . 25.0 109.952 -176.622 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.46 -5.86 84.23 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 118.286 -1.285 . . . . 25.0 115.863 -171.383 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.56 155.42 28.18 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.003 1.901 . . . . 25.0 110.501 175.436 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.05 122.54 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 123.536 0.523 . . . . 25.0 109.899 -176.491 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.2 ptp -130.69 156.5 44.82 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -175.96 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -93.99 125.82 38.84 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.264 0.626 . . . . 25.0 111.716 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.67 121.21 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.362 -1.347 . . . . 25.0 107.362 177.532 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.3 -40.33 11.55 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.768 -0.651 . . . . 25.0 110.51 178.82 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.42 168.14 27.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.606 0.763 . . . . 25.0 110.051 178.867 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -122.2 155.13 36.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.923 -1.51 . . . . 25.0 106.923 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 56.13 38.36 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.506 1.753 . . . . 25.0 111.454 177.5 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -66.36 -15.67 63.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.693 2.108 . . . . 25.0 116.693 -167.973 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -116.63 13.11 15.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 -178.999 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.22 78.08 Favored Glycine 0 C--O 1.203 -1.785 0 CA-C-O 122.706 1.17 . . . . 25.0 111.025 -177.016 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.28 116.51 21.83 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.762 -1.199 . . . . 25.0 107.762 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -65.2 115.34 5.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.306 -0.861 . . . . 25.0 108.758 176.218 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.23 0.97 47.76 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 117.554 -1.692 . . . . 25.0 115.287 178.322 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -109.45 117.95 35.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 120.452 2.126 . . . . 25.0 110.586 175.594 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -105.82 154.51 20.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.387 -1.279 . . . . 25.0 108.178 -170.8 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.5 tp -93.99 119.54 33.01 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 106.636 -1.616 . . . . 25.0 106.636 177.032 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.4 m -118.01 163.25 16.87 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 119.554 -0.859 . . . . 25.0 110.392 178.398 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.5 t -118.85 129.04 55.0 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 124.076 0.86 . . . . 25.0 112.166 173.673 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 tp -157.55 142.22 16.54 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-N 114.056 -1.429 . . . . 25.0 109.033 -176.225 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.4 t60 56.71 27.31 12.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.176 0.436 . . . . 25.0 112.176 -178.37 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.71 -3.41 74.84 Favored Glycine 0 C--O 1.246 0.856 0 CA-C-O 116.54 -2.255 . . . . 25.0 115.018 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -113.48 160.35 18.56 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.5 1.15 . . . . 25.0 108.267 -178.128 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -109.82 149.25 30.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.322 -2.103 . . . . 25.0 105.322 175.922 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.22 163.33 36.78 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.883 -1.287 . . . . 25.0 109.883 177.471 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 pt -82.64 141.54 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.419 1.104 . . . . 25.0 108.812 -179.174 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.75 137.69 20.36 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.189 -2.152 . . . . 25.0 105.189 -175.334 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -72.69 122.49 8.26 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 113.723 -3.718 . . . . 25.0 115.384 175.391 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.61 -19.95 78.19 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.509 -1.223 . . . . 25.0 113.918 -177.419 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -70.45 -8.95 54.95 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 118.716 -1.194 . . . . 25.0 112.215 172.598 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -108.93 4.37 23.3 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.589 0.709 . . . . 25.0 109.857 -179.601 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.3 mt -111.85 146.35 37.85 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-O 123.069 1.414 . . . . 25.0 112.186 179.919 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -114.65 116.92 29.49 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.525 -1.216 . . . . 25.0 111.089 170.649 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mm -59.62 128.27 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 178.727 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.1 173.56 7.78 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 -172.037 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.0 t 67.7 136.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.187 -2.218 0 O-C-N 124.86 1.35 . . . . 25.0 112.555 -176.142 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.62 -152.75 7.49 Favored Glycine 0 C--O 1.21 -1.359 0 N-CA-C 115.446 0.938 . . . . 25.0 115.446 -178.993 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 mmt -68.45 -35.48 77.65 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.576 -0.85 . . . . 25.0 110.103 -176.363 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -77.69 120.51 22.72 Favored 'General case' 0 C--O 1.26 1.638 0 N-CA-C 107.324 -1.361 . . . . 25.0 107.324 179.888 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -77.51 99.49 5.7 Favored 'General case' 0 C--O 1.199 -1.563 0 CA-C-N 114.677 -1.147 . . . . 25.0 110.243 -174.551 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt 68.27 115.6 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.693 1.197 . . . . 25.0 112.816 177.786 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -58.99 146.09 78.11 Favored Pre-proline 0 CA--C 1.558 1.274 0 O-C-N 121.327 -0.858 . . . . 25.0 109.854 177.088 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.08 86.41 1.43 Allowed 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.474 2.116 . . . . 25.0 112.588 176.59 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.49 159.28 44.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.706 -1.961 . . . . 25.0 105.706 176.59 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.45 131.4 3.26 Favored Glycine 0 C--N 1.338 0.68 0 O-C-N 122.093 -0.379 . . . . 25.0 113.672 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -79.64 132.99 36.39 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.246 -0.65 . . . . 25.0 109.246 -174.471 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -81.42 59.96 4.26 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.121 0.568 . . . . 25.0 109.987 -179.641 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.1 pt -64.42 150.79 9.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.779 -0.646 . . . . 25.0 109.336 174.627 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.8 m -140.3 164.02 22.78 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.268 0 CA-C-O 122.906 1.336 . . . . 25.0 108.442 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.64 18.32 9.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.548 -0.751 . . . . 25.0 109.474 175.481 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 . . . . . 0 C--N 1.311 -1.105 0 CA-C-O 124.091 1.9 . . . . 25.0 112.242 -179.074 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.194 -2.384 0 CA-C-O 121.47 0.483 . . . . 25.0 113.905 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m 51.65 50.48 18.66 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.364 0.875 . . . . 25.0 113.364 175.656 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 ttp -113.83 41.19 2.27 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.859 0.688 . . . . 25.0 112.859 -176.378 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -135.88 112.92 10.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.042 0.925 . . . . 25.0 111.64 178.396 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -143.22 177.08 8.65 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 102.752 -3.055 . . . . 25.0 102.752 174.812 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.14 -40.96 91.63 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 114.639 1.348 . . . . 25.0 114.639 -173.387 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.4 t30 44.36 46.42 7.75 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.566 1.321 . . . . 25.0 114.566 -179.143 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.86 157.11 35.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 N-CA-C 103.596 -2.742 . . . . 25.0 103.596 -177.06 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.11 163.36 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.16 156.36 43.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 25.0 110.938 -177.533 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.14 137.36 37.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.217 -1.031 . . . . 25.0 108.217 174.629 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -73.82 135.04 43.44 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 172.63 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -94.24 -33.18 13.36 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 125.122 1.514 . . . . 25.0 112.103 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -121.57 162.2 21.02 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.553 -1.647 . . . . 25.0 106.553 -177.574 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.04 149.25 23.67 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 121.896 -0.502 . . . . 25.0 110.806 177.423 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -145.42 122.47 11.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.144 0.974 . . . . 25.0 111.942 -172.943 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -84.21 132.1 32.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 105.76 -1.941 . . . . 25.0 105.76 171.983 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.18 122.1 26.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.216 -0.994 . . . . 25.0 108.674 178.629 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.44 -12.15 18.79 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.504 0.722 . . . . 25.0 110.101 -178.858 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 m -127.78 152.68 77.43 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 -176.13 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.01 -15.19 23.5 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 114.866 -2.956 . . . . 25.0 112.672 -179.662 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.48 -15.06 57.66 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.578 -1.267 . . . . 25.0 107.578 -179.476 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -89.88 144.47 25.91 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.29 -0.868 . . . . 25.0 112.65 -173.387 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 128.81 37.94 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.836 -0.745 . . . . 25.0 110.607 177.52 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -73.31 131.21 41.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.834 -2.284 . . . . 25.0 104.834 171.995 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.75 167.46 30.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.089 0.471 . . . . 25.0 110.048 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -133.37 159.88 39.0 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 -178.81 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -63.0 139.62 58.79 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 107.593 -1.262 . . . . 25.0 107.593 -179.877 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -12.3 68.53 Favored Glycine 0 CA--C 1.498 -0.974 0 CA-C-N 115.209 -0.905 . . . . 25.0 112.626 179.007 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -84.75 157.54 21.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.158 -0.682 . . . . 25.0 109.158 -179.489 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 mp -128.28 131.24 69.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-O 122.03 0.919 . . . . 25.0 109.383 -176.419 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.13 144.37 50.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.661 -0.699 . . . . 25.0 111.287 -177.126 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 m -75.14 134.11 41.34 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.13 -1.063 . . . . 25.0 108.13 175.728 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.48 124.82 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.024 -1.102 . . . . 25.0 108.024 174.301 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.0 mt -96.54 -47.25 6.02 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 123.9 0.75 . . . . 25.0 112.13 -174.751 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.69 168.37 23.04 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.75 -1.944 . . . . 25.0 105.75 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -120.55 160.29 23.5 Favored 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 108.92 -0.771 . . . . 25.0 108.92 -179.261 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 51.32 42.51 29.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 123.496 1.617 . . . . 25.0 111.038 179.925 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -67.4 -21.87 65.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 115.305 1.594 . . . . 25.0 115.305 -168.18 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -109.08 8.14 25.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.398 -0.521 . . . . 25.0 111.019 178.732 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.17 -1.8 86.57 Favored Glycine 0 C--O 1.215 -1.04 0 CA-C-O 122.901 1.278 . . . . 25.0 110.257 -175.797 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.92 122.13 37.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.34 132.36 49.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.174 -1.417 . . . . 25.0 107.174 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.75 -12.85 61.08 Favored Glycine 0 CA--C 1.485 -1.797 0 O-C-N 121.722 -0.611 . . . . 25.0 114.348 174.29 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.462 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 92.8 m95 -97.43 110.26 22.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.16 -0.612 . . . . 25.0 111.7 177.769 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -101.81 145.39 29.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -174.709 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.09 121.8 28.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.363 -1.347 . . . . 25.0 107.363 173.822 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.3 m -123.94 164.65 18.88 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.4 -0.963 . . . . 25.0 108.4 178.541 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -124.27 128.06 48.59 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.003 -1.061 . . . . 25.0 109.23 -178.227 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -158.23 151.45 23.01 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 125.202 1.564 . . . . 25.0 110.548 -176.908 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 55.24 31.84 17.37 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.761 0.791 . . . . 25.0 110.545 -179.586 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.22 21.95 66.69 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 117.906 1.922 . . . . 25.0 117.906 -176.101 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -143.7 165.66 27.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.199 -1.778 . . . . 25.0 106.199 -177.912 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -117.72 161.03 20.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.7 -1.593 . . . . 25.0 106.7 -176.648 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.73 166.35 36.58 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.736 -0.745 . . . . 25.0 112.763 176.57 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 pt -73.71 144.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 122.788 1.28 . . . . 25.0 109.675 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.8 t -142.84 134.32 12.91 Favored Pre-proline 0 C--O 1.217 -0.643 0 O-C-N 120.408 -1.433 . . . . 25.0 107.695 179.489 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD3' ' CZ3' ' A' ' 45' ' ' TRP . 79.1 Cg_endo -73.58 116.98 4.87 Favored 'Trans proline' 0 C--O 1.255 1.344 0 C-N-CA 115.87 -2.286 . . . . 25.0 113.038 176.86 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.05 -23.25 59.21 Favored Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 120.666 -0.778 . . . . 25.0 114.711 -175.241 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.91 -4.9 14.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 120.606 -1.526 . . . . 25.0 112.527 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -114.94 11.97 16.69 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 122.842 0.457 . . . . 25.0 110.403 178.522 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 12' ' ' ALA . 92.4 mt -118.33 153.86 33.29 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.33 -0.85 . . . . 25.0 111.181 -179.293 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -121.1 127.17 51.37 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.502 -0.555 . . . . 25.0 109.502 169.815 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.6 mm -59.57 133.88 24.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 121.792 0.806 . . . . 25.0 110.686 179.058 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mp -126.64 159.83 32.47 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 124.767 1.227 . . . . 25.0 108.364 179.253 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.4 t 56.0 76.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.241 0.543 . . . . 25.0 111.758 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -165.82 73.59 0.16 Allowed Glycine 0 C--O 1.206 -1.648 0 C-N-CA 120.331 -0.938 . . . . 25.0 110.877 175.496 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 5.6 ttt 54.51 40.43 31.82 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.958 1.096 . . . . 25.0 113.958 -177.785 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -102.33 157.81 16.64 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.961 -1.018 . . . . 25.0 108.384 176.5 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -67.89 151.32 47.34 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.582 0.753 . . . . 25.0 110.469 -179.803 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -144.09 161.39 38.93 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 -178.242 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -70.72 153.05 95.09 Favored Pre-proline 0 N--CA 1.475 0.811 0 N-CA-C 102.038 -3.319 . . . . 25.0 102.038 175.272 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.45 114.93 4.09 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 114.02 -3.52 . . . . 25.0 112.493 -176.738 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.04 164.4 35.48 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.167 -1.42 . . . . 25.0 107.167 177.743 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.62 -130.5 5.66 Favored Glycine 0 C--O 1.241 0.591 0 N-CA-C 109.486 -1.446 . . . . 25.0 109.486 176.692 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.24 171.84 0.09 Allowed 'General case' 0 C--O 1.2 -1.504 0 N-CA-C 115.544 1.683 . . . . 25.0 115.544 178.172 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 52.52 39.79 28.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.149 0.976 . . . . 25.0 111.164 -178.598 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 tt -123.45 144.55 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.482 -0.932 . . . . 25.0 108.482 -176.176 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 m -65.37 152.6 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 108.782 -0.821 . . . . 25.0 108.782 -176.415 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.8 p -118.67 -39.33 3.0 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.426 0.899 . . . . 25.0 113.426 175.678 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 . . . . . 0 C--N 1.352 0.688 0 CA-C-O 125.996 2.807 . . . . 25.0 110.4 176.717 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.532 5.084 0 N-CA-C 114.94 0.736 . . . . 25.0 114.94 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 p -61.64 -37.21 83.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 120.816 -0.354 . . . . 25.0 110.502 -179.151 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 ptm -156.17 -47.27 0.08 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.399 0.619 . . . . 25.0 111.141 172.032 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 91.9 mttt 55.65 -162.26 0.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.385 1.074 . . . . 25.0 109.969 -175.194 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -139.04 174.25 10.7 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.162 -1.792 . . . . 25.0 106.162 -177.919 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.31 -46.44 86.13 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 121.869 0.842 . . . . 25.0 109.405 177.197 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.3 m120 53.54 32.78 14.88 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-O 122.685 1.231 . . . . 25.0 111.366 -178.239 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.45 147.1 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 101.686 -3.45 . . . . 25.0 101.686 179.168 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.49 163.53 28.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.235 -0.654 . . . . 25.0 109.235 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.14 153.63 38.01 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 122.025 -0.422 . . . . 25.0 109.962 -175.956 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -101.41 137.28 39.96 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.088 -1.449 . . . . 25.0 107.088 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.63 128.72 33.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 112.917 0.71 . . . . 25.0 112.917 179.157 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.4 mt -89.2 -18.2 27.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.918 0.887 . . . . 25.0 111.218 179.765 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.9 169.49 17.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.89 154.4 25.25 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.675 0.79 . . . . 25.0 111.523 179.089 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.5 162.56 40.68 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-O 122.118 0.961 . . . . 25.0 110.996 -174.018 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.42 129.21 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.081 -2.933 . . . . 25.0 103.081 173.979 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.43 126.54 30.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.286 -0.635 . . . . 25.0 109.286 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.47 -14.27 33.12 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.998 0.904 . . . . 25.0 111.178 176.385 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -131.03 155.25 81.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.079 -1.082 . . . . 25.0 108.079 -175.983 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.26 -10.23 20.72 Favored 'Trans proline' 0 C--O 1.205 -1.132 0 CA-C-N 119.967 1.024 . . . . 25.0 113.343 176.013 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -85.29 -4.6 59.21 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.503 -1.295 . . . . 25.0 107.503 178.661 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -118.24 149.37 41.23 Favored 'General case' 0 C--O 1.252 1.217 0 N-CA-C 105.464 -2.05 . . . . 25.0 105.464 -170.654 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -102.97 133.8 47.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.468 1.128 . . . . 25.0 113.579 -178.435 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.8 82.72 8.0 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 121.015 -1.053 . . . . 25.0 113.154 170.341 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -97.21 154.67 17.24 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.882 -1.508 . . . . 25.0 112.698 176.856 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -125.84 152.95 44.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 -178.376 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -59.19 135.0 57.5 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 120.303 -0.559 . . . . 25.0 111.455 -179.117 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.07 -14.84 62.42 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 115.43 -0.804 . . . . 25.0 114.231 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -73.39 158.86 34.22 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 121.735 -0.862 . . . . 25.0 112.563 173.359 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -117.46 133.61 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 O-C-N 124.363 1.039 . . . . 25.0 110.295 -178.912 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 ptp -140.84 147.98 39.83 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.36 1.076 . . . . 25.0 111.578 177.636 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 m -86.34 130.57 34.47 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.007 -1.451 . . . . 25.0 111.181 -177.764 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t -90.77 126.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 -179.736 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.8 mt -101.06 -35.99 9.15 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 124.255 0.972 . . . . 25.0 112.412 -178.644 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -147.53 145.48 29.11 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.836 -1.172 . . . . 25.0 107.836 177.688 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -112.48 151.01 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 104.003 -2.591 . . . . 25.0 104.003 173.843 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 59.61 42.16 17.67 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.952 0.882 . . . . 25.0 110.66 -175.533 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.71 -18.44 62.81 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 116.866 2.173 . . . . 25.0 116.866 -169.855 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.76 5.06 13.06 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.169 0.985 . . . . 25.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.69 -17.41 25.84 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.184 -0.916 . . . . 25.0 112.349 -168.978 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.4 126.61 28.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 172.254 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.0 124.04 19.72 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 122.666 1.222 . . . . 25.0 112.821 -179.852 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.59 79.0 Favored Glycine 0 CA--C 1.503 -0.716 0 N-CA-C 118.094 1.998 . . . . 25.0 118.094 176.903 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -104.82 119.14 38.29 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.912 1.356 . . . . 25.0 108.694 178.552 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -106.12 142.64 35.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.872 -0.604 . . . . 25.0 111.588 -169.404 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -82.31 120.67 25.69 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.431 -0.581 . . . . 25.0 109.431 171.226 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 m -126.17 160.72 29.45 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 112.837 0.68 . . . . 25.0 112.837 -179.217 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.0 t -120.2 135.35 55.01 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 123.731 0.644 . . . . 25.0 110.758 174.906 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 tp -150.58 137.04 18.79 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.927 -1.508 . . . . 25.0 106.927 178.073 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.5 m170 57.44 30.88 19.35 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.361 0.875 . . . . 25.0 113.361 179.855 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.84 9.43 79.33 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 117.22 1.648 . . . . 25.0 117.22 -175.461 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -110.03 158.99 17.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.81 -1.181 . . . . 25.0 107.81 177.53 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -123.73 142.76 50.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.632 -1.293 . . . . 25.0 108.059 171.887 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.94 161.36 35.05 Favored Glycine 0 CA--C 1.491 -1.43 0 O-C-N 124.294 0.996 . . . . 25.0 111.117 177.6 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.9 pt -77.53 149.74 5.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.539 1.161 . . . . 25.0 108.727 -176.08 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.2 t -145.66 134.91 11.3 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 -176.933 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.21 119.47 6.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 117.188 -1.408 . . . . 25.0 113.114 179.33 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -24.1 63.34 Favored Glycine 0 C--O 1.198 -2.127 0 N-CA-C 117.249 1.66 . . . . 25.0 117.249 -177.463 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.06 -16.33 62.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 118.088 0.944 . . . . 25.0 109.623 178.553 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -94.42 9.53 37.98 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.15 0.976 . . . . 25.0 111.341 178.255 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.6 mt -124.86 147.63 48.68 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.603 -0.686 . . . . 25.0 111.006 -176.918 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -116.34 125.21 51.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.748 -1.114 . . . . 25.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.71 130.08 26.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 118.452 0.569 . . . . 25.0 110.973 177.375 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -112.26 124.97 53.62 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.768 0.827 . . . . 25.0 109.496 179.354 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.3 t -117.65 124.95 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-O 121.315 0.578 . . . . 25.0 110.506 -175.324 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.44 54.98 0.08 OUTLIER Glycine 0 C--O 1.198 -2.105 0 C-N-CA 119.186 -1.483 . . . . 25.0 111.901 -170.886 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.5 tpt -135.15 153.11 52.1 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-N 118.504 1.152 . . . . 25.0 109.391 -174.77 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.63 143.66 40.02 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.098 -1.445 . . . . 25.0 107.098 179.098 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.84 -37.77 79.36 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.855 0.687 . . . . 25.0 112.855 -176.965 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 40.73 55.11 3.04 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 113.382 0.882 . . . . 25.0 113.382 -179.016 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -68.3 138.27 91.72 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 174.989 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.35 146.5 80.85 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 117.235 -1.377 . . . . 25.0 113.738 -170.895 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.64 -6.82 57.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.386 -0.825 . . . . 25.0 109.953 176.69 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.49 -37.34 1.56 Allowed Glycine 0 C--O 1.21 -1.354 0 C-N-CA 121.332 -0.461 . . . . 25.0 113.533 176.6 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 54.09 31.87 14.63 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.562 0.345 . . . . 25.0 111.005 178.558 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -79.33 3.09 19.2 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.166 0.802 . . . . 25.0 113.166 -174.569 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -69.11 122.17 19.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 -176.883 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t 52.22 77.83 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.301 0 O-C-N 126.258 2.224 . . . . 25.0 110.279 178.628 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.9 p -66.26 147.07 53.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.943 0.402 . . . . 25.0 111.96 178.132 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.447 -0.587 0 CA-C-O 127.034 3.302 . . . . 25.0 113.958 -174.001 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 112.392 0.515 . . . . 25.0 112.392 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.5 t30 55.0 39.61 31.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.09 0.774 . . . . 25.0 113.09 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 m -113.75 155.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.282 -2.488 . . . . 25.0 104.282 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.51 172.02 8.13 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 107.007 -1.479 . . . . 25.0 107.007 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.73 144.87 29.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.317 -0.401 . . . . 25.0 110.811 173.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -95.36 135.76 36.58 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.0 -0.741 . . . . 25.0 109.0 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 130.36 39.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.548 0.69 . . . . 25.0 109.367 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.53 -28.08 15.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.78 -0.645 . . . . 25.0 109.466 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -129.77 160.52 33.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.365 -1.346 . . . . 25.0 107.365 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.508 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.0 p-10 -101.76 159.88 14.95 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.581 0.752 . . . . 25.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.83 -177.99 5.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.013 0.435 . . . . 25.0 110.583 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.89 147.81 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.696 -3.816 . . . . 25.0 100.696 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.97 139.61 38.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -99.55 -13.3 19.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.245 0.545 . . . . 25.0 110.295 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -128.8 151.11 76.71 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.518 . . . . 25.0 109.865 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.01 -15.14 36.03 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 117.046 -1.502 . . . . 25.0 113.687 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.63 -7.72 59.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.701 0.763 . . . . 25.0 110.294 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -106.62 143.86 34.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 134.88 34.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.425 0.631 . . . . 25.0 111.89 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.0 p -93.09 122.6 35.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.459 ' CE2' HG13 ' A' ' 57' ' ' VAL . 40.9 p90 -141.21 164.76 29.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.379 -1.341 . . . . 25.0 107.379 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -132.3 154.51 49.63 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.842 -0.799 . . . . 25.0 108.842 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.508 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 64.0 pttt -56.37 137.32 52.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.375 0.607 . . . . 25.0 109.685 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.42 45.98 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.551 -0.749 . . . . 25.0 112.869 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -77.89 160.63 28.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.221 0.51 . . . . 25.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -130.44 132.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.6 ptp -131.59 151.12 51.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.454 . . . . 25.0 110.634 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -85.02 130.47 34.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.872 -0.418 . . . . 25.0 109.872 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.6 t -90.23 124.38 42.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.577 -1.268 . . . . 25.0 107.577 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.54 -43.15 8.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 25.0 110.862 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -156.42 171.79 19.64 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -127.38 154.73 44.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.754 -0.461 . . . . 25.0 109.754 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 58.81 39.01 24.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 25.0 108.9 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -65.54 -20.47 66.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.982 -1.917 . . . . 25.0 114.96 -168.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -114.76 13.05 17.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.661 -0.649 . . . . 25.0 110.265 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 -3.59 81.73 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.582 -1.007 . . . . 25.0 110.582 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.42 118.61 30.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.052 -0.721 . . . . 25.0 109.052 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -60.34 130.33 46.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.584 -0.735 . . . . 25.0 109.269 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.75 -1.71 83.81 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 114.982 0.753 . . . . 25.0 114.982 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -101.05 121.66 42.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.677 1.239 . . . . 25.0 108.762 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -111.07 146.49 36.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 25.0 109.493 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.8 tp -85.13 111.84 20.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.034 -2.21 . . . . 25.0 105.034 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.31 164.9 12.69 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.79 -0.819 . . . . 25.0 108.79 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -127.65 130.55 49.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -159.29 142.79 14.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 53.61 38.94 29.41 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.097 1.147 . . . . 25.0 114.097 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 2.93 89.56 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 115.289 0.876 . . . . 25.0 115.289 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -125.9 165.46 18.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -127.2 148.2 50.2 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 104.113 -2.551 . . . . 25.0 104.113 167.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.58 172.57 45.04 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 110.043 -1.223 . . . . 25.0 110.043 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 pt -75.27 141.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 25.0 110.308 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.459 HG13 ' CE2' ' A' ' 26' ' ' PHE . 74.0 t -140.67 133.9 14.79 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 108.877 -0.786 . . . . 25.0 108.877 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 112.97 3.45 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 117.339 -1.307 . . . . 25.0 111.751 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.75 -19.11 69.05 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.997 -0.547 . . . . 25.0 112.949 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.18 -5.86 7.91 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.351 0.5 . . . . 25.0 112.351 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -116.64 11.27 14.63 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.914 -0.491 . . . . 25.0 110.642 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.3 mt -122.33 155.2 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.035 0.445 . . . . 25.0 111.332 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -121.55 118.06 28.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.677 0.275 . . . . 25.0 110.537 179.554 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.467 0.381 0 N-CA-C 115.058 1.503 . . . . 25.0 115.058 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 t30 50.15 42.44 25.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.197 0.814 . . . . 25.0 113.197 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.74 157.74 32.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 N-CA-C 105.887 -1.894 . . . . 25.0 105.887 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 161.66 36.48 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.325 0.583 . . . . 25.0 110.941 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.34 163.27 33.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.196 -0.911 . . . . 25.0 110.869 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -111.27 133.35 53.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.997 -1.112 . . . . 25.0 107.997 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.67 133.54 43.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.313 0.578 . . . . 25.0 109.585 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.46 -25.81 17.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.669 -0.696 . . . . 25.0 109.814 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -129.9 160.66 32.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.281 -1.007 . . . . 25.0 108.281 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.6 p-10 -98.15 158.54 15.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.325 -0.62 . . . . 25.0 109.325 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -156.42 135.84 12.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.909 -0.587 . . . . 25.0 112.168 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.32 127.03 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 127.14 30.41 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.143 -0.317 . . . . 25.0 110.143 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -100.08 -8.59 23.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.961 0.886 . . . . 25.0 108.615 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.1 m -128.4 152.33 78.01 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.783 -1.099 . . . . 25.0 108.655 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.24 -25.62 21.87 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 117.043 -1.504 . . . . 25.0 114.374 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -83.98 -9.92 58.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.195 0.521 . . . . 25.0 110.77 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -87.11 148.5 25.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.497 -0.557 . . . . 25.0 109.497 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.64 134.73 38.2 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.072 -0.392 . . . . 25.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 m -85.04 124.9 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.814 -1.55 . . . . 25.0 106.814 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.434 ' CE2' HG13 ' A' ' 57' ' ' VAL . 49.0 p90 -145.57 167.93 21.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.341 -0.985 . . . . 25.0 108.341 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -128.99 154.45 46.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 121.972 -0.455 . . . . 25.0 111.509 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.8 pttp -57.75 131.27 49.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.89 46.42 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-O 119.351 -0.694 . . . . 25.0 113.973 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -73.19 161.72 30.23 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.345 0.573 . . . . 25.0 111.035 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -121.84 130.15 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.22 -0.659 . . . . 25.0 109.22 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.39 147.81 47.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.551 . . . . 25.0 111.439 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -82.59 132.79 35.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.0 t -94.12 121.37 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.111 -1.811 . . . . 25.0 106.111 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.45 -46.73 9.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.654 -0.703 . . . . 25.0 110.191 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -154.7 163.05 40.82 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.554 -0.906 . . . . 25.0 108.554 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.6 154.09 37.22 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.989 0.516 . . . . 25.0 110.024 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.4 t0 54.66 45.85 25.94 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 123.454 1.597 . . . . 25.0 108.719 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.55 -6.34 35.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.776 -1.556 . . . . 25.0 114.347 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -136.57 6.15 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.294 1.22 . . . . 25.0 114.294 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.14 22.82 64.72 Favored Glycine 0 CA--C 1.517 0.209 0 N-CA-C 108.578 -1.809 . . . . 25.0 108.578 -174.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt -122.72 110.01 14.95 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 104.619 -2.363 . . . . 25.0 104.619 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -65.1 144.15 57.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.954 0.883 . . . . 25.0 109.053 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.34 -16.49 43.9 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-O 118.456 -1.191 . . . . 25.0 114.033 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -88.65 132.28 34.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.596 1.698 . . . . 25.0 109.998 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -120.19 144.22 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.63 118.6 25.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.933 -1.877 . . . . 25.0 105.933 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.1 m -120.46 164.43 16.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.292 -0.262 . . . . 25.0 110.292 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.6 t -125.62 130.48 51.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.364 -0.606 . . . . 25.0 109.364 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.7 tp -161.61 146.63 13.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.493 -0.928 . . . . 25.0 108.493 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 58.18 32.73 22.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.281 0.845 . . . . 25.0 113.281 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 6.56 88.79 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.877 -0.677 . . . . 25.0 114.735 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -133.31 162.9 30.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 117.839 0.82 . . . . 25.0 109.863 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -105.36 158.28 16.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 104.265 -2.494 . . . . 25.0 104.265 172.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.01 161.1 29.47 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.852 -0.689 . . . . 25.0 111.557 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -78.58 141.82 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG13 ' CE2' ' A' ' 26' ' ' PHE . 74.9 t -140.1 133.89 15.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.38 117.04 4.89 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 114.93 -2.913 . . . . 25.0 110.758 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -19.52 70.0 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 116.068 -0.514 . . . . 25.0 113.607 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -72.8 -3.23 24.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.264 -0.55 . . . . 25.0 111.767 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -108.71 8.95 27.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.09 -0.708 . . . . 25.0 109.09 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.18 155.3 34.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -126.12 120.75 30.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.801 -0.814 . . . . 25.0 108.801 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 mm . . . . . 0 C--O 1.242 0.663 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 179.009 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 114.24 1.2 . . . . 25.0 114.24 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t30 53.84 31.86 13.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.456 0.91 . . . . 25.0 113.456 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -119.53 156.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.29 158.82 43.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.816 -0.438 . . . . 25.0 109.816 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.21 151.18 44.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 25.0 110.983 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -97.24 134.29 40.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.771 -0.825 . . . . 25.0 108.771 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.82 130.52 40.09 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.717 -0.475 . . . . 25.0 109.717 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.2 mt -92.07 -28.1 17.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 25.0 109.593 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -129.28 162.21 28.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.3 p-10 -98.72 163.01 12.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.791 0.329 . . . . 25.0 110.699 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -150.42 153.39 35.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 25.0 110.784 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.09 118.12 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.614 -2.365 . . . . 25.0 104.614 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.57 30.41 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.217 0.323 . . . . 25.0 110.511 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.7 -22.05 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.559 174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.9 m -97.79 151.02 37.37 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.243 -0.28 . . . . 25.0 110.243 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.82 -17.99 25.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 117.697 -1.069 . . . . 25.0 113.297 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -85.53 -7.58 58.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.09 -0.505 . . . . 25.0 110.436 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -103.39 146.47 28.45 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.64 0.776 . . . . 25.0 110.007 -176.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -100.26 135.65 41.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.608 0.595 . . . . 25.0 112.608 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -84.95 139.85 31.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.387 -2.079 . . . . 25.0 105.387 168.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.449 ' CE1' HG13 ' A' ' 57' ' ' VAL . 44.7 p90 -159.11 163.7 35.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.593 -2.003 . . . . 25.0 105.593 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -129.77 154.81 46.85 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 120.222 -0.591 . . . . 25.0 111.855 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.485 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.0 pttp -55.73 130.34 42.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.413 -0.812 . . . . 25.0 109.621 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.52 22.74 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.397 -0.819 . . . . 25.0 113.082 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -73.37 162.15 29.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 122.731 0.413 . . . . 25.0 111.745 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -121.47 130.97 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.545 0.738 . . . . 25.0 109.34 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -135.44 145.79 47.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.787 0.327 . . . . 25.0 110.344 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -84.77 131.26 34.57 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.124 -1.065 . . . . 25.0 108.124 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -90.05 124.68 42.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.6 mt -91.75 -49.18 6.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 25.0 110.156 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -153.58 171.92 18.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.529 -1.285 . . . . 25.0 107.529 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -126.88 157.18 40.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 110.203 -0.295 . . . . 25.0 110.203 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 60.17 32.58 20.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 123.129 1.442 . . . . 25.0 109.467 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.57 -20.52 62.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.356 -1.747 . . . . 25.0 114.544 -170.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -100.99 3.09 41.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.367 0.603 . . . . 25.0 109.713 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.66 79.76 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 109.489 -1.444 . . . . 25.0 109.489 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.33 124.35 39.32 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.33 -1.359 . . . . 25.0 107.33 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.02 133.86 55.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.24 -0.652 . . . . 25.0 109.24 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 1.03 88.94 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 115.352 0.901 . . . . 25.0 115.352 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -99.04 124.13 43.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.173 1.486 . . . . 25.0 108.635 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -113.89 143.84 44.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.03 -0.419 . . . . 25.0 110.329 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.6 tp -82.87 118.07 23.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.417 -2.068 . . . . 25.0 105.417 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.63 163.84 16.76 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.255 -0.646 . . . . 25.0 109.255 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -122.91 137.81 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.118 0.485 . . . . 25.0 110.765 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 tp -159.46 143.4 14.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.94 -1.504 . . . . 25.0 106.94 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 58.99 22.25 10.21 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.606 0.965 . . . . 25.0 113.606 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.8 89.44 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.996 -0.621 . . . . 25.0 112.509 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -112.09 167.28 10.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.168 -1.79 . . . . 25.0 106.168 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.58 150.88 50.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.65 167.06 39.87 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 109.525 -1.43 . . . . 25.0 109.525 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.87 144.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.811 0.815 . . . . 25.0 111.131 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' CE1' ' A' ' 26' ' ' PHE . 64.4 t -140.2 134.18 15.44 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.66 117.99 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 114.621 -3.12 . . . . 25.0 110.696 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.0 -21.61 69.83 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 116.143 -0.48 . . . . 25.0 113.491 -174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -67.67 -14.5 63.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.533 -0.392 . . . . 25.0 111.696 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -94.63 6.72 48.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.037 -0.414 . . . . 25.0 111.123 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.82 154.33 34.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 25.0 111.751 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -123.97 117.72 25.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 25.0 108.969 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 25.0 111.177 -177.461 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 109.361 -0.607 . . . . 25.0 109.361 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 t30 51.36 40.25 26.06 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.484 1.291 . . . . 25.0 114.484 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.34 166.16 11.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 N-CA-C 105.03 -2.211 . . . . 25.0 105.03 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.62 157.52 43.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.536 0.684 . . . . 25.0 111.495 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.58 152.3 43.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.008 -0.996 . . . . 25.0 110.46 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.45 137.43 35.54 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 131.99 42.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.1 mt -86.59 -25.8 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.48 161.21 35.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 25.0 109.081 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.585 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.6 p-10 -99.91 155.79 17.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.429 -0.952 . . . . 25.0 108.429 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.13 172.96 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.674 0.749 . . . . 25.0 112.729 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.71 135.93 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 1 N-CA-C 100.141 -4.022 . . . . 25.0 100.141 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.38 47.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.396 -0.965 . . . . 25.0 108.396 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.63 -25.07 8.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.585 0.553 . . . . 25.0 112.055 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -93.88 148.36 35.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.339 -0.225 . . . . 25.0 110.876 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.3 -15.7 38.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 116.762 -1.692 . . . . 25.0 112.614 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -83.73 -15.56 48.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.862 0.363 . . . . 25.0 110.103 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -95.34 135.06 37.42 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.946 0.498 . . . . 25.0 111.532 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 136.53 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.508 -0.477 . . . . 25.0 110.954 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -91.23 118.47 30.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -136.13 166.33 23.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.316 0.579 . . . . 25.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -125.2 152.27 44.74 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.771 -0.455 . . . . 25.0 109.771 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.585 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.9 pttt -56.61 132.62 52.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.746 . . . . 25.0 108.987 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -13.04 66.98 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 119.247 -0.751 . . . . 25.0 114.265 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -76.28 158.04 31.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 117.936 0.868 . . . . 25.0 110.126 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mm -116.66 125.1 73.46 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 123.061 0.544 . . . . 25.0 109.868 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -131.42 147.25 52.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 25.0 111.376 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -89.0 127.12 35.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.084 -0.71 . . . . 25.0 109.084 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.3 t -86.73 123.13 39.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.77 -40.9 8.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 25.0 110.81 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.83 158.59 44.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.33 -0.618 . . . . 25.0 109.33 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -129.6 148.61 51.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.733 -0.84 . . . . 25.0 108.733 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.3 t0 55.38 43.6 28.59 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.361 1.553 . . . . 25.0 107.1 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -70.63 -6.34 36.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.568 -1.651 . . . . 25.0 114.352 -170.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.08 6.76 3.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.718 0.636 . . . . 25.0 112.718 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.86 9.65 85.13 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 109.496 -1.441 . . . . 25.0 109.496 -174.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -109.43 110.04 21.06 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 105.509 -2.034 . . . . 25.0 105.509 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.36 145.86 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.083 0.944 . . . . 25.0 108.701 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.4 48.12 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-O 118.624 -1.098 . . . . 25.0 113.749 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -93.5 129.7 39.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 119.367 1.583 . . . . 25.0 110.007 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -119.07 143.72 46.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.33 116.4 22.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 105.614 -1.995 . . . . 25.0 105.614 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -118.18 164.24 15.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.9 p -129.72 132.98 46.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.98 -0.748 . . . . 25.0 108.98 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.1 tp -159.31 141.56 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 25.0 109.252 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 57.35 31.18 19.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.282 1.216 . . . . 25.0 114.282 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.26 85.98 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 115.239 0.856 . . . . 25.0 115.239 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -135.01 162.81 31.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.726 -0.842 . . . . 25.0 108.726 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -117.75 160.23 21.69 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.25 167.55 39.64 Favored Glycine 0 C--O 1.238 0.374 0 N-CA-C 110.316 -1.114 . . . . 25.0 110.316 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -78.25 142.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.371 0.605 . . . . 25.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -141.68 134.63 14.16 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.994 -1.113 . . . . 25.0 107.994 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.58 119.72 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 114.672 -3.086 . . . . 25.0 111.182 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.68 -18.4 65.98 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.088 -0.506 . . . . 25.0 114.155 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.1 -29.98 70.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.424 -0.457 . . . . 25.0 110.282 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.53 10.28 26.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.377 -0.374 . . . . 25.0 111.983 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.8 mt -117.68 152.59 34.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.326 0.584 . . . . 25.0 111.078 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -124.72 117.99 25.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.121 -0.696 . . . . 25.0 109.121 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.4 mm . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 109.453 -0.573 . . . . 25.0 109.453 -179.824 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 110.927 -0.027 . . . . 25.0 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.1 t30 46.9 46.05 15.43 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.071 1.137 . . . . 25.0 114.071 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -125.29 149.04 29.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.549 -1.649 . . . . 25.0 106.549 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 155.33 30.75 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.248 0.547 . . . . 25.0 110.511 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 154.73 49.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.04 -0.982 . . . . 25.0 108.703 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -105.67 135.45 47.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.03 131.39 42.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.191 0.52 . . . . 25.0 109.74 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.68 -26.9 18.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.573 0.702 . . . . 25.0 109.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -130.58 158.72 39.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.508 -1.293 . . . . 25.0 107.508 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.6 p-10 -97.42 160.05 14.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.242 -0.651 . . . . 25.0 109.242 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.38 171.88 13.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 25.0 110.563 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.2 124.59 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 101.029 -3.693 . . . . 25.0 101.029 172.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.51 140.17 29.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -119.12 -29.37 5.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.658 0.599 . . . . 25.0 111.553 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -89.21 148.98 42.03 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.764 -0.828 . . . . 25.0 108.764 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.77 -18.22 32.41 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 116.746 -1.703 . . . . 25.0 112.797 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.84 -13.8 59.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 25.0 110.744 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -96.08 142.51 28.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.199 0.523 . . . . 25.0 110.94 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.47 137.7 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.867 -0.333 . . . . 25.0 110.605 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -93.23 124.5 37.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.268 -1.382 . . . . 25.0 107.268 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.88 168.25 24.3 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.361 -1.348 . . . . 25.0 107.361 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -133.02 159.32 40.38 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.964 -0.46 . . . . 25.0 110.229 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.489 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 27.0 pttt -56.57 136.35 54.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.584 0.707 . . . . 25.0 110.078 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.63 -24.04 31.28 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.08 -0.964 . . . . 25.0 113.303 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.61 159.39 34.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 117.141 0.47 . . . . 25.0 110.219 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.9 127.95 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.193 0.597 . . . . 25.0 110.101 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.63 148.52 50.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.366 0.603 . . . . 25.0 110.094 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -87.45 126.83 35.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.52 127.18 41.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 106.632 -1.618 . . . . 25.0 106.632 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -108.42 -33.36 7.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.82 -0.627 . . . . 25.0 112.52 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -151.68 163.76 38.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.383 -1.34 . . . . 25.0 107.383 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -126.08 152.29 46.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.582 0.628 . . . . 25.0 110.823 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 55.25 38.77 30.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.745 1.259 . . . . 25.0 109.382 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.54 -12.68 61.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 -165.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -116.07 6.67 14.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.287 0.565 . . . . 25.0 109.617 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.12 -5.93 69.57 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.731 -0.948 . . . . 25.0 110.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.09 124.84 30.2 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.539 -1.652 . . . . 25.0 106.539 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.47 132.25 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.635 0.731 . . . . 25.0 110.964 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.36 -0.12 85.37 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 115.38 0.912 . . . . 25.0 115.38 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -95.39 108.59 20.8 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.767 1.784 . . . . 25.0 110.21 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -97.8 144.28 27.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.158 -0.473 . . . . 25.0 110.977 -172.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.8 111.76 19.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.582 -2.007 . . . . 25.0 105.582 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.1 m -114.85 163.33 15.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.479 -0.934 . . . . 25.0 108.479 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -125.1 132.22 53.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.457 -0.572 . . . . 25.0 109.457 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.99 140.17 13.0 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.226 -1.027 . . . . 25.0 108.226 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 57.74 27.6 14.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.823 0.82 . . . . 25.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.94 -0.63 86.72 Favored Glycine 0 N--CA 1.458 0.152 0 N-CA-C 114.445 0.538 . . . . 25.0 114.445 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -107.08 153.98 21.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -116.22 140.02 49.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 103.507 -2.775 . . . . 25.0 103.507 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.43 168.07 40.7 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.959 -0.639 . . . . 25.0 112.126 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -76.48 141.22 16.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.771 0.796 . . . . 25.0 110.005 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.21 132.99 13.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.2 114.47 3.78 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 116.564 -1.824 . . . . 25.0 111.548 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.4 -22.35 65.46 Favored Glycine 0 C--O 1.219 -0.838 0 N-CA-C 114.667 0.627 . . . . 25.0 114.667 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.67 -23.42 67.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.739 0.78 . . . . 25.0 111.21 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.92 6.41 46.33 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 121.513 -0.742 . . . . 25.0 111.377 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -118.47 152.72 35.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.2 0.524 . . . . 25.0 111.183 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -123.28 117.46 25.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.738 -0.467 . . . . 25.0 109.738 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.2 mm . . . . . 0 C--O 1.238 0.451 0 N-CA-C 108.838 -0.801 . . . . 25.0 108.838 -179.781 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 110.102 -0.333 . . . . 25.0 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.1 t30 50.86 46.12 26.54 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.069 0.856 . . . . 25.0 113.089 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.8 m -111.46 169.99 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 103.717 -2.697 . . . . 25.0 103.717 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.97 159.81 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.181 0.901 . . . . 25.0 111.178 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.03 40.27 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.063 -0.971 . . . . 25.0 111.404 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -97.39 131.62 43.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.306 -1.368 . . . . 25.0 107.306 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.16 138.62 43.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.649 0.738 . . . . 25.0 109.544 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -96.38 -21.4 17.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.41 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -128.33 160.17 33.02 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.435 -1.32 . . . . 25.0 107.435 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.7 p-10 -100.5 153.03 19.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -156.37 151.6 26.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.568 -0.742 . . . . 25.0 110.937 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -116.13 150.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.62 110.51 16.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -93.89 -8.84 39.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 t -134.8 149.02 69.52 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.734 -1.58 . . . . 25.0 106.734 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.76 -18.9 41.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 116.687 -1.742 . . . . 25.0 113.666 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.57 -15.7 58.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.194 0.521 . . . . 25.0 110.817 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -92.39 143.21 26.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.041 0.536 . . . . 25.0 110.703 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.08 133.83 35.85 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.706 -0.798 . . . . 25.0 111.098 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.2 p -82.29 137.59 34.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 25.0 106.974 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.406 ' CE2' HG13 ' A' ' 57' ' ' VAL . 36.8 p90 -156.49 165.77 35.36 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -124.78 155.13 39.86 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.574 -0.703 . . . . 25.0 110.932 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.456 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.3 pttp -59.1 128.05 35.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.91 -12.19 68.8 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.703 -0.68 . . . . 25.0 113.903 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -79.37 158.02 27.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.039 -0.726 . . . . 25.0 109.039 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -120.66 127.63 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.957 -0.386 . . . . 25.0 109.957 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.69 152.27 51.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 25.0 111.873 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 m -86.84 133.86 33.6 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.5 t -98.72 121.42 49.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -93.64 -42.31 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.682 -0.69 . . . . 25.0 110.988 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.11 164.61 30.71 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 -173.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -132.01 150.04 52.26 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.466 -1.679 . . . . 25.0 106.466 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 58.28 39.91 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.81 1.319 . . . . 25.0 108.675 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -70.46 -14.22 62.45 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.808 -1.542 . . . . 25.0 114.35 -169.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -116.39 11.13 14.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.996 -0.547 . . . . 25.0 109.704 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.43 -6.8 63.11 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.806 -0.918 . . . . 25.0 110.806 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -86.0 118.13 25.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.429 -0.952 . . . . 25.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.5 128.78 38.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.793 -0.818 . . . . 25.0 108.793 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.12 78.55 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 115.779 1.071 . . . . 25.0 115.779 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -104.13 112.83 26.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.541 1.671 . . . . 25.0 110.046 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -107.82 142.73 37.42 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.228 -0.295 . . . . 25.0 111.643 -170.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.95 116.09 22.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.43 -1.322 . . . . 25.0 107.43 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.5 m -117.97 169.53 9.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.727 -0.215 . . . . 25.0 110.443 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -133.11 129.1 37.5 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.66 -0.496 . . . . 25.0 109.66 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.2 tp -161.04 155.47 23.22 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.4 t60 60.03 23.55 12.72 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.801 0.667 . . . . 25.0 112.801 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.08 11.56 85.25 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 25.0 114.051 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -142.28 162.84 34.44 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.0 -0.37 . . . . 25.0 110.0 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -110.72 155.85 21.89 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.224 -1.028 . . . . 25.0 108.224 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.45 165.97 37.15 Favored Glycine 0 C--O 1.24 0.523 0 N-CA-C 110.179 -1.168 . . . . 25.0 110.179 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -79.25 147.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 25.0 109.851 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 26' ' ' PHE . 86.5 t -142.46 131.81 12.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 25.0 107.289 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 121.84 8.69 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 114.882 -2.945 . . . . 25.0 111.326 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -22.8 61.74 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 115.954 -0.566 . . . . 25.0 113.686 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -65.67 -13.01 58.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.091 -0.652 . . . . 25.0 112.418 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -103.18 7.98 38.57 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 25.0 110.747 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -118.64 152.82 35.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.612 0.72 . . . . 25.0 111.044 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -126.87 117.72 23.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.646 -1.242 . . . . 25.0 107.646 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 108.705 -0.85 . . . . 25.0 108.705 -179.872 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 109.369 -0.604 . . . . 25.0 109.369 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 t30 46.91 46.91 15.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.988 1.107 . . . . 25.0 113.988 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.93 125.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.671 -1.233 . . . . 25.0 107.671 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -82.01 154.4 25.7 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.81 0.814 . . . . 25.0 108.975 -175.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.62 161.63 35.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.498 -1.228 . . . . 25.0 108.231 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -113.11 133.87 54.81 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.112 -1.07 . . . . 25.0 108.112 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.76 123.44 24.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.433 0.635 . . . . 25.0 109.797 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -82.46 -29.96 30.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.783 -0.644 . . . . 25.0 109.989 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -132.4 164.06 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 25.0 107.38 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.599 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.3 p-10 -99.22 166.62 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.487 -0.19 . . . . 25.0 110.487 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -148.15 160.53 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 25.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.54 118.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 102.855 -3.017 . . . . 25.0 102.855 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 144.27 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.9 -0.407 . . . . 25.0 109.9 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -33.89 3.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 25.0 110.002 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 t -81.03 146.75 59.69 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.969 -1.122 . . . . 25.0 107.969 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.88 -13.76 29.32 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 117.493 -1.205 . . . . 25.0 114.058 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -86.79 -15.65 38.65 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.875 0.845 . . . . 25.0 109.762 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -85.24 137.31 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 25.0 111.253 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.56 134.69 34.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.33 0.586 . . . . 25.0 111.105 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -84.29 114.05 21.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE2' HG13 ' A' ' 57' ' ' VAL . 55.2 p90 -140.14 161.06 38.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -131.08 164.11 26.16 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.936 0.398 . . . . 25.0 111.887 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.599 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 49.5 pttt -60.23 137.68 58.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.179 0.514 . . . . 25.0 110.712 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.96 -23.82 31.36 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.236 -0.893 . . . . 25.0 112.679 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -70.47 157.67 37.43 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 122.572 0.349 . . . . 25.0 111.407 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.13 127.47 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.308 0.643 . . . . 25.0 110.017 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.46 146.91 46.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.308 -0.256 . . . . 25.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 37.4 m -90.1 122.94 33.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 25.0 110.081 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -82.95 121.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 107.297 -1.371 . . . . 25.0 107.297 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -90.16 -45.91 8.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.751 -0.659 . . . . 25.0 110.067 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -153.5 171.89 18.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 25.0 109.388 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -130.19 155.53 46.1 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.884 -1.895 . . . . 25.0 105.884 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.3 t0 60.57 41.12 15.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 123.19 1.471 . . . . 25.0 108.905 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -70.72 -18.53 62.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.806 -1.543 . . . . 25.0 114.181 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -120.27 8.88 10.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.182 0.438 . . . . 25.0 112.182 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.79 7.88 85.2 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 109.642 -1.383 . . . . 25.0 109.642 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.9 mt -113.54 110.03 19.6 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.066 -1.457 . . . . 25.0 107.066 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -66.77 147.83 52.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.6 -22.27 40.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.457 -0.792 . . . . 25.0 112.466 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -93.18 132.01 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.208 1.004 . . . . 25.0 108.95 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -119.4 139.7 51.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.596 -0.89 . . . . 25.0 108.596 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.08 121.86 28.0 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.257 -1.757 . . . . 25.0 106.257 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.8 m -123.04 156.31 35.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.944 -0.391 . . . . 25.0 109.944 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.0 p -117.18 131.15 56.93 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.708 -1.219 . . . . 25.0 107.708 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.83 131.78 13.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.419 -0.81 . . . . 25.0 108.856 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 52.91 37.41 24.27 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.659 0.985 . . . . 25.0 113.659 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.36 3.45 85.94 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.096 -0.573 . . . . 25.0 114.476 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -118.08 167.2 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.495 -1.668 . . . . 25.0 106.495 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -134.03 157.37 46.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.024 -1.473 . . . . 25.0 107.024 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.1 171.49 43.95 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 109.315 -1.514 . . . . 25.0 109.315 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.85 144.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.703 0.763 . . . . 25.0 110.507 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG13 ' CE2' ' A' ' 26' ' ' PHE . 79.0 t -138.62 134.82 17.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 119.48 6.34 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 115.1 -2.8 . . . . 25.0 110.812 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.31 62.48 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 115.009 0.764 . . . . 25.0 115.009 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.99 -28.58 67.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 25.0 111.281 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -89.39 8.98 27.96 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.718 0.636 . . . . 25.0 112.718 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.23 151.51 39.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.249 0.547 . . . . 25.0 112.394 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -122.93 117.67 26.08 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.75 -0.833 . . . . 25.0 108.75 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 C--N 1.324 -0.512 0 N-CA-C 108.015 -1.106 . . . . 25.0 108.015 175.852 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--O 1.226 -0.178 0 N-CA-C 109.852 -0.425 . . . . 25.0 109.852 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.0 t30 51.23 38.85 22.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.283 -0.871 . . . . 25.0 112.485 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.19 170.5 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 104.327 -2.472 . . . . 25.0 104.327 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.85 153.46 51.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 118.879 0.763 . . . . 25.0 110.54 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -134.67 149.47 50.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.998 -1.001 . . . . 25.0 110.93 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -95.34 131.39 41.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.529 -1.285 . . . . 25.0 107.529 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.41 136.63 42.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.43 -20.59 18.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.441 -0.799 . . . . 25.0 109.64 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -134.03 159.66 40.1 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.636 -0.876 . . . . 25.0 108.636 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 5.6 p-10 -100.36 156.66 17.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.013 0.525 . . . . 25.0 109.663 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -155.34 161.13 41.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.738 -0.665 . . . . 25.0 110.577 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 p -122.72 147.76 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.97 114.91 22.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.778 -0.823 . . . . 25.0 108.778 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -93.2 -8.49 42.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.231 -1.025 . . . . 25.0 108.231 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -129.85 148.14 68.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.53 -12.45 31.46 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 117.211 -1.393 . . . . 25.0 113.248 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -85.89 -14.19 45.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.932 0.872 . . . . 25.0 110.013 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -94.41 147.84 22.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 25.0 109.931 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.08 137.79 34.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.149 0.5 . . . . 25.0 111.233 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -87.37 116.7 25.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.691 -1.226 . . . . 25.0 107.691 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.423 ' CE1' HG13 ' A' ' 57' ' ' VAL . 47.9 p90 -135.07 162.56 32.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 80.0 mtm-85 -131.38 154.01 49.07 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.958 -0.463 . . . . 25.0 111.009 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.455 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.1 pttp -58.89 131.89 52.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 25.0 109.938 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.92 -19.52 53.57 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.426 -0.806 . . . . 25.0 113.374 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -75.35 159.11 31.81 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.275 0.537 . . . . 25.0 110.312 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.5 mm -119.38 127.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.123 -0.695 . . . . 25.0 109.123 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptp -133.83 149.35 51.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.0 0.429 . . . . 25.0 111.767 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.7 m -79.9 136.31 36.63 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.301 -1.0 . . . . 25.0 108.301 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -104.38 120.8 55.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.79 -45.64 10.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 25.0 111.322 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.27 171.84 18.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.459 -1.312 . . . . 25.0 107.459 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.66 154.75 44.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 110.302 -0.259 . . . . 25.0 110.302 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 57.57 35.53 25.85 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 125.032 1.458 . . . . 25.0 109.472 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -70.48 -20.48 62.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.676 -1.602 . . . . 25.0 113.513 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -99.4 0.98 43.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.376 0.608 . . . . 25.0 110.193 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 -6.02 67.48 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 109.787 -1.325 . . . . 25.0 109.787 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.7 mt -88.25 126.81 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.827 -1.546 . . . . 25.0 106.827 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -61.02 131.15 49.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.375 0.607 . . . . 25.0 109.899 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.69 0.66 90.24 Favored Glycine 0 C--O 1.219 -0.788 0 CA-C-O 118.428 -1.207 . . . . 25.0 116.055 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -97.43 110.76 23.25 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.125 1.962 . . . . 25.0 110.93 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.78 144.85 30.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 25.0 111.058 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.95 118.0 23.17 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.3 m -119.86 167.76 11.79 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.479 -0.563 . . . . 25.0 109.479 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -134.0 130.86 38.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.851 0.358 . . . . 25.0 110.238 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 tp -160.75 152.34 19.5 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 106.976 -1.49 . . . . 25.0 106.976 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.2 m80 58.69 24.16 11.86 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.76 82.4 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.665 -0.779 . . . . 25.0 112.295 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -125.13 167.13 15.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.629 -1.619 . . . . 25.0 106.629 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.78 150.55 50.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 105.123 -2.176 . . . . 25.0 105.123 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.1 171.08 43.93 Favored Glycine 0 C--O 1.241 0.532 0 N-CA-C 110.682 -0.967 . . . . 25.0 110.682 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -78.41 143.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 25.0 111.157 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 26' ' ' PHE . 71.0 t -141.44 134.23 14.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.81 118.69 5.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 114.987 -2.875 . . . . 25.0 111.472 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.55 -21.24 66.68 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 114.772 0.669 . . . . 25.0 114.772 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -64.42 -21.81 66.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.571 . . . . 25.0 110.83 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -91.91 9.86 31.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.992 -0.443 . . . . 25.0 111.152 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.1 mt -125.36 155.04 40.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.78 0.432 . . . . 25.0 110.404 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -129.19 117.68 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.497 HD13 ' HB2' ' A' ' 10' ' ' ALA . 9.7 mm . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 109.247 -0.649 . . . . 25.0 109.247 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.8 mt . . . . . 0 C--O 1.217 -0.647 0 N-CA-C 115.14 1.534 . . . . 25.0 115.14 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.9 t30 49.52 41.99 22.06 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.316 1.228 . . . . 25.0 114.316 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.82 166.38 5.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 105.186 -2.153 . . . . 25.0 105.186 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 155.98 45.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.147 0.499 . . . . 25.0 110.108 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.45 144.69 33.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.75 -0.659 . . . . 25.0 112.107 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -90.84 135.45 33.72 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.56 121.27 22.16 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.89 0.744 . . . . 25.0 109.118 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.98 -26.43 27.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.147 -0.479 . . . . 25.0 110.324 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.29 163.87 26.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.0 p-10 -97.21 157.66 15.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.975 -0.75 . . . . 25.0 108.975 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -147.17 131.14 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.936 0.495 . . . . 25.0 110.492 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -100.87 121.97 52.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 101.616 -3.475 . . . . 25.0 101.616 168.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 143.09 48.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.977 -0.749 . . . . 25.0 108.977 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -110.92 -26.29 9.38 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 123.479 0.487 . . . . 25.0 110.058 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.6 t -97.02 146.26 31.0 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 108.366 -0.976 . . . . 25.0 108.366 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.55 -14.95 27.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 116.763 -1.691 . . . . 25.0 113.153 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.47 -15.54 57.6 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 122.969 0.508 . . . . 25.0 110.58 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -93.73 143.46 26.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.318 0.647 . . . . 25.0 111.864 -171.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.15 133.13 35.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 25.0 110.729 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 84.0 6.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.849 0.833 . . . . 25.0 108.947 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.522 ' CE1' HG13 ' A' ' 57' ' ' VAL . 36.3 p90 -93.88 162.99 13.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.636 -0.875 . . . . 25.0 108.636 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -126.26 155.96 41.07 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.252 0.549 . . . . 25.0 110.795 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.7 ptmt -57.95 132.85 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 25.0 109.922 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.05 -21.44 46.01 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-O 119.014 -0.881 . . . . 25.0 114.245 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -74.93 160.59 30.42 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.61 133.51 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.284 -1.006 . . . . 25.0 108.284 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.67 148.68 52.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 25.0 110.889 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -81.0 127.26 32.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -91.15 122.17 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 mt -96.93 -41.09 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.123 -0.944 . . . . 25.0 111.884 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.46 157.69 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -134.29 147.26 50.59 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.013 -1.477 . . . . 25.0 107.013 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 t0 59.29 38.93 23.03 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 123.98 1.848 . . . . 25.0 107.335 -170.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -69.32 -11.8 61.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.322 -1.763 . . . . 25.0 114.626 -169.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -129.77 15.11 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.131 0.491 . . . . 25.0 110.806 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.83 22.26 77.23 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 109.514 -1.434 . . . . 25.0 109.514 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.93 114.06 21.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.788 -1.93 . . . . 25.0 105.788 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -59.52 141.16 55.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.882 0.849 . . . . 25.0 109.456 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.8 38.96 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-O 118.92 -0.933 . . . . 25.0 115.1 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.2 130.78 40.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.474 1.637 . . . . 25.0 110.422 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -119.92 149.39 42.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.593 -0.521 . . . . 25.0 109.593 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.1 tp -89.8 120.46 31.07 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 106.436 -1.69 . . . . 25.0 106.436 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -122.23 155.64 35.45 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 121.026 -0.269 . . . . 25.0 110.568 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 p -111.69 125.81 54.36 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.362 -0.607 . . . . 25.0 109.362 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -152.93 143.62 22.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.834 -1.172 . . . . 25.0 107.834 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.87 26.1 12.86 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.582 0.706 . . . . 25.0 112.73 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.21 9.17 87.18 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.491 -0.861 . . . . 25.0 114.474 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -128.24 163.25 25.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.693 -0.484 . . . . 25.0 109.693 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.05 149.54 38.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.088 -1.079 . . . . 25.0 108.088 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 171.21 42.86 Favored Glycine 0 C--O 1.241 0.561 0 N-CA-C 108.887 -1.685 . . . . 25.0 108.887 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -86.81 146.4 6.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.67 0.748 . . . . 25.0 110.226 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.522 HG13 ' CE1' ' A' ' 26' ' ' PHE . 54.7 t -139.42 133.67 16.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.412 -0.813 . . . . 25.0 109.067 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.99 115.49 4.01 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 115.278 -2.682 . . . . 25.0 110.536 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.6 -17.56 66.96 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 115.051 0.78 . . . . 25.0 115.051 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.16 -17.92 64.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.258 1.029 . . . . 25.0 111.436 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -90.78 5.61 47.61 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.81 -0.556 . . . . 25.0 110.658 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.29 151.58 37.41 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.541 0.525 . . . . 25.0 111.328 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -122.1 117.46 26.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.419 -0.956 . . . . 25.0 108.419 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 107.86 -1.163 . . . . 25.0 107.86 177.294 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.215 -0.724 0 N-CA-C 109.052 -0.721 . . . . 25.0 109.052 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 51.08 45.45 27.79 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.491 1.116 . . . . 25.0 112.906 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.72 163.48 6.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 105.478 -2.045 . . . . 25.0 105.478 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.13 148.57 52.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.235 1.017 . . . . 25.0 111.13 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.64 157.72 44.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.269 -1.332 . . . . 25.0 108.981 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -111.16 134.26 52.89 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.713 -0.847 . . . . 25.0 108.713 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.91 130.44 42.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.44 -26.8 19.66 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.857 -0.794 . . . . 25.0 108.857 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.05 158.33 35.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.545 -1.28 . . . . 25.0 107.545 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.4 p-10 -90.58 160.52 15.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.733 -1.581 . . . . 25.0 106.733 174.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -143.8 168.01 20.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 25.0 110.069 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.56 120.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 101.929 -3.359 . . . . 25.0 101.929 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 122.27 23.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.188 -1.042 . . . . 25.0 108.188 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -104.32 -21.14 13.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.888 -0.596 . . . . 25.0 111.325 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.3 m -102.26 150.35 37.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.83 -21.1 33.61 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 116.204 -2.064 . . . . 25.0 113.369 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.57 -8.02 58.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.177 -0.465 . . . . 25.0 111.477 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -90.05 140.93 29.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.672 0.273 . . . . 25.0 110.601 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mt -85.02 137.88 32.79 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.826 -0.546 . . . . 25.0 110.843 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -91.67 118.46 30.66 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.916 -1.142 . . . . 25.0 107.916 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.67 170.9 14.84 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.079 -0.712 . . . . 25.0 109.079 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.5 158.13 40.78 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 109.175 -0.676 . . . . 25.0 109.175 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.8 pttp -59.27 129.81 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -20.8 42.9 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.507 -0.77 . . . . 25.0 113.293 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.0 149.42 50.27 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 117.599 0.7 . . . . 25.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -114.13 127.68 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.457 -0.942 . . . . 25.0 108.457 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.8 ptp -137.81 147.7 44.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.824 0.345 . . . . 25.0 110.368 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 m -84.38 130.82 34.75 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 107.912 -1.144 . . . . 25.0 107.912 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.22 125.92 47.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 N-CA-C 107.39 -1.337 . . . . 25.0 107.39 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.77 -39.04 7.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.595 -0.729 . . . . 25.0 112.253 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -146.0 161.61 39.7 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.071 -0.715 . . . . 25.0 109.071 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -125.78 150.42 47.78 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 109.139 -0.689 . . . . 25.0 109.139 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 54.2 37.19 26.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.496 1.617 . . . . 25.0 108.889 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -69.55 -12.67 61.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 112.842 -1.981 . . . . 25.0 114.188 -169.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 7.91 17.21 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.219 -0.659 . . . . 25.0 109.219 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.42 -17.42 13.97 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.882 -0.887 . . . . 25.0 110.882 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.98 127.13 31.59 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.343 -1.355 . . . . 25.0 107.343 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.8 135.11 57.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.733 0.778 . . . . 25.0 110.459 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 -0.07 89.02 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-O 119.181 -0.788 . . . . 25.0 114.805 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -97.95 104.76 16.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.221 1.51 . . . . 25.0 110.534 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -94.82 147.59 23.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 25.0 111.371 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -85.99 117.27 24.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.948 -1.871 . . . . 25.0 105.948 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.7 m -115.89 162.14 17.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -122.64 124.94 44.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.519 -0.919 . . . . 25.0 108.519 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 tp -155.65 139.81 16.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.989 -0.745 . . . . 25.0 108.989 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 54.48 38.16 29.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.943 0.877 . . . . 25.0 113.049 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.07 0.7 77.39 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 115.129 0.812 . . . . 25.0 115.129 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -119.25 154.41 33.49 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.135 -0.691 . . . . 25.0 109.135 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -110.35 148.12 32.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 104.441 -2.429 . . . . 25.0 104.441 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.72 168.82 41.64 Favored Glycine 0 C--O 1.243 0.706 0 N-CA-C 111.39 -0.684 . . . . 25.0 111.39 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -78.26 142.91 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.877 0.846 . . . . 25.0 109.964 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.17 134.57 14.61 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.39 114.69 4.01 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 114.659 -3.094 . . . . 25.0 112.319 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 -23.07 63.49 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 114.263 0.465 . . . . 25.0 114.263 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.0 -25.46 67.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.267 -0.549 . . . . 25.0 111.206 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -92.19 8.34 38.5 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 112.266 0.469 . . . . 25.0 112.266 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -116.71 149.99 38.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 25.0 112.326 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.47 118.77 28.18 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.408 -0.59 . . . . 25.0 109.408 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.1 mm . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 108.634 -0.876 . . . . 25.0 108.634 177.672 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--O 1.224 -0.247 0 CA-C-O 120.627 0.251 . . . . 25.0 111.44 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.7 t30 49.33 46.93 22.85 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.6 m -109.81 169.98 3.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.97 158.76 43.62 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.382 -0.599 . . . . 25.0 109.382 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 149.64 34.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.746 -0.661 . . . . 25.0 112.091 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.18 134.38 37.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.964 -0.562 . . . . 25.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.78 132.0 42.14 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.209 0.528 . . . . 25.0 109.676 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 mt -96.9 -23.95 16.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.636 -0.711 . . . . 25.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.06 161.45 26.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.274 -1.38 . . . . 25.0 107.274 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.567 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.4 p-10 -102.16 162.37 12.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 25.0 109.269 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -151.96 159.11 43.86 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.507 0.504 . . . . 25.0 111.163 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.62 133.2 68.83 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 110.6 7.03 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -78.46 -35.4 46.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.012 -1.449 . . . . 25.0 107.708 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -119.36 154.55 54.08 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 25.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.5 -15.94 34.37 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.661 -1.093 . . . . 25.0 113.697 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.79 -10.2 58.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 25.0 110.698 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -94.29 144.16 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.039 -0.726 . . . . 25.0 109.039 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.46 135.24 33.57 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.774 -0.77 . . . . 25.0 110.21 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -85.27 125.08 32.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.842 -1.91 . . . . 25.0 105.842 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -148.81 163.72 36.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.028 -1.471 . . . . 25.0 107.028 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -129.52 159.03 37.59 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.224 0.535 . . . . 25.0 110.803 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.9 pttp -59.2 132.5 54.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.816 -1.179 . . . . 25.0 107.816 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.99 -23.34 32.52 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.783 -0.644 . . . . 25.0 113.06 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.35 163.28 26.58 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.073 0.437 . . . . 25.0 110.207 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.01 132.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -133.4 153.5 51.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 25.0 110.585 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -88.18 131.02 34.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.289 -0.634 . . . . 25.0 109.289 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.3 t -96.06 124.18 48.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.09 -42.2 8.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.771 -0.649 . . . . 25.0 112.096 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.38 159.75 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 25.0 109.009 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -129.91 151.28 50.65 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t0 58.83 39.6 23.83 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.144 1.45 . . . . 25.0 107.973 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -71.29 -13.8 62.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.854 -1.521 . . . . 25.0 112.859 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -119.46 4.88 11.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.961 0.726 . . . . 25.0 112.961 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.37 20.34 69.58 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 110.086 -1.206 . . . . 25.0 110.086 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.57 113.76 15.23 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.337 -1.727 . . . . 25.0 106.337 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -64.84 141.78 58.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.483 -1.302 . . . . 25.0 107.483 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.57 -15.43 63.33 Favored Glycine 0 C--O 1.209 -1.406 0 CA-C-O 118.441 -1.199 . . . . 25.0 113.377 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -98.57 125.23 43.74 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.658 1.729 . . . . 25.0 109.798 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -119.61 146.96 45.06 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.941 -0.392 . . . . 25.0 109.941 -172.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.1 tp -85.43 116.2 23.6 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.624 -1.251 . . . . 25.0 107.624 176.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -115.31 167.19 11.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.641 0.258 . . . . 25.0 110.652 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 m -131.62 132.94 44.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.448 -0.575 . . . . 25.0 109.448 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 tp -160.24 146.29 15.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 58.5 24.4 11.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.004 1.113 . . . . 25.0 114.004 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.44 4.66 87.68 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.909 -0.662 . . . . 25.0 113.228 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -122.83 163.89 19.42 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 122.947 0.499 . . . . 25.0 109.669 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -118.1 154.55 31.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.942 -1.873 . . . . 25.0 105.942 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.6 162.66 31.33 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 111.779 -0.528 . . . . 25.0 111.779 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.4 pt -78.12 145.64 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.557 . . . . 25.0 110.682 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -144.84 133.69 11.07 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 108.492 -0.929 . . . . 25.0 108.492 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.6 121.21 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 115.534 -2.511 . . . . 25.0 112.02 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.62 -22.36 65.91 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-N 115.342 -0.845 . . . . 25.0 114.188 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -70.47 -2.4 13.82 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.089 -0.654 . . . . 25.0 111.675 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.0 11.23 17.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.917 -0.401 . . . . 25.0 109.917 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.95 152.63 38.29 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.367 0.417 . . . . 25.0 111.078 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -117.88 117.81 30.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 N--CA 1.471 0.581 0 O-C-N 123.821 0.7 . . . . 25.0 109.254 177.088 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 120.544 0.211 . . . . 25.0 111.564 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 51.44 43.78 29.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.4 1.259 . . . . 25.0 114.4 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.63 164.34 13.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 103.025 -2.954 . . . . 25.0 103.025 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.61 160.85 37.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.714 0.688 . . . . 25.0 110.386 -174.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.45 163.24 33.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.448 -0.796 . . . . 25.0 110.887 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.58 134.4 52.43 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.042 -1.466 . . . . 25.0 107.042 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.87 136.11 43.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.721 0.772 . . . . 25.0 109.231 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.82 -24.62 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.489 -0.778 . . . . 25.0 109.63 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -128.98 162.75 26.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.818 -1.178 . . . . 25.0 107.818 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.17 156.69 17.06 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -156.49 135.77 12.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.357 0.503 . . . . 25.0 112.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -100.64 146.92 8.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.98 -1.859 . . . . 25.0 105.98 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.93 133.54 37.26 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.255 -0.276 . . . . 25.0 110.255 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.55 -7.17 23.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.666 0.745 . . . . 25.0 109.117 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.7 t -129.46 148.65 70.18 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.631 -0.713 . . . . 25.0 109.347 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.32 -16.84 35.3 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.716 -1.722 . . . . 25.0 113.3 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -82.17 -15.56 52.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.471 0.653 . . . . 25.0 110.674 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -92.5 140.85 29.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.628 -0.879 . . . . 25.0 108.628 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 132.56 36.04 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.123 -0.631 . . . . 25.0 110.044 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p -84.53 133.08 34.47 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.394 -2.076 . . . . 25.0 105.394 171.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.413 ' CE1' HG13 ' A' ' 57' ' ' VAL . 45.8 p90 -150.64 166.12 31.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.933 -0.766 . . . . 25.0 108.933 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -127.04 152.99 46.53 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.872 -0.518 . . . . 25.0 110.696 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -59.49 138.37 57.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.651 -0.704 . . . . 25.0 109.279 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.5 -16.02 57.27 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.503 -0.771 . . . . 25.0 114.035 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -76.89 159.76 29.76 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 117.387 0.593 . . . . 25.0 109.93 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.51 130.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.983 0.513 . . . . 25.0 109.638 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.12 147.07 45.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.972 0.415 . . . . 25.0 110.728 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -85.66 130.74 34.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.6 t -88.83 116.41 30.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.809 -1.923 . . . . 25.0 105.809 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.24 -37.76 13.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.309 -0.859 . . . . 25.0 111.147 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -147.43 156.18 42.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.597 -1.26 . . . . 25.0 107.597 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -124.51 147.43 48.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.621 -0.511 . . . . 25.0 109.621 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 57.25 38.21 28.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.745 1.736 . . . . 25.0 107.618 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.5 t -70.56 -11.4 60.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 112.283 -2.235 . . . . 25.0 115.699 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.06 10.07 13.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.145 0.497 . . . . 25.0 110.028 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.62 66.79 Favored Glycine 0 C--O 1.225 -0.425 0 N-CA-C 109.688 -1.365 . . . . 25.0 109.688 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.69 116.74 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.643 -1.614 . . . . 25.0 106.643 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.42 133.82 55.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.795 -0.639 . . . . 25.0 109.457 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.29 -0.43 85.58 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.506 0.962 . . . . 25.0 115.506 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -102.92 116.57 32.8 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.127 1.464 . . . . 25.0 110.538 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -108.59 145.0 35.54 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.208 -0.308 . . . . 25.0 111.09 -174.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.52 120.98 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.473 -1.677 . . . . 25.0 106.473 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.2 m -119.86 165.22 14.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.697 -0.483 . . . . 25.0 109.697 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 p -122.95 131.66 53.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.059 0.457 . . . . 25.0 110.027 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 tp -160.27 148.61 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.664 -1.235 . . . . 25.0 107.664 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 59.64 23.25 12.01 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.272 0.841 . . . . 25.0 113.272 176.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.07 81.08 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.842 -0.694 . . . . 25.0 112.686 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -130.76 164.21 25.6 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.48 -0.933 . . . . 25.0 108.48 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -117.77 152.91 34.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.941 -1.874 . . . . 25.0 105.941 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.04 163.98 36.44 Favored Glycine 0 C--O 1.239 0.462 0 N-CA-C 110.387 -1.085 . . . . 25.0 110.387 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.8 pt -79.43 145.19 9.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.611 . . . . 25.0 110.062 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.413 HG13 ' CE1' ' A' ' 26' ' ' PHE . 71.4 t -140.74 133.7 14.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 107.64 -1.244 . . . . 25.0 107.64 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.41 121.57 8.11 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 114.667 -3.089 . . . . 25.0 111.212 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.16 -25.67 62.59 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 116.015 -0.539 . . . . 25.0 114.263 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -65.48 -18.52 65.38 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.23 -0.57 . . . . 25.0 112.374 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.84 8.0 41.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.888 -0.507 . . . . 25.0 111.232 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.0 mt -122.41 156.79 33.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.903 0.383 . . . . 25.0 110.786 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -131.62 120.07 22.32 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.1 mm . . . . . 0 N--CA 1.469 0.519 0 O-C-N 123.67 0.606 . . . . 25.0 110.358 -179.071 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 114.892 1.441 . . . . 25.0 114.892 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.4 43.26 26.88 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.042 1.497 . . . . 25.0 115.042 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.2 163.63 8.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 104.297 -2.483 . . . . 25.0 104.297 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.17 154.06 47.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 118.891 0.769 . . . . 25.0 110.63 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.91 143.79 34.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.657 -0.701 . . . . 25.0 111.36 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -95.19 132.42 40.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.083 -0.71 . . . . 25.0 109.083 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 134.88 41.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.392 0.615 . . . . 25.0 109.417 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.27 -25.1 17.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.578 -0.737 . . . . 25.0 109.488 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -131.22 157.65 42.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.512 -1.292 . . . . 25.0 107.512 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -95.35 161.65 14.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.667 -0.494 . . . . 25.0 109.667 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -152.92 149.84 28.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -124.1 128.74 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 103.773 -2.677 . . . . 25.0 103.773 173.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.91 136.09 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.913 -0.585 . . . . 25.0 109.923 -176.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -102.94 -12.9 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.35 155.66 53.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 25.0 110.312 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.23 -19.31 20.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 117.71 -1.06 . . . . 25.0 114.418 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -86.37 -15.03 41.71 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.985 0.898 . . . . 25.0 109.591 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -89.89 145.6 25.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.418 -0.81 . . . . 25.0 108.897 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.44 135.79 40.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.31 138.67 32.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 170.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.442 ' CE1' HG13 ' A' ' 57' ' ' VAL . 42.3 p90 -157.4 164.01 37.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -124.15 153.06 42.07 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.618 -0.676 . . . . 25.0 112.197 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.543 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 46.2 pttt -58.3 132.43 53.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.543 -1.28 . . . . 25.0 107.543 175.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.21 -14.52 65.15 Favored Glycine 0 C--O 1.226 -0.348 0 CA-C-O 118.79 -1.005 . . . . 25.0 114.089 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.53 163.02 20.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.686 0.743 . . . . 25.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.49 132.11 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.026 -0.731 . . . . 25.0 109.026 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -129.13 151.37 49.88 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 116.055 -0.521 . . . . 25.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.1 m -85.42 129.08 34.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.259 -1.015 . . . . 25.0 108.259 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 83.7 t -91.87 119.62 39.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.684 -1.598 . . . . 25.0 106.684 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -97.87 -40.45 8.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.303 -0.862 . . . . 25.0 111.129 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -148.03 164.68 33.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -130.56 152.88 49.46 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 56.57 37.17 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.884 1.365 . . . . 25.0 108.166 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -69.34 -17.39 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 113.631 -1.622 . . . . 25.0 112.857 -169.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.17 6.48 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.721 -0.672 . . . . 25.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 -8.22 67.42 Favored Glycine 0 C--O 1.228 -0.257 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt -83.63 117.27 23.07 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.713 . . . . 25.0 109.076 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -60.39 128.27 35.88 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 25.0 109.412 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.22 -1.3 82.41 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 115.461 0.944 . . . . 25.0 115.461 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -100.63 122.59 43.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.926 1.363 . . . . 25.0 109.247 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -112.49 145.42 40.26 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.993 -0.442 . . . . 25.0 111.162 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.9 tp -83.57 115.07 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.545 -1.65 . . . . 25.0 106.545 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.6 m -122.45 164.84 17.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.536 0.208 . . . . 25.0 110.857 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.5 p -123.18 131.36 53.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -157.93 139.71 13.93 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 57.45 32.98 22.64 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.732 0.777 . . . . 25.0 112.632 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.08 4.47 63.18 Favored Glycine 0 CA--C 1.522 0.491 0 O-C-N 121.567 -0.708 . . . . 25.0 113.427 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.73 164.1 13.77 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -132.19 146.0 51.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 104.22 -2.511 . . . . 25.0 104.22 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.62 177.87 48.55 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 111.11 -0.796 . . . . 25.0 111.11 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.34 143.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.387 0.613 . . . . 25.0 110.299 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 26' ' ' PHE . 72.7 t -139.33 134.18 16.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.75 118.54 5.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 115.015 -2.857 . . . . 25.0 110.749 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -23.92 70.78 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.706 -0.679 . . . . 25.0 113.988 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.59 -16.47 64.19 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.289 -0.536 . . . . 25.0 111.62 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -90.06 1.14 56.68 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.93 -0.481 . . . . 25.0 110.918 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.58 150.64 36.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.306 0.574 . . . . 25.0 111.343 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -121.96 113.86 20.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.331 -0.988 . . . . 25.0 108.331 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.754 0.311 . . . . 25.0 110.848 -177.138 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 114.699 1.37 . . . . 25.0 114.699 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.06 30.24 19.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.816 1.413 . . . . 25.0 114.816 173.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -115.94 164.01 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.175 -1.787 . . . . 25.0 106.175 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.95 164.11 23.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.28 145.21 30.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 25.0 110.857 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -95.05 134.49 37.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.31 136.55 40.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.274 0.559 . . . . 25.0 109.616 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.26 -26.22 17.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 25.0 110.071 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -130.24 162.78 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.55 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.9 p-10 -101.71 157.07 17.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.888 -0.412 . . . . 25.0 109.888 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -157.87 122.78 4.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.575 -0.739 . . . . 25.0 110.099 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 138.93 19.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.13 148.97 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -111.22 -20.41 12.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.639 -0.504 . . . . 25.0 109.639 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -105.09 152.46 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.49 -0.323 . . . . 25.0 110.265 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.6 -20.91 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 117.1 -1.466 . . . . 25.0 114.013 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.35 -4.79 59.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.536 0.684 . . . . 25.0 110.599 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -99.26 141.73 31.66 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.18 -1.044 . . . . 25.0 108.18 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.97 134.14 35.06 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.674 -0.641 . . . . 25.0 111.724 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.8 m -84.16 119.44 25.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.526 -1.657 . . . . 25.0 106.526 170.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -136.16 161.62 35.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.55 -0.537 . . . . 25.0 109.55 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -123.43 153.74 40.02 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.062 0.458 . . . . 25.0 110.079 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.55 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 14.0 ptmt -59.6 133.74 56.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 -10.81 72.17 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-O 119.102 -0.832 . . . . 25.0 114.302 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.65 158.29 25.68 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.916 0.858 . . . . 25.0 109.207 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.86 129.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.453 -0.573 . . . . 25.0 109.453 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -130.76 153.23 49.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 25.0 109.899 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 m -87.53 132.32 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.68 -1.229 . . . . 25.0 107.68 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.12 125.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -92.95 -47.78 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.04 -0.527 . . . . 25.0 111.183 -175.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.74 171.92 18.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -121.9 155.0 36.38 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.234 -0.654 . . . . 25.0 109.234 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 57.51 38.6 28.1 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.64 1.213 . . . . 25.0 109.924 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -69.88 -18.59 63.42 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.067 -1.424 . . . . 25.0 114.374 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -110.97 9.73 22.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.265 -0.643 . . . . 25.0 109.265 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.58 1.84 89.26 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.445 -1.062 . . . . 25.0 110.445 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.38 122.36 35.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.144 -1.058 . . . . 25.0 108.144 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -61.45 129.36 40.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.419 0.628 . . . . 25.0 109.98 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 0.45 87.96 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -101.58 108.43 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 118.827 1.313 . . . . 25.0 110.227 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.718 -0.475 . . . . 25.0 109.718 -173.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -82.41 120.1 25.02 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.671 -1.974 . . . . 25.0 105.671 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.71 160.68 24.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 25.0 109.236 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -121.47 132.53 54.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.435 0.636 . . . . 25.0 109.746 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.22 141.38 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.157 -0.928 . . . . 25.0 108.617 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 58.79 26.75 15.12 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.677 0.992 . . . . 25.0 113.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.74 6.06 89.61 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 121.097 -0.573 . . . . 25.0 113.293 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -122.11 167.33 13.28 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.05 -1.463 . . . . 25.0 107.05 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -135.41 154.32 51.5 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.777 -1.564 . . . . 25.0 106.777 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.7 171.33 44.27 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.856 -0.898 . . . . 25.0 110.856 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.5 143.3 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.506 0.67 . . . . 25.0 110.587 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.4 t -141.9 132.42 12.86 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.255 -1.017 . . . . 25.0 108.255 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.77 119.52 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 115.178 -2.748 . . . . 25.0 111.582 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.45 -21.77 62.77 Favored Glycine 0 C--O 1.221 -0.678 0 CA-C-N 115.888 -0.597 . . . . 25.0 114.473 -175.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -61.25 -28.12 68.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.267 -0.549 . . . . 25.0 111.37 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -89.15 6.28 40.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.869 0.322 . . . . 25.0 111.869 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.73 143.97 44.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.6 . . . . 25.0 111.913 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -117.75 117.69 30.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm . . . . . 0 C--O 1.24 0.563 0 CA-C-O 121.202 0.525 . . . . 25.0 110.157 -177.517 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.826 -0.435 . . . . 25.0 109.826 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 t30 56.17 36.83 28.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.464 -0.789 . . . . 25.0 112.284 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.16 129.75 55.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 106.728 -1.582 . . . . 25.0 106.728 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -100.47 153.85 19.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.738 0.78 . . . . 25.0 110.101 -179.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.23 152.13 42.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.826 -1.079 . . . . 25.0 109.948 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -103.49 135.09 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.558 -0.904 . . . . 25.0 108.558 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 135.54 43.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.361 0.601 . . . . 25.0 110.169 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.44 -27.19 17.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.5 -0.773 . . . . 25.0 110.68 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.51 158.26 33.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.35 -1.722 . . . . 25.0 106.35 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 12.0 p-10 -97.95 146.16 25.76 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.296 -1.372 . . . . 25.0 107.296 174.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -144.6 129.99 18.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.776 -0.647 . . . . 25.0 110.741 -174.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -103.91 121.3 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.403 -1.703 . . . . 25.0 106.403 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.66 35.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.911 -0.586 . . . . 25.0 110.108 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -99.55 -17.26 17.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.158 0.504 . . . . 25.0 109.941 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 143.32 40.61 Favored Pre-proline 0 CA--C 1.513 -0.455 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 -15.61 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 116.937 -1.576 . . . . 25.0 114.023 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -94.48 -9.0 36.83 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.315 0.579 . . . . 25.0 110.964 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.62 140.82 30.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.776 -0.824 . . . . 25.0 108.776 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.38 132.3 34.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.432 0.634 . . . . 25.0 111.169 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -86.93 136.32 32.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.14 -1.8 . . . . 25.0 106.14 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -156.55 166.78 32.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.978 0.418 . . . . 25.0 110.441 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -121.44 154.88 35.97 Favored 'General case' 0 C--O 1.213 -0.868 0 O-C-N 121.909 -0.495 . . . . 25.0 110.683 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.3 pttt -60.56 131.79 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 174.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.91 -20.57 49.81 Favored Glycine 0 C--O 1.224 -0.515 0 CA-C-N 115.903 -0.589 . . . . 25.0 113.026 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -71.49 154.19 41.67 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.326 0.563 . . . . 25.0 110.117 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -117.47 126.96 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.109 -0.7 . . . . 25.0 109.109 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.7 ptp -134.89 157.73 46.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 31.6 m -107.03 126.75 52.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.233 -0.284 . . . . 25.0 110.233 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -79.95 123.55 36.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.434 -1.321 . . . . 25.0 107.434 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.92 -46.62 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.92 -0.771 . . . . 25.0 108.92 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.26 169.25 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.165 -1.42 . . . . 25.0 107.165 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -124.16 157.14 35.39 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 110.259 -0.274 . . . . 25.0 110.259 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 56.53 41.42 28.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.74 1.275 . . . . 25.0 108.681 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.47 -16.26 62.9 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.704 1.372 . . . . 25.0 114.704 -167.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -111.94 9.0 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.509 -0.552 . . . . 25.0 109.509 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.11 -9.78 59.83 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 110.864 -0.894 . . . . 25.0 110.864 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.92 124.53 28.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -61.08 131.32 50.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.449 0.642 . . . . 25.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.45 89.58 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 118.566 -1.13 . . . . 25.0 115.482 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -99.02 105.44 17.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.755 1.777 . . . . 25.0 109.817 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -102.34 143.37 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.038 -0.528 . . . . 25.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.0 tp -83.66 112.78 20.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.673 -1.603 . . . . 25.0 106.673 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 67.3 m -112.08 163.14 14.63 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.555 -0.906 . . . . 25.0 108.555 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.2 p -123.74 130.7 53.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 25.0 109.048 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 tp -162.26 146.56 12.21 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 57.43 30.74 19.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.785 1.032 . . . . 25.0 113.785 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.56 11.44 82.81 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 120.702 -0.761 . . . . 25.0 113.161 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -124.55 165.51 17.71 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.44 -1.318 . . . . 25.0 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.36 152.61 47.97 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 103.448 -2.797 . . . . 25.0 103.448 167.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.59 167.09 38.82 Favored Glycine 0 C--O 1.24 0.508 0 N-CA-C 110.262 -1.135 . . . . 25.0 110.262 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.9 pt -75.48 143.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.548 0.69 . . . . 25.0 110.509 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -141.62 132.27 13.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.959 -1.126 . . . . 25.0 107.959 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.07 120.29 6.73 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 115.185 -2.743 . . . . 25.0 111.737 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.38 -25.8 60.97 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-N 115.742 -0.663 . . . . 25.0 114.397 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -63.42 -22.94 67.18 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.191 0.52 . . . . 25.0 111.646 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -91.56 5.5 49.33 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.757 -0.59 . . . . 25.0 111.667 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.5 mt -115.4 156.28 25.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 25.0 111.458 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -122.8 117.7 26.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.114 . . . . 25.0 107.991 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 178.93 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 113.949 1.092 . . . . 25.0 113.949 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.88 38.51 29.47 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.89 0.853 . . . . 25.0 111.967 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.0 t -107.52 149.09 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 104.527 -2.398 . . . . 25.0 104.527 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.69 153.28 50.93 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.251 -1.018 . . . . 25.0 108.251 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.57 149.68 36.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.912 -0.585 . . . . 25.0 111.2 -172.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -96.3 136.44 36.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.81 134.18 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.203 0.525 . . . . 25.0 109.717 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.86 -32.73 15.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.351 0.596 . . . . 25.0 109.768 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.86 164.7 17.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.528 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.7 p-10 -98.9 163.06 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -151.62 144.66 24.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.181 -0.463 . . . . 25.0 111.626 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.14 125.33 73.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.214 -2.884 . . . . 25.0 103.214 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.03 146.22 41.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 25.0 110.147 -175.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -31.29 7.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.465 -0.568 . . . . 25.0 109.465 173.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -94.93 150.34 37.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.58 -16.96 26.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.734 -1.044 . . . . 25.0 113.303 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.94 -9.5 58.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 25.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.18 144.53 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.17 0.588 . . . . 25.0 110.236 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mt -94.9 134.55 37.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.56 0.695 . . . . 25.0 112.645 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.3 m -88.3 140.71 29.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.289 -1.374 . . . . 25.0 107.289 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.42 ' CE2' HG13 ' A' ' 57' ' ' VAL . 40.4 p90 -160.19 167.17 28.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -118.56 156.51 29.02 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.635 -0.665 . . . . 25.0 110.911 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 11.0 ptmm? -59.58 129.68 43.13 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.494 -0.928 . . . . 25.0 108.494 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.05 67.83 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 115.836 -0.62 . . . . 25.0 113.937 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.36 161.24 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.892 -0.781 . . . . 25.0 108.892 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.07 134.05 65.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.353 -0.98 . . . . 25.0 108.353 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -135.48 152.82 51.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.669 -0.696 . . . . 25.0 110.614 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.7 m -89.04 131.9 35.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 25.0 108.031 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.59 120.6 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.748 -1.575 . . . . 25.0 106.748 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.4 mt -92.37 -42.35 9.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 25.0 110.065 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.98 166.23 29.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.984 -0.747 . . . . 25.0 108.984 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -133.38 152.76 51.95 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 117.936 0.334 . . . . 25.0 110.236 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 57.32 36.36 27.15 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.95 1.357 . . . . 25.0 107.766 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.48 -7.1 40.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.17 -1.832 . . . . 25.0 115.644 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -126.87 12.36 7.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.82 -5.78 68.84 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.712 -0.955 . . . . 25.0 110.712 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.99 120.98 25.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.329 -0.989 . . . . 25.0 108.329 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -61.88 127.43 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.706 -0.679 . . . . 25.0 109.939 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.58 1.5 90.1 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.754 1.062 . . . . 25.0 115.754 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -98.68 119.09 36.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.301 1.551 . . . . 25.0 109.898 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -110.0 143.8 39.47 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.185 -0.322 . . . . 25.0 111.304 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.7 tp -81.57 111.59 18.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.614 -1.995 . . . . 25.0 105.614 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.2 m -115.34 164.15 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.834 -0.802 . . . . 25.0 108.834 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -139.26 130.7 27.03 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.758 0.313 . . . . 25.0 111.738 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.21 152.16 25.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 25.0 109.644 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.4 t60 53.07 36.45 22.25 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.83 7.24 74.86 Favored Glycine 0 C--O 1.226 -0.394 0 N-CA-C 114.874 0.71 . . . . 25.0 114.874 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -120.82 156.57 31.64 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.096 -1.446 . . . . 25.0 107.096 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -134.34 145.74 49.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.765 -1.939 . . . . 25.0 105.765 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.61 44.2 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.743 -0.943 . . . . 25.0 110.743 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 pt -76.29 143.89 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.614 0.721 . . . . 25.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 26' ' ' PHE . 71.8 t -141.91 133.34 13.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.35 119.15 6.13 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 114.974 -2.884 . . . . 25.0 110.984 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.09 -18.02 66.41 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.703 -0.681 . . . . 25.0 113.781 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.07 -28.65 69.76 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.513 -0.404 . . . . 25.0 110.883 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -87.7 7.17 31.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.074 0.398 . . . . 25.0 112.074 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -118.92 147.91 43.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.111 0.481 . . . . 25.0 111.091 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -116.21 117.59 30.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.582 -0.895 . . . . 25.0 108.582 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm . . . . . 0 C--O 1.242 0.686 0 C-N-CA 123.417 0.687 . . . . 25.0 110.103 178.308 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 mt . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 113.109 0.781 . . . . 25.0 113.109 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 54.69 24.53 5.62 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.361 1.245 . . . . 25.0 114.361 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.63 174.28 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 106.911 -1.514 . . . . 25.0 106.911 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.22 152.38 49.81 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.765 -0.584 . . . . 25.0 110.55 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.419 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -138.59 146.67 42.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 25.0 111.628 -175.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -95.17 134.57 37.76 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.35 135.03 39.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.529 0.681 . . . . 25.0 110.676 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.0 mt -94.92 -23.05 17.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.12 -0.945 . . . . 25.0 109.531 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -127.61 159.04 35.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -99.39 145.35 27.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.531 -0.544 . . . . 25.0 109.531 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.58 109.89 3.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 25.0 110.299 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.52 138.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 105.335 -2.098 . . . . 25.0 105.335 175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.86 122.38 24.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -101.27 -17.66 16.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.969 -0.752 . . . . 25.0 108.969 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -109.63 151.59 42.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.99 -0.744 . . . . 25.0 108.99 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.48 -20.91 20.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.015 -1.523 . . . . 25.0 114.467 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -84.91 -9.54 58.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.693 0.759 . . . . 25.0 110.601 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -88.51 140.81 29.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.36 -0.836 . . . . 25.0 110.35 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.39 134.45 34.33 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.497 -0.557 . . . . 25.0 109.497 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -95.18 131.51 41.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.44 -0.578 . . . . 25.0 109.44 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -157.14 168.03 28.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.869 0.366 . . . . 25.0 110.03 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -127.14 158.37 37.22 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.807 -0.558 . . . . 25.0 110.33 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.503 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 13.7 pttt -60.86 133.67 56.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.418 -1.327 . . . . 25.0 107.418 174.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.28 55.24 Favored Glycine 0 C--O 1.223 -0.541 0 CA-C-O 119.357 -0.69 . . . . 25.0 113.358 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -81.57 163.02 22.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.218 0.509 . . . . 25.0 109.668 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.8 132.01 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.459 -0.571 . . . . 25.0 109.459 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.86 156.35 41.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.064 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -84.27 133.56 34.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.91 121.81 49.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 25.0 106.462 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.71 -49.62 5.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.237 -0.892 . . . . 25.0 111.695 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.19 162.98 34.19 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.622 0.576 . . . . 25.0 109.564 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -132.17 151.58 51.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.518 -0.919 . . . . 25.0 108.518 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t0 56.84 40.29 29.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.325 1.536 . . . . 25.0 107.663 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 t -70.58 -6.12 34.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.784 -1.553 . . . . 25.0 114.202 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -136.16 10.93 3.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.969 0.729 . . . . 25.0 112.969 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.79 20.31 73.93 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 109.201 -1.56 . . . . 25.0 109.201 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.5 mt -122.32 109.92 15.03 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 105.557 -2.016 . . . . 25.0 105.557 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -68.65 149.07 49.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.645 -1.242 . . . . 25.0 107.645 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.18 -14.21 58.0 Favored Glycine 0 C--O 1.222 -0.611 0 CA-C-O 119.068 -0.851 . . . . 25.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -97.94 134.22 41.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.678 1.239 . . . . 25.0 109.782 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -121.13 147.58 45.37 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.034 -0.728 . . . . 25.0 109.034 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 tp -85.89 115.48 23.54 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 105.907 -1.886 . . . . 25.0 105.907 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.3 m -118.08 160.63 21.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.391 -0.226 . . . . 25.0 110.391 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -131.18 132.2 44.56 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.137 0.494 . . . . 25.0 111.699 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tt -150.49 141.17 22.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.058 -0.974 . . . . 25.0 108.682 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 56.86 33.37 23.02 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.159 0.8 . . . . 25.0 113.159 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.1 10.75 81.49 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.731 -0.747 . . . . 25.0 113.686 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -118.45 162.76 17.8 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.37 149.48 41.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.466 -1.309 . . . . 25.0 107.466 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.64 -179.14 43.23 Favored Glycine 0 C--O 1.239 0.435 0 N-CA-C 110.97 -0.852 . . . . 25.0 110.97 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.14 146.14 7.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.345 0.593 . . . . 25.0 112.244 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -142.72 134.66 13.2 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.397 -0.819 . . . . 25.0 108.813 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.36 115.89 4.38 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 114.64 -3.107 . . . . 25.0 110.178 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.59 -17.01 66.29 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.277 0.471 . . . . 25.0 114.277 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -70.24 -4.13 20.34 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.415 -0.462 . . . . 25.0 111.661 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -104.69 10.28 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.226 -0.296 . . . . 25.0 110.629 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.4 153.27 40.62 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.88 0.326 . . . . 25.0 111.88 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.24 117.68 24.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.419 HD13 ' HB2' ' A' ' 10' ' ' ALA . 25.4 mm . . . . . 0 N--CA 1.476 0.825 0 C-N-CA 122.778 0.431 . . . . 25.0 111.359 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 114.849 1.425 . . . . 25.0 114.849 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t30 50.75 45.24 27.39 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.76 1.393 . . . . 25.0 114.76 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.65 147.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.169 -1.789 . . . . 25.0 106.169 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.66 162.84 13.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.566 0.698 . . . . 25.0 110.136 -174.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.47 138.7 29.44 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.394 -0.821 . . . . 25.0 109.92 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -95.28 134.99 37.44 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.648 -0.871 . . . . 25.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.25 134.59 42.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.247 0.546 . . . . 25.0 110.548 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.06 -30.56 15.96 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.646 . . . . 25.0 109.352 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -126.44 163.66 22.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.219 -1.4 . . . . 25.0 107.219 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.8 p-10 -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.665 -0.865 . . . . 25.0 108.665 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -151.46 129.87 12.11 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.697 0.629 . . . . 25.0 112.697 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -98.62 128.15 50.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.174 -2.899 . . . . 25.0 103.174 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.59 117.49 9.6 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.819 -0.808 . . . . 25.0 108.819 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -95.1 -13.34 25.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.536 0.684 . . . . 25.0 109.286 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 m -120.41 150.7 52.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.81 -20.43 26.14 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 117.636 -1.109 . . . . 25.0 114.487 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -82.13 -15.45 53.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.763 0.792 . . . . 25.0 109.801 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -84.05 147.18 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.48 -0.782 . . . . 25.0 110.517 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.432 HD22 ' H ' ' A' ' 55' ' ' GLY . 4.9 tp -97.92 132.52 43.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.95 0.405 . . . . 25.0 109.941 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -89.34 143.21 27.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.991 -1.115 . . . . 25.0 107.991 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 57' ' ' VAL . 38.8 p90 -160.93 170.17 21.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.151 -1.796 . . . . 25.0 106.151 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtm-85 -124.26 159.29 30.55 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.928 -0.483 . . . . 25.0 111.087 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 10.6 ptmm? -59.09 133.44 56.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.042 -0.725 . . . . 25.0 109.042 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.1 -11.39 72.07 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.57 -0.741 . . . . 25.0 113.635 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -80.93 161.31 24.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.37 134.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.965 -0.754 . . . . 25.0 108.965 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.0 ptp -130.61 158.71 39.27 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 m -97.86 125.43 42.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.241 -0.652 . . . . 25.0 109.241 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.5 t -82.62 127.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.478 -1.305 . . . . 25.0 107.478 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -102.34 -41.09 6.46 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 25.0 110.454 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -146.67 164.58 32.23 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.772 -1.196 . . . . 25.0 107.772 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -132.69 152.39 51.72 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.505 -1.294 . . . . 25.0 107.505 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 31.04 20.81 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 123.052 1.406 . . . . 25.0 108.42 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.1 t -70.5 -20.43 62.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 113.311 -1.768 . . . . 25.0 114.701 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -102.85 3.82 37.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.29 0.567 . . . . 25.0 109.873 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.51 85.81 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 109.052 -1.619 . . . . 25.0 109.052 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.0 mt -111.26 122.8 48.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.394 -1.706 . . . . 25.0 106.394 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.7 132.69 54.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.695 0.759 . . . . 25.0 110.08 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -1.11 89.22 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-O 118.767 -1.018 . . . . 25.0 115.506 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.359 1.58 . . . . 25.0 108.712 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -110.23 142.5 41.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.202 -0.311 . . . . 25.0 110.921 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.73 114.83 20.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.336 -2.098 . . . . 25.0 105.336 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -117.89 162.96 17.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -129.68 138.63 51.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.96 0.41 . . . . 25.0 110.265 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.66 140.19 15.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.586 -1.264 . . . . 25.0 107.586 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 55.65 29.27 13.34 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.422 1.267 . . . . 25.0 114.422 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.92 1.87 90.64 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.952 -0.642 . . . . 25.0 114.351 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -114.06 162.8 16.01 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -131.83 138.51 48.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.901 -1.518 . . . . 25.0 106.901 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -145.53 164.46 28.07 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.378 -1.089 . . . . 25.0 110.378 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.6 pt -81.63 145.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG13 ' CE1' ' A' ' 26' ' ' PHE . 76.8 t -141.62 135.29 14.62 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -176.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.13 113.32 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 115.765 -2.357 . . . . 25.0 111.641 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.1 -20.0 59.89 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 114.545 0.578 . . . . 25.0 114.545 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.22 -30.11 68.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.932 0.396 . . . . 25.0 111.373 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -89.53 8.82 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.213 0.449 . . . . 25.0 112.213 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.69 153.67 36.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.149 0.499 . . . . 25.0 112.298 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -125.09 117.58 24.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.198 -0.667 . . . . 25.0 109.198 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 123.179 0.592 . . . . 25.0 110.535 179.86 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 114.677 1.362 . . . . 25.0 114.677 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.9 t30 53.87 41.65 31.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.771 1.026 . . . . 25.0 113.771 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -120.12 151.98 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 105.901 -1.888 . . . . 25.0 105.901 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.73 151.97 37.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.128 0.489 . . . . 25.0 111.614 -174.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -133.63 148.62 51.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.54 -0.755 . . . . 25.0 112.465 -175.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.31 132.61 40.13 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 114.988 -1.005 . . . . 25.0 108.295 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.97 125.4 28.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.2 mt -91.64 -26.99 18.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 25.0 110.752 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -127.96 163.03 25.38 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.411 -1.329 . . . . 25.0 107.411 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.62 165.63 12.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.273 -0.639 . . . . 25.0 109.273 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -148.61 156.55 42.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.608 -0.516 . . . . 25.0 109.608 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.36 105.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.41 30.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.167 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -104.91 -12.31 16.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 25.0 111.753 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -122.39 149.83 55.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.984 -0.553 . . . . 25.0 110.511 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.89 -16.07 40.89 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 117.393 -1.271 . . . . 25.0 114.583 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -76.86 -19.64 57.24 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.77 0.795 . . . . 25.0 109.945 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -94.18 137.89 32.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.805 0.812 . . . . 25.0 110.49 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.62 131.48 35.21 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.83 -0.748 . . . . 25.0 111.276 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.7 t -78.72 109.98 13.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.16 162.46 35.43 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.461 -0.94 . . . . 25.0 108.461 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.47 167.49 20.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.879 . . . . 25.0 108.625 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -61.92 140.66 58.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.522 -0.547 . . . . 25.0 109.522 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.51 -15.0 62.43 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-O 118.792 -1.004 . . . . 25.0 113.272 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -73.07 155.74 39.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.505 1.152 . . . . 25.0 110.697 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.9 mm -122.38 126.14 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.371 -1.344 . . . . 25.0 107.371 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.4 ptp -135.97 154.92 50.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.18 0.192 . . . . 25.0 111.31 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 m -92.96 129.8 38.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.625 -0.879 . . . . 25.0 108.625 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.95 125.74 40.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.502 -1.295 . . . . 25.0 107.502 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.3 mt -94.74 -48.11 6.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.046 -0.524 . . . . 25.0 110.442 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.2 167.12 22.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.237 0.96 . . . . 25.0 109.11 -174.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -129.92 155.46 46.02 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 57.5 36.02 26.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 123.55 1.643 . . . . 25.0 107.914 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -70.17 -12.5 61.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.835 -1.529 . . . . 25.0 114.089 -171.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -110.46 4.79 20.83 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.42 0.628 . . . . 25.0 109.337 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 -20.29 11.17 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 109.431 -1.468 . . . . 25.0 109.431 -173.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 40' ' ' GLN . 91.7 mt -81.02 123.77 28.62 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.751 -1.574 . . . . 25.0 106.751 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.7 135.46 57.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.511 -0.922 . . . . 25.0 108.511 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.75 -3.65 83.24 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 115.878 1.111 . . . . 25.0 115.878 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -96.35 121.56 38.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.635 1.218 . . . . 25.0 108.078 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -111.87 143.99 41.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.728 -0.389 . . . . 25.0 110.55 -172.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -85.37 120.77 27.2 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.818 -2.29 . . . . 25.0 104.818 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.4 m -121.68 161.78 21.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.59 -0.522 . . . . 25.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -123.44 129.87 51.88 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.88 142.22 14.82 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.918 -1.142 . . . . 25.0 107.918 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 58.57 29.95 19.15 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.355 0.662 . . . . 25.0 112.662 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.0 7.77 88.25 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.766 -0.731 . . . . 25.0 114.706 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.9 164.9 25.88 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -124.43 153.7 41.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.51 -1.293 . . . . 25.0 107.51 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 169.4 42.4 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 110.441 -1.064 . . . . 25.0 110.441 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 pt -78.22 147.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 117.742 0.771 . . . . 25.0 111.995 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.92 135.42 13.49 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.749 -1.204 . . . . 25.0 107.749 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.15 116.57 4.56 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 115.844 -2.304 . . . . 25.0 111.489 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.88 -25.49 69.27 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 115.935 1.134 . . . . 25.0 115.935 -172.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -69.07 -12.4 61.65 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.874 -0.78 . . . . 25.0 112.043 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.58 5.77 50.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.356 -0.84 . . . . 25.0 110.252 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -116.94 154.8 30.22 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 122.61 0.364 . . . . 25.0 111.462 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -126.86 114.5 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.547 HD13 ' HB2' ' A' ' 10' ' ' ALA . 11.3 mm . . . . . 0 C--N 1.321 -0.649 0 N-CA-C 108.145 -1.058 . . . . 25.0 108.145 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.47 0.176 . . . . 25.0 111.182 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 57.48 22.38 7.97 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.547 0.943 . . . . 25.0 113.547 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -89.7 132.94 33.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -95.27 160.51 14.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.334 0.588 . . . . 25.0 109.747 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.09 150.75 34.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.616 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.79 133.5 39.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 25.0 109.649 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.42 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -76.95 134.13 38.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.391 0.615 . . . . 25.0 109.854 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.24 -21.55 19.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.524 -0.762 . . . . 25.0 110.152 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.88 159.88 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 25.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 17.3 p-10 -101.98 147.57 26.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -153.07 156.95 39.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.7 -0.682 . . . . 25.0 110.875 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -124.96 131.48 72.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 104.472 -2.418 . . . . 25.0 104.472 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 121.65 14.31 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.13 0.269 . . . . 25.0 110.406 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -94.6 -14.62 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.358 -0.978 . . . . 25.0 108.358 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.7 155.44 59.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.471 -0.786 . . . . 25.0 109.774 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.16 -19.86 25.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 117.31 -1.327 . . . . 25.0 113.753 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -15.57 49.1 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.618 0.723 . . . . 25.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.29 153.17 21.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 25.0 111.232 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.6 136.61 41.15 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.039 -0.413 . . . . 25.0 111.841 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.1 m -85.19 109.81 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 171.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -126.55 162.05 26.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.649 -0.871 . . . . 25.0 108.649 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 43.5 mtm105 -127.39 155.23 43.96 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.918 -0.488 . . . . 25.0 111.102 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.8 pttt -59.99 128.9 39.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 175.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.19 65.83 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.627 -0.715 . . . . 25.0 114.353 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.75 156.76 30.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.881 0.841 . . . . 25.0 109.872 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.16 130.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -135.28 160.6 37.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.584 -0.524 . . . . 25.0 109.584 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 33.4 m -101.85 127.15 48.79 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 25.0 109.824 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.93 125.53 40.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.7 mt -95.5 -41.57 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.607 -0.724 . . . . 25.0 110.237 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -148.23 164.17 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.324 -0.621 . . . . 25.0 109.324 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -135.11 151.88 51.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.494 -1.669 . . . . 25.0 106.494 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 59.39 34.45 22.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.175 1.464 . . . . 25.0 107.913 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -70.55 -16.54 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.829 -1.532 . . . . 25.0 112.613 -172.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -113.35 7.98 17.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 25.0 112.05 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.84 19.81 78.54 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 109.418 -1.473 . . . . 25.0 109.418 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.7 mt -130.05 114.86 16.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -65.7 149.93 49.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.68 -1.6 . . . . 25.0 106.68 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.86 -12.55 69.17 Favored Glycine 0 C--O 1.215 -1.07 0 CA-C-O 118.573 -1.126 . . . . 25.0 112.224 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -106.28 128.28 53.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.179 1.489 . . . . 25.0 110.337 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.16 142.34 50.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.77 -0.456 . . . . 25.0 109.77 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.2 tp -83.87 119.03 24.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.0 m -123.42 164.79 18.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.349 0.119 . . . . 25.0 111.209 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.7 p -121.94 124.13 43.34 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.032 0.444 . . . . 25.0 110.256 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 tp -162.17 164.64 27.75 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 106.076 -1.824 . . . . 25.0 106.076 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.19 17.63 7.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.789 1.403 . . . . 25.0 114.789 169.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.33 13.57 80.32 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.934 -0.65 . . . . 25.0 113.261 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.9 167.61 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.559 -0.534 . . . . 25.0 109.559 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -105.98 154.81 20.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 103.6 -2.741 . . . . 25.0 103.6 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.78 163.77 34.27 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 110.121 -1.192 . . . . 25.0 110.121 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 pt -79.61 141.93 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.877 0.846 . . . . 25.0 109.983 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.6 132.99 17.74 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.362 -1.347 . . . . 25.0 107.362 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.07 121.74 8.36 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 114.218 -3.388 . . . . 25.0 111.258 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.17 -19.07 69.86 Favored Glycine 0 C--O 1.22 -0.763 0 CA-C-N 115.801 -0.636 . . . . 25.0 112.121 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -69.73 -5.59 26.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.109 0.481 . . . . 25.0 111.378 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -114.4 11.43 17.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.748 -0.464 . . . . 25.0 109.748 175.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 12' ' ' ALA . 89.0 mt -120.57 150.09 41.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.275 0.56 . . . . 25.0 110.779 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -120.45 119.75 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.882 -0.599 . . . . 25.0 109.772 179.138 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 114.191 1.182 . . . . 25.0 114.191 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.7 t30 47.09 46.56 16.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.124 1.527 . . . . 25.0 115.124 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.7 m -111.25 169.5 4.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 104.483 -2.414 . . . . 25.0 104.483 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.41 164.38 29.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.42 28.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.496 -0.774 . . . . 25.0 109.75 -175.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.35 136.34 53.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.681 -1.229 . . . . 25.0 107.681 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 135.38 45.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.48 0.657 . . . . 25.0 109.727 177.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.01 -30.16 16.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.182 -0.917 . . . . 25.0 109.356 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.83 158.49 39.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 -177.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.1 p-10 -87.91 152.98 21.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.432 . . . . 25.0 110.08 177.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.76 87.25 1.41 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.16 121.55 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.59 51.64 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.379 0.424 . . . . 25.0 111.418 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.05 -18.18 12.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.361 -0.836 . . . . 25.0 110.184 175.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -104.93 150.79 39.1 Favored Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 109.613 -0.514 . . . . 25.0 109.613 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.62 -21.6 19.05 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 117.585 -1.144 . . . . 25.0 114.42 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.62 -14.95 56.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 25.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -89.15 140.61 29.29 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.91 . . . . 25.0 111.134 -176.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.87 124.74 34.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.674 -0.641 . . . . 25.0 111.147 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -80.45 121.22 25.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.544 -0.539 . . . . 25.0 109.544 174.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.503 ' CE1' HG13 ' A' ' 57' ' ' VAL . 52.7 p90 -143.26 168.56 19.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.306 -0.998 . . . . 25.0 108.306 178.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -129.28 164.82 22.69 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.973 -0.455 . . . . 25.0 111.23 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 34.9 pttt -62.03 134.27 56.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 25.0 109.729 -177.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.47 -13.38 67.45 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 115.524 -0.762 . . . . 25.0 113.407 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -75.87 157.64 33.05 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 117.419 0.609 . . . . 25.0 110.988 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.88 126.37 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.292 0.637 . . . . 25.0 111.042 -175.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -129.49 147.78 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.41 0.624 . . . . 25.0 111.43 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -87.97 130.25 35.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.24 124.13 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 177.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -99.59 -41.32 7.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.3 -0.864 . . . . 25.0 111.791 -174.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.06 160.41 42.43 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.88 -0.785 . . . . 25.0 108.88 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -128.36 154.58 45.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.899 -1.149 . . . . 25.0 107.899 176.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t0 55.67 40.57 30.92 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.547 1.642 . . . . 25.0 108.309 -175.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -70.86 -8.0 49.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.646 -1.616 . . . . 25.0 114.193 -171.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -135.86 12.49 3.39 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.811 0.671 . . . . 25.0 112.811 -175.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 15.96 74.41 Favored Glycine 0 N--CA 1.459 0.224 0 N-CA-C 110.692 -0.963 . . . . 25.0 110.692 -176.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.3 mt -122.52 110.68 15.88 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.479 -1.674 . . . . 25.0 106.479 176.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.9 144.07 57.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.559 -1.275 . . . . 25.0 107.559 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 -17.2 57.04 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 115.217 -0.902 . . . . 25.0 113.107 -177.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -94.33 128.2 40.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.96 1.38 . . . . 25.0 108.61 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -119.72 146.3 45.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 -174.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.2 tp -86.22 112.64 21.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.654 -1.61 . . . . 25.0 106.654 174.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -112.04 168.32 9.69 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.923 -0.399 . . . . 25.0 109.923 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -128.71 131.71 47.95 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.064 -1.088 . . . . 25.0 108.064 174.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -158.61 140.12 13.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 -176.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 56.43 33.2 22.05 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.547 0.689 . . . . 25.0 112.356 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.2 3.34 90.68 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 115.758 1.063 . . . . 25.0 115.758 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -127.85 161.48 28.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 118.503 1.152 . . . . 25.0 109.035 177.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -113.15 151.74 30.51 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 105.903 -1.888 . . . . 25.0 105.903 176.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.73 38.19 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.437 -1.065 . . . . 25.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -78.62 144.79 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.51 0.671 . . . . 25.0 109.217 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.503 HG13 ' CE1' ' A' ' 26' ' ' PHE . 46.3 t -140.55 134.12 15.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.314 -0.857 . . . . 25.0 109.106 -176.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.95 114.65 3.96 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 116.05 -2.167 . . . . 25.0 110.855 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.57 -18.28 63.4 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-N 116.066 -0.515 . . . . 25.0 113.07 -176.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.47 -31.13 67.52 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.53 0.332 . . . . 25.0 111.414 174.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -88.58 6.9 35.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.112 0.412 . . . . 25.0 112.112 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.9 mt -119.4 151.33 38.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.851 0.358 . . . . 25.0 111.818 -176.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -124.43 123.31 39.89 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.956 -0.757 . . . . 25.0 108.956 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.471 0.593 0 C-N-CA 123.284 0.633 . . . . 25.0 110.388 -177.84 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 120.257 0.075 . . . . 25.0 111.144 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.6 t30 48.55 47.35 20.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.352 1.241 . . . . 25.0 114.352 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 165.8 12.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 N-CA-C 105.334 -2.098 . . . . 25.0 105.334 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.23 159.64 39.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.524 -0.917 . . . . 25.0 108.524 -178.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.35 164.65 29.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.562 -0.744 . . . . 25.0 110.388 -172.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -114.81 135.15 54.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.75 -1.204 . . . . 25.0 107.75 175.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.99 124.49 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 25.0 110.7 178.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.42 -29.42 41.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.041 -0.527 . . . . 25.0 109.972 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -126.73 162.7 25.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.76 -0.83 . . . . 25.0 108.76 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.498 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 p-10 -98.29 160.38 14.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 175.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -144.14 175.0 10.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.462 0.648 . . . . 25.0 112.265 177.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.8 t -126.96 137.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 100.215 -3.994 . . . . 25.0 100.215 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.8 16.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.173 -1.047 . . . . 25.0 108.173 -178.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.64 -11.45 53.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.22 1.01 . . . . 25.0 109.354 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -138.33 152.52 71.57 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.02 -0.991 . . . . 25.0 109.088 -176.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.98 -15.78 29.25 Favored 'Trans proline' 0 C--N 1.35 0.608 0 N-CA-C 114.016 0.737 . . . . 25.0 114.016 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -84.35 -20.01 32.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.835 0.826 . . . . 25.0 109.621 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.56 135.73 35.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.662 -0.699 . . . . 25.0 110.199 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.95 138.46 36.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.108 -0.701 . . . . 25.0 109.108 177.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 p -90.03 131.74 35.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.194 -1.409 . . . . 25.0 107.194 172.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.39 169.02 22.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.716 -1.216 . . . . 25.0 107.716 -177.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -128.24 158.78 37.2 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 109.25 -0.648 . . . . 25.0 109.25 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.4 pttt -56.29 128.62 36.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 173.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.78 -20.84 42.5 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.944 -0.571 . . . . 25.0 113.868 -176.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -66.89 151.02 48.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.403 0.601 . . . . 25.0 109.989 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -115.42 128.38 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.541 -0.911 . . . . 25.0 108.541 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.5 148.61 50.58 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.455 0.645 . . . . 25.0 111.168 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 m -89.86 126.43 35.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.141 -1.429 . . . . 25.0 107.141 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.2 t -91.57 114.05 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.279 -1.748 . . . . 25.0 106.279 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.2 mt -88.77 -43.21 11.42 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.187 -0.915 . . . . 25.0 110.206 -176.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -145.72 161.19 40.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.499 -0.926 . . . . 25.0 108.499 -173.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -126.8 150.32 49.21 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.823 -1.547 . . . . 25.0 106.823 177.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 58.92 34.02 23.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.995 1.379 . . . . 25.0 108.267 177.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -69.61 -20.53 63.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.693 -1.594 . . . . 25.0 113.673 -169.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -102.46 6.22 39.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.701 -0.681 . . . . 25.0 110.144 -177.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 12.36 84.64 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 109.658 -1.377 . . . . 25.0 109.658 -173.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -113.36 121.02 43.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.783 -0.821 . . . . 25.0 108.783 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.4 128.51 37.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.54 0.686 . . . . 25.0 110.311 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.98 -0.92 84.63 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 115.766 1.066 . . . . 25.0 115.766 175.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -100.79 123.86 45.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.049 1.424 . . . . 25.0 109.237 177.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -113.3 143.02 45.14 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.251 -0.28 . . . . 25.0 111.133 -171.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.6 tp -81.99 112.98 19.57 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.661 -1.607 . . . . 25.0 106.661 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.3 m -114.11 159.05 20.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.901 0.382 . . . . 25.0 110.43 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -135.59 127.0 28.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.698 -0.683 . . . . 25.0 109.76 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.98 141.82 29.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.545 0.528 . . . . 25.0 110.889 176.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 48.08 38.57 9.87 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 178.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.61 89.82 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 115.019 0.768 . . . . 25.0 115.019 176.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -122.96 145.27 48.63 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.103 -0.703 . . . . 25.0 109.103 178.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -118.04 150.35 39.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.696 -0.853 . . . . 25.0 108.696 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.5 169.22 42.17 Favored Glycine 0 C--O 1.243 0.704 0 N-CA-C 109.789 -1.324 . . . . 25.0 109.789 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -82.27 146.89 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.504 0.652 . . . . 25.0 109.706 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.3 t -140.83 135.02 15.19 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 -177.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.06 119.76 6.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 115.323 -2.652 . . . . 25.0 110.776 174.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.63 -22.6 68.13 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 114.31 0.484 . . . . 25.0 114.31 -173.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.91 -26.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 122.524 -0.398 . . . . 25.0 111.932 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -85.71 6.62 26.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -118.98 146.69 44.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.47 0.544 . . . . 25.0 112.47 -175.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -118.2 121.77 41.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.497 -1.297 . . . . 25.0 107.497 170.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm . . . . . 0 C--O 1.24 0.56 0 O-C-N 123.982 0.801 . . . . 25.0 109.009 -179.805 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 115.35 1.611 . . . . 25.0 115.35 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.1 t30 51.77 41.69 29.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.402 1.63 . . . . 25.0 115.402 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 m -114.84 163.07 12.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 175.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 155.8 49.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.618 0.723 . . . . 25.0 111.839 -176.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.49 152.97 47.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.916 -1.038 . . . . 25.0 110.71 -173.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.41 139.23 37.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.708 -0.849 . . . . 25.0 108.708 174.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.98 130.34 41.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.419 -0.586 . . . . 25.0 109.419 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.31 -34.39 15.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -123.95 168.51 12.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.0 p-10 -103.77 158.77 16.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.054 0.454 . . . . 25.0 110.387 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -153.06 133.52 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 25.0 110.53 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.94 125.77 57.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 102.901 -2.999 . . . . 25.0 102.901 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.12 129.33 38.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -100.47 -9.69 21.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.688 1.232 . . . . 25.0 109.054 177.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 m -127.71 152.66 77.27 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.402 -1.272 . . . . 25.0 108.948 -177.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.46 -25.62 17.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 114.718 1.007 . . . . 25.0 114.718 -176.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.71 -19.44 60.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.51 0.672 . . . . 25.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -90.02 143.59 26.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.28 -0.873 . . . . 25.0 109.972 -175.06 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.37 137.11 33.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.222 -0.591 . . . . 25.0 111.428 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.0 m -85.6 128.02 34.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 106.32 -1.733 . . . . 25.0 106.32 171.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.451 ' CE2' HG13 ' A' ' 57' ' ' VAL . 48.3 p90 -149.43 156.69 42.42 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.67 152.78 41.66 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 119.962 -0.695 . . . . 25.0 110.009 179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.525 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.4 pttp -55.57 126.33 24.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.158 -178.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.39 -22.67 28.44 Favored Glycine 0 C--O 1.221 -0.662 0 CA-C-N 115.379 -0.828 . . . . 25.0 112.902 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -70.74 157.95 37.15 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.565 0.683 . . . . 25.0 112.044 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -118.03 126.61 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.334 0.653 . . . . 25.0 109.979 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.9 ptp -132.45 151.36 51.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.924 0.392 . . . . 25.0 111.131 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.2 m -92.79 128.11 38.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 25.0 107.808 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.17 124.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 178.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 mt -102.83 -33.14 9.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.665 0.617 . . . . 25.0 112.665 -176.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.84 162.01 41.13 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 124.247 0.967 . . . . 25.0 108.603 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -133.86 144.46 48.94 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 108.392 -0.966 . . . . 25.0 108.392 178.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.51 32.98 20.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.511 1.624 . . . . 25.0 107.521 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.41 -14.34 62.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.892 -1.958 . . . . 25.0 115.221 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -110.84 6.15 21.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.2 -6.88 73.99 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.578 -1.409 . . . . 25.0 109.578 -174.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.72 115.38 27.82 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.768 -0.827 . . . . 25.0 108.768 179.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -61.75 132.65 53.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.397 -0.964 . . . . 25.0 108.397 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.59 -0.49 67.92 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-O 118.908 -0.94 . . . . 25.0 114.497 176.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -106.11 124.23 49.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.663 1.231 . . . . 25.0 109.574 177.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -111.31 145.42 38.85 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 121.968 -0.457 . . . . 25.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.4 tp -85.02 114.56 22.27 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 105.547 -2.02 . . . . 25.0 105.547 175.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.1 m -119.92 157.05 29.59 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.842 -0.429 . . . . 25.0 109.842 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 p -123.74 130.58 52.86 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.954 -1.128 . . . . 25.0 107.954 177.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -151.79 137.72 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.787 -1.097 . . . . 25.0 108.618 -174.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.7 t60 55.48 33.99 22.13 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.819 1.044 . . . . 25.0 113.819 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.05 7.03 89.02 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.816 0.686 . . . . 25.0 114.816 177.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -128.42 163.82 24.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.735 -1.209 . . . . 25.0 107.735 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -124.98 157.99 34.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 173.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.26 172.61 45.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.463 -1.455 . . . . 25.0 109.463 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.2 pt -84.22 143.05 12.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-O 121.785 0.802 . . . . 25.0 109.653 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 26' ' ' PHE . 58.1 t -138.83 134.05 16.88 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.676 -1.231 . . . . 25.0 107.676 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.3 119.57 6.6 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 114.61 -3.126 . . . . 25.0 110.95 175.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -26.68 72.04 Favored Glycine 0 C--O 1.223 -0.576 0 CA-C-N 115.867 -0.606 . . . . 25.0 114.375 -173.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.33 -9.97 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.956 -0.732 . . . . 25.0 111.325 178.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -93.12 4.59 53.74 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.699 -0.626 . . . . 25.0 109.633 174.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.42 165.24 14.13 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.83 0.452 . . . . 25.0 111.032 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -137.31 118.18 14.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.929 -0.578 . . . . 25.0 109.991 173.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 107.639 -1.245 . . . . 25.0 107.639 178.752 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 C--O 1.224 -0.253 0 CA-C-O 120.227 0.061 . . . . 25.0 110.925 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 55.26 30.03 13.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.792 0.837 . . . . 25.0 110.518 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.96 162.74 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 104.06 -2.57 . . . . 25.0 104.06 -179.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.15 160.94 38.61 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.383 -0.969 . . . . 25.0 108.383 -177.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.71 159.32 44.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.668 -0.696 . . . . 25.0 110.77 -174.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.88 135.59 48.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 174.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.24 135.84 46.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.371 0.605 . . . . 25.0 109.794 178.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.31 -25.79 16.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.041 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -124.01 158.51 31.94 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.632 -1.247 . . . . 25.0 107.632 -178.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 13.4 p-10 -101.52 159.12 15.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -150.78 158.34 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.355 0.409 . . . . 25.0 111.068 -173.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.71 125.38 65.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 103.076 -2.935 . . . . 25.0 103.076 173.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.81 121.73 17.84 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.74 -0.384 . . . . 25.0 110.029 -176.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -101.65 -15.1 17.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.383 0.611 . . . . 25.0 109.385 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 t -111.62 147.55 37.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 25.0 109.352 175.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.39 -15.4 34.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 117.775 -1.016 . . . . 25.0 113.491 175.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.47 -15.49 56.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.756 0.789 . . . . 25.0 110.19 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -92.62 143.29 26.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.178 -0.919 . . . . 25.0 112.803 -172.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.62 137.57 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.861 -0.524 . . . . 25.0 110.493 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 117.41 23.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 172.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 164.66 32.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 36.9 ptt-85 -137.01 164.03 29.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.68 -0.408 . . . . 25.0 111.985 177.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.6 pttt -60.01 136.81 58.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.193 0.52 . . . . 25.0 110.358 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.36 -19.43 54.28 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.186 -0.915 . . . . 25.0 113.317 -178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -77.54 156.78 30.72 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 117.168 0.484 . . . . 25.0 110.412 -178.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.1 mm -115.18 130.5 69.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 123.332 0.653 . . . . 25.0 109.282 -174.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.9 ptp -138.94 151.83 47.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.949 0.404 . . . . 25.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 m -87.23 146.05 26.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.923 -1.51 . . . . 25.0 106.923 177.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.86 121.03 63.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 106.844 -1.539 . . . . 25.0 106.844 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.08 -49.44 8.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.596 . . . . 25.0 110.303 -177.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.55 170.84 19.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 -177.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -134.72 153.69 51.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.731 -0.176 . . . . 25.0 111.163 -175.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 60.46 38.75 19.01 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.298 1.523 . . . . 25.0 107.8 -177.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.45 -18.83 63.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.237 -1.802 . . . . 25.0 114.785 -167.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -111.4 6.38 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.497 0.665 . . . . 25.0 109.597 -177.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.53 -4.39 81.98 Favored Glycine 0 CA--C 1.518 0.241 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -174.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.4 127.02 35.49 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.274 -1.38 . . . . 25.0 107.274 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.53 132.41 52.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.297 0.57 . . . . 25.0 110.167 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.2 1.59 90.4 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 115.519 0.968 . . . . 25.0 115.519 174.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -100.94 115.41 30.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.143 1.472 . . . . 25.0 110.075 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -108.21 146.84 32.21 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.258 -0.276 . . . . 25.0 110.335 -172.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.1 tp -86.26 110.97 20.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.749 -1.575 . . . . 25.0 106.749 176.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -113.69 161.02 18.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.865 -0.42 . . . . 25.0 109.865 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.33 131.46 53.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.16 140.62 14.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 25.0 108.881 -177.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 56.96 35.06 25.88 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.074 1.138 . . . . 25.0 114.074 175.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.35 85.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.905 -0.664 . . . . 25.0 114.05 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.87 167.61 14.99 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -136.46 150.24 48.62 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.243 -1.762 . . . . 25.0 106.243 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.69 174.58 45.73 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 109.636 -1.386 . . . . 25.0 109.636 -176.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 pt -77.84 144.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.328 0.585 . . . . 25.0 110.437 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.0 t -144.26 136.19 13.04 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.34 112.05 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 116.009 -2.194 . . . . 25.0 111.662 174.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -24.86 73.29 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 115.902 -0.59 . . . . 25.0 113.941 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -70.44 -0.56 8.56 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 25.0 111.559 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -114.28 13.77 17.93 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.3 mt -118.75 155.19 31.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 25.0 109.928 178.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.81 117.76 27.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.179 -0.304 . . . . 25.0 110.179 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm . . . . . 0 C--O 1.24 0.558 0 O-C-N 123.773 0.671 . . . . 25.0 110.31 -179.285 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 114.69 1.367 . . . . 25.0 114.69 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t30 54.82 24.49 5.76 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.982 1.475 . . . . 25.0 114.982 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.81 174.16 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 N-CA-C 104.69 -2.337 . . . . 25.0 104.69 174.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.72 162.26 33.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.563 0.619 . . . . 25.0 109.961 -177.193 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.6 144.18 30.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.94 -0.573 . . . . 25.0 111.656 -177.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.24 135.09 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 25.0 109.837 176.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.04 131.05 40.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 25.0 110.062 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.41 -30.63 17.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 25.0 110.784 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -130.57 162.53 29.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.22 -1.771 . . . . 25.0 106.22 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.53 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.4 p-10 -96.83 160.37 14.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.977 0.353 . . . . 25.0 110.39 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -150.02 144.4 25.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.399 0.518 . . . . 25.0 112.399 -177.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 126.79 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.748 -2.315 . . . . 25.0 104.748 174.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.63 128.57 33.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 -178.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -97.2 -24.1 15.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -104.31 147.16 33.91 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.174 -0.676 . . . . 25.0 109.174 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.1 -14.81 35.47 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.118 -1.455 . . . . 25.0 113.932 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -81.89 -19.81 40.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.898 0.856 . . . . 25.0 110.289 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.07 144.6 25.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.496 -0.774 . . . . 25.0 109.526 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.69 132.92 44.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.189 0.519 . . . . 25.0 110.648 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t -88.86 145.16 25.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 175.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 57' ' ' VAL . 35.6 p90 -159.36 165.58 32.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 -178.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -120.71 154.06 36.1 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 121.836 -0.54 . . . . 25.0 109.774 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 22.4 pttp -58.5 134.02 56.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.17 -14.01 65.93 Favored Glycine 0 C--O 1.221 -0.699 0 CA-C-O 119.209 -0.773 . . . . 25.0 112.996 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.21 159.8 28.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.02 0.91 . . . . 25.0 109.398 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.78 131.47 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.6 ptp -130.89 155.26 47.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.185 0.594 . . . . 25.0 110.051 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.3 m -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.825 -1.176 . . . . 25.0 107.825 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.7 125.63 54.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.757 -1.201 . . . . 25.0 107.757 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.0 mt -102.34 -36.59 8.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.554 -0.748 . . . . 25.0 111.876 -174.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.82 161.28 42.56 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.434 -1.321 . . . . 25.0 107.434 -178.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -129.41 150.25 50.85 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.553 -1.277 . . . . 25.0 107.553 177.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 59.09 35.64 23.9 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.287 1.617 . . . . 25.0 106.961 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.53 -10.48 59.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 112.546 -2.116 . . . . 25.0 115.923 -163.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -126.48 13.96 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.448 0.642 . . . . 25.0 109.611 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.58 -5.38 78.33 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 109.802 -1.319 . . . . 25.0 109.802 -175.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.18 115.59 26.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.041 -1.096 . . . . 25.0 108.041 178.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.33 130.83 48.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.793 0.806 . . . . 25.0 109.806 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 2.22 85.81 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-O 118.62 -1.1 . . . . 25.0 115.316 176.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -102.67 128.3 49.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.224 1.512 . . . . 25.0 108.442 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -117.1 144.43 44.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 25.0 109.647 -174.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.7 tp -84.34 117.38 23.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 175.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.92 158.08 27.44 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.34 129.93 52.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 177.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.08 137.76 19.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.509 -0.768 . . . . 25.0 109.173 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 54.99 30.94 15.06 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 176.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.33 13.02 82.45 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.138 -0.554 . . . . 25.0 113.991 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.37 165.3 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.243 -1.762 . . . . 25.0 106.243 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -137.23 140.61 41.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 118.471 0.578 . . . . 25.0 109.721 175.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.46 164.48 29.4 Favored Glycine 0 C--O 1.238 0.374 0 O-C-N 124.039 0.837 . . . . 25.0 111.574 -176.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.21 143.81 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.947 -1.131 . . . . 25.0 107.947 174.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG13 ' CE1' ' A' ' 26' ' ' PHE . 53.5 t -140.26 135.63 16.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 -175.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.58 116.99 4.8 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 115.21 -2.727 . . . . 25.0 110.385 174.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.05 -16.85 71.18 Favored Glycine 0 CA--C 1.508 -0.397 0 CA-C-N 116.163 -0.471 . . . . 25.0 112.948 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.49 -4.29 18.19 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.61 -0.347 . . . . 25.0 111.008 175.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -109.89 10.67 24.39 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.414 -0.179 . . . . 25.0 111.049 175.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.82 157.04 33.31 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.623 0.601 . . . . 25.0 112.623 -176.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -127.18 117.55 22.58 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.661 -0.866 . . . . 25.0 108.661 174.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.6 mm . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.614 0.245 . . . . 25.0 110.382 -177.963 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.98 1.104 . . . . 25.0 113.98 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 56.12 34.28 23.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.927 0.891 . . . . 25.0 112.67 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.87 135.49 39.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 104.153 -2.536 . . . . 25.0 104.153 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.75 161.47 29.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.991 0.814 . . . . 25.0 109.75 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.62 153.86 33.11 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.486 0.66 . . . . 25.0 112.768 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -91.64 134.58 34.57 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.167 -0.924 . . . . 25.0 109.962 176.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.97 127.56 32.98 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 108.33 -0.989 . . . . 25.0 108.33 173.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -87.03 -27.73 23.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.93 0.871 . . . . 25.0 109.602 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -124.97 160.0 29.94 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.926 -1.034 . . . . 25.0 108.972 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -98.76 158.22 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.586 -1.635 . . . . 25.0 106.586 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -142.91 159.84 41.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 112.703 0.631 . . . . 25.0 112.703 -174.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.63 119.77 55.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 102.535 -3.135 . . . . 25.0 102.535 172.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.07 113.25 13.39 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.354 -0.539 . . . . 25.0 109.593 -177.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -82.48 -15.52 52.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.937 0.875 . . . . 25.0 109.221 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.3 m -122.21 156.28 60.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.746 -0.661 . . . . 25.0 109.323 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.39 -14.13 22.77 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 117.548 -1.168 . . . . 25.0 112.739 175.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -84.85 -16.57 40.85 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.804 1.288 . . . . 25.0 110.962 178.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -91.59 140.93 29.25 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.32 134.32 34.11 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.675 0.75 . . . . 25.0 112.573 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -86.91 106.05 17.5 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.313 -0.858 . . . . 25.0 109.101 177.226 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -128.79 165.12 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.565 -0.709 . . . . 25.0 112.595 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 mtt85 -122.69 156.7 33.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.507 -0.183 . . . . 25.0 110.507 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -62.18 134.38 56.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 178.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.38 -11.54 68.73 Favored Glycine 0 C--O 1.214 -1.148 0 CA-C-N 115.484 -0.78 . . . . 25.0 112.559 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.16 159.82 32.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.342 1.071 . . . . 25.0 109.361 177.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.55 124.17 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.017 -0.734 . . . . 25.0 109.017 -176.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.6 ptp -131.86 152.35 51.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.26 0.837 . . . . 25.0 113.26 -176.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 m -92.83 131.24 38.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.22 -0.445 . . . . 25.0 110.223 -177.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.84 126.78 43.57 Favored 'Isoleucine or valine' 0 C--O 1.257 1.5 0 N-CA-C 108.104 -1.073 . . . . 25.0 108.104 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.8 mt -102.98 -38.75 7.21 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 114.735 -1.12 . . . . 25.0 111.889 -177.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -143.39 160.99 39.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.827 -1.078 . . . . 25.0 108.215 -176.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 -131.77 145.3 51.52 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.059 -1.83 . . . . 25.0 106.059 174.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 63.59 37.68 10.12 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 123.858 1.79 . . . . 25.0 108.305 -176.081 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -69.39 -19.63 63.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.03 -1.895 . . . . 25.0 116.054 -172.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -119.55 10.51 11.81 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.013 0.911 . . . . 25.0 108.82 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.23 79.64 Favored Glycine 0 CA--C 1.511 -0.16 0 CA-C-N 115.397 -0.819 . . . . 25.0 111.242 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.89 139.1 31.07 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 106.675 -1.602 . . . . 25.0 106.675 176.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.58 150.31 48.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.175 0.988 . . . . 25.0 110.404 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.4 -3.69 38.94 Favored Glycine 0 C--O 1.207 -1.572 0 O-C-N 120.873 -1.142 . . . . 25.0 115.329 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -99.73 131.04 45.97 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 118.967 1.384 . . . . 25.0 110.298 -179.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -125.82 142.34 51.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.97 -0.292 . . . . 25.0 111.389 -172.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp -82.77 120.73 26.0 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 106.618 -1.623 . . . . 25.0 106.618 176.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.46 164.13 15.72 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.386 0.275 . . . . 25.0 110.393 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 89.8 p -120.32 127.05 51.99 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.353 -0.61 . . . . 25.0 109.353 175.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 tp -153.1 146.24 24.68 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 -179.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.7 t60 60.92 10.86 2.97 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.406 1.261 . . . . 25.0 114.406 178.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 10.21 62.1 Favored Glycine 0 C--O 1.22 -0.761 0 C-N-CA 120.429 -0.891 . . . . 25.0 112.17 -179.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -124.39 165.76 17.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 178.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -118.82 156.88 28.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.026 -2.213 . . . . 25.0 105.026 172.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.72 162.87 31.55 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.879 -0.676 . . . . 25.0 111.865 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -77.02 141.97 14.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 122.313 1.054 . . . . 25.0 108.806 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.23 136.85 17.26 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.434 -1.257 . . . . 25.0 110.228 178.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.37 115.63 4.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 117.564 -1.157 . . . . 25.0 111.338 178.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.85 -25.46 70.63 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 115.996 -0.547 . . . . 25.0 113.576 -174.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -64.77 -22.85 67.07 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.899 0.849 . . . . 25.0 111.551 178.04 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -91.59 10.42 28.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.413 -0.358 . . . . 25.0 111.463 -178.073 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.9 144.87 45.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.528 0.68 . . . . 25.0 111.987 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -112.64 113.28 25.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 121.96 -0.463 . . . . 25.0 110.649 178.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mm . . . . . 0 C--O 1.214 -0.785 0 C-N-CA 123.063 0.545 . . . . 25.0 109.812 -174.645 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.347 0.117 . . . . 25.0 110.959 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 49.95 39.19 18.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.581 0.956 . . . . 25.0 113.581 176.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.55 141.56 32.18 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 -178.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.88 154.48 18.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.749 0.785 . . . . 25.0 111.879 -174.009 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.16 46.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.829 -1.078 . . . . 25.0 109.866 -179.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -97.02 134.62 40.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.024 -1.102 . . . . 25.0 108.024 175.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.85 136.79 45.4 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.638 0.732 . . . . 25.0 110.088 176.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.7 mt -94.61 -34.32 12.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 25.0 109.169 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -125.4 164.85 19.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.405 -1.702 . . . . 25.0 106.405 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.17 165.39 13.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.851 -0.796 . . . . 25.0 108.851 174.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.09 110.53 3.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.6 . . . . 25.0 109.787 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.57 131.87 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 174.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.92 15.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.478 -1.305 . . . . 25.0 107.478 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -96.84 -6.75 35.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.323 1.058 . . . . 25.0 108.296 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -132.31 149.58 73.56 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.194 -1.41 . . . . 25.0 107.194 178.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.38 -24.51 19.34 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 116.038 -2.175 . . . . 25.0 115.068 -174.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.62 -15.62 58.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.752 0.787 . . . . 25.0 110.617 -179.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -81.02 141.36 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.361 -1.348 . . . . 25.0 107.361 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.08 130.2 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.726 -0.609 . . . . 25.0 110.124 178.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.38 116.34 21.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.87 -1.159 . . . . 25.0 107.87 174.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.546 ' CE1' HG13 ' A' ' 57' ' ' VAL . 52.1 p90 -141.34 165.88 26.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.484 -0.562 . . . . 25.0 109.484 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.69 155.21 46.26 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.938 0.399 . . . . 25.0 111.921 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.5 129.84 37.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.981 -0.554 . . . . 25.0 110.594 176.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -21.74 44.32 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.435 -179.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -72.16 160.99 31.52 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 117.34 0.57 . . . . 25.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.7 mm -119.65 128.67 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.888 -0.782 . . . . 25.0 108.888 -176.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -135.87 148.45 48.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.068 0.461 . . . . 25.0 110.237 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -87.07 128.77 35.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.463 -0.94 . . . . 25.0 108.463 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.3 t -89.01 124.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.755 -1.572 . . . . 25.0 106.755 175.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.12 -45.29 7.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.624 -0.716 . . . . 25.0 110.247 -179.223 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.27 164.63 34.29 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.488 -0.56 . . . . 25.0 109.488 -175.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -129.88 152.66 49.12 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.402 -0.592 . . . . 25.0 109.402 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t0 56.53 39.43 29.91 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 123.608 1.67 . . . . 25.0 107.414 -175.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -70.48 -12.93 61.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.401 -1.727 . . . . 25.0 114.179 -169.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.05 9.85 5.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 25.0 111.472 -176.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.39 14.49 78.46 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 108.951 -1.66 . . . . 25.0 108.951 -174.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.92 111.25 23.82 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 177.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -63.78 141.75 58.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.814 -0.81 . . . . 25.0 108.814 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.04 -14.75 31.0 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-O 119.273 -0.737 . . . . 25.0 114.846 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -94.01 136.44 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.794 1.297 . . . . 25.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -121.83 146.14 47.37 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.232 -0.655 . . . . 25.0 109.232 -175.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -84.91 116.05 23.12 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.486 -1.672 . . . . 25.0 106.486 175.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.1 m -117.41 164.73 14.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.581 -0.526 . . . . 25.0 109.581 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -125.59 127.66 46.7 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.7 tp -161.11 152.36 18.87 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 -177.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.1 t60 58.95 28.23 17.33 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.64 0.733 . . . . 25.0 112.109 177.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.74 2.12 85.1 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 115.023 0.769 . . . . 25.0 115.023 178.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -133.86 164.21 27.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 117.866 0.833 . . . . 25.0 110.656 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -101.71 158.93 15.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.618 -1.623 . . . . 25.0 106.618 176.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 162.66 33.11 Favored Glycine 0 C--O 1.24 0.496 0 N-CA-C 109.872 -1.291 . . . . 25.0 109.872 178.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -81.88 145.7 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.514 0.673 . . . . 25.0 109.643 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.546 HG13 ' CE1' ' A' ' 26' ' ' PHE . 40.5 t -139.31 134.83 16.76 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 25.0 108.809 -176.841 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.22 109.19 2.15 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.079 -1.481 . . . . 25.0 110.696 172.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.15 61.84 Favored Glycine 0 C--O 1.22 -0.723 0 N-CA-C 115.394 0.918 . . . . 25.0 115.394 -172.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -16.99 64.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.874 -0.78 . . . . 25.0 111.464 177.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.53 3.83 51.2 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.908 -0.495 . . . . 25.0 111.002 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.436 HD11 HG11 ' A' ' 57' ' ' VAL . 80.1 mt -118.51 157.59 26.99 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.613 0.365 . . . . 25.0 110.321 -178.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -127.49 117.82 22.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.381 -0.97 . . . . 25.0 108.381 171.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.0 mm . . . . . 0 C--N 1.32 -0.683 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 177.926 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.549 0.214 . . . . 25.0 111.141 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 55.31 26.7 8.92 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.904 0.882 . . . . 25.0 113.214 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.73 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 N-CA-C 105.798 -1.927 . . . . 25.0 105.798 177.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.24 159.63 37.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.279 -0.419 . . . . 25.0 109.973 -178.662 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -95.42 133.86 38.91 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.108 -0.701 . . . . 25.0 109.108 178.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 132.18 42.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.199 0.523 . . . . 25.0 110.686 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.8 -32.8 15.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.65 162.18 18.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.073 -0.967 . . . . 25.0 108.825 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.34 148.99 22.19 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.339 -2.097 . . . . 25.0 105.339 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -148.28 130.51 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 25.0 111.672 -172.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.46 132.26 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 102.833 -3.025 . . . . 25.0 102.833 172.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.13 126.33 28.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.96 -0.755 . . . . 25.0 108.96 -178.709 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.33 -7.07 32.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.9 155.68 80.19 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.316 -0.856 . . . . 25.0 109.171 178.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.38 -24.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 116.994 -1.537 . . . . 25.0 113.591 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.76 -15.55 51.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.222 -0.444 . . . . 25.0 110.143 -178.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.74 147.06 29.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.602 0.715 . . . . 25.0 110.894 -178.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.89 134.24 36.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.102 -0.499 . . . . 25.0 110.224 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -84.62 142.84 29.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.758 -1.571 . . . . 25.0 106.758 172.027 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.472 ' CE2' HG13 ' A' ' 57' ' ' VAL . 36.5 p90 -158.24 166.35 32.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -126.14 155.5 41.59 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.942 -0.474 . . . . 25.0 110.653 -178.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.04 135.3 56.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.119 -0.697 . . . . 25.0 109.119 -179.027 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.68 -9.97 76.09 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.153 -0.804 . . . . 25.0 114.711 -178.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -81.42 162.98 23.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.966 0.883 . . . . 25.0 108.71 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.54 131.48 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.659 -0.867 . . . . 25.0 108.659 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.6 ptp -129.48 152.21 49.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.002 -178.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 m -82.31 131.64 35.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.217 -1.031 . . . . 25.0 108.217 178.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.4 t -100.03 121.07 50.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.658 -1.608 . . . . 25.0 106.658 176.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.5 mt -91.28 -52.36 4.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.724 -0.671 . . . . 25.0 110.689 -176.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -146.43 170.55 16.61 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 -177.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -128.27 157.04 42.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.154 -1.795 . . . . 25.0 106.154 -179.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.6 t0 62.17 35.56 15.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 123.397 1.57 . . . . 25.0 108.759 177.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -70.98 -12.59 61.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.476 -1.693 . . . . 25.0 112.349 -176.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -118.9 5.81 11.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.347 0.499 . . . . 25.0 112.347 -175.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.52 11.14 82.4 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.555 -1.418 . . . . 25.0 109.555 -174.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.65 114.91 16.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.301 -1.741 . . . . 25.0 106.301 176.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.95 156.88 31.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.82 -1.548 . . . . 25.0 106.82 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.56 -15.4 62.07 Favored Glycine 0 C--O 1.218 -0.848 0 N-CA-C 108.186 -1.966 . . . . 25.0 108.186 -173.054 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.91 126.41 52.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 173.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -119.79 143.07 48.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -177.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.8 tp -82.97 107.86 15.87 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.377 -1.712 . . . . 25.0 106.377 177.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.7 m -108.65 163.81 12.92 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.371 -0.604 . . . . 25.0 109.371 179.383 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 48.5 t -130.1 129.67 43.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 175.109 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 tp -161.39 155.05 21.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 -175.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 58.8 23.83 11.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.438 0.903 . . . . 25.0 113.438 174.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.76 4.21 88.99 Favored Glycine 0 C--O 1.202 -1.904 0 N-CA-C 115.602 1.001 . . . . 25.0 115.602 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -129.36 166.16 20.07 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.372 1.069 . . . . 25.0 108.136 -178.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 21.7 pt20 -118.44 158.2 25.76 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.986 -1.857 . . . . 25.0 105.986 169.011 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.67 167.37 39.95 Favored Glycine 0 CA--C 1.507 -0.435 0 N-CA-C 110.747 -0.941 . . . . 25.0 110.747 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 pt -75.86 145.56 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.291 -1.374 . . . . 25.0 107.291 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 26' ' ' PHE . 40.9 t -140.26 133.6 15.09 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 -179.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.12 108.4 1.95 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 116.374 -1.951 . . . . 25.0 110.246 172.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.18 -18.62 58.15 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-N 115.565 -0.743 . . . . 25.0 114.112 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -65.19 -18.48 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.59 -0.359 . . . . 25.0 111.062 176.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -90.47 4.51 50.85 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.969 -0.457 . . . . 25.0 111.736 176.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.422 HD11 HG11 ' A' ' 57' ' ' VAL . 59.9 mt -122.85 157.23 32.94 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.628 0.603 . . . . 25.0 112.628 -173.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -125.08 117.78 24.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.88 -0.785 . . . . 25.0 108.88 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 116.105 -0.498 . . . . 25.0 112.171 -174.75 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 115.186 1.55 . . . . 25.0 115.186 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 t30 49.91 42.35 24.14 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.1 p -116.4 161.95 14.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 103.685 -2.709 . . . . 25.0 103.685 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.52 156.93 45.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.179 0.899 . . . . 25.0 109.714 -177.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.85 151.78 43.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.654 -0.703 . . . . 25.0 110.4 -174.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -97.63 133.33 42.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 174.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.74 137.06 43.75 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.417 0.627 . . . . 25.0 109.378 176.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.29 -26.66 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.458 -0.792 . . . . 25.0 109.541 178.203 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -127.26 159.47 34.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 -178.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -100.06 163.5 12.4 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.29 0.636 . . . . 25.0 109.481 178.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.21 160.29 43.92 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.311 -0.996 . . . . 25.0 108.311 -178.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.15 133.42 68.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 102.391 -3.188 . . . . 25.0 102.391 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.94 143.47 27.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.96 -0.385 . . . . 25.0 109.96 -175.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -122.34 -23.97 5.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.553 0.533 . . . . 25.0 110.662 173.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.3 m -85.46 147.22 46.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 176.574 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -71.63 -20.36 26.85 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.968 -1.555 . . . . 25.0 113.718 -178.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -86.15 -4.5 59.18 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.763 0.425 . . . . 25.0 111.099 179.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.91 143.08 28.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.927 0.491 . . . . 25.0 111.128 -175.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mt -96.49 133.5 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.82 -0.55 . . . . 25.0 111.611 177.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.2 t -88.75 85.06 6.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.446 ' CE1' HG13 ' A' ' 57' ' ' VAL . 47.7 p90 -96.46 160.33 14.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.347 -0.612 . . . . 25.0 109.347 -179.063 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -129.56 152.87 48.61 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 122.202 -0.311 . . . . 25.0 110.742 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -60.11 136.25 57.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 25.0 109.813 178.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.35 -27.54 13.33 Favored Glycine 0 C--N 1.321 -0.286 0 CA-C-N 115.418 -0.81 . . . . 25.0 113.053 -178.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -73.57 162.53 29.13 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.075 0.437 . . . . 25.0 111.048 -178.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.67 129.54 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 122.91 0.484 . . . . 25.0 110.227 -174.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -132.24 146.22 51.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.088 0.471 . . . . 25.0 110.937 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.0 m -85.19 132.0 34.35 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.77 126.79 51.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -101.83 -50.7 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 25.0 111.1 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -136.3 170.45 16.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.34 0.656 . . . . 25.0 110.097 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -133.25 155.49 49.27 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.447 -1.686 . . . . 25.0 106.447 174.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.6 t0 56.89 41.95 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.133 1.444 . . . . 25.0 109.213 -177.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 t -76.29 4.58 8.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.235 -1.348 . . . . 25.0 113.507 -174.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -139.49 -0.68 1.75 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.956 0.724 . . . . 25.0 112.956 -177.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.32 -2.61 87.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 108.383 -1.887 . . . . 25.0 108.383 -170.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.7 mt -96.02 110.09 22.38 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.734 -1.951 . . . . 25.0 105.734 174.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.89 150.11 47.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.672 -1.233 . . . . 25.0 107.672 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.97 -16.12 44.29 Favored Glycine 0 C--O 1.222 -0.63 0 CA-C-O 119.089 -0.839 . . . . 25.0 113.337 -178.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -93.37 133.84 36.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.831 1.316 . . . . 25.0 108.877 177.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -118.94 146.28 45.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.195 -0.669 . . . . 25.0 109.195 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -84.07 113.97 21.41 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 106.052 -1.833 . . . . 25.0 106.052 176.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.5 m -116.9 166.22 12.42 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.977 -0.379 . . . . 25.0 109.977 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -129.28 132.22 47.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.795 -0.446 . . . . 25.0 109.795 175.127 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -150.95 137.57 18.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.414 -0.958 . . . . 25.0 108.414 -176.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 54.53 32.69 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.776 1.028 . . . . 25.0 113.776 177.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -0.54 89.24 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 114.825 0.69 . . . . 25.0 114.825 177.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -111.81 162.76 14.93 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.906 -1.146 . . . . 25.0 107.906 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -117.25 155.5 29.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.298 -2.482 . . . . 25.0 104.298 170.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.77 164.98 34.31 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.4 -0.68 . . . . 25.0 111.4 179.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -80.41 142.63 13.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.615 0.721 . . . . 25.0 110.239 -177.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.446 HG13 ' CE1' ' A' ' 26' ' ' PHE . 77.7 t -140.43 133.08 14.63 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.235 -1.024 . . . . 25.0 108.235 -177.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 115.046 -2.836 . . . . 25.0 110.449 174.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.72 -20.49 68.29 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 115.033 0.773 . . . . 25.0 115.033 -173.109 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.03 -8.44 49.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.369 0.584 . . . . 25.0 111.705 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -98.46 6.45 47.2 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.091 -0.381 . . . . 25.0 110.609 175.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.94 143.95 45.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.939 0.4 . . . . 25.0 111.487 -176.071 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -111.16 117.64 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.709 -1.589 . . . . 25.0 106.709 173.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 ' H ' ' A' ' 64' ' ' ILE . 4.0 mp . . . . . 0 C--O 1.242 0.71 0 CA-C-N 116.19 -0.459 . . . . 25.0 111.039 -177.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 119.841 -0.123 . . . . 25.0 110.958 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.0 t30 55.53 42.2 29.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.215 0.531 . . . . 25.0 111.934 178.018 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.92 172.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.998 -1.853 . . . . 25.0 105.998 176.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 162.53 34.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.423 0.63 . . . . 25.0 110.956 -177.304 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.69 150.09 36.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.016 -0.993 . . . . 25.0 110.42 -178.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -99.53 136.67 39.12 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.595 -0.891 . . . . 25.0 108.595 176.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.33 46.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.982 0.42 . . . . 25.0 109.995 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.98 -24.98 14.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.721 -0.672 . . . . 25.0 110.372 178.428 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -123.69 158.27 31.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.795 -1.928 . . . . 25.0 105.795 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.512 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.4 p-10 -103.02 144.33 31.42 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 175.399 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -148.9 122.29 9.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.375 -0.375 . . . . 25.0 110.421 -175.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.91 130.5 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 175.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.91 8.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.945 0.402 . . . . 25.0 111.477 -175.564 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -89.39 -11.54 42.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.435 0.636 . . . . 25.0 109.807 176.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 m -122.86 146.31 47.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -23.11 27.83 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 117.388 -1.275 . . . . 25.0 114.873 -174.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -77.66 -20.52 53.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.15 0.5 . . . . 25.0 110.567 -178.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.42 152.35 25.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.211 -1.033 . . . . 25.0 108.211 178.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 139.76 32.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.929 0.395 . . . . 25.0 111.093 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -84.66 126.56 33.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 172.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.18 163.98 37.6 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -129.78 154.23 47.43 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.762 -0.586 . . . . 25.0 109.943 176.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.512 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 53.3 pttt -56.97 135.12 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.379 0.609 . . . . 25.0 110.198 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.02 -25.66 27.43 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.127 -0.942 . . . . 25.0 112.669 -175.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -72.65 155.89 39.54 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.117 0.458 . . . . 25.0 110.33 -179.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.4 mm -117.06 129.02 74.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.375 0.67 . . . . 25.0 109.67 -175.552 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -130.89 149.61 52.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.579 0.705 . . . . 25.0 110.525 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.3 m -84.88 128.28 34.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.541 -0.911 . . . . 25.0 108.541 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.64 123.47 46.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.066 -1.457 . . . . 25.0 107.066 177.098 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.39 -42.94 9.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.6 -0.727 . . . . 25.0 111.787 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -156.31 171.31 20.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.123 -1.066 . . . . 25.0 108.123 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -134.21 157.13 47.05 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 107.287 -1.375 . . . . 25.0 107.287 -178.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t0 60.11 38.47 20.39 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 123.341 1.543 . . . . 25.0 107.691 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -70.51 -12.27 61.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.578 -1.646 . . . . 25.0 114.055 -171.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.16 13.88 6.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.836 0.31 . . . . 25.0 111.836 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.99 18.89 79.23 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.365 -1.094 . . . . 25.0 110.365 -176.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.44 114.84 22.93 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 178.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -62.18 144.32 55.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.124 0.964 . . . . 25.0 109.453 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 -16.16 40.89 Favored Glycine 0 C--O 1.217 -0.926 0 CA-C-O 118.876 -0.958 . . . . 25.0 114.112 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -89.58 131.12 35.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.325 1.563 . . . . 25.0 109.94 178.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -120.53 146.19 46.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.976 -0.749 . . . . 25.0 108.976 -175.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.1 tp -86.43 115.35 23.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.457 -1.683 . . . . 25.0 106.457 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -112.75 158.47 20.05 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 -178.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -124.99 126.24 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 178.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -159.23 148.42 18.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.316 -1.364 . . . . 25.0 107.316 -174.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 58.24 25.84 13.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.734 0.778 . . . . 25.0 112.494 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.68 88.98 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 114.834 0.693 . . . . 25.0 114.834 176.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -136.16 162.73 32.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 117.773 0.786 . . . . 25.0 110.636 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -96.08 160.61 14.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.242 -1.021 . . . . 25.0 108.242 175.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.75 161.97 34.91 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.917 -1.673 . . . . 25.0 108.917 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 pt -81.77 143.86 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.13 133.95 13.38 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.46 114.39 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 116.524 -1.85 . . . . 25.0 111.033 175.088 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.02 -21.79 66.12 Favored Glycine 0 C--O 1.223 -0.584 0 N-CA-C 116.165 1.226 . . . . 25.0 116.165 -173.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -67.54 -16.88 64.43 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.879 . . . . 25.0 110.542 177.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -93.1 9.33 36.33 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.451 -0.156 . . . . 25.0 110.83 177.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -121.34 154.69 36.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.168 0.509 . . . . 25.0 110.852 -178.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -119.07 116.28 26.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.086 -1.079 . . . . 25.0 108.086 175.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 175.972 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 114.604 1.335 . . . . 25.0 114.604 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.3 t30 49.91 42.32 24.08 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.574 2.064 . . . . 25.0 116.574 175.466 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -118.05 164.68 14.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 N-CA-C 105.227 -2.138 . . . . 25.0 105.227 170.357 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.57 157.86 42.51 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.681 0.753 . . . . 25.0 109.611 -173.767 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.37 162.59 32.61 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.423 -0.808 . . . . 25.0 110.119 -172.727 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.2 134.99 47.38 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.515 -1.291 . . . . 25.0 107.515 178.095 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 120.04 19.77 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.856 -1.164 . . . . 25.0 107.856 173.85 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.56 -16.86 31.49 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.946 -0.39 . . . . 25.0 109.946 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -138.75 169.25 18.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.156 -1.424 . . . . 25.0 107.156 -176.7 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -104.01 164.97 11.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.824 0.449 . . . . 25.0 111.958 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -156.31 156.73 34.5 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.435 0.694 . . . . 25.0 111.38 175.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -125.55 129.55 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.919 -2.623 . . . . 25.0 103.919 171.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.27 130.6 41.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.739 0.644 . . . . 25.0 112.739 -177.365 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -100.57 -41.53 6.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.59 -1.633 . . . . 25.0 106.59 175.685 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -85.33 147.97 48.6 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.51 -15.2 27.74 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 119.123 0.722 . . . . 25.0 113.346 175.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 -18.64 49.73 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 121.404 0.621 . . . . 25.0 110.504 177.938 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -87.5 154.08 20.92 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.643 1.211 . . . . 25.0 110.28 -173.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.81 136.92 42.58 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 120.691 -1.256 . . . . 25.0 110.551 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.28 125.13 31.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.119 -2.549 . . . . 25.0 104.119 169.176 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -137.72 159.33 42.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 177.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -124.49 152.12 43.77 Favored 'General case' 0 CA--C 1.491 -1.314 0 O-C-N 121.701 -0.624 . . . . 25.0 112.345 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -57.02 123.08 13.93 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.187 -0.915 . . . . 25.0 111.558 178.146 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -12.76 49.99 Favored Glycine 0 C--O 1.236 0.227 0 CA-C-O 118.944 -0.92 . . . . 25.0 113.859 179.908 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.65 160.13 25.13 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.253 0.62 . . . . 25.0 111.946 -176.382 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.14 136.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.385 0.674 . . . . 25.0 109.311 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -144.86 151.6 38.99 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.518 -0.739 . . . . 25.0 111.078 179.374 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -82.57 132.25 35.2 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.566 -0.288 . . . . 25.0 110.833 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.3 t -88.81 122.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 174.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.6 mt -92.67 -51.28 5.18 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.184 0.516 . . . . 25.0 110.402 -176.648 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -137.15 163.82 29.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.868 -1.901 . . . . 25.0 105.868 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -131.35 148.45 52.67 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.85 38.94 30.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.205 1.566 . . . . 25.0 108.133 -177.749 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -67.76 -13.45 62.13 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.012 -1.904 . . . . 25.0 115.359 -175.157 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.78 0.01 20.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.95 -0.389 . . . . 25.0 109.95 -179.248 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.77 77.72 Favored Glycine 0 CA--C 1.511 -0.196 0 N-CA-C 109.263 -1.535 . . . . 25.0 109.263 -174.524 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.39 116.72 29.07 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 106.53 -1.656 . . . . 25.0 106.53 177.045 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.67 138.77 58.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 178.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 0.74 72.36 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.43 -1.206 . . . . 25.0 113.54 178.616 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -109.59 115.92 30.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.733 1.766 . . . . 25.0 111.21 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -109.5 144.65 37.48 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.348 -0.845 . . . . 25.0 112.093 -173.535 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.5 tp -82.56 122.27 27.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.649 -1.982 . . . . 25.0 105.649 175.563 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.2 m -120.07 161.49 20.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 177.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.3 t -125.88 133.78 51.81 Favored 'General case' 0 C--O 1.256 1.425 0 C-N-CA 123.476 0.711 . . . . 25.0 109.729 177.258 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -160.88 138.52 9.36 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.888 -1.051 . . . . 25.0 108.884 -177.004 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 t60 58.24 34.9 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.525 0.679 . . . . 25.0 112.675 176.939 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.55 2.34 63.61 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 121.245 -0.502 . . . . 25.0 113.85 177.442 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -115.06 160.29 19.81 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.237 -2.135 . . . . 25.0 105.237 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -137.35 143.41 42.0 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 103.007 -2.96 . . . . 25.0 103.007 175.457 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 174.67 43.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.831 -1.308 . . . . 25.0 109.831 -174.501 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -83.12 140.44 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.675 0.75 . . . . 25.0 112.066 -172.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.4 131.3 15.07 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.044 -1.435 . . . . 25.0 108.843 -176.731 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.13 119.14 6.16 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 114.813 -2.992 . . . . 25.0 112.873 175.316 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.42 -16.84 69.89 Favored Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 119.466 -0.63 . . . . 25.0 114.175 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.82 -15.35 63.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 120.553 -0.459 . . . . 25.0 110.374 174.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -101.42 8.79 42.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.942 0.349 . . . . 25.0 111.942 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 mt -117.66 149.23 41.07 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.284 1.04 . . . . 25.0 111.818 -173.055 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -120.32 120.66 36.66 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.583 -1.266 . . . . 25.0 107.583 174.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 C--O 1.247 0.972 0 O-C-N 123.656 0.598 . . . . 25.0 109.848 -179.952 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 114.932 1.456 . . . . 25.0 114.932 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 t30 51.66 40.38 27.22 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.103 1.149 . . . . 25.0 114.103 -178.476 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.72 172.54 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 105.563 -2.014 . . . . 25.0 105.563 177.08 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.7 156.69 48.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.705 0.684 . . . . 25.0 110.162 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.29 158.6 43.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.21 -0.904 . . . . 25.0 111.059 -173.633 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.8 134.65 48.57 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.367 -0.975 . . . . 25.0 108.367 175.231 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.77 130.29 39.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.742 -0.466 . . . . 25.0 109.742 178.026 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.35 -26.29 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.946 -0.57 . . . . 25.0 109.571 179.306 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -126.28 162.55 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 -179.399 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 25.3 p-10 -103.89 151.21 23.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.864 -0.421 . . . . 25.0 109.864 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -144.58 126.88 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.155 -0.475 . . . . 25.0 110.885 -176.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.7 t -92.04 126.99 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 102.983 -2.969 . . . . 25.0 102.983 174.277 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.46 114.85 5.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 -179.084 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -99.05 -10.97 21.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.724 0.773 . . . . 25.0 108.981 179.18 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 t -116.03 146.72 37.7 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 106.873 -1.528 . . . . 25.0 106.873 172.708 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.68 -18.71 32.47 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 115.819 -2.321 . . . . 25.0 113.618 177.328 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -79.96 -15.71 56.7 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.039 0.923 . . . . 25.0 110.348 179.304 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -86.38 142.68 28.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.653 -0.703 . . . . 25.0 110.19 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 134.25 34.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.741 -0.466 . . . . 25.0 109.741 178.25 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.39 118.67 25.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 175.343 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.445 ' CE2' HG13 ' A' ' 57' ' ' VAL . 53.9 p90 -143.91 164.57 30.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -178.481 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -131.58 157.1 44.52 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 121.254 0.55 . . . . 25.0 112.056 179.58 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.542 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.0 pttt -56.69 131.67 49.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.468 -0.787 . . . . 25.0 108.987 179.191 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.07 -25.7 25.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.692 -0.686 . . . . 25.0 113.321 -176.651 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.17 161.85 30.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.216 0.508 . . . . 25.0 111.826 -176.456 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.12 131.17 73.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.241 -1.022 . . . . 25.0 108.241 -177.427 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -139.81 154.02 47.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.058 -0.349 . . . . 25.0 110.058 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -87.79 131.02 34.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.583 -1.265 . . . . 25.0 107.583 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.9 t -95.48 116.27 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.327 -2.101 . . . . 25.0 105.327 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.45 -45.66 10.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.4 -0.818 . . . . 25.0 109.636 -176.475 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -146.09 169.47 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.96 -0.756 . . . . 25.0 108.96 -177.458 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -129.58 156.03 44.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.16 33.9 23.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.147 1.451 . . . . 25.0 109.286 174.629 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.8 t -70.53 -19.01 62.94 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.594 1.701 . . . . 25.0 115.594 -168.005 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -101.26 2.59 40.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.135 0.493 . . . . 25.0 110.362 -175.61 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.34 -2.36 87.25 Favored Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.003 -1.639 . . . . 25.0 109.003 -172.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -100.83 119.37 38.56 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 176.78 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -60.17 136.12 57.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.507 0.67 . . . . 25.0 109.218 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.3 -2.35 86.57 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 115.693 1.037 . . . . 25.0 115.693 177.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -99.94 116.91 33.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.312 1.556 . . . . 25.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -107.05 148.13 29.12 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.094 -0.379 . . . . 25.0 110.806 -171.644 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.0 tp -87.93 113.45 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.765 -1.569 . . . . 25.0 106.765 176.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.14 160.28 21.28 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.2 -0.2 . . . . 25.0 110.749 179.707 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -119.9 128.93 54.08 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.263 0.554 . . . . 25.0 109.594 175.344 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 tp -162.29 152.83 17.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.114 -1.81 . . . . 25.0 106.114 -177.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 58.57 27.75 16.12 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.459 0.647 . . . . 25.0 112.737 177.009 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.5 16.66 77.54 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.803 -0.713 . . . . 25.0 114.11 178.347 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.52 21.99 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.836 -0.802 . . . . 25.0 108.836 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -109.3 156.92 19.39 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.141 -2.17 . . . . 25.0 105.141 173.232 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.5 37.47 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 108.87 -1.692 . . . . 25.0 108.87 177.53 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.3 pt -78.83 145.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.504 0.669 . . . . 25.0 109.255 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.445 HG13 ' CE2' ' A' ' 26' ' ' PHE . 55.2 t -140.39 134.2 15.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 -178.491 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 106.49 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 117.261 -1.36 . . . . 25.0 110.559 174.258 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.21 69.83 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 116.176 1.23 . . . . 25.0 116.176 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -69.92 -8.44 48.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.534 0.667 . . . . 25.0 111.373 178.364 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -93.68 6.28 48.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.03 -0.419 . . . . 25.0 110.451 175.492 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.3 mt -119.15 155.2 32.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.633 -0.506 . . . . 25.0 109.633 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -122.34 121.57 37.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.128 -0.323 . . . . 25.0 110.128 171.347 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.6 mm . . . . . 0 C--O 1.245 0.855 0 C-N-CA 123.278 0.631 . . . . 25.0 109.884 177.924 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 113.045 0.757 . . . . 25.0 113.045 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.57 48.47 16.93 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.777 1.028 . . . . 25.0 113.777 -179.123 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 m -112.79 172.7 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 103.469 -2.789 . . . . 25.0 103.469 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 155.42 50.23 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.61 0.719 . . . . 25.0 110.944 -177.822 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.71 153.08 44.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.781 -1.1 . . . . 25.0 110.901 -175.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -95.52 133.59 39.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 176.828 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.59 123.99 24.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.047 -0.723 . . . . 25.0 109.047 171.37 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.89 -25.98 21.84 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 108.946 -0.761 . . . . 25.0 108.946 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.27 166.51 20.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 -178.478 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.95 159.18 15.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.581 0.229 . . . . 25.0 110.71 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -151.49 143.61 23.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.989 -0.551 . . . . 25.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -117.41 126.17 74.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 102.591 -3.114 . . . . 25.0 102.591 174.219 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 127.92 34.07 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.812 0.339 . . . . 25.0 111.2 -174.352 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -97.84 -6.14 33.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.066 0.936 . . . . 25.0 109.193 179.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -141.55 153.15 65.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.773 . . . . 25.0 108.949 -177.082 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.13 -22.83 46.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 116.99 -1.54 . . . . 25.0 112.869 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -73.76 -19.75 60.69 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.482 0.489 . . . . 25.0 110.512 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -95.3 153.08 17.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.963 0.411 . . . . 25.0 111.939 -172.297 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.52 138.33 36.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.699 1.0 . . . . 25.0 113.699 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -87.02 136.87 32.77 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.838 -1.542 . . . . 25.0 106.838 172.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -160.81 162.35 32.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -129.19 158.34 39.29 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.387 -0.821 . . . . 25.0 111.319 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -53.77 131.97 40.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.18 -0.918 . . . . 25.0 109.951 178.725 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.01 -23.18 36.83 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.618 -0.719 . . . . 25.0 113.166 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.68 157.19 38.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.115 0.957 . . . . 25.0 110.791 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -120.79 131.02 73.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 -176.039 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -131.47 152.21 50.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.065 0.46 . . . . 25.0 111.332 178.186 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 m -84.76 132.02 34.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 25.0 107.972 177.293 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.9 t -96.03 123.05 48.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 106.282 -1.747 . . . . 25.0 106.282 176.093 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -93.42 -39.79 10.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.561 -0.745 . . . . 25.0 110.823 -174.2 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -159.81 171.92 18.6 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.608 -0.886 . . . . 25.0 108.608 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -120.92 160.98 22.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.97 -1.122 . . . . 25.0 107.97 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.3 42.73 22.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.34 1.067 . . . . 25.0 110.837 179.204 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -68.72 -22.02 64.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.491 -176.767 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' C ' ' H ' ' A' ' 42' ' ' LEU . 2.3 tp60 -97.83 1.02 47.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 25.0 110.133 179.603 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 -20.13 8.13 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.159 -1.176 . . . . 25.0 110.159 -172.542 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 40' ' ' GLN . 95.8 mt -78.19 133.49 37.76 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.993 -1.854 . . . . 25.0 105.993 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.72 153.9 42.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.727 0.775 . . . . 25.0 110.702 -177.075 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.5 -19.65 4.7 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 115.557 0.983 . . . . 25.0 115.557 177.095 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -84.33 107.12 16.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.715 1.258 . . . . 25.0 111.291 -179.404 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -96.81 147.31 24.07 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.061 -0.348 . . . . 25.0 110.061 -176.007 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.1 tp -85.72 117.3 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.765 -1.939 . . . . 25.0 105.765 172.916 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 63.9 m -120.28 163.24 18.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.387 -0.597 . . . . 25.0 109.387 179.294 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -124.51 125.82 44.84 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.037 0.535 . . . . 25.0 111.774 -179.658 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.69 153.09 18.61 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 106.946 -1.501 . . . . 25.0 106.946 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 59.06 36.3 24.21 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.825 0.821 . . . . 25.0 110.912 178.575 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 14.32 59.3 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 115.518 0.967 . . . . 25.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -142.36 163.86 31.71 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 118.002 0.901 . . . . 25.0 109.195 177.591 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.85 154.73 26.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 173.987 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.13 169.56 41.51 Favored Glycine 0 C--O 1.248 0.971 0 N-CA-C 108.416 -1.873 . . . . 25.0 108.416 -177.684 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.03 143.08 13.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 117.217 0.508 . . . . 25.0 110.441 -177.764 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -140.07 131.53 14.4 Favored Pre-proline 0 C--O 1.242 0.681 0 C-N-CA 123.765 0.826 . . . . 25.0 108.833 178.583 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.09 119.4 6.33 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 115.29 -2.673 . . . . 25.0 111.156 177.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.55 -25.74 61.28 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 114.893 0.717 . . . . 25.0 114.893 -175.77 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.5 -21.3 66.25 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.865 0.364 . . . . 25.0 111.747 178.395 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.35 3.57 53.33 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.66 -0.65 . . . . 25.0 112.257 178.157 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.51 154.98 30.53 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.99 0.424 . . . . 25.0 112.031 -177.31 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -123.17 117.95 26.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.533 -0.303 . . . . 25.0 110.366 171.442 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 C--N 1.321 -0.634 0 O-C-N 123.88 0.738 . . . . 25.0 109.697 179.468 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 112.983 0.734 . . . . 25.0 112.983 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.4 m120 45.59 48.32 11.22 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.227 1.011 . . . . 25.0 113.471 178.014 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.96 151.92 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 106.605 -1.628 . . . . 25.0 106.605 179.449 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 162.43 13.41 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.137 0.494 . . . . 25.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.06 154.05 42.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.285 -0.87 . . . . 25.0 111.373 172.085 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -107.66 133.72 51.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.167 0.987 . . . . 25.0 109.628 -179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 134.95 45.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 124.525 1.141 . . . . 25.0 111.359 175.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.51 -34.06 12.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.832 0.825 . . . . 25.0 109.918 177.323 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.86 165.24 14.86 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 106.642 -1.614 . . . . 25.0 106.642 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.494 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.8 p-10 -103.48 155.85 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.992 0.36 . . . . 25.0 111.93 177.588 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.56 98.48 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.705 0.802 . . . . 25.0 108.953 -177.867 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -78.52 140.06 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 172.42 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.43 140.9 54.14 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 123.488 0.715 . . . . 25.0 112.395 -173.062 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -110.74 -9.72 14.49 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 114.333 -1.303 . . . . 25.0 110.864 174.93 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -131.44 158.64 74.73 Favored Pre-proline 0 N--CA 1.475 0.81 0 O-C-N 121.248 -0.907 . . . . 25.0 110.707 -178.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -71.14 -21.98 26.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 116.69 -1.74 . . . . 25.0 113.995 -179.699 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -16.14 59.49 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 124.297 0.998 . . . . 25.0 109.491 -179.732 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -98.0 150.64 21.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 122.121 0.962 . . . . 25.0 110.28 -168.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.04 133.86 42.7 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.595 -0.691 . . . . 25.0 112.039 178.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.66 104.18 15.82 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.363 -0.606 . . . . 25.0 109.363 179.217 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.447 ' CE2' HG13 ' A' ' 57' ' ' VAL . 52.5 p90 -134.46 162.57 31.86 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.888 -0.782 . . . . 25.0 108.888 -178.709 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -126.84 162.47 25.82 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.946 -0.761 . . . . 25.0 108.946 -179.169 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.494 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 19.8 ptpt -56.01 139.86 45.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 178.233 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.11 -14.2 59.62 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 115.611 1.005 . . . . 25.0 115.611 177.943 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.69 163.85 27.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.268 -1.012 . . . . 25.0 108.268 176.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.17 131.12 73.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -178.705 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.7 ptp -130.85 155.49 46.63 Favored 'General case' 0 C--O 1.251 1.158 0 O-C-N 121.627 -0.671 . . . . 25.0 111.604 176.268 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -90.65 135.92 33.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.761 -1.94 . . . . 25.0 105.761 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -96.68 126.69 49.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.148 -1.427 . . . . 25.0 107.148 176.743 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 mt -97.7 -42.85 7.43 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.298 -0.865 . . . . 25.0 110.961 -176.569 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -143.21 161.63 37.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.313 -1.366 . . . . 25.0 107.313 -178.555 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -128.16 144.38 51.11 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.843 -0.799 . . . . 25.0 108.843 173.241 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 59.03 43.15 18.04 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.427 -1.323 . . . . 25.0 107.427 -177.739 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -68.99 -15.11 63.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.722 1.749 . . . . 25.0 115.722 -172.335 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.79 16.63 13.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 122.409 1.1 . . . . 25.0 109.157 178.252 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.98 -21.91 7.4 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.31 -0.859 . . . . 25.0 112.052 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.96 119.15 12.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.905 -0.569 . . . . 25.0 109.819 176.361 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -56.34 132.64 51.51 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.711 0.767 . . . . 25.0 110.132 178.826 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.02 89.66 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.722 -1.043 . . . . 25.0 115.239 175.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -96.35 102.19 13.94 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.718 1.759 . . . . 25.0 110.804 179.155 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -91.71 140.35 29.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.549 -0.75 . . . . 25.0 111.917 -172.848 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.21 115.52 21.98 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.405 -1.702 . . . . 25.0 106.405 174.213 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.4 m -112.0 166.87 10.84 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 25.0 110.39 -179.702 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -135.5 125.82 26.51 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.767 -0.457 . . . . 25.0 109.767 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tt -152.34 138.86 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.123 -0.944 . . . . 25.0 108.839 -174.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 53.82 38.51 28.76 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 113.557 0.947 . . . . 25.0 113.557 176.527 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.66 -0.51 85.74 Favored Glycine 0 C--O 1.217 -0.965 0 CA-C-O 118.467 -1.185 . . . . 25.0 115.765 175.773 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -126.07 164.53 20.68 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 118.849 1.324 . . . . 25.0 108.193 178.417 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -113.29 164.15 13.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.101 -1.444 . . . . 25.0 107.101 176.574 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.07 162.55 31.55 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.765 -0.934 . . . . 25.0 110.765 174.581 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 pt -79.38 142.32 14.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 175.698 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.447 HG13 ' CE2' ' A' ' 26' ' ' PHE . 82.6 t -139.64 133.65 15.79 Favored Pre-proline 0 C--N 1.311 -1.078 0 C-N-CA 123.407 0.683 . . . . 25.0 109.525 -175.363 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.2 114.79 3.17 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 116.471 -1.886 . . . . 25.0 112.161 175.937 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.66 -16.58 72.14 Favored Glycine 0 C--O 1.21 -1.352 0 C-N-CA 119.567 -1.301 . . . . 25.0 115.133 -173.552 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.8 -16.01 62.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.518 1.159 . . . . 25.0 111.722 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -94.65 8.48 42.24 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.594 -0.73 . . . . 25.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.08 157.06 29.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.118 0.961 . . . . 25.0 109.92 -177.047 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.05 122.31 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.346 -0.843 . . . . 25.0 108.758 174.382 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.7 mm . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -179.839 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 C--O 1.204 -1.311 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.0 t30 53.12 42.33 32.18 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 113.521 0.934 . . . . 25.0 113.521 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -112.44 147.17 16.37 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.718 0 N-CA-C 105.188 -2.153 . . . . 25.0 105.188 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.65 155.38 46.68 Favored 'General case' 0 C--O 1.267 2.024 0 CA-C-N 119.611 1.096 . . . . 25.0 112.521 177.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.5 161.72 36.8 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.897 -1.047 . . . . 25.0 111.021 -170.166 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -110.68 132.27 54.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.378 0.671 . . . . 25.0 110.574 177.261 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.66 127.52 33.32 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.544 0.688 . . . . 25.0 110.247 178.126 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.0 mt -93.44 -23.91 18.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 -179.255 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -126.4 165.36 19.19 Favored 'General case' 0 C--O 1.202 -1.432 0 N-CA-C 109.866 -0.42 . . . . 25.0 109.866 178.162 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -100.77 160.85 14.02 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.725 0.81 . . . . 25.0 109.742 178.274 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -148.2 135.79 20.7 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 113.158 0.799 . . . . 25.0 113.158 -177.731 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -94.89 119.81 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 168.159 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.68 116.93 12.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 -177.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.11 -21.28 29.35 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.714 1.245 . . . . 25.0 111.798 -178.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -133.44 154.13 80.75 Favored Pre-proline 0 C--O 1.215 -0.751 0 CA-C-N 115.477 -0.783 . . . . 25.0 109.948 -170.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.48 -21.54 60.13 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 116.22 1.585 . . . . 25.0 116.22 -178.981 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.24 -19.89 45.8 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.058 0.932 . . . . 25.0 110.273 176.425 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -81.87 140.33 34.18 Favored 'General case' 0 C--O 1.195 -1.771 0 O-C-N 121.022 -1.049 . . . . 25.0 112.246 -176.344 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.02 135.99 33.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 123.566 1.65 . . . . 25.0 110.627 177.725 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.28 110.17 18.88 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.801 -1.545 . . . . 25.0 108.192 176.212 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 57' ' ' VAL . 53.8 p90 -135.87 166.39 23.41 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.405 0.621 . . . . 25.0 112.424 -176.282 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -128.4 152.79 47.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 -179.203 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -62.27 139.64 58.5 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.828 -1.175 . . . . 25.0 107.828 175.413 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -22.51 40.58 Favored Glycine 0 C--O 1.264 2.02 0 CA-C-O 117.843 -1.531 . . . . 25.0 110.284 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.19 166.17 23.06 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 119.468 1.634 . . . . 25.0 109.977 -176.616 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -121.71 132.24 71.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 114.781 -1.099 . . . . 25.0 110.253 -174.519 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.6 ptp -139.96 155.53 47.09 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 124.028 0.83 . . . . 25.0 112.071 -178.602 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -93.41 138.68 31.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 -179.406 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -103.02 119.22 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 106.787 -1.56 . . . . 25.0 106.787 177.744 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.9 mt -93.87 -41.04 9.84 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.341 -1.3 . . . . 25.0 111.555 -174.166 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -149.27 159.19 44.48 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 104.978 -2.23 . . . . 25.0 104.978 -177.479 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -130.73 149.11 52.53 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 101.496 -3.52 . . . . 25.0 101.496 178.795 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 t0 62.86 34.55 14.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.997 0.919 . . . . 25.0 108.583 -177.464 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -66.24 -20.63 66.17 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.363 1.616 . . . . 25.0 115.363 -177.387 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -5.97 21.76 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.239 -0.891 . . . . 25.0 112.292 -177.391 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.9 -6.47 83.44 Favored Glycine 0 N--CA 1.464 0.52 0 CA-C-O 122.597 1.11 . . . . 25.0 111.48 -170.388 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.1 mt -94.14 118.69 31.91 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 106.912 -1.514 . . . . 25.0 106.912 177.584 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -56.83 126.68 28.04 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 106.997 -1.483 . . . . 25.0 106.997 171.831 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.0 64.37 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-O 116.634 -2.203 . . . . 25.0 115.302 178.25 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -104.52 125.81 51.03 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 120.772 2.286 . . . . 25.0 110.025 171.235 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -116.61 148.68 40.72 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.438 -1.319 . . . . 25.0 107.438 -176.054 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.3 tp -92.33 113.35 25.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.847 -1.538 . . . . 25.0 106.847 178.276 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.2 m -121.94 157.1 31.98 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.47 0.652 . . . . 25.0 110.121 -177.539 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -118.64 133.43 55.86 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.063 0.945 . . . . 25.0 110.097 173.279 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.2 138.93 19.75 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 124.625 1.203 . . . . 25.0 109.45 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t60 57.86 29.35 17.4 Favored 'General case' 0 C--O 1.183 -2.428 0 O-C-N 124.218 0.949 . . . . 25.0 110.727 173.287 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.76 -2.24 74.76 Favored Glycine 0 N--CA 1.473 1.159 0 C-N-CA 118.922 -1.609 . . . . 25.0 113.443 -179.31 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -107.12 167.4 9.93 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.081 -1.822 . . . . 25.0 106.081 -179.919 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -141.34 144.5 34.59 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 103.493 -2.78 . . . . 25.0 103.493 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -177.85 47.53 Favored Glycine 0 CA--C 1.545 1.96 0 O-C-N 125.394 1.684 . . . . 25.0 110.208 179.291 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.06 143.08 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.29 0.545 . . . . 25.0 111.042 -174.331 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 26' ' ' PHE . 79.3 t -139.08 136.21 18.03 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 -172.16 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.66 112.42 3.05 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 CA-C-O 122.819 1.091 . . . . 25.0 111.828 172.594 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -26.26 63.42 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-N 115.407 -0.815 . . . . 25.0 115.038 -179.313 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -68.89 -15.3 63.46 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.678 0.739 . . . . 25.0 109.913 179.622 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -92.18 3.46 55.29 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 120.655 -0.418 . . . . 25.0 110.896 175.505 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -117.33 157.13 26.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.002 0.521 . . . . 25.0 111.127 -177.188 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -124.02 129.08 50.31 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.082 -1.451 . . . . 25.0 107.082 172.795 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.1 mm . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 104.484 -2.413 . . . . 25.0 104.484 -179.762 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 114.275 1.213 . . . . 25.0 114.275 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.4 t30 45.81 47.36 12.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.32 0.648 . . . . 25.0 112.258 -178.073 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.97 165.35 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 105.751 -1.944 . . . . 25.0 105.751 165.673 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.32 156.2 45.24 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 115.507 -0.769 . . . . 25.0 109.518 -177.139 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.55 162.47 35.0 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 123.896 0.878 . . . . 25.0 110.894 -175.211 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -101.45 133.57 45.89 Favored 'General case' 0 C--O 1.206 -1.23 0 O-C-N 124.185 0.928 . . . . 25.0 108.631 172.246 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 130.5 39.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 105.616 -1.994 . . . . 25.0 105.616 174.731 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.32 -16.54 22.32 Favored 'General case' 0 C--O 1.264 1.82 0 O-C-N 121.439 -0.788 . . . . 25.0 110.44 -178.72 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -135.85 164.78 27.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.383 -1.339 . . . . 25.0 107.383 -178.847 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -100.5 161.01 13.88 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 109.036 -0.727 . . . . 25.0 109.036 -175.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -147.97 136.24 21.38 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 123.863 1.792 . . . . 25.0 111.922 178.731 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.85 122.38 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.8 -1.187 . . . . 25.0 108.719 169.72 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.27 115.41 22.45 Favored 'General case' 0 CA--C 1.565 1.558 0 O-C-N 124.041 0.838 . . . . 25.0 109.386 -177.657 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.54 -20.63 14.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.272 -0.876 . . . . 25.0 111.309 177.049 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -96.22 151.45 38.18 Favored Pre-proline 0 C--O 1.207 -1.14 0 CA-C-N 115.36 -0.836 . . . . 25.0 110.165 177.291 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.95 -19.66 13.74 Favored 'Trans proline' 0 C--O 1.205 -1.129 0 C-N-CA 117.184 -1.41 . . . . 25.0 113.241 -179.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -86.08 -20.57 28.55 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.122 1.439 . . . . 25.0 109.838 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -77.5 143.95 38.08 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.947 1.092 . . . . 25.0 113.947 178.151 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.86 137.51 32.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.94 1.352 . . . . 25.0 112.522 176.231 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 p -82.06 125.09 30.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.486 -1.233 . . . . 25.0 109.653 171.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -150.96 172.75 15.2 Favored 'General case' 0 C--O 1.191 -2.002 0 CA-C-O 121.588 0.709 . . . . 25.0 112.449 175.676 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -134.19 163.72 28.97 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.716 -1.587 . . . . 25.0 106.716 -178.436 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -63.98 141.0 58.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.292 -1.373 . . . . 25.0 107.292 174.836 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.59 -15.36 51.79 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 117.302 1.681 . . . . 25.0 117.302 -177.01 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.5 156.81 34.78 Favored 'General case' 0 C--O 1.263 1.765 0 C-N-CA 120.522 -0.471 . . . . 25.0 110.652 173.648 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.96 130.02 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 107.553 -1.277 . . . . 25.0 107.553 -176.547 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.9 150.65 48.36 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 121.026 -1.046 . . . . 25.0 110.853 179.85 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 m -81.62 138.87 35.29 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.046 -0.979 . . . . 25.0 109.585 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.93 122.3 59.36 Favored 'Isoleucine or valine' 0 C--O 1.254 1.314 0 N-CA-C 105.759 -1.941 . . . . 25.0 105.759 178.274 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.52 -36.91 12.19 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 124.329 1.018 . . . . 25.0 113.14 -177.709 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -155.79 149.08 24.68 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 -174.515 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.13 147.87 36.47 Favored 'General case' 0 C--O 1.197 -1.669 0 CA-C-O 117.086 -1.435 . . . . 25.0 107.677 -178.645 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 55.81 44.08 26.63 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 125.252 1.595 . . . . 25.0 109.104 179.104 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -72.38 -12.92 61.33 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 116.269 1.952 . . . . 25.0 116.269 -173.7 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -115.39 3.12 14.09 Favored 'General case' 0 C--O 1.256 1.439 0 CA-C-O 121.748 0.785 . . . . 25.0 109.693 -174.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.41 -15.77 59.25 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.05 -1.432 . . . . 25.0 109.925 -178.401 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.34 127.07 32.87 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.462 1.331 . . . . 25.0 111.111 176.336 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.06 129.05 38.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.849 1.309 . . . . 25.0 109.776 -177.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.63 10.16 73.7 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 174.882 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -107.77 103.3 12.54 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 123.778 1.751 . . . . 25.0 113.019 171.346 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -97.86 152.98 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.729 -1.232 . . . . 25.0 110.744 -174.527 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.54 119.93 29.46 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.541 1.15 . . . . 25.0 108.004 174.144 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -122.09 162.58 20.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.347 -0.983 . . . . 25.0 108.347 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.1 t -127.04 133.74 50.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.637 -1.245 . . . . 25.0 107.637 174.591 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 tp -154.89 136.69 14.46 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.752 1.283 . . . . 25.0 110.287 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 59.39 31.76 21.32 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-N 114.428 -1.26 . . . . 25.0 109.771 179.249 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.67 4.69 85.44 Favored Glycine 0 CA--C 1.545 1.937 0 C-N-CA 119.816 -1.183 . . . . 25.0 113.568 -179.775 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.7 mtp85 -117.66 140.11 50.1 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.746 1.773 . . . . 25.0 107.673 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -103.51 151.93 22.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.716 -1.587 . . . . 25.0 106.716 176.118 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.15 172.29 45.21 Favored Glycine 0 C--O 1.263 1.921 0 C-N-CA 118.714 -1.708 . . . . 25.0 113.9 175.051 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -79.83 142.74 13.54 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 117.448 0.624 . . . . 25.0 109.922 -177.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.09 132.05 14.58 Favored Pre-proline 0 C--O 1.263 1.764 0 O-C-N 122.014 -0.429 . . . . 25.0 110.588 -174.27 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 125.89 11.69 Favored 'Trans proline' 0 C--O 1.208 -0.985 1 C-N-CA 111.387 -5.275 . . . . 25.0 111.464 178.791 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.06 -21.53 67.69 Favored Glycine 0 C--N 1.306 -1.09 0 CA-C-N 114.75 -1.114 . . . . 25.0 113.756 -171.922 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.98 -3.65 33.57 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 120.199 -1.765 . . . . 25.0 108.031 178.123 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -109.38 12.21 24.76 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.673 0.749 . . . . 25.0 110.222 176.473 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.8 mt -120.02 154.28 34.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 122.344 1.069 . . . . 25.0 111.508 177.218 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -126.89 113.85 17.09 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.412 -0.813 . . . . 25.0 109.488 171.219 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.3 mm . . . . . 0 N--CA 1.516 2.836 0 O-C-N 124.787 1.305 . . . . 25.0 108.965 175.592 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--O 1.216 -0.674 0 CA-C-O 121.184 0.516 . . . . 25.0 111.379 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.87 37.64 17.79 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.356 -1.293 . . . . 25.0 113.662 174.598 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 p -109.34 160.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 103.49 -2.782 . . . . 25.0 103.49 175.299 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 159.03 28.67 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 107.064 -1.458 . . . . 25.0 107.064 -177.869 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.88 155.71 49.9 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 124.194 0.934 . . . . 25.0 109.597 -176.299 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -98.65 137.03 37.87 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 122.789 0.435 . . . . 25.0 110.86 169.207 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.9 130.6 36.8 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.209 0.448 . . . . 25.0 112.209 172.695 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.69 -22.1 17.77 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.091 -1.078 . . . . 25.0 108.091 -177.017 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -130.99 162.79 28.99 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 125.168 1.542 . . . . 25.0 111.869 178.42 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.53 161.83 13.55 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.781 -0.574 . . . . 25.0 109.782 -179.141 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -151.52 153.85 35.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.871 0.468 . . . . 25.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.1 t -116.87 123.55 71.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.551 -1.648 . . . . 25.0 106.551 167.302 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.35 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.128 -0.983 . . . . 25.0 113.227 -178.376 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -81.9 -15.4 54.06 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.983 -1.008 . . . . 25.0 110.72 176.387 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -134.25 151.67 76.81 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 108.685 -0.857 . . . . 25.0 108.685 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.62 -11.38 26.12 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 117.722 -1.052 . . . . 25.0 112.115 -178.332 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.91 -12.33 55.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.06 0.944 . . . . 25.0 110.531 175.287 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.6 149.49 22.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.233 -0.44 . . . . 25.0 111.554 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.28 139.93 31.7 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 114.189 1.181 . . . . 25.0 114.189 177.071 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 m -85.1 80.44 9.25 Favored 'General case' 0 C--O 1.271 2.206 0 N-CA-C 109.062 -0.718 . . . . 25.0 109.062 169.381 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -86.7 157.75 19.58 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.578 -1.638 . . . . 25.0 106.578 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.66 146.51 50.53 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 107.063 -1.458 . . . . 25.0 107.063 -174.776 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.54 138.07 57.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.133 -0.627 . . . . 25.0 111.246 177.996 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.44 -16.74 47.68 Favored Glycine 0 C--O 1.255 1.437 0 CA-C-O 117.319 -1.823 . . . . 25.0 112.351 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.75 163.68 26.58 Favored 'General case' 0 C--O 1.269 2.086 0 CA-C-N 119.06 1.43 . . . . 25.0 110.642 179.884 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.5 mm -122.41 128.01 75.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.005 -1.109 . . . . 25.0 108.005 -176.057 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.73 148.12 52.55 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.654 0.74 . . . . 25.0 112.329 177.257 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -81.27 131.24 35.28 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.265 -0.88 . . . . 25.0 110.976 175.545 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.25 128.59 45.44 Favored 'Isoleucine or valine' 0 C--O 1.273 2.29 0 N-CA-C 106.771 -1.566 . . . . 25.0 106.771 179.585 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.73 -38.52 7.04 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 113.442 0.904 . . . . 25.0 113.442 -173.856 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -151.12 147.79 27.49 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.359 -0.837 . . . . 25.0 109.613 -177.131 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -113.66 156.08 24.36 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.859 -1.163 . . . . 25.0 107.859 175.377 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t0 58.34 39.83 25.03 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.187 1.47 . . . . 25.0 109.163 -177.53 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -70.04 -20.11 63.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 121.185 -0.947 . . . . 25.0 113.554 -168.3 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -115.73 6.9 14.53 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-N 118.294 0.497 . . . . 25.0 111.851 -174.193 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.98 -18.21 32.6 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.757 -1.337 . . . . 25.0 109.757 -172.922 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.6 mt -83.97 117.77 23.59 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.535 -2.024 . . . . 25.0 105.535 178.072 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.94 144.12 56.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.999 -1.111 . . . . 25.0 107.999 -175.859 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.58 81.58 Favored Glycine 0 N--CA 1.437 -1.266 0 O-C-N 121.062 -1.023 . . . . 25.0 114.971 179.798 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -97.39 116.42 29.57 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 118.328 1.064 . . . . 25.0 109.794 177.085 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -108.36 148.53 29.96 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.843 1.783 . . . . 25.0 108.914 -174.753 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -87.78 117.93 26.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.316 -1.311 . . . . 25.0 109.155 172.499 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -121.06 162.84 19.29 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.527 0.566 . . . . 25.0 112.527 -179.756 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.4 t -121.78 131.24 53.96 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.522 -0.751 . . . . 25.0 110.179 175.519 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 tp -161.49 142.88 11.39 Favored 'General case' 0 C--O 1.181 -2.541 0 CA-C-O 118.121 -0.942 . . . . 25.0 110.487 -175.887 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t60 54.18 29.76 11.06 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.917 1.081 . . . . 25.0 113.917 178.743 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.38 7.04 87.08 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 115.65 1.02 . . . . 25.0 115.65 175.571 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -123.94 164.89 18.39 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 107.458 -1.312 . . . . 25.0 107.458 175.214 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -124.97 150.75 46.33 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 105.264 -2.124 . . . . 25.0 105.264 166.548 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.0 175.0 47.51 Favored Glycine 0 C--O 1.283 3.157 0 N-CA-C 108.522 -1.831 . . . . 25.0 108.522 -178.54 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.2 pt -78.9 140.11 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 124.832 2.253 . . . . 25.0 112.066 -179.378 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -137.32 133.45 18.26 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-N 113.34 -1.755 . . . . 25.0 107.258 -178.722 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.58 118.9 5.95 Favored 'Trans proline' 0 CA--C 1.56 1.816 0 C-N-CA 114.217 -3.389 . . . . 25.0 113.068 172.631 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.65 -21.9 65.49 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 115.023 0.769 . . . . 25.0 115.023 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -56.57 -32.59 65.34 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.234 0.54 . . . . 25.0 111.417 173.179 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -92.06 5.14 51.35 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 113.838 1.051 . . . . 25.0 113.838 179.498 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.9 mt -110.0 155.98 21.09 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.454 1.121 . . . . 25.0 113.288 177.42 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -125.82 115.28 19.75 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 174.164 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm . . . . . 0 C--O 1.256 1.447 0 CA-C-N 116.165 -0.47 . . . . 25.0 111.406 176.605 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.4 mt . . . . . 0 C--O 1.249 1.063 0 N-CA-C 109.27 -0.641 . . . . 25.0 109.27 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 59.01 36.86 24.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 125.041 1.463 . . . . 25.0 111.041 177.624 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t -104.87 146.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 177.252 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 153.4 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 119.304 0.957 . . . . 25.0 111.395 -179.299 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.3 162.34 33.81 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 116.115 -0.493 . . . . 25.0 109.929 -172.92 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -110.65 140.8 44.66 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.797 -2.297 . . . . 25.0 104.797 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.87 124.98 28.77 Favored 'General case' 0 C--O 1.2 -1.509 0 O-C-N 125.275 1.609 . . . . 25.0 111.09 176.836 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -92.94 -18.83 22.27 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.665 -0.698 . . . . 25.0 110.241 -176.542 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -134.79 163.73 29.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.147 -1.798 . . . . 25.0 106.147 178.883 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -93.47 168.69 10.88 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 119.625 -0.83 . . . . 25.0 110.078 177.809 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -150.29 144.69 25.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.527 0.936 . . . . 25.0 113.527 -179.865 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -116.38 103.78 15.65 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.004 0 N-CA-C 104.082 -2.562 . . . . 25.0 104.082 176.034 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.91 127.38 32.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.076 -1.42 . . . . 25.0 111.268 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.48 -19.96 15.31 Favored 'General case' 0 C--O 1.262 1.759 0 CA-C-O 121.104 0.478 . . . . 25.0 109.715 -176.877 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -107.95 153.49 41.64 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 121.838 -0.539 . . . . 25.0 110.922 -176.467 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.06 -14.66 23.51 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 N-CA-C 113.92 0.7 . . . . 25.0 113.92 178.262 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -85.88 -10.64 54.96 Favored 'General case' 0 C--O 1.209 -1.036 0 O-C-N 124.895 1.372 . . . . 25.0 109.569 176.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.41 144.1 30.63 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.987 0.899 . . . . 25.0 111.137 -174.2 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -92.12 130.61 37.8 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 120.197 -1.564 . . . . 25.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 t -78.18 132.29 37.55 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 167.726 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -157.83 166.79 31.78 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.436 -1.69 . . . . 25.0 106.436 176.343 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -133.65 163.99 28.2 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.602 1.191 . . . . 25.0 109.212 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -60.28 132.72 54.79 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 114.683 -1.144 . . . . 25.0 109.952 -176.622 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.46 -5.86 84.23 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 118.286 -1.285 . . . . 25.0 115.863 -171.383 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.56 155.42 28.18 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.003 1.901 . . . . 25.0 110.501 175.436 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.05 122.54 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 123.536 0.523 . . . . 25.0 109.899 -176.491 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.2 ptp -130.69 156.5 44.82 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -175.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -93.99 125.82 38.84 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.264 0.626 . . . . 25.0 111.716 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.67 121.21 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.362 -1.347 . . . . 25.0 107.362 177.532 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.3 -40.33 11.55 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.768 -0.651 . . . . 25.0 110.51 178.82 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.42 168.14 27.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.606 0.763 . . . . 25.0 110.051 178.867 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -122.2 155.13 36.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.923 -1.51 . . . . 25.0 106.923 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 56.13 38.36 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.506 1.753 . . . . 25.0 111.454 177.5 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -66.36 -15.67 63.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.693 2.108 . . . . 25.0 116.693 -167.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -116.63 13.11 15.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 -178.999 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.22 78.08 Favored Glycine 0 C--O 1.203 -1.785 0 CA-C-O 122.706 1.17 . . . . 25.0 111.025 -177.016 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.28 116.51 21.83 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.762 -1.199 . . . . 25.0 107.762 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -65.2 115.34 5.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.306 -0.861 . . . . 25.0 108.758 176.218 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.23 0.97 47.76 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 117.554 -1.692 . . . . 25.0 115.287 178.322 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -109.45 117.95 35.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 120.452 2.126 . . . . 25.0 110.586 175.594 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -105.82 154.51 20.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.387 -1.279 . . . . 25.0 108.178 -170.8 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.5 tp -93.99 119.54 33.01 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 106.636 -1.616 . . . . 25.0 106.636 177.032 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.4 m -118.01 163.25 16.87 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 119.554 -0.859 . . . . 25.0 110.392 178.398 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.5 t -118.85 129.04 55.0 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 124.076 0.86 . . . . 25.0 112.166 173.673 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 tp -157.55 142.22 16.54 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-N 114.056 -1.429 . . . . 25.0 109.033 -176.225 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.4 t60 56.71 27.31 12.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.176 0.436 . . . . 25.0 112.176 -178.37 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.71 -3.41 74.84 Favored Glycine 0 C--O 1.246 0.856 0 CA-C-O 116.54 -2.255 . . . . 25.0 115.018 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -113.48 160.35 18.56 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.5 1.15 . . . . 25.0 108.267 -178.128 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -109.82 149.25 30.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.322 -2.103 . . . . 25.0 105.322 175.922 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.22 163.33 36.78 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.883 -1.287 . . . . 25.0 109.883 177.471 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 pt -82.64 141.54 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.419 1.104 . . . . 25.0 108.812 -179.174 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.75 137.69 20.36 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.189 -2.152 . . . . 25.0 105.189 -175.334 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -72.69 122.49 8.26 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 113.723 -3.718 . . . . 25.0 115.384 175.391 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.61 -19.95 78.19 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.509 -1.223 . . . . 25.0 113.918 -177.419 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -70.45 -8.95 54.95 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 118.716 -1.194 . . . . 25.0 112.215 172.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -108.93 4.37 23.3 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.589 0.709 . . . . 25.0 109.857 -179.601 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.3 mt -111.85 146.35 37.85 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-O 123.069 1.414 . . . . 25.0 112.186 179.919 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -114.65 116.92 29.49 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.525 -1.216 . . . . 25.0 111.089 170.649 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mm . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 178.727 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 CA--C 1.497 -1.074 0 N-CA-C 114.639 1.348 . . . . 25.0 114.639 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.4 t30 44.36 46.42 7.75 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.566 1.321 . . . . 25.0 114.566 -179.143 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.86 157.11 35.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 N-CA-C 103.596 -2.742 . . . . 25.0 103.596 -177.06 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.11 163.36 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.16 156.36 43.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 25.0 110.938 -177.533 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.14 137.36 37.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.217 -1.031 . . . . 25.0 108.217 174.629 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -73.82 135.04 43.44 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 172.63 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -94.24 -33.18 13.36 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 125.122 1.514 . . . . 25.0 112.103 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -121.57 162.2 21.02 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.553 -1.647 . . . . 25.0 106.553 -177.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.04 149.25 23.67 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 121.896 -0.502 . . . . 25.0 110.806 177.423 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -145.42 122.47 11.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.144 0.974 . . . . 25.0 111.942 -172.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -84.21 132.1 32.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 105.76 -1.941 . . . . 25.0 105.76 171.983 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.18 122.1 26.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.216 -0.994 . . . . 25.0 108.674 178.629 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.44 -12.15 18.79 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.504 0.722 . . . . 25.0 110.101 -178.858 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 m -127.78 152.68 77.43 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 -176.13 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.01 -15.19 23.5 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 114.866 -2.956 . . . . 25.0 112.672 -179.662 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.48 -15.06 57.66 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.578 -1.267 . . . . 25.0 107.578 -179.476 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -89.88 144.47 25.91 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.29 -0.868 . . . . 25.0 112.65 -173.387 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 128.81 37.94 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.836 -0.745 . . . . 25.0 110.607 177.52 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -73.31 131.21 41.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.834 -2.284 . . . . 25.0 104.834 171.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.75 167.46 30.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.089 0.471 . . . . 25.0 110.048 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -133.37 159.88 39.0 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 -178.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -63.0 139.62 58.79 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 107.593 -1.262 . . . . 25.0 107.593 -179.877 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -12.3 68.53 Favored Glycine 0 CA--C 1.498 -0.974 0 CA-C-N 115.209 -0.905 . . . . 25.0 112.626 179.007 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -84.75 157.54 21.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.158 -0.682 . . . . 25.0 109.158 -179.489 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 mp -128.28 131.24 69.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-O 122.03 0.919 . . . . 25.0 109.383 -176.419 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.13 144.37 50.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.661 -0.699 . . . . 25.0 111.287 -177.126 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 m -75.14 134.11 41.34 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.13 -1.063 . . . . 25.0 108.13 175.728 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.48 124.82 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.024 -1.102 . . . . 25.0 108.024 174.301 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.0 mt -96.54 -47.25 6.02 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 123.9 0.75 . . . . 25.0 112.13 -174.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.69 168.37 23.04 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.75 -1.944 . . . . 25.0 105.75 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -120.55 160.29 23.5 Favored 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 108.92 -0.771 . . . . 25.0 108.92 -179.261 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 51.32 42.51 29.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 123.496 1.617 . . . . 25.0 111.038 179.925 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -67.4 -21.87 65.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 115.305 1.594 . . . . 25.0 115.305 -168.18 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -109.08 8.14 25.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.398 -0.521 . . . . 25.0 111.019 178.732 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.17 -1.8 86.57 Favored Glycine 0 C--O 1.215 -1.04 0 CA-C-O 122.901 1.278 . . . . 25.0 110.257 -175.797 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.92 122.13 37.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.34 132.36 49.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.174 -1.417 . . . . 25.0 107.174 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.75 -12.85 61.08 Favored Glycine 0 CA--C 1.485 -1.797 0 O-C-N 121.722 -0.611 . . . . 25.0 114.348 174.29 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.462 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 92.8 m95 -97.43 110.26 22.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.16 -0.612 . . . . 25.0 111.7 177.769 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -101.81 145.39 29.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -174.709 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.09 121.8 28.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.363 -1.347 . . . . 25.0 107.363 173.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.3 m -123.94 164.65 18.88 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.4 -0.963 . . . . 25.0 108.4 178.541 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -124.27 128.06 48.59 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.003 -1.061 . . . . 25.0 109.23 -178.227 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -158.23 151.45 23.01 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 125.202 1.564 . . . . 25.0 110.548 -176.908 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 55.24 31.84 17.37 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.761 0.791 . . . . 25.0 110.545 -179.586 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.22 21.95 66.69 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 117.906 1.922 . . . . 25.0 117.906 -176.101 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -143.7 165.66 27.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.199 -1.778 . . . . 25.0 106.199 -177.912 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -117.72 161.03 20.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.7 -1.593 . . . . 25.0 106.7 -176.648 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.73 166.35 36.58 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.736 -0.745 . . . . 25.0 112.763 176.57 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 pt -73.71 144.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 122.788 1.28 . . . . 25.0 109.675 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.8 t -142.84 134.32 12.91 Favored Pre-proline 0 C--O 1.217 -0.643 0 O-C-N 120.408 -1.433 . . . . 25.0 107.695 179.489 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD3' ' CZ3' ' A' ' 45' ' ' TRP . 79.1 Cg_endo -73.58 116.98 4.87 Favored 'Trans proline' 0 C--O 1.255 1.344 0 C-N-CA 115.87 -2.286 . . . . 25.0 113.038 176.86 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.05 -23.25 59.21 Favored Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 120.666 -0.778 . . . . 25.0 114.711 -175.241 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.91 -4.9 14.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 120.606 -1.526 . . . . 25.0 112.527 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -114.94 11.97 16.69 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 122.842 0.457 . . . . 25.0 110.403 178.522 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 12' ' ' ALA . 92.4 mt -118.33 153.86 33.29 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.33 -0.85 . . . . 25.0 111.181 -179.293 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -121.1 127.17 51.37 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.502 -0.555 . . . . 25.0 109.502 169.815 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.6 mm . . . . . 0 C--O 1.24 0.576 0 CA-C-O 121.792 0.806 . . . . 25.0 110.686 179.058 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 121.869 0.842 . . . . 25.0 109.405 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.3 m120 53.54 32.78 14.88 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-O 122.685 1.231 . . . . 25.0 111.366 -178.239 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.45 147.1 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 101.686 -3.45 . . . . 25.0 101.686 179.168 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.49 163.53 28.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.235 -0.654 . . . . 25.0 109.235 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.14 153.63 38.01 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 122.025 -0.422 . . . . 25.0 109.962 -175.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -101.41 137.28 39.96 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.088 -1.449 . . . . 25.0 107.088 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.63 128.72 33.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 112.917 0.71 . . . . 25.0 112.917 179.157 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.4 mt -89.2 -18.2 27.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.918 0.887 . . . . 25.0 111.218 179.765 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.9 169.49 17.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.89 154.4 25.25 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.675 0.79 . . . . 25.0 111.523 179.089 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.5 162.56 40.68 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-O 122.118 0.961 . . . . 25.0 110.996 -174.018 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.42 129.21 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.081 -2.933 . . . . 25.0 103.081 173.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.43 126.54 30.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.286 -0.635 . . . . 25.0 109.286 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.47 -14.27 33.12 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.998 0.904 . . . . 25.0 111.178 176.385 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -131.03 155.25 81.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.079 -1.082 . . . . 25.0 108.079 -175.983 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.26 -10.23 20.72 Favored 'Trans proline' 0 C--O 1.205 -1.132 0 CA-C-N 119.967 1.024 . . . . 25.0 113.343 176.013 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -85.29 -4.6 59.21 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.503 -1.295 . . . . 25.0 107.503 178.661 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -118.24 149.37 41.23 Favored 'General case' 0 C--O 1.252 1.217 0 N-CA-C 105.464 -2.05 . . . . 25.0 105.464 -170.654 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -102.97 133.8 47.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.468 1.128 . . . . 25.0 113.579 -178.435 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.8 82.72 8.0 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 121.015 -1.053 . . . . 25.0 113.154 170.341 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -97.21 154.67 17.24 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.882 -1.508 . . . . 25.0 112.698 176.856 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -125.84 152.95 44.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 -178.376 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -59.19 135.0 57.5 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 120.303 -0.559 . . . . 25.0 111.455 -179.117 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.07 -14.84 62.42 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 115.43 -0.804 . . . . 25.0 114.231 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -73.39 158.86 34.22 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 121.735 -0.862 . . . . 25.0 112.563 173.359 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -117.46 133.61 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 O-C-N 124.363 1.039 . . . . 25.0 110.295 -178.912 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 ptp -140.84 147.98 39.83 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.36 1.076 . . . . 25.0 111.578 177.636 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 m -86.34 130.57 34.47 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.007 -1.451 . . . . 25.0 111.181 -177.764 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t -90.77 126.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 -179.736 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.8 mt -101.06 -35.99 9.15 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 124.255 0.972 . . . . 25.0 112.412 -178.644 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -147.53 145.48 29.11 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.836 -1.172 . . . . 25.0 107.836 177.688 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -112.48 151.01 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 104.003 -2.591 . . . . 25.0 104.003 173.843 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 59.61 42.16 17.67 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.952 0.882 . . . . 25.0 110.66 -175.533 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.71 -18.44 62.81 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 116.866 2.173 . . . . 25.0 116.866 -169.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.76 5.06 13.06 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.169 0.985 . . . . 25.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.69 -17.41 25.84 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.184 -0.916 . . . . 25.0 112.349 -168.978 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.4 126.61 28.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 172.254 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.0 124.04 19.72 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 122.666 1.222 . . . . 25.0 112.821 -179.852 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.59 79.0 Favored Glycine 0 CA--C 1.503 -0.716 0 N-CA-C 118.094 1.998 . . . . 25.0 118.094 176.903 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -104.82 119.14 38.29 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.912 1.356 . . . . 25.0 108.694 178.552 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -106.12 142.64 35.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.872 -0.604 . . . . 25.0 111.588 -169.404 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -82.31 120.67 25.69 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.431 -0.581 . . . . 25.0 109.431 171.226 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 m -126.17 160.72 29.45 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 112.837 0.68 . . . . 25.0 112.837 -179.217 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.0 t -120.2 135.35 55.01 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 123.731 0.644 . . . . 25.0 110.758 174.906 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 tp -150.58 137.04 18.79 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.927 -1.508 . . . . 25.0 106.927 178.073 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.5 m170 57.44 30.88 19.35 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.361 0.875 . . . . 25.0 113.361 179.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.84 9.43 79.33 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 117.22 1.648 . . . . 25.0 117.22 -175.461 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -110.03 158.99 17.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.81 -1.181 . . . . 25.0 107.81 177.53 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -123.73 142.76 50.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.632 -1.293 . . . . 25.0 108.059 171.887 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.94 161.36 35.05 Favored Glycine 0 CA--C 1.491 -1.43 0 O-C-N 124.294 0.996 . . . . 25.0 111.117 177.6 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.9 pt -77.53 149.74 5.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.539 1.161 . . . . 25.0 108.727 -176.08 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.2 t -145.66 134.91 11.3 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 -176.933 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.21 119.47 6.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 117.188 -1.408 . . . . 25.0 113.114 179.33 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -24.1 63.34 Favored Glycine 0 C--O 1.198 -2.127 0 N-CA-C 117.249 1.66 . . . . 25.0 117.249 -177.463 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.06 -16.33 62.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 118.088 0.944 . . . . 25.0 109.623 178.553 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -94.42 9.53 37.98 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.15 0.976 . . . . 25.0 111.341 178.255 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.6 mt -124.86 147.63 48.68 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.603 -0.686 . . . . 25.0 111.006 -176.918 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -116.34 125.21 51.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.748 -1.114 . . . . 25.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 C--N 1.317 -0.846 0 CA-C-N 118.452 0.569 . . . . 25.0 110.973 177.375 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.637 0 N-CA-C 116.807 1.483 . . . . 25.0 116.807 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 p -85.74 165.11 17.18 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.985 -1.303 . . . . 25.0 111.811 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 tpt 49.76 49.15 20.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.667 1.729 . . . . 25.0 115.667 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -91.95 144.77 25.13 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.05 -0.523 . . . . 25.0 110.812 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -87.36 165.76 15.36 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.598 -0.519 . . . . 25.0 109.598 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.95 -41.59 99.56 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.392 0.515 . . . . 25.0 112.392 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.5 t30 55.0 39.61 31.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.09 0.774 . . . . 25.0 113.09 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 m -113.75 155.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.282 -2.488 . . . . 25.0 104.282 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.51 172.02 8.13 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 107.007 -1.479 . . . . 25.0 107.007 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.73 144.87 29.72 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 116.317 -0.401 . . . . 25.0 110.811 173.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -95.36 135.76 36.58 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.0 -0.741 . . . . 25.0 109.0 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 130.36 39.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.548 0.69 . . . . 25.0 109.367 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.53 -28.08 15.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.78 -0.645 . . . . 25.0 109.466 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -129.77 160.52 33.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.365 -1.346 . . . . 25.0 107.365 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.508 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.0 p-10 -101.76 159.88 14.95 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.581 0.752 . . . . 25.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -145.83 -177.99 5.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.013 0.435 . . . . 25.0 110.583 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.89 147.81 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 100.696 -3.816 . . . . 25.0 100.696 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.97 139.61 38.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -99.55 -13.3 19.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.245 0.545 . . . . 25.0 110.295 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -128.8 151.11 76.71 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.518 . . . . 25.0 109.865 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.01 -15.14 36.03 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 117.046 -1.502 . . . . 25.0 113.687 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -82.63 -7.72 59.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.701 0.763 . . . . 25.0 110.294 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -106.62 143.86 34.12 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mt -92.13 134.88 34.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.425 0.631 . . . . 25.0 111.89 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.0 p -93.09 122.6 35.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.459 ' CE2' HG13 ' A' ' 57' ' ' VAL . 40.9 p90 -141.21 164.76 29.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.379 -1.341 . . . . 25.0 107.379 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -132.3 154.51 49.63 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.842 -0.799 . . . . 25.0 108.842 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.508 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 64.0 pttt -56.37 137.32 52.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.375 0.607 . . . . 25.0 109.685 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.42 45.98 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.551 -0.749 . . . . 25.0 112.869 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -77.89 160.63 28.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.221 0.51 . . . . 25.0 110.117 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -130.44 132.46 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.6 ptp -131.59 151.12 51.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.454 . . . . 25.0 110.634 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -85.02 130.47 34.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.872 -0.418 . . . . 25.0 109.872 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.6 t -90.23 124.38 42.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.577 -1.268 . . . . 25.0 107.577 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -93.54 -43.15 8.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 25.0 110.862 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -156.42 171.79 19.64 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -127.38 154.73 44.64 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.754 -0.461 . . . . 25.0 109.754 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 58.81 39.01 24.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.881 1.324 . . . . 25.0 108.9 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -65.54 -20.47 66.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 112.982 -1.917 . . . . 25.0 114.96 -168.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -114.76 13.05 17.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.661 -0.649 . . . . 25.0 110.265 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 -3.59 81.73 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.582 -1.007 . . . . 25.0 110.582 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.42 118.61 30.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.052 -0.721 . . . . 25.0 109.052 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -60.34 130.33 46.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.584 -0.735 . . . . 25.0 109.269 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.75 -1.71 83.81 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 114.982 0.753 . . . . 25.0 114.982 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -101.05 121.66 42.19 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.677 1.239 . . . . 25.0 108.762 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -111.07 146.49 36.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.493 -0.558 . . . . 25.0 109.493 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.8 tp -85.13 111.84 20.14 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.034 -2.21 . . . . 25.0 105.034 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.31 164.9 12.69 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.79 -0.819 . . . . 25.0 108.79 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -127.65 130.55 49.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 tp -159.29 142.79 14.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 53.61 38.94 29.41 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.097 1.147 . . . . 25.0 114.097 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.2 2.93 89.56 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 115.289 0.876 . . . . 25.0 115.289 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -125.9 165.46 18.68 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -127.2 148.2 50.2 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 104.113 -2.551 . . . . 25.0 104.113 167.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.58 172.57 45.04 Favored Glycine 0 C--O 1.244 0.732 0 N-CA-C 110.043 -1.223 . . . . 25.0 110.043 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.0 pt -75.27 141.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 25.0 110.308 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.459 HG13 ' CE2' ' A' ' 26' ' ' PHE . 74.0 t -140.67 133.9 14.79 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 108.877 -0.786 . . . . 25.0 108.877 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.24 112.97 3.45 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 117.339 -1.307 . . . . 25.0 111.751 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.75 -19.11 69.05 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.997 -0.547 . . . . 25.0 112.949 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.18 -5.86 7.91 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.351 0.5 . . . . 25.0 112.351 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -116.64 11.27 14.63 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.914 -0.491 . . . . 25.0 110.642 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.3 mt -122.33 155.2 36.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.035 0.445 . . . . 25.0 111.332 -176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -121.55 118.06 28.34 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.4 mm -60.27 132.24 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 120.677 0.275 . . . . 25.0 110.537 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.8 mt -137.24 133.1 34.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.983 -1.118 . . . . 25.0 107.983 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.2 t -86.84 89.43 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.615 -1.254 . . . . 25.0 107.615 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.16 -19.66 56.83 Favored Glycine 0 C--O 1.225 -0.461 0 C-N-CA 120.514 -0.851 . . . . 25.0 113.661 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.84 135.23 45.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 120.979 0.419 . . . . 25.0 110.085 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -110.15 -45.74 3.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.187 -1.412 . . . . 25.0 107.187 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -71.19 143.77 50.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.267 -1.383 . . . . 25.0 107.267 172.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -171.16 171.47 5.72 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.984 -1.487 . . . . 25.0 106.984 -172.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -60.28 142.42 90.16 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.117 -0.697 . . . . 25.0 109.117 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -70.8 -24.28 25.09 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 117.239 -1.374 . . . . 25.0 113.046 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.08 -154.18 0.36 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.662 0.785 . . . . 25.0 110.061 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.86 -14.74 62.58 Favored Glycine 0 C--O 1.227 -0.336 0 CA-C-O 120.076 -0.291 . . . . 25.0 112.951 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -72.98 90.72 1.5 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.234 -0.654 . . . . 25.0 109.234 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -161.12 165.39 29.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.262 -1.014 . . . . 25.0 108.262 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 pt -72.84 162.88 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.481 0.658 . . . . 25.0 110.046 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.5 m -66.27 148.6 12.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.52 -0.548 . . . . 25.0 109.52 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.49 150.76 33.97 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.897 -1.149 . . . . 25.0 107.897 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 C--O 1.21 -0.982 0 CA-C-O 123.734 1.73 . . . . 25.0 112.873 179.384 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.799 0 CA-C-O 124.007 1.893 . . . . 25.0 114.045 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -74.48 161.46 29.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 113.229 -1.485 . . . . 25.0 111.256 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.3 mtm 54.77 54.98 8.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.535 0.734 . . . . 25.0 112.545 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -97.72 165.86 11.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.308 -0.627 . . . . 25.0 109.308 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -139.73 133.15 30.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.287 -1.746 . . . . 25.0 106.287 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.7 mt -95.81 -16.31 21.96 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 115.058 1.503 . . . . 25.0 115.058 -172.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 t30 50.15 42.44 25.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.197 0.814 . . . . 25.0 113.197 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.74 157.74 32.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.62 0 N-CA-C 105.887 -1.894 . . . . 25.0 105.887 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.52 161.66 36.48 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.325 0.583 . . . . 25.0 110.941 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.34 163.27 33.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.196 -0.911 . . . . 25.0 110.869 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -111.27 133.35 53.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.997 -1.112 . . . . 25.0 107.997 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.67 133.54 43.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.313 0.578 . . . . 25.0 109.585 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.46 -25.81 17.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.669 -0.696 . . . . 25.0 109.814 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -129.9 160.66 32.88 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.281 -1.007 . . . . 25.0 108.281 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.6 p-10 -98.15 158.54 15.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.325 -0.62 . . . . 25.0 109.325 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -156.42 135.84 12.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.909 -0.587 . . . . 25.0 112.168 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.32 127.03 60.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 104.321 -2.474 . . . . 25.0 104.321 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 127.14 30.41 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.143 -0.317 . . . . 25.0 110.143 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -100.08 -8.59 23.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.961 0.886 . . . . 25.0 108.615 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.1 m -128.4 152.33 78.01 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 114.783 -1.099 . . . . 25.0 108.655 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.24 -25.62 21.87 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 117.043 -1.504 . . . . 25.0 114.374 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -83.98 -9.92 58.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.195 0.521 . . . . 25.0 110.77 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -87.11 148.5 25.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.497 -0.557 . . . . 25.0 109.497 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.64 134.73 38.2 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 122.072 -0.392 . . . . 25.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.1 m -85.04 124.9 32.27 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.814 -1.55 . . . . 25.0 106.814 171.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.434 ' CE2' HG13 ' A' ' 57' ' ' VAL . 49.0 p90 -145.57 167.93 21.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.341 -0.985 . . . . 25.0 108.341 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -128.99 154.45 46.59 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 121.972 -0.455 . . . . 25.0 111.509 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.8 pttp -57.75 131.27 49.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.52 -20.89 46.42 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-O 119.351 -0.694 . . . . 25.0 113.973 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -73.19 161.72 30.23 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 117.345 0.573 . . . . 25.0 111.035 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -121.84 130.15 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.22 -0.659 . . . . 25.0 109.22 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.39 147.81 47.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.551 . . . . 25.0 111.439 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -82.59 132.79 35.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.0 t -94.12 121.37 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.111 -1.811 . . . . 25.0 106.111 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.7 mt -86.45 -46.73 9.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.654 -0.703 . . . . 25.0 110.191 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -154.7 163.05 40.82 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.554 -0.906 . . . . 25.0 108.554 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.6 154.09 37.22 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.989 0.516 . . . . 25.0 110.024 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.4 t0 54.66 45.85 25.94 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 123.454 1.597 . . . . 25.0 108.719 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.55 -6.34 35.72 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.776 -1.556 . . . . 25.0 114.347 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -136.57 6.15 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.294 1.22 . . . . 25.0 114.294 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.14 22.82 64.72 Favored Glycine 0 CA--C 1.517 0.209 0 N-CA-C 108.578 -1.809 . . . . 25.0 108.578 -174.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.0 mt -122.72 110.01 14.95 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 104.619 -2.363 . . . . 25.0 104.619 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -65.1 144.15 57.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.954 0.883 . . . . 25.0 109.053 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.34 -16.49 43.9 Favored Glycine 0 C--O 1.218 -0.864 0 CA-C-O 118.456 -1.191 . . . . 25.0 114.033 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -88.65 132.28 34.63 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.596 1.698 . . . . 25.0 109.998 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -120.19 144.22 47.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.63 118.6 25.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.933 -1.877 . . . . 25.0 105.933 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.1 m -120.46 164.43 16.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.292 -0.262 . . . . 25.0 110.292 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.6 t -125.62 130.48 51.72 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.364 -0.606 . . . . 25.0 109.364 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.7 tp -161.61 146.63 13.37 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.493 -0.928 . . . . 25.0 108.493 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 58.18 32.73 22.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.281 0.845 . . . . 25.0 113.281 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 6.56 88.79 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.877 -0.677 . . . . 25.0 114.735 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -133.31 162.9 30.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 117.839 0.82 . . . . 25.0 109.863 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -105.36 158.28 16.75 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 104.265 -2.494 . . . . 25.0 104.265 172.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.01 161.1 29.47 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.852 -0.689 . . . . 25.0 111.557 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -78.58 141.82 14.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG13 ' CE2' ' A' ' 26' ' ' PHE . 74.9 t -140.1 133.89 15.41 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.056 -1.09 . . . . 25.0 108.056 -178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.38 117.04 4.89 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 114.93 -2.913 . . . . 25.0 110.758 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -19.52 70.0 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 116.068 -0.514 . . . . 25.0 113.607 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -72.8 -3.23 24.15 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.264 -0.55 . . . . 25.0 111.767 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -108.71 8.95 27.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.09 -0.708 . . . . 25.0 109.09 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.18 155.3 34.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -126.12 120.75 30.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.801 -0.814 . . . . 25.0 108.801 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.4 mm -58.58 129.26 20.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.7 tp -154.18 105.85 2.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.577 -0.738 . . . . 25.0 109.178 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.9 t -110.36 112.05 38.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.157 -1.423 . . . . 25.0 107.157 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.83 4.46 2.7 Favored Glycine 0 C--O 1.227 -0.316 0 CA-C-N 116.158 -0.474 . . . . 25.0 112.444 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 27.6 ttt -104.13 148.18 26.57 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.856 -2.275 . . . . 25.0 104.856 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -59.43 125.74 24.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.549 0.214 . . . . 25.0 110.625 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -69.72 127.99 34.88 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.397 -1.334 . . . . 25.0 107.397 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.51 143.06 30.66 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -66.41 146.9 99.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.291 -1.374 . . . . 25.0 107.291 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.73 159.63 52.73 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 117.838 -0.975 . . . . 25.0 112.13 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.38 -21.79 58.02 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.108 0.48 . . . . 25.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.73 178.81 23.24 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 106.165 -2.774 . . . . 25.0 106.165 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.16 -53.3 3.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.853 0.826 . . . . 25.0 110.744 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 58.3 -169.67 0.12 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.163 0.985 . . . . 25.0 112.153 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.7 pt -134.74 157.94 41.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -109.23 -13.12 10.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.056 0.455 . . . . 25.0 111.134 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.7 p -145.53 145.06 30.89 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.315 -2.106 . . . . 25.0 105.315 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 C--O 1.208 -1.13 0 CA-C-O 124.929 2.3 . . . . 25.0 112.345 178.611 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 122.785 1.214 . . . . 25.0 115.269 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -151.46 153.71 35.16 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 107.726 -1.213 . . . . 25.0 107.726 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.14 164.28 37.63 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.17 47.54 2.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.353 1.073 . . . . 25.0 109.153 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -144.55 133.12 22.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.441 -1.254 . . . . 25.0 107.653 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.4 mt -110.85 -11.03 14.4 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.24 1.2 . . . . 25.0 114.24 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t30 53.84 31.86 13.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.456 0.91 . . . . 25.0 113.456 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -119.53 156.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.29 158.82 43.54 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.816 -0.438 . . . . 25.0 109.816 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.21 151.18 44.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.659 -0.7 . . . . 25.0 110.983 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -97.24 134.29 40.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.771 -0.825 . . . . 25.0 108.771 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.82 130.52 40.09 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.717 -0.475 . . . . 25.0 109.717 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.2 mt -92.07 -28.1 17.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.878 -0.601 . . . . 25.0 109.593 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -129.28 162.21 28.45 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 6.3 p-10 -98.72 163.01 12.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.791 0.329 . . . . 25.0 110.699 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -150.42 153.39 35.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 25.0 110.784 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.09 118.12 52.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 104.614 -2.365 . . . . 25.0 104.614 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.57 30.41 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.217 0.323 . . . . 25.0 110.511 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.7 -22.05 9.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.559 174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.9 m -97.79 151.02 37.37 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.243 -0.28 . . . . 25.0 110.243 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.82 -17.99 25.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 117.697 -1.069 . . . . 25.0 113.297 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -85.53 -7.58 58.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.09 -0.505 . . . . 25.0 110.436 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -103.39 146.47 28.45 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.64 0.776 . . . . 25.0 110.007 -176.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -100.26 135.65 41.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.608 0.595 . . . . 25.0 112.608 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -84.95 139.85 31.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.387 -2.079 . . . . 25.0 105.387 168.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.449 ' CE1' HG13 ' A' ' 57' ' ' VAL . 44.7 p90 -159.11 163.7 35.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 105.593 -2.003 . . . . 25.0 105.593 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -129.77 154.81 46.85 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 120.222 -0.591 . . . . 25.0 111.855 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.485 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.0 pttp -55.73 130.34 42.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.413 -0.812 . . . . 25.0 109.621 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.52 22.74 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.397 -0.819 . . . . 25.0 113.082 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -73.37 162.15 29.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 122.731 0.413 . . . . 25.0 111.745 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.4 mm -121.47 130.97 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.545 0.738 . . . . 25.0 109.34 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -135.44 145.79 47.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.787 0.327 . . . . 25.0 110.344 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -84.77 131.26 34.57 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 108.124 -1.065 . . . . 25.0 108.124 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -90.05 124.68 42.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.6 mt -91.75 -49.18 6.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 25.0 110.156 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -153.58 171.92 18.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.529 -1.285 . . . . 25.0 107.529 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -126.88 157.18 40.05 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 110.203 -0.295 . . . . 25.0 110.203 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 60.17 32.58 20.94 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 123.129 1.442 . . . . 25.0 109.467 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.57 -20.52 62.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.356 -1.747 . . . . 25.0 114.544 -170.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -100.99 3.09 41.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.367 0.603 . . . . 25.0 109.713 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.13 -3.66 79.76 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 109.489 -1.444 . . . . 25.0 109.489 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.33 124.35 39.32 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.33 -1.359 . . . . 25.0 107.33 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.02 133.86 55.88 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.24 -0.652 . . . . 25.0 109.24 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.0 1.03 88.94 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 115.352 0.901 . . . . 25.0 115.352 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -99.04 124.13 43.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.173 1.486 . . . . 25.0 108.635 176.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -113.89 143.84 44.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.03 -0.419 . . . . 25.0 110.329 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.6 tp -82.87 118.07 23.18 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.417 -2.068 . . . . 25.0 105.417 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.63 163.84 16.76 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.255 -0.646 . . . . 25.0 109.255 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -122.91 137.81 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.118 0.485 . . . . 25.0 110.765 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 tp -159.46 143.4 14.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.94 -1.504 . . . . 25.0 106.94 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 58.99 22.25 10.21 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.606 0.965 . . . . 25.0 113.606 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.8 89.44 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.996 -0.621 . . . . 25.0 112.509 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -112.09 167.28 10.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 106.168 -1.79 . . . . 25.0 106.168 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -134.58 150.88 50.76 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.65 167.06 39.87 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 109.525 -1.43 . . . . 25.0 109.525 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.87 144.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.811 0.815 . . . . 25.0 111.131 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG13 ' CE1' ' A' ' 26' ' ' PHE . 64.4 t -140.2 134.18 15.44 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.516 -1.29 . . . . 25.0 107.516 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.66 117.99 5.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 114.621 -3.12 . . . . 25.0 110.696 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.0 -21.61 69.83 Favored Glycine 0 C--O 1.22 -0.742 0 CA-C-N 116.143 -0.48 . . . . 25.0 113.491 -174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -67.67 -14.5 63.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.533 -0.392 . . . . 25.0 111.696 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -94.63 6.72 48.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.037 -0.414 . . . . 25.0 111.123 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.2 mt -119.82 154.33 34.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 25.0 111.751 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -123.97 117.72 25.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.969 -0.752 . . . . 25.0 108.969 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.6 mt -66.78 136.51 26.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.634 -0.712 . . . . 25.0 111.177 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.42 144.14 26.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.459 -2.793 . . . . 25.0 103.459 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.6 t -46.39 109.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 114.073 1.138 . . . . 25.0 114.073 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.39 39.03 0.04 OUTLIER Glycine 0 C--O 1.225 -0.46 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.7 ttm -68.03 113.19 5.5 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.118 -0.637 . . . . 25.0 111.323 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 53.77 46.73 25.23 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.176 0.922 . . . . 25.0 112.013 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -61.65 138.17 58.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.971 -0.559 . . . . 25.0 109.823 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -146.09 153.11 40.33 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.265 -0.643 . . . . 25.0 109.265 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -71.91 147.35 91.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 105.502 -2.036 . . . . 25.0 105.502 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.01 -3.22 13.52 Favored 'Trans proline' 0 C--N 1.346 0.408 0 N-CA-C 114.492 0.92 . . . . 25.0 114.492 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.32 168.82 22.97 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.725 -1.583 . . . . 25.0 106.725 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.93 -179.93 27.09 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 108.572 -1.811 . . . . 25.0 108.572 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.01 161.02 28.67 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.786 -0.45 . . . . 25.0 109.786 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -83.93 138.47 33.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.777 0.322 . . . . 25.0 110.143 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.4 tt -84.46 143.57 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.137 -1.431 . . . . 25.0 107.137 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.09 -4.52 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.42 0.629 . . . . 25.0 111.564 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.9 m -63.49 -44.19 95.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.403 0.621 . . . . 25.0 112.242 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 C--O 1.211 -0.933 0 CA-C-O 125.458 2.551 . . . . 25.0 112.105 -174.858 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.671 0 CA-C-O 122.867 1.259 . . . . 25.0 114.319 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -140.92 132.02 26.32 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.4 -1.647 . . . . 25.0 109.979 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.8 mtm 51.07 37.23 17.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.071 0.548 . . . . 25.0 112.041 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 65.78 3.58 2.57 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.432 1.641 . . . . 25.0 115.432 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -93.69 159.66 15.11 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.206 -0.665 . . . . 25.0 109.206 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.54 -46.71 88.09 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.361 -0.607 . . . . 25.0 109.361 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.9 t30 51.36 40.25 26.06 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.484 1.291 . . . . 25.0 114.484 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.34 166.16 11.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 N-CA-C 105.03 -2.211 . . . . 25.0 105.03 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.62 157.52 43.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.536 0.684 . . . . 25.0 111.495 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.58 152.3 43.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.008 -0.996 . . . . 25.0 110.46 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.45 137.43 35.54 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 131.99 42.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.1 mt -86.59 -25.8 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -133.48 161.21 35.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 25.0 109.081 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.585 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.6 p-10 -99.91 155.79 17.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.429 -0.952 . . . . 25.0 108.429 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.13 172.96 12.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.674 0.749 . . . . 25.0 112.729 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.0 t -122.71 135.93 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 1 N-CA-C 100.141 -4.022 . . . . 25.0 100.141 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.38 47.69 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.396 -0.965 . . . . 25.0 108.396 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.63 -25.07 8.88 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.585 0.553 . . . . 25.0 112.055 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -93.88 148.36 35.15 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.339 -0.225 . . . . 25.0 110.876 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.3 -15.7 38.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 116.762 -1.692 . . . . 25.0 112.614 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -83.73 -15.56 48.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.862 0.363 . . . . 25.0 110.103 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -95.34 135.06 37.42 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.946 0.498 . . . . 25.0 111.532 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.41 136.53 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.508 -0.477 . . . . 25.0 110.954 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 p -91.23 118.47 30.49 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -136.13 166.33 23.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.316 0.579 . . . . 25.0 110.319 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -125.2 152.27 44.74 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.771 -0.455 . . . . 25.0 109.771 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.585 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.9 pttt -56.61 132.62 52.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.987 -0.746 . . . . 25.0 108.987 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.81 -13.04 66.98 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-O 119.247 -0.751 . . . . 25.0 114.265 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -76.28 158.04 31.95 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 117.936 0.868 . . . . 25.0 110.126 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.0 mm -116.66 125.1 73.46 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 123.061 0.544 . . . . 25.0 109.868 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.0 ptp -131.42 147.25 52.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 25.0 111.376 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -89.0 127.12 35.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.084 -0.71 . . . . 25.0 109.084 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.3 t -86.73 123.13 39.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.77 -40.9 8.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.489 -0.778 . . . . 25.0 110.81 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.83 158.59 44.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.33 -0.618 . . . . 25.0 109.33 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -129.6 148.61 51.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.733 -0.84 . . . . 25.0 108.733 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.3 t0 55.38 43.6 28.59 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.361 1.553 . . . . 25.0 107.1 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -70.63 -6.34 36.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.568 -1.651 . . . . 25.0 114.352 -170.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -136.08 6.76 3.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.718 0.636 . . . . 25.0 112.718 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.86 9.65 85.13 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 109.496 -1.441 . . . . 25.0 109.496 -174.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -109.43 110.04 21.06 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 105.509 -2.034 . . . . 25.0 105.509 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -65.36 145.86 55.64 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.083 0.944 . . . . 25.0 108.701 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.4 48.12 Favored Glycine 0 C--O 1.22 -0.734 0 CA-C-O 118.624 -1.098 . . . . 25.0 113.749 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -93.5 129.7 39.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 119.367 1.583 . . . . 25.0 110.007 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -119.07 143.72 46.97 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.8 tp -83.33 116.4 22.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 105.614 -1.995 . . . . 25.0 105.614 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -118.18 164.24 15.46 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.9 p -129.72 132.98 46.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.98 -0.748 . . . . 25.0 108.98 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.1 tp -159.31 141.56 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.376 -0.829 . . . . 25.0 109.252 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 57.35 31.18 19.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.282 1.216 . . . . 25.0 114.282 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.26 85.98 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 115.239 0.856 . . . . 25.0 115.239 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -135.01 162.81 31.38 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.726 -0.842 . . . . 25.0 108.726 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -117.75 160.23 21.69 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.25 167.55 39.64 Favored Glycine 0 C--O 1.238 0.374 0 N-CA-C 110.316 -1.114 . . . . 25.0 110.316 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -78.25 142.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.371 0.605 . . . . 25.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -141.68 134.63 14.16 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.994 -1.113 . . . . 25.0 107.994 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.58 119.72 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 114.672 -3.086 . . . . 25.0 111.182 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.68 -18.4 65.98 Favored Glycine 0 C--O 1.22 -0.744 0 CA-C-N 116.088 -0.506 . . . . 25.0 114.155 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -62.1 -29.98 70.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.424 -0.457 . . . . 25.0 110.282 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -90.53 10.28 26.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.377 -0.374 . . . . 25.0 111.983 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.8 mt -117.68 152.59 34.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.326 0.584 . . . . 25.0 111.078 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -124.72 117.99 25.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.121 -0.696 . . . . 25.0 109.121 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.4 mm -57.62 137.81 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.453 -0.573 . . . . 25.0 109.453 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.62 173.41 8.53 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.238 -0.653 . . . . 25.0 109.238 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t 60.25 79.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-O 122.258 1.028 . . . . 25.0 112.297 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.23 47.21 0.92 Allowed Glycine 0 C--O 1.223 -0.532 0 CA-C-N 115.217 -0.901 . . . . 25.0 112.164 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.5 tpt -114.71 123.33 49.0 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.573 -0.529 . . . . 25.0 109.573 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -80.29 -45.44 17.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.46 0.648 . . . . 25.0 110.294 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -73.93 138.66 44.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.629 -0.714 . . . . 25.0 110.181 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -154.26 161.95 41.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.251 -0.648 . . . . 25.0 109.251 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -93.31 151.63 40.48 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.627 -1.249 . . . . 25.0 107.627 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.86 163.46 38.33 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 117.489 -1.207 . . . . 25.0 111.538 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.28 163.43 35.52 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.191 -1.411 . . . . 25.0 107.191 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.76 86.95 0.54 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 109.391 -1.484 . . . . 25.0 109.391 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -118.43 146.5 44.41 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 -175.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -135.55 143.52 45.75 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.2 pt -88.59 161.62 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.434 0.159 . . . . 25.0 110.892 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 t 38.5 75.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.736 1.384 . . . . 25.0 114.736 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -129.73 133.98 47.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.668 -1.605 . . . . 25.0 106.668 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 124.522 2.106 . . . . 25.0 111.513 -174.552 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.857 0 CA-C-O 124.02 1.9 . . . . 25.0 115.382 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 p -82.66 149.76 27.18 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.461 -1.023 . . . . 25.0 108.945 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.6 ttm -81.64 -73.31 0.39 Allowed 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 120.771 -0.372 . . . . 25.0 110.372 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -157.54 152.43 25.54 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.282 -1.377 . . . . 25.0 107.282 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.12 175.8 11.4 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 103.392 -2.818 . . . . 25.0 103.392 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.39 -45.92 72.99 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.926 0.784 . . . . 25.0 110.927 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.1 t30 46.9 46.05 15.43 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.071 1.137 . . . . 25.0 114.071 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -125.29 149.04 29.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 106.549 -1.649 . . . . 25.0 106.549 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 155.33 30.75 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.248 0.547 . . . . 25.0 110.511 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 154.73 49.74 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.04 -0.982 . . . . 25.0 108.703 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -105.67 135.45 47.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.03 131.39 42.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.191 0.52 . . . . 25.0 109.74 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.68 -26.9 18.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.573 0.702 . . . . 25.0 109.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -130.58 158.72 39.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.508 -1.293 . . . . 25.0 107.508 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.6 p-10 -97.42 160.05 14.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.242 -0.651 . . . . 25.0 109.242 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.38 171.88 13.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.548 . . . . 25.0 110.563 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.2 124.59 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 101.029 -3.693 . . . . 25.0 101.029 172.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.51 140.17 29.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -119.12 -29.37 5.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.658 0.599 . . . . 25.0 111.553 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.5 m -89.21 148.98 42.03 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.764 -0.828 . . . . 25.0 108.764 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.77 -18.22 32.41 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 116.746 -1.703 . . . . 25.0 112.797 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.84 -13.8 59.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.534 -0.757 . . . . 25.0 110.744 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -96.08 142.51 28.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.199 0.523 . . . . 25.0 110.94 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -91.47 137.7 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.867 -0.333 . . . . 25.0 110.605 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -93.23 124.5 37.25 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.268 -1.382 . . . . 25.0 107.268 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.88 168.25 24.3 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.361 -1.348 . . . . 25.0 107.361 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -133.02 159.32 40.38 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.964 -0.46 . . . . 25.0 110.229 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.489 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 27.0 pttt -56.57 136.35 54.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.584 0.707 . . . . 25.0 110.078 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.63 -24.04 31.28 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.08 -0.964 . . . . 25.0 113.303 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.61 159.39 34.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 117.141 0.47 . . . . 25.0 110.219 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.9 127.95 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.193 0.597 . . . . 25.0 110.101 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.63 148.52 50.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.366 0.603 . . . . 25.0 110.094 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -87.45 126.83 35.13 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.52 127.18 41.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 106.632 -1.618 . . . . 25.0 106.632 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.3 mt -108.42 -33.36 7.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.82 -0.627 . . . . 25.0 112.52 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -151.68 163.76 38.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.383 -1.34 . . . . 25.0 107.383 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -126.08 152.29 46.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.582 0.628 . . . . 25.0 110.823 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 55.25 38.77 30.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.745 1.259 . . . . 25.0 109.382 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -69.54 -12.68 61.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 115.372 1.619 . . . . 25.0 115.372 -165.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -116.07 6.67 14.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.287 0.565 . . . . 25.0 109.617 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.12 -5.93 69.57 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.731 -0.948 . . . . 25.0 110.731 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.09 124.84 30.2 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.539 -1.652 . . . . 25.0 106.539 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -62.47 132.25 51.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.635 0.731 . . . . 25.0 110.964 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.36 -0.12 85.37 Favored Glycine 0 C--O 1.222 -0.599 0 N-CA-C 115.38 0.912 . . . . 25.0 115.38 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -95.39 108.59 20.8 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.767 1.784 . . . . 25.0 110.21 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -97.8 144.28 27.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.158 -0.473 . . . . 25.0 110.977 -172.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.4 tp -82.8 111.76 19.01 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.582 -2.007 . . . . 25.0 105.582 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.1 m -114.85 163.33 15.68 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.479 -0.934 . . . . 25.0 108.479 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -125.1 132.22 53.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.457 -0.572 . . . . 25.0 109.457 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.99 140.17 13.0 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.226 -1.027 . . . . 25.0 108.226 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 57.74 27.6 14.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.823 0.82 . . . . 25.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.94 -0.63 86.72 Favored Glycine 0 N--CA 1.458 0.152 0 N-CA-C 114.445 0.538 . . . . 25.0 114.445 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -107.08 153.98 21.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -116.22 140.02 49.74 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 103.507 -2.775 . . . . 25.0 103.507 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.43 168.07 40.7 Favored Glycine 0 C--N 1.317 -0.499 0 C-N-CA 120.959 -0.639 . . . . 25.0 112.126 -176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -76.48 141.22 16.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.771 0.796 . . . . 25.0 110.005 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.21 132.99 13.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.696 -1.594 . . . . 25.0 106.696 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.2 114.47 3.78 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 116.564 -1.824 . . . . 25.0 111.548 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.4 -22.35 65.46 Favored Glycine 0 C--O 1.219 -0.838 0 N-CA-C 114.667 0.627 . . . . 25.0 114.667 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -63.67 -23.42 67.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.739 0.78 . . . . 25.0 111.21 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.92 6.41 46.33 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 121.513 -0.742 . . . . 25.0 111.377 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -118.47 152.72 35.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.2 0.524 . . . . 25.0 111.183 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -123.28 117.46 25.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.738 -0.467 . . . . 25.0 109.738 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.12 135.63 27.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.838 -0.801 . . . . 25.0 108.838 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.98 109.11 10.53 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 t 59.22 72.13 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -149.76 116.55 0.79 Allowed Glycine 0 N--CA 1.459 0.174 0 N-CA-C 110.961 -0.855 . . . . 25.0 110.961 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.3 ttm -169.59 173.49 6.36 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.01 116.49 0.05 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.565 1.691 . . . . 25.0 115.565 173.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.91 -36.59 3.25 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 114.636 1.347 . . . . 25.0 114.636 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 89.7 mttt 46.55 66.63 0.93 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.546 0.943 . . . . 25.0 113.546 -174.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -59.27 155.48 35.33 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.574 -0.739 . . . . 25.0 110.123 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.56 172.23 16.59 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 N-CA-C 113.293 0.459 . . . . 25.0 113.293 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.13 170.89 18.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.546 -1.649 . . . . 25.0 106.546 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.1 118.79 0.92 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 110.127 -1.189 . . . . 25.0 110.127 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.69 -15.71 41.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.032 0.444 . . . . 25.0 111.869 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -115.72 112.09 21.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.114 0.783 . . . . 25.0 113.114 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.4 pt -131.81 155.22 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 104.636 -2.357 . . . . 25.0 104.636 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.3 m -141.39 156.9 21.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.717 -1.216 . . . . 25.0 107.717 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.1 p -135.12 -69.6 0.5 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.409 0.623 . . . . 25.0 110.14 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 C--O 1.204 -1.3 0 CA-C-O 124.162 1.934 . . . . 25.0 112.244 -173.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 CA-C-O 124.96 2.422 . . . . 25.0 113.659 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -83.93 95.22 8.44 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 113.159 -1.521 . . . . 25.0 111.544 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.6 ttt -126.36 137.78 53.49 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -164.04 116.16 1.37 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.487 0.315 . . . . 25.0 111.224 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -147.23 165.92 28.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.136 -2.172 . . . . 25.0 105.136 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.14 -42.98 83.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.419 0.554 . . . . 25.0 110.102 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.1 t30 50.86 46.12 26.54 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.069 0.856 . . . . 25.0 113.089 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.8 m -111.46 169.99 3.87 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 103.717 -2.697 . . . . 25.0 103.717 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.97 159.81 41.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.181 0.901 . . . . 25.0 111.178 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.12 151.03 40.27 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.063 -0.971 . . . . 25.0 111.404 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -97.39 131.62 43.89 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.306 -1.368 . . . . 25.0 107.306 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.16 138.62 43.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.649 0.738 . . . . 25.0 109.544 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -96.38 -21.4 17.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.41 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -128.33 160.17 33.02 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.435 -1.32 . . . . 25.0 107.435 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.7 p-10 -100.5 153.03 19.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -156.37 151.6 26.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.568 -0.742 . . . . 25.0 110.937 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -116.13 150.69 18.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 106.761 -1.57 . . . . 25.0 106.761 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.62 110.51 16.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.385 -1.339 . . . . 25.0 107.385 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -93.89 -8.84 39.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 t -134.8 149.02 69.52 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.734 -1.58 . . . . 25.0 106.734 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.76 -18.9 41.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 116.687 -1.742 . . . . 25.0 113.666 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.57 -15.7 58.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.194 0.521 . . . . 25.0 110.817 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -92.39 143.21 26.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.041 0.536 . . . . 25.0 110.703 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.08 133.83 35.85 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.706 -0.798 . . . . 25.0 111.098 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.2 p -82.29 137.59 34.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.974 -1.491 . . . . 25.0 106.974 171.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.406 ' CE2' HG13 ' A' ' 57' ' ' VAL . 36.8 p90 -156.49 165.77 35.36 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -124.78 155.13 39.86 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.574 -0.703 . . . . 25.0 110.932 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.456 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.3 pttp -59.1 128.05 35.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.91 -12.19 68.8 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 115.703 -0.68 . . . . 25.0 113.903 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -79.37 158.02 27.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.039 -0.726 . . . . 25.0 109.039 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -120.66 127.63 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.957 -0.386 . . . . 25.0 109.957 -174.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -134.69 152.27 51.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 25.0 111.873 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 m -86.84 133.86 33.6 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.5 t -98.72 121.42 49.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -93.64 -42.31 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.682 -0.69 . . . . 25.0 110.988 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.11 164.61 30.71 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 -173.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -132.01 150.04 52.26 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 106.466 -1.679 . . . . 25.0 106.466 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 58.28 39.91 25.15 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.81 1.319 . . . . 25.0 108.675 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -70.46 -14.22 62.45 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 113.808 -1.542 . . . . 25.0 114.35 -169.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -116.39 11.13 14.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.996 -0.547 . . . . 25.0 109.704 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.43 -6.8 63.11 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 110.806 -0.918 . . . . 25.0 110.806 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -86.0 118.13 25.28 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.429 -0.952 . . . . 25.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.5 128.78 38.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.793 -0.818 . . . . 25.0 108.793 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.12 78.55 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 115.779 1.071 . . . . 25.0 115.779 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -104.13 112.83 26.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.541 1.671 . . . . 25.0 110.046 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -107.82 142.73 37.42 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.228 -0.295 . . . . 25.0 111.643 -170.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.95 116.09 22.63 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.43 -1.322 . . . . 25.0 107.43 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.5 m -117.97 169.53 9.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.727 -0.215 . . . . 25.0 110.443 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -133.11 129.1 37.5 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.66 -0.496 . . . . 25.0 109.66 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.2 tp -161.04 155.47 23.22 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.4 t60 60.03 23.55 12.72 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.801 0.667 . . . . 25.0 112.801 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.08 11.56 85.25 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 25.0 114.051 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -142.28 162.84 34.44 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.0 -0.37 . . . . 25.0 110.0 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -110.72 155.85 21.89 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.224 -1.028 . . . . 25.0 108.224 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.45 165.97 37.15 Favored Glycine 0 C--O 1.24 0.523 0 N-CA-C 110.179 -1.168 . . . . 25.0 110.179 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -79.25 147.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.387 0.613 . . . . 25.0 109.851 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 26' ' ' PHE . 86.5 t -142.46 131.81 12.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.289 -1.374 . . . . 25.0 107.289 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.07 121.84 8.69 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 114.882 -2.945 . . . . 25.0 111.326 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -22.8 61.74 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 115.954 -0.566 . . . . 25.0 113.686 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -65.67 -13.01 58.34 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.091 -0.652 . . . . 25.0 112.418 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -103.18 7.98 38.57 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.958 -0.464 . . . . 25.0 110.747 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -118.64 152.82 35.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.612 0.72 . . . . 25.0 111.044 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -126.87 117.72 23.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.646 -1.242 . . . . 25.0 107.646 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.1 mm -57.8 135.41 21.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.705 -0.85 . . . . 25.0 108.705 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mt -106.1 -176.24 3.02 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t 73.6 92.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.434 1.494 . . . . 25.0 111.622 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.9 -38.73 0.97 Allowed Glycine 0 C--O 1.226 -0.403 0 CA-C-N 114.993 -1.003 . . . . 25.0 114.419 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 20.8 mmt -139.27 114.92 9.96 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 52.72 45.25 29.06 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.645 -0.707 . . . . 25.0 112.34 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -59.49 -40.73 87.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.804 1.409 . . . . 25.0 114.804 -171.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -156.2 166.11 34.4 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.096 0.474 . . . . 25.0 110.896 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.09 158.17 32.29 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.441 -2.059 . . . . 25.0 105.441 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.75 149.88 67.53 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 116.396 -1.936 . . . . 25.0 112.74 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.1 165.63 29.32 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.839 -2.652 . . . . 25.0 103.839 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.97 155.62 35.16 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.001 -2.039 . . . . 25.0 108.001 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -89.24 141.57 28.41 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.69 131.94 35.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.953 -0.567 . . . . 25.0 112.404 -173.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.95 131.68 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 105.554 -2.017 . . . . 25.0 105.554 174.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.7 m -105.95 146.67 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.243 -1.392 . . . . 25.0 107.243 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.9 m -154.0 95.88 1.9 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.707 0.765 . . . . 25.0 109.137 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.213 -0.851 0 CA-C-O 124.037 1.875 . . . . 25.0 112.62 -178.405 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.041 0 CA-C-O 124.51 2.172 . . . . 25.0 113.733 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -148.71 126.02 11.53 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 113.384 -1.408 . . . . 25.0 108.269 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.5 mmm -76.4 118.35 19.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.82 -0.437 . . . . 25.0 109.82 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -157.77 162.65 38.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.168 -0.308 . . . . 25.0 110.168 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -146.81 168.13 22.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 103.666 -2.716 . . . . 25.0 103.666 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.61 -42.65 74.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.754 0.706 . . . . 25.0 109.369 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 t30 46.91 46.91 15.71 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.988 1.107 . . . . 25.0 113.988 176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.93 125.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.671 -1.233 . . . . 25.0 107.671 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -82.01 154.4 25.7 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.81 0.814 . . . . 25.0 108.975 -175.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.62 161.63 35.37 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.498 -1.228 . . . . 25.0 108.231 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -113.11 133.87 54.81 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.112 -1.07 . . . . 25.0 108.112 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.76 123.44 24.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.433 0.635 . . . . 25.0 109.797 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -82.46 -29.96 30.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.783 -0.644 . . . . 25.0 109.989 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -132.4 164.06 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.38 -1.341 . . . . 25.0 107.38 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.599 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.3 p-10 -99.22 166.62 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.487 -0.19 . . . . 25.0 110.487 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -148.15 160.53 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.711 -0.477 . . . . 25.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -126.54 118.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 102.855 -3.017 . . . . 25.0 102.855 171.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 144.27 43.17 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.9 -0.407 . . . . 25.0 109.9 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.99 -33.89 3.85 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 25.0 110.002 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.1 t -81.03 146.75 59.69 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.969 -1.122 . . . . 25.0 107.969 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.88 -13.76 29.32 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 117.493 -1.205 . . . . 25.0 114.058 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -86.79 -15.65 38.65 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.875 0.845 . . . . 25.0 109.762 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -85.24 137.31 33.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.474 0.654 . . . . 25.0 111.253 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.56 134.69 34.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.33 0.586 . . . . 25.0 111.105 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -84.29 114.05 21.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CE2' HG13 ' A' ' 57' ' ' VAL . 55.2 p90 -140.14 161.06 38.55 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -131.08 164.11 26.16 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.936 0.398 . . . . 25.0 111.887 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.599 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 49.5 pttt -60.23 137.68 58.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.179 0.514 . . . . 25.0 110.712 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.96 -23.82 31.36 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.236 -0.893 . . . . 25.0 112.679 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -70.47 157.67 37.43 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 122.572 0.349 . . . . 25.0 111.407 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.13 127.47 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.308 0.643 . . . . 25.0 110.017 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -136.46 146.91 46.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.308 -0.256 . . . . 25.0 110.308 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 37.4 m -90.1 122.94 33.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 25.0 110.081 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -82.95 121.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 107.297 -1.371 . . . . 25.0 107.297 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -90.16 -45.91 8.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.751 -0.659 . . . . 25.0 110.067 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -153.5 171.89 18.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 25.0 109.388 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -130.19 155.53 46.1 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 105.884 -1.895 . . . . 25.0 105.884 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.3 t0 60.57 41.12 15.94 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 123.19 1.471 . . . . 25.0 108.905 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -70.72 -18.53 62.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.806 -1.543 . . . . 25.0 114.181 -173.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -120.27 8.88 10.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.182 0.438 . . . . 25.0 112.182 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.79 7.88 85.2 Favored Glycine 0 CA--C 1.517 0.213 0 N-CA-C 109.642 -1.383 . . . . 25.0 109.642 -174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.9 mt -113.54 110.03 19.6 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.066 -1.457 . . . . 25.0 107.066 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -66.77 147.83 52.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.6 -22.27 40.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.457 -0.792 . . . . 25.0 112.466 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -93.18 132.01 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.208 1.004 . . . . 25.0 108.95 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -119.4 139.7 51.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.596 -0.89 . . . . 25.0 108.596 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.08 121.86 28.0 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 106.257 -1.757 . . . . 25.0 106.257 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.8 m -123.04 156.31 35.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.944 -0.391 . . . . 25.0 109.944 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.0 p -117.18 131.15 56.93 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.708 -1.219 . . . . 25.0 107.708 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.83 131.78 13.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.419 -0.81 . . . . 25.0 108.856 -172.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 52.91 37.41 24.27 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.659 0.985 . . . . 25.0 113.659 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.36 3.45 85.94 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 121.096 -0.573 . . . . 25.0 114.476 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -118.08 167.2 11.69 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 106.495 -1.668 . . . . 25.0 106.495 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -134.03 157.37 46.28 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.024 -1.473 . . . . 25.0 107.024 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.1 171.49 43.95 Favored Glycine 0 C--O 1.242 0.625 0 N-CA-C 109.315 -1.514 . . . . 25.0 109.315 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.85 144.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.703 0.763 . . . . 25.0 110.507 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG13 ' CE2' ' A' ' 26' ' ' PHE . 79.0 t -138.62 134.82 17.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 107.766 -1.198 . . . . 25.0 107.766 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 119.48 6.34 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 115.1 -2.8 . . . . 25.0 110.812 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.56 -21.31 62.48 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 115.009 0.764 . . . . 25.0 115.009 -174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.99 -28.58 67.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.91 0.386 . . . . 25.0 111.281 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -89.39 8.98 27.96 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.718 0.636 . . . . 25.0 112.718 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.23 151.51 39.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.249 0.547 . . . . 25.0 112.394 -176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -122.93 117.67 26.08 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.75 -0.833 . . . . 25.0 108.75 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.0 mm -63.19 134.13 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.015 -1.106 . . . . 25.0 108.015 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.84 116.8 24.31 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.549 -0.908 . . . . 25.0 108.549 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.4 t -95.77 128.45 46.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.157 -1.053 . . . . 25.0 108.157 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.64 42.0 0.33 Allowed Glycine 0 C--O 1.225 -0.428 0 C-N-CA 121.433 -0.413 . . . . 25.0 112.288 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -133.8 165.65 24.49 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.94 -0.763 . . . . 25.0 108.94 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -65.63 148.93 50.94 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.153 0.283 . . . . 25.0 110.943 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.01 148.47 50.07 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.636 0.731 . . . . 25.0 110.704 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -72.17 161.72 30.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.257 -0.883 . . . . 25.0 112.71 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.52 168.9 15.69 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.904 -1.517 . . . . 25.0 106.904 172.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.52 171.02 13.75 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 115.91 -2.26 . . . . 25.0 110.043 170.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.37 136.33 43.31 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 106.87 -1.53 . . . . 25.0 106.87 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.87 164.32 38.2 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 108.767 -1.733 . . . . 25.0 108.767 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -154.74 -48.95 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.922 0.342 . . . . 25.0 111.922 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -133.18 163.87 28.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.786 0.326 . . . . 25.0 110.481 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.9 tt -82.91 155.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.018 -0.734 . . . . 25.0 109.018 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.64 133.77 65.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.374 -1.343 . . . . 25.0 107.374 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.2 m 56.67 66.07 1.27 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.307 1.051 . . . . 25.0 113.629 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 124.718 2.199 . . . . 25.0 111.141 173.844 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 CA-C-O 123.364 1.535 . . . . 25.0 115.644 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -77.09 18.75 0.35 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 114.874 1.435 . . . . 25.0 114.874 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.8 ttt -124.58 131.2 53.49 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.311 -0.626 . . . . 25.0 109.311 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt 54.88 59.36 4.11 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 123.818 0.699 . . . . 25.0 112.618 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -65.33 159.44 23.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.494 -0.928 . . . . 25.0 108.494 173.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.3 mt -63.72 -42.04 97.98 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.852 -0.425 . . . . 25.0 109.852 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.0 t30 51.23 38.85 22.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.283 -0.871 . . . . 25.0 112.485 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.19 170.5 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 104.327 -2.472 . . . . 25.0 104.327 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.85 153.46 51.72 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 118.879 0.763 . . . . 25.0 110.54 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -134.67 149.47 50.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.998 -1.001 . . . . 25.0 110.93 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -95.34 131.39 41.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.529 -1.285 . . . . 25.0 107.529 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.41 136.63 42.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.9 mt -96.43 -20.59 18.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.441 -0.799 . . . . 25.0 109.64 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -134.03 159.66 40.1 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.636 -0.876 . . . . 25.0 108.636 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 5.6 p-10 -100.36 156.66 17.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.013 0.525 . . . . 25.0 109.663 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -155.34 161.13 41.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.738 -0.665 . . . . 25.0 110.577 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 p -122.72 147.76 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 104.708 -2.33 . . . . 25.0 104.708 174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.97 114.91 22.5 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.778 -0.823 . . . . 25.0 108.778 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -93.2 -8.49 42.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.231 -1.025 . . . . 25.0 108.231 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 t -129.85 148.14 68.33 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.939 -1.134 . . . . 25.0 107.939 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.53 -12.45 31.46 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 117.211 -1.393 . . . . 25.0 113.248 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -85.89 -14.19 45.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.932 0.872 . . . . 25.0 110.013 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -94.41 147.84 22.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.818 -0.628 . . . . 25.0 109.931 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.08 137.79 34.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.149 0.5 . . . . 25.0 111.233 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -87.37 116.7 25.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.691 -1.226 . . . . 25.0 107.691 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.423 ' CE1' HG13 ' A' ' 57' ' ' VAL . 47.9 p90 -135.07 162.56 32.13 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 80.0 mtm-85 -131.38 154.01 49.07 Favored 'General case' 0 CA--C 1.505 -0.772 0 O-C-N 121.958 -0.463 . . . . 25.0 111.009 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.455 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 21.1 pttp -58.89 131.89 52.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.134 0.492 . . . . 25.0 109.938 177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.92 -19.52 53.57 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.426 -0.806 . . . . 25.0 113.374 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -75.35 159.11 31.81 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.275 0.537 . . . . 25.0 110.312 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.5 mm -119.38 127.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.123 -0.695 . . . . 25.0 109.123 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptp -133.83 149.35 51.38 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.0 0.429 . . . . 25.0 111.767 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.7 m -79.9 136.31 36.63 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.301 -1.0 . . . . 25.0 108.301 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -104.38 120.8 55.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.79 -45.64 10.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 25.0 111.322 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.27 171.84 18.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.459 -1.312 . . . . 25.0 107.459 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.66 154.75 44.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 110.302 -0.259 . . . . 25.0 110.302 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 57.57 35.53 25.85 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 125.032 1.458 . . . . 25.0 109.472 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -70.48 -20.48 62.86 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 113.676 -1.602 . . . . 25.0 113.513 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -99.4 0.98 43.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.376 0.608 . . . . 25.0 110.193 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 -6.02 67.48 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 109.787 -1.325 . . . . 25.0 109.787 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.7 mt -88.25 126.81 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.827 -1.546 . . . . 25.0 106.827 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -61.02 131.15 49.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.375 0.607 . . . . 25.0 109.899 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.69 0.66 90.24 Favored Glycine 0 C--O 1.219 -0.788 0 CA-C-O 118.428 -1.207 . . . . 25.0 116.055 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -97.43 110.76 23.25 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.125 1.962 . . . . 25.0 110.93 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.78 144.85 30.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 25.0 111.058 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.6 tp -82.95 118.0 23.17 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.3 m -119.86 167.76 11.79 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.479 -0.563 . . . . 25.0 109.479 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -134.0 130.86 38.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.851 0.358 . . . . 25.0 110.238 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 tp -160.75 152.34 19.5 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 106.976 -1.49 . . . . 25.0 106.976 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.2 m80 58.69 24.16 11.86 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.784 1.031 . . . . 25.0 113.784 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.76 82.4 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.665 -0.779 . . . . 25.0 112.295 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -125.13 167.13 15.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.629 -1.619 . . . . 25.0 106.629 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -134.78 150.55 50.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 105.123 -2.176 . . . . 25.0 105.123 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.1 171.08 43.93 Favored Glycine 0 C--O 1.241 0.532 0 N-CA-C 110.682 -0.967 . . . . 25.0 110.682 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 pt -78.41 143.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.303 0.573 . . . . 25.0 111.157 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 26' ' ' PHE . 71.0 t -141.44 134.23 14.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.81 118.69 5.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 114.987 -2.875 . . . . 25.0 111.472 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.55 -21.24 66.68 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 114.772 0.669 . . . . 25.0 114.772 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -64.42 -21.81 66.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.571 . . . . 25.0 110.83 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -91.91 9.86 31.21 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.992 -0.443 . . . . 25.0 111.152 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.1 mt -125.36 155.04 40.93 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.78 0.432 . . . . 25.0 110.404 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -129.19 117.68 21.16 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.497 HD13 ' HB2' ' A' ' 10' ' ' ALA . 9.7 mm -67.88 133.72 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.247 -0.649 . . . . 25.0 109.247 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.88 121.59 22.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.0 t 50.48 45.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 115.093 -0.958 . . . . 25.0 111.862 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.81 7.67 8.94 Favored Glycine 0 C--O 1.225 -0.446 0 N-CA-C 116.815 1.486 . . . . 25.0 116.815 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 54.6 ttp -148.62 101.95 3.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.781 0.791 . . . . 25.0 109.33 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -157.36 111.41 2.63 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 112.154 0.427 . . . . 25.0 112.154 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -76.65 152.27 35.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.71 0.29 . . . . 25.0 111.675 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -142.33 -37.94 0.38 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.643 1.349 . . . . 25.0 114.643 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.66 151.95 57.92 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 122.122 -0.361 . . . . 25.0 110.134 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.14 170.54 19.91 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 117.939 -0.907 . . . . 25.0 110.51 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.28 147.83 51.64 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.758 -0.83 . . . . 25.0 108.758 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.96 -179.93 45.85 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 108.8 -1.72 . . . . 25.0 108.8 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.83 164.08 26.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.73 125.05 49.94 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.42 -0.956 . . . . 25.0 108.42 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.1 pt -79.43 161.87 4.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.794 -0.639 . . . . 25.0 111.849 -175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.32 19.02 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.28 -0.873 . . . . 25.0 109.39 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.9 p -117.61 124.29 48.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.553 -0.749 . . . . 25.0 110.697 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 C--O 1.215 -0.733 0 CA-C-O 124.245 1.974 . . . . 25.0 111.249 178.045 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.101 0 N-CA-C 115.817 1.087 . . . . 25.0 115.817 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m 60.87 2.01 0.5 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.672 1.989 . . . . 25.0 116.049 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.3 ttt -146.62 124.13 11.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -111.74 -31.7 6.88 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.114 0.483 . . . . 25.0 110.095 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -147.81 173.23 13.01 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 102.403 -3.184 . . . . 25.0 102.403 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.8 mt -58.43 -47.56 83.55 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 115.14 1.534 . . . . 25.0 115.14 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.9 t30 49.52 41.99 22.06 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.316 1.228 . . . . 25.0 114.316 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.82 166.38 5.52 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 N-CA-C 105.186 -2.153 . . . . 25.0 105.186 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 155.98 45.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.147 0.499 . . . . 25.0 110.108 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.45 144.69 33.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.75 -0.659 . . . . 25.0 112.107 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -90.84 135.45 33.72 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.767 -0.827 . . . . 25.0 108.767 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.56 121.27 22.16 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.89 0.744 . . . . 25.0 109.118 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.98 -26.43 27.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.147 -0.479 . . . . 25.0 110.324 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.29 163.87 26.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.0 p-10 -97.21 157.66 15.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.975 -0.75 . . . . 25.0 108.975 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -147.17 131.14 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.936 0.495 . . . . 25.0 110.492 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -100.87 121.97 52.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 101.616 -3.475 . . . . 25.0 101.616 168.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 143.09 48.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.977 -0.749 . . . . 25.0 108.977 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -110.92 -26.29 9.38 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 123.479 0.487 . . . . 25.0 110.058 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.6 t -97.02 146.26 31.0 Favored Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 108.366 -0.976 . . . . 25.0 108.366 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.55 -14.95 27.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 116.763 -1.691 . . . . 25.0 113.153 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.47 -15.54 57.6 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 122.969 0.508 . . . . 25.0 110.58 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -93.73 143.46 26.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.318 0.647 . . . . 25.0 111.864 -171.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.15 133.13 35.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 25.0 110.729 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 84.0 6.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.849 0.833 . . . . 25.0 108.947 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.522 ' CE1' HG13 ' A' ' 57' ' ' VAL . 36.3 p90 -93.88 162.99 13.69 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.636 -0.875 . . . . 25.0 108.636 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -126.26 155.96 41.07 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.252 0.549 . . . . 25.0 110.795 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.7 ptmt -57.95 132.85 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.395 -0.821 . . . . 25.0 109.922 -178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.05 -21.44 46.01 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-O 119.014 -0.881 . . . . 25.0 114.245 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -74.93 160.59 30.42 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.61 133.51 61.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.284 -1.006 . . . . 25.0 108.284 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.67 148.68 52.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 25.0 110.889 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -81.0 127.26 32.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -91.15 122.17 42.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.3 mt -96.93 -41.09 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.123 -0.944 . . . . 25.0 111.884 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.46 157.69 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -134.29 147.26 50.59 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.013 -1.477 . . . . 25.0 107.013 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.0 t0 59.29 38.93 23.03 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 123.98 1.848 . . . . 25.0 107.335 -170.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -69.32 -11.8 61.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.322 -1.763 . . . . 25.0 114.626 -169.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -129.77 15.11 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.131 0.491 . . . . 25.0 110.806 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.83 22.26 77.23 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 109.514 -1.434 . . . . 25.0 109.514 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.93 114.06 21.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.788 -1.93 . . . . 25.0 105.788 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -59.52 141.16 55.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.882 0.849 . . . . 25.0 109.456 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.8 -11.8 38.96 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-O 118.92 -0.933 . . . . 25.0 115.1 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.2 130.78 40.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.474 1.637 . . . . 25.0 110.422 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -119.92 149.39 42.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.593 -0.521 . . . . 25.0 109.593 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.1 tp -89.8 120.46 31.07 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 106.436 -1.69 . . . . 25.0 106.436 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.5 m -122.23 155.64 35.45 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 121.026 -0.269 . . . . 25.0 110.568 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 p -111.69 125.81 54.36 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.362 -0.607 . . . . 25.0 109.362 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.3 tp -152.93 143.62 22.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.834 -1.172 . . . . 25.0 107.834 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 t60 57.87 26.1 12.86 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.582 0.706 . . . . 25.0 112.73 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.21 9.17 87.18 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.491 -0.861 . . . . 25.0 114.474 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -128.24 163.25 25.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.693 -0.484 . . . . 25.0 109.693 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.05 149.54 38.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.088 -1.079 . . . . 25.0 108.088 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 171.21 42.86 Favored Glycine 0 C--O 1.241 0.561 0 N-CA-C 108.887 -1.685 . . . . 25.0 108.887 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -86.81 146.4 6.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.67 0.748 . . . . 25.0 110.226 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.522 HG13 ' CE1' ' A' ' 26' ' ' PHE . 54.7 t -139.42 133.67 16.04 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.412 -0.813 . . . . 25.0 109.067 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.99 115.49 4.01 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 115.278 -2.682 . . . . 25.0 110.536 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.6 -17.56 66.96 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 115.051 0.78 . . . . 25.0 115.051 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.16 -17.92 64.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.258 1.029 . . . . 25.0 111.436 175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -90.78 5.61 47.61 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.81 -0.556 . . . . 25.0 110.658 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.29 151.58 37.41 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.541 0.525 . . . . 25.0 111.328 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -122.1 117.46 26.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.419 -0.956 . . . . 25.0 108.419 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm -59.52 133.72 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.86 -1.163 . . . . 25.0 107.86 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.4 -170.68 2.05 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.007 0.817 . . . . 25.0 108.936 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -63.58 147.67 12.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.884 -0.326 . . . . 25.0 111.706 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.73 104.93 0.53 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.224 -0.513 . . . . 25.0 113.317 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -139.45 152.86 47.36 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.551 -1.648 . . . . 25.0 106.551 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -80.9 125.48 30.17 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -153.06 161.0 43.02 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 107.136 -1.431 . . . . 25.0 107.136 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 90.7 mttt 62.19 -167.68 0.2 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.63 1.205 . . . . 25.0 113.819 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -67.39 155.1 91.7 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.474 -1.239 . . . . 25.0 108.479 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.77 169.75 15.44 Favored 'Trans proline' 0 C--N 1.348 0.551 0 O-C-N 122.431 0.701 . . . . 25.0 113.627 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.37 146.56 47.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.384 -0.826 . . . . 25.0 111.134 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.49 56.29 2.72 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.56 -0.745 . . . . 25.0 114.478 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -85.42 118.42 24.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.532 0.666 . . . . 25.0 109.596 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -150.73 -2.22 0.36 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.077 0.769 . . . . 25.0 113.077 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.6 mt -96.23 123.42 48.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.065 -1.087 . . . . 25.0 108.065 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.6 m -92.34 150.67 3.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 t -154.24 -51.44 0.09 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.064 0.459 . . . . 25.0 109.942 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 124.557 2.123 . . . . 25.0 111.561 178.186 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.007 0 CA-C-O 123.346 1.526 . . . . 25.0 114.596 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -144.45 142.58 30.39 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 120.948 -1.325 . . . . 25.0 108.664 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.0 ttp -154.0 156.98 38.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.499 -1.667 . . . . 25.0 106.499 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -117.3 127.91 54.54 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.568 -0.901 . . . . 25.0 108.568 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.0 173.74 7.59 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.086 -0.709 . . . . 25.0 109.086 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.57 -43.52 93.58 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.052 -0.721 . . . . 25.0 109.052 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 51.08 45.45 27.79 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.491 1.116 . . . . 25.0 112.906 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.72 163.48 6.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 N-CA-C 105.478 -2.045 . . . . 25.0 105.478 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.13 148.57 52.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.235 1.017 . . . . 25.0 111.13 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.64 157.72 44.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.269 -1.332 . . . . 25.0 108.981 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -111.16 134.26 52.89 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.713 -0.847 . . . . 25.0 108.713 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.91 130.44 42.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.44 -26.8 19.66 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.857 -0.794 . . . . 25.0 108.857 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -126.05 158.33 35.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.545 -1.28 . . . . 25.0 107.545 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 4.4 p-10 -90.58 160.52 15.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.733 -1.581 . . . . 25.0 106.733 174.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -143.8 168.01 20.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 25.0 110.069 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.56 120.91 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 101.929 -3.359 . . . . 25.0 101.929 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 122.27 23.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.188 -1.042 . . . . 25.0 108.188 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -104.32 -21.14 13.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.888 -0.596 . . . . 25.0 111.325 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.3 m -102.26 150.35 37.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.443 -0.947 . . . . 25.0 108.443 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.83 -21.1 33.61 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 116.204 -2.064 . . . . 25.0 113.369 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.57 -8.02 58.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.177 -0.465 . . . . 25.0 111.477 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -90.05 140.93 29.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.672 0.273 . . . . 25.0 110.601 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mt -85.02 137.88 32.79 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.826 -0.546 . . . . 25.0 110.843 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -91.67 118.46 30.66 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.916 -1.142 . . . . 25.0 107.916 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.67 170.9 14.84 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.079 -0.712 . . . . 25.0 109.079 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.5 158.13 40.78 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 109.175 -0.676 . . . . 25.0 109.175 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.8 pttp -59.27 129.81 43.88 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -20.8 42.9 Favored Glycine 0 C--O 1.222 -0.604 0 CA-C-N 115.507 -0.77 . . . . 25.0 113.293 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.0 149.42 50.27 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 117.599 0.7 . . . . 25.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -114.13 127.68 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.457 -0.942 . . . . 25.0 108.457 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.8 ptp -137.81 147.7 44.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.824 0.345 . . . . 25.0 110.368 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 m -84.38 130.82 34.75 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 107.912 -1.144 . . . . 25.0 107.912 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.22 125.92 47.8 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 N-CA-C 107.39 -1.337 . . . . 25.0 107.39 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.77 -39.04 7.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.595 -0.729 . . . . 25.0 112.253 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -146.0 161.61 39.7 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.071 -0.715 . . . . 25.0 109.071 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -125.78 150.42 47.78 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 109.139 -0.689 . . . . 25.0 109.139 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 54.2 37.19 26.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.496 1.617 . . . . 25.0 108.889 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.3 t -69.55 -12.67 61.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 112.842 -1.981 . . . . 25.0 114.188 -169.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.82 7.91 17.21 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.219 -0.659 . . . . 25.0 109.219 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.42 -17.42 13.97 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.882 -0.887 . . . . 25.0 110.882 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.98 127.13 31.59 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.343 -1.355 . . . . 25.0 107.343 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -62.8 135.11 57.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.733 0.778 . . . . 25.0 110.459 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.05 -0.07 89.02 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-O 119.181 -0.788 . . . . 25.0 114.805 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -97.95 104.76 16.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.221 1.51 . . . . 25.0 110.534 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -94.82 147.59 23.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 25.0 111.371 -173.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -85.99 117.27 24.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.948 -1.871 . . . . 25.0 105.948 174.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.7 m -115.89 162.14 17.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.539 -0.912 . . . . 25.0 108.539 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -122.64 124.94 44.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.519 -0.919 . . . . 25.0 108.519 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.5 tp -155.65 139.81 16.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.989 -0.745 . . . . 25.0 108.989 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 54.48 38.16 29.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.943 0.877 . . . . 25.0 113.049 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.07 0.7 77.39 Favored Glycine 0 N--CA 1.464 0.536 0 N-CA-C 115.129 0.812 . . . . 25.0 115.129 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -119.25 154.41 33.49 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 109.135 -0.691 . . . . 25.0 109.135 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -110.35 148.12 32.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 104.441 -2.429 . . . . 25.0 104.441 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.72 168.82 41.64 Favored Glycine 0 C--O 1.243 0.706 0 N-CA-C 111.39 -0.684 . . . . 25.0 111.39 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -78.26 142.91 13.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.877 0.846 . . . . 25.0 109.964 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.6 t -141.17 134.57 14.61 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.469 -1.308 . . . . 25.0 107.469 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.39 114.69 4.01 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 114.659 -3.094 . . . . 25.0 112.319 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 -23.07 63.49 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 114.263 0.465 . . . . 25.0 114.263 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.0 -25.46 67.65 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.267 -0.549 . . . . 25.0 111.206 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -92.19 8.34 38.5 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 112.266 0.469 . . . . 25.0 112.266 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -116.71 149.99 38.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 25.0 112.326 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.47 118.77 28.18 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.408 -0.59 . . . . 25.0 109.408 174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.09 138.31 20.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.634 -0.876 . . . . 25.0 108.634 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.55 70.11 2.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.522 0.677 . . . . 25.0 111.46 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.56 124.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.814 -1.18 . . . . 25.0 107.814 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.15 22.06 62.42 Favored Glycine 0 C--O 1.217 -0.909 0 CA-C-O 119.608 -0.551 . . . . 25.0 113.028 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 79.1 mtp 51.02 37.11 16.9 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.926 0.49 . . . . 25.0 111.452 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.7 t80 64.29 58.77 1.08 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.694 0.759 . . . . 25.0 110.975 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -56.04 119.02 5.21 Favored 'General case' 0 C--O 1.253 1.285 0 N-CA-C 107.982 -1.118 . . . . 25.0 107.982 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -118.9 113.68 21.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.253 -0.885 . . . . 25.0 110.323 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -71.31 150.34 94.21 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 106.345 -1.724 . . . . 25.0 106.345 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.32 -27.01 20.04 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 117.358 -1.294 . . . . 25.0 114.158 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 140.86 44.6 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.784 -0.821 . . . . 25.0 108.784 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.03 176.54 48.11 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.575 -1.41 . . . . 25.0 109.575 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.93 173.78 11.85 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 103.305 -2.85 . . . . 25.0 103.305 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.6 t80 58.72 84.1 0.11 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.511 1.148 . . . . 25.0 112.101 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.7 pt -127.96 159.06 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.277 -1.009 . . . . 25.0 108.277 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.88 81.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 104.372 -2.455 . . . . 25.0 104.372 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.3 m -123.17 -50.82 1.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.287 -0.869 . . . . 25.0 110.928 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 t70 . . . . . 0 C--O 1.209 -1.028 0 CA-C-O 124.631 2.158 . . . . 25.0 111.6 -177.041 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 CA-C-O 122.791 1.217 . . . . 25.0 115.308 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -62.04 129.25 40.0 Favored 'General case' 0 C--O 1.231 0.095 0 O-C-N 121.318 -1.107 . . . . 25.0 110.855 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.6 ttm -64.22 142.45 58.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.09 0.471 . . . . 25.0 111.938 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -153.77 -45.01 0.09 Allowed 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 123.253 0.621 . . . . 25.0 109.734 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.62 159.04 16.08 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt -65.31 -46.96 78.26 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.377 0.423 . . . . 25.0 111.44 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.7 t30 49.33 46.93 22.85 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.6 m -109.81 169.98 3.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.97 158.76 43.62 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.382 -0.599 . . . . 25.0 109.382 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.37 149.64 34.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.746 -0.661 . . . . 25.0 112.091 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.18 134.38 37.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.964 -0.562 . . . . 25.0 109.827 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.78 132.0 42.14 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.209 0.528 . . . . 25.0 109.676 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.9 mt -96.9 -23.95 16.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.636 -0.711 . . . . 25.0 109.605 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.06 161.45 26.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.274 -1.38 . . . . 25.0 107.274 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.567 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.4 p-10 -102.16 162.37 12.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.269 -0.641 . . . . 25.0 109.269 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -151.96 159.11 43.86 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 123.507 0.504 . . . . 25.0 111.163 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -121.62 133.2 68.83 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 110.6 7.03 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -78.46 -35.4 46.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.012 -1.449 . . . . 25.0 107.708 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.7 m -119.36 154.55 54.08 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 114.971 -1.013 . . . . 25.0 109.824 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.5 -15.94 34.37 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.661 -1.093 . . . . 25.0 113.697 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.79 -10.2 58.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 25.0 110.698 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -94.29 144.16 25.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.039 -0.726 . . . . 25.0 109.039 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.46 135.24 33.57 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.774 -0.77 . . . . 25.0 110.21 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -85.27 125.08 32.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.842 -1.91 . . . . 25.0 105.842 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -148.81 163.72 36.56 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.028 -1.471 . . . . 25.0 107.028 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -129.52 159.03 37.59 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.224 0.535 . . . . 25.0 110.803 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.9 pttp -59.2 132.5 54.2 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.816 -1.179 . . . . 25.0 107.816 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.99 -23.34 32.52 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.783 -0.644 . . . . 25.0 113.06 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.35 163.28 26.58 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.073 0.437 . . . . 25.0 110.207 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.01 132.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.7 ptp -133.4 153.5 51.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 25.0 110.585 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -88.18 131.02 34.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.289 -0.634 . . . . 25.0 109.289 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.3 t -96.06 124.18 48.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.09 -42.2 8.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.771 -0.649 . . . . 25.0 112.096 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -146.38 159.75 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.009 -0.737 . . . . 25.0 109.009 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -129.91 151.28 50.65 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t0 58.83 39.6 23.83 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.144 1.45 . . . . 25.0 107.973 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -71.29 -13.8 62.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.854 -1.521 . . . . 25.0 112.859 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -119.46 4.88 11.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.961 0.726 . . . . 25.0 112.961 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.37 20.34 69.58 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 110.086 -1.206 . . . . 25.0 110.086 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.57 113.76 15.23 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 106.337 -1.727 . . . . 25.0 106.337 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -64.84 141.78 58.66 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.483 -1.302 . . . . 25.0 107.483 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.57 -15.43 63.33 Favored Glycine 0 C--O 1.209 -1.406 0 CA-C-O 118.441 -1.199 . . . . 25.0 113.377 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -98.57 125.23 43.74 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.658 1.729 . . . . 25.0 109.798 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -119.61 146.96 45.06 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.941 -0.392 . . . . 25.0 109.941 -172.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.1 tp -85.43 116.2 23.6 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.624 -1.251 . . . . 25.0 107.624 176.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -115.31 167.19 11.07 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.641 0.258 . . . . 25.0 110.652 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.8 m -131.62 132.94 44.45 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.448 -0.575 . . . . 25.0 109.448 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 tp -160.24 146.29 15.44 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 58.5 24.4 11.83 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.004 1.113 . . . . 25.0 114.004 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.44 4.66 87.68 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.909 -0.662 . . . . 25.0 113.228 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -122.83 163.89 19.42 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 122.947 0.499 . . . . 25.0 109.669 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -118.1 154.55 31.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.942 -1.873 . . . . 25.0 105.942 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.6 162.66 31.33 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 111.779 -0.528 . . . . 25.0 111.779 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.4 pt -78.12 145.64 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.557 . . . . 25.0 110.682 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.4 t -144.84 133.69 11.07 Favored Pre-proline 0 C--O 1.238 0.451 0 N-CA-C 108.492 -0.929 . . . . 25.0 108.492 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.6 121.21 7.49 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 115.534 -2.511 . . . . 25.0 112.02 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.62 -22.36 65.91 Favored Glycine 0 C--O 1.221 -0.718 0 CA-C-N 115.342 -0.845 . . . . 25.0 114.188 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -70.47 -2.4 13.82 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.089 -0.654 . . . . 25.0 111.675 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -114.0 11.23 17.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.917 -0.401 . . . . 25.0 109.917 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.95 152.63 38.29 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.367 0.417 . . . . 25.0 111.078 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -117.88 117.81 30.29 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.35 134.67 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 123.821 0.7 . . . . 25.0 109.254 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.94 108.5 18.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 25.0 111.427 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.5 t -124.68 126.12 71.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.215 -1.402 . . . . 25.0 107.215 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.54 5.95 38.21 Favored Glycine 0 C--O 1.22 -0.742 0 O-C-N 123.269 0.356 . . . . 25.0 112.761 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.9 mtt -79.18 83.1 5.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.413 0.625 . . . . 25.0 111.325 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -117.61 23.84 11.47 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.168 -1.79 . . . . 25.0 106.168 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -73.33 152.16 41.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.462 -1.245 . . . . 25.0 108.88 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.65 166.31 30.9 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.17 -0.331 . . . . 25.0 110.212 -175.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -115.19 158.49 40.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 107.453 -1.314 . . . . 25.0 107.453 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.29 154.67 65.46 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 116.299 -2.001 . . . . 25.0 110.71 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.98 75.78 1.26 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.335 -0.393 . . . . 25.0 110.038 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.9 54.65 4.05 Favored Glycine 0 C--O 1.216 -0.98 0 CA-C-O 119.171 -0.794 . . . . 25.0 112.798 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 51.32 74.38 0.25 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.487 1.137 . . . . 25.0 113.003 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -69.13 123.48 21.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.507 -0.77 . . . . 25.0 111.566 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.61 150.9 19.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 104.801 -2.296 . . . . 25.0 104.801 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.9 p -142.84 144.43 24.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 105.583 -2.006 . . . . 25.0 105.583 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.3 p -126.19 109.0 11.84 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.88 -0.415 . . . . 25.0 109.88 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.0 t0 . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 125.174 1.389 . . . . 25.0 113.179 179.332 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.979 0 CA-C-O 124.023 1.902 . . . . 25.0 115.484 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -142.34 127.42 18.49 Favored 'General case' 0 CA--C 1.514 -0.435 0 O-C-N 121.349 -1.089 . . . . 25.0 109.809 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.2 mtt -142.28 120.74 12.43 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.094 0.247 . . . . 25.0 110.361 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.0 tptt 50.85 33.81 9.25 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 117.167 2.284 . . . . 25.0 117.167 169.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -65.25 158.96 24.86 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.129 -0.357 . . . . 25.0 110.242 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.19 -40.5 81.68 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.804 0.442 . . . . 25.0 111.564 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 51.44 43.78 29.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.4 1.259 . . . . 25.0 114.4 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.8 m -116.63 164.34 13.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 N-CA-C 103.025 -2.954 . . . . 25.0 103.025 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.61 160.85 37.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 118.714 0.688 . . . . 25.0 110.386 -174.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.45 163.24 33.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.448 -0.796 . . . . 25.0 110.887 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -110.58 134.4 52.43 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.042 -1.466 . . . . 25.0 107.042 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.87 136.11 43.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.721 0.772 . . . . 25.0 109.231 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.82 -24.62 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.489 -0.778 . . . . 25.0 109.63 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -128.98 162.75 26.87 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.818 -1.178 . . . . 25.0 107.818 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.17 156.69 17.06 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -156.49 135.77 12.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.357 0.503 . . . . 25.0 112.357 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -100.64 146.92 8.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.98 -1.859 . . . . 25.0 105.98 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.93 133.54 37.26 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.255 -0.276 . . . . 25.0 110.255 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.55 -7.17 23.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.666 0.745 . . . . 25.0 109.117 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.7 t -129.46 148.65 70.18 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.631 -0.713 . . . . 25.0 109.347 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.32 -16.84 35.3 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 116.716 -1.722 . . . . 25.0 113.3 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -82.17 -15.56 52.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.471 0.653 . . . . 25.0 110.674 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -92.5 140.85 29.14 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.628 -0.879 . . . . 25.0 108.628 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 132.56 36.04 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.123 -0.631 . . . . 25.0 110.044 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p -84.53 133.08 34.47 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.394 -2.076 . . . . 25.0 105.394 171.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.413 ' CE1' HG13 ' A' ' 57' ' ' VAL . 45.8 p90 -150.64 166.12 31.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.933 -0.766 . . . . 25.0 108.933 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -127.04 152.99 46.53 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 121.872 -0.518 . . . . 25.0 110.696 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -59.49 138.37 57.7 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.651 -0.704 . . . . 25.0 109.279 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.5 -16.02 57.27 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.503 -0.771 . . . . 25.0 114.035 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -76.89 159.76 29.76 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 117.387 0.593 . . . . 25.0 109.93 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.51 130.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.983 0.513 . . . . 25.0 109.638 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -137.12 147.07 45.78 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.972 0.415 . . . . 25.0 110.728 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -85.66 130.74 34.49 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.6 t -88.83 116.41 30.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.809 -1.923 . . . . 25.0 105.809 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.24 -37.76 13.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.309 -0.859 . . . . 25.0 111.147 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -147.43 156.18 42.63 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.597 -1.26 . . . . 25.0 107.597 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtm105 -124.51 147.43 48.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.621 -0.511 . . . . 25.0 109.621 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 57.25 38.21 28.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.745 1.736 . . . . 25.0 107.618 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.5 t -70.56 -11.4 60.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 112.283 -2.235 . . . . 25.0 115.699 -165.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.06 10.07 13.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.145 0.497 . . . . 25.0 110.028 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.62 66.79 Favored Glycine 0 C--O 1.225 -0.425 0 N-CA-C 109.688 -1.365 . . . . 25.0 109.688 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.69 116.74 29.29 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.643 -1.614 . . . . 25.0 106.643 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.42 133.82 55.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.795 -0.639 . . . . 25.0 109.457 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.29 -0.43 85.58 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 115.506 0.962 . . . . 25.0 115.506 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -102.92 116.57 32.8 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.127 1.464 . . . . 25.0 110.538 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -108.59 145.0 35.54 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.208 -0.308 . . . . 25.0 111.09 -174.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.52 120.98 27.57 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.473 -1.677 . . . . 25.0 106.473 175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.2 m -119.86 165.22 14.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.697 -0.483 . . . . 25.0 109.697 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 p -122.95 131.66 53.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.059 0.457 . . . . 25.0 110.027 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 tp -160.27 148.61 16.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.664 -1.235 . . . . 25.0 107.664 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 59.64 23.25 12.01 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.272 0.841 . . . . 25.0 113.272 176.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.07 81.08 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 120.842 -0.694 . . . . 25.0 112.686 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -130.76 164.21 25.6 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.48 -0.933 . . . . 25.0 108.48 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -117.77 152.91 34.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 105.941 -1.874 . . . . 25.0 105.941 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.04 163.98 36.44 Favored Glycine 0 C--O 1.239 0.462 0 N-CA-C 110.387 -1.085 . . . . 25.0 110.387 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.8 pt -79.43 145.19 9.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.611 . . . . 25.0 110.062 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.413 HG13 ' CE1' ' A' ' 26' ' ' PHE . 71.4 t -140.74 133.7 14.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 107.64 -1.244 . . . . 25.0 107.64 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.41 121.57 8.11 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 114.667 -3.089 . . . . 25.0 111.212 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.16 -25.67 62.59 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 116.015 -0.539 . . . . 25.0 114.263 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -65.48 -18.52 65.38 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.23 -0.57 . . . . 25.0 112.374 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -92.84 8.0 41.4 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.888 -0.507 . . . . 25.0 111.232 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.0 mt -122.41 156.79 33.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.903 0.383 . . . . 25.0 110.786 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -131.62 120.07 22.32 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.1 mm -61.32 136.21 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.67 0.606 . . . . 25.0 110.358 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.53 124.41 44.69 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.376 -1.712 . . . . 25.0 106.376 174.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -142.18 146.7 22.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.12 94.18 0.12 Allowed Glycine 0 C--O 1.216 -0.974 0 C-N-CA 120.912 -0.661 . . . . 25.0 114.484 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 36.1 ttm 49.84 67.21 0.94 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.443 1.646 . . . . 25.0 115.443 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -105.0 154.55 19.97 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 50.65 41.09 25.41 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.995 1.479 . . . . 25.0 114.995 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -89.71 109.76 20.71 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.908 -0.495 . . . . 25.0 111.365 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 163.21 31.18 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.62 -0.881 . . . . 25.0 108.62 176.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.87 -178.23 2.65 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 117.618 -1.121 . . . . 25.0 110.106 170.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.28 55.62 4.95 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.497 0.665 . . . . 25.0 111.37 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.28 178.08 16.43 Favored Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.345 -1.102 . . . . 25.0 110.345 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.28 163.73 24.39 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 113.635 0.976 . . . . 25.0 113.635 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -140.48 141.77 35.37 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.268 -0.424 . . . . 25.0 110.364 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.88 126.92 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.73 164.41 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.836 0.35 . . . . 25.0 110.822 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 m -70.84 150.42 45.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.946 -0.57 . . . . 25.0 110.192 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 C--O 1.217 -0.626 0 CA-C-O 125.792 2.711 . . . . 25.0 111.998 173.712 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.52 0 CA-C-O 123.015 1.341 . . . . 25.0 113.741 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m 59.89 20.44 9.4 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.015 1.726 . . . . 25.0 112.602 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 62.9 mtt -79.79 -14.84 58.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.948 -0.569 . . . . 25.0 112.189 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -141.86 148.8 39.38 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.809 -0.812 . . . . 25.0 108.809 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -147.18 177.27 9.32 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 102.901 -3.0 . . . . 25.0 102.901 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.7 mt -55.92 -45.81 78.62 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.892 1.441 . . . . 25.0 114.892 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.4 43.26 26.88 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.042 1.497 . . . . 25.0 115.042 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.2 163.63 8.97 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 104.297 -2.483 . . . . 25.0 104.297 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.17 154.06 47.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 118.891 0.769 . . . . 25.0 110.63 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.91 143.79 34.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.657 -0.701 . . . . 25.0 111.36 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -95.19 132.42 40.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.083 -0.71 . . . . 25.0 109.083 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 134.88 41.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.392 0.615 . . . . 25.0 109.417 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.27 -25.1 17.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.578 -0.737 . . . . 25.0 109.488 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -131.22 157.65 42.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.512 -1.292 . . . . 25.0 107.512 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -95.35 161.65 14.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.667 -0.494 . . . . 25.0 109.667 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -152.92 149.84 28.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -124.1 128.74 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 103.773 -2.677 . . . . 25.0 103.773 173.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.91 136.09 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.913 -0.585 . . . . 25.0 109.923 -176.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -102.94 -12.9 17.16 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.35 155.66 53.67 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.885 -0.598 . . . . 25.0 110.312 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.23 -19.31 20.01 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 117.71 -1.06 . . . . 25.0 114.418 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -86.37 -15.03 41.71 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.985 0.898 . . . . 25.0 109.591 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -89.89 145.6 25.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.418 -0.81 . . . . 25.0 108.897 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.44 135.79 40.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.31 138.67 32.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 170.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.442 ' CE1' HG13 ' A' ' 57' ' ' VAL . 42.3 p90 -157.4 164.01 37.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtt-85 -124.15 153.06 42.07 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 121.618 -0.676 . . . . 25.0 112.197 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.543 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 46.2 pttt -58.3 132.43 53.59 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.543 -1.28 . . . . 25.0 107.543 175.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.21 -14.52 65.15 Favored Glycine 0 C--O 1.226 -0.348 0 CA-C-O 118.79 -1.005 . . . . 25.0 114.089 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.53 163.02 20.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.686 0.743 . . . . 25.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.49 132.11 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.026 -0.731 . . . . 25.0 109.026 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -129.13 151.37 49.88 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 116.055 -0.521 . . . . 25.0 110.438 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.1 m -85.42 129.08 34.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.259 -1.015 . . . . 25.0 108.259 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 83.7 t -91.87 119.62 39.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.684 -1.598 . . . . 25.0 106.684 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -97.87 -40.45 8.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.303 -0.862 . . . . 25.0 111.129 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -148.03 164.68 33.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.888 -1.523 . . . . 25.0 106.888 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -130.56 152.88 49.46 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 56.57 37.17 28.6 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.884 1.365 . . . . 25.0 108.166 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -69.34 -17.39 63.7 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 113.631 -1.622 . . . . 25.0 112.857 -169.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.17 6.48 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.721 -0.672 . . . . 25.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 -8.22 67.42 Favored Glycine 0 C--O 1.228 -0.257 0 N-CA-C 110.08 -1.208 . . . . 25.0 110.08 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt -83.63 117.27 23.07 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.076 -0.713 . . . . 25.0 109.076 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -60.39 128.27 35.88 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 25.0 109.412 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.22 -1.3 82.41 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 115.461 0.944 . . . . 25.0 115.461 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -100.63 122.59 43.55 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.926 1.363 . . . . 25.0 109.247 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -112.49 145.42 40.26 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.993 -0.442 . . . . 25.0 111.162 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.9 tp -83.57 115.07 21.95 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.545 -1.65 . . . . 25.0 106.545 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.6 m -122.45 164.84 17.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.536 0.208 . . . . 25.0 110.857 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.5 p -123.18 131.36 53.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.224 -0.658 . . . . 25.0 109.224 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -157.93 139.71 13.93 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 57.45 32.98 22.64 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.732 0.777 . . . . 25.0 112.632 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.08 4.47 63.18 Favored Glycine 0 CA--C 1.522 0.491 0 O-C-N 121.567 -0.708 . . . . 25.0 113.427 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.73 164.1 13.77 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -132.19 146.0 51.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 104.22 -2.511 . . . . 25.0 104.22 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.62 177.87 48.55 Favored Glycine 0 C--O 1.242 0.601 0 N-CA-C 111.11 -0.796 . . . . 25.0 111.11 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.34 143.43 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.387 0.613 . . . . 25.0 110.299 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 26' ' ' PHE . 72.7 t -139.33 134.18 16.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.75 118.54 5.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 115.015 -2.857 . . . . 25.0 110.749 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -23.92 70.78 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.706 -0.679 . . . . 25.0 113.988 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -67.59 -16.47 64.19 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.289 -0.536 . . . . 25.0 111.62 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -90.06 1.14 56.68 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.93 -0.481 . . . . 25.0 110.918 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -115.58 150.64 36.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.306 0.574 . . . . 25.0 111.343 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -121.96 113.86 20.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.331 -0.988 . . . . 25.0 108.331 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.0 mt -67.63 134.27 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 120.754 0.311 . . . . 25.0 110.848 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.9 mt -117.68 136.94 53.0 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.692 -0.855 . . . . 25.0 108.692 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.5 t 25.44 82.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 116.268 1.951 . . . . 25.0 116.268 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.1 -72.6 1.11 Allowed Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.596 -0.811 . . . . 25.0 113.612 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.34 161.41 37.6 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -161.06 164.52 30.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.22 -0.659 . . . . 25.0 109.22 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -135.53 -174.13 3.55 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.294 0.638 . . . . 25.0 111.245 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -114.67 141.21 48.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 120.945 0.403 . . . . 25.0 110.227 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -71.79 146.35 90.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 108.779 -0.823 . . . . 25.0 108.779 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.51 -19.86 21.28 Favored 'Trans proline' 0 C--N 1.349 0.566 0 N-CA-C 114.09 0.765 . . . . 25.0 114.09 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 55.48 25.52 7.91 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.787 1.773 . . . . 25.0 115.787 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.35 7.94 66.62 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 115.296 0.879 . . . . 25.0 115.296 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -121.02 64.89 0.86 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.396 0.617 . . . . 25.0 112.088 -174.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.53 118.21 9.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.154 -0.684 . . . . 25.0 109.154 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.5 tt -144.56 134.82 19.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.371 -0.974 . . . . 25.0 108.371 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.41 11.22 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.416 0.627 . . . . 25.0 109.516 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 53.83 51.18 15.34 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.53 1.157 . . . . 25.0 112.65 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.9 t0 . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 123.026 1.393 . . . . 25.0 110.595 175.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 114.832 0.693 . . . . 25.0 114.832 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 t 57.68 16.53 3.51 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.001 1.32 . . . . 25.0 114.027 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.0 ptp -102.9 -12.64 17.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.117 0.784 . . . . 25.0 113.117 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -146.88 157.79 43.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.742 0.306 . . . . 25.0 110.216 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -147.18 -179.45 6.84 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 101.878 -3.378 . . . . 25.0 101.878 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.3 mt -54.29 -37.43 64.77 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.699 1.37 . . . . 25.0 114.699 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.06 30.24 19.99 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.816 1.413 . . . . 25.0 114.816 173.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -115.94 164.01 12.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.175 -1.787 . . . . 25.0 106.175 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.95 164.11 23.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.207 -0.664 . . . . 25.0 109.207 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.28 145.21 30.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 25.0 110.857 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -95.05 134.49 37.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.31 136.55 40.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.274 0.559 . . . . 25.0 109.616 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.26 -26.22 17.44 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 25.0 110.071 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -130.24 162.78 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.55 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.9 p-10 -101.71 157.07 17.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.888 -0.412 . . . . 25.0 109.888 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -157.87 122.78 4.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.575 -0.739 . . . . 25.0 110.099 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 138.93 19.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.051 -2.574 . . . . 25.0 104.051 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.13 148.97 27.17 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -111.22 -20.41 12.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.639 -0.504 . . . . 25.0 109.639 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -105.09 152.46 39.7 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.49 -0.323 . . . . 25.0 110.265 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.6 -20.91 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 117.1 -1.466 . . . . 25.0 114.013 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -86.35 -4.79 59.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.536 0.684 . . . . 25.0 110.599 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -99.26 141.73 31.66 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.18 -1.044 . . . . 25.0 108.18 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.97 134.14 35.06 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.674 -0.641 . . . . 25.0 111.724 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.8 m -84.16 119.44 25.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.526 -1.657 . . . . 25.0 106.526 170.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -136.16 161.62 35.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.55 -0.537 . . . . 25.0 109.55 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -123.43 153.74 40.02 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.062 0.458 . . . . 25.0 110.079 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.55 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 14.0 ptmt -59.6 133.74 56.38 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 -10.81 72.17 Favored Glycine 0 C--O 1.225 -0.424 0 CA-C-O 119.102 -0.832 . . . . 25.0 114.302 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.65 158.29 25.68 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.916 0.858 . . . . 25.0 109.207 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.86 129.96 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.453 -0.573 . . . . 25.0 109.453 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 9.1 ptp -130.76 153.23 49.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.622 -0.717 . . . . 25.0 109.899 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.8 m -87.53 132.32 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.68 -1.229 . . . . 25.0 107.68 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.12 125.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -92.95 -47.78 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.04 -0.527 . . . . 25.0 111.183 -175.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.74 171.92 18.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -121.9 155.0 36.38 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 109.234 -0.654 . . . . 25.0 109.234 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 57.51 38.6 28.1 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.64 1.213 . . . . 25.0 109.924 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 t -69.88 -18.59 63.42 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.067 -1.424 . . . . 25.0 114.374 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -110.97 9.73 22.22 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.265 -0.643 . . . . 25.0 109.265 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.58 1.84 89.26 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.445 -1.062 . . . . 25.0 110.445 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.38 122.36 35.72 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.144 -1.058 . . . . 25.0 108.144 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -61.45 129.36 40.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.419 0.628 . . . . 25.0 109.98 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 0.45 87.96 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 115.413 0.925 . . . . 25.0 115.413 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -101.58 108.43 19.98 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 118.827 1.313 . . . . 25.0 110.227 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -99.2 143.87 28.98 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.718 -0.475 . . . . 25.0 109.718 -173.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 tp -82.41 120.1 25.02 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.671 -1.974 . . . . 25.0 105.671 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -121.71 160.68 24.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.236 -0.653 . . . . 25.0 109.236 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.5 p -121.47 132.53 54.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.435 0.636 . . . . 25.0 109.746 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.22 141.38 14.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.157 -0.928 . . . . 25.0 108.617 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.9 t60 58.79 26.75 15.12 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.677 0.992 . . . . 25.0 113.677 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.74 6.06 89.61 Favored Glycine 0 C--O 1.224 -0.507 0 C-N-CA 121.097 -0.573 . . . . 25.0 113.293 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -122.11 167.33 13.28 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.05 -1.463 . . . . 25.0 107.05 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -135.41 154.32 51.5 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.777 -1.564 . . . . 25.0 106.777 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.7 171.33 44.27 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.856 -0.898 . . . . 25.0 110.856 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.5 143.3 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.506 0.67 . . . . 25.0 110.587 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.4 t -141.9 132.42 12.86 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.255 -1.017 . . . . 25.0 108.255 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.77 119.52 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 115.178 -2.748 . . . . 25.0 111.582 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.45 -21.77 62.77 Favored Glycine 0 C--O 1.221 -0.678 0 CA-C-N 115.888 -0.597 . . . . 25.0 114.473 -175.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -61.25 -28.12 68.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.267 -0.549 . . . . 25.0 111.37 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -89.15 6.28 40.74 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.869 0.322 . . . . 25.0 111.869 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.4 mt -115.73 143.97 44.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.6 . . . . 25.0 111.913 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -117.75 117.69 30.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.1 mm -55.32 127.63 14.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 121.202 0.525 . . . . 25.0 110.157 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -107.45 92.98 4.3 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 107.79 -1.189 . . . . 25.0 107.79 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t 53.87 79.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 122.167 0.984 . . . . 25.0 111.678 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.57 49.65 3.91 Favored Glycine 0 C--O 1.225 -0.425 0 CA-C-N 115.374 -0.83 . . . . 25.0 113.446 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 162.6 19.99 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.137 -0.69 . . . . 25.0 109.137 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.68 148.86 51.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.365 0.603 . . . . 25.0 111.545 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.35 174.73 7.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.963 0.887 . . . . 25.0 112.008 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.92 157.26 17.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.222 -1.769 . . . . 25.0 106.222 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -58.32 143.25 80.23 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.382 -0.599 . . . . 25.0 109.382 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -70.22 156.91 61.07 Favored 'Trans proline' 0 C--N 1.347 0.474 0 O-C-N 122.3 0.632 . . . . 25.0 112.925 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.69 6.55 48.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.839 -0.619 . . . . 25.0 112.27 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.62 3.66 66.36 Favored Glycine 0 C--O 1.219 -0.798 0 C-N-CA 121.235 -0.507 . . . . 25.0 112.784 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -77.45 124.66 28.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.686 -0.487 . . . . 25.0 109.686 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -160.06 168.15 26.23 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.688 -0.856 . . . . 25.0 108.688 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 pt -128.21 166.05 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 108.708 -0.849 . . . . 25.0 108.708 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.7 m -86.62 160.78 3.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.637 -0.875 . . . . 25.0 108.637 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.2 p -78.2 150.99 33.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.685 -0.487 . . . . 25.0 109.685 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.213 -0.84 0 CA-C-O 123.068 1.413 . . . . 25.0 112.19 176.635 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 CA-C-O 122.698 1.165 . . . . 25.0 115.346 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 p -78.76 59.3 2.5 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.457 -1.025 . . . . 25.0 110.889 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.0 mmt -70.41 101.76 2.03 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.299 -0.41 . . . . 25.0 112.037 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 61.39 17.2 8.14 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.224 1.194 . . . . 25.0 114.224 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -75.31 164.89 25.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.458 -0.941 . . . . 25.0 108.458 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.68 -37.95 88.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.826 -0.435 . . . . 25.0 109.826 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 t30 56.17 36.83 28.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.464 -0.789 . . . . 25.0 112.284 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.16 129.75 55.94 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.783 0 N-CA-C 106.728 -1.582 . . . . 25.0 106.728 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -100.47 153.85 19.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.738 0.78 . . . . 25.0 110.101 -179.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.23 152.13 42.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.826 -1.079 . . . . 25.0 109.948 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -103.49 135.09 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.558 -0.904 . . . . 25.0 108.558 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 135.54 43.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.361 0.601 . . . . 25.0 110.169 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -92.44 -27.19 17.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.5 -0.773 . . . . 25.0 110.68 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -124.51 158.26 33.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.35 -1.722 . . . . 25.0 106.35 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 12.0 p-10 -97.95 146.16 25.76 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.296 -1.372 . . . . 25.0 107.296 174.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -144.6 129.99 18.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.776 -0.647 . . . . 25.0 110.741 -174.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -103.91 121.3 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.403 -1.703 . . . . 25.0 106.403 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.66 35.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.911 -0.586 . . . . 25.0 110.108 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -99.55 -17.26 17.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.158 0.504 . . . . 25.0 109.941 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 143.32 40.61 Favored Pre-proline 0 CA--C 1.513 -0.455 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.56 -15.61 24.51 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 116.937 -1.576 . . . . 25.0 114.023 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -94.48 -9.0 36.83 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.315 0.579 . . . . 25.0 110.964 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.62 140.82 30.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.776 -0.824 . . . . 25.0 108.776 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.38 132.3 34.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.432 0.634 . . . . 25.0 111.169 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -86.93 136.32 32.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.14 -1.8 . . . . 25.0 106.14 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -156.55 166.78 32.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.978 0.418 . . . . 25.0 110.441 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -121.44 154.88 35.97 Favored 'General case' 0 C--O 1.213 -0.868 0 O-C-N 121.909 -0.495 . . . . 25.0 110.683 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.3 pttt -60.56 131.79 51.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 174.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.91 -20.57 49.81 Favored Glycine 0 C--O 1.224 -0.515 0 CA-C-N 115.903 -0.589 . . . . 25.0 113.026 -176.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -71.49 154.19 41.67 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.326 0.563 . . . . 25.0 110.117 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.0 mm -117.47 126.96 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.109 -0.7 . . . . 25.0 109.109 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.7 ptp -134.89 157.73 46.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 31.6 m -107.03 126.75 52.75 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.233 -0.284 . . . . 25.0 110.233 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -79.95 123.55 36.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.434 -1.321 . . . . 25.0 107.434 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.92 -46.62 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.92 -0.771 . . . . 25.0 108.92 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.26 169.25 23.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.165 -1.42 . . . . 25.0 107.165 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -124.16 157.14 35.39 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 110.259 -0.274 . . . . 25.0 110.259 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 56.53 41.42 28.67 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.74 1.275 . . . . 25.0 108.681 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.47 -16.26 62.9 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.704 1.372 . . . . 25.0 114.704 -167.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -111.94 9.0 20.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.509 -0.552 . . . . 25.0 109.509 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.11 -9.78 59.83 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 110.864 -0.894 . . . . 25.0 110.864 -175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.92 124.53 28.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -61.08 131.32 50.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.449 0.642 . . . . 25.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.45 89.58 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-O 118.566 -1.13 . . . . 25.0 115.482 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -99.02 105.44 17.58 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.755 1.777 . . . . 25.0 109.817 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -102.34 143.37 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.038 -0.528 . . . . 25.0 110.818 -171.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.0 tp -83.66 112.78 20.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.673 -1.603 . . . . 25.0 106.673 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 67.3 m -112.08 163.14 14.63 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.555 -0.906 . . . . 25.0 108.555 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.2 p -123.74 130.7 53.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 25.0 109.048 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.4 tp -162.26 146.56 12.21 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 57.43 30.74 19.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.785 1.032 . . . . 25.0 113.785 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.56 11.44 82.81 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 120.702 -0.761 . . . . 25.0 113.161 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -124.55 165.51 17.71 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.44 -1.318 . . . . 25.0 107.44 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -128.36 152.61 47.97 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 103.448 -2.797 . . . . 25.0 103.448 167.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.59 167.09 38.82 Favored Glycine 0 C--O 1.24 0.508 0 N-CA-C 110.262 -1.135 . . . . 25.0 110.262 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.9 pt -75.48 143.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.548 0.69 . . . . 25.0 110.509 -177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -141.62 132.27 13.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 107.959 -1.126 . . . . 25.0 107.959 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.07 120.29 6.73 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 115.185 -2.743 . . . . 25.0 111.737 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.38 -25.8 60.97 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-N 115.742 -0.663 . . . . 25.0 114.397 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -63.42 -22.94 67.18 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.191 0.52 . . . . 25.0 111.646 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -91.56 5.5 49.33 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.757 -0.59 . . . . 25.0 111.667 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.5 mt -115.4 156.28 25.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.593 0.711 . . . . 25.0 111.458 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -122.8 117.7 26.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.114 . . . . 25.0 107.991 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm -62.63 132.51 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.06 -165.14 1.28 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.156 -0.475 . . . . 25.0 110.344 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.9 p -61.38 142.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.237 0.541 . . . . 25.0 109.603 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.56 -175.82 45.95 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 106.277 -2.729 . . . . 25.0 106.277 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.3 mtt -82.51 126.95 32.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.118 0.959 . . . . 25.0 110.123 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.47 150.88 9.18 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.476 -2.046 . . . . 25.0 105.476 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.24 -44.34 59.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.411 0.624 . . . . 25.0 109.673 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 tptt 55.61 -166.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.827 -1.078 . . . . 25.0 110.484 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -122.16 158.17 56.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 103.784 -2.673 . . . . 25.0 103.784 170.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -65.69 147.34 85.85 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 115.638 -2.441 . . . . 25.0 111.204 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.81 173.06 16.55 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.683 -1.229 . . . . 25.0 107.683 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.39 -119.93 0.61 Allowed Glycine 0 C--O 1.225 -0.448 0 N-CA-C 107.105 -2.398 . . . . 25.0 107.105 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 59.44 49.3 8.86 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.733 1.012 . . . . 25.0 113.733 172.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -148.54 163.05 38.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.931 -1.137 . . . . 25.0 107.931 174.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.8 pt -139.86 158.94 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 105.718 -1.956 . . . . 25.0 105.718 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.0 p -162.95 157.19 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.821 -1.918 . . . . 25.0 105.821 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m 51.43 77.27 0.14 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.482 1.289 . . . . 25.0 114.482 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 123.881 1.8 . . . . 25.0 114.174 178.769 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 115.381 0.912 . . . . 25.0 115.381 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 t 55.83 33.46 21.58 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.624 1.17 . . . . 25.0 113.218 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 ptp -125.66 17.32 8.1 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.228 0.825 . . . . 25.0 113.228 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -84.89 125.65 32.82 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.593 0.96 . . . . 25.0 113.593 -176.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -147.22 -178.64 6.33 Favored 'General case' 0 C--N 1.319 -0.723 1 N-CA-C 99.323 -4.325 . . . . 25.0 99.323 170.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt -51.36 -41.43 60.63 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.92 1.236 . . . . 25.0 113.949 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.88 38.51 29.47 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.89 0.853 . . . . 25.0 111.967 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.0 t -107.52 149.09 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 104.527 -2.398 . . . . 25.0 104.527 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.69 153.28 50.93 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.251 -1.018 . . . . 25.0 108.251 176.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.57 149.68 36.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.912 -0.585 . . . . 25.0 111.2 -172.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -96.3 136.44 36.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.81 134.18 43.33 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.203 0.525 . . . . 25.0 109.717 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.86 -32.73 15.21 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.351 0.596 . . . . 25.0 109.768 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.86 164.7 17.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.528 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 10.7 p-10 -98.9 163.06 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -151.62 144.66 24.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.181 -0.463 . . . . 25.0 111.626 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.14 125.33 73.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.214 -2.884 . . . . 25.0 103.214 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.03 146.22 41.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 25.0 110.147 -175.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -31.29 7.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.465 -0.568 . . . . 25.0 109.465 173.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -94.93 150.34 37.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.58 -16.96 26.88 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.734 -1.044 . . . . 25.0 113.303 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.94 -9.5 58.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 25.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -96.18 144.53 26.32 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.17 0.588 . . . . 25.0 110.236 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mt -94.9 134.55 37.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.56 0.695 . . . . 25.0 112.645 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.3 m -88.3 140.71 29.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.289 -1.374 . . . . 25.0 107.289 171.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.42 ' CE2' HG13 ' A' ' 57' ' ' VAL . 40.4 p90 -160.19 167.17 28.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.636 -1.246 . . . . 25.0 107.636 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -118.56 156.51 29.02 Favored 'General case' 0 C--O 1.219 -0.551 0 O-C-N 121.635 -0.665 . . . . 25.0 110.911 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 11.0 ptmm? -59.58 129.68 43.13 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.494 -0.928 . . . . 25.0 108.494 176.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.05 67.83 Favored Glycine 0 C--O 1.223 -0.583 0 CA-C-N 115.836 -0.62 . . . . 25.0 113.937 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.36 161.24 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.892 -0.781 . . . . 25.0 108.892 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.07 134.05 65.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.353 -0.98 . . . . 25.0 108.353 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -135.48 152.82 51.72 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.669 -0.696 . . . . 25.0 110.614 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.7 m -89.04 131.9 35.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.031 -1.099 . . . . 25.0 108.031 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.59 120.6 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.748 -1.575 . . . . 25.0 106.748 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.4 mt -92.37 -42.35 9.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.55 -0.75 . . . . 25.0 110.065 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.98 166.23 29.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.984 -0.747 . . . . 25.0 108.984 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -133.38 152.76 51.95 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 117.936 0.334 . . . . 25.0 110.236 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 57.32 36.36 27.15 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.95 1.357 . . . . 25.0 107.766 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -70.48 -7.1 40.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.17 -1.832 . . . . 25.0 115.644 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -126.87 12.36 7.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.82 -5.78 68.84 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.712 -0.955 . . . . 25.0 110.712 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.99 120.98 25.93 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.329 -0.989 . . . . 25.0 108.329 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -61.88 127.43 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.706 -0.679 . . . . 25.0 109.939 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.58 1.5 90.1 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.754 1.062 . . . . 25.0 115.754 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -98.68 119.09 36.83 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.301 1.551 . . . . 25.0 109.898 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -110.0 143.8 39.47 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.185 -0.322 . . . . 25.0 111.304 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.7 tp -81.57 111.59 18.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.614 -1.995 . . . . 25.0 105.614 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.2 m -115.34 164.15 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.834 -0.802 . . . . 25.0 108.834 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -139.26 130.7 27.03 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.758 0.313 . . . . 25.0 111.738 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.21 152.16 25.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 25.0 109.644 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.4 t60 53.07 36.45 22.25 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.83 7.24 74.86 Favored Glycine 0 C--O 1.226 -0.394 0 N-CA-C 114.874 0.71 . . . . 25.0 114.874 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -120.82 156.57 31.64 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.096 -1.446 . . . . 25.0 107.096 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -134.34 145.74 49.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.765 -1.939 . . . . 25.0 105.765 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.55 172.61 44.2 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.743 -0.943 . . . . 25.0 110.743 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 pt -76.29 143.89 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.614 0.721 . . . . 25.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 26' ' ' PHE . 71.8 t -141.91 133.34 13.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.35 119.15 6.13 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 114.974 -2.884 . . . . 25.0 110.984 175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.09 -18.02 66.41 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 115.703 -0.681 . . . . 25.0 113.781 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.07 -28.65 69.76 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.513 -0.404 . . . . 25.0 110.883 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -87.7 7.17 31.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.074 0.398 . . . . 25.0 112.074 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -118.92 147.91 43.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.111 0.481 . . . . 25.0 111.091 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -116.21 117.59 30.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.582 -0.895 . . . . 25.0 108.582 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm -60.72 130.74 25.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.417 0.687 . . . . 25.0 110.103 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.6 mt -92.09 164.94 13.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.382 -0.969 . . . . 25.0 108.382 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 p -71.27 149.53 9.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.122 -0.945 . . . . 25.0 108.955 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.91 -43.78 0.1 Allowed Glycine 0 C--O 1.227 -0.324 0 N-CA-C 111.598 -0.601 . . . . 25.0 111.598 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.34 146.72 46.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 175.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -113.75 152.85 29.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.73 0.644 . . . . 25.0 110.6 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 t0 57.59 -154.36 0.35 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.182 -0.917 . . . . 25.0 111.946 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -145.83 166.95 24.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.349 -0.611 . . . . 25.0 109.349 -171.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -83.01 155.62 67.45 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 107.13 -1.433 . . . . 25.0 107.13 176.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.54 167.41 25.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 117.109 -1.461 . . . . 25.0 111.031 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.44 147.1 30.88 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.08 43.11 0.12 Allowed Glycine 0 C--O 1.221 -0.662 0 C-N-CA 120.97 -0.633 . . . . 25.0 112.914 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -64.23 133.3 52.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.205 0.502 . . . . 25.0 110.78 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -146.41 110.86 5.13 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.286 -0.635 . . . . 25.0 109.286 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.4 tt -141.74 120.31 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.799 -0.815 . . . . 25.0 108.799 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.7 m -85.54 -8.31 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 113.984 1.105 . . . . 25.0 113.984 -171.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.1 p -87.79 -22.42 24.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.291 0.567 . . . . 25.0 111.009 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 C--O 1.21 -0.978 0 CA-C-O 123.823 1.773 . . . . 25.0 112.789 -179.718 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.682 0 CA-C-O 123.669 1.705 . . . . 25.0 115.561 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.4 m -94.18 98.51 11.01 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.73 -1.453 . . . . 25.0 110.697 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.2 ptt? -112.8 75.73 0.93 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.995 0.902 . . . . 25.0 109.49 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.22 97.51 9.96 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.022 -0.733 . . . . 25.0 109.022 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.38 162.97 15.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.613 -0.514 . . . . 25.0 109.613 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.16 -47.02 72.25 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.109 0.781 . . . . 25.0 113.109 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 54.69 24.53 5.62 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.361 1.245 . . . . 25.0 114.361 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.63 174.28 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 106.911 -1.514 . . . . 25.0 106.911 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.22 152.38 49.81 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.765 -0.584 . . . . 25.0 110.55 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.419 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -138.59 146.67 42.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.55 -0.75 . . . . 25.0 111.628 -175.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -95.17 134.57 37.76 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.35 135.03 39.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.529 0.681 . . . . 25.0 110.676 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 74.0 mt -94.92 -23.05 17.59 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.12 -0.945 . . . . 25.0 109.531 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -127.61 159.04 35.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.8 p-10 -99.39 145.35 27.48 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.531 -0.544 . . . . 25.0 109.531 177.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -153.58 109.89 3.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 25.0 110.299 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.52 138.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 105.335 -2.098 . . . . 25.0 105.335 175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.86 122.38 24.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.551 -0.537 . . . . 25.0 109.551 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -101.27 -17.66 16.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.969 -0.752 . . . . 25.0 108.969 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -109.63 151.59 42.34 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.99 -0.744 . . . . 25.0 108.99 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.48 -20.91 20.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 117.015 -1.523 . . . . 25.0 114.467 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -84.91 -9.54 58.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.693 0.759 . . . . 25.0 110.601 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -88.51 140.81 29.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.36 -0.836 . . . . 25.0 110.35 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.39 134.45 34.33 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.497 -0.557 . . . . 25.0 109.497 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 t -95.18 131.51 41.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.44 -0.578 . . . . 25.0 109.44 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -157.14 168.03 28.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.869 0.366 . . . . 25.0 110.03 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -127.14 158.37 37.22 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.807 -0.558 . . . . 25.0 110.33 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.503 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 13.7 pttt -60.86 133.67 56.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.418 -1.327 . . . . 25.0 107.418 174.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.28 55.24 Favored Glycine 0 C--O 1.223 -0.541 0 CA-C-O 119.357 -0.69 . . . . 25.0 113.358 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -81.57 163.02 22.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.218 0.509 . . . . 25.0 109.668 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.8 132.01 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.459 -0.571 . . . . 25.0 109.459 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.86 156.35 41.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.064 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.4 m -84.27 133.56 34.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.91 121.81 49.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.462 -1.681 . . . . 25.0 106.462 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.6 mt -96.71 -49.62 5.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.237 -0.892 . . . . 25.0 111.695 -174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.19 162.98 34.19 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.622 0.576 . . . . 25.0 109.564 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -132.17 151.58 51.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.518 -0.919 . . . . 25.0 108.518 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 t0 56.84 40.29 29.05 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 123.325 1.536 . . . . 25.0 107.663 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 t -70.58 -6.12 34.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.784 -1.553 . . . . 25.0 114.202 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -136.16 10.93 3.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.969 0.729 . . . . 25.0 112.969 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.79 20.31 73.93 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 109.201 -1.56 . . . . 25.0 109.201 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.5 mt -122.32 109.92 15.03 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 105.557 -2.016 . . . . 25.0 105.557 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -68.65 149.07 49.55 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.645 -1.242 . . . . 25.0 107.645 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.18 -14.21 58.0 Favored Glycine 0 C--O 1.222 -0.611 0 CA-C-O 119.068 -0.851 . . . . 25.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -97.94 134.22 41.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.678 1.239 . . . . 25.0 109.782 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -121.13 147.58 45.37 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.034 -0.728 . . . . 25.0 109.034 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.4 tp -85.89 115.48 23.54 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 105.907 -1.886 . . . . 25.0 105.907 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.3 m -118.08 160.63 21.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.391 -0.226 . . . . 25.0 110.391 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -131.18 132.2 44.56 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.137 0.494 . . . . 25.0 111.699 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tt -150.49 141.17 22.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.058 -0.974 . . . . 25.0 108.682 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 56.86 33.37 23.02 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.159 0.8 . . . . 25.0 113.159 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.1 10.75 81.49 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.731 -0.747 . . . . 25.0 113.686 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -118.45 162.76 17.8 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.37 149.48 41.16 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.466 -1.309 . . . . 25.0 107.466 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.64 -179.14 43.23 Favored Glycine 0 C--O 1.239 0.435 0 N-CA-C 110.97 -0.852 . . . . 25.0 110.97 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.14 146.14 7.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.345 0.593 . . . . 25.0 112.244 -176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -142.72 134.66 13.2 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.397 -0.819 . . . . 25.0 108.813 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.36 115.89 4.38 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 114.64 -3.107 . . . . 25.0 110.178 170.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.59 -17.01 66.29 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.277 0.471 . . . . 25.0 114.277 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -70.24 -4.13 20.34 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.415 -0.462 . . . . 25.0 111.661 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -104.69 10.28 34.81 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.226 -0.296 . . . . 25.0 110.629 175.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.4 153.27 40.62 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.88 0.326 . . . . 25.0 111.88 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.24 117.68 24.35 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.419 HD13 ' HB2' ' A' ' 10' ' ' ALA . 25.4 mm -63.35 133.13 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.778 0.431 . . . . 25.0 111.359 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 114.43 19.29 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 106.413 -1.699 . . . . 25.0 106.413 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.0 t 63.91 104.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 124.62 1.2 . . . . 25.0 112.095 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.63 -166.38 33.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.258 -1.137 . . . . 25.0 110.258 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.0 tpt -73.3 18.78 0.11 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.74 1.015 . . . . 25.0 113.74 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -148.37 114.45 5.81 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.895 -0.503 . . . . 25.0 111.704 -175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -137.77 52.69 1.86 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.366 1.079 . . . . 25.0 112.654 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.9 mmmt -74.44 135.29 42.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 105.828 -1.916 . . . . 25.0 105.828 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.29 152.98 74.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 105.57 -2.011 . . . . 25.0 105.57 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.14 -18.93 26.75 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 115.927 1.472 . . . . 25.0 115.927 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 51.76 47.19 25.27 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.962 1.097 . . . . 25.0 113.962 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.78 160.83 28.79 Favored Glycine 0 CA--C 1.511 -0.202 0 N-CA-C 108.821 -1.712 . . . . 25.0 108.821 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -144.57 153.53 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.73 11.23 1.63 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.543 0.572 . . . . 25.0 112.543 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 tt -93.09 147.71 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.426 -1.324 . . . . 25.0 107.426 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.2 t -126.23 130.44 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.5 m -115.88 -42.7 3.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.555 -0.905 . . . . 25.0 108.555 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.8 t0 . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 124.878 1.271 . . . . 25.0 109.536 176.771 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.804 0 CA-C-O 123.375 1.542 . . . . 25.0 115.683 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -75.92 -26.84 57.3 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.689 -0.889 . . . . 25.0 112.353 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.7 ptp -155.37 172.96 17.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.804 -1.554 . . . . 25.0 106.804 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -110.43 -39.67 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.684 -0.487 . . . . 25.0 109.684 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -147.2 172.32 14.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 102.34 -3.208 . . . . 25.0 102.34 176.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.36 -45.99 80.23 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.849 1.425 . . . . 25.0 114.849 -171.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.9 t30 50.75 45.24 27.39 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.76 1.393 . . . . 25.0 114.76 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.65 147.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.169 -1.789 . . . . 25.0 106.169 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.66 162.84 13.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.566 0.698 . . . . 25.0 110.136 -174.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.47 138.7 29.44 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.394 -0.821 . . . . 25.0 109.92 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -95.28 134.99 37.44 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.648 -0.871 . . . . 25.0 108.648 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.25 134.59 42.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.247 0.546 . . . . 25.0 110.548 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.06 -30.56 15.96 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.78 -0.646 . . . . 25.0 109.352 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -126.44 163.66 22.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.219 -1.4 . . . . 25.0 107.219 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 9.8 p-10 -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.665 -0.865 . . . . 25.0 108.665 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -151.46 129.87 12.11 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.697 0.629 . . . . 25.0 112.697 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -98.62 128.15 50.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 103.174 -2.899 . . . . 25.0 103.174 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.59 117.49 9.6 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.819 -0.808 . . . . 25.0 108.819 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -95.1 -13.34 25.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.536 0.684 . . . . 25.0 109.286 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.8 m -120.41 150.7 52.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.81 -20.43 26.14 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 117.636 -1.109 . . . . 25.0 114.487 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -82.13 -15.45 53.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.763 0.792 . . . . 25.0 109.801 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -84.05 147.18 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.48 -0.782 . . . . 25.0 110.517 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.432 HD22 ' H ' ' A' ' 55' ' ' GLY . 4.9 tp -97.92 132.52 43.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.95 0.405 . . . . 25.0 109.941 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -89.34 143.21 27.0 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.991 -1.115 . . . . 25.0 107.991 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 57' ' ' VAL . 38.8 p90 -160.93 170.17 21.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.151 -1.796 . . . . 25.0 106.151 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.6 mtm-85 -124.26 159.29 30.55 Favored 'General case' 0 C--O 1.215 -0.72 0 O-C-N 121.928 -0.483 . . . . 25.0 111.087 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 10.6 ptmm? -59.09 133.44 56.09 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.042 -0.725 . . . . 25.0 109.042 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.1 -11.39 72.07 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 115.57 -0.741 . . . . 25.0 113.635 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -80.93 161.31 24.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.37 134.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.965 -0.754 . . . . 25.0 108.965 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.0 ptp -130.61 158.71 39.27 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 m -97.86 125.43 42.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.241 -0.652 . . . . 25.0 109.241 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.5 t -82.62 127.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.478 -1.305 . . . . 25.0 107.478 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -102.34 -41.09 6.46 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.662 -0.699 . . . . 25.0 110.454 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -146.67 164.58 32.23 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.772 -1.196 . . . . 25.0 107.772 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -132.69 152.39 51.72 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.505 -1.294 . . . . 25.0 107.505 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 31.04 20.81 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 123.052 1.406 . . . . 25.0 108.42 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.1 t -70.5 -20.43 62.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 113.311 -1.768 . . . . 25.0 114.701 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -102.85 3.82 37.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.29 0.567 . . . . 25.0 109.873 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.51 85.81 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 109.052 -1.619 . . . . 25.0 109.052 -173.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.0 mt -111.26 122.8 48.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.394 -1.706 . . . . 25.0 106.394 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -60.7 132.69 54.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.695 0.759 . . . . 25.0 110.08 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -1.11 89.22 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-O 118.767 -1.018 . . . . 25.0 115.506 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -93.96 120.87 34.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.359 1.58 . . . . 25.0 108.712 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -110.23 142.5 41.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.202 -0.311 . . . . 25.0 110.921 -172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -81.73 114.83 20.65 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.336 -2.098 . . . . 25.0 105.336 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.8 m -117.89 162.96 17.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.9 t -129.68 138.63 51.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.96 0.41 . . . . 25.0 110.265 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.66 140.19 15.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.586 -1.264 . . . . 25.0 107.586 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 55.65 29.27 13.34 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.422 1.267 . . . . 25.0 114.422 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.92 1.87 90.64 Favored Glycine 0 C--O 1.225 -0.432 0 C-N-CA 120.952 -0.642 . . . . 25.0 114.351 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -114.06 162.8 16.01 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -131.83 138.51 48.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.901 -1.518 . . . . 25.0 106.901 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' H ' HD22 ' A' ' 24' ' ' LEU . . . -145.53 164.46 28.07 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.378 -1.089 . . . . 25.0 110.378 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.6 pt -81.63 145.32 8.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG13 ' CE1' ' A' ' 26' ' ' PHE . 76.8 t -141.62 135.29 14.62 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 -176.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.13 113.32 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 115.765 -2.357 . . . . 25.0 111.641 174.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.1 -20.0 59.89 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 114.545 0.578 . . . . 25.0 114.545 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.22 -30.11 68.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.932 0.396 . . . . 25.0 111.373 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -89.53 8.82 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.213 0.449 . . . . 25.0 112.213 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.69 153.67 36.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.149 0.499 . . . . 25.0 112.298 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -125.09 117.58 24.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.198 -0.667 . . . . 25.0 109.198 174.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.3 mm -64.31 136.46 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.179 0.592 . . . . 25.0 110.535 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.7 158.09 43.74 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 122.545 0.338 . . . . 25.0 110.455 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t 52.5 90.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 114.816 1.413 . . . . 25.0 114.816 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.75 45.01 2.02 Favored Glycine 0 C--O 1.222 -0.636 0 CA-C-N 115.157 -0.929 . . . . 25.0 111.371 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.1 mpt? 54.19 -119.26 1.44 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.436 0.694 . . . . 25.0 110.426 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -154.55 155.51 34.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.919 0.781 . . . . 25.0 110.285 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.53 -43.75 7.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.2 0.524 . . . . 25.0 111.179 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 52.37 -105.31 0.22 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.471 0.708 . . . . 25.0 111.126 -175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -122.01 148.03 50.48 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 108.681 -0.859 . . . . 25.0 108.681 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.85 9.72 2.58 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 N-CA-C 114.21 0.812 . . . . 25.0 114.21 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.19 144.93 31.12 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.034 -1.098 . . . . 25.0 108.034 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.89 -27.22 0.09 OUTLIER Glycine 0 C--O 1.224 -0.518 0 C-N-CA 121.488 -0.387 . . . . 25.0 112.354 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -123.84 167.05 14.59 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.891 -1.151 . . . . 25.0 107.891 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -73.18 164.54 26.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.958 0.409 . . . . 25.0 110.103 177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.4 pt -115.52 162.57 13.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.245 -0.65 . . . . 25.0 109.245 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.37 91.63 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.0 t -93.61 -1.68 55.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.686 0.755 . . . . 25.0 110.528 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.2 t0 . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 123.774 1.749 . . . . 25.0 111.641 179.446 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.091 0 CA-C-O 123.57 1.65 . . . . 25.0 114.8 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 m -81.43 -13.28 58.42 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.844 -1.386 . . . . 25.0 111.138 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 mmt -79.37 138.76 37.79 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.301 -0.629 . . . . 25.0 109.301 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -78.26 133.83 37.63 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -134.51 173.92 11.12 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 105.857 -1.905 . . . . 25.0 105.857 174.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -58.24 -46.04 86.66 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.677 1.362 . . . . 25.0 114.677 -170.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.9 t30 53.87 41.65 31.98 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.771 1.026 . . . . 25.0 113.771 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -120.12 151.98 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 N-CA-C 105.901 -1.888 . . . . 25.0 105.901 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.73 151.97 37.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.128 0.489 . . . . 25.0 111.614 -174.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 64' ' ' ILE . . . -133.63 148.62 51.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.54 -0.755 . . . . 25.0 112.465 -175.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.31 132.61 40.13 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 114.988 -1.005 . . . . 25.0 108.295 176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.97 125.4 28.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.2 mt -91.64 -26.99 18.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 25.0 110.752 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -127.96 163.03 25.38 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.411 -1.329 . . . . 25.0 107.411 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.62 165.63 12.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.273 -0.639 . . . . 25.0 109.273 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -148.61 156.55 42.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.608 -0.516 . . . . 25.0 109.608 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.36 105.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.068 -1.827 . . . . 25.0 106.068 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.41 30.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.167 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -104.91 -12.31 16.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.225 0.536 . . . . 25.0 111.753 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -122.39 149.83 55.97 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.984 -0.553 . . . . 25.0 110.511 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.89 -16.07 40.89 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 117.393 -1.271 . . . . 25.0 114.583 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -76.86 -19.64 57.24 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.77 0.795 . . . . 25.0 109.945 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -94.18 137.89 32.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.805 0.812 . . . . 25.0 110.49 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.62 131.48 35.21 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.83 -0.748 . . . . 25.0 111.276 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.7 t -78.72 109.98 13.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.16 162.46 35.43 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.461 -0.94 . . . . 25.0 108.461 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.47 167.49 20.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.625 -0.879 . . . . 25.0 108.625 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -61.92 140.66 58.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.522 -0.547 . . . . 25.0 109.522 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.51 -15.0 62.43 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-O 118.792 -1.004 . . . . 25.0 113.272 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -73.07 155.74 39.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 118.505 1.152 . . . . 25.0 110.697 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.9 mm -122.38 126.14 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 107.371 -1.344 . . . . 25.0 107.371 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.4 ptp -135.97 154.92 50.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.18 0.192 . . . . 25.0 111.31 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 m -92.96 129.8 38.76 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.625 -0.879 . . . . 25.0 108.625 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.95 125.74 40.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.502 -1.295 . . . . 25.0 107.502 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.3 mt -94.74 -48.11 6.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.046 -0.524 . . . . 25.0 110.442 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.2 167.12 22.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.237 0.96 . . . . 25.0 109.11 -174.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -129.92 155.46 46.02 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 57.5 36.02 26.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 123.55 1.643 . . . . 25.0 107.914 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -70.17 -12.5 61.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.835 -1.529 . . . . 25.0 114.089 -171.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -110.46 4.79 20.83 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.42 0.628 . . . . 25.0 109.337 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.32 -20.29 11.17 Favored Glycine 0 C--O 1.217 -0.926 0 N-CA-C 109.431 -1.468 . . . . 25.0 109.431 -173.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 40' ' ' GLN . 91.7 mt -81.02 123.77 28.62 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 106.751 -1.574 . . . . 25.0 106.751 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.7 135.46 57.38 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.511 -0.922 . . . . 25.0 108.511 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.75 -3.65 83.24 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 115.878 1.111 . . . . 25.0 115.878 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -96.35 121.56 38.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.635 1.218 . . . . 25.0 108.078 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -111.87 143.99 41.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.728 -0.389 . . . . 25.0 110.55 -172.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.9 tp -85.37 120.77 27.2 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.818 -2.29 . . . . 25.0 104.818 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.4 m -121.68 161.78 21.92 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.59 -0.522 . . . . 25.0 109.59 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -123.44 129.87 51.88 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 tp -158.88 142.22 14.82 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.918 -1.142 . . . . 25.0 107.918 -175.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 58.57 29.95 19.15 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 123.355 0.662 . . . . 25.0 112.662 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.0 7.77 88.25 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.766 -0.731 . . . . 25.0 114.706 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -132.9 164.9 25.88 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -124.43 153.7 41.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.51 -1.293 . . . . 25.0 107.51 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 169.4 42.4 Favored Glycine 0 C--O 1.243 0.67 0 N-CA-C 110.441 -1.064 . . . . 25.0 110.441 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 pt -78.22 147.89 6.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 117.742 0.771 . . . . 25.0 111.995 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.92 135.42 13.49 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.749 -1.204 . . . . 25.0 107.749 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.15 116.57 4.56 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 115.844 -2.304 . . . . 25.0 111.489 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.88 -25.49 69.27 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 115.935 1.134 . . . . 25.0 115.935 -172.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -69.07 -12.4 61.65 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.874 -0.78 . . . . 25.0 112.043 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -93.58 5.77 50.48 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.356 -0.84 . . . . 25.0 110.252 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.6 mt -116.94 154.8 30.22 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 122.61 0.364 . . . . 25.0 111.462 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -126.86 114.5 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.547 HD13 ' HB2' ' A' ' 10' ' ' ALA . 11.3 mm -67.73 141.82 17.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.145 -1.058 . . . . 25.0 108.145 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.06 -159.64 0.48 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.828 0.451 . . . . 25.0 109.967 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.05 141.21 18.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 122.869 0.467 . . . . 25.0 109.771 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.15 37.14 1.39 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-O 119.999 -0.334 . . . . 25.0 113.3 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.42 162.85 39.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.618 0.709 . . . . 25.0 111.499 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 15.7 t80 54.61 52.86 11.51 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.356 1.074 . . . . 25.0 113.809 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.94 -22.02 66.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.321 -0.854 . . . . 25.0 112.928 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -99.73 111.85 24.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.412 0.625 . . . . 25.0 111.718 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.64 155.41 50.76 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 114.686 -1.143 . . . . 25.0 110.143 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.0 175.04 11.77 Favored 'Trans proline' 0 C--O 1.243 0.727 0 N-CA-C 113.722 0.624 . . . . 25.0 113.722 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.8 163.88 35.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 104.665 -2.346 . . . . 25.0 104.665 174.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.01 -171.78 44.29 Favored Glycine 0 C--O 1.218 -0.878 0 N-CA-C 108.073 -2.011 . . . . 25.0 108.073 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.63 172.65 7.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.082 -1.081 . . . . 25.0 108.082 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -126.04 161.63 27.13 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.702 0.287 . . . . 25.0 110.342 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.1 mt -109.55 134.02 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.826 -1.546 . . . . 25.0 106.826 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -118.78 169.01 10.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.374 -1.713 . . . . 25.0 106.374 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.84 120.9 15.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.175 0.512 . . . . 25.0 110.889 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 . . . . . 0 C--O 1.207 -1.133 0 CA-C-O 126.581 3.086 . . . . 25.0 113.938 178.443 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 115.314 0.886 . . . . 25.0 115.314 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m 56.5 18.08 3.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.98 1.474 . . . . 25.0 114.98 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.3 ttm -75.3 80.72 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.691 0.758 . . . . 25.0 110.44 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -163.17 -34.51 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.163 -0.926 . . . . 25.0 110.107 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -116.28 170.02 8.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.604 -1.258 . . . . 25.0 107.604 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -58.35 -42.62 87.33 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.294 0.371 . . . . 25.0 111.182 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 57.48 22.38 7.97 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.547 0.943 . . . . 25.0 113.547 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.4 t -89.7 132.94 33.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 N-CA-C 107.737 -1.209 . . . . 25.0 107.737 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -95.27 160.51 14.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.334 0.588 . . . . 25.0 109.747 -179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.09 150.75 34.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.565 -0.743 . . . . 25.0 110.616 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -95.79 133.5 39.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.55 -0.75 . . . . 25.0 109.649 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.42 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -76.95 134.13 38.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.391 0.615 . . . . 25.0 109.854 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.24 -21.55 19.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.524 -0.762 . . . . 25.0 110.152 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -128.88 159.88 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.796 -0.638 . . . . 25.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 17.3 p-10 -101.98 147.57 26.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 175.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -153.07 156.95 39.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.7 -0.682 . . . . 25.0 110.875 -174.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -124.96 131.48 72.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 104.472 -2.418 . . . . 25.0 104.472 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 121.65 14.31 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.13 0.269 . . . . 25.0 110.406 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -94.6 -14.62 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.358 -0.978 . . . . 25.0 108.358 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.7 155.44 59.95 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.471 -0.786 . . . . 25.0 109.774 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.16 -19.86 25.61 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 117.31 -1.327 . . . . 25.0 113.753 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -15.57 49.1 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.618 0.723 . . . . 25.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -87.29 153.17 21.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.972 -0.558 . . . . 25.0 111.232 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.6 136.61 41.15 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.039 -0.413 . . . . 25.0 111.841 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.1 m -85.19 109.81 18.57 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 171.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -126.55 162.05 26.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.649 -0.871 . . . . 25.0 108.649 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 43.5 mtm105 -127.39 155.23 43.96 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.918 -0.488 . . . . 25.0 111.102 -178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.8 pttt -59.99 128.9 39.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 175.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.19 65.83 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.627 -0.715 . . . . 25.0 114.353 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.75 156.76 30.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.881 0.841 . . . . 25.0 109.872 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.16 130.79 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.676 -0.861 . . . . 25.0 108.676 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -135.28 160.6 37.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.584 -0.524 . . . . 25.0 109.584 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 9' ' ' LEU . 33.4 m -101.85 127.15 48.79 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.824 -0.436 . . . . 25.0 109.824 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.93 125.53 40.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.7 mt -95.5 -41.57 8.89 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.607 -0.724 . . . . 25.0 110.237 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -148.23 164.17 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.324 -0.621 . . . . 25.0 109.324 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -135.11 151.88 51.13 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.494 -1.669 . . . . 25.0 106.494 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.0 t0 59.39 34.45 22.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.175 1.464 . . . . 25.0 107.913 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -70.55 -16.54 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.829 -1.532 . . . . 25.0 112.613 -172.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -113.35 7.98 17.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 25.0 112.05 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.84 19.81 78.54 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 109.418 -1.473 . . . . 25.0 109.418 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.7 mt -130.05 114.86 16.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -65.7 149.93 49.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.68 -1.6 . . . . 25.0 106.68 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.86 -12.55 69.17 Favored Glycine 0 C--O 1.215 -1.07 0 CA-C-O 118.573 -1.126 . . . . 25.0 112.224 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -106.28 128.28 53.86 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.179 1.489 . . . . 25.0 110.337 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -122.16 142.34 50.51 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.77 -0.456 . . . . 25.0 109.77 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.2 tp -83.87 119.03 24.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.0 m -123.42 164.79 18.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.349 0.119 . . . . 25.0 111.209 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.7 p -121.94 124.13 43.34 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.032 0.444 . . . . 25.0 110.256 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 tp -162.17 164.64 27.75 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 106.076 -1.824 . . . . 25.0 106.076 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.19 17.63 7.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.789 1.403 . . . . 25.0 114.789 169.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.33 13.57 80.32 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.934 -0.65 . . . . 25.0 113.261 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.9 167.61 21.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.559 -0.534 . . . . 25.0 109.559 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -105.98 154.81 20.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 103.6 -2.741 . . . . 25.0 103.6 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.78 163.77 34.27 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 110.121 -1.192 . . . . 25.0 110.121 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 pt -79.61 141.93 14.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.877 0.846 . . . . 25.0 109.983 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.4 t -137.6 132.99 17.74 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.362 -1.347 . . . . 25.0 107.362 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.07 121.74 8.36 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 114.218 -3.388 . . . . 25.0 111.258 175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.17 -19.07 69.86 Favored Glycine 0 C--O 1.22 -0.763 0 CA-C-N 115.801 -0.636 . . . . 25.0 112.121 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -69.73 -5.59 26.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.109 0.481 . . . . 25.0 111.378 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -114.4 11.43 17.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.748 -0.464 . . . . 25.0 109.748 175.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 12' ' ' ALA . 89.0 mt -120.57 150.09 41.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.275 0.56 . . . . 25.0 110.779 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -120.45 119.75 33.91 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm -57.71 134.41 22.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.882 -0.599 . . . . 25.0 109.772 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.87 -166.97 1.72 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.661 -0.699 . . . . 25.0 110.367 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m -61.82 160.55 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 114.006 1.113 . . . . 25.0 114.006 -176.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.78 175.04 35.86 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 108.922 -1.671 . . . . 25.0 108.922 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.6 mtp -56.05 -30.64 62.25 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 116.148 1.907 . . . . 25.0 116.148 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.45 26.56 4.77 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.78 0.8 . . . . 25.0 110.313 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -68.78 156.01 39.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.203 -0.908 . . . . 25.0 109.746 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -118.32 111.65 19.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.461 0.648 . . . . 25.0 110.626 -175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -61.17 131.77 92.22 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.918 -1.037 . . . . 25.0 109.591 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.65 167.55 26.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 117.987 -0.875 . . . . 25.0 111.562 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.11 156.47 43.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.73 82.33 1.66 Allowed Glycine 0 C--O 1.219 -0.835 0 N-CA-C 110.939 -0.864 . . . . 25.0 110.939 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 57.21 29.98 17.61 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.828 1.047 . . . . 25.0 113.828 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -115.87 136.15 53.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.139 0.495 . . . . 25.0 110.225 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 79.9 mt -102.03 129.33 53.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.397 -1.705 . . . . 25.0 106.397 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.21 19.5 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.938 0.718 . . . . 25.0 112.938 -173.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.5 p -79.03 149.86 32.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.052 0.453 . . . . 25.0 110.423 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 C--O 1.21 -1.007 0 CA-C-O 124.641 2.162 . . . . 25.0 111.766 176.359 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.901 0 CA-C-O 122.815 1.231 . . . . 25.0 113.777 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -150.11 164.01 36.71 Favored 'General case' 0 C--O 1.223 -0.326 0 O-C-N 120.706 -1.467 . . . . 25.0 107.732 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.1 tpt 51.24 70.9 0.48 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.939 1.088 . . . . 25.0 113.939 177.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.2 tttm 62.81 58.62 1.52 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 122.223 1.011 . . . . 25.0 113.475 177.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -91.36 -179.47 5.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 105.927 -1.879 . . . . 25.0 105.927 171.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.6 mt -53.57 -49.87 66.79 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.191 1.182 . . . . 25.0 114.191 -175.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.7 t30 47.09 46.56 16.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.124 1.527 . . . . 25.0 115.124 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.7 m -111.25 169.5 4.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 104.483 -2.414 . . . . 25.0 104.483 175.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.41 164.38 29.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 -178.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.69 165.42 28.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.496 -0.774 . . . . 25.0 109.75 -175.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -115.35 136.34 53.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.681 -1.229 . . . . 25.0 107.681 174.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 135.38 45.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.48 0.657 . . . . 25.0 109.727 177.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.01 -30.16 16.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.182 -0.917 . . . . 25.0 109.356 178.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.83 158.49 39.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 -177.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 5.1 p-10 -87.91 152.98 21.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.432 . . . . 25.0 110.08 177.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.76 87.25 1.41 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -176.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.16 121.55 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 103.889 -2.634 . . . . 25.0 103.889 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.59 51.64 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.379 0.424 . . . . 25.0 111.418 -173.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.05 -18.18 12.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.361 -0.836 . . . . 25.0 110.184 175.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -104.93 150.79 39.1 Favored Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 109.613 -0.514 . . . . 25.0 109.613 177.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.62 -21.6 19.05 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 117.585 -1.144 . . . . 25.0 114.42 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.62 -14.95 56.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 25.0 109.957 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -89.15 140.61 29.29 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.199 -0.91 . . . . 25.0 111.134 -176.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.87 124.74 34.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.674 -0.641 . . . . 25.0 111.147 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -80.45 121.22 25.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.544 -0.539 . . . . 25.0 109.544 174.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.503 ' CE1' HG13 ' A' ' 57' ' ' VAL . 52.7 p90 -143.26 168.56 19.5 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.306 -0.998 . . . . 25.0 108.306 178.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -129.28 164.82 22.69 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.973 -0.455 . . . . 25.0 111.23 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 34.9 pttt -62.03 134.27 56.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.729 -0.471 . . . . 25.0 109.729 -177.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.47 -13.38 67.45 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 115.524 -0.762 . . . . 25.0 113.407 -178.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -75.87 157.64 33.05 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 117.419 0.609 . . . . 25.0 110.988 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.88 126.37 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.292 0.637 . . . . 25.0 111.042 -175.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -129.49 147.78 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.41 0.624 . . . . 25.0 111.43 178.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -87.97 130.25 35.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 176.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.24 124.13 46.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 177.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -99.59 -41.32 7.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.3 -0.864 . . . . 25.0 111.791 -174.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.06 160.41 42.43 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.88 -0.785 . . . . 25.0 108.88 -176.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.5 mtm-85 -128.36 154.58 45.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.899 -1.149 . . . . 25.0 107.899 176.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t0 55.67 40.57 30.92 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.547 1.642 . . . . 25.0 108.309 -175.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -70.86 -8.0 49.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.646 -1.616 . . . . 25.0 114.193 -171.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -135.86 12.49 3.39 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.811 0.671 . . . . 25.0 112.811 -175.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 15.96 74.41 Favored Glycine 0 N--CA 1.459 0.224 0 N-CA-C 110.692 -0.963 . . . . 25.0 110.692 -176.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.3 mt -122.52 110.68 15.88 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.479 -1.674 . . . . 25.0 106.479 176.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.9 144.07 57.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.559 -1.275 . . . . 25.0 107.559 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 -17.2 57.04 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 115.217 -0.902 . . . . 25.0 113.107 -177.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -94.33 128.2 40.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.96 1.38 . . . . 25.0 108.61 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -119.72 146.3 45.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 -174.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.2 tp -86.22 112.64 21.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.654 -1.61 . . . . 25.0 106.654 174.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -112.04 168.32 9.69 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.923 -0.399 . . . . 25.0 109.923 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -128.71 131.71 47.95 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.064 -1.088 . . . . 25.0 108.064 174.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -158.61 140.12 13.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 -176.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 56.43 33.2 22.05 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.547 0.689 . . . . 25.0 112.356 177.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.2 3.34 90.68 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 115.758 1.063 . . . . 25.0 115.758 176.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -127.85 161.48 28.93 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 118.503 1.152 . . . . 25.0 109.035 177.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -113.15 151.74 30.51 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 105.903 -1.888 . . . . 25.0 105.903 176.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.77 165.73 38.19 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.437 -1.065 . . . . 25.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 pt -78.62 144.79 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.51 0.671 . . . . 25.0 109.217 -178.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.503 HG13 ' CE1' ' A' ' 26' ' ' PHE . 46.3 t -140.55 134.12 15.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.314 -0.857 . . . . 25.0 109.106 -176.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.95 114.65 3.96 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 116.05 -2.167 . . . . 25.0 110.855 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.57 -18.28 63.4 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-N 116.066 -0.515 . . . . 25.0 113.07 -176.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -58.47 -31.13 67.52 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.53 0.332 . . . . 25.0 111.414 174.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -88.58 6.9 35.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.112 0.412 . . . . 25.0 112.112 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.9 mt -119.4 151.33 38.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.851 0.358 . . . . 25.0 111.818 -176.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -124.43 123.31 39.89 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.956 -0.757 . . . . 25.0 108.956 172.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.12 140.36 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.284 0.633 . . . . 25.0 110.388 -177.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.3 165.58 13.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.933 -0.765 . . . . 25.0 108.933 -179.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t 58.38 44.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.487 1.115 . . . . 25.0 112.385 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.34 -45.27 4.43 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.706 -0.759 . . . . 25.0 114.159 177.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 51.3 mtt 50.92 -137.37 1.16 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.092 0.557 . . . . 25.0 110.789 -176.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -154.19 146.97 24.29 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.265 -1.383 . . . . 25.0 107.265 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 49.42 -152.3 0.14 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 124.211 0.944 . . . . 25.0 112.917 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -145.93 144.98 30.5 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.143 -1.058 . . . . 25.0 108.143 -176.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -71.61 147.02 91.95 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.511 -1.663 . . . . 25.0 106.511 175.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.3 100.25 0.99 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 117.812 -0.992 . . . . 25.0 113.103 -178.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.44 146.68 16.97 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.305 -0.628 . . . . 25.0 109.305 -179.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.97 -99.99 1.88 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 111.27 -0.732 . . . . 25.0 111.27 178.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.09 163.11 26.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.712 0.291 . . . . 25.0 110.945 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -103.58 139.8 38.41 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.995 -1.483 . . . . 25.0 106.995 175.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 48.5 pt -73.67 159.3 5.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.791 0.329 . . . . 25.0 111.74 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 t 54.64 80.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 122.13 0.967 . . . . 25.0 113.051 179.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.0 t -132.48 168.8 17.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 105.155 -2.165 . . . . 25.0 105.155 175.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.215 -0.715 0 CA-C-O 124.85 2.262 . . . . 25.0 112.784 179.396 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.621 0 CA-C-O 124.943 2.413 . . . . 25.0 113.141 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -63.77 -20.7 65.97 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 112.066 -2.067 . . . . 25.0 113.308 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 91.0 mtp -104.36 -52.38 2.92 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 176.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -169.49 -47.87 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.28 0.562 . . . . 25.0 111.083 174.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -117.82 166.09 12.88 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.247 -1.02 . . . . 25.0 108.247 -178.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.42 -46.87 75.1 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 123.234 0.334 . . . . 25.0 111.144 -177.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.6 t30 48.55 47.35 20.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.352 1.241 . . . . 25.0 114.352 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.13 165.8 12.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 N-CA-C 105.334 -2.098 . . . . 25.0 105.334 175.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.23 159.64 39.62 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.524 -0.917 . . . . 25.0 108.524 -178.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.35 164.65 29.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.562 -0.744 . . . . 25.0 110.388 -172.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -114.81 135.15 54.5 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.75 -1.204 . . . . 25.0 107.75 175.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.99 124.49 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 25.0 110.7 178.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -79.42 -29.42 41.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.041 -0.527 . . . . 25.0 109.972 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -126.73 162.7 25.2 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.76 -0.83 . . . . 25.0 108.76 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.498 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 p-10 -98.29 160.38 14.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 175.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -144.14 175.0 10.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.462 0.648 . . . . 25.0 112.265 177.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.8 t -126.96 137.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 100.215 -3.994 . . . . 25.0 100.215 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.84 115.8 16.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.173 -1.047 . . . . 25.0 108.173 -178.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -85.64 -11.45 53.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.22 1.01 . . . . 25.0 109.354 -179.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -138.33 152.52 71.57 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.02 -0.991 . . . . 25.0 109.088 -176.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -71.98 -15.78 29.25 Favored 'Trans proline' 0 C--N 1.35 0.608 0 N-CA-C 114.016 0.737 . . . . 25.0 114.016 -179.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -84.35 -20.01 32.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.835 0.826 . . . . 25.0 109.621 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.56 135.73 35.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.662 -0.699 . . . . 25.0 110.199 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.95 138.46 36.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.108 -0.701 . . . . 25.0 109.108 177.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 p -90.03 131.74 35.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.194 -1.409 . . . . 25.0 107.194 172.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.39 169.02 22.42 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.716 -1.216 . . . . 25.0 107.716 -177.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -128.24 158.78 37.2 Favored 'General case' 0 C--O 1.212 -0.871 0 N-CA-C 109.25 -0.648 . . . . 25.0 109.25 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 16.4 pttt -56.29 128.62 36.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 173.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.78 -20.84 42.5 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-N 115.944 -0.571 . . . . 25.0 113.868 -176.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -66.89 151.02 48.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.403 0.601 . . . . 25.0 109.989 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -115.42 128.38 72.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.541 -0.911 . . . . 25.0 108.541 -177.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -134.5 148.61 50.58 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.455 0.645 . . . . 25.0 111.168 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 m -89.86 126.43 35.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.141 -1.429 . . . . 25.0 107.141 177.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.2 t -91.57 114.05 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.279 -1.748 . . . . 25.0 106.279 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.2 mt -88.77 -43.21 11.42 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.187 -0.915 . . . . 25.0 110.206 -176.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -145.72 161.19 40.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.499 -0.926 . . . . 25.0 108.499 -173.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -126.8 150.32 49.21 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.823 -1.547 . . . . 25.0 106.823 177.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 58.92 34.02 23.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.995 1.379 . . . . 25.0 108.267 177.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 t -69.61 -20.53 63.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.693 -1.594 . . . . 25.0 113.673 -169.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -102.46 6.22 39.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.701 -0.681 . . . . 25.0 110.144 -177.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.36 12.36 84.64 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 109.658 -1.377 . . . . 25.0 109.658 -173.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -113.36 121.02 43.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.783 -0.821 . . . . 25.0 108.783 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.4 128.51 37.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.54 0.686 . . . . 25.0 110.311 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.98 -0.92 84.63 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 115.766 1.066 . . . . 25.0 115.766 175.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -100.79 123.86 45.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.049 1.424 . . . . 25.0 109.237 177.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -113.3 143.02 45.14 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.251 -0.28 . . . . 25.0 111.133 -171.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.6 tp -81.99 112.98 19.57 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.661 -1.607 . . . . 25.0 106.661 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 75.3 m -114.11 159.05 20.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.901 0.382 . . . . 25.0 110.43 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -135.59 127.0 28.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.698 -0.683 . . . . 25.0 109.76 178.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.98 141.82 29.28 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.545 0.528 . . . . 25.0 110.889 176.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 48.08 38.57 9.87 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.991 1.108 . . . . 25.0 113.991 178.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.5 5.61 89.82 Favored Glycine 0 C--O 1.226 -0.385 0 N-CA-C 115.019 0.768 . . . . 25.0 115.019 176.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -122.96 145.27 48.63 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.103 -0.703 . . . . 25.0 109.103 178.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -118.04 150.35 39.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.696 -0.853 . . . . 25.0 108.696 178.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.5 169.22 42.17 Favored Glycine 0 C--O 1.243 0.704 0 N-CA-C 109.789 -1.324 . . . . 25.0 109.789 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -82.27 146.89 6.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 117.504 0.652 . . . . 25.0 109.706 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.3 t -140.83 135.02 15.19 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.542 -1.281 . . . . 25.0 107.542 -177.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.06 119.76 6.72 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 115.323 -2.652 . . . . 25.0 110.776 174.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.63 -22.6 68.13 Favored Glycine 0 CA--C 1.504 -0.602 0 N-CA-C 114.31 0.484 . . . . 25.0 114.31 -173.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.91 -26.85 66.25 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 122.524 -0.398 . . . . 25.0 111.932 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -85.71 6.62 26.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -118.98 146.69 44.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.47 0.544 . . . . 25.0 112.47 -175.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -118.2 121.77 41.32 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.497 -1.297 . . . . 25.0 107.497 170.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.4 mm -59.71 136.74 23.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 O-C-N 123.982 0.801 . . . . 25.0 109.009 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.22 179.88 7.59 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.002 -0.74 . . . . 25.0 109.002 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 t 58.65 59.99 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 122.688 1.233 . . . . 25.0 108.937 -175.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.33 -178.34 32.26 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.702 -1.759 . . . . 25.0 108.702 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 76.9 mtm -67.36 130.51 43.29 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 118.245 1.022 . . . . 25.0 109.645 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -109.6 -18.59 13.45 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.119 1.155 . . . . 25.0 114.119 -176.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t0 49.54 48.89 20.81 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.701 1.001 . . . . 25.0 113.701 -177.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -157.64 167.99 28.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.358 -0.608 . . . . 25.0 109.358 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -82.3 156.1 69.06 Favored Pre-proline 0 C--O 1.243 0.723 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 173.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -67.79 155.9 68.09 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 116.762 -1.692 . . . . 25.0 110.125 173.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.42 59.82 0.82 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.945 0.402 . . . . 25.0 110.926 -177.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.49 161.65 26.75 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 108.721 -1.752 . . . . 25.0 108.721 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -79.03 84.19 5.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.862 -0.421 . . . . 25.0 109.862 -177.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 53.78 22.98 3.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.11 1.152 . . . . 25.0 114.11 -176.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp 56.36 46.03 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.164 0.986 . . . . 25.0 111.976 176.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.7 m -79.28 170.09 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.977 -1.12 . . . . 25.0 107.977 171.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.0 t -141.65 144.41 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.14 -0.689 . . . . 25.0 109.14 176.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 . . . . . 0 C--O 1.21 -1.009 0 CA-C-O 123.823 1.773 . . . . 25.0 112.858 -179.367 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.899 0 CA-C-O 124.167 1.981 . . . . 25.0 113.485 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -78.95 58.77 2.47 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.554 -1.323 . . . . 25.0 111.169 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.7 ttt -123.36 44.92 2.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.463 0.649 . . . . 25.0 109.924 -177.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.8 tttt 59.75 85.91 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 122.819 1.295 . . . . 25.0 113.744 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -124.15 176.74 6.21 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 177.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mp -51.48 -50.87 59.02 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.35 1.611 . . . . 25.0 115.35 -174.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.1 t30 51.77 41.69 29.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.402 1.63 . . . . 25.0 115.402 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 m -114.84 163.07 12.47 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 175.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 155.8 49.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.618 0.723 . . . . 25.0 111.839 -176.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.49 152.97 47.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.916 -1.038 . . . . 25.0 110.71 -173.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -101.41 139.23 37.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.708 -0.849 . . . . 25.0 108.708 174.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.98 130.34 41.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.419 -0.586 . . . . 25.0 109.419 175.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -90.31 -34.39 15.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -123.95 168.51 12.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 7.0 p-10 -103.77 158.77 16.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.054 0.454 . . . . 25.0 110.387 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -153.06 133.52 13.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.585 . . . . 25.0 110.53 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.94 125.77 57.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 102.901 -2.999 . . . . 25.0 102.901 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.12 129.33 38.24 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.298 -1.001 . . . . 25.0 108.298 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -100.47 -9.69 21.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.688 1.232 . . . . 25.0 109.054 177.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.9 m -127.71 152.66 77.27 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.402 -1.272 . . . . 25.0 108.948 -177.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.46 -25.62 17.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 114.718 1.007 . . . . 25.0 114.718 -176.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.71 -19.44 60.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.51 0.672 . . . . 25.0 110.623 179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -90.02 143.59 26.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.28 -0.873 . . . . 25.0 109.972 -175.06 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.37 137.11 33.91 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.222 -0.591 . . . . 25.0 111.428 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.0 m -85.6 128.02 34.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 106.32 -1.733 . . . . 25.0 106.32 171.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.451 ' CE2' HG13 ' A' ' 57' ' ' VAL . 48.3 p90 -149.43 156.69 42.42 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.67 152.78 41.66 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 119.962 -0.695 . . . . 25.0 110.009 179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.525 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 20.4 pttp -55.57 126.33 24.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.158 -178.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.39 -22.67 28.44 Favored Glycine 0 C--O 1.221 -0.662 0 CA-C-N 115.379 -0.828 . . . . 25.0 112.902 -177.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -70.74 157.95 37.15 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 117.565 0.683 . . . . 25.0 112.044 -178.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 mm -118.03 126.61 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.334 0.653 . . . . 25.0 109.979 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.9 ptp -132.45 151.36 51.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.924 0.392 . . . . 25.0 111.131 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.2 m -92.79 128.11 38.53 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 25.0 107.808 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.17 124.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 178.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 mt -102.83 -33.14 9.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.665 0.617 . . . . 25.0 112.665 -176.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.84 162.01 41.13 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 124.247 0.967 . . . . 25.0 108.603 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -133.86 144.46 48.94 Favored 'General case' 0 C--O 1.207 -1.163 0 N-CA-C 108.392 -0.966 . . . . 25.0 108.392 178.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 60.51 32.98 20.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.511 1.624 . . . . 25.0 107.521 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.9 t -67.41 -14.34 62.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.892 -1.958 . . . . 25.0 115.221 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -110.84 6.15 21.11 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.2 -6.88 73.99 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.578 -1.409 . . . . 25.0 109.578 -174.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.72 115.38 27.82 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.768 -0.827 . . . . 25.0 108.768 179.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -61.75 132.65 53.84 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.397 -0.964 . . . . 25.0 108.397 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.59 -0.49 67.92 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-O 118.908 -0.94 . . . . 25.0 114.497 176.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -106.11 124.23 49.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.663 1.231 . . . . 25.0 109.574 177.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -111.31 145.42 38.85 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 121.968 -0.457 . . . . 25.0 110.922 -174.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.4 tp -85.02 114.56 22.27 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 105.547 -2.02 . . . . 25.0 105.547 175.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.1 m -119.92 157.05 29.59 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.842 -0.429 . . . . 25.0 109.842 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 p -123.74 130.58 52.86 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.954 -1.128 . . . . 25.0 107.954 177.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -151.79 137.72 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.787 -1.097 . . . . 25.0 108.618 -174.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.7 t60 55.48 33.99 22.13 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.819 1.044 . . . . 25.0 113.819 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.05 7.03 89.02 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.816 0.686 . . . . 25.0 114.816 177.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -128.42 163.82 24.05 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.735 -1.209 . . . . 25.0 107.735 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -124.98 157.99 34.76 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 173.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.26 172.61 45.63 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.463 -1.455 . . . . 25.0 109.463 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.2 pt -84.22 143.05 12.53 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 CA-C-O 121.785 0.802 . . . . 25.0 109.653 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 26' ' ' PHE . 58.1 t -138.83 134.05 16.88 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.676 -1.231 . . . . 25.0 107.676 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.3 119.57 6.6 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 114.61 -3.126 . . . . 25.0 110.95 175.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.6 -26.68 72.04 Favored Glycine 0 C--O 1.223 -0.576 0 CA-C-N 115.867 -0.606 . . . . 25.0 114.375 -173.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.33 -9.97 59.0 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.956 -0.732 . . . . 25.0 111.325 178.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -93.12 4.59 53.74 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.699 -0.626 . . . . 25.0 109.633 174.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.42 165.24 14.13 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 122.83 0.452 . . . . 25.0 111.032 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -137.31 118.18 14.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.929 -0.578 . . . . 25.0 109.991 173.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.19 134.31 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.639 -1.245 . . . . 25.0 107.639 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.3 mt -93.21 138.09 31.93 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.362 -0.977 . . . . 25.0 108.362 -178.032 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t 56.4 35.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.842 -1.072 . . . . 25.0 111.852 -178.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.89 -38.76 96.54 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 115.198 0.839 . . . . 25.0 115.198 -178.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -159.61 164.31 34.26 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.089 0.944 . . . . 25.0 109.493 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -86.36 179.15 6.93 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 106.597 -1.631 . . . . 25.0 106.597 172.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 52.8 48.74 21.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.318 1.056 . . . . 25.0 111.963 174.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -63.34 153.07 36.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.798 -1.092 . . . . 25.0 108.174 178.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.11 147.89 89.8 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 25.0 109.521 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 172.75 14.48 Favored 'Trans proline' 0 C--N 1.352 0.726 0 O-C-N 122.615 0.797 . . . . 25.0 112.77 179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.73 166.62 23.3 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.699 -0.682 . . . . 25.0 109.802 177.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.7 -146.5 4.98 Favored Glycine 0 C--N 1.321 -0.302 0 N-CA-C 108.999 -1.64 . . . . 25.0 108.999 178.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 68.23 -168.15 0.19 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.541 1.136 . . . . 25.0 111.97 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.3 t80 47.82 78.81 0.07 Allowed 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.356 1.613 . . . . 25.0 115.356 -178.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.53 157.86 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.765 -1.198 . . . . 25.0 107.765 173.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.73 166.07 25.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.579 -0.526 . . . . 25.0 109.579 -178.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 p -90.82 153.43 20.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.975 -1.12 . . . . 25.0 107.975 177.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--O 1.211 -0.925 0 CA-C-O 124.886 2.279 . . . . 25.0 111.225 178.401 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.695 0 CA-C-O 125.069 2.483 . . . . 25.0 113.223 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 m -79.03 58.4 2.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 112.581 -1.81 . . . . 25.0 112.012 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.9 mtt -75.61 45.08 0.3 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.267 0.839 . . . . 25.0 113.267 -176.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -96.28 -23.68 16.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.347 -0.388 . . . . 25.0 109.97 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -109.94 168.59 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.789 -2.3 . . . . 25.0 104.789 173.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.1 mt -62.36 -38.51 89.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.283 -0.167 . . . . 25.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 55.26 30.03 13.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.792 0.837 . . . . 25.0 110.518 -179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.96 162.74 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 104.06 -2.57 . . . . 25.0 104.06 -179.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.15 160.94 38.61 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.383 -0.969 . . . . 25.0 108.383 -177.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.71 159.32 44.44 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.668 -0.696 . . . . 25.0 110.77 -174.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -106.88 135.59 48.17 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 174.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.24 135.84 46.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.371 0.605 . . . . 25.0 109.794 178.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.31 -25.79 16.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.469 -0.787 . . . . 25.0 110.041 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -124.01 158.51 31.94 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.632 -1.247 . . . . 25.0 107.632 -178.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 13.4 p-10 -101.52 159.12 15.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -150.78 158.34 44.03 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.355 0.409 . . . . 25.0 111.068 -173.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.71 125.38 65.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 103.076 -2.935 . . . . 25.0 103.076 173.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.81 121.73 17.84 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.74 -0.384 . . . . 25.0 110.029 -176.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -101.65 -15.1 17.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.383 0.611 . . . . 25.0 109.385 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 t -111.62 147.55 37.01 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 25.0 109.352 175.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.39 -15.4 34.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 117.775 -1.016 . . . . 25.0 113.491 175.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -80.47 -15.49 56.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.756 0.789 . . . . 25.0 110.19 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -92.62 143.29 26.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.178 -0.919 . . . . 25.0 112.803 -172.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.62 137.57 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.861 -0.524 . . . . 25.0 110.493 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 117.41 23.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 172.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 164.66 32.3 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 36.9 ptt-85 -137.01 164.03 29.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.68 -0.408 . . . . 25.0 111.985 177.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 18.6 pttt -60.01 136.81 58.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.193 0.52 . . . . 25.0 110.358 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.36 -19.43 54.28 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.186 -0.915 . . . . 25.0 113.317 -178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -77.54 156.78 30.72 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 117.168 0.484 . . . . 25.0 110.412 -178.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.1 mm -115.18 130.5 69.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 C-N-CA 123.332 0.653 . . . . 25.0 109.282 -174.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 18.9 ptp -138.94 151.83 47.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.949 0.404 . . . . 25.0 110.325 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 m -87.23 146.05 26.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.923 -1.51 . . . . 25.0 106.923 177.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.86 121.03 63.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 106.844 -1.539 . . . . 25.0 106.844 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.6 mt -85.08 -49.44 8.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.596 . . . . 25.0 110.303 -177.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.55 170.84 19.19 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 -177.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -134.72 153.69 51.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.731 -0.176 . . . . 25.0 111.163 -175.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 60.46 38.75 19.01 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.298 1.523 . . . . 25.0 107.8 -177.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -70.45 -18.83 63.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.237 -1.802 . . . . 25.0 114.785 -167.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -111.4 6.38 20.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.497 0.665 . . . . 25.0 109.597 -177.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.53 -4.39 81.98 Favored Glycine 0 CA--C 1.518 0.241 0 N-CA-C 110.107 -1.197 . . . . 25.0 110.107 -174.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.4 127.02 35.49 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.274 -1.38 . . . . 25.0 107.274 177.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.53 132.41 52.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.297 0.57 . . . . 25.0 110.167 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.2 1.59 90.4 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 115.519 0.968 . . . . 25.0 115.519 174.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -100.94 115.41 30.37 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.143 1.472 . . . . 25.0 110.075 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -108.21 146.84 32.21 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.258 -0.276 . . . . 25.0 110.335 -172.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.1 tp -86.26 110.97 20.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.749 -1.575 . . . . 25.0 106.749 176.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -113.69 161.02 18.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.865 -0.42 . . . . 25.0 109.865 -179.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.33 131.46 53.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -158.16 140.62 14.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.39 -0.823 . . . . 25.0 108.881 -177.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 56.96 35.06 25.88 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.074 1.138 . . . . 25.0 114.074 175.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.35 85.58 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.905 -0.664 . . . . 25.0 114.05 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.87 167.61 14.99 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -136.46 150.24 48.62 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.243 -1.762 . . . . 25.0 106.243 174.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.69 174.58 45.73 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 109.636 -1.386 . . . . 25.0 109.636 -176.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 pt -77.84 144.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.328 0.585 . . . . 25.0 110.437 -177.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.0 t -144.26 136.19 13.04 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -178.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.34 112.05 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 116.009 -2.194 . . . . 25.0 111.662 174.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.03 -24.86 73.29 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 115.902 -0.59 . . . . 25.0 113.941 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -70.44 -0.56 8.56 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.316 0.579 . . . . 25.0 111.559 176.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -114.28 13.77 17.93 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.752 -0.462 . . . . 25.0 109.752 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.3 mt -118.75 155.19 31.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.468 . . . . 25.0 109.928 178.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -121.81 117.76 27.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.179 -0.304 . . . . 25.0 110.179 174.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -54.68 130.56 16.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 O-C-N 123.773 0.671 . . . . 25.0 110.31 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 tp -114.62 113.66 24.66 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 115.692 -0.685 . . . . 25.0 110.264 -175.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t 58.08 5.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 114.702 1.371 . . . . 25.0 114.702 -178.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.49 44.39 3.2 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 117.314 1.686 . . . . 25.0 117.314 -179.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 55.7 mtt 43.05 42.41 3.21 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.536 1.31 . . . . 25.0 114.536 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -50.69 -38.74 48.67 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.715 1.376 . . . . 25.0 114.715 -175.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -121.69 48.81 1.63 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.569 0.7 . . . . 25.0 109.172 179.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 tttp 46.85 46.35 15.33 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 123.294 1.521 . . . . 25.0 112.162 -177.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -74.54 146.32 83.46 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 114.084 -1.417 . . . . 25.0 110.191 -175.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.2 160.87 46.16 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 118.332 -0.645 . . . . 25.0 112.662 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -158.56 174.97 14.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.088 -2.19 . . . . 25.0 105.088 177.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.12 -175.09 49.82 Favored Glycine 0 C--O 1.227 -0.331 0 N-CA-C 108.628 -1.789 . . . . 25.0 108.628 174.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -66.83 -32.53 73.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.265 1.033 . . . . 25.0 110.198 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.45 92.79 5.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.8 0.81 . . . . 25.0 109.129 175.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 pt -93.65 165.6 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.147 -0.933 . . . . 25.0 109.859 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.9 t 72.95 130.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.238 1.415 . . . . 25.0 111.941 -178.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.1 p -133.38 156.85 46.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.454 -1.313 . . . . 25.0 107.454 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 124.778 2.228 . . . . 25.0 113.439 177.796 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.733 0 CA-C-O 123.615 1.675 . . . . 25.0 115.7 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 t -156.1 152.35 27.87 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.433 -1.321 . . . . 25.0 107.433 177.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -141.03 152.36 44.8 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.127 -2.546 . . . . 25.0 104.127 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.66 147.27 46.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.071 -0.714 . . . . 25.0 109.071 -178.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -82.97 172.95 12.24 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.876 -1.527 . . . . 25.0 106.876 175.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.18 -58.63 6.66 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.69 1.367 . . . . 25.0 114.69 -172.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t30 54.82 24.49 5.76 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.982 1.475 . . . . 25.0 114.982 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.81 174.16 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 N-CA-C 104.69 -2.337 . . . . 25.0 104.69 174.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.72 162.26 33.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 118.563 0.619 . . . . 25.0 109.961 -177.193 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.6 144.18 30.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.94 -0.573 . . . . 25.0 111.656 -177.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.24 135.09 38.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.75 -0.659 . . . . 25.0 109.837 176.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.04 131.05 40.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 25.0 110.062 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.41 -30.63 17.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.925 -0.579 . . . . 25.0 110.784 179.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -130.57 162.53 29.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.22 -1.771 . . . . 25.0 106.22 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.53 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.4 p-10 -96.83 160.37 14.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.977 0.353 . . . . 25.0 110.39 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -150.02 144.4 25.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.399 0.518 . . . . 25.0 112.399 -177.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 126.79 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 104.748 -2.315 . . . . 25.0 104.748 174.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.63 128.57 33.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 -178.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -97.2 -24.1 15.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -104.31 147.16 33.91 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 109.174 -0.676 . . . . 25.0 109.174 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -70.1 -14.81 35.47 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.118 -1.455 . . . . 25.0 113.932 174.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -81.89 -19.81 40.09 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.898 0.856 . . . . 25.0 110.289 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.07 144.6 25.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.496 -0.774 . . . . 25.0 109.526 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.69 132.92 44.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.189 0.519 . . . . 25.0 110.648 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t -88.86 145.16 25.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.949 -1.13 . . . . 25.0 107.949 175.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CE1' HG13 ' A' ' 57' ' ' VAL . 35.6 p90 -159.36 165.58 32.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 -178.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -120.71 154.06 36.1 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 121.836 -0.54 . . . . 25.0 109.774 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 22.4 pttp -58.5 134.02 56.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 177.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.17 -14.01 65.93 Favored Glycine 0 C--O 1.221 -0.699 0 CA-C-O 119.209 -0.773 . . . . 25.0 112.996 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -78.21 159.8 28.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.02 0.91 . . . . 25.0 109.398 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.78 131.47 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 -178.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 11.6 ptp -130.89 155.26 47.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.185 0.594 . . . . 25.0 110.051 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.3 m -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.825 -1.176 . . . . 25.0 107.825 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.7 125.63 54.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.757 -1.201 . . . . 25.0 107.757 177.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.0 mt -102.34 -36.59 8.4 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.554 -0.748 . . . . 25.0 111.876 -174.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.82 161.28 42.56 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.434 -1.321 . . . . 25.0 107.434 -178.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 mtm105 -129.41 150.25 50.85 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.553 -1.277 . . . . 25.0 107.553 177.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 59.09 35.64 23.9 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.287 1.617 . . . . 25.0 106.961 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -70.53 -10.48 59.33 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 112.546 -2.116 . . . . 25.0 115.923 -163.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -126.48 13.96 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.448 0.642 . . . . 25.0 109.611 -178.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.58 -5.38 78.33 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 109.802 -1.319 . . . . 25.0 109.802 -175.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.18 115.59 26.8 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.041 -1.096 . . . . 25.0 108.041 178.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -61.33 130.83 48.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.793 0.806 . . . . 25.0 109.806 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 2.22 85.81 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-O 118.62 -1.1 . . . . 25.0 115.316 176.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -102.67 128.3 49.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.224 1.512 . . . . 25.0 108.442 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -117.1 144.43 44.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 25.0 109.647 -174.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.7 tp -84.34 117.38 23.55 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 106.061 -1.829 . . . . 25.0 106.061 175.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -119.92 158.08 27.44 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 110.316 -0.253 . . . . 25.0 110.316 -177.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.34 129.93 52.01 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 177.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.8 tp -150.08 137.76 19.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.509 -0.768 . . . . 25.0 109.173 -176.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 54.99 30.94 15.06 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.835 1.42 . . . . 25.0 114.835 176.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.33 13.02 82.45 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.138 -0.554 . . . . 25.0 113.991 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.37 165.3 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.243 -1.762 . . . . 25.0 106.243 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -137.23 140.61 41.79 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 118.471 0.578 . . . . 25.0 109.721 175.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.46 164.48 29.4 Favored Glycine 0 C--O 1.238 0.374 0 O-C-N 124.039 0.837 . . . . 25.0 111.574 -176.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.21 143.81 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.947 -1.131 . . . . 25.0 107.947 174.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG13 ' CE1' ' A' ' 26' ' ' PHE . 53.5 t -140.26 135.63 16.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 -175.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.58 116.99 4.8 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 115.21 -2.727 . . . . 25.0 110.385 174.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.05 -16.85 71.18 Favored Glycine 0 CA--C 1.508 -0.397 0 CA-C-N 116.163 -0.471 . . . . 25.0 112.948 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -69.49 -4.29 18.19 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.61 -0.347 . . . . 25.0 111.008 175.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -109.89 10.67 24.39 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.414 -0.179 . . . . 25.0 111.049 175.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.82 157.04 33.31 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.623 0.601 . . . . 25.0 112.623 -176.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 tptt -127.18 117.55 22.58 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.661 -0.866 . . . . 25.0 108.661 174.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.6 mm -63.75 139.43 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.614 0.245 . . . . 25.0 110.382 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.6 mt -121.05 149.8 42.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.431 -1.322 . . . . 25.0 107.431 176.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.35 169.32 19.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.683 -0.858 . . . . 25.0 108.683 -177.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.3 -64.37 0.38 Allowed Glycine 0 C--O 1.214 -1.147 0 C-N-CA 121.035 -0.602 . . . . 25.0 112.873 177.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 38.7 mmt -81.62 80.76 7.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.753 -0.263 . . . . 25.0 110.568 -178.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -75.91 -27.39 57.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.946 0.403 . . . . 25.0 110.234 178.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -84.97 88.02 7.41 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 175.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -131.9 122.02 24.97 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.317 -0.994 . . . . 25.0 108.317 179.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -70.49 138.99 86.37 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 107.417 -1.327 . . . . 25.0 107.417 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.97 -18.14 16.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 N-CA-C 114.895 1.075 . . . . 25.0 114.895 -177.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 52.62 40.28 29.79 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.562 0.745 . . . . 25.0 111.207 -178.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.22 44.52 1.43 Allowed Glycine 0 C--O 1.225 -0.423 0 N-CA-C 110.794 -0.922 . . . . 25.0 110.794 -174.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -70.59 -16.92 62.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.029 0.442 . . . . 25.0 110.649 -177.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -115.07 129.7 56.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.342 -1.355 . . . . 25.0 107.342 170.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.0 pt -130.49 171.27 17.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.704 -0.85 . . . . 25.0 108.704 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.8 m -111.08 165.59 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 106.582 -1.636 . . . . 25.0 106.582 175.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.3 t -151.68 151.21 31.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.375 -1.343 . . . . 25.0 107.375 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 . . . . . 0 C--O 1.206 -1.224 0 CA-C-O 124.76 2.219 . . . . 25.0 111.986 -177.175 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.167 0 CA-C-O 123.374 1.541 . . . . 25.0 115.328 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 p -69.82 81.24 0.45 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.001 1.72 . . . . 25.0 112.653 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.6 mmm -75.32 -16.53 60.4 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.539 -0.726 . . . . 25.0 110.145 -179.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -161.43 151.38 17.06 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.688 0.795 . . . . 25.0 111.616 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -75.1 178.69 5.51 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.346 1.029 . . . . 25.0 110.459 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.4 -34.86 77.56 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.98 1.104 . . . . 25.0 113.98 -178.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 56.12 34.28 23.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.927 0.891 . . . . 25.0 112.67 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.87 135.49 39.97 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 104.153 -2.536 . . . . 25.0 104.153 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.75 161.47 29.66 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.991 0.814 . . . . 25.0 109.75 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.62 153.86 33.11 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.486 0.66 . . . . 25.0 112.768 -173.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -91.64 134.58 34.57 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.167 -0.924 . . . . 25.0 109.962 176.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.97 127.56 32.98 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 108.33 -0.989 . . . . 25.0 108.33 173.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -87.03 -27.73 23.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.93 0.871 . . . . 25.0 109.602 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -124.97 160.0 29.94 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.926 -1.034 . . . . 25.0 108.972 -176.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -98.76 158.22 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.586 -1.635 . . . . 25.0 106.586 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -142.91 159.84 41.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 112.703 0.631 . . . . 25.0 112.703 -174.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.9 t -125.63 119.77 55.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 102.535 -3.135 . . . . 25.0 102.535 172.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.07 113.25 13.39 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.354 -0.539 . . . . 25.0 109.593 -177.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -82.48 -15.52 52.17 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.937 0.875 . . . . 25.0 109.221 -176.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.3 m -122.21 156.28 60.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.746 -0.661 . . . . 25.0 109.323 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.39 -14.13 22.77 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 117.548 -1.168 . . . . 25.0 112.739 175.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -84.85 -16.57 40.85 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.804 1.288 . . . . 25.0 110.962 178.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -91.59 140.93 29.25 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.32 134.32 34.11 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.675 0.75 . . . . 25.0 112.573 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 p -86.91 106.05 17.5 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.313 -0.858 . . . . 25.0 109.101 177.226 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -128.79 165.12 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.565 -0.709 . . . . 25.0 112.595 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 mtt85 -122.69 156.7 33.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.507 -0.183 . . . . 25.0 110.507 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -62.18 134.38 56.47 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 178.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.38 -11.54 68.73 Favored Glycine 0 C--O 1.214 -1.148 0 CA-C-N 115.484 -0.78 . . . . 25.0 112.559 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.16 159.82 32.03 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.342 1.071 . . . . 25.0 109.361 177.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mm -124.55 124.17 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.017 -0.734 . . . . 25.0 109.017 -176.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 13.6 ptp -131.86 152.35 51.08 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.26 0.837 . . . . 25.0 113.26 -176.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 m -92.83 131.24 38.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.22 -0.445 . . . . 25.0 110.223 -177.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.84 126.78 43.57 Favored 'Isoleucine or valine' 0 C--O 1.257 1.5 0 N-CA-C 108.104 -1.073 . . . . 25.0 108.104 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.8 mt -102.98 -38.75 7.21 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-N 114.735 -1.12 . . . . 25.0 111.889 -177.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -143.39 160.99 39.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.827 -1.078 . . . . 25.0 108.215 -176.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 -131.77 145.3 51.52 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.059 -1.83 . . . . 25.0 106.059 174.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 63.59 37.68 10.12 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 123.858 1.79 . . . . 25.0 108.305 -176.081 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -69.39 -19.63 63.82 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 113.03 -1.895 . . . . 25.0 116.054 -172.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -119.55 10.51 11.81 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.013 0.911 . . . . 25.0 108.82 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.23 79.64 Favored Glycine 0 CA--C 1.511 -0.16 0 CA-C-N 115.397 -0.819 . . . . 25.0 111.242 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.89 139.1 31.07 Favored 'General case' 0 C--O 1.25 1.12 0 N-CA-C 106.675 -1.602 . . . . 25.0 106.675 176.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.58 150.31 48.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.175 0.988 . . . . 25.0 110.404 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.4 -3.69 38.94 Favored Glycine 0 C--O 1.207 -1.572 0 O-C-N 120.873 -1.142 . . . . 25.0 115.329 175.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -99.73 131.04 45.97 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 118.967 1.384 . . . . 25.0 110.298 -179.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -125.82 142.34 51.56 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.97 -0.292 . . . . 25.0 111.389 -172.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp -82.77 120.73 26.0 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 106.618 -1.623 . . . . 25.0 106.618 176.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.46 164.13 15.72 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.386 0.275 . . . . 25.0 110.393 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 89.8 p -120.32 127.05 51.99 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.353 -0.61 . . . . 25.0 109.353 175.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 tp -153.1 146.24 24.68 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 -179.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.7 t60 60.92 10.86 2.97 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.406 1.261 . . . . 25.0 114.406 178.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 10.21 62.1 Favored Glycine 0 C--O 1.22 -0.761 0 C-N-CA 120.429 -0.891 . . . . 25.0 112.17 -179.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -124.39 165.76 17.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.677 -1.601 . . . . 25.0 106.677 178.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -118.82 156.88 28.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.026 -2.213 . . . . 25.0 105.026 172.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.72 162.87 31.55 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.879 -0.676 . . . . 25.0 111.865 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -77.02 141.97 14.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-O 122.313 1.054 . . . . 25.0 108.806 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.23 136.85 17.26 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.434 -1.257 . . . . 25.0 110.228 178.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.37 115.63 4.27 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 117.564 -1.157 . . . . 25.0 111.338 178.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.85 -25.46 70.63 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 115.996 -0.547 . . . . 25.0 113.576 -174.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -64.77 -22.85 67.07 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.899 0.849 . . . . 25.0 111.551 178.04 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -91.59 10.42 28.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.413 -0.358 . . . . 25.0 111.463 -178.073 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.9 144.87 45.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.528 0.68 . . . . 25.0 111.987 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -112.64 113.28 25.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 121.96 -0.463 . . . . 25.0 110.649 178.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.1 mm -54.37 137.14 15.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 C-N-CA 123.063 0.545 . . . . 25.0 109.812 -174.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.46 173.54 6.55 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 105.923 -1.88 . . . . 25.0 105.923 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 m -80.14 163.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.305 -0.628 . . . . 25.0 109.305 179.245 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.96 149.39 42.78 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 120.316 -0.945 . . . . 25.0 112.542 -176.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.1 tpt -137.33 163.24 31.46 Favored 'General case' 0 C--O 1.205 -1.257 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 179.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.56 142.81 56.39 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 124.062 0.851 . . . . 25.0 110.953 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -134.53 163.77 28.97 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.041 -0.527 . . . . 25.0 110.409 177.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -89.05 140.55 29.33 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.317 -1.364 . . . . 25.0 107.317 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -54.8 135.09 65.53 Favored Pre-proline 0 N--CA 1.48 1.061 0 O-C-N 125.028 1.455 . . . . 25.0 110.394 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.44 173.57 14.03 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.881 2.388 . . . . 25.0 112.995 178.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.07 167.48 29.13 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.822 -1.547 . . . . 25.0 106.822 175.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.62 122.32 4.78 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 120.604 -0.808 . . . . 25.0 111.296 178.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.88 -25.11 23.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.18 1.178 . . . . 25.0 114.18 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 56.24 -164.98 0.14 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.397 1.079 . . . . 25.0 113.163 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.25 137.47 23.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 N-CA-C 103.398 -2.815 . . . . 25.0 103.398 172.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 m -74.66 156.22 6.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.669 0.747 . . . . 25.0 110.704 -175.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -81.84 117.12 21.86 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.109 -1.812 . . . . 25.0 106.109 172.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 C--O 1.193 -1.895 0 CA-C-O 124.369 2.033 . . . . 25.0 113.133 -172.104 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 CA-C-O 123.268 1.482 . . . . 25.0 115.079 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -65.72 -15.99 63.34 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.084 -1.245 . . . . 25.0 113.701 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.8 ttt 47.09 34.6 2.96 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.462 1.653 . . . . 25.0 115.462 176.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 60.59 15.79 5.99 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.201 1.556 . . . . 25.0 115.201 178.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.67 165.03 20.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.143 -1.058 . . . . 25.0 108.143 172.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.5 mt -64.02 -43.05 96.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 121.072 -0.251 . . . . 25.0 110.959 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 49.95 39.19 18.11 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.581 0.956 . . . . 25.0 113.581 176.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.55 141.56 32.18 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.861 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 -178.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.88 154.48 18.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.749 0.785 . . . . 25.0 111.879 -174.009 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.16 46.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.829 -1.078 . . . . 25.0 109.866 -179.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -97.02 134.62 40.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.024 -1.102 . . . . 25.0 108.024 175.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.85 136.79 45.4 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.638 0.732 . . . . 25.0 110.088 176.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.7 mt -94.61 -34.32 12.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 25.0 109.169 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -125.4 164.85 19.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.405 -1.702 . . . . 25.0 106.405 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.17 165.39 13.16 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.851 -0.796 . . . . 25.0 108.851 174.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -152.09 110.53 3.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.6 . . . . 25.0 109.787 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.57 131.87 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 104.629 -2.36 . . . . 25.0 104.629 174.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.92 15.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.478 -1.305 . . . . 25.0 107.478 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -96.84 -6.75 35.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.323 1.058 . . . . 25.0 108.296 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -132.31 149.58 73.56 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.194 -1.41 . . . . 25.0 107.194 178.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.38 -24.51 19.34 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 116.038 -2.175 . . . . 25.0 115.068 -174.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.62 -15.62 58.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.752 0.787 . . . . 25.0 110.617 -179.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -81.02 141.36 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.361 -1.348 . . . . 25.0 107.361 178.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.08 130.2 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.726 -0.609 . . . . 25.0 110.124 178.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.38 116.34 21.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.87 -1.159 . . . . 25.0 107.87 174.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.546 ' CE1' HG13 ' A' ' 57' ' ' VAL . 52.1 p90 -141.34 165.88 26.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.484 -0.562 . . . . 25.0 109.484 179.667 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.69 155.21 46.26 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 120.938 0.399 . . . . 25.0 111.921 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.5 129.84 37.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.981 -0.554 . . . . 25.0 110.594 176.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -21.74 44.32 Favored Glycine 0 C--O 1.222 -0.612 0 CA-C-N 115.621 -0.718 . . . . 25.0 113.435 -179.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -72.16 160.99 31.52 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 117.34 0.57 . . . . 25.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.7 mm -119.65 128.67 75.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.888 -0.782 . . . . 25.0 108.888 -176.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -135.87 148.45 48.63 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.068 0.461 . . . . 25.0 110.237 177.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.7 m -87.07 128.77 35.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.463 -0.94 . . . . 25.0 108.463 179.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.3 t -89.01 124.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 106.755 -1.572 . . . . 25.0 106.755 175.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.12 -45.29 7.27 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.624 -0.716 . . . . 25.0 110.247 -179.223 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.27 164.63 34.29 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.488 -0.56 . . . . 25.0 109.488 -175.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -129.88 152.66 49.12 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.402 -0.592 . . . . 25.0 109.402 178.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t0 56.53 39.43 29.91 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 123.608 1.67 . . . . 25.0 107.414 -175.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -70.48 -12.93 61.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.401 -1.727 . . . . 25.0 114.179 -169.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.05 9.85 5.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.683 0.278 . . . . 25.0 111.472 -176.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.39 14.49 78.46 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 108.951 -1.66 . . . . 25.0 108.951 -174.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.92 111.25 23.82 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 177.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -63.78 141.75 58.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.814 -0.81 . . . . 25.0 108.814 179.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.04 -14.75 31.0 Favored Glycine 0 C--O 1.226 -0.387 0 CA-C-O 119.273 -0.737 . . . . 25.0 114.846 179.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -94.01 136.44 34.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.794 1.297 . . . . 25.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -121.83 146.14 47.37 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.232 -0.655 . . . . 25.0 109.232 -175.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -84.91 116.05 23.12 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 106.486 -1.672 . . . . 25.0 106.486 175.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.1 m -117.41 164.73 14.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.581 -0.526 . . . . 25.0 109.581 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -125.59 127.66 46.7 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.7 tp -161.11 152.36 18.87 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 -177.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.1 t60 58.95 28.23 17.33 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.64 0.733 . . . . 25.0 112.109 177.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.74 2.12 85.1 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 115.023 0.769 . . . . 25.0 115.023 178.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -133.86 164.21 27.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 117.866 0.833 . . . . 25.0 110.656 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -101.71 158.93 15.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.618 -1.623 . . . . 25.0 106.618 176.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.3 162.66 33.11 Favored Glycine 0 C--O 1.24 0.496 0 N-CA-C 109.872 -1.291 . . . . 25.0 109.872 178.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -81.88 145.7 8.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.514 0.673 . . . . 25.0 109.643 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.546 HG13 ' CE1' ' A' ' 26' ' ' PHE . 40.5 t -139.31 134.83 16.76 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.35 -0.841 . . . . 25.0 108.809 -176.841 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.22 109.19 2.15 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.079 -1.481 . . . . 25.0 110.696 172.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.15 61.84 Favored Glycine 0 C--O 1.22 -0.723 0 N-CA-C 115.394 0.918 . . . . 25.0 115.394 -172.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 -16.99 64.5 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.874 -0.78 . . . . 25.0 111.464 177.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.53 3.83 51.2 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.908 -0.495 . . . . 25.0 111.002 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.436 HD11 HG11 ' A' ' 57' ' ' VAL . 80.1 mt -118.51 157.59 26.99 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.613 0.365 . . . . 25.0 110.321 -178.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -127.49 117.82 22.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.381 -0.97 . . . . 25.0 108.381 171.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.0 mm -59.27 137.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 177.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.55 119.44 11.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.108 -1.071 . . . . 25.0 108.108 177.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -84.62 151.9 3.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.277 -0.874 . . . . 25.0 109.963 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -106.42 173.47 19.59 Favored Glycine 0 N--CA 1.454 -0.126 0 N-CA-C 110.539 -1.024 . . . . 25.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 57.8 mtt -83.25 161.47 21.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.89 -0.782 . . . . 25.0 108.89 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -80.67 38.79 0.45 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.007 0.743 . . . . 25.0 113.007 -177.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.27 -29.91 68.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.296 0.569 . . . . 25.0 112.167 -175.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -132.18 147.18 52.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.986 -0.446 . . . . 25.0 110.87 -178.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.73 150.01 47.51 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 106.808 -1.553 . . . . 25.0 106.808 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.39 -18.1 16.1 Favored 'Trans proline' 0 C--N 1.348 0.525 0 N-CA-C 114.775 1.029 . . . . 25.0 114.775 -178.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -160.64 168.35 25.11 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.382 -2.081 . . . . 25.0 105.382 -179.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.74 19.23 0.1 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.241 -0.504 . . . . 25.0 113.787 176.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -88.64 163.26 15.89 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.047 0.539 . . . . 25.0 111.003 -175.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -135.84 142.9 44.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.4 tt -127.65 138.48 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.442 -0.947 . . . . 25.0 108.442 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -86.7 -43.72 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.04 0.448 . . . . 25.0 110.385 -178.1 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -155.72 -59.31 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.376 0.608 . . . . 25.0 110.721 -179.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 124.266 1.984 . . . . 25.0 111.328 -178.194 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.87 0 CA-C-O 123.833 1.796 . . . . 25.0 113.475 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 m 56.14 28.18 12.65 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 112.348 -1.926 . . . . 25.0 112.457 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.1 mtt -69.24 143.21 54.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.137 -0.69 . . . . 25.0 109.137 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -134.64 -38.0 0.83 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 -178.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -137.63 156.36 48.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 -177.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt -68.69 -44.83 73.16 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.354 0.409 . . . . 25.0 111.141 -175.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 55.31 26.7 8.92 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.904 0.882 . . . . 25.0 113.214 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.73 174.13 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 N-CA-C 105.798 -1.927 . . . . 25.0 105.798 177.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.24 159.63 37.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.23 142.42 33.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.279 -0.419 . . . . 25.0 109.973 -178.662 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -95.42 133.86 38.91 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.108 -0.701 . . . . 25.0 109.108 178.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.83 132.18 42.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.199 0.523 . . . . 25.0 110.686 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.8 -32.8 15.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.65 162.18 18.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.073 -0.967 . . . . 25.0 108.825 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.34 148.99 22.19 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.339 -2.097 . . . . 25.0 105.339 172.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -148.28 130.51 15.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 25.0 111.672 -172.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.7 t -102.46 132.26 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 102.833 -3.025 . . . . 25.0 102.833 172.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.13 126.33 28.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.96 -0.755 . . . . 25.0 108.96 -178.709 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -97.33 -7.07 32.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.9 155.68 80.19 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.316 -0.856 . . . . 25.0 109.171 178.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.38 -24.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 116.994 -1.537 . . . . 25.0 113.591 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -82.76 -15.55 51.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.222 -0.444 . . . . 25.0 110.143 -178.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.74 147.06 29.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.602 0.715 . . . . 25.0 110.894 -178.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.89 134.24 36.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.102 -0.499 . . . . 25.0 110.224 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -84.62 142.84 29.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.758 -1.571 . . . . 25.0 106.758 172.027 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.472 ' CE2' HG13 ' A' ' 57' ' ' VAL . 36.5 p90 -158.24 166.35 32.58 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -126.14 155.5 41.59 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 121.942 -0.474 . . . . 25.0 110.653 -178.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.04 135.3 56.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.119 -0.697 . . . . 25.0 109.119 -179.027 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.68 -9.97 76.09 Favored Glycine 0 C--N 1.318 -0.418 0 CA-C-O 119.153 -0.804 . . . . 25.0 114.711 -178.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -81.42 162.98 23.11 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.966 0.883 . . . . 25.0 108.71 178.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.54 131.48 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.659 -0.867 . . . . 25.0 108.659 -178.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 10.6 ptp -129.48 152.21 49.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.002 -178.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 m -82.31 131.64 35.23 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.217 -1.031 . . . . 25.0 108.217 178.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.4 t -100.03 121.07 50.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.658 -1.608 . . . . 25.0 106.658 176.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.5 mt -91.28 -52.36 4.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.724 -0.671 . . . . 25.0 110.689 -176.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -146.43 170.55 16.61 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 -177.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.9 mtm105 -128.27 157.04 42.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.154 -1.795 . . . . 25.0 106.154 -179.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.6 t0 62.17 35.56 15.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 123.397 1.57 . . . . 25.0 108.759 177.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -70.98 -12.59 61.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.476 -1.693 . . . . 25.0 112.349 -176.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -118.9 5.81 11.42 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.347 0.499 . . . . 25.0 112.347 -175.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.52 11.14 82.4 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.555 -1.418 . . . . 25.0 109.555 -174.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.1 mt -129.65 114.91 16.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.301 -1.741 . . . . 25.0 106.301 176.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -76.95 156.88 31.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.82 -1.548 . . . . 25.0 106.82 175.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.56 -15.4 62.07 Favored Glycine 0 C--O 1.218 -0.848 0 N-CA-C 108.186 -1.966 . . . . 25.0 108.186 -173.054 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.91 126.41 52.15 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 173.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -119.79 143.07 48.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -177.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.8 tp -82.97 107.86 15.87 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.377 -1.712 . . . . 25.0 106.377 177.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.7 m -108.65 163.81 12.92 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.371 -0.604 . . . . 25.0 109.371 179.383 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 48.5 t -130.1 129.67 43.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 175.109 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.1 tp -161.39 155.05 21.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 -175.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 58.8 23.83 11.66 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.438 0.903 . . . . 25.0 113.438 174.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.76 4.21 88.99 Favored Glycine 0 C--O 1.202 -1.904 0 N-CA-C 115.602 1.001 . . . . 25.0 115.602 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -129.36 166.16 20.07 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 124.372 1.069 . . . . 25.0 108.136 -178.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 21.7 pt20 -118.44 158.2 25.76 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.986 -1.857 . . . . 25.0 105.986 169.011 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.67 167.37 39.95 Favored Glycine 0 CA--C 1.507 -0.435 0 N-CA-C 110.747 -0.941 . . . . 25.0 110.747 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.2 pt -75.86 145.56 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.291 -1.374 . . . . 25.0 107.291 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 26' ' ' PHE . 40.9 t -140.26 133.6 15.09 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 -179.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.12 108.4 1.95 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 116.374 -1.951 . . . . 25.0 110.246 172.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.18 -18.62 58.15 Favored Glycine 0 C--O 1.222 -0.623 0 CA-C-N 115.565 -0.743 . . . . 25.0 114.112 -175.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -65.19 -18.48 65.34 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.59 -0.359 . . . . 25.0 111.062 176.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -90.47 4.51 50.85 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.969 -0.457 . . . . 25.0 111.736 176.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.422 HD11 HG11 ' A' ' 57' ' ' VAL . 59.9 mt -122.85 157.23 32.94 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.628 0.603 . . . . 25.0 112.628 -173.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -125.08 117.78 24.69 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.88 -0.785 . . . . 25.0 108.88 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.49 135.93 27.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.105 -0.498 . . . . 25.0 112.171 -174.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -88.89 105.91 18.06 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 102.498 -3.149 . . . . 25.0 102.498 167.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.54 90.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.692 0.758 . . . . 25.0 112.058 -170.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -105.18 31.26 8.74 Favored Glycine 0 C--O 1.219 -0.808 0 N-CA-C 109.683 -1.367 . . . . 25.0 109.683 175.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.0 mtp -78.74 -10.28 59.71 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.355 0.872 . . . . 25.0 113.355 -175.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.5 t80 63.52 -174.84 0.16 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.561 -0.903 . . . . 25.0 108.561 -172.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -148.2 176.97 9.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.483 0.659 . . . . 25.0 110.375 -178.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -69.73 163.94 24.6 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.067 0.947 . . . . 25.0 110.404 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -69.8 143.84 92.74 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 105.75 -1.945 . . . . 25.0 105.75 170.489 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.41 153.83 69.98 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 116.459 -1.894 . . . . 25.0 111.837 178.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.03 163.11 40.75 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.324 -2.102 . . . . 25.0 105.324 178.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.38 -176.14 47.55 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 107.929 -2.069 . . . . 25.0 107.929 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -138.5 159.2 42.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.233 -2.136 . . . . 25.0 105.233 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -118.17 4.32 11.98 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.75 0.648 . . . . 25.0 112.75 -173.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.7 pt -125.87 160.68 32.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 106.554 -1.647 . . . . 25.0 106.554 178.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.38 25.57 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.647 1.213 . . . . 25.0 108.395 -174.656 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.0 p -97.36 9.38 42.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.526 1.155 . . . . 25.0 108.176 177.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 125.389 2.519 . . . . 25.0 113.55 -175.767 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.815 0 CA-C-O 124.506 2.17 . . . . 25.0 113.097 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.4 t -78.42 -4.77 49.99 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 112.39 -1.905 . . . . 25.0 111.25 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 ttt -146.37 150.33 35.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 105.501 -2.037 . . . . 25.0 105.501 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -131.11 109.67 10.63 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.087 0.47 . . . . 25.0 111.359 178.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -147.03 170.77 16.43 Favored 'General case' 0 C--N 1.319 -0.749 1 N-CA-C 98.676 -4.564 . . . . 25.0 98.676 171.135 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.02 -44.03 97.08 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.186 1.55 . . . . 25.0 115.186 -170.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.7 t30 49.91 42.35 24.14 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -179.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.1 p -116.4 161.95 14.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 103.685 -2.709 . . . . 25.0 103.685 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.52 156.93 45.91 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.179 0.899 . . . . 25.0 109.714 -177.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.85 151.78 43.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.654 -0.703 . . . . 25.0 110.4 -174.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -97.63 133.33 42.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 174.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.74 137.06 43.75 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.417 0.627 . . . . 25.0 109.378 176.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -93.29 -26.66 17.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.458 -0.792 . . . . 25.0 109.541 178.203 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -127.26 159.47 34.26 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 -178.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -100.06 163.5 12.4 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.29 0.636 . . . . 25.0 109.481 178.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.21 160.29 43.92 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.311 -0.996 . . . . 25.0 108.311 -178.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.15 133.42 68.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 102.391 -3.188 . . . . 25.0 102.391 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.94 143.47 27.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.96 -0.385 . . . . 25.0 109.96 -175.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -122.34 -23.97 5.14 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.553 0.533 . . . . 25.0 110.662 173.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.3 m -85.46 147.22 46.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 176.574 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -71.63 -20.36 26.85 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.968 -1.555 . . . . 25.0 113.718 -178.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -86.15 -4.5 59.18 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.763 0.425 . . . . 25.0 111.099 179.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -97.91 143.08 28.87 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.927 0.491 . . . . 25.0 111.128 -175.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mt -96.49 133.5 40.85 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.82 -0.55 . . . . 25.0 111.611 177.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.2 t -88.75 85.06 6.7 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 175.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.446 ' CE1' HG13 ' A' ' 57' ' ' VAL . 47.7 p90 -96.46 160.33 14.46 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.347 -0.612 . . . . 25.0 109.347 -179.063 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -129.56 152.87 48.61 Favored 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 122.202 -0.311 . . . . 25.0 110.742 -179.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -60.11 136.25 57.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 25.0 109.813 178.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.35 -27.54 13.33 Favored Glycine 0 C--N 1.321 -0.286 0 CA-C-N 115.418 -0.81 . . . . 25.0 113.053 -178.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -73.57 162.53 29.13 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 117.075 0.437 . . . . 25.0 111.048 -178.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.67 129.54 75.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 122.91 0.484 . . . . 25.0 110.227 -174.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -132.24 146.22 51.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.088 0.471 . . . . 25.0 110.937 178.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.0 m -85.19 132.0 34.35 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.77 126.79 51.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.7 mt -101.83 -50.7 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 25.0 111.1 -176.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -136.3 170.45 16.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.34 0.656 . . . . 25.0 110.097 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -133.25 155.49 49.27 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.447 -1.686 . . . . 25.0 106.447 174.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.6 t0 56.89 41.95 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.133 1.444 . . . . 25.0 109.213 -177.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 t -76.29 4.58 8.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.235 -1.348 . . . . 25.0 113.507 -174.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -139.49 -0.68 1.75 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.956 0.724 . . . . 25.0 112.956 -177.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.32 -2.61 87.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 108.383 -1.887 . . . . 25.0 108.383 -170.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.7 mt -96.02 110.09 22.38 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.734 -1.951 . . . . 25.0 105.734 174.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.89 150.11 47.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.672 -1.233 . . . . 25.0 107.672 178.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.97 -16.12 44.29 Favored Glycine 0 C--O 1.222 -0.63 0 CA-C-O 119.089 -0.839 . . . . 25.0 113.337 -178.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -93.37 133.84 36.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.831 1.316 . . . . 25.0 108.877 177.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -118.94 146.28 45.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.195 -0.669 . . . . 25.0 109.195 -175.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -84.07 113.97 21.41 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 106.052 -1.833 . . . . 25.0 106.052 176.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.5 m -116.9 166.22 12.42 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.977 -0.379 . . . . 25.0 109.977 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -129.28 132.22 47.13 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.795 -0.446 . . . . 25.0 109.795 175.127 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 tp -150.95 137.57 18.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.414 -0.958 . . . . 25.0 108.414 -176.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 54.53 32.69 17.38 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.776 1.028 . . . . 25.0 113.776 177.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -0.54 89.24 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 114.825 0.69 . . . . 25.0 114.825 177.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -111.81 162.76 14.93 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.906 -1.146 . . . . 25.0 107.906 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -117.25 155.5 29.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.298 -2.482 . . . . 25.0 104.298 170.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.77 164.98 34.31 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.4 -0.68 . . . . 25.0 111.4 179.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.2 pt -80.41 142.63 13.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.615 0.721 . . . . 25.0 110.239 -177.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG13 ' CE1' ' A' ' 26' ' ' PHE . 77.7 t -140.43 133.08 14.63 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.235 -1.024 . . . . 25.0 108.235 -177.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 115.046 -2.836 . . . . 25.0 110.449 174.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.72 -20.49 68.29 Favored Glycine 0 C--O 1.22 -0.752 0 N-CA-C 115.033 0.773 . . . . 25.0 115.033 -173.109 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -70.03 -8.44 49.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.369 0.584 . . . . 25.0 111.705 177.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -98.46 6.45 47.2 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 122.091 -0.381 . . . . 25.0 110.609 175.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.94 143.95 45.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.939 0.4 . . . . 25.0 111.487 -176.071 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -111.16 117.64 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.709 -1.589 . . . . 25.0 106.709 173.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 ' H ' ' A' ' 64' ' ' ILE . 4.0 mp -67.41 133.37 31.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-N 116.19 -0.459 . . . . 25.0 111.039 -177.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.5 mt -86.84 109.38 19.25 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.944 -1.873 . . . . 25.0 105.944 175.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.27 133.15 40.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.047 -1.094 . . . . 25.0 108.047 -175.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.29 174.39 52.1 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 121.289 -0.481 . . . . 25.0 112.208 -179.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.5 ttt -115.25 156.3 25.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.191 -1.411 . . . . 25.0 107.191 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.6 t80 68.19 2.1 3.09 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.945 1.091 . . . . 25.0 113.945 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -66.72 118.38 10.18 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.942 -0.762 . . . . 25.0 108.942 175.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -139.69 60.54 1.56 Allowed 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.026 -0.731 . . . . 25.0 109.026 -179.25 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.99 143.43 42.18 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 174.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.27 162.46 42.39 Favored 'Trans proline' 0 C--N 1.346 0.405 0 N-CA-C 114.805 1.04 . . . . 25.0 114.805 -173.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.55 164.42 29.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.21 -1.774 . . . . 25.0 106.21 177.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.71 -86.5 1.51 Allowed Glycine 0 C--O 1.225 -0.418 0 C-N-CA 121.284 -0.484 . . . . 25.0 112.747 177.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -79.53 130.89 35.81 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.84 0.352 . . . . 25.0 110.961 -178.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -142.86 64.61 1.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.494 -0.928 . . . . 25.0 108.494 176.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -102.16 141.17 18.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.287 0.565 . . . . 25.0 109.897 -177.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.47 -39.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.724 -0.671 . . . . 25.0 109.397 178.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.1 m -150.84 -72.11 0.17 Allowed 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.897 -0.779 . . . . 25.0 108.897 177.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.209 -1.034 0 CA-C-O 124.34 2.019 . . . . 25.0 110.945 177.741 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 CA-C-O 123.499 1.611 . . . . 25.0 115.646 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -78.15 157.73 29.32 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 121.053 -1.263 . . . . 25.0 111.745 -178.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.2 ptm -68.59 -6.47 25.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.915 0.709 . . . . 25.0 112.915 178.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -156.86 149.17 23.17 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.095 -1.076 . . . . 25.0 108.095 -178.264 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -116.51 168.59 10.03 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.632 -1.247 . . . . 25.0 107.632 175.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.3 -40.5 90.72 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.014 0.37 . . . . 25.0 110.958 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.0 t30 55.53 42.2 29.98 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.215 0.531 . . . . 25.0 111.934 178.018 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.92 172.82 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.998 -1.853 . . . . 25.0 105.998 176.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 162.53 34.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.423 0.63 . . . . 25.0 110.956 -177.304 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.69 150.09 36.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.016 -0.993 . . . . 25.0 110.42 -178.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -99.53 136.67 39.12 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.595 -0.891 . . . . 25.0 108.595 176.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.36 136.33 46.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.982 0.42 . . . . 25.0 109.995 177.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.98 -24.98 14.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.721 -0.672 . . . . 25.0 110.372 178.428 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -123.69 158.27 31.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.795 -1.928 . . . . 25.0 105.795 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.512 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 8.4 p-10 -103.02 144.33 31.42 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 175.399 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -148.9 122.29 9.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.375 -0.375 . . . . 25.0 110.421 -175.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.91 130.5 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 104.674 -2.343 . . . . 25.0 104.674 175.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.02 114.91 8.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.945 0.402 . . . . 25.0 111.477 -175.564 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -89.39 -11.54 42.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.435 0.636 . . . . 25.0 109.807 176.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 m -122.86 146.31 47.96 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.196 -1.409 . . . . 25.0 107.196 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -23.11 27.83 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 117.388 -1.275 . . . . 25.0 114.873 -174.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -77.66 -20.52 53.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.15 0.5 . . . . 25.0 110.567 -178.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.42 152.35 25.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.211 -1.033 . . . . 25.0 108.211 178.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 139.76 32.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.929 0.395 . . . . 25.0 111.093 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -84.66 126.56 33.47 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 172.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.18 163.98 37.6 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -129.78 154.23 47.43 Favored 'General case' 0 CA--C 1.506 -0.745 0 O-C-N 121.762 -0.586 . . . . 25.0 109.943 176.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.512 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 53.3 pttt -56.97 135.12 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.379 0.609 . . . . 25.0 110.198 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.02 -25.66 27.43 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.127 -0.942 . . . . 25.0 112.669 -175.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -72.65 155.89 39.54 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 117.117 0.458 . . . . 25.0 110.33 -179.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.4 mm -117.06 129.02 74.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.375 0.67 . . . . 25.0 109.67 -175.552 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -130.89 149.61 52.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.579 0.705 . . . . 25.0 110.525 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.3 m -84.88 128.28 34.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.541 -0.911 . . . . 25.0 108.541 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.64 123.47 46.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.066 -1.457 . . . . 25.0 107.066 177.098 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.39 -42.94 9.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.6 -0.727 . . . . 25.0 111.787 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -156.31 171.31 20.43 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.123 -1.066 . . . . 25.0 108.123 -176.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -134.21 157.13 47.05 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 107.287 -1.375 . . . . 25.0 107.287 -178.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.0 t0 60.11 38.47 20.39 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 123.341 1.543 . . . . 25.0 107.691 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -70.51 -12.27 61.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.578 -1.646 . . . . 25.0 114.055 -171.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.16 13.88 6.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.836 0.31 . . . . 25.0 111.836 -178.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.99 18.89 79.23 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.365 -1.094 . . . . 25.0 110.365 -176.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.7 mt -119.44 114.84 22.93 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 178.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -62.18 144.32 55.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.124 0.964 . . . . 25.0 109.453 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 -16.16 40.89 Favored Glycine 0 C--O 1.217 -0.926 0 CA-C-O 118.876 -0.958 . . . . 25.0 114.112 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -89.58 131.12 35.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.325 1.563 . . . . 25.0 109.94 178.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -120.53 146.19 46.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.976 -0.749 . . . . 25.0 108.976 -175.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.1 tp -86.43 115.35 23.88 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.457 -1.683 . . . . 25.0 106.457 176.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 84.3 m -112.75 158.47 20.05 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 -178.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -124.99 126.24 45.14 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 178.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.9 tp -159.23 148.42 18.43 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.316 -1.364 . . . . 25.0 107.316 -174.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 58.24 25.84 13.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.734 0.778 . . . . 25.0 112.494 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.68 88.98 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 114.834 0.693 . . . . 25.0 114.834 176.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -136.16 162.73 32.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 117.773 0.786 . . . . 25.0 110.636 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -96.08 160.61 14.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.242 -1.021 . . . . 25.0 108.242 175.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.75 161.97 34.91 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.917 -1.673 . . . . 25.0 108.917 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 pt -81.77 143.86 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.13 133.95 13.38 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 -179.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.46 114.39 3.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 116.524 -1.85 . . . . 25.0 111.033 175.088 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.02 -21.79 66.12 Favored Glycine 0 C--O 1.223 -0.584 0 N-CA-C 116.165 1.226 . . . . 25.0 116.165 -173.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -67.54 -16.88 64.43 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.879 . . . . 25.0 110.542 177.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -93.1 9.33 36.33 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.451 -0.156 . . . . 25.0 110.83 177.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -121.34 154.69 36.1 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.168 0.509 . . . . 25.0 110.852 -178.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -119.07 116.28 26.05 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.086 -1.079 . . . . 25.0 108.086 175.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm -62.35 132.4 28.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 175.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.54 142.67 35.16 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 -179.408 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m -90.92 152.71 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 106.982 -1.488 . . . . 25.0 106.982 175.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.94 76.14 0.02 OUTLIER Glycine 0 C--O 1.223 -0.557 0 N-CA-C 110.708 -0.957 . . . . 25.0 110.708 -176.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -72.66 135.81 45.52 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.924 -1.139 . . . . 25.0 107.924 -179.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -79.77 74.36 6.48 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.35 0.406 . . . . 25.0 110.356 178.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 52.4 28.16 5.57 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.872 1.434 . . . . 25.0 114.872 175.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -71.59 143.35 49.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.442 0.639 . . . . 25.0 111.136 179.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -117.77 160.12 39.78 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.83 174.15 12.32 Favored 'Trans proline' 0 C--N 1.349 0.568 0 O-C-N 122.28 0.621 . . . . 25.0 111.426 177.117 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.61 161.27 40.88 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.124 -1.065 . . . . 25.0 108.124 178.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.8 85.1 0.24 Allowed Glycine 0 C--O 1.219 -0.832 0 N-CA-C 109.961 -1.256 . . . . 25.0 109.961 -178.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -102.34 -3.45 27.12 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.077 1.14 . . . . 25.0 114.077 -173.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -149.46 156.52 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.72 -0.845 . . . . 25.0 108.72 178.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 44.2 pt -128.67 14.95 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.895 -0.593 . . . . 25.0 111.273 -177.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.7 t 62.59 80.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 122.308 1.051 . . . . 25.0 110.081 -177.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.54 -42.04 71.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.885 -1.052 . . . . 25.0 111.055 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 CA--C 1.559 1.321 0 CA-C-O 122.498 1.142 . . . . 25.0 112.002 -178.933 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.282 0 N-CA-C 114.877 0.711 . . . . 25.0 114.877 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -68.43 -34.12 75.43 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.961 0.41 . . . . 25.0 111.419 -178.096 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.3 ttm -125.26 93.09 3.77 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 106.855 -1.535 . . . . 25.0 106.855 -179.435 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -152.08 -40.08 0.11 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.363 0.875 . . . . 25.0 113.363 -179.423 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -149.92 180.0 7.6 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 176.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.0 mt -61.14 -41.78 97.35 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.604 1.335 . . . . 25.0 114.604 -171.469 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.3 t30 49.91 42.32 24.08 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.574 2.064 . . . . 25.0 116.574 175.466 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 m -118.05 164.68 14.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 N-CA-C 105.227 -2.138 . . . . 25.0 105.227 170.357 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.57 157.86 42.51 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 121.681 0.753 . . . . 25.0 109.611 -173.767 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.37 162.59 32.61 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.423 -0.808 . . . . 25.0 110.119 -172.727 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -105.2 134.99 47.38 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.515 -1.291 . . . . 25.0 107.515 178.095 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 120.04 19.77 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.856 -1.164 . . . . 25.0 107.856 173.85 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.56 -16.86 31.49 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 109.946 -0.39 . . . . 25.0 109.946 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -138.75 169.25 18.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.156 -1.424 . . . . 25.0 107.156 -176.7 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -104.01 164.97 11.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.824 0.449 . . . . 25.0 111.958 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -156.31 156.73 34.5 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.435 0.694 . . . . 25.0 111.38 175.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -125.55 129.55 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 103.919 -2.623 . . . . 25.0 103.919 171.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.27 130.6 41.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.739 0.644 . . . . 25.0 112.739 -177.365 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -100.57 -41.53 6.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.59 -1.633 . . . . 25.0 106.59 175.685 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.4 t -85.33 147.97 48.6 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.51 -15.2 27.74 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 119.123 0.722 . . . . 25.0 113.346 175.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 -18.64 49.73 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 121.404 0.621 . . . . 25.0 110.504 177.938 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -87.5 154.08 20.92 Favored 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.643 1.211 . . . . 25.0 110.28 -173.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.81 136.92 42.58 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 120.691 -1.256 . . . . 25.0 110.551 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.7 m -84.28 125.13 31.96 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.119 -2.549 . . . . 25.0 104.119 169.176 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -137.72 159.33 42.29 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 177.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -124.49 152.12 43.77 Favored 'General case' 0 CA--C 1.491 -1.314 0 O-C-N 121.701 -0.624 . . . . 25.0 112.345 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -57.02 123.08 13.93 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.187 -0.915 . . . . 25.0 111.558 178.146 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.82 -12.76 49.99 Favored Glycine 0 C--O 1.236 0.227 0 CA-C-O 118.944 -0.92 . . . . 25.0 113.859 179.908 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.65 160.13 25.13 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.253 0.62 . . . . 25.0 111.946 -176.382 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.14 136.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.385 0.674 . . . . 25.0 109.311 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -144.86 151.6 38.99 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.518 -0.739 . . . . 25.0 111.078 179.374 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -82.57 132.25 35.2 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.566 -0.288 . . . . 25.0 110.833 -179.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.3 t -88.81 122.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 174.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.6 mt -92.67 -51.28 5.18 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.184 0.516 . . . . 25.0 110.402 -176.648 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -137.15 163.82 29.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 105.868 -1.901 . . . . 25.0 105.868 -175.227 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -131.35 148.45 52.67 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 55.85 38.94 30.62 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.205 1.566 . . . . 25.0 108.133 -177.749 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -67.76 -13.45 62.13 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.012 -1.904 . . . . 25.0 115.359 -175.157 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.78 0.01 20.17 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.95 -0.389 . . . . 25.0 109.95 -179.248 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.77 77.72 Favored Glycine 0 CA--C 1.511 -0.196 0 N-CA-C 109.263 -1.535 . . . . 25.0 109.263 -174.524 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.39 116.72 29.07 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 106.53 -1.656 . . . . 25.0 106.53 177.045 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.67 138.77 58.58 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 178.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.54 0.74 72.36 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.43 -1.206 . . . . 25.0 113.54 178.616 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 44.2 m95 -109.59 115.92 30.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.733 1.766 . . . . 25.0 111.21 177.274 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -109.5 144.65 37.48 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.348 -0.845 . . . . 25.0 112.093 -173.535 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.5 tp -82.56 122.27 27.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.649 -1.982 . . . . 25.0 105.649 175.563 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.2 m -120.07 161.49 20.88 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 177.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.3 t -125.88 133.78 51.81 Favored 'General case' 0 C--O 1.256 1.425 0 C-N-CA 123.476 0.711 . . . . 25.0 109.729 177.258 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 tp -160.88 138.52 9.36 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.888 -1.051 . . . . 25.0 108.884 -177.004 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 t60 58.24 34.9 24.54 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.525 0.679 . . . . 25.0 112.675 176.939 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.55 2.34 63.61 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 121.245 -0.502 . . . . 25.0 113.85 177.442 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -115.06 160.29 19.81 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 105.237 -2.135 . . . . 25.0 105.237 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -137.35 143.41 42.0 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 103.007 -2.96 . . . . 25.0 103.007 175.457 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.99 174.67 43.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.831 -1.308 . . . . 25.0 109.831 -174.501 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 pt -83.12 140.44 16.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.675 0.75 . . . . 25.0 112.066 -172.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -139.4 131.3 15.07 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.044 -1.435 . . . . 25.0 108.843 -176.731 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.13 119.14 6.16 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 114.813 -2.992 . . . . 25.0 112.873 175.316 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.42 -16.84 69.89 Favored Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 119.466 -0.63 . . . . 25.0 114.175 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.82 -15.35 63.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 120.553 -0.459 . . . . 25.0 110.374 174.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -101.42 8.79 42.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.942 0.349 . . . . 25.0 111.942 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 mt -117.66 149.23 41.07 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.284 1.04 . . . . 25.0 111.818 -173.055 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -120.32 120.66 36.66 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.583 -1.266 . . . . 25.0 107.583 174.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.4 mm -64.72 138.98 22.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 O-C-N 123.656 0.598 . . . . 25.0 109.848 -179.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -125.1 177.34 6.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.235 -1.394 . . . . 25.0 107.235 176.39 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 t 58.56 70.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 122.563 1.173 . . . . 25.0 109.935 -176.835 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.53 46.94 1.09 Allowed Glycine 0 C--O 1.217 -0.927 0 CA-C-N 115.127 -0.942 . . . . 25.0 112.55 -179.662 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 53.1 tpp 56.65 87.49 0.06 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.456 1.122 . . . . 25.0 112.204 -175.33 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -138.23 144.45 40.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.573 -1.194 . . . . 25.0 108.016 -177.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -73.4 56.89 0.51 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.117 0.961 . . . . 25.0 113.389 -176.388 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -134.59 155.75 49.9 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.577 -1.638 . . . . 25.0 106.577 177.258 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -83.49 149.69 58.32 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 106.705 -1.591 . . . . 25.0 106.705 179.718 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.52 151.88 65.03 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 117.033 -1.511 . . . . 25.0 111.382 -175.598 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.69 172.19 9.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.947 -1.131 . . . . 25.0 107.947 175.72 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.76 -83.83 0.9 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.539 -1.024 . . . . 25.0 110.539 178.113 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 49.83 74.34 0.21 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 117.735 2.494 . . . . 25.0 117.735 174.424 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -71.51 137.84 48.46 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.914 -0.773 . . . . 25.0 108.914 171.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 pt -68.42 123.84 22.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-O 121.929 0.871 . . . . 25.0 110.609 176.444 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.44 23.53 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 122.827 1.299 . . . . 25.0 107.887 -176.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -72.7 135.14 45.33 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.072 -0.967 . . . . 25.0 108.776 -179.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--O 1.215 -0.734 0 CA-C-O 124.727 2.203 . . . . 25.0 111.848 179.545 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 122.513 1.063 . . . . 25.0 114.949 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.4 p -153.59 146.79 24.69 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 121.238 -1.154 . . . . 25.0 109.045 178.515 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.2 mtp -88.06 98.25 11.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.527 -1.286 . . . . 25.0 107.527 177.328 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -92.4 80.6 4.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.72 0.295 . . . . 25.0 111.638 -176.423 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -114.46 176.7 4.93 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.187 -2.523 . . . . 25.0 104.187 175.784 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 68.8 mt -61.76 -46.3 90.17 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.932 1.456 . . . . 25.0 114.932 -171.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 t30 51.66 40.38 27.22 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.103 1.149 . . . . 25.0 114.103 -178.476 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.72 172.54 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 105.563 -2.014 . . . . 25.0 105.563 177.08 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.7 156.69 48.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 118.705 0.684 . . . . 25.0 110.162 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.29 158.6 43.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.21 -0.904 . . . . 25.0 111.059 -173.633 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.8 134.65 48.57 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.367 -0.975 . . . . 25.0 108.367 175.231 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.77 130.29 39.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.742 -0.466 . . . . 25.0 109.742 178.026 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.35 -26.29 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.946 -0.57 . . . . 25.0 109.571 179.306 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -126.28 162.55 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 -179.399 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 25.3 p-10 -103.89 151.21 23.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.864 -0.421 . . . . 25.0 109.864 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -144.58 126.88 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.155 -0.475 . . . . 25.0 110.885 -176.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.7 t -92.04 126.99 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 102.983 -2.969 . . . . 25.0 102.983 174.277 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.46 114.85 5.77 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 -179.084 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -99.05 -10.97 21.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.724 0.773 . . . . 25.0 108.981 179.18 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 t -116.03 146.72 37.7 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 106.873 -1.528 . . . . 25.0 106.873 172.708 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.68 -18.71 32.47 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 115.819 -2.321 . . . . 25.0 113.618 177.328 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -79.96 -15.71 56.7 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.039 0.923 . . . . 25.0 110.348 179.304 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -86.38 142.68 28.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.653 -0.703 . . . . 25.0 110.19 -178.305 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 134.25 34.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.741 -0.466 . . . . 25.0 109.741 178.25 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.39 118.67 25.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 175.343 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.445 ' CE2' HG13 ' A' ' 57' ' ' VAL . 53.9 p90 -143.91 164.57 30.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 -178.481 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -131.58 157.1 44.52 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 121.254 0.55 . . . . 25.0 112.056 179.58 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.542 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 12.0 pttt -56.69 131.67 49.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.468 -0.787 . . . . 25.0 108.987 179.191 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.07 -25.7 25.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.692 -0.686 . . . . 25.0 113.321 -176.651 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -72.17 161.85 30.29 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.216 0.508 . . . . 25.0 111.826 -176.456 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -122.12 131.17 73.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.241 -1.022 . . . . 25.0 108.241 -177.427 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.0 ptp -139.81 154.02 47.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.058 -0.349 . . . . 25.0 110.058 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.0 m -87.79 131.02 34.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.583 -1.265 . . . . 25.0 107.583 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.9 t -95.48 116.27 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.327 -2.101 . . . . 25.0 105.327 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.45 -45.66 10.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.4 -0.818 . . . . 25.0 109.636 -176.475 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -146.09 169.47 18.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.96 -0.756 . . . . 25.0 108.96 -177.458 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -129.58 156.03 44.84 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.16 33.9 23.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 123.147 1.451 . . . . 25.0 109.286 174.629 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.8 t -70.53 -19.01 62.94 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.594 1.701 . . . . 25.0 115.594 -168.005 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -101.26 2.59 40.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.135 0.493 . . . . 25.0 110.362 -175.61 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.34 -2.36 87.25 Favored Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.003 -1.639 . . . . 25.0 109.003 -172.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.4 mt -100.83 119.37 38.56 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 176.78 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -60.17 136.12 57.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.507 0.67 . . . . 25.0 109.218 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.3 -2.35 86.57 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 115.693 1.037 . . . . 25.0 115.693 177.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -99.94 116.91 33.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.312 1.556 . . . . 25.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -107.05 148.13 29.12 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.094 -0.379 . . . . 25.0 110.806 -171.644 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.0 tp -87.93 113.45 23.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.765 -1.569 . . . . 25.0 106.765 176.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.14 160.28 21.28 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 121.2 -0.2 . . . . 25.0 110.749 179.707 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -119.9 128.93 54.08 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.263 0.554 . . . . 25.0 109.594 175.344 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 tp -162.29 152.83 17.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.114 -1.81 . . . . 25.0 106.114 -177.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 58.57 27.75 16.12 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.459 0.647 . . . . 25.0 112.737 177.009 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.5 16.66 77.54 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.803 -0.713 . . . . 25.0 114.11 178.347 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 167.52 21.99 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.836 -0.802 . . . . 25.0 108.836 178.712 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -109.3 156.92 19.39 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.141 -2.17 . . . . 25.0 105.141 173.232 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.5 37.47 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 108.87 -1.692 . . . . 25.0 108.87 177.53 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.3 pt -78.83 145.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.504 0.669 . . . . 25.0 109.255 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.445 HG13 ' CE2' ' A' ' 26' ' ' PHE . 55.2 t -140.39 134.2 15.24 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 -178.491 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.7 106.49 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 117.261 -1.36 . . . . 25.0 110.559 174.258 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.21 69.83 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 116.176 1.23 . . . . 25.0 116.176 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -69.92 -8.44 48.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.534 0.667 . . . . 25.0 111.373 178.364 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -93.68 6.28 48.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.03 -0.419 . . . . 25.0 110.451 175.492 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.3 mt -119.15 155.2 32.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.633 -0.506 . . . . 25.0 109.633 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -122.34 121.57 37.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.128 -0.323 . . . . 25.0 110.128 171.347 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.6 mm -58.27 137.58 20.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.278 0.631 . . . . 25.0 109.884 177.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.0 mt -107.51 -173.07 2.2 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.227 -0.897 . . . . 25.0 108.807 -179.507 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 t 64.21 75.09 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-O 122.395 1.093 . . . . 25.0 111.208 179.353 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.58 95.98 0.1 Allowed Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 110.091 -1.204 . . . . 25.0 110.091 -179.791 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.4 ttm -160.83 157.74 27.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.33 -1.359 . . . . 25.0 107.33 -176.728 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -69.35 -41.78 76.14 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.601 0.715 . . . . 25.0 109.773 179.051 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -80.19 149.13 30.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.094 -0.957 . . . . 25.0 110.751 -179.294 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -94.46 149.72 20.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 -175.635 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -75.85 150.9 84.16 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.948 -1.13 . . . . 25.0 107.948 178.403 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.27 2.93 6.21 Favored 'Trans proline' 0 C--N 1.35 0.619 0 N-CA-C 113.842 0.67 . . . . 25.0 113.842 176.614 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.41 -152.13 0.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.897 0.879 . . . . 25.0 113.04 177.521 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.24 -143.5 4.27 Favored Glycine 0 C--O 1.224 -0.488 0 N-CA-C 105.561 -3.016 . . . . 25.0 105.561 -177.684 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.7 -25.89 68.4 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.84 0.82 . . . . 25.0 110.612 176.36 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.78 138.14 50.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.542 -0.91 . . . . 25.0 108.542 176.299 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.9 tt -142.57 150.27 18.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 106.02 -1.844 . . . . 25.0 106.02 -179.145 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.32 158.51 38.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.892 -1.522 . . . . 25.0 106.892 178.96 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.9 p -130.92 161.79 31.1 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.577 -1.268 . . . . 25.0 107.577 179.168 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 C--O 1.212 -0.874 0 CA-C-O 125.417 2.532 . . . . 25.0 111.897 176.877 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.536 0 CA-C-O 124.015 1.897 . . . . 25.0 115.095 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -137.9 36.48 2.38 Favored 'General case' 0 C--O 1.244 0.801 0 O-C-N 121.214 -1.168 . . . . 25.0 111.283 -178.33 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -71.12 141.95 50.77 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 121.864 0.84 . . . . 25.0 108.759 -178.629 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -88.16 84.56 6.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.014 -0.539 . . . . 25.0 109.788 178.151 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.44 167.5 22.03 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 102.62 -3.104 . . . . 25.0 102.62 177.781 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.53 -51.65 67.74 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.556 1.071 . . . . 25.0 113.045 -173.308 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.2 t30 47.57 48.47 16.93 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.777 1.028 . . . . 25.0 113.777 -179.123 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 m -112.79 172.7 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 103.469 -2.789 . . . . 25.0 103.469 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.06 155.42 50.23 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.61 0.719 . . . . 25.0 110.944 -177.822 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.71 153.08 44.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.781 -1.1 . . . . 25.0 110.901 -175.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -95.52 133.59 39.35 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 176.828 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.59 123.99 24.34 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.047 -0.723 . . . . 25.0 109.047 171.37 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.89 -25.98 21.84 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 108.946 -0.761 . . . . 25.0 108.946 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.27 166.51 20.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 -178.478 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.95 159.18 15.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.581 0.229 . . . . 25.0 110.71 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -151.49 143.61 23.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.989 -0.551 . . . . 25.0 111.24 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -117.41 126.17 74.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 102.591 -3.114 . . . . 25.0 102.591 174.219 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 127.92 34.07 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.812 0.339 . . . . 25.0 111.2 -174.352 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -97.84 -6.14 33.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.066 0.936 . . . . 25.0 109.193 179.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.9 t -141.55 153.15 65.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.773 . . . . 25.0 108.949 -177.082 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.13 -22.83 46.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 116.99 -1.54 . . . . 25.0 112.869 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -73.76 -19.75 60.69 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 123.482 0.489 . . . . 25.0 110.512 179.357 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -95.3 153.08 17.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.963 0.411 . . . . 25.0 111.939 -172.297 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.52 138.33 36.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.699 1.0 . . . . 25.0 113.699 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 m -87.02 136.87 32.77 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.838 -1.542 . . . . 25.0 106.838 172.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -160.81 162.35 32.27 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -129.19 158.34 39.29 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.387 -0.821 . . . . 25.0 111.319 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -53.77 131.97 40.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.18 -0.918 . . . . 25.0 109.951 178.725 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.01 -23.18 36.83 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.618 -0.719 . . . . 25.0 113.166 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.68 157.19 38.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.115 0.957 . . . . 25.0 110.791 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -120.79 131.02 73.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 -176.039 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -131.47 152.21 50.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.065 0.46 . . . . 25.0 111.332 178.186 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.7 m -84.76 132.02 34.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.972 -1.121 . . . . 25.0 107.972 177.293 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.9 t -96.03 123.05 48.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 106.282 -1.747 . . . . 25.0 106.282 176.093 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -93.42 -39.79 10.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.561 -0.745 . . . . 25.0 110.823 -174.2 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -159.81 171.92 18.6 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.608 -0.886 . . . . 25.0 108.608 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -120.92 160.98 22.37 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 107.97 -1.122 . . . . 25.0 107.97 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.3 42.73 22.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.34 1.067 . . . . 25.0 110.837 179.204 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -68.72 -22.02 64.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.491 -176.767 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' C ' ' H ' ' A' ' 42' ' ' LEU . 2.3 tp60 -97.83 1.02 47.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 25.0 110.133 179.603 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 -20.13 8.13 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.159 -1.176 . . . . 25.0 110.159 -172.542 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 40' ' ' GLN . 95.8 mt -78.19 133.49 37.76 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.993 -1.854 . . . . 25.0 105.993 177.176 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -67.72 153.9 42.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.727 0.775 . . . . 25.0 110.702 -177.075 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.5 -19.65 4.7 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 115.557 0.983 . . . . 25.0 115.557 177.095 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -84.33 107.12 16.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.715 1.258 . . . . 25.0 111.291 -179.404 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -96.81 147.31 24.07 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.061 -0.348 . . . . 25.0 110.061 -176.007 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.1 tp -85.72 117.3 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.765 -1.939 . . . . 25.0 105.765 172.916 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 63.9 m -120.28 163.24 18.11 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.387 -0.597 . . . . 25.0 109.387 179.294 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -124.51 125.82 44.84 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.037 0.535 . . . . 25.0 111.774 -179.658 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.69 153.09 18.61 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 106.946 -1.501 . . . . 25.0 106.946 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 59.06 36.3 24.21 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.825 0.821 . . . . 25.0 110.912 178.575 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.24 14.32 59.3 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 115.518 0.967 . . . . 25.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.6 ptt85 -142.36 163.86 31.71 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 118.002 0.901 . . . . 25.0 109.195 177.591 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.85 154.73 26.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 173.987 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.13 169.56 41.51 Favored Glycine 0 C--O 1.248 0.971 0 N-CA-C 108.416 -1.873 . . . . 25.0 108.416 -177.684 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -77.03 143.08 13.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 117.217 0.508 . . . . 25.0 110.441 -177.764 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -140.07 131.53 14.4 Favored Pre-proline 0 C--O 1.242 0.681 0 C-N-CA 123.765 0.826 . . . . 25.0 108.833 178.583 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.09 119.4 6.33 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 115.29 -2.673 . . . . 25.0 111.156 177.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.55 -25.74 61.28 Favored Glycine 0 C--N 1.321 -0.27 0 N-CA-C 114.893 0.717 . . . . 25.0 114.893 -175.77 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.5 -21.3 66.25 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.865 0.364 . . . . 25.0 111.747 178.395 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.35 3.57 53.33 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.66 -0.65 . . . . 25.0 112.257 178.157 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.51 154.98 30.53 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.99 0.424 . . . . 25.0 112.031 -177.31 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -123.17 117.95 26.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.533 -0.303 . . . . 25.0 110.366 171.442 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.9 mm -60.33 140.08 18.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 O-C-N 123.88 0.738 . . . . 25.0 109.697 179.468 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.81 -178.41 3.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.446 -1.687 . . . . 25.0 106.446 176.715 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 t 67.8 94.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.374 1.069 . . . . 25.0 112.03 179.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.55 -44.93 0.61 Allowed Glycine 0 C--O 1.218 -0.891 0 N-CA-C 109.568 -1.413 . . . . 25.0 109.568 -178.75 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -147.57 120.08 8.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.806 -1.183 . . . . 25.0 107.806 174.49 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -163.89 152.29 13.29 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.9 -0.407 . . . . 25.0 109.9 177.593 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.27 166.35 18.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.346 -0.613 . . . . 25.0 109.346 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -55.19 144.87 22.9 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.084 0.401 . . . . 25.0 112.084 175.408 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.68 162.25 29.82 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 123.641 0.777 . . . . 25.0 108.979 -179.522 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.03 169.89 21.13 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 117.494 -1.204 . . . . 25.0 110.647 173.461 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.61 160.03 23.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.893 -0.41 . . . . 25.0 109.893 177.73 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.63 -61.2 0.04 OUTLIER Glycine 0 C--O 1.215 -1.035 0 C-N-CA 120.341 -0.933 . . . . 25.0 112.85 178.17 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 53.97 32.6 15.69 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.585 1.183 . . . . 25.0 112.735 178.237 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -78.47 137.58 38.02 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.72 -0.673 . . . . 25.0 112.016 -178.181 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.8 tt -119.85 153.22 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 105.736 -1.95 . . . . 25.0 105.736 175.036 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.8 t -106.4 -34.25 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.384 0.611 . . . . 25.0 111.827 -174.162 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 p -75.73 155.21 35.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.272 0.558 . . . . 25.0 111.125 179.76 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 125.35 2.5 . . . . 25.0 113.435 177.93 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.266 0 CA-C-O 122.564 1.091 . . . . 25.0 115.429 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 m -69.73 139.32 53.35 Favored 'General case' 0 CA--C 1.51 -0.558 0 O-C-N 120.97 -1.312 . . . . 25.0 108.51 179.387 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.6 mmm -130.35 -82.14 0.54 Allowed 'General case' 0 C--O 1.212 -0.893 0 O-C-N 124.106 0.879 . . . . 25.0 109.725 175.12 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -130.72 -26.8 2.18 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 -175.835 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -119.66 167.63 11.84 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.913 -1.143 . . . . 25.0 107.913 179.59 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.86 -35.5 78.66 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.698 -1.137 . . . . 25.0 112.983 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.4 m120 45.59 48.32 11.22 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 124.227 1.011 . . . . 25.0 113.471 178.014 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.96 151.92 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 106.605 -1.628 . . . . 25.0 106.605 179.449 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 162.43 13.41 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.137 0.494 . . . . 25.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.06 154.05 42.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.285 -0.87 . . . . 25.0 111.373 172.085 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -107.66 133.72 51.68 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.167 0.987 . . . . 25.0 109.628 -179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.6 134.95 45.41 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 124.525 1.141 . . . . 25.0 111.359 175.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.51 -34.06 12.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.832 0.825 . . . . 25.0 109.918 177.323 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.86 165.24 14.86 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 106.642 -1.614 . . . . 25.0 106.642 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.494 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 11.8 p-10 -103.48 155.85 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.992 0.36 . . . . 25.0 111.93 177.588 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -162.56 98.48 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.705 0.802 . . . . 25.0 108.953 -177.867 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -78.52 140.06 17.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 105.523 -2.029 . . . . 25.0 105.523 172.42 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.43 140.9 54.14 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 123.488 0.715 . . . . 25.0 112.395 -173.062 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -110.74 -9.72 14.49 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 114.333 -1.303 . . . . 25.0 110.864 174.93 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.2 m -131.44 158.64 74.73 Favored Pre-proline 0 N--CA 1.475 0.81 0 O-C-N 121.248 -0.907 . . . . 25.0 110.707 -178.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -71.14 -21.98 26.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 116.69 -1.74 . . . . 25.0 113.995 -179.699 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.88 -16.14 59.49 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 124.297 0.998 . . . . 25.0 109.491 -179.732 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -98.0 150.64 21.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 122.121 0.962 . . . . 25.0 110.28 -168.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.04 133.86 42.7 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.595 -0.691 . . . . 25.0 112.039 178.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.66 104.18 15.82 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.363 -0.606 . . . . 25.0 109.363 179.217 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.447 ' CE2' HG13 ' A' ' 57' ' ' VAL . 52.5 p90 -134.46 162.57 31.86 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.888 -0.782 . . . . 25.0 108.888 -178.709 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -126.84 162.47 25.82 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.946 -0.761 . . . . 25.0 108.946 -179.169 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.494 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 19.8 ptpt -56.01 139.86 45.27 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.682 -1.229 . . . . 25.0 107.682 178.233 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.11 -14.2 59.62 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 115.611 1.005 . . . . 25.0 115.611 177.943 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.69 163.85 27.44 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.268 -1.012 . . . . 25.0 108.268 176.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.5 mm -124.17 131.12 73.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -178.705 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 6.7 ptp -130.85 155.49 46.63 Favored 'General case' 0 C--O 1.251 1.158 0 O-C-N 121.627 -0.671 . . . . 25.0 111.604 176.268 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -90.65 135.92 33.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.761 -1.94 . . . . 25.0 105.761 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -96.68 126.69 49.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.148 -1.427 . . . . 25.0 107.148 176.743 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 mt -97.7 -42.85 7.43 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.298 -0.865 . . . . 25.0 110.961 -176.569 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -143.21 161.63 37.75 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.313 -1.366 . . . . 25.0 107.313 -178.555 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -128.16 144.38 51.11 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.843 -0.799 . . . . 25.0 108.843 173.241 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 59.03 43.15 18.04 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.427 -1.323 . . . . 25.0 107.427 -177.739 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -68.99 -15.11 63.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.722 1.749 . . . . 25.0 115.722 -172.335 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.79 16.63 13.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 122.409 1.1 . . . . 25.0 109.157 178.252 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.98 -21.91 7.4 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.31 -0.859 . . . . 25.0 112.052 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.96 119.15 12.14 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 118.905 -0.569 . . . . 25.0 109.819 176.361 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -56.34 132.64 51.51 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.711 0.767 . . . . 25.0 110.132 178.826 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.02 89.66 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 118.722 -1.043 . . . . 25.0 115.239 175.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -96.35 102.19 13.94 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.718 1.759 . . . . 25.0 110.804 179.155 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -91.71 140.35 29.8 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 115.549 -0.75 . . . . 25.0 111.917 -172.848 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.21 115.52 21.98 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.405 -1.702 . . . . 25.0 106.405 174.213 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.4 m -112.0 166.87 10.84 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 25.0 110.39 -179.702 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -135.5 125.82 26.51 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.767 -0.457 . . . . 25.0 109.767 173.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 tt -152.34 138.86 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.123 -0.944 . . . . 25.0 108.839 -174.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 53.82 38.51 28.76 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 113.557 0.947 . . . . 25.0 113.557 176.527 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.66 -0.51 85.74 Favored Glycine 0 C--O 1.217 -0.965 0 CA-C-O 118.467 -1.185 . . . . 25.0 115.765 175.773 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -126.07 164.53 20.68 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 118.849 1.324 . . . . 25.0 108.193 178.417 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -113.29 164.15 13.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.101 -1.444 . . . . 25.0 107.101 176.574 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.07 162.55 31.55 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.765 -0.934 . . . . 25.0 110.765 174.581 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 pt -79.38 142.32 14.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 175.698 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.447 HG13 ' CE2' ' A' ' 26' ' ' PHE . 82.6 t -139.64 133.65 15.79 Favored Pre-proline 0 C--N 1.311 -1.078 0 C-N-CA 123.407 0.683 . . . . 25.0 109.525 -175.363 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.2 114.79 3.17 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 116.471 -1.886 . . . . 25.0 112.161 175.937 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.66 -16.58 72.14 Favored Glycine 0 C--O 1.21 -1.352 0 C-N-CA 119.567 -1.301 . . . . 25.0 115.133 -173.552 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.8 -16.01 62.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.518 1.159 . . . . 25.0 111.722 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -94.65 8.48 42.24 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.594 -0.73 . . . . 25.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.08 157.06 29.75 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 122.118 0.961 . . . . 25.0 109.92 -177.047 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.05 122.31 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.346 -0.843 . . . . 25.0 108.758 174.382 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.7 mm -63.14 134.36 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -179.839 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.61 177.35 8.75 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.767 0.794 . . . . 25.0 110.093 179.79 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.8 t -56.01 134.81 19.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 108.064 -1.088 . . . . 25.0 108.064 174.154 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.21 -38.82 0.1 Allowed Glycine 0 C--O 1.217 -0.929 0 O-C-N 123.685 0.616 . . . . 25.0 112.104 -177.519 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -108.77 157.45 18.55 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.833 -1.173 . . . . 25.0 107.833 176.309 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -96.22 21.31 9.1 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 107.66 -1.237 . . . . 25.0 107.66 178.243 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.89 -167.81 0.18 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.869 -1.514 . . . . 25.0 112.134 -175.815 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -116.83 162.63 17.41 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.065 -1.022 . . . . 25.0 110.112 -176.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -60.7 146.44 86.11 Favored Pre-proline 0 C--O 1.248 1.006 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 177.058 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.32 171.54 17.89 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 120.417 0.745 . . . . 25.0 113.412 178.51 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.47 -42.83 2.53 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 115.731 -0.668 . . . . 25.0 111.376 179.686 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.14 152.95 27.88 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.298 -0.477 . . . . 25.0 113.036 -177.166 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -149.32 84.94 1.44 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -178.287 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.98 160.92 28.28 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -177.226 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.4 pt -135.97 157.24 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 174.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.2 p -154.54 145.59 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 -176.777 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 m 47.51 47.61 17.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.353 0.597 . . . . 25.0 112.325 -179.016 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t0 . . . . . 0 C--O 1.203 -1.392 0 C-N-CA 124.938 1.295 . . . . 25.0 113.059 -176.176 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.219 0 N-CA-C 116.837 1.495 . . . . 25.0 116.837 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.9 t -80.61 154.38 27.44 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 121.664 -0.903 . . . . 25.0 110.814 178.22 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 mtm -127.48 160.69 30.72 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 104.197 -2.52 . . . . 25.0 104.197 179.905 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -127.89 -44.46 1.47 Allowed 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 116.506 2.039 . . . . 25.0 116.506 -173.91 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.97 176.25 9.84 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 101.703 -3.443 . . . . 25.0 101.703 -174.342 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.2 mt -56.62 -43.69 80.46 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 -173.703 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.0 t30 53.12 42.33 32.18 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 113.521 0.934 . . . . 25.0 113.521 178.973 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -112.44 147.17 16.37 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.718 0 N-CA-C 105.188 -2.153 . . . . 25.0 105.188 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.65 155.38 46.68 Favored 'General case' 0 C--O 1.267 2.024 0 CA-C-N 119.611 1.096 . . . . 25.0 112.521 177.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.5 161.72 36.8 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.897 -1.047 . . . . 25.0 111.021 -170.166 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -110.68 132.27 54.34 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.378 0.671 . . . . 25.0 110.574 177.261 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.66 127.52 33.32 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.544 0.688 . . . . 25.0 110.247 178.126 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.0 mt -93.44 -23.91 18.23 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 -179.255 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -126.4 165.36 19.19 Favored 'General case' 0 C--O 1.202 -1.432 0 N-CA-C 109.866 -0.42 . . . . 25.0 109.866 178.162 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -100.77 160.85 14.02 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.725 0.81 . . . . 25.0 109.742 178.274 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -148.2 135.79 20.7 Favored 'General case' 0 C--O 1.212 -0.895 0 N-CA-C 113.158 0.799 . . . . 25.0 113.158 -177.731 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -94.89 119.81 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.158 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 168.159 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.68 116.93 12.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 -177.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.11 -21.28 29.35 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 122.714 1.245 . . . . 25.0 111.798 -178.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -133.44 154.13 80.75 Favored Pre-proline 0 C--O 1.215 -0.751 0 CA-C-N 115.477 -0.783 . . . . 25.0 109.948 -170.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.48 -21.54 60.13 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 N-CA-C 116.22 1.585 . . . . 25.0 116.22 -178.981 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.24 -19.89 45.8 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.058 0.932 . . . . 25.0 110.273 176.425 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -81.87 140.33 34.18 Favored 'General case' 0 C--O 1.195 -1.771 0 O-C-N 121.022 -1.049 . . . . 25.0 112.246 -176.344 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.02 135.99 33.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 123.566 1.65 . . . . 25.0 110.627 177.725 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.28 110.17 18.88 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.801 -1.545 . . . . 25.0 108.192 176.212 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 57' ' ' VAL . 53.8 p90 -135.87 166.39 23.41 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.405 0.621 . . . . 25.0 112.424 -176.282 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -128.4 152.79 47.79 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.594 -1.262 . . . . 25.0 107.594 -179.203 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -62.27 139.64 58.5 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.828 -1.175 . . . . 25.0 107.828 175.413 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -22.51 40.58 Favored Glycine 0 C--O 1.264 2.02 0 CA-C-O 117.843 -1.531 . . . . 25.0 110.284 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.19 166.17 23.06 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 119.468 1.634 . . . . 25.0 109.977 -176.616 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -121.71 132.24 71.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 114.781 -1.099 . . . . 25.0 110.253 -174.519 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 19.6 ptp -139.96 155.53 47.09 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 124.028 0.83 . . . . 25.0 112.071 -178.602 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 m -93.41 138.68 31.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 -179.406 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -103.02 119.22 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 106.787 -1.56 . . . . 25.0 106.787 177.744 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.9 mt -93.87 -41.04 9.84 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.341 -1.3 . . . . 25.0 111.555 -174.166 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -149.27 159.19 44.48 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 104.978 -2.23 . . . . 25.0 104.978 -177.479 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -130.73 149.11 52.53 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 101.496 -3.52 . . . . 25.0 101.496 178.795 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 t0 62.86 34.55 14.27 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.997 0.919 . . . . 25.0 108.583 -177.464 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -66.24 -20.63 66.17 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.363 1.616 . . . . 25.0 115.363 -177.387 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.92 -5.97 21.76 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.239 -0.891 . . . . 25.0 112.292 -177.391 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.9 -6.47 83.44 Favored Glycine 0 N--CA 1.464 0.52 0 CA-C-O 122.597 1.11 . . . . 25.0 111.48 -170.388 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.1 mt -94.14 118.69 31.91 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 106.912 -1.514 . . . . 25.0 106.912 177.584 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -56.83 126.68 28.04 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 106.997 -1.483 . . . . 25.0 106.997 171.831 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.0 64.37 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-O 116.634 -2.203 . . . . 25.0 115.302 178.25 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -104.52 125.81 51.03 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 120.772 2.286 . . . . 25.0 110.025 171.235 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -116.61 148.68 40.72 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.438 -1.319 . . . . 25.0 107.438 -176.054 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.3 tp -92.33 113.35 25.6 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.847 -1.538 . . . . 25.0 106.847 178.276 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.2 m -121.94 157.1 31.98 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.47 0.652 . . . . 25.0 110.121 -177.539 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -118.64 133.43 55.86 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.063 0.945 . . . . 25.0 110.097 173.279 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.2 138.93 19.75 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 124.625 1.203 . . . . 25.0 109.45 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.4 t60 57.86 29.35 17.4 Favored 'General case' 0 C--O 1.183 -2.428 0 O-C-N 124.218 0.949 . . . . 25.0 110.727 173.287 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.76 -2.24 74.76 Favored Glycine 0 N--CA 1.473 1.159 0 C-N-CA 118.922 -1.609 . . . . 25.0 113.443 -179.31 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -107.12 167.4 9.93 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.081 -1.822 . . . . 25.0 106.081 -179.919 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -141.34 144.5 34.59 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 103.493 -2.78 . . . . 25.0 103.493 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.59 -177.85 47.53 Favored Glycine 0 CA--C 1.545 1.96 0 O-C-N 125.394 1.684 . . . . 25.0 110.208 179.291 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.06 143.08 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 117.29 0.545 . . . . 25.0 111.042 -174.331 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 26' ' ' PHE . 79.3 t -139.08 136.21 18.03 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 -172.16 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.66 112.42 3.05 Favored 'Trans proline' 0 CA--C 1.556 1.585 0 CA-C-O 122.819 1.091 . . . . 25.0 111.828 172.594 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -26.26 63.42 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-N 115.407 -0.815 . . . . 25.0 115.038 -179.313 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -68.89 -15.3 63.46 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.678 0.739 . . . . 25.0 109.913 179.622 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -92.18 3.46 55.29 Favored 'General case' 0 C--O 1.252 1.236 0 C-N-CA 120.655 -0.418 . . . . 25.0 110.896 175.505 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -117.33 157.13 26.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 123.002 0.521 . . . . 25.0 111.127 -177.188 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -124.02 129.08 50.31 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 107.082 -1.451 . . . . 25.0 107.082 172.795 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.1 mm -67.18 127.84 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 104.484 -2.413 . . . . 25.0 104.484 -179.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -157.75 109.99 2.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.258 -1.016 . . . . 25.0 108.258 -178.581 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -71.42 165.71 2.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.919 0 CA-C-O 121.43 0.633 . . . . 25.0 111.329 177.902 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.44 81.16 0.03 OUTLIER Glycine 0 C--O 1.215 -1.074 0 CA-C-N 116.042 -0.527 . . . . 25.0 111.998 177.742 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.32 153.84 45.68 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.963 -0.384 . . . . 25.0 109.963 -178.928 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -122.26 -39.45 2.58 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 122.329 1.062 . . . . 25.0 112.775 -175.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.07 174.82 8.12 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.185 -1.37 . . . . 25.0 113.437 179.616 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -117.36 158.15 24.92 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 120.555 -1.34 . . . . 25.0 111.183 -173.661 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -84.1 149.54 56.13 Favored Pre-proline 0 C--O 1.258 1.533 0 CA-C-N 114.036 -1.438 . . . . 25.0 109.008 176.219 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.54 161.18 40.33 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 117.917 -0.922 . . . . 25.0 109.859 178.671 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.74 150.33 29.3 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.019 -2.585 . . . . 25.0 104.019 179.01 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.28 7.72 61.9 Favored Glycine 0 C--O 1.258 1.618 0 CA-C-O 117.912 -1.493 . . . . 25.0 112.38 179.223 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -110.27 144.29 39.2 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 118.76 1.28 . . . . 25.0 109.377 -178.28 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -155.16 123.89 6.09 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 174.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.1 tt -146.75 143.99 20.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 O-C-N 120.94 -1.1 . . . . 25.0 109.562 -174.147 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.97 146.55 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.329 -0.619 . . . . 25.0 109.329 179.8 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -131.53 139.7 49.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.519 -1.659 . . . . 25.0 106.519 177.821 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t0 . . . . . 0 N--CA 1.493 1.707 0 C-N-CA 125.794 1.638 . . . . 25.0 111.455 -175.11 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.531 5.02 0 CA-C-O 123.948 1.86 . . . . 25.0 116.176 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 m -60.99 142.0 56.9 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 127.048 2.139 . . . . 25.0 111.923 177.684 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.6 mtt -123.94 91.34 3.44 Favored 'General case' 0 C--O 1.193 -1.907 0 CA-C-O 121.748 0.785 . . . . 25.0 109.628 -179.478 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 57.53 40.32 27.11 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 113.869 1.063 . . . . 25.0 113.869 178.182 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.61 166.75 16.87 Favored 'General case' 0 C--O 1.267 1.981 0 CA-C-N 113.867 -1.515 . . . . 25.0 109.812 169.879 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.05 -48.12 79.31 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.275 1.213 . . . . 25.0 114.275 -175.671 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.4 t30 45.81 47.36 12.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.32 0.648 . . . . 25.0 112.258 -178.073 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m -108.97 165.35 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 105.751 -1.944 . . . . 25.0 105.751 165.673 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.32 156.2 45.24 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 115.507 -0.769 . . . . 25.0 109.518 -177.139 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.55 162.47 35.0 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 123.896 0.878 . . . . 25.0 110.894 -175.211 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -101.45 133.57 45.89 Favored 'General case' 0 C--O 1.206 -1.23 0 O-C-N 124.185 0.928 . . . . 25.0 108.631 172.246 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 130.5 39.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 105.616 -1.994 . . . . 25.0 105.616 174.731 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.32 -16.54 22.32 Favored 'General case' 0 C--O 1.264 1.82 0 O-C-N 121.439 -0.788 . . . . 25.0 110.44 -178.72 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -135.85 164.78 27.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.383 -1.339 . . . . 25.0 107.383 -178.847 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -100.5 161.01 13.88 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 109.036 -0.727 . . . . 25.0 109.036 -175.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -147.97 136.24 21.38 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 123.863 1.792 . . . . 25.0 111.922 178.731 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.85 122.38 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.8 -1.187 . . . . 25.0 108.719 169.72 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.27 115.41 22.45 Favored 'General case' 0 CA--C 1.565 1.558 0 O-C-N 124.041 0.838 . . . . 25.0 109.386 -177.657 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -102.54 -20.63 14.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.272 -0.876 . . . . 25.0 111.309 177.049 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 t -96.22 151.45 38.18 Favored Pre-proline 0 C--O 1.207 -1.14 0 CA-C-N 115.36 -0.836 . . . . 25.0 110.165 177.291 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.95 -19.66 13.74 Favored 'Trans proline' 0 C--O 1.205 -1.129 0 C-N-CA 117.184 -1.41 . . . . 25.0 113.241 -179.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -86.08 -20.57 28.55 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.122 1.439 . . . . 25.0 109.838 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -77.5 143.95 38.08 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.947 1.092 . . . . 25.0 113.947 178.151 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.86 137.51 32.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.94 1.352 . . . . 25.0 112.522 176.231 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.6 p -82.06 125.09 30.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.486 -1.233 . . . . 25.0 109.653 171.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -150.96 172.75 15.2 Favored 'General case' 0 C--O 1.191 -2.002 0 CA-C-O 121.588 0.709 . . . . 25.0 112.449 175.676 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -134.19 163.72 28.97 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.716 -1.587 . . . . 25.0 106.716 -178.436 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -63.98 141.0 58.93 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.292 -1.373 . . . . 25.0 107.292 174.836 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.59 -15.36 51.79 Favored Glycine 0 CA--C 1.494 -1.276 0 N-CA-C 117.302 1.681 . . . . 25.0 117.302 -177.01 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.5 156.81 34.78 Favored 'General case' 0 C--O 1.263 1.765 0 C-N-CA 120.522 -0.471 . . . . 25.0 110.652 173.648 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.96 130.02 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 107.553 -1.277 . . . . 25.0 107.553 -176.547 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.9 150.65 48.36 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 121.026 -1.046 . . . . 25.0 110.853 179.85 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 m -81.62 138.87 35.29 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.046 -0.979 . . . . 25.0 109.585 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.93 122.3 59.36 Favored 'Isoleucine or valine' 0 C--O 1.254 1.314 0 N-CA-C 105.759 -1.941 . . . . 25.0 105.759 178.274 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.52 -36.91 12.19 Favored 'General case' 0 N--CA 1.433 -1.317 0 O-C-N 124.329 1.018 . . . . 25.0 113.14 -177.709 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -155.79 149.08 24.68 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 -174.515 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -113.13 147.87 36.47 Favored 'General case' 0 C--O 1.197 -1.669 0 CA-C-O 117.086 -1.435 . . . . 25.0 107.677 -178.645 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 55.81 44.08 26.63 Favored 'General case' 0 C--O 1.202 -1.419 0 O-C-N 125.252 1.595 . . . . 25.0 109.104 179.104 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 t -72.38 -12.92 61.33 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 116.269 1.952 . . . . 25.0 116.269 -173.7 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -115.39 3.12 14.09 Favored 'General case' 0 C--O 1.256 1.439 0 CA-C-O 121.748 0.785 . . . . 25.0 109.693 -174.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.41 -15.77 59.25 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.05 -1.432 . . . . 25.0 109.925 -178.401 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -82.34 127.07 32.87 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 125.462 1.331 . . . . 25.0 111.111 176.336 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.06 129.05 38.27 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.849 1.309 . . . . 25.0 109.776 -177.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.63 10.16 73.7 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.61 1.004 . . . . 25.0 115.61 174.882 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -107.77 103.3 12.54 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 123.778 1.751 . . . . 25.0 113.019 171.346 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -97.86 152.98 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.729 -1.232 . . . . 25.0 110.744 -174.527 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.54 119.93 29.46 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.541 1.15 . . . . 25.0 108.004 174.144 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.2 m -122.09 162.58 20.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.347 -0.983 . . . . 25.0 108.347 -179.752 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.1 t -127.04 133.74 50.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.637 -1.245 . . . . 25.0 107.637 174.591 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.7 tp -154.89 136.69 14.46 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.752 1.283 . . . . 25.0 110.287 -178.839 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 59.39 31.76 21.32 Favored 'General case' 0 C--O 1.185 -2.305 0 CA-C-N 114.428 -1.26 . . . . 25.0 109.771 179.249 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.67 4.69 85.44 Favored Glycine 0 CA--C 1.545 1.937 0 C-N-CA 119.816 -1.183 . . . . 25.0 113.568 -179.775 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.7 mtp85 -117.66 140.11 50.1 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.746 1.773 . . . . 25.0 107.673 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -103.51 151.93 22.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.716 -1.587 . . . . 25.0 106.716 176.118 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.15 172.29 45.21 Favored Glycine 0 C--O 1.263 1.921 0 C-N-CA 118.714 -1.708 . . . . 25.0 113.9 175.051 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 pt -79.83 142.74 13.54 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 117.448 0.624 . . . . 25.0 109.922 -177.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.09 132.05 14.58 Favored Pre-proline 0 C--O 1.263 1.764 0 O-C-N 122.014 -0.429 . . . . 25.0 110.588 -174.27 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 125.89 11.69 Favored 'Trans proline' 0 C--O 1.208 -0.985 1 C-N-CA 111.387 -5.275 . . . . 25.0 111.464 178.791 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.06 -21.53 67.69 Favored Glycine 0 C--N 1.306 -1.09 0 CA-C-N 114.75 -1.114 . . . . 25.0 113.756 -171.922 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -74.98 -3.65 33.57 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 120.199 -1.765 . . . . 25.0 108.031 178.123 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -109.38 12.21 24.76 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.673 0.749 . . . . 25.0 110.222 176.473 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.8 mt -120.02 154.28 34.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 CA-C-O 122.344 1.069 . . . . 25.0 111.508 177.218 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -126.89 113.85 17.09 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.412 -0.813 . . . . 25.0 109.488 171.219 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.3 mm -54.77 136.38 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 O-C-N 124.787 1.305 . . . . 25.0 108.965 175.592 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -171.26 1.79 Allowed 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 124.107 0.879 . . . . 25.0 113.098 -177.912 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.4 m -58.17 162.53 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.419 0.628 . . . . 25.0 112.283 178.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.02 -33.29 2.62 Favored Glycine 0 C--O 1.265 2.076 0 N-CA-C 110.921 -0.872 . . . . 25.0 110.921 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -157.89 153.65 26.62 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.555 -1.276 . . . . 25.0 107.555 179.314 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -145.92 118.4 8.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 118.681 -0.676 . . . . 25.0 111.703 179.523 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -138.32 69.2 1.38 Allowed 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 107.063 -1.458 . . . . 25.0 107.063 -179.587 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -142.74 152.31 42.18 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.356 -1.465 . . . . 25.0 113.5 -179.452 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -77.6 144.73 70.04 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 106.003 -1.851 . . . . 25.0 106.003 179.038 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -69.46 149.35 68.68 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 117.156 -1.429 . . . . 25.0 112.548 178.273 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.05 147.69 32.73 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.301 -0.999 . . . . 25.0 108.301 -178.169 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.25 142.87 9.15 Favored Glycine 0 C--O 1.248 0.992 0 CA-C-O 119.14 -0.811 . . . . 25.0 111.73 -179.785 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -70.28 169.18 14.29 Favored 'General case' 0 C--O 1.199 -1.56 0 CA-C-O 121.46 0.648 . . . . 25.0 110.492 172.977 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -129.98 165.53 21.95 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 125.055 1.342 . . . . 25.0 110.586 179.859 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.4 pt -104.05 164.5 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 118.732 -0.651 . . . . 25.0 110.705 176.847 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.8 165.44 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 107.424 -1.325 . . . . 25.0 107.424 175.357 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.51 162.05 27.33 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 106.602 -1.629 . . . . 25.0 106.602 -173.227 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t0 . . . . . 0 N--CA 1.507 2.402 0 C-N-CA 125.133 1.373 . . . . 25.0 113.98 179.641 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.482 0 N-CA-C 118.323 2.089 . . . . 25.0 118.323 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.7 t -69.14 135.81 51.25 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.686 -0.891 . . . . 25.0 110.018 -179.079 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -72.93 154.65 40.46 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 116.084 1.883 . . . . 25.0 116.084 -173.225 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -93.68 -35.88 12.61 Favored 'General case' 0 C--O 1.202 -1.447 0 CA-C-N 111.941 -2.39 . . . . 25.0 112.503 -177.786 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -115.45 161.12 19.01 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.374 -1.713 . . . . 25.0 106.374 -177.755 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.44 -43.24 93.18 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 123.917 0.76 . . . . 25.0 111.379 -177.537 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.9 t30 50.87 37.64 17.79 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-N 114.356 -1.293 . . . . 25.0 113.662 174.598 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.0 p -109.34 160.48 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 103.49 -2.782 . . . . 25.0 103.49 175.299 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 159.03 28.67 Favored 'General case' 0 C--O 1.251 1.145 0 N-CA-C 107.064 -1.458 . . . . 25.0 107.064 -177.869 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.88 155.71 49.9 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 124.194 0.934 . . . . 25.0 109.597 -176.299 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -98.65 137.03 37.87 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 122.789 0.435 . . . . 25.0 110.86 169.207 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.9 130.6 36.8 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 112.209 0.448 . . . . 25.0 112.209 172.695 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.69 -22.1 17.77 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.091 -1.078 . . . . 25.0 108.091 -177.017 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -130.99 162.79 28.99 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 125.168 1.542 . . . . 25.0 111.869 178.42 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -103.53 161.83 13.55 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.781 -0.574 . . . . 25.0 109.782 -179.141 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -151.52 153.85 35.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.871 0.468 . . . . 25.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 81.1 t -116.87 123.55 71.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.551 -1.648 . . . . 25.0 106.551 167.302 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.35 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.128 -0.983 . . . . 25.0 113.227 -178.376 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -81.9 -15.4 54.06 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.983 -1.008 . . . . 25.0 110.72 176.387 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -134.25 151.67 76.81 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 108.685 -0.857 . . . . 25.0 108.685 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.62 -11.38 26.12 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 117.722 -1.052 . . . . 25.0 112.115 -178.332 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.91 -12.33 55.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.06 0.944 . . . . 25.0 110.531 175.287 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.6 149.49 22.72 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 116.233 -0.44 . . . . 25.0 111.554 -179.657 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.28 139.93 31.7 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 114.189 1.181 . . . . 25.0 114.189 177.071 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 m -85.1 80.44 9.25 Favored 'General case' 0 C--O 1.271 2.206 0 N-CA-C 109.062 -0.718 . . . . 25.0 109.062 169.381 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -86.7 157.75 19.58 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.578 -1.638 . . . . 25.0 106.578 178.683 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.66 146.51 50.53 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 107.063 -1.458 . . . . 25.0 107.063 -174.776 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -59.54 138.07 57.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.133 -0.627 . . . . 25.0 111.246 177.996 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.44 -16.74 47.68 Favored Glycine 0 C--O 1.255 1.437 0 CA-C-O 117.319 -1.823 . . . . 25.0 112.351 -178.203 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.75 163.68 26.58 Favored 'General case' 0 C--O 1.269 2.086 0 CA-C-N 119.06 1.43 . . . . 25.0 110.642 179.884 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.5 mm -122.41 128.01 75.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.005 -1.109 . . . . 25.0 108.005 -176.057 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptp -131.73 148.12 52.55 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.654 0.74 . . . . 25.0 112.329 177.257 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -81.27 131.24 35.28 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.265 -0.88 . . . . 25.0 110.976 175.545 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.25 128.59 45.44 Favored 'Isoleucine or valine' 0 C--O 1.273 2.29 0 N-CA-C 106.771 -1.566 . . . . 25.0 106.771 179.585 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.73 -38.52 7.04 Favored 'General case' 0 C--O 1.246 0.902 0 N-CA-C 113.442 0.904 . . . . 25.0 113.442 -173.856 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -151.12 147.79 27.49 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.359 -0.837 . . . . 25.0 109.613 -177.131 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -113.66 156.08 24.36 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.859 -1.163 . . . . 25.0 107.859 175.377 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t0 58.34 39.83 25.03 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 123.187 1.47 . . . . 25.0 109.163 -177.53 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -70.04 -20.11 63.26 Favored 'General case' 0 C--O 1.208 -1.083 0 O-C-N 121.185 -0.947 . . . . 25.0 113.554 -168.3 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -115.73 6.9 14.53 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-N 118.294 0.497 . . . . 25.0 111.851 -174.193 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.98 -18.21 32.6 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 109.757 -1.337 . . . . 25.0 109.757 -172.922 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.6 mt -83.97 117.77 23.59 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 105.535 -2.024 . . . . 25.0 105.535 178.072 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.94 144.12 56.98 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.999 -1.111 . . . . 25.0 107.999 -175.859 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.62 -4.58 81.58 Favored Glycine 0 N--CA 1.437 -1.266 0 O-C-N 121.062 -1.023 . . . . 25.0 114.971 179.798 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -97.39 116.42 29.57 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 118.328 1.064 . . . . 25.0 109.794 177.085 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -108.36 148.53 29.96 Favored 'General case' 0 CA--C 1.479 -1.75 0 CA-C-O 123.843 1.783 . . . . 25.0 108.914 -174.753 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -87.78 117.93 26.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.316 -1.311 . . . . 25.0 109.155 172.499 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -121.06 162.84 19.29 Favored 'General case' 0 C--O 1.214 -0.781 0 N-CA-C 112.527 0.566 . . . . 25.0 112.527 -179.756 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.4 t -121.78 131.24 53.96 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 118.522 -0.751 . . . . 25.0 110.179 175.519 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 tp -161.49 142.88 11.39 Favored 'General case' 0 C--O 1.181 -2.541 0 CA-C-O 118.121 -0.942 . . . . 25.0 110.487 -175.887 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.2 t60 54.18 29.76 11.06 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.917 1.081 . . . . 25.0 113.917 178.743 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.38 7.04 87.08 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 115.65 1.02 . . . . 25.0 115.65 175.571 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -123.94 164.89 18.39 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 107.458 -1.312 . . . . 25.0 107.458 175.214 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -124.97 150.75 46.33 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 105.264 -2.124 . . . . 25.0 105.264 166.548 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.0 175.0 47.51 Favored Glycine 0 C--O 1.283 3.157 0 N-CA-C 108.522 -1.831 . . . . 25.0 108.522 -178.54 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.2 pt -78.9 140.11 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 124.832 2.253 . . . . 25.0 112.066 -179.378 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.4 t -137.32 133.45 18.26 Favored Pre-proline 0 CA--C 1.573 1.836 0 CA-C-N 113.34 -1.755 . . . . 25.0 107.258 -178.722 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.58 118.9 5.95 Favored 'Trans proline' 0 CA--C 1.56 1.816 0 C-N-CA 114.217 -3.389 . . . . 25.0 113.068 172.631 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.65 -21.9 65.49 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 115.023 0.769 . . . . 25.0 115.023 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -56.57 -32.59 65.34 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.234 0.54 . . . . 25.0 111.417 173.179 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -92.06 5.14 51.35 Favored 'General case' 0 C--O 1.25 1.101 0 N-CA-C 113.838 1.051 . . . . 25.0 113.838 179.498 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.9 mt -110.0 155.98 21.09 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.454 1.121 . . . . 25.0 113.288 177.42 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -125.82 115.28 19.75 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.626 -0.879 . . . . 25.0 108.626 174.164 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm -61.14 126.17 18.63 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 CA-C-N 116.165 -0.47 . . . . 25.0 111.406 176.605 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.8 mt -78.74 90.83 4.64 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.642 -0.873 . . . . 25.0 108.642 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 m -81.22 161.61 3.72 Favored 'Isoleucine or valine' 0 C--O 1.255 1.391 0 N-CA-C 106.402 -1.703 . . . . 25.0 106.402 -178.937 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.7 -178.64 47.95 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 118.117 -1.38 . . . . 25.0 111.689 179.475 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.8 mtp -97.45 18.36 15.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.675 1.19 . . . . 25.0 111.989 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -81.94 122.38 27.7 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 120.989 -1.069 . . . . 25.0 112.83 -177.452 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -146.99 163.49 36.03 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.262 -1.384 . . . . 25.0 107.262 176.571 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 40.69 64.76 0.89 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.707 1.002 . . . . 25.0 113.707 -174.69 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.69 160.99 56.93 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-N 114.78 -1.1 . . . . 25.0 109.57 174.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.87 -23.77 40.87 Favored 'Trans proline' 0 C--N 1.357 0.974 0 N-CA-C 117.695 2.152 . . . . 25.0 117.695 -168.229 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 53.45 41.82 32.06 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.417 -0.802 . . . . 25.0 110.541 174.111 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.8 111.41 0.6 Allowed Glycine 0 N--CA 1.44 -1.084 0 O-C-N 125.505 1.753 . . . . 25.0 111.001 178.732 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -128.37 -163.69 1.3 Allowed 'General case' 0 C--O 1.208 -1.125 0 N-CA-C 106.196 -1.779 . . . . 25.0 106.196 175.725 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.9 t80 65.19 38.05 6.21 Favored 'General case' 0 C--O 1.25 1.098 0 C-N-CA 125.349 1.46 . . . . 25.0 113.445 173.351 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.0 pt -130.85 162.4 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.02 1.328 . . . . 25.0 107.576 178.607 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.0 t -77.33 129.84 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.117 0.484 . . . . 25.0 111.481 -179.701 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 p -74.53 -47.5 32.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.479 -0.782 . . . . 25.0 110.832 174.895 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 C--O 1.198 -1.643 0 CA-C-O 124.977 2.323 . . . . 25.0 113.562 -175.744 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.197 -2.184 0 CA-C-O 120.009 -0.328 . . . . 25.0 113.512 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m 57.5 29.83 17.7 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.579 1.696 . . . . 25.0 115.579 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 33.0 ttm -64.6 -16.33 62.53 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 124.544 2.116 . . . . 25.0 114.57 178.278 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -75.99 -8.97 58.19 Favored 'General case' 0 C--O 1.2 -1.505 0 CA-C-N 114.529 -1.214 . . . . 25.0 112.23 179.27 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -124.19 173.76 8.12 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.272 -1.381 . . . . 25.0 107.272 172.722 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.4 mt -64.86 -39.63 93.86 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 109.27 -0.641 . . . . 25.0 109.27 -177.774 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 59.01 36.86 24.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 125.041 1.463 . . . . 25.0 111.041 177.624 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t -104.87 146.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 177.252 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 153.4 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 119.304 0.957 . . . . 25.0 111.395 -179.299 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.3 162.34 33.81 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 116.115 -0.493 . . . . 25.0 109.929 -172.92 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -110.65 140.8 44.66 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 104.797 -2.297 . . . . 25.0 104.797 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.87 124.98 28.77 Favored 'General case' 0 C--O 1.2 -1.509 0 O-C-N 125.275 1.609 . . . . 25.0 111.09 176.836 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -92.94 -18.83 22.27 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.665 -0.698 . . . . 25.0 110.241 -176.542 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -134.79 163.73 29.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 106.147 -1.798 . . . . 25.0 106.147 178.883 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -93.47 168.69 10.88 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 119.625 -0.83 . . . . 25.0 110.078 177.809 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -150.29 144.69 25.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.527 0.936 . . . . 25.0 113.527 -179.865 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.0 t -116.38 103.78 15.65 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.004 0 N-CA-C 104.082 -2.562 . . . . 25.0 104.082 176.034 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.91 127.38 32.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.076 -1.42 . . . . 25.0 111.268 -178.279 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.48 -19.96 15.31 Favored 'General case' 0 C--O 1.262 1.759 0 CA-C-O 121.104 0.478 . . . . 25.0 109.715 -176.877 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -107.95 153.49 41.64 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 121.838 -0.539 . . . . 25.0 110.922 -176.467 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.06 -14.66 23.51 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 N-CA-C 113.92 0.7 . . . . 25.0 113.92 178.262 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -85.88 -10.64 54.96 Favored 'General case' 0 C--O 1.209 -1.036 0 O-C-N 124.895 1.372 . . . . 25.0 109.569 176.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.41 144.1 30.63 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-O 121.987 0.899 . . . . 25.0 111.137 -174.2 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 mt -92.12 130.61 37.8 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 120.197 -1.564 . . . . 25.0 111.352 179.548 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 t -78.18 132.29 37.55 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 167.726 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -157.83 166.79 31.78 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.436 -1.69 . . . . 25.0 106.436 176.343 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -133.65 163.99 28.2 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.602 1.191 . . . . 25.0 109.212 -179.761 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -60.28 132.72 54.79 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 114.683 -1.144 . . . . 25.0 109.952 -176.622 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.46 -5.86 84.23 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 118.286 -1.285 . . . . 25.0 115.863 -171.383 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.56 155.42 28.18 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 120.003 1.901 . . . . 25.0 110.501 175.436 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.05 122.54 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 123.536 0.523 . . . . 25.0 109.899 -176.491 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 7.2 ptp -130.69 156.5 44.82 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -175.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -93.99 125.82 38.84 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.264 0.626 . . . . 25.0 111.716 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.67 121.21 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.362 -1.347 . . . . 25.0 107.362 177.532 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.3 -40.33 11.55 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.768 -0.651 . . . . 25.0 110.51 178.82 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -154.42 168.14 27.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.606 0.763 . . . . 25.0 110.051 178.867 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -122.2 155.13 36.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.923 -1.51 . . . . 25.0 106.923 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 56.13 38.36 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 125.506 1.753 . . . . 25.0 111.454 177.5 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 t -66.36 -15.67 63.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.693 2.108 . . . . 25.0 116.693 -167.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -116.63 13.11 15.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 108.321 -0.992 . . . . 25.0 108.321 -178.999 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.34 -2.22 78.08 Favored Glycine 0 C--O 1.203 -1.785 0 CA-C-O 122.706 1.17 . . . . 25.0 111.025 -177.016 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.28 116.51 21.83 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.762 -1.199 . . . . 25.0 107.762 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -65.2 115.34 5.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.306 -0.861 . . . . 25.0 108.758 176.218 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.23 0.97 47.76 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 117.554 -1.692 . . . . 25.0 115.287 178.322 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -109.45 117.95 35.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 120.452 2.126 . . . . 25.0 110.586 175.594 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -105.82 154.51 20.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.387 -1.279 . . . . 25.0 108.178 -170.8 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.5 tp -93.99 119.54 33.01 Favored 'General case' 0 C--O 1.268 2.048 0 N-CA-C 106.636 -1.616 . . . . 25.0 106.636 177.032 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.4 m -118.01 163.25 16.87 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 119.554 -0.859 . . . . 25.0 110.392 178.398 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.5 t -118.85 129.04 55.0 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 124.076 0.86 . . . . 25.0 112.166 173.673 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.6 tp -157.55 142.22 16.54 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-N 114.056 -1.429 . . . . 25.0 109.033 -176.225 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.4 t60 56.71 27.31 12.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.176 0.436 . . . . 25.0 112.176 -178.37 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.71 -3.41 74.84 Favored Glycine 0 C--O 1.246 0.856 0 CA-C-O 116.54 -2.255 . . . . 25.0 115.018 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -113.48 160.35 18.56 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.5 1.15 . . . . 25.0 108.267 -178.128 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -109.82 149.25 30.11 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.322 -2.103 . . . . 25.0 105.322 175.922 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.22 163.33 36.78 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.883 -1.287 . . . . 25.0 109.883 177.471 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.5 pt -82.64 141.54 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 122.419 1.104 . . . . 25.0 108.812 -179.174 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.75 137.69 20.36 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.189 -2.152 . . . . 25.0 105.189 -175.334 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -72.69 122.49 8.26 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 113.723 -3.718 . . . . 25.0 115.384 175.391 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.61 -19.95 78.19 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.509 -1.223 . . . . 25.0 113.918 -177.419 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -70.45 -8.95 54.95 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 118.716 -1.194 . . . . 25.0 112.215 172.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -108.93 4.37 23.3 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.589 0.709 . . . . 25.0 109.857 -179.601 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.3 mt -111.85 146.35 37.85 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-O 123.069 1.414 . . . . 25.0 112.186 179.919 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -114.65 116.92 29.49 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.525 -1.216 . . . . 25.0 111.089 170.649 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mm -59.62 128.27 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 178.727 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.1 173.56 7.78 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 -172.037 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.0 t 67.7 136.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.187 -2.218 0 O-C-N 124.86 1.35 . . . . 25.0 112.555 -176.142 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.62 -152.75 7.49 Favored Glycine 0 C--O 1.21 -1.359 0 N-CA-C 115.446 0.938 . . . . 25.0 115.446 -178.993 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.1 mmt -68.45 -35.48 77.65 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.576 -0.85 . . . . 25.0 110.103 -176.363 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -77.69 120.51 22.72 Favored 'General case' 0 C--O 1.26 1.638 0 N-CA-C 107.324 -1.361 . . . . 25.0 107.324 179.888 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -77.51 99.49 5.7 Favored 'General case' 0 C--O 1.199 -1.563 0 CA-C-N 114.677 -1.147 . . . . 25.0 110.243 -174.551 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt 68.27 115.6 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.693 1.197 . . . . 25.0 112.816 177.786 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -58.99 146.09 78.11 Favored Pre-proline 0 CA--C 1.558 1.274 0 O-C-N 121.327 -0.858 . . . . 25.0 109.854 177.088 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.08 86.41 1.43 Allowed 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.474 2.116 . . . . 25.0 112.588 176.59 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.49 159.28 44.21 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.706 -1.961 . . . . 25.0 105.706 176.59 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.45 131.4 3.26 Favored Glycine 0 C--N 1.338 0.68 0 O-C-N 122.093 -0.379 . . . . 25.0 113.672 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -79.64 132.99 36.39 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.246 -0.65 . . . . 25.0 109.246 -174.471 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -81.42 59.96 4.26 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.121 0.568 . . . . 25.0 109.987 -179.641 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.1 pt -64.42 150.79 9.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.779 -0.646 . . . . 25.0 109.336 174.627 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.8 m -140.3 164.02 22.78 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.268 0 CA-C-O 122.906 1.336 . . . . 25.0 108.442 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.64 18.32 9.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.548 -0.751 . . . . 25.0 109.474 175.481 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 . . . . . 0 C--N 1.311 -1.105 0 CA-C-O 124.091 1.9 . . . . 25.0 112.242 -179.074 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.194 -2.384 0 CA-C-O 121.47 0.483 . . . . 25.0 113.905 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m 51.65 50.48 18.66 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.364 0.875 . . . . 25.0 113.364 175.656 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 ttp -113.83 41.19 2.27 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.859 0.688 . . . . 25.0 112.859 -176.378 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -135.88 112.92 10.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.042 0.925 . . . . 25.0 111.64 178.396 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -143.22 177.08 8.65 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 102.752 -3.055 . . . . 25.0 102.752 174.812 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.14 -40.96 91.63 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 114.639 1.348 . . . . 25.0 114.639 -173.387 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.4 t30 44.36 46.42 7.75 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.566 1.321 . . . . 25.0 114.566 -179.143 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -125.86 157.11 35.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 N-CA-C 103.596 -2.742 . . . . 25.0 103.596 -177.06 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.11 163.36 23.96 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.16 156.36 43.83 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 25.0 110.938 -177.533 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.14 137.36 37.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.217 -1.031 . . . . 25.0 108.217 174.629 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -73.82 135.04 43.44 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 172.63 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -94.24 -33.18 13.36 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 125.122 1.514 . . . . 25.0 112.103 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -121.57 162.2 21.02 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.553 -1.647 . . . . 25.0 106.553 -177.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.04 149.25 23.67 Favored 'General case' 0 C--O 1.253 1.247 0 O-C-N 121.896 -0.502 . . . . 25.0 110.806 177.423 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -145.42 122.47 11.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.144 0.974 . . . . 25.0 111.942 -172.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.3 t -84.21 132.1 32.35 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.066 0 N-CA-C 105.76 -1.941 . . . . 25.0 105.76 171.983 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.18 122.1 26.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.216 -0.994 . . . . 25.0 108.674 178.629 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.44 -12.15 18.79 Favored 'General case' 0 CA--C 1.501 -0.927 0 C-N-CA 123.504 0.722 . . . . 25.0 110.101 -178.858 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 m -127.78 152.68 77.43 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 -176.13 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.01 -15.19 23.5 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 114.866 -2.956 . . . . 25.0 112.672 -179.662 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.48 -15.06 57.66 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.578 -1.267 . . . . 25.0 107.578 -179.476 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -89.88 144.47 25.91 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.29 -0.868 . . . . 25.0 112.65 -173.387 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.96 128.81 37.94 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.836 -0.745 . . . . 25.0 110.607 177.52 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -73.31 131.21 41.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.834 -2.284 . . . . 25.0 104.834 171.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.75 167.46 30.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.089 0.471 . . . . 25.0 110.048 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -133.37 159.88 39.0 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 -178.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -63.0 139.62 58.79 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 107.593 -1.262 . . . . 25.0 107.593 -179.877 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.05 -12.3 68.53 Favored Glycine 0 CA--C 1.498 -0.974 0 CA-C-N 115.209 -0.905 . . . . 25.0 112.626 179.007 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -84.75 157.54 21.0 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.158 -0.682 . . . . 25.0 109.158 -179.489 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 mp -128.28 131.24 69.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 CA-C-O 122.03 0.919 . . . . 25.0 109.383 -176.419 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.13 144.37 50.65 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.661 -0.699 . . . . 25.0 111.287 -177.126 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.4 m -75.14 134.11 41.34 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.13 -1.063 . . . . 25.0 108.13 175.728 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.48 124.82 48.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.024 -1.102 . . . . 25.0 108.024 174.301 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.0 mt -96.54 -47.25 6.02 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 123.9 0.75 . . . . 25.0 112.13 -174.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.69 168.37 23.04 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 105.75 -1.944 . . . . 25.0 105.75 179.111 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -120.55 160.29 23.5 Favored 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 108.92 -0.771 . . . . 25.0 108.92 -179.261 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 51.32 42.51 29.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 123.496 1.617 . . . . 25.0 111.038 179.925 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -67.4 -21.87 65.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 115.305 1.594 . . . . 25.0 115.305 -168.18 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -109.08 8.14 25.98 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 120.398 -0.521 . . . . 25.0 111.019 178.732 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.17 -1.8 86.57 Favored Glycine 0 C--O 1.215 -1.04 0 CA-C-O 122.901 1.278 . . . . 25.0 110.257 -175.797 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.92 122.13 37.25 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.697 -1.594 . . . . 25.0 106.697 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.34 132.36 49.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.174 -1.417 . . . . 25.0 107.174 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.75 -12.85 61.08 Favored Glycine 0 CA--C 1.485 -1.797 0 O-C-N 121.722 -0.611 . . . . 25.0 114.348 174.29 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.462 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 92.8 m95 -97.43 110.26 22.85 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.16 -0.612 . . . . 25.0 111.7 177.769 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -101.81 145.39 29.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -174.709 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.09 121.8 28.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.363 -1.347 . . . . 25.0 107.363 173.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.3 m -123.94 164.65 18.88 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.4 -0.963 . . . . 25.0 108.4 178.541 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -124.27 128.06 48.59 Favored 'General case' 0 C--N 1.342 0.271 0 O-C-N 121.003 -1.061 . . . . 25.0 109.23 -178.227 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.7 tp -158.23 151.45 23.01 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 125.202 1.564 . . . . 25.0 110.548 -176.908 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 55.24 31.84 17.37 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 121.761 0.791 . . . . 25.0 110.545 -179.586 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.22 21.95 66.69 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 117.906 1.922 . . . . 25.0 117.906 -176.101 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -143.7 165.66 27.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.199 -1.778 . . . . 25.0 106.199 -177.912 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -117.72 161.03 20.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.7 -1.593 . . . . 25.0 106.7 -176.648 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.73 166.35 36.58 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.736 -0.745 . . . . 25.0 112.763 176.57 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 pt -73.71 144.08 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 122.788 1.28 . . . . 25.0 109.675 -179.283 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.8 t -142.84 134.32 12.91 Favored Pre-proline 0 C--O 1.217 -0.643 0 O-C-N 120.408 -1.433 . . . . 25.0 107.695 179.489 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD3' ' CZ3' ' A' ' 45' ' ' TRP . 79.1 Cg_endo -73.58 116.98 4.87 Favored 'Trans proline' 0 C--O 1.255 1.344 0 C-N-CA 115.87 -2.286 . . . . 25.0 113.038 176.86 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.05 -23.25 59.21 Favored Glycine 0 CA--C 1.482 -1.974 0 C-N-CA 120.666 -0.778 . . . . 25.0 114.711 -175.241 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -67.91 -4.9 14.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 120.606 -1.526 . . . . 25.0 112.527 179.395 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -114.94 11.97 16.69 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 122.842 0.457 . . . . 25.0 110.403 178.522 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 12' ' ' ALA . 92.4 mt -118.33 153.86 33.29 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.33 -0.85 . . . . 25.0 111.181 -179.293 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -121.1 127.17 51.37 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.502 -0.555 . . . . 25.0 109.502 169.815 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.6 mm -59.57 133.88 24.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-O 121.792 0.806 . . . . 25.0 110.686 179.058 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mp -126.64 159.83 32.47 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 124.767 1.227 . . . . 25.0 108.364 179.253 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.4 t 56.0 76.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.241 0.543 . . . . 25.0 111.758 179.837 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -165.82 73.59 0.16 Allowed Glycine 0 C--O 1.206 -1.648 0 C-N-CA 120.331 -0.938 . . . . 25.0 110.877 175.496 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 5.6 ttt 54.51 40.43 31.82 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.958 1.096 . . . . 25.0 113.958 -177.785 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -102.33 157.81 16.64 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.961 -1.018 . . . . 25.0 108.384 176.5 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -67.89 151.32 47.34 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.582 0.753 . . . . 25.0 110.469 -179.803 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -144.09 161.39 38.93 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 -178.242 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -70.72 153.05 95.09 Favored Pre-proline 0 N--CA 1.475 0.811 0 N-CA-C 102.038 -3.319 . . . . 25.0 102.038 175.272 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.45 114.93 4.09 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 114.02 -3.52 . . . . 25.0 112.493 -176.738 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.04 164.4 35.48 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.167 -1.42 . . . . 25.0 107.167 177.743 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.62 -130.5 5.66 Favored Glycine 0 C--O 1.241 0.591 0 N-CA-C 109.486 -1.446 . . . . 25.0 109.486 176.692 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.24 171.84 0.09 Allowed 'General case' 0 C--O 1.2 -1.504 0 N-CA-C 115.544 1.683 . . . . 25.0 115.544 178.172 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 52.52 39.79 28.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.149 0.976 . . . . 25.0 111.164 -178.598 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 tt -123.45 144.55 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.482 -0.932 . . . . 25.0 108.482 -176.176 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 m -65.37 152.6 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 108.782 -0.821 . . . . 25.0 108.782 -176.415 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.8 p -118.67 -39.33 3.0 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.426 0.899 . . . . 25.0 113.426 175.678 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 . . . . . 0 C--N 1.352 0.688 0 CA-C-O 125.996 2.807 . . . . 25.0 110.4 176.717 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.532 5.084 0 N-CA-C 114.94 0.736 . . . . 25.0 114.94 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 p -61.64 -37.21 83.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 120.816 -0.354 . . . . 25.0 110.502 -179.151 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 ptm -156.17 -47.27 0.08 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.399 0.619 . . . . 25.0 111.141 172.032 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 91.9 mttt 55.65 -162.26 0.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.385 1.074 . . . . 25.0 109.969 -175.194 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -139.04 174.25 10.7 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.162 -1.792 . . . . 25.0 106.162 -177.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.31 -46.44 86.13 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 121.869 0.842 . . . . 25.0 109.405 177.197 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.3 m120 53.54 32.78 14.88 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-O 122.685 1.231 . . . . 25.0 111.366 -178.239 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.45 147.1 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 101.686 -3.45 . . . . 25.0 101.686 179.168 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.49 163.53 28.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.235 -0.654 . . . . 25.0 109.235 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.14 153.63 38.01 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 122.025 -0.422 . . . . 25.0 109.962 -175.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -101.41 137.28 39.96 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 107.088 -1.449 . . . . 25.0 107.088 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.63 128.72 33.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 112.917 0.71 . . . . 25.0 112.917 179.157 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.4 mt -89.2 -18.2 27.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.918 0.887 . . . . 25.0 111.218 179.765 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.9 169.49 17.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.89 154.4 25.25 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.675 0.79 . . . . 25.0 111.523 179.089 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.5 162.56 40.68 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-O 122.118 0.961 . . . . 25.0 110.996 -174.018 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.42 129.21 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 103.081 -2.933 . . . . 25.0 103.081 173.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.43 126.54 30.91 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.286 -0.635 . . . . 25.0 109.286 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.47 -14.27 33.12 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.998 0.904 . . . . 25.0 111.178 176.385 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -131.03 155.25 81.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.079 -1.082 . . . . 25.0 108.079 -175.983 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.26 -10.23 20.72 Favored 'Trans proline' 0 C--O 1.205 -1.132 0 CA-C-N 119.967 1.024 . . . . 25.0 113.343 176.013 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -85.29 -4.6 59.21 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.503 -1.295 . . . . 25.0 107.503 178.661 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -118.24 149.37 41.23 Favored 'General case' 0 C--O 1.252 1.217 0 N-CA-C 105.464 -2.05 . . . . 25.0 105.464 -170.654 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -102.97 133.8 47.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.468 1.128 . . . . 25.0 113.579 -178.435 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.8 82.72 8.0 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 121.015 -1.053 . . . . 25.0 113.154 170.341 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -97.21 154.67 17.24 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.882 -1.508 . . . . 25.0 112.698 176.856 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -125.84 152.95 44.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.16 -1.793 . . . . 25.0 106.16 -178.376 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -59.19 135.0 57.5 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 120.303 -0.559 . . . . 25.0 111.455 -179.117 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.07 -14.84 62.42 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 115.43 -0.804 . . . . 25.0 114.231 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -73.39 158.86 34.22 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 121.735 -0.862 . . . . 25.0 112.563 173.359 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -117.46 133.61 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 O-C-N 124.363 1.039 . . . . 25.0 110.295 -178.912 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.7 ptp -140.84 147.98 39.83 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.36 1.076 . . . . 25.0 111.578 177.636 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 m -86.34 130.57 34.47 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.007 -1.451 . . . . 25.0 111.181 -177.764 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t -90.77 126.15 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 -179.736 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.8 mt -101.06 -35.99 9.15 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 124.255 0.972 . . . . 25.0 112.412 -178.644 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -147.53 145.48 29.11 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.836 -1.172 . . . . 25.0 107.836 177.688 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -112.48 151.01 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 104.003 -2.591 . . . . 25.0 104.003 173.843 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 59.61 42.16 17.67 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.952 0.882 . . . . 25.0 110.66 -175.533 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -70.71 -18.44 62.81 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 116.866 2.173 . . . . 25.0 116.866 -169.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.76 5.06 13.06 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.169 0.985 . . . . 25.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.69 -17.41 25.84 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.184 -0.916 . . . . 25.0 112.349 -168.978 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.4 126.61 28.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.632 -0.507 . . . . 25.0 109.632 172.254 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.0 124.04 19.72 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 122.666 1.222 . . . . 25.0 112.821 -179.852 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.59 79.0 Favored Glycine 0 CA--C 1.503 -0.716 0 N-CA-C 118.094 1.998 . . . . 25.0 118.094 176.903 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -104.82 119.14 38.29 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 118.912 1.356 . . . . 25.0 108.694 178.552 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -106.12 142.64 35.48 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.872 -0.604 . . . . 25.0 111.588 -169.404 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -82.31 120.67 25.69 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.431 -0.581 . . . . 25.0 109.431 171.226 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 m -126.17 160.72 29.45 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 112.837 0.68 . . . . 25.0 112.837 -179.217 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.0 t -120.2 135.35 55.01 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 123.731 0.644 . . . . 25.0 110.758 174.906 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.5 tp -150.58 137.04 18.79 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.927 -1.508 . . . . 25.0 106.927 178.073 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.5 m170 57.44 30.88 19.35 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.361 0.875 . . . . 25.0 113.361 179.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.84 9.43 79.33 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 117.22 1.648 . . . . 25.0 117.22 -175.461 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -110.03 158.99 17.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.81 -1.181 . . . . 25.0 107.81 177.53 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -123.73 142.76 50.78 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.632 -1.293 . . . . 25.0 108.059 171.887 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.94 161.36 35.05 Favored Glycine 0 CA--C 1.491 -1.43 0 O-C-N 124.294 0.996 . . . . 25.0 111.117 177.6 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.9 pt -77.53 149.74 5.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 122.539 1.161 . . . . 25.0 108.727 -176.08 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.2 t -145.66 134.91 11.3 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 107.172 -1.418 . . . . 25.0 107.172 -176.933 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.21 119.47 6.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 117.188 -1.408 . . . . 25.0 113.114 179.33 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.43 -24.1 63.34 Favored Glycine 0 C--O 1.198 -2.127 0 N-CA-C 117.249 1.66 . . . . 25.0 117.249 -177.463 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.06 -16.33 62.58 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 118.088 0.944 . . . . 25.0 109.623 178.553 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -94.42 9.53 37.98 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.15 0.976 . . . . 25.0 111.341 178.255 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.6 mt -124.86 147.63 48.68 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.603 -0.686 . . . . 25.0 111.006 -176.918 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -116.34 125.21 51.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.748 -1.114 . . . . 25.0 108.139 175.895 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.71 130.08 26.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 118.452 0.569 . . . . 25.0 110.973 177.375 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.0 tp -112.26 124.97 53.62 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.768 0.827 . . . . 25.0 109.496 179.354 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.3 t -117.65 124.95 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 CA-C-O 121.315 0.578 . . . . 25.0 110.506 -175.324 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.44 54.98 0.08 OUTLIER Glycine 0 C--O 1.198 -2.105 0 C-N-CA 119.186 -1.483 . . . . 25.0 111.901 -170.886 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.5 tpt -135.15 153.11 52.1 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-N 118.504 1.152 . . . . 25.0 109.391 -174.77 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.63 143.66 40.02 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.098 -1.445 . . . . 25.0 107.098 179.098 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.84 -37.77 79.36 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.855 0.687 . . . . 25.0 112.855 -176.965 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 40.73 55.11 3.04 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 113.382 0.882 . . . . 25.0 113.382 -179.016 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -68.3 138.27 91.72 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 174.989 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.35 146.5 80.85 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 117.235 -1.377 . . . . 25.0 113.738 -170.895 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.64 -6.82 57.9 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.386 -0.825 . . . . 25.0 109.953 176.69 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.49 -37.34 1.56 Allowed Glycine 0 C--O 1.21 -1.354 0 C-N-CA 121.332 -0.461 . . . . 25.0 113.533 176.6 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 54.09 31.87 14.63 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.562 0.345 . . . . 25.0 111.005 178.558 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -79.33 3.09 19.2 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.166 0.802 . . . . 25.0 113.166 -174.569 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -69.11 122.17 19.98 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 N-CA-C 106.735 -1.58 . . . . 25.0 106.735 -176.883 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t 52.22 77.83 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.301 0 O-C-N 126.258 2.224 . . . . 25.0 110.279 178.628 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.9 p -66.26 147.07 53.87 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.943 0.402 . . . . 25.0 111.96 178.132 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.447 -0.587 0 CA-C-O 127.034 3.302 . . . . 25.0 113.958 -174.001 . . . . . . . . 0 0 . 1 stop_ save_